data_2dgw_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2dgw _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 294' ' ' HIS . . . . . 0.563 ' CE1' ' HG3' ' A' ' 343' ' ' GLU . 28.5 m-70 . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.865 0.364 . . . . 0.0 110.866 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 63.0 m -139.66 142.35 36.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.142 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 296' ' ' VAL . . . . . 0.445 ' CG2' ' HB ' ' A' ' 338' ' ' VAL . 29.2 m -118.5 151.06 20.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.145 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 5.5 ttpm? -119.62 138.51 53.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.868 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 7.4 mp -126.36 128.47 47.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.927 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 27.2 ptt180 -131.93 163.39 28.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.839 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 90.99 28.23 16.14 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.527 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -98.22 148.45 34.52 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.545 0.688 . . . . 0.0 111.115 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -165.9 0.17 Allowed 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.702 2.268 . . . . 0.0 112.303 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -93.21 -13.97 27.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.863 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -102.68 27.6 6.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.935 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 305' ' ' VAL . . . . . . . . . . . . . 10.6 p -90.41 141.78 13.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.068 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 306' ' ' THR . . . . . . . . . . . . . 35.2 p -139.26 -179.05 5.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.137 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -55.26 -35.91 65.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.876 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 28.1 tttp -58.13 -59.37 5.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.881 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -46.1 -47.68 17.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.882 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 58.4 t -58.34 -44.94 89.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.098 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 311' ' ' MET . . . . . . . . . . . . . 4.0 mmt -58.49 -52.0 67.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.884 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -64.12 -29.27 70.41 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.86 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 313' ' ' PHE . . . . . 0.475 ' CD1' ' C ' ' A' ' 313' ' ' PHE . 3.1 t80 -75.49 -41.34 55.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.907 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 46.5 mt -81.65 -25.83 35.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.922 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 315' ' ' ALA . . . . . 0.47 ' HA ' ' N ' ' A' ' 317' ' ' LEU . . . -46.37 166.56 0.16 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.647 0.736 . . . . 0.0 111.084 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 316' ' ' PRO . . . . . 0.466 ' HA ' ' CB ' ' A' ' 315' ' ' ALA . 54.4 Cg_endo -69.68 -3.58 7.67 Favored 'Cis proline' 0 C--O 1.232 0.205 0 C-N-CA 122.66 -1.808 . . . . 0.0 112.386 -0.044 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 317' ' ' LEU . . . . . 0.47 ' N ' ' HA ' ' A' ' 315' ' ' ALA . 20.8 mt -53.19 156.32 2.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.908 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 9.6 tttp -130.83 102.71 16.12 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.593 0.711 . . . . 0.0 110.895 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 319' ' ' PRO . . . . . 0.547 ' HA ' ' CD2' ' A' ' 340' ' ' PHE . 53.5 Cg_endo -69.77 -179.07 2.66 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.691 2.261 . . . . 0.0 112.333 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 21.7 t -100.72 -39.25 6.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.112 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -156.15 129.92 8.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.086 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 322' ' ' ILE . . . . . . . . . . . . . 54.3 mt -105.78 99.79 9.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.124 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 18.6 mtp85 -94.0 118.62 31.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.874 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 51.7 mt -87.06 124.37 40.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.139 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . 0.467 HG23 ' CD2' ' A' ' 337' ' ' PHE . 53.7 t . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.152 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 335' ' ' TYR . . . . . 0.439 ' HB3' ' CG2' ' A' ' 325' ' ' VAL . 14.9 m-85 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.833 0.349 . . . . 0.0 110.914 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 67.5 mt -145.27 117.13 2.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.167 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . 0.467 ' CD2' HG23 ' A' ' 325' ' ' VAL . 71.5 m-85 -87.47 121.35 29.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.835 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . 0.445 ' HB ' ' CG2' ' A' ' 296' ' ' VAL . 46.4 t -124.43 132.06 71.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.138 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 43.4 m-20 -107.95 161.01 15.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.866 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 340' ' ' PHE . . . . . 0.547 ' CD2' ' HA ' ' A' ' 319' ' ' PRO . 62.1 m-85 -138.08 168.78 19.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.895 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 9.5 t -85.22 -62.2 1.59 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.829 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -99.51 150.0 22.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.902 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 343' ' ' GLU . . . . . 0.563 ' HG3' ' CE1' ' A' ' 294' ' ' HIS . 23.3 tt0 -54.72 -45.27 74.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.888 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -40.17 -64.19 0.53 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.871 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 345' ' ' GLU . . . . . 0.537 ' HB3' ' CD2' ' A' ' 340' ' ' PHE . 16.0 mm-40 -39.43 -46.17 1.62 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.875 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 65.9 t -67.38 -52.24 44.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.112 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 20.6 mtpp -50.73 -39.85 52.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.865 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -73.87 -30.07 62.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.931 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -56.68 -35.56 68.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.055 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 350' ' ' LEU . . . . . . . . . . . . . 83.7 mt -65.5 -35.77 81.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.963 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 76.4 mttt -45.92 -50.29 14.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.914 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 352' ' ' CYS . . . . . . . . . . . . . 31.7 m -69.06 72.23 0.26 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.92 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -107.68 158.94 16.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.902 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 70.0 mtt180 54.22 46.72 24.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.907 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 355' ' ' GLU . . . . . 0.478 ' C ' ' CD1' ' A' ' 356' ' ' TYR . 1.5 mm-40 -98.55 173.84 6.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.932 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 356' ' ' TYR . . . . . 0.478 ' CD1' ' C ' ' A' ' 355' ' ' GLU . 2.9 m-85 -139.22 115.98 10.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.958 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 357' ' ' MET . . . . . . . . . . . . . 3.6 ptt? -142.07 145.96 34.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.902 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 78.01 -46.81 2.74 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.487 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 359' ' ' GLY . . . . . 0.433 ' O ' ' CG ' ' A' ' 360' ' ' ARG . . . 141.74 34.89 0.1 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.477 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 360' ' ' ARG . . . . . 0.433 ' CG ' ' O ' ' A' ' 359' ' ' GLY . 56.8 mtt180 -164.3 156.04 16.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.793 0.33 . . . . 0.0 110.897 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 361' ' ' TYR . . . . . 0.519 ' O ' ' CD1' ' A' ' 361' ' ' TYR . 1.8 p90 -70.66 133.48 46.7 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.871 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 27.2 mm -111.98 143.75 21.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.128 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 363' ' ' GLU . . . . . 0.511 ' HB3' ' CZ ' ' A' ' 365' ' ' PHE . 21.1 mm-40 -130.96 113.18 13.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.904 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 21.6 t -88.68 141.85 13.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.129 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 365' ' ' PHE . . . . . 0.511 ' CZ ' ' HB3' ' A' ' 363' ' ' GLU . 56.7 m-85 -141.8 141.49 33.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.906 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 31.7 ttt180 -87.71 114.78 24.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.841 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.869 -179.956 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 294' ' ' HIS . . . . . 0.441 ' HB3' ' CG2' ' A' ' 346' ' ' VAL . 22.7 m-70 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.88 0.371 . . . . 0.0 110.876 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 6.3 m -134.0 133.85 41.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.121 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 36.0 m -112.05 148.64 15.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.147 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 8.2 ttpm? -117.96 150.6 38.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.884 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . 0.557 HD23 ' CE2' ' A' ' 313' ' ' PHE . 7.0 mp -132.92 152.23 51.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.956 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 13.2 ptt180 -154.16 176.44 12.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.825 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 82.79 -21.36 7.79 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.555 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -58.2 151.78 45.19 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.637 0.732 . . . . 0.0 111.062 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.8 178.6 4.43 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.705 2.27 . . . . 0.0 112.313 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -85.17 -15.66 42.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.902 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 35.7 t-20 -99.24 35.75 1.87 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.904 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 305' ' ' VAL . . . . . . . . . . . . . 6.3 p -100.8 142.55 15.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.155 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 306' ' ' THR . . . . . . . . . . . . . 25.5 p -128.46 164.74 22.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.13 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -44.35 -50.25 9.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.881 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -43.53 -52.12 6.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.865 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -56.13 -43.87 78.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.889 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 92.2 t -61.98 -39.06 82.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.153 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 311' ' ' MET . . . . . . . . . . . . . 4.1 mmt -63.67 -44.17 94.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.858 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -67.96 -29.06 68.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.907 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 313' ' ' PHE . . . . . 0.557 ' CE2' HD23 ' A' ' 298' ' ' LEU . 36.6 t80 -72.64 -47.06 50.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.9 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . 0.433 ' CD1' HG13 ' A' ' 338' ' ' VAL . 49.4 mt -79.04 -18.27 53.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.904 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 315' ' ' ALA . . . . . 0.468 ' HA ' ' N ' ' A' ' 317' ' ' LEU . . . -51.25 166.78 0.31 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.613 0.72 . . . . 0.0 111.082 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 316' ' ' PRO . . . . . 0.465 ' HA ' ' CB ' ' A' ' 315' ' ' ALA . 54.0 Cg_endo -69.72 -3.81 7.87 Favored 'Cis proline' 0 C--O 1.232 0.204 0 C-N-CA 122.72 -1.783 . . . . 0.0 112.321 -0.004 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 317' ' ' LEU . . . . . 0.468 ' N ' ' HA ' ' A' ' 315' ' ' ALA . 19.4 mt -50.72 165.28 0.11 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.897 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 35.3 tttt -140.4 105.05 6.51 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.609 0.718 . . . . 0.0 110.889 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -177.61 1.94 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.684 2.256 . . . . 0.0 112.359 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 59.1 t -100.58 -41.41 8.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.145 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -158.2 134.57 9.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.079 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 322' ' ' ILE . . . . . . . . . . . . . 60.9 mt -105.6 101.56 12.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.121 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 20.5 mmt85 -96.29 96.79 9.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.847 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 74.6 mt -68.0 122.14 18.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.124 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 47.0 t . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.156 179.829 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 335' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.876 0.369 . . . . 0.0 110.866 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 55.3 mt -137.64 122.96 24.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.158 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -98.05 126.58 43.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.87 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . 0.433 HG13 ' CD1' ' A' ' 314' ' ' LEU . 99.1 t -124.0 131.01 73.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.132 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -105.55 160.41 15.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.879 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -137.94 166.0 25.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.887 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 2.1 m -90.64 -44.19 9.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.891 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -98.63 169.39 9.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.926 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 343' ' ' GLU . . . . . 0.43 ' HB3' ' CE1' ' A' ' 294' ' ' HIS . 2.2 mp0 -85.15 -55.48 4.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.882 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -43.32 -46.72 6.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.863 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 345' ' ' GLU . . . . . 0.405 ' CD ' HD23 ' A' ' 317' ' ' LEU . 5.7 mm-40 -50.05 -39.04 40.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.912 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . 0.441 ' CG2' ' HB3' ' A' ' 294' ' ' HIS . 46.3 t -70.35 -58.24 5.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.15 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 15.7 mtmt -50.03 -26.21 4.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.91 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 25.2 mm100 -82.54 -38.95 23.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.918 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -47.32 -30.93 3.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.131 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 350' ' ' LEU . . . . . . . . . . . . . 48.0 mt -63.78 -36.96 85.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.873 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -47.19 -44.2 21.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.92 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 352' ' ' CYS . . . . . . . . . . . . . 8.0 m -64.59 83.19 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.922 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . 0.449 ' O ' ' CG ' ' A' ' 354' ' ' ARG . 48.8 t30 -140.43 177.91 7.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.868 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . 0.449 ' CG ' ' O ' ' A' ' 353' ' ' ASN . 7.9 ptp85 44.78 37.22 2.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.904 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 355' ' ' GLU . . . . . 0.423 ' C ' ' CD ' ' A' ' 355' ' ' GLU . 0.0 OUTLIER -125.69 172.63 9.63 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.904 -179.974 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 356' ' ' TYR . . . . . 0.414 ' CD1' ' N ' ' A' ' 356' ' ' TYR . 1.8 m-85 -118.94 146.61 44.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.911 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 357' ' ' MET . . . . . . . . . . . . . 3.2 ptt? -164.24 125.58 2.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.887 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 86.02 -31.75 3.95 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.449 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 359' ' ' GLY . . . . . 0.461 ' O ' ' CG ' ' A' ' 360' ' ' ARG . . . 126.91 30.6 0.8 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.509 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 360' ' ' ARG . . . . . 0.461 ' CG ' ' O ' ' A' ' 359' ' ' GLY . 59.8 mtt180 -164.76 164.59 21.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.743 0.306 . . . . 0.0 110.93 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 361' ' ' TYR . . . . . . . . . . . . . 27.3 p90 -67.05 159.34 28.93 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.891 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 12.5 mm -138.07 125.22 28.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.11 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 363' ' ' GLU . . . . . 0.421 ' HB3' ' CZ ' ' A' ' 365' ' ' PHE . 28.2 mm-40 -118.85 118.23 30.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.824 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 93.8 t -95.15 143.78 11.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.123 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 365' ' ' PHE . . . . . 0.421 ' CZ ' ' HB3' ' A' ' 363' ' ' GLU . 68.6 m-85 -141.97 148.95 39.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.863 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 35.7 ttp85 -96.98 112.18 24.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.884 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.881 -179.934 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 294' ' ' HIS . . . . . 0.412 ' HB3' ' CG2' ' A' ' 346' ' ' VAL . 3.8 m170 . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.864 0.364 . . . . 0.0 110.838 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 295' ' ' THR . . . . . 0.404 HG23 ' N ' ' A' ' 296' ' ' VAL . 12.1 m -125.64 142.43 51.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.147 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 296' ' ' VAL . . . . . 0.404 ' N ' HG23 ' A' ' 295' ' ' THR . 27.0 m -118.64 147.47 22.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.124 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -120.85 138.78 53.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.925 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 6.9 mp -119.57 141.9 48.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.926 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 299' ' ' ARG . . . . . 0.417 ' HB2' ' CE1' ' A' ' 335' ' ' TYR . 13.3 ptt180 -141.58 151.14 42.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.887 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 96.24 16.66 36.99 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.488 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -78.87 147.29 70.19 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.566 0.698 . . . . 0.0 111.105 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.69 169.79 18.0 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.698 2.265 . . . . 0.0 112.386 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 303' ' ' PHE . . . . . 0.458 ' O ' ' CG ' ' A' ' 303' ' ' PHE . 10.3 t80 -70.93 -8.93 56.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.858 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -111.51 41.42 1.89 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.923 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 305' ' ' VAL . . . . . . . . . . . . . 7.7 p -101.98 149.23 6.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.132 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 306' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -148.31 167.26 25.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.178 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -49.68 -20.41 0.81 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.921 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 9.9 ttmm -74.88 -53.32 9.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.852 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -51.67 -34.16 37.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.87 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 54.2 t -69.74 -46.01 75.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.146 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 311' ' ' MET . . . . . 0.416 ' HG2' ' CD1' ' A' ' 322' ' ' ILE . 4.1 mmt -53.37 -48.25 68.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.87 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -68.17 -25.5 65.28 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.929 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 313' ' ' PHE . . . . . 0.494 ' CD1' ' C ' ' A' ' 313' ' ' PHE . 2.6 t80 -75.58 -46.81 29.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.886 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 65.4 mt -78.01 -25.39 47.94 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.919 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 315' ' ' ALA . . . . . 0.467 ' HA ' ' N ' ' A' ' 317' ' ' LEU . . . -44.4 166.25 0.12 Allowed Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.585 0.707 . . . . 0.0 111.08 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 316' ' ' PRO . . . . . 0.451 ' C ' ' HA ' ' A' ' 315' ' ' ALA . 53.5 Cg_endo -69.72 -3.77 7.84 Favored 'Cis proline' 0 C--N 1.341 0.178 0 C-N-CA 122.664 -1.806 . . . . 0.0 112.361 0.03 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 317' ' ' LEU . . . . . 0.467 ' N ' ' HA ' ' A' ' 315' ' ' ALA . 27.7 mt -50.03 170.8 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.895 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 33.3 tttt -145.24 105.05 4.38 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.551 0.691 . . . . 0.0 110.923 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 319' ' ' PRO . . . . . 0.545 ' HA ' ' CD2' ' A' ' 340' ' ' PHE . 53.5 Cg_endo -69.79 -175.94 1.33 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.692 2.261 . . . . 0.0 112.33 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 320' ' ' VAL . . . . . 0.4 HG21 ' C ' ' A' ' 340' ' ' PHE . 31.1 t -101.12 -39.78 7.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.12 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -156.84 131.64 8.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.123 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 322' ' ' ILE . . . . . 0.416 ' CD1' ' HG2' ' A' ' 311' ' ' MET . 66.7 mt -110.23 108.74 26.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.131 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 27.7 mmm-85 -108.18 121.85 45.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.877 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 60.8 mt -89.71 120.59 38.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.131 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 20.6 t . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.107 179.863 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 335' ' ' TYR . . . . . 0.417 ' CE1' ' HB2' ' A' ' 299' ' ' ARG . 3.6 m-85 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.84 0.352 . . . . 0.0 110.938 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 43.5 mt -145.95 147.51 18.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.169 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -119.89 128.46 53.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.879 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 21.7 t -129.31 136.82 58.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.167 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -113.74 155.46 25.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.857 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 340' ' ' PHE . . . . . 0.545 ' CD2' ' HA ' ' A' ' 319' ' ' PRO . 53.5 m-85 -132.08 166.35 21.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.848 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 36.2 p -88.53 -58.12 2.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.896 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 67.3 m-80 -87.63 159.13 18.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.925 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -78.28 -23.54 47.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.902 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -67.64 -49.25 63.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.894 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -48.58 -50.3 33.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.848 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . 0.43 ' CG2' ' HB2' ' A' ' 340' ' ' PHE . 54.9 t -60.8 -56.01 20.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.143 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 24.9 mtpp -51.38 -32.62 26.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.877 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -83.27 -24.03 32.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.879 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -65.0 -26.25 68.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.075 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 350' ' ' LEU . . . . . . . . . . . . . 42.8 mt -75.34 -7.83 55.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.919 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 1.5 mmmp? -72.95 -32.61 65.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.915 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 352' ' ' CYS . . . . . . . . . . . . . 15.5 m -79.69 72.36 6.37 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.899 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -122.55 174.08 7.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.906 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 23.6 mtt180 53.22 28.42 7.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.847 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 355' ' ' GLU . . . . . 0.411 ' OE1' ' C ' ' A' ' 355' ' ' GLU . 0.0 OUTLIER -117.7 174.45 6.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.906 -179.951 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 356' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -124.8 128.14 48.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.925 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 357' ' ' MET . . . . . 0.422 ' HG3' ' CD1' ' A' ' 362' ' ' ILE . 0.0 OUTLIER -130.77 130.92 44.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.875 179.914 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 83.14 -41.7 2.93 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.462 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 359' ' ' GLY . . . . . 0.447 ' O ' ' CG ' ' A' ' 360' ' ' ARG . . . 141.92 33.27 0.12 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.468 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 360' ' ' ARG . . . . . 0.447 ' CG ' ' O ' ' A' ' 359' ' ' GLY . 71.5 mtt180 -165.19 161.64 19.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.794 0.331 . . . . 0.0 110.924 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 361' ' ' TYR . . . . . . . . . . . . . 13.6 p90 -63.74 144.27 57.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.976 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 362' ' ' ILE . . . . . 0.422 ' CD1' ' HG3' ' A' ' 357' ' ' MET . 6.5 mm -130.72 135.05 61.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.161 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 363' ' ' GLU . . . . . 0.493 ' HB2' ' CZ ' ' A' ' 365' ' ' PHE . 15.7 mt-10 -126.35 112.71 15.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.864 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 57.3 t -88.61 124.0 41.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.129 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 365' ' ' PHE . . . . . 0.493 ' CZ ' ' HB2' ' A' ' 363' ' ' GLU . 21.9 m-85 -121.66 142.74 49.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.856 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . 0.432 ' HB3' ' CZ ' ' A' ' 366' ' ' ARG . 9.8 ttp-105 -84.94 127.98 34.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.871 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.921 -179.934 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 294' ' ' HIS . . . . . 0.443 ' CE1' ' HG2' ' A' ' 343' ' ' GLU . 33.6 m80 . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.907 0.384 . . . . 0.0 110.9 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 26.5 m -139.42 139.65 37.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.161 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 296' ' ' VAL . . . . . 0.453 ' CG1' HG12 ' A' ' 346' ' ' VAL . 33.2 m -112.27 148.88 15.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.154 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . 0.538 ' HE3' ' CD1' ' A' ' 335' ' ' TYR . 56.4 tttt -122.55 131.19 53.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.931 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 7.9 mp -108.82 154.55 21.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.885 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 299' ' ' ARG . . . . . 0.482 ' HD2' ' CE1' ' A' ' 335' ' ' TYR . 13.0 ttt-85 -162.08 136.02 6.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.878 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 128.6 -18.19 5.74 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.487 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -65.64 151.42 94.69 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.547 0.689 . . . . 0.0 111.117 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -176.4 1.48 Allowed 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.679 2.253 . . . . 0.0 112.347 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 303' ' ' PHE . . . . . 0.484 ' C ' ' CD1' ' A' ' 303' ' ' PHE . 0.5 OUTLIER -76.43 -27.74 56.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.931 179.986 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 23.8 p-10 -92.81 43.76 1.13 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.893 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 305' ' ' VAL . . . . . . . . . . . . . 12.7 p -101.98 141.02 19.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.106 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 306' ' ' THR . . . . . . . . . . . . . 66.8 p -130.93 169.38 15.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.169 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -46.7 -45.91 19.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.903 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 20.9 ttmm -48.29 -57.07 6.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.919 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 25.4 m120 -48.45 -41.76 30.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.904 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 95.9 t -69.33 -42.01 81.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.109 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 311' ' ' MET . . . . . . . . . . . . . 3.6 mmt -58.41 -50.38 73.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.896 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -65.77 -24.83 67.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.883 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 313' ' ' PHE . . . . . 0.602 ' CD1' ' C ' ' A' ' 313' ' ' PHE . 0.5 OUTLIER -83.77 -28.68 28.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.888 -179.938 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 33.1 mt -90.9 -23.66 20.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.865 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 315' ' ' ALA . . . . . 0.46 ' HA ' ' C ' ' A' ' 316' ' ' PRO . . . -52.1 166.02 0.44 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.546 0.688 . . . . 0.0 111.136 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 316' ' ' PRO . . . . . 0.46 ' C ' ' HA ' ' A' ' 315' ' ' ALA . 53.6 Cg_endo -69.72 -7.6 9.98 Favored 'Cis proline' 0 C--O 1.231 0.161 0 C-N-CA 122.703 -1.791 . . . . 0.0 112.328 -0.031 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 317' ' ' LEU . . . . . . . . . . . . . 47.3 mt -56.04 144.35 29.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.883 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 14.3 tptp -120.42 110.73 35.51 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.563 0.696 . . . . 0.0 110.86 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 319' ' ' PRO . . . . . 0.545 ' HA ' ' CD1' ' A' ' 340' ' ' PHE . 53.7 Cg_endo -69.78 -163.83 0.12 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.694 2.262 . . . . 0.0 112.328 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 21.7 t -118.61 -41.25 2.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.131 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -151.69 124.13 8.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.075 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 322' ' ' ILE . . . . . . . . . . . . . 65.4 mt -98.86 102.39 13.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.141 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 9.2 tpt180 -86.1 116.04 24.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.82 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 72.5 mt -88.63 117.11 31.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.115 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 50.7 t . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.124 179.811 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 335' ' ' TYR . . . . . 0.538 ' CD1' ' HE3' ' A' ' 297' ' ' LYS . 7.0 m-85 . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.811 0.338 . . . . 0.0 110.995 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 336' ' ' ILE . . . . . 0.411 HG13 ' C ' ' A' ' 335' ' ' TYR . 85.4 mt -149.73 136.93 13.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.188 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . 0.58 ' CD1' ' OE2' ' A' ' 367' ' ' GLU . 55.5 m-85 -108.71 116.08 31.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.889 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . 0.407 ' HB ' ' CG2' ' A' ' 296' ' ' VAL . 87.0 t -112.62 127.67 69.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.117 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -105.36 139.19 40.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.854 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 340' ' ' PHE . . . . . 0.545 ' CD1' ' HA ' ' A' ' 319' ' ' PRO . 64.2 m-85 -117.22 157.86 25.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.887 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 2.4 m -79.11 -56.07 4.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.872 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 47.3 m-20 -91.93 158.3 16.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.871 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 343' ' ' GLU . . . . . 0.443 ' HG2' ' CE1' ' A' ' 294' ' ' HIS . 53.7 mt-10 -71.46 -44.84 64.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.892 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -47.91 -50.5 26.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.874 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -46.19 -45.65 16.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.91 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . 0.453 HG12 ' CG1' ' A' ' 296' ' ' VAL . 66.7 t -68.14 -52.08 41.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.118 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 25.1 mtpp -51.37 -38.44 53.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.903 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 70.4 mm-40 -78.13 -42.85 30.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.886 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -42.8 -42.4 3.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.054 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 350' ' ' LEU . . . . . . . . . . . . . 40.3 mt -58.85 -42.95 90.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.879 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 65.6 mmtt -42.89 -48.05 5.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.893 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 352' ' ' CYS . . . . . . . . . . . . . 19.9 m -69.11 72.68 0.28 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.883 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -112.55 156.01 23.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.923 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 7.6 ttt85 66.72 29.27 8.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.896 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 355' ' ' GLU . . . . . 0.424 ' HB2' ' CE2' ' A' ' 313' ' ' PHE . 4.4 mm-40 -83.87 173.4 11.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.861 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 356' ' ' TYR . . . . . 0.45 ' CD1' ' N ' ' A' ' 356' ' ' TYR . 1.3 m-85 -131.8 127.41 36.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.904 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 357' ' ' MET . . . . . . . . . . . . . 3.9 ptt? -154.74 142.32 19.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.859 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 78.45 -42.86 2.24 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.448 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 135.65 29.76 0.36 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.542 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 360' ' ' ARG . . . . . . . . . . . . . 61.3 mtt-85 -158.67 158.09 33.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.789 0.328 . . . . 0.0 110.929 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 361' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -66.88 157.17 33.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.941 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 9.1 mm -140.15 149.55 21.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.145 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 363' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -137.17 121.0 17.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.907 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 72.0 t -90.48 131.83 36.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.166 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -125.76 138.62 53.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.874 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 18.2 ttp180 -92.67 109.31 20.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.863 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 367' ' ' GLU . . . . . 0.58 ' OE2' ' CD1' ' A' ' 337' ' ' PHE . 20.1 mt-10 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.866 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 294' ' ' HIS . . . . . 0.499 ' CE1' ' HB3' ' A' ' 343' ' ' GLU . 33.4 m80 . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.818 0.342 . . . . 0.0 110.858 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 25.5 m -121.17 142.65 49.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.182 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 28.2 m -119.15 149.49 21.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.121 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . 0.531 ' HG3' ' CE1' ' A' ' 337' ' ' PHE . 16.8 ttmt -117.37 143.62 45.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.896 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . 0.496 HD23 ' CD2' ' A' ' 313' ' ' PHE . 7.1 mp -122.0 121.43 37.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.917 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 299' ' ' ARG . . . . . 0.618 ' NE ' ' CD2' ' A' ' 365' ' ' PHE . 25.4 mtt180 -122.36 162.01 22.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.896 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 95.12 -23.28 34.07 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.511 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -56.13 152.49 21.93 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.588 0.708 . . . . 0.0 111.11 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.71 -173.14 0.66 Allowed 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.701 2.267 . . . . 0.0 112.376 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -90.7 -26.03 19.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.891 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -95.34 44.44 1.09 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.886 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 305' ' ' VAL . . . . . . . . . . . . . 10.8 p -105.22 139.69 25.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.134 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 306' ' ' THR . . . . . . . . . . . . . 41.6 p -124.33 171.2 10.09 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.151 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -48.61 -54.14 15.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.862 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 21.5 ttmt -41.34 -48.81 3.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.91 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -56.95 -41.06 77.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.908 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 87.2 t -65.7 -51.23 64.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.093 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 311' ' ' MET . . . . . . . . . . . . . 3.2 mmt -51.58 -40.06 59.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.851 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -74.09 -30.81 62.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.885 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 313' ' ' PHE . . . . . 0.555 ' CZ ' HG22 ' A' ' 362' ' ' ILE . 27.2 t80 -73.24 -41.67 63.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.892 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 86.9 mt -80.95 -26.11 36.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.922 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 315' ' ' ALA . . . . . 0.491 ' HA ' ' C ' ' A' ' 316' ' ' PRO . . . -45.54 161.54 0.24 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.569 0.7 . . . . 0.0 111.097 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 316' ' ' PRO . . . . . 0.491 ' C ' ' HA ' ' A' ' 315' ' ' ALA . 53.9 Cg_endo -69.71 -13.76 12.32 Favored 'Cis proline' 0 C--O 1.232 0.219 0 C-N-CA 122.725 -1.781 . . . . 0.0 112.341 -0.04 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 317' ' ' LEU . . . . . . . . . . . . . 83.1 mt -43.09 135.13 3.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.916 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 4.9 tmtt? -111.71 100.54 48.65 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.574 0.702 . . . . 0.0 110.905 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 319' ' ' PRO . . . . . 0.569 ' HA ' ' CD2' ' A' ' 340' ' ' PHE . 53.9 Cg_endo -69.77 -175.39 1.14 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.644 2.23 . . . . 0.0 112.36 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 39.0 t -100.04 -43.63 11.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.102 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -157.3 144.19 18.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.138 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 322' ' ' ILE . . . . . . . . . . . . . 60.4 mt -116.15 103.41 15.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.112 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 55.2 mtt-85 -98.42 116.3 30.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.862 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 60.0 mt -85.87 124.89 40.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.114 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . 0.554 ' CG2' ' CD2' ' A' ' 337' ' ' PHE . 15.8 t . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.104 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 335' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.835 0.35 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 78.5 mt -146.9 149.11 16.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.145 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . 0.554 ' CD2' ' CG2' ' A' ' 325' ' ' VAL . 17.4 m-85 -121.38 122.02 38.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.902 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 38.1 t -121.21 126.02 74.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.114 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -104.14 157.29 17.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.884 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 340' ' ' PHE . . . . . 0.569 ' CD2' ' HA ' ' A' ' 319' ' ' PRO . 69.4 m-85 -134.52 167.96 19.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.881 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 30.8 t -87.65 -57.2 3.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.881 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -89.91 160.18 16.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.893 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 343' ' ' GLU . . . . . 0.499 ' HB3' ' CE1' ' A' ' 294' ' ' HIS . 10.5 pt-20 -78.05 -14.35 59.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.874 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -75.73 -44.51 41.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.906 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 345' ' ' GLU . . . . . 0.5 ' HB3' ' CD2' ' A' ' 340' ' ' PHE . 45.5 mt-10 -55.4 -40.17 71.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.883 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . 0.476 HG23 ' CD1' ' A' ' 340' ' ' PHE . 67.3 t -74.17 -41.28 51.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.158 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 33.5 mtpt -59.89 -29.54 68.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.882 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -88.16 -28.34 21.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.907 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -55.57 -35.72 66.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.082 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 350' ' ' LEU . . . . . . . . . . . . . 42.6 mt -67.41 -38.63 84.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.905 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 16.8 mmtp -56.63 -25.47 53.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.909 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 352' ' ' CYS . . . . . . . . . . . . . 40.4 t -78.44 57.9 2.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.86 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -110.57 170.64 7.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.906 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 13.4 mmt180 61.85 29.24 17.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.83 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 355' ' ' GLU . . . . . 0.516 ' C ' ' CD1' ' A' ' 356' ' ' TYR . 12.4 mm-40 -97.68 172.5 7.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.908 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 356' ' ' TYR . . . . . 0.516 ' CD1' ' C ' ' A' ' 355' ' ' GLU . 1.3 m-85 -138.44 122.87 18.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.931 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 357' ' ' MET . . . . . . . . . . . . . 1.7 ptt? -148.23 155.74 41.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.878 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 60.57 7.93 8.71 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.449 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 83.76 27.18 39.21 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.517 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 360' ' ' ARG . . . . . . . . . . . . . 15.1 mmm180 -147.68 177.43 9.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.8 0.333 . . . . 0.0 110.893 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 361' ' ' TYR . . . . . . . . . . . . . 29.2 p90 -92.39 149.3 21.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.891 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 362' ' ' ILE . . . . . 0.555 HG22 ' CZ ' ' A' ' 313' ' ' PHE . 14.5 mm -118.64 149.93 20.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.127 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 363' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -141.02 112.67 7.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.891 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 11.2 t -88.23 140.7 15.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.148 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 365' ' ' PHE . . . . . 0.618 ' CD2' ' NE ' ' A' ' 299' ' ' ARG . 72.4 m-85 -139.93 143.7 36.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.891 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 17.7 ttp85 -91.81 122.19 34.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.836 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 367' ' ' GLU . . . . . 0.411 ' OE1' ' N ' ' A' ' 297' ' ' LYS . 5.7 mp0 . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.829 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.9 0.381 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 54.5 m -121.41 150.1 42.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.141 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 296' ' ' VAL . . . . . 0.403 ' CG2' ' HB ' ' A' ' 338' ' ' VAL . 27.3 m -118.02 146.16 22.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.113 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . 0.553 ' HG3' ' CE1' ' A' ' 337' ' ' PHE . 16.3 ttmt -117.67 142.68 46.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.917 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . 0.518 HD22 ' CE2' ' A' ' 313' ' ' PHE . 7.9 mp -123.67 135.63 54.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.913 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 9.7 ttm-85 -144.76 132.94 21.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.877 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 129.18 -19.89 5.38 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.455 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -57.75 152.15 38.28 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.571 0.7 . . . . 0.0 111.1 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.72 177.38 5.61 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.711 2.274 . . . . 0.0 112.338 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -72.37 -24.11 61.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.9 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -98.71 47.78 0.98 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.891 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 305' ' ' VAL . . . . . . . . . . . . . 9.4 p -104.62 141.44 20.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.148 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 306' ' ' THR . . . . . . . . . . . . . 66.6 p -136.3 162.86 31.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.155 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -37.85 -46.74 0.97 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.923 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 36.4 tttm -45.5 -56.83 4.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.886 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 21.2 m120 -50.82 -49.11 59.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.905 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 86.9 t -58.0 -41.54 80.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.082 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 311' ' ' MET . . . . . . . . . . . . . 1.9 mmt -61.12 -53.08 61.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.86 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.64 -36.23 78.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.905 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 313' ' ' PHE . . . . . 0.518 ' CE2' HD22 ' A' ' 298' ' ' LEU . 15.4 t80 -70.67 -44.28 67.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.878 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . 0.472 ' CD1' HG11 ' A' ' 338' ' ' VAL . 32.9 mt -73.41 -25.59 60.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.934 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 315' ' ' ALA . . . . . 0.461 ' HA ' ' C ' ' A' ' 316' ' ' PRO . . . -51.25 165.4 0.4 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.579 0.704 . . . . 0.0 111.102 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 316' ' ' PRO . . . . . 0.461 ' C ' ' HA ' ' A' ' 315' ' ' ALA . 54.1 Cg_endo -69.75 -9.52 11.04 Favored 'Cis proline' 0 C--O 1.232 0.183 0 C-N-CA 122.673 -1.803 . . . . 0.0 112.367 -0.017 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 317' ' ' LEU . . . . . . . . . . . . . 33.8 mt -54.96 139.03 42.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.888 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.32 109.48 51.47 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.591 0.71 . . . . 0.0 110.904 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 319' ' ' PRO . . . . . 0.519 ' HA ' ' CD2' ' A' ' 340' ' ' PHE . 53.5 Cg_endo -69.78 -171.94 0.53 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.673 2.249 . . . . 0.0 112.329 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 80.2 t -104.51 -39.55 5.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.098 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -164.18 129.09 2.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.118 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 322' ' ' ILE . . . . . . . . . . . . . 50.8 mt -100.53 105.25 17.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.147 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 15.4 mmm180 -99.04 119.98 38.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.856 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 324' ' ' ILE . . . . . 0.43 ' O ' ' C ' ' A' ' 325' ' ' VAL . 64.0 mt -91.38 117.48 34.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.148 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . 0.43 ' C ' ' O ' ' A' ' 324' ' ' ILE . 22.4 t . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.115 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 335' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.881 0.372 . . . . 0.0 110.921 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 73.6 mt -147.4 129.3 6.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.126 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . 0.553 ' CE1' ' HG3' ' A' ' 297' ' ' LYS . 61.6 m-85 -104.25 127.52 51.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.893 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . 0.472 HG11 ' CD1' ' A' ' 314' ' ' LEU . 22.5 t -126.07 135.72 63.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.128 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -106.05 161.19 14.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.852 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 340' ' ' PHE . . . . . 0.55 ' CD2' ' HB3' ' A' ' 345' ' ' GLU . 41.6 m-85 -138.06 171.03 15.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.842 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 3.9 m -81.46 -64.35 1.2 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.855 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -95.42 166.04 12.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.863 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -76.11 -16.09 59.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.861 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -70.99 -50.8 30.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.892 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 345' ' ' GLU . . . . . 0.55 ' HB3' ' CD2' ' A' ' 340' ' ' PHE . 16.5 mm-40 -50.67 -41.03 55.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.904 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 95.0 t -68.1 -53.2 31.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.132 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp -52.31 -44.65 65.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.897 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -64.5 -40.56 95.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.919 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -42.52 -43.06 3.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.15 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 350' ' ' LEU . . . . . . . . . . . . . 21.4 mt -57.42 -36.77 71.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.9 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 1.5 mmmp? -44.73 -50.55 9.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.859 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 352' ' ' CYS . . . . . . . . . . . . . 3.5 m -73.97 80.33 1.68 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.871 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -121.63 149.61 42.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.898 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? 73.18 35.82 0.9 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.907 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 355' ' ' GLU . . . . . 0.431 ' C ' ' CD1' ' A' ' 356' ' ' TYR . 3.1 mm-40 -95.89 173.52 7.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.87 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 356' ' ' TYR . . . . . 0.488 ' CD1' ' N ' ' A' ' 356' ' ' TYR . 1.1 m-85 -134.55 124.22 25.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.93 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 357' ' ' MET . . . . . 0.427 ' HE2' ' CG ' ' A' ' 313' ' ' PHE . 2.4 ptt? -147.82 139.53 23.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.859 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 78.98 -14.37 14.44 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.455 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 113.25 6.08 22.49 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.461 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 360' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -134.03 168.49 18.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.785 0.326 . . . . 0.0 110.899 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 361' ' ' TYR . . . . . . . . . . . . . 8.4 p90 -84.59 157.31 21.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.878 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 10.7 mm -133.69 156.93 41.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.122 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 363' ' ' GLU . . . . . 0.438 ' HB3' ' CZ ' ' A' ' 365' ' ' PHE . 7.4 mm-40 -142.95 123.66 14.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.909 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 364' ' ' VAL . . . . . 0.497 ' O ' ' CD1' ' A' ' 365' ' ' PHE . 53.1 t -98.7 141.65 16.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.101 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 365' ' ' PHE . . . . . 0.497 ' CD1' ' O ' ' A' ' 364' ' ' VAL . 28.5 m-85 -144.37 137.04 26.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.854 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . 0.467 ' HB3' ' CZ ' ' A' ' 366' ' ' ARG . 9.4 ttp-105 -81.65 119.32 23.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.885 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.865 -179.885 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 294' ' ' HIS . . . . . 0.559 ' CE1' ' HB3' ' A' ' 343' ' ' GLU . 48.9 m80 . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.885 0.374 . . . . 0.0 110.895 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 28.1 m -129.28 144.89 51.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.121 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 27.8 m -117.19 147.93 20.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.135 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . 0.487 ' HG3' ' CE1' ' A' ' 337' ' ' PHE . 9.2 ttmm -116.01 135.58 53.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.901 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 6.4 mp -122.92 126.66 47.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.909 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 299' ' ' ARG . . . . . 0.547 ' NH1' ' CZ ' ' A' ' 335' ' ' TYR . 0.7 OUTLIER -127.01 167.96 15.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.873 179.945 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 76.82 38.32 31.59 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.477 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -104.64 152.31 39.41 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.568 0.699 . . . . 0.0 111.099 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 -172.79 0.62 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.669 2.246 . . . . 0.0 112.312 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -87.21 -31.18 20.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.88 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -87.42 39.98 0.9 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.907 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 305' ' ' VAL . . . . . . . . . . . . . 7.2 p -102.37 136.99 32.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.144 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 306' ' ' THR . . . . . . . . . . . . . 52.8 p -136.73 173.5 11.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.13 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -46.62 -30.8 2.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.881 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -69.18 -59.21 3.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.913 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -44.11 -34.4 1.79 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.909 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 22.0 t -74.6 -46.05 43.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.12 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 311' ' ' MET . . . . . . . . . . . . . 5.5 mmt -53.68 -44.45 69.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.892 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -67.47 -30.69 70.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.903 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 313' ' ' PHE . . . . . 0.527 ' CE2' HG22 ' A' ' 362' ' ' ILE . 2.4 t80 -74.68 -39.05 62.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.919 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 34.5 mt -81.01 -21.6 40.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.913 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 315' ' ' ALA . . . . . 0.467 ' CB ' ' HA ' ' A' ' 316' ' ' PRO . . . -51.93 166.57 0.38 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.561 0.696 . . . . 0.0 111.142 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 316' ' ' PRO . . . . . 0.467 ' HA ' ' CB ' ' A' ' 315' ' ' ALA . 53.9 Cg_endo -69.75 -8.49 10.51 Favored 'Cis proline' 0 C--O 1.232 0.194 0 C-N-CA 122.694 -1.794 . . . . 0.0 112.342 -0.005 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 317' ' ' LEU . . . . . . . . . . . . . 46.0 mt -48.09 165.72 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.943 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 6.7 tttp -140.31 104.96 6.56 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.59 0.71 . . . . 0.0 110.91 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 319' ' ' PRO . . . . . 0.475 ' HA ' ' CD2' ' A' ' 340' ' ' PHE . 53.1 Cg_endo -69.75 -168.64 0.28 Allowed 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.72 2.28 . . . . 0.0 112.345 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 25.6 t -111.23 -38.07 3.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.127 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -156.06 140.6 16.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.119 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 322' ' ' ILE . . . . . . . . . . . . . 53.1 mt -118.57 115.26 47.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.128 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -105.56 128.19 53.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.887 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 73.2 mt -94.06 136.89 24.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.089 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . 0.453 HG21 ' CE2' ' A' ' 337' ' ' PHE . 43.4 t . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.109 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 335' ' ' TYR . . . . . 0.547 ' CZ ' ' NH1' ' A' ' 299' ' ' ARG . 8.7 m-85 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.819 0.343 . . . . 0.0 110.959 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 96.9 mt -144.98 144.99 21.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.146 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . 0.487 ' CE1' ' HG3' ' A' ' 297' ' ' LYS . 68.7 m-85 -120.51 131.78 54.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.86 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 46.7 t -130.58 140.66 48.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.103 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -110.62 159.22 17.76 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.878 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 340' ' ' PHE . . . . . 0.475 ' CD2' ' HA ' ' A' ' 319' ' ' PRO . 71.3 m-85 -134.72 172.02 13.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.875 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 40.8 t -79.33 -66.36 0.88 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.874 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 342' ' ' ASN . . . . . 0.553 ' ND2' ' H ' ' A' ' 342' ' ' ASN . 0.0 OUTLIER -98.7 176.94 5.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.908 -179.992 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 343' ' ' GLU . . . . . 0.559 ' HB3' ' CE1' ' A' ' 294' ' ' HIS . 3.1 pm0 -84.81 -16.25 42.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.863 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -68.91 -33.36 73.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.86 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 345' ' ' GLU . . . . . 0.405 ' HB3' ' CD2' ' A' ' 340' ' ' PHE . 52.0 mt-10 -68.55 -51.01 47.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.834 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 87.1 t -58.63 -52.16 63.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.104 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 33.4 mtpt -46.95 -45.49 20.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.884 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 22.5 mm-40 -67.78 -33.5 74.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.9 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -55.19 -36.06 65.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.107 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 350' ' ' LEU . . . . . . . . . . . . . 69.2 mt -64.66 -42.58 95.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.898 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 58.1 mmtt -42.57 -48.55 5.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.858 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 352' ' ' CYS . . . . . . . . . . . . . 16.1 m -70.68 73.95 0.57 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.869 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -110.65 152.9 25.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.923 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 22.0 mtt85 61.78 37.6 15.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.893 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 355' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -92.47 174.17 7.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.865 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 356' ' ' TYR . . . . . 0.454 ' CD1' ' N ' ' A' ' 356' ' ' TYR . 1.4 m-85 -126.58 105.62 8.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.937 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 357' ' ' MET . . . . . 0.403 ' O ' ' CG ' ' A' ' 357' ' ' MET . 0.1 OUTLIER -127.37 118.82 24.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.914 179.923 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 90.09 -36.99 3.42 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.468 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 131.03 29.53 0.61 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.497 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 360' ' ' ARG . . . . . . . . . . . . . 47.0 mtt-85 -152.99 140.42 19.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.782 0.325 . . . . 0.0 110.878 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 361' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -54.1 129.95 36.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.962 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 362' ' ' ILE . . . . . 0.527 HG22 ' CE2' ' A' ' 313' ' ' PHE . 32.4 mm -109.14 146.12 15.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.113 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 363' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -138.26 112.14 8.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.87 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 58.8 t -86.56 136.15 23.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.148 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -131.82 129.73 40.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.909 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 18.8 ttt180 -78.46 115.98 18.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.897 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.89 -179.927 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 39.4 m-70 . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.877 0.37 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 38.9 m -137.45 139.35 40.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.18 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 14.4 m -118.64 153.92 20.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.137 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . 0.563 ' HE2' ' CE1' ' A' ' 337' ' ' PHE . 2.1 tppp? -112.38 145.94 39.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.875 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . 0.465 ' N ' ' HG3' ' A' ' 297' ' ' LYS . 6.9 mp -132.78 108.57 9.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.902 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 21.9 ptt180 -119.14 146.9 44.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.909 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 114.29 -9.13 22.58 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.447 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -68.48 151.51 97.18 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.572 0.701 . . . . 0.0 111.095 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.71 173.35 11.06 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.676 2.25 . . . . 0.0 112.317 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 303' ' ' PHE . . . . . 0.437 ' C ' ' CD1' ' A' ' 303' ' ' PHE . 6.1 t80 -74.07 -33.23 63.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.854 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 55.7 m-20 -90.44 48.51 1.56 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.861 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 305' ' ' VAL . . . . . . . . . . . . . 9.5 p -105.07 164.22 4.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.165 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 306' ' ' THR . . . . . 0.435 ' OG1' ' N ' ' A' ' 307' ' ' GLU . 0.0 OUTLIER -149.19 171.06 17.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.169 -179.968 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 307' ' ' GLU . . . . . 0.435 ' N ' ' OG1' ' A' ' 306' ' ' THR . 38.6 mt-10 -54.98 -23.38 18.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.914 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 53.6 tttp -70.74 -65.52 0.72 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.926 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -40.14 -37.88 0.68 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.876 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 46.9 t -65.64 -50.47 71.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.144 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 311' ' ' MET . . . . . . . . . . . . . 3.4 mmt -51.38 -39.24 56.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.875 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -66.53 -39.72 88.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.913 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -70.46 -46.24 64.19 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.836 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 29.9 mt -72.83 -26.16 61.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.956 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 315' ' ' ALA . . . . . 0.481 ' HA ' ' C ' ' A' ' 316' ' ' PRO . . . -48.49 162.89 0.33 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.616 0.722 . . . . 0.0 111.074 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 316' ' ' PRO . . . . . 0.481 ' C ' ' HA ' ' A' ' 315' ' ' ALA . 53.9 Cg_endo -69.74 -10.61 11.54 Favored 'Cis proline' 0 C--N 1.342 0.195 0 C-N-CA 122.693 -1.794 . . . . 0.0 112.383 -0.036 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 317' ' ' LEU . . . . . . . . . . . . . 33.9 mt -39.48 157.97 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.963 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 36.6 tttm -135.05 96.77 14.09 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.602 0.715 . . . . 0.0 110.877 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 319' ' ' PRO . . . . . 0.562 ' HA ' ' CD2' ' A' ' 340' ' ' PHE . 54.3 Cg_endo -69.76 -175.67 1.23 Allowed 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.666 2.244 . . . . 0.0 112.355 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 38.8 t -100.1 -43.62 11.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.112 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -155.74 141.07 17.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.083 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 322' ' ' ILE . . . . . . . . . . . . . 56.8 mt -117.13 100.72 10.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.123 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -100.22 105.06 16.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.89 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 83.5 mt -69.69 114.0 6.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.162 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 59.8 t . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.075 179.906 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 335' ' ' TYR . . . . . 0.412 ' C ' HG13 ' A' ' 336' ' ' ILE . 5.8 m-85 . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.838 0.351 . . . . 0.0 110.971 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 336' ' ' ILE . . . . . 0.412 HG13 ' C ' ' A' ' 335' ' ' TYR . 28.5 mt -144.54 143.27 23.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.109 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . 0.563 ' CE1' ' HE2' ' A' ' 297' ' ' LYS . 15.7 m-85 -108.32 120.99 43.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.875 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 39.3 t -121.03 124.27 71.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.124 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -103.58 159.12 15.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.851 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 340' ' ' PHE . . . . . 0.562 ' CD2' ' HA ' ' A' ' 319' ' ' PRO . 66.7 m-85 -134.93 160.57 37.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.877 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 17.7 t -83.41 -50.43 8.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.808 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 60.5 m-20 -98.32 159.8 14.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.909 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -74.53 -43.57 55.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.929 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -48.38 -41.37 28.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.863 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 345' ' ' GLU . . . . . 0.423 ' HB3' ' CD2' ' A' ' 340' ' ' PHE . 29.6 mt-10 -56.46 -47.17 79.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.885 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 48.8 t -57.64 -56.87 12.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.113 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.59 -38.19 20.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.929 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 17.9 mm100 -72.84 -37.69 67.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.946 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -52.54 -39.52 61.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.115 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 350' ' ' LEU . . . . . . . . . . . . . 81.4 mt -67.38 -25.13 65.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.958 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 6.5 mmpt? -60.73 -59.7 4.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.895 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 352' ' ' CYS . . . . . . . . . . . . . 69.5 m -65.71 74.05 0.07 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.886 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 55.9 p30 -118.16 168.58 10.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.877 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 19.7 mtt180 61.54 28.96 18.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.908 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 355' ' ' GLU . . . . . 0.42 ' C ' ' CD1' ' A' ' 356' ' ' TYR . 7.0 mm-40 -86.71 174.2 8.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.859 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 356' ' ' TYR . . . . . 0.51 ' CD1' ' N ' ' A' ' 356' ' ' TYR . 0.9 OUTLIER -133.92 99.7 4.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.893 -179.825 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 357' ' ' MET . . . . . . . . . . . . . 5.3 ptt? -126.61 141.93 51.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.936 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 79.22 -43.37 2.48 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.452 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 359' ' ' GLY . . . . . 0.472 ' O ' ' CG ' ' A' ' 360' ' ' ARG . . . 140.92 32.67 0.14 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.481 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 360' ' ' ARG . . . . . 0.472 ' CG ' ' O ' ' A' ' 359' ' ' GLY . 58.1 mtt-85 -164.85 158.15 17.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.802 0.334 . . . . 0.0 110.879 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 361' ' ' TYR . . . . . . . . . . . . . 27.0 p90 -71.83 144.1 49.23 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.908 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 31.2 mm -115.09 142.46 27.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.13 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 363' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -131.15 113.68 14.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.856 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 20.1 t -89.32 134.43 28.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.181 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -131.43 140.82 49.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.886 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 2.1 tmm_? -85.88 124.49 32.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.906 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 367' ' ' GLU . . . . . 0.412 ' OE1' ' CE1' ' A' ' 337' ' ' PHE . 16.3 mt-10 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.935 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 294' ' ' HIS . . . . . 0.562 ' CE1' ' HB3' ' A' ' 343' ' ' GLU . 34.6 m80 . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.833 0.349 . . . . 0.0 110.856 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 5.0 m -137.12 136.62 38.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.189 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 296' ' ' VAL . . . . . 0.468 ' CG1' HG12 ' A' ' 346' ' ' VAL . 26.8 m -118.13 146.79 22.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.162 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . 0.494 ' HG3' ' CE1' ' A' ' 337' ' ' PHE . 8.3 ttmm -114.2 141.85 47.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.87 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . 0.515 ' CD2' ' CE2' ' A' ' 313' ' ' PHE . 7.4 mp -123.0 149.93 43.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.915 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 64.0 mtt180 -143.91 165.41 27.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.906 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 87.71 -21.25 23.59 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.5 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -58.28 152.09 44.48 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.571 0.701 . . . . 0.0 111.13 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.8 179.25 3.85 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.667 2.244 . . . . 0.0 112.323 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -86.45 -38.09 17.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.864 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -85.4 46.28 1.28 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.929 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 305' ' ' VAL . . . . . . . . . . . . . 12.3 p -103.09 141.39 19.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.14 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 306' ' ' THR . . . . . . . . . . . . . 41.6 p -121.99 169.94 10.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.173 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 41.7 mp0 -50.3 -51.47 44.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.823 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 12.2 tttp -45.02 -45.13 10.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.89 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -61.02 -49.12 78.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.901 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 78.5 t -59.5 -48.58 86.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.14 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 311' ' ' MET . . . . . . . . . . . . . 4.4 mmt -51.08 -42.78 60.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.84 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -69.69 -25.56 63.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.93 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 313' ' ' PHE . . . . . 0.54 ' CZ ' ' CG2' ' A' ' 362' ' ' ILE . 37.1 t80 -76.26 -45.86 30.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.869 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 89.4 mt -79.24 -20.46 48.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.905 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 315' ' ' ALA . . . . . 0.484 ' HA ' ' C ' ' A' ' 316' ' ' PRO . . . -49.86 162.62 0.46 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.571 0.7 . . . . 0.0 111.095 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 316' ' ' PRO . . . . . 0.484 ' C ' ' HA ' ' A' ' 315' ' ' ALA . 53.2 Cg_endo -69.8 -8.51 10.62 Favored 'Cis proline' 0 C--O 1.232 0.198 0 C-N-CA 122.675 -1.802 . . . . 0.0 112.305 0.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 317' ' ' LEU . . . . . . . . . . . . . 17.5 mt -46.7 156.69 0.18 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.893 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 18.0 ttpt -133.44 105.51 12.07 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.604 0.716 . . . . 0.0 110.89 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -174.65 0.95 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.688 2.259 . . . . 0.0 112.345 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 320' ' ' VAL . . . . . 0.413 HG23 ' C ' ' A' ' 340' ' ' PHE . 21.8 t -108.08 -31.64 2.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.126 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -161.27 130.3 4.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.126 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 322' ' ' ILE . . . . . . . . . . . . . 68.2 mt -107.21 106.82 21.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.139 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 32.7 mmt180 -104.75 101.95 11.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.848 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 66.0 mt -74.68 131.99 34.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.136 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . 0.544 HG23 ' CE2' ' A' ' 337' ' ' PHE . 46.5 t . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.127 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 335' ' ' TYR . . . . . 0.41 ' C ' HG13 ' A' ' 336' ' ' ILE . 17.2 m-85 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.839 0.352 . . . . 0.0 110.93 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 336' ' ' ILE . . . . . 0.467 HG23 ' N ' ' A' ' 337' ' ' PHE . 84.7 mt -149.18 138.11 15.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.145 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . 0.544 ' CE2' HG23 ' A' ' 325' ' ' VAL . 30.9 m-85 -110.51 125.28 53.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.863 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . 0.466 ' HB ' ' CG2' ' A' ' 296' ' ' VAL . 24.2 t -125.5 143.02 40.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.12 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 339' ' ' ASP . . . . . 0.405 ' N ' HG11 ' A' ' 338' ' ' VAL . 4.5 m-20 -119.37 156.68 29.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.905 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 340' ' ' PHE . . . . . 0.511 ' CD2' ' HB3' ' A' ' 345' ' ' GLU . 57.0 m-85 -134.88 166.23 23.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.86 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 1.9 m -85.41 -55.41 4.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.86 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -99.6 162.86 12.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.877 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 343' ' ' GLU . . . . . 0.562 ' HB3' ' CE1' ' A' ' 294' ' ' HIS . 1.2 pm0 -81.13 -15.28 56.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.864 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -71.15 -34.13 70.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.884 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 345' ' ' GLU . . . . . 0.511 ' HB3' ' CD2' ' A' ' 340' ' ' PHE . 27.1 mt-10 -68.23 -44.84 74.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.932 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . 0.468 HG12 ' CG1' ' A' ' 296' ' ' VAL . 55.4 t -63.66 -47.22 92.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.155 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 32.0 mttm -49.53 -38.89 32.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.914 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 3.7 mm100 -71.88 -46.09 59.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.892 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -49.45 -36.44 22.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.12 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 350' ' ' LEU . . . . . . . . . . . . . 55.5 mt -66.62 -42.77 86.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.938 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 66.6 mttt -58.1 -38.39 76.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.878 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 352' ' ' CYS . . . . . 0.42 ' HB3' ' CD ' ' A' ' 355' ' ' GLU . 72.3 m -76.11 83.9 2.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.873 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -120.71 169.99 9.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.865 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 27.9 mmm180 53.85 39.18 30.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.896 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 355' ' ' GLU . . . . . 0.439 ' OE2' ' CE1' ' A' ' 313' ' ' PHE . 12.3 mt-10 -95.39 174.73 6.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.884 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 356' ' ' TYR . . . . . 0.418 ' CD1' ' N ' ' A' ' 356' ' ' TYR . 1.6 m-85 -122.88 105.38 9.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.928 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 357' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.31 123.69 30.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.904 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 85.13 -33.06 3.42 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.471 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 129.72 29.15 0.71 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.481 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 360' ' ' ARG . . . . . . . . . . . . . 36.6 mtt85 -162.32 145.38 11.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.836 0.35 . . . . 0.0 110.83 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 361' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -47.01 165.93 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.91 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 362' ' ' ILE . . . . . 0.54 ' CG2' ' CZ ' ' A' ' 313' ' ' PHE . 42.7 mm -139.93 145.79 25.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.136 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 363' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -134.63 115.71 14.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.842 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 50.6 t -96.61 142.81 13.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.092 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -144.07 126.75 16.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.868 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 8.1 ttp-105 -68.82 139.09 55.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.862 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.883 -179.941 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 25.3 m80 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.896 0.379 . . . . 0.0 110.851 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 50.1 m -132.69 151.73 51.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.127 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 296' ' ' VAL . . . . . 0.42 ' CG1' HG12 ' A' ' 346' ' ' VAL . 26.3 m -129.65 157.37 42.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.167 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . 0.416 ' HG3' ' CE1' ' A' ' 337' ' ' PHE . 4.5 ttpm? -125.89 152.4 45.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.899 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . 0.606 ' CD2' ' CE2' ' A' ' 313' ' ' PHE . 6.8 mp -126.35 131.3 51.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.844 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 34.1 ttp85 -136.44 127.78 28.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.872 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 125.41 -8.68 7.85 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.459 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -69.73 150.14 96.67 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.592 0.71 . . . . 0.0 111.092 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 174.32 9.7 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.669 2.246 . . . . 0.0 112.366 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 303' ' ' PHE . . . . . 0.489 ' C ' ' CD1' ' A' ' 303' ' ' PHE . 2.4 t80 -75.54 -27.07 58.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.876 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 25.6 p30 -92.86 46.38 1.23 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.891 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 305' ' ' VAL . . . . . . . . . . . . . 9.8 p -106.93 144.27 16.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.151 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 306' ' ' THR . . . . . . . . . . . . . 61.1 p -132.76 167.52 20.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.182 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -43.89 -52.59 6.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.9 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 36.7 tttt -41.25 -55.91 2.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.899 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -50.91 -48.83 60.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.908 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 61.9 t -57.87 -42.36 82.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.133 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 311' ' ' MET . . . . . 0.463 ' HG2' ' CD1' ' A' ' 322' ' ' ILE . 2.6 mmt -61.17 -52.69 63.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.833 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -65.5 -28.0 68.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.892 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 313' ' ' PHE . . . . . 0.606 ' CE2' ' CD2' ' A' ' 298' ' ' LEU . 14.9 t80 -71.11 -43.81 66.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.875 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 61.6 mt -80.86 -26.12 37.16 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.953 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 315' ' ' ALA . . . . . 0.491 ' HA ' ' C ' ' A' ' 316' ' ' PRO . . . -41.31 161.06 0.13 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.553 0.692 . . . . 0.0 111.108 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 316' ' ' PRO . . . . . 0.491 ' C ' ' HA ' ' A' ' 315' ' ' ALA . 53.5 Cg_endo -69.86 -9.43 11.21 Favored 'Cis proline' 0 C--O 1.232 0.183 0 C-N-CA 122.657 -1.81 . . . . 0.0 112.348 0.071 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 317' ' ' LEU . . . . . . . . . . . . . 73.0 mt -44.62 149.77 0.38 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.944 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 26.2 tttp -127.54 101.33 24.38 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.596 0.712 . . . . 0.0 110.964 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 319' ' ' PRO . . . . . 0.557 ' HA ' ' CD2' ' A' ' 340' ' ' PHE . 53.2 Cg_endo -69.76 -169.96 0.36 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.718 2.278 . . . . 0.0 112.301 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 53.0 t -110.27 -37.18 3.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.137 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -159.18 134.61 8.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.097 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 322' ' ' ILE . . . . . 0.463 ' CD1' ' HG2' ' A' ' 311' ' ' MET . 48.6 mt -110.52 100.52 10.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.106 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -96.03 108.3 20.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.89 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 95.9 mt -74.14 118.43 19.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.132 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . 0.423 ' HB ' ' CB ' ' A' ' 335' ' ' TYR . 25.5 t . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.131 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 335' ' ' TYR . . . . . 0.423 ' CB ' ' HB ' ' A' ' 325' ' ' VAL . 9.1 m-85 . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.843 0.354 . . . . 0.0 110.927 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 53.4 mt -138.0 124.94 27.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.12 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . 0.416 ' CE1' ' HG3' ' A' ' 297' ' ' LYS . 25.1 m-85 -99.29 122.3 42.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.864 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 44.1 t -119.7 134.34 63.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.102 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -109.88 164.74 12.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.859 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 340' ' ' PHE . . . . . 0.557 ' CD2' ' HA ' ' A' ' 319' ' ' PRO . 76.1 m-85 -143.37 170.95 14.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.854 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 3.0 p -96.32 -45.99 6.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.872 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -92.43 163.55 13.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.879 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 -87.62 -33.93 18.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.909 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -63.98 -41.05 97.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.901 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -56.34 -49.26 74.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.917 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . 0.42 HG12 ' CG1' ' A' ' 296' ' ' VAL . 71.9 t -58.77 -41.74 83.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.1 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 9.9 mtpm? -58.11 -43.25 87.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.892 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -65.53 -37.71 87.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.907 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -54.46 -17.17 2.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.141 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 350' ' ' LEU . . . . . . . . . . . . . 32.1 mt -92.33 -23.21 19.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.921 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.96 -7.81 9.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.866 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 352' ' ' CYS . . . . . . . . . . . . . 75.7 m -112.24 98.34 7.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.854 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . 0.487 ' O ' ' C ' ' A' ' 354' ' ' ARG . 6.9 p-10 -118.54 -179.64 3.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.907 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . 0.487 ' C ' ' O ' ' A' ' 353' ' ' ASN . 0.0 OUTLIER 31.44 38.25 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.843 179.969 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 355' ' ' GLU . . . . . 0.486 ' N ' ' O ' ' A' ' 353' ' ' ASN . 3.9 mm-40 -81.2 174.67 11.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.877 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 356' ' ' TYR . . . . . 0.494 ' CD1' ' N ' ' A' ' 356' ' ' TYR . 1.0 OUTLIER -134.05 110.28 9.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.929 -179.912 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 357' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.02 124.98 22.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.891 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 87.53 -37.28 3.24 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.515 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 133.92 29.78 0.45 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.495 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 360' ' ' ARG . . . . . . . . . . . . . 55.5 mtt180 -159.63 145.56 15.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.829 0.347 . . . . 0.0 110.884 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 361' ' ' TYR . . . . . . . . . . . . . 48.6 p90 -50.56 159.65 0.49 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.906 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 4.6 mm -143.35 129.15 16.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.137 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 363' ' ' GLU . . . . . 0.473 ' HB3' ' CZ ' ' A' ' 365' ' ' PHE . 6.5 mm-40 -119.3 112.21 19.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.895 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 38.4 t -88.03 131.83 34.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.104 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 365' ' ' PHE . . . . . 0.473 ' CZ ' ' HB3' ' A' ' 363' ' ' GLU . 25.7 m-85 -130.25 150.99 51.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.848 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 28.5 ttt180 -95.57 122.33 38.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.836 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.919 -179.964 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 294' ' ' HIS . . . . . 0.531 ' CE1' ' HB2' ' A' ' 343' ' ' GLU . 13.9 m-70 . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.847 0.356 . . . . 0.0 110.89 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 32.3 m -138.89 116.37 11.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.129 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 29.6 m -98.13 160.67 3.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.138 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . 0.562 ' HD3' ' CE1' ' A' ' 337' ' ' PHE . 31.3 ttpt -139.34 150.14 45.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.892 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . 0.566 HD22 ' CE1' ' A' ' 313' ' ' PHE . 6.8 mp -124.71 135.51 53.09 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.931 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 18.0 ttt-85 -133.56 138.42 46.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.9 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 110.23 10.57 21.93 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.511 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -75.96 143.65 74.6 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.57 0.7 . . . . 0.0 111.09 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 -170.08 0.37 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.667 2.245 . . . . 0.0 112.339 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -90.67 -10.56 42.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.84 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -101.42 25.98 7.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.895 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 305' ' ' VAL . . . . . . . . . . . . . 9.2 p -94.66 140.23 17.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.103 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 306' ' ' THR . . . . . 0.401 ' O ' ' N ' ' A' ' 308' ' ' LYS . 21.3 p -137.03 160.69 38.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.132 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -38.1 -32.61 0.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.877 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 308' ' ' LYS . . . . . 0.444 ' O ' ' N ' ' A' ' 311' ' ' MET . 23.6 ttmt -63.38 -67.7 0.4 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.921 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . 0.41 ' C ' ' O ' ' A' ' 308' ' ' LYS . 9.4 m-80 -37.65 -45.66 0.8 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.92 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 61.7 t -57.82 -43.55 84.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.116 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 311' ' ' MET . . . . . 0.444 ' N ' ' O ' ' A' ' 308' ' ' LYS . 4.7 mmt -59.73 -50.67 72.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.893 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 15.2 mp0 -62.31 -36.38 81.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.906 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 313' ' ' PHE . . . . . 0.566 ' CE1' HD22 ' A' ' 298' ' ' LEU . 3.5 t80 -65.09 -44.63 88.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.873 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . 0.462 ' CD1' HG12 ' A' ' 338' ' ' VAL . 54.6 mt -78.43 -21.07 49.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.905 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 315' ' ' ALA . . . . . 0.472 ' CB ' ' HA ' ' A' ' 316' ' ' PRO . . . -51.58 166.84 0.34 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.573 0.702 . . . . 0.0 111.143 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 316' ' ' PRO . . . . . 0.472 ' HA ' ' CB ' ' A' ' 315' ' ' ALA . 54.1 Cg_endo -69.73 -4.58 8.33 Favored 'Cis proline' 0 C--O 1.232 0.202 0 C-N-CA 122.66 -1.809 . . . . 0.0 112.348 -0.028 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 317' ' ' LEU . . . . . 0.449 ' N ' ' HA ' ' A' ' 315' ' ' ALA . 21.1 mt -54.1 161.1 1.35 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.885 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 46.2 tttt -134.46 107.19 11.01 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.586 0.708 . . . . 0.0 110.925 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 319' ' ' PRO . . . . . 0.525 ' HA ' ' CD2' ' A' ' 340' ' ' PHE . 53.7 Cg_endo -69.79 -175.76 1.27 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.713 2.275 . . . . 0.0 112.358 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 42.3 t -102.4 -35.74 4.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.107 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -164.14 138.12 5.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.092 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 322' ' ' ILE . . . . . . . . . . . . . 80.5 mt -112.22 111.51 36.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.121 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 87.0 mtt180 -110.01 103.33 12.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.849 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 94.4 mt -64.26 118.24 6.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.141 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . 0.501 ' CG2' ' CD2' ' A' ' 337' ' ' PHE . 27.1 t . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.157 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 335' ' ' TYR . . . . . 0.458 ' CE1' ' HE3' ' A' ' 297' ' ' LYS . 10.6 m-85 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.854 0.359 . . . . 0.0 110.915 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 58.7 mt -141.54 113.79 3.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.158 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . 0.562 ' CE1' ' HD3' ' A' ' 297' ' ' LYS . 18.0 m-85 -87.88 129.85 35.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.893 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . 0.462 HG12 ' CD1' ' A' ' 314' ' ' LEU . 22.0 t -134.33 135.34 54.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.174 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -111.75 162.68 14.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.877 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 340' ' ' PHE . . . . . 0.525 ' CD2' ' HA ' ' A' ' 319' ' ' PRO . 60.3 m-85 -136.64 172.3 13.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.882 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 29.3 t -79.42 -67.6 0.74 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.878 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -100.05 173.25 6.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.876 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 343' ' ' GLU . . . . . 0.531 ' HB2' ' CE1' ' A' ' 294' ' ' HIS . 11.0 pt-20 -75.19 -40.36 59.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.923 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 344' ' ' GLU . . . . . 0.402 ' N ' ' HG3' ' A' ' 343' ' ' GLU . 34.5 tt0 -44.23 -50.75 8.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.913 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -53.96 -61.81 2.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.897 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . 0.484 HG21 ' CD1' ' A' ' 340' ' ' PHE . 60.5 t -50.21 -47.04 25.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.086 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 45.2 mtpt -50.95 -39.3 54.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.946 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -79.44 -29.11 41.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.903 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -57.54 -27.05 62.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.074 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 350' ' ' LEU . . . . . . . . . . . . . 92.6 mt -77.21 -34.99 56.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.912 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 18.3 mmtp -46.33 -43.35 15.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.886 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 352' ' ' CYS . . . . . . . . . . . . . 8.3 m -62.05 85.04 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.897 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . 0.483 ' O ' ' C ' ' A' ' 354' ' ' ARG . 33.7 p-10 -122.9 -176.9 3.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.873 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . 0.483 ' C ' ' O ' ' A' ' 353' ' ' ASN . 2.9 ppt_? 30.59 44.59 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.894 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 355' ' ' GLU . . . . . 0.446 ' C ' ' OE1' ' A' ' 355' ' ' GLU . 0.0 OUTLIER -118.1 173.1 6.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.891 -179.906 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 356' ' ' TYR . . . . . 0.476 ' CD1' ' N ' ' A' ' 356' ' ' TYR . 1.3 m-85 -128.47 149.29 50.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.902 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 357' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -166.66 125.79 1.48 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.868 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 87.74 -15.2 56.12 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.476 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 105.15 19.77 10.39 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.483 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 360' ' ' ARG . . . . . . . . . . . . . 10.5 mmt180 -146.03 158.86 43.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.828 0.347 . . . . 0.0 110.875 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 361' ' ' TYR . . . . . . . . . . . . . 9.1 p90 -66.22 151.51 46.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.905 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 15.7 mm -135.3 155.27 37.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.145 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 363' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 -147.57 114.82 6.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.842 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 58.4 t -88.22 140.12 16.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.114 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -137.37 154.79 49.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.831 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 3.0 tmm_? -101.87 109.05 20.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.849 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.892 -179.935 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 294' ' ' HIS . . . . . 0.55 ' CE1' ' HB3' ' A' ' 343' ' ' GLU . 75.1 m80 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.867 0.365 . . . . 0.0 110.83 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 69.0 m -135.45 149.81 49.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.13 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 30.8 m -125.74 156.73 35.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.115 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . 0.558 ' HD3' ' CE1' ' A' ' 337' ' ' PHE . 13.4 ttpt -130.35 143.67 50.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.877 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 6.8 mp -118.23 151.86 36.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.9 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 299' ' ' ARG . . . . . 0.496 ' HB2' ' CE1' ' A' ' 335' ' ' TYR . 8.8 ttm-85 -146.42 136.37 23.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.901 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 98.9 48.13 1.81 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.454 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -114.61 148.36 40.14 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.601 0.715 . . . . 0.0 111.05 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 153.3 69.16 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.681 2.254 . . . . 0.0 112.306 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -58.49 -30.47 67.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.905 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -85.0 34.41 0.55 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.847 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 305' ' ' VAL . . . . . . . . . . . . . 9.0 p -96.02 139.64 18.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.126 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 306' ' ' THR . . . . . 0.45 ' O ' ' C ' ' A' ' 307' ' ' GLU . 70.7 p -136.2 155.51 50.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.171 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 307' ' ' GLU . . . . . 0.45 ' C ' ' O ' ' A' ' 306' ' ' THR . 30.2 mt-10 -34.46 -38.48 0.07 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.884 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 29.7 ttmt -57.43 -55.52 33.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.916 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -49.79 -46.7 51.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.906 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 85.0 t -61.55 -40.79 87.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.155 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 311' ' ' MET . . . . . . . . . . . . . 4.1 mmt -58.71 -40.75 84.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.896 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -68.94 -31.55 70.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.909 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 313' ' ' PHE . . . . . 0.536 ' CE2' HG22 ' A' ' 362' ' ' ILE . 1.9 t80 -74.13 -48.93 26.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.919 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . 0.409 ' CD1' ' CG1' ' A' ' 338' ' ' VAL . 27.8 mt -72.45 -24.95 61.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.944 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 315' ' ' ALA . . . . . 0.466 ' HA ' ' C ' ' A' ' 316' ' ' PRO . . . -49.73 164.52 0.34 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.577 0.703 . . . . 0.0 111.127 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 316' ' ' PRO . . . . . 0.466 ' C ' ' HA ' ' A' ' 315' ' ' ALA . 54.0 Cg_endo -69.79 -7.43 10.02 Favored 'Cis proline' 0 C--O 1.232 0.188 0 C-N-CA 122.701 -1.791 . . . . 0.0 112.358 0.067 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 317' ' ' LEU . . . . . . . . . . . . . 33.0 mt -57.57 134.29 56.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.926 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.88 111.7 56.32 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.56 0.695 . . . . 0.0 110.906 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 319' ' ' PRO . . . . . 0.43 ' HA ' ' CD2' ' A' ' 340' ' ' PHE . 53.7 Cg_endo -69.75 -176.62 1.54 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.707 2.271 . . . . 0.0 112.327 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 320' ' ' VAL . . . . . 0.405 HG21 ' C ' ' A' ' 340' ' ' PHE . 93.0 t -100.52 -40.27 7.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.092 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -160.56 131.67 5.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.095 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 322' ' ' ILE . . . . . . . . . . . . . 86.5 mt -102.11 119.96 51.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.122 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 61.5 mtm180 -115.54 98.69 6.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.884 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 41.8 mt -74.72 125.0 33.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.108 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 88.0 t . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.126 179.842 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 335' ' ' TYR . . . . . 0.496 ' CE1' ' HB2' ' A' ' 299' ' ' ARG . 18.2 m-85 . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.842 0.354 . . . . 0.0 110.937 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 85.5 mt -138.91 113.75 8.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.171 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . 0.558 ' CE1' ' HD3' ' A' ' 297' ' ' LYS . 77.0 m-85 -84.95 135.87 33.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.91 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . 0.409 ' CG1' ' CD1' ' A' ' 314' ' ' LEU . 58.0 t -137.64 120.15 19.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.15 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -97.38 158.06 15.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.838 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 340' ' ' PHE . . . . . 0.43 ' CD2' ' HA ' ' A' ' 319' ' ' PRO . 41.8 m-85 -133.18 172.19 13.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.874 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 48.5 t -83.23 -63.08 1.43 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.872 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -96.02 159.8 14.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.891 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 343' ' ' GLU . . . . . 0.55 ' HB3' ' CE1' ' A' ' 294' ' ' HIS . 10.7 pt-20 -68.64 -47.25 67.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.875 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -45.87 -55.34 6.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.931 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -41.92 -44.83 3.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.879 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 83.8 t -69.86 -48.57 63.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.159 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 18.8 mtpp -46.07 -42.47 13.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.921 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 348' ' ' GLN . . . . . 0.401 ' O ' ' N ' ' A' ' 351' ' ' LYS . 15.7 mm100 -70.44 -41.43 72.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.873 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -40.49 -43.47 1.85 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.048 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 350' ' ' LEU . . . . . . . . . . . . . 22.6 mt -64.08 -40.72 96.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.913 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 351' ' ' LYS . . . . . 0.401 ' N ' ' O ' ' A' ' 348' ' ' GLN . 15.6 mmtp -54.38 -25.55 25.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.881 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 352' ' ' CYS . . . . . . . . . . . . . 85.6 m -95.93 52.17 1.3 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.864 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . 0.408 ' CG ' ' N ' ' A' ' 354' ' ' ARG . 1.8 t30 -100.38 164.05 12.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.907 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . 0.408 ' N ' ' CG ' ' A' ' 353' ' ' ASN . 11.2 ttm180 68.99 33.33 3.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.886 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 355' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -102.57 174.01 6.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.909 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 356' ' ' TYR . . . . . 0.462 ' CD1' ' N ' ' A' ' 356' ' ' TYR . 1.3 m-85 -124.62 135.3 52.98 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.952 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 357' ' ' MET . . . . . 0.465 ' CG ' HG13 ' A' ' 362' ' ' ILE . 0.0 OUTLIER -148.59 123.33 9.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.867 179.98 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 82.87 -13.59 42.44 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.478 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 110.56 5.22 28.02 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.487 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 360' ' ' ARG . . . . . 0.436 ' HB3' ' NH1' ' A' ' 360' ' ' ARG . 5.1 mmm180 -123.8 130.67 52.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.836 0.35 . . . . 0.0 110.886 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 361' ' ' TYR . . . . . . . . . . . . . 20.4 p90 -49.38 128.5 17.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.915 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 362' ' ' ILE . . . . . 0.536 HG22 ' CE2' ' A' ' 313' ' ' PHE . 37.1 mm -106.51 144.96 14.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.136 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 363' ' ' GLU . . . . . . . . . . . . . 56.0 mm-40 -139.67 112.29 7.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.841 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 364' ' ' VAL . . . . . 0.436 ' O ' ' CD1' ' A' ' 365' ' ' PHE . 15.0 t -85.25 149.57 4.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.117 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 365' ' ' PHE . . . . . 0.436 ' CD1' ' O ' ' A' ' 364' ' ' VAL . 43.0 m-85 -148.64 121.62 8.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.886 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 1.3 tmm_? -69.17 127.78 34.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.888 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.9 -179.926 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 294' ' ' HIS . . . . . 0.564 ' CE1' ' HB3' ' A' ' 343' ' ' GLU . 1.5 m-70 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.893 0.378 . . . . 0.0 110.884 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 36.6 m -132.06 142.42 49.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.171 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 31.6 m -115.68 150.05 17.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.127 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 17.0 ttpt -120.59 138.11 54.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.875 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . 0.439 HD21 ' CE2' ' A' ' 313' ' ' PHE . 6.1 mp -120.23 141.38 49.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.897 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 20.3 ptt180 -149.82 145.94 26.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.931 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 107.18 14.22 19.19 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.512 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -83.85 151.59 61.24 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.607 0.718 . . . . 0.0 111.088 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -165.97 0.17 Allowed 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.724 2.283 . . . . 0.0 112.365 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -90.35 -17.79 26.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.849 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -93.3 14.58 17.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.892 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 305' ' ' VAL . . . . . . . . . . . . . 11.8 p -78.84 138.55 19.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.108 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 306' ' ' THR . . . . . . . . . . . . . 39.0 p -145.35 177.45 8.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.128 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -49.42 -31.61 10.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.897 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 20.1 ttpt -67.78 -60.98 2.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.914 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -46.57 -38.62 9.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.866 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 53.6 t -69.47 -46.76 75.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.172 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 311' ' ' MET . . . . . . . . . . . . . 2.8 mmt -56.66 -49.65 74.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.908 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -66.52 -24.72 66.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.882 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 313' ' ' PHE . . . . . 0.439 ' CE2' HD21 ' A' ' 298' ' ' LEU . 24.4 t80 -74.57 -38.75 62.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.91 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . 0.405 ' CD1' HG11 ' A' ' 338' ' ' VAL . 27.1 mt -88.12 -24.37 23.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.882 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 315' ' ' ALA . . . . . 0.488 ' HA ' ' C ' ' A' ' 316' ' ' PRO . . . -48.4 161.95 0.37 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.561 0.696 . . . . 0.0 111.15 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 316' ' ' PRO . . . . . 0.488 ' C ' ' HA ' ' A' ' 315' ' ' ALA . 53.0 Cg_endo -69.83 -2.45 7.25 Favored 'Cis proline' 0 C--N 1.342 0.198 0 C-N-CA 122.621 -1.825 . . . . 0.0 112.299 0.054 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 317' ' ' LEU . . . . . 0.466 ' N ' ' HA ' ' A' ' 315' ' ' ALA . 24.7 mt -55.62 124.59 17.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.864 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -102.65 105.29 43.62 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.517 0.675 . . . . 0.0 110.895 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 319' ' ' PRO . . . . . 0.437 ' HA ' ' CD2' ' A' ' 340' ' ' PHE . 54.1 Cg_endo -69.74 -175.54 1.18 Allowed 'Trans proline' 0 N--CA 1.465 -0.155 0 C-N-CA 122.728 2.285 . . . . 0.0 112.36 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 97.7 t -100.03 -43.45 11.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.147 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -156.88 139.67 15.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.14 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 322' ' ' ILE . . . . . . . . . . . . . 90.6 mt -108.39 108.49 25.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.084 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -103.12 98.08 8.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.878 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 71.9 mt -70.38 118.22 14.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.105 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . 0.509 HG22 ' CE2' ' A' ' 337' ' ' PHE . 35.2 t . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.125 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 335' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.895 0.379 . . . . 0.0 110.932 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 73.7 mt -143.72 124.44 9.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.126 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . 0.509 ' CE2' HG22 ' A' ' 325' ' ' VAL . 25.9 m-85 -100.24 126.82 46.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.907 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . 0.405 HG11 ' CD1' ' A' ' 314' ' ' LEU . 31.2 t -126.83 132.79 69.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.147 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -106.2 162.14 13.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.853 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 340' ' ' PHE . . . . . 0.437 ' CD2' ' HA ' ' A' ' 319' ' ' PRO . 67.0 m-85 -136.62 161.0 37.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.86 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 46.0 m -76.83 -61.02 2.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.825 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -92.3 157.98 16.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.872 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 343' ' ' GLU . . . . . 0.564 ' HB3' ' CE1' ' A' ' 294' ' ' HIS . 8.3 pt-20 -70.22 -41.8 73.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.852 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 344' ' ' GLU . . . . . 0.41 ' O ' ' C ' ' A' ' 345' ' ' GLU . 36.3 mm-40 -47.07 -61.01 2.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.917 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 345' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 344' ' ' GLU . 30.2 mt-10 -37.47 -44.44 0.65 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.878 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 39.6 t -58.81 -54.11 38.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.133 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -49.78 -37.08 28.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.914 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -71.65 -46.23 59.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.902 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -46.1 -34.72 4.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.071 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 350' ' ' LEU . . . . . . . . . . . . . 65.5 mt -71.36 -41.01 70.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.935 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 27.5 mmtp -40.25 -52.41 2.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.879 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 352' ' ' CYS . . . . . . . . . . . . . 89.7 m -74.27 80.23 1.83 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.903 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -107.83 171.25 7.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.87 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 10.6 ptm180 41.99 50.43 4.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.907 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 355' ' ' GLU . . . . . 0.506 ' C ' ' CD1' ' A' ' 356' ' ' TYR . 9.8 mm-40 -98.08 174.38 6.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.916 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 356' ' ' TYR . . . . . 0.506 ' CD1' ' C ' ' A' ' 355' ' ' GLU . 1.0 OUTLIER -137.96 117.91 13.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.922 -179.862 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 357' ' ' MET . . . . . . . . . . . . . 4.4 ptt? -143.71 139.61 29.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.89 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 82.02 -33.76 2.63 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.5 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 129.14 15.89 2.01 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.499 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 360' ' ' ARG . . . . . . . . . . . . . 15.7 mmm180 -142.67 148.98 38.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.78 0.324 . . . . 0.0 110.889 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 361' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -61.0 152.7 27.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.961 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 8.5 mm -135.55 145.26 31.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.17 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 363' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -135.7 119.18 16.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.893 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 4.1 t -91.68 128.57 43.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.106 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -125.9 139.38 53.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.861 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 15.9 ttt-85 -88.17 114.02 24.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.835 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 64.4 mm-40 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.872 -179.946 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 294' ' ' HIS . . . . . 0.545 ' CE1' ' CG ' ' A' ' 343' ' ' GLU . 12.3 m-70 . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.914 0.388 . . . . 0.0 110.824 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 96.5 m -139.38 147.19 41.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.098 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 29.9 m -127.59 146.81 32.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.176 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . 0.562 ' HD3' ' CE1' ' A' ' 337' ' ' PHE . 30.6 ttpt -117.02 145.99 43.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.936 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . 0.482 HD23 ' CE2' ' A' ' 313' ' ' PHE . 6.4 mp -117.17 129.08 55.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.897 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 6.4 ttt85 -129.13 150.09 50.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.876 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 91.06 36.83 6.51 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.494 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -109.84 152.36 42.91 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.519 0.676 . . . . 0.0 111.105 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 -178.51 2.38 Favored 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.692 2.261 . . . . 0.0 112.316 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -89.51 -4.21 58.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.901 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -100.34 3.28 43.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.907 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 305' ' ' VAL . . . . . . . . . . . . . 4.1 p -65.11 153.13 8.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.088 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 306' ' ' THR . . . . . 0.439 ' OG1' ' N ' ' A' ' 307' ' ' GLU . 0.0 OUTLIER -149.12 170.84 17.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.104 -179.93 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 307' ' ' GLU . . . . . 0.439 ' N ' ' OG1' ' A' ' 306' ' ' THR . 30.7 mt-10 -54.71 -24.38 21.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.864 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 21.4 tttm -74.78 -51.44 14.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.881 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -54.23 -32.84 56.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.881 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 30.0 t -70.81 -45.83 71.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.126 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 311' ' ' MET . . . . . . . . . . . . . 4.1 mmt -57.58 -53.13 61.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.919 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -63.41 -24.39 67.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.901 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 313' ' ' PHE . . . . . 0.542 ' CZ ' HG21 ' A' ' 362' ' ' ILE . 31.2 t80 -77.6 -49.75 13.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.879 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . 0.407 ' CD1' HG11 ' A' ' 338' ' ' VAL . 74.2 mt -74.44 -22.65 59.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.913 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 315' ' ' ALA . . . . . 0.479 ' HA ' ' C ' ' A' ' 316' ' ' PRO . . . -46.22 163.33 0.23 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.551 0.691 . . . . 0.0 111.149 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 316' ' ' PRO . . . . . 0.479 ' C ' ' HA ' ' A' ' 315' ' ' ALA . 53.5 Cg_endo -69.79 -6.55 9.54 Favored 'Cis proline' 0 C--O 1.232 0.195 0 C-N-CA 122.68 -1.8 . . . . 0.0 112.316 0.027 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 317' ' ' LEU . . . . . . . . . . . . . 81.6 mt -52.66 135.6 34.52 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.875 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 14.6 tptm -113.96 103.39 55.22 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.539 0.685 . . . . 0.0 110.892 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 319' ' ' PRO . . . . . 0.412 ' HA ' ' CD2' ' A' ' 340' ' ' PHE . 53.8 Cg_endo -69.76 -169.9 0.36 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.636 2.224 . . . . 0.0 112.361 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 47.2 t -103.34 -46.24 10.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.093 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -156.06 138.28 14.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.062 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 322' ' ' ILE . . . . . . . . . . . . . 66.2 mt -114.21 122.86 69.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.135 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 65.9 mmt-85 -118.05 107.78 14.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.832 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 52.3 mt -77.56 119.97 27.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.133 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . 0.424 HG21 ' CE2' ' A' ' 337' ' ' PHE . 18.8 t . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.132 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 335' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.828 0.347 . . . . 0.0 110.947 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 54.2 mt -144.49 123.75 6.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.141 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . 0.562 ' CE1' ' HD3' ' A' ' 297' ' ' LYS . 62.1 m-85 -93.65 135.99 34.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.863 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . 0.464 HG12 ' CE1' ' A' ' 340' ' ' PHE . 41.5 t -134.96 122.92 39.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.14 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -98.24 160.52 14.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.853 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 340' ' ' PHE . . . . . 0.464 ' CE1' HG12 ' A' ' 338' ' ' VAL . 60.7 m-85 -139.79 162.92 33.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.912 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 2.8 m -98.88 -42.3 7.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.851 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 342' ' ' ASN . . . . . 0.408 ' O ' ' C ' ' A' ' 343' ' ' GLU . 19.5 m-80 -99.56 111.08 23.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.86 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 343' ' ' GLU . . . . . 0.545 ' CG ' ' CE1' ' A' ' 294' ' ' HIS . 0.5 OUTLIER -37.37 -60.61 0.66 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.85 -179.97 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 344' ' ' GLU . . . . . 0.454 ' C ' ' O ' ' A' ' 343' ' ' GLU . 13.1 tt0 -34.3 -51.37 0.45 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.873 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -47.48 -45.56 26.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.892 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . 0.459 ' N ' ' O ' ' A' ' 343' ' ' GLU . 23.7 t -57.49 -51.67 66.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.14 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 49.3 mtpt -54.46 -43.14 71.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.896 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 60.0 mm-40 -65.29 -39.18 92.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.943 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -48.02 -40.87 24.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.072 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 350' ' ' LEU . . . . . . . . . . . . . 39.7 mt -65.0 -40.91 95.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.913 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 34.2 mmtm -46.18 -46.22 17.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.916 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 352' ' ' CYS . . . . . . . . . . . . . 58.0 m -69.76 69.42 0.29 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.893 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 14.6 p30 -109.83 171.84 7.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.851 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? 55.75 33.22 20.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.851 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 355' ' ' GLU . . . . . 0.47 ' C ' ' CD1' ' A' ' 356' ' ' TYR . 2.5 mm-40 -97.09 173.68 7.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.903 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 356' ' ' TYR . . . . . 0.521 ' CD1' ' N ' ' A' ' 356' ' ' TYR . 0.9 OUTLIER -138.65 130.29 27.65 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.953 -179.877 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 357' ' ' MET . . . . . 0.457 ' HG2' ' CG1' ' A' ' 362' ' ' ILE . 5.8 ptt? -152.16 120.13 6.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.865 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 92.56 -23.29 28.75 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.522 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 125.96 -5.52 7.86 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.446 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 360' ' ' ARG . . . . . . . . . . . . . 15.4 mmm180 -119.34 158.52 25.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.873 0.368 . . . . 0.0 110.864 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 361' ' ' TYR . . . . . 0.547 ' CG ' ' O ' ' A' ' 361' ' ' TYR . 3.0 p90 -77.2 117.48 18.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.951 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 362' ' ' ILE . . . . . 0.542 HG21 ' CZ ' ' A' ' 313' ' ' PHE . 45.9 mm -83.23 117.01 28.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.112 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 363' ' ' GLU . . . . . 0.566 ' HG3' ' CZ ' ' A' ' 365' ' ' PHE . 4.2 tp10 -111.23 112.06 23.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.919 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 7.0 t -87.16 144.72 8.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.131 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 365' ' ' PHE . . . . . 0.566 ' CZ ' ' HG3' ' A' ' 363' ' ' GLU . 58.0 m-85 -140.85 133.24 28.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.916 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 6.0 ttm180 -84.73 115.51 22.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.907 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.877 -179.901 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 34.2 m80 . . . . . 0 C--O 1.233 0.191 0 CA-C-O 120.856 0.36 . . . . 0.0 110.879 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 19.5 m -131.01 132.14 44.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.129 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 296' ' ' VAL . . . . . 0.462 ' CG2' ' HB ' ' A' ' 338' ' ' VAL . 34.9 m -104.01 154.72 5.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.133 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . 0.562 ' HE2' ' CZ ' ' A' ' 337' ' ' PHE . 2.1 tppp? -113.26 142.34 45.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.94 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . 0.567 HD21 ' CD2' ' A' ' 313' ' ' PHE . 6.9 mp -128.69 119.78 25.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.906 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 19.2 ptt85 -127.68 165.65 19.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.868 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 94.36 -24.08 29.0 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.497 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -57.36 151.78 36.13 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.558 0.694 . . . . 0.0 111.103 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 163.11 39.49 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.703 2.269 . . . . 0.0 112.37 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 303' ' ' PHE . . . . . 0.557 ' C ' ' CD1' ' A' ' 303' ' ' PHE . 0.5 OUTLIER -69.05 -24.52 64.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.877 -179.979 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -93.58 36.72 1.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.916 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 305' ' ' VAL . . . . . . . . . . . . . 9.9 p -94.8 146.15 7.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.16 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 306' ' ' THR . . . . . . . . . . . . . 7.1 p -128.27 159.87 33.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.159 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -43.17 -43.45 4.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.885 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 56.1 tttt -52.89 -61.79 2.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.885 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -41.48 -46.81 3.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.864 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 92.4 t -60.2 -55.9 21.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.142 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 311' ' ' MET . . . . . . . . . . . . . 3.6 mmt -43.14 -45.55 5.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.885 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -62.33 -41.66 98.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.855 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 313' ' ' PHE . . . . . 0.567 ' CD2' HD21 ' A' ' 298' ' ' LEU . 21.2 t80 -67.05 -44.24 80.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.833 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 94.3 mt -75.99 -25.7 56.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.914 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 315' ' ' ALA . . . . . 0.497 ' HA ' ' C ' ' A' ' 316' ' ' PRO . . . -50.65 158.48 1.08 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.613 0.72 . . . . 0.0 111.076 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 316' ' ' PRO . . . . . 0.497 ' C ' ' HA ' ' A' ' 315' ' ' ALA . 54.2 Cg_endo -69.72 -19.55 11.14 Favored 'Cis proline' 0 C--N 1.342 0.185 0 C-N-CA 122.702 -1.791 . . . . 0.0 112.362 -0.031 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 317' ' ' LEU . . . . . . . . . . . . . 60.3 mt -38.33 125.34 1.31 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.915 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 318' ' ' LYS . . . . . 0.442 ' HA ' ' CE ' ' A' ' 318' ' ' LYS . 0.6 OUTLIER -105.44 103.37 42.53 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.625 0.726 . . . . 0.0 110.905 179.83 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 319' ' ' PRO . . . . . 0.418 ' HA ' ' CD2' ' A' ' 340' ' ' PHE . 52.8 Cg_endo -69.81 -172.07 0.54 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.698 2.265 . . . . 0.0 112.301 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 79.6 t -103.45 -44.52 9.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.149 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -157.6 134.45 10.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.079 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 322' ' ' ILE . . . . . . . . . . . . . 64.5 mt -105.99 105.09 18.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.111 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 73.9 mtt-85 -108.69 107.98 18.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.849 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 59.9 mt -72.22 128.02 34.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.125 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . 0.556 ' CG2' ' CD2' ' A' ' 337' ' ' PHE . 66.8 t . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.143 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 335' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.891 0.377 . . . . 0.0 110.882 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 42.6 mt -134.39 130.16 53.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.134 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . 0.562 ' CZ ' ' HE2' ' A' ' 297' ' ' LYS . 7.2 m-85 -98.15 127.86 44.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.9 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . 0.462 ' HB ' ' CG2' ' A' ' 296' ' ' VAL . 75.0 t -127.38 120.65 55.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.129 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -95.86 156.01 16.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.876 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 340' ' ' PHE . . . . . 0.422 ' CE1' HG13 ' A' ' 338' ' ' VAL . 61.3 m-85 -134.42 165.42 25.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.921 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 2.0 m -93.98 -53.34 4.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.858 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 35.8 m-20 -95.16 128.49 42.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.87 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -49.45 -43.46 44.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.903 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -45.5 -55.82 5.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.858 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 62.1 mt-10 -43.76 -53.68 5.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.876 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 66.7 t -54.55 -50.5 58.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.17 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -54.34 -33.67 59.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.895 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -78.45 -36.63 45.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.894 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -47.1 -38.67 11.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.054 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 350' ' ' LEU . . . . . . . . . . . . . 49.5 mt -63.35 -39.43 94.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.898 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 18.9 mmtm -47.31 -45.4 24.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.886 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 352' ' ' CYS . . . . . . . . . . . . . 4.1 m -75.21 64.94 1.5 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.915 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -108.71 160.83 15.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.871 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 25.0 ttp180 63.09 34.72 13.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.865 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 355' ' ' GLU . . . . . 0.455 ' C ' ' CD1' ' A' ' 356' ' ' TYR . 3.9 mm-40 -94.82 172.78 7.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.886 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 356' ' ' TYR . . . . . 0.473 ' CD1' ' N ' ' A' ' 356' ' ' TYR . 1.3 m-85 -135.68 120.05 17.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.912 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 357' ' ' MET . . . . . . . . . . . . . 3.3 ptt? -145.45 143.9 30.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.857 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 75.98 -9.96 16.25 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.492 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 106.4 18.33 11.21 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.483 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 360' ' ' ARG . . . . . . . . . . . . . 20.2 mmt180 -145.46 178.11 8.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.836 0.35 . . . . 0.0 110.862 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 361' ' ' TYR . . . . . . . . . . . . . 18.9 p90 -90.67 163.83 14.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.932 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 8.0 mm -141.6 155.34 20.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.112 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 363' ' ' GLU . . . . . 0.527 ' HB3' ' CZ ' ' A' ' 365' ' ' PHE . 13.8 mt-10 -147.47 119.45 8.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.851 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 20.0 t -89.01 140.06 16.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.139 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 365' ' ' PHE . . . . . 0.527 ' CZ ' ' HB3' ' A' ' 363' ' ' GLU . 16.8 m-85 -140.92 128.3 21.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.889 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 36.4 mtp180 -73.21 143.0 47.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.865 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.939 -179.996 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 294' ' ' HIS . . . . . 0.47 ' CE1' ' HB3' ' A' ' 343' ' ' GLU . 6.1 m80 . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.875 0.369 . . . . 0.0 110.889 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 95.4 m -138.44 137.29 37.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.146 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 296' ' ' VAL . . . . . 0.425 ' CG2' ' HB ' ' A' ' 338' ' ' VAL . 35.9 m -110.69 152.24 12.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.158 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . 0.541 ' HG3' ' CE1' ' A' ' 337' ' ' PHE . 0.2 OUTLIER -118.08 136.01 53.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.848 179.992 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . 0.558 HD22 ' CE2' ' A' ' 313' ' ' PHE . 6.7 mp -113.98 142.28 46.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.89 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 299' ' ' ARG . . . . . 0.531 ' HD3' ' CE2' ' A' ' 335' ' ' TYR . 25.1 tpt85 -148.79 134.14 18.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.868 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 126.07 -23.88 5.77 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.446 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -56.62 147.55 50.46 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.568 0.699 . . . . 0.0 111.105 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 -172.45 0.57 Allowed 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.673 2.249 . . . . 0.0 112.325 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 303' ' ' PHE . . . . . 0.429 ' O ' ' CG ' ' A' ' 303' ' ' PHE . 73.1 t80 -89.56 -3.41 58.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.895 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 36.3 t30 -110.41 29.34 7.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.871 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 305' ' ' VAL . . . . . . . . . . . . . 9.1 p -97.04 148.91 5.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.12 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 306' ' ' THR . . . . . . . . . . . . . 23.5 p -134.89 161.23 35.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.129 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -39.77 -49.28 2.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.868 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 33.1 ttmt -46.84 -58.87 3.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.92 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 32.7 m120 -45.17 -45.17 11.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.899 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 61.6 t -57.81 -43.6 84.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.149 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 311' ' ' MET . . . . . . . . . . . . . 3.3 mmt -59.28 -50.49 73.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.869 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -64.28 -29.74 70.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.917 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 313' ' ' PHE . . . . . 0.558 ' CE2' HD22 ' A' ' 298' ' ' LEU . 4.4 t80 -72.27 -31.78 66.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.893 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 92.1 mt -90.93 -22.95 20.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.906 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 315' ' ' ALA . . . . . 0.502 ' HA ' ' C ' ' A' ' 316' ' ' PRO . . . -44.06 159.32 0.24 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.557 0.694 . . . . 0.0 111.127 179.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 316' ' ' PRO . . . . . 0.502 ' C ' ' HA ' ' A' ' 315' ' ' ALA . 53.6 Cg_endo -69.73 -8.98 10.73 Favored 'Cis proline' 0 C--N 1.341 0.183 0 C-N-CA 122.662 -1.807 . . . . 0.0 112.357 -0.034 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 317' ' ' LEU . . . . . . . . . . . . . 26.4 mt -46.72 161.15 0.07 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.899 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 29.2 tttm -143.79 105.0 4.91 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.563 0.697 . . . . 0.0 110.884 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 319' ' ' PRO . . . . . 0.469 ' HA ' ' CD2' ' A' ' 340' ' ' PHE . 53.8 Cg_endo -69.71 -173.6 0.74 Allowed 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.706 2.271 . . . . 0.0 112.36 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 93.7 t -103.18 -41.11 7.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.136 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -157.47 139.08 13.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.109 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 322' ' ' ILE . . . . . . . . . . . . . 92.0 mt -106.79 106.77 21.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.151 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 45.2 mtt180 -102.47 105.29 15.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.884 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 55.8 mt -73.93 119.85 21.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.122 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . 0.409 HG21 ' CD2' ' A' ' 337' ' ' PHE . 94.4 t . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.13 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 335' ' ' TYR . . . . . 0.531 ' CE2' ' HD3' ' A' ' 299' ' ' ARG . 2.8 m-85 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.855 0.36 . . . . 0.0 110.919 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 72.8 mt -142.45 114.34 3.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.123 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . 0.541 ' CE1' ' HG3' ' A' ' 297' ' ' LYS . 15.6 m-85 -88.5 135.35 33.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.918 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . 0.425 ' HB ' ' CG2' ' A' ' 296' ' ' VAL . 63.3 t -132.5 129.91 59.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.11 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -103.18 161.8 13.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.886 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 340' ' ' PHE . . . . . 0.469 ' CD2' ' HA ' ' A' ' 319' ' ' PRO . 55.6 m-85 -139.57 166.53 24.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.868 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 32.2 m -82.59 -62.06 1.71 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.874 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 21.1 m-80 -91.87 158.01 16.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.893 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 343' ' ' GLU . . . . . 0.47 ' HB3' ' CE1' ' A' ' 294' ' ' HIS . 1.7 pp20? -73.92 -28.56 61.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.85 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 45.7 mm-40 -59.3 -53.05 62.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.91 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -46.27 -51.74 13.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.907 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 21.2 t -49.96 -50.64 18.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.146 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 6.2 mtpm? -51.61 -48.76 63.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.875 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -62.38 -26.13 68.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.914 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -63.23 -35.92 81.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.101 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 350' ' ' LEU . . . . . . . . . . . . . 57.6 mt -63.74 -40.94 97.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.978 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 5.4 mtmp? -46.63 -51.15 16.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.934 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 352' ' ' CYS . . . . . . . . . . . . . 4.2 m -69.36 85.19 0.4 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.897 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . 0.452 ' O ' ' C ' ' A' ' 354' ' ' ARG . 1.1 p30 -124.91 -176.37 3.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.91 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . 0.482 ' O ' ' CD ' ' A' ' 354' ' ' ARG . 0.0 OUTLIER 32.44 38.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.883 -179.925 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 355' ' ' GLU . . . . . 0.469 ' C ' ' CD1' ' A' ' 356' ' ' TYR . 57.1 mm-40 -86.95 176.16 7.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.87 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 356' ' ' TYR . . . . . 0.469 ' CD1' ' C ' ' A' ' 355' ' ' GLU . 1.2 m-85 -135.31 107.95 7.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.964 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 357' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -138.38 145.83 41.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.918 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 72.89 -6.13 14.48 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.494 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 102.96 21.91 9.78 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.479 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 360' ' ' ARG . . . . . . . . . . . . . 14.2 mmt180 -148.71 175.7 10.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.807 0.337 . . . . 0.0 110.9 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 361' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -82.59 172.21 13.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.924 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 25.7 mm -142.27 155.53 18.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.11 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 363' ' ' GLU . . . . . 0.532 ' HB3' ' CZ ' ' A' ' 365' ' ' PHE . 7.0 mm-40 -147.87 112.92 5.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.888 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 17.2 t -91.46 143.53 11.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.078 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 365' ' ' PHE . . . . . 0.532 ' CZ ' ' HB3' ' A' ' 363' ' ' GLU . 32.0 m-85 -143.09 122.38 13.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.898 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 35.2 ttp85 -75.84 112.69 12.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.847 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.854 -179.91 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 294' ' ' HIS . . . . . 0.568 ' CE1' ' HB3' ' A' ' 343' ' ' GLU . 3.0 m-70 . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.883 0.373 . . . . 0.0 110.869 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 87.4 m -126.34 144.57 50.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.106 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 19.6 m -121.72 157.65 25.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.136 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 8.8 ttpp -128.43 142.34 51.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.873 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . 0.416 HD23 ' CE1' ' A' ' 313' ' ' PHE . 7.6 mp -114.93 149.83 36.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.89 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 7.7 ttt180 -150.41 140.2 21.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.893 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 103.43 44.94 1.62 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.474 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -113.84 151.42 44.71 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.597 0.713 . . . . 0.0 111.091 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -171.95 0.53 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.637 2.225 . . . . 0.0 112.319 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -87.55 -7.69 57.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.897 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 33.0 m120 -108.97 32.01 5.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.88 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 305' ' ' VAL . . . . . . . . . . . . . 4.5 p -96.2 139.89 18.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.139 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 306' ' ' THR . . . . . . . . . . . . . 67.7 p -142.97 170.63 15.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.146 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -46.68 -35.35 5.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.883 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 11.4 tmtt? -59.7 -50.32 74.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.884 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 34.8 m120 -55.09 -48.89 72.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.944 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 310' ' ' VAL . . . . . 0.438 ' CG1' HD11 ' A' ' 314' ' ' LEU . 76.6 t -58.17 -55.31 22.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.14 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 311' ' ' MET . . . . . . . . . . . . . 2.3 mmt -46.35 -44.47 16.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.889 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -73.99 -26.28 60.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.875 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 313' ' ' PHE . . . . . 0.591 ' CD2' ' SD ' ' A' ' 357' ' ' MET . 1.9 t80 -78.37 -30.9 48.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.822 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . 0.438 HD11 ' CG1' ' A' ' 310' ' ' VAL . 93.9 mt -91.5 -24.53 19.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.952 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 315' ' ' ALA . . . . . 0.475 ' HA ' ' C ' ' A' ' 316' ' ' PRO . . . -48.68 163.87 0.3 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.592 0.711 . . . . 0.0 111.098 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 316' ' ' PRO . . . . . 0.475 ' C ' ' HA ' ' A' ' 315' ' ' ALA . 53.7 Cg_endo -69.72 -3.2 7.5 Favored 'Cis proline' 0 C--O 1.231 0.165 0 C-N-CA 122.713 -1.786 . . . . 0.0 112.341 -0.026 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 317' ' ' LEU . . . . . 0.467 ' N ' ' HA ' ' A' ' 315' ' ' ALA . 13.5 mt -55.63 142.95 31.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.93 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -120.52 106.31 40.21 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.588 0.708 . . . . 0.0 110.883 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 -164.54 0.13 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.72 2.28 . . . . 0.0 112.369 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 24.5 t -113.62 -45.04 4.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.104 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -153.59 128.94 9.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.09 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 322' ' ' ILE . . . . . . . . . . . . . 49.3 mt -107.67 99.86 9.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.144 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -100.19 104.73 16.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.875 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 58.4 mt -73.73 118.34 19.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.104 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . 0.414 HG22 ' CE2' ' A' ' 337' ' ' PHE . 84.5 t . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.109 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 335' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.915 0.388 . . . . 0.0 110.928 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 42.6 mt -139.93 132.02 33.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.137 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . 0.414 ' CE2' HG22 ' A' ' 325' ' ' VAL . 22.7 m-85 -99.52 142.78 30.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.849 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 27.6 t -146.33 131.53 12.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.181 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -103.22 168.09 9.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.856 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 340' ' ' PHE . . . . . 0.472 ' HB2' ' CG2' ' A' ' 346' ' ' VAL . 65.6 m-85 -148.22 157.56 43.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.852 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 13.1 t -70.16 -64.6 0.86 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.856 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -99.39 177.43 5.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.863 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 343' ' ' GLU . . . . . 0.568 ' HB3' ' CE1' ' A' ' 294' ' ' HIS . 20.1 pt-20 -78.22 -45.84 21.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.868 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -42.26 -60.03 1.61 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.892 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 345' ' ' GLU . . . . . 0.419 ' CD ' HD22 ' A' ' 317' ' ' LEU . 19.5 mm-40 -45.3 -32.45 1.99 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.873 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . 0.472 ' CG2' ' HB2' ' A' ' 340' ' ' PHE . 74.9 t -82.6 -36.75 13.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.114 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -64.22 -35.43 80.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.915 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 45.9 mm-40 -76.03 -40.01 54.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.92 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -51.82 -33.53 36.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.141 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 350' ' ' LEU . . . . . . . . . . . . . 96.8 mt -72.48 -40.15 67.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.935 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 46.7 mttm -46.27 -40.69 11.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.885 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 352' ' ' CYS . . . . . . . . . . . . . 33.1 m -78.77 80.45 5.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.915 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . 0.438 ' O ' ' C ' ' A' ' 354' ' ' ARG . 31.5 p-10 -109.28 178.56 4.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.86 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . 0.438 ' C ' ' O ' ' A' ' 353' ' ' ASN . 20.7 ptt180 35.42 42.86 0.13 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.922 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 355' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -89.45 173.9 8.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.85 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 356' ' ' TYR . . . . . 0.497 ' CD1' ' N ' ' A' ' 356' ' ' TYR . 1.1 m-85 -128.13 115.56 18.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.952 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 357' ' ' MET . . . . . 0.591 ' SD ' ' CD2' ' A' ' 313' ' ' PHE . 4.6 ptt? -145.81 127.52 15.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.866 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 81.36 -17.94 12.11 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.526 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 113.25 19.03 6.89 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.467 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 360' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -143.87 134.71 25.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.812 0.339 . . . . 0.0 110.9 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 361' ' ' TYR . . . . . 0.557 ' O ' ' CD1' ' A' ' 361' ' ' TYR . 12.6 p90 -56.27 127.23 29.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.897 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 362' ' ' ILE . . . . . 0.429 ' CD1' ' HG2' ' A' ' 357' ' ' MET . 4.2 mm -106.31 151.57 8.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.163 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 363' ' ' GLU . . . . . 0.413 ' CB ' ' CZ ' ' A' ' 365' ' ' PHE . 28.1 mm-40 -143.4 116.93 9.14 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.846 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 364' ' ' VAL . . . . . 0.442 ' O ' ' CD1' ' A' ' 365' ' ' PHE . 21.7 t -88.82 142.53 12.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.15 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 365' ' ' PHE . . . . . 0.442 ' CD1' ' O ' ' A' ' 364' ' ' VAL . 10.3 m-85 -139.93 146.87 39.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.909 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.68 109.36 19.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.878 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.888 -179.922 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 294' ' ' HIS . . . . . 0.564 ' CE1' ' HB3' ' A' ' 343' ' ' GLU . 11.3 m80 . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.864 0.364 . . . . 0.0 110.861 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 63.1 m -136.17 145.36 45.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.178 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 29.8 m -118.86 147.21 22.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.154 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . 0.552 ' HD3' ' CD1' ' A' ' 335' ' ' TYR . 8.8 ttmm -116.87 146.33 42.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.944 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 6.9 mp -115.55 157.55 23.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.917 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -158.02 130.22 7.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.859 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 123.1 -23.2 6.96 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.484 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -57.17 147.71 55.4 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.594 0.711 . . . . 0.0 111.066 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 -176.54 1.52 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.71 2.273 . . . . 0.0 112.301 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -78.1 -35.74 48.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.904 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -88.59 48.46 1.64 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.858 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 305' ' ' VAL . . . . . . . . . . . . . 11.4 p -99.24 141.38 16.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.163 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 306' ' ' THR . . . . . 0.414 ' O ' ' C ' ' A' ' 307' ' ' GLU . 69.2 p -132.43 153.27 51.01 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.096 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 307' ' ' GLU . . . . . 0.414 ' C ' ' O ' ' A' ' 306' ' ' THR . 26.1 mt-10 -35.68 -52.17 0.68 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.891 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 14.7 ttpt -40.83 -47.25 2.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.892 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -57.85 -54.87 42.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.873 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 56.2 t -55.9 -50.4 69.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.159 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 311' ' ' MET . . . . . . . . . . . . . 2.7 mmt -48.91 -52.46 24.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.866 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -67.31 -24.73 65.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.871 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 313' ' ' PHE . . . . . 0.402 ' CZ ' HG23 ' A' ' 362' ' ' ILE . 11.2 t80 -77.34 -35.66 54.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.848 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 85.9 mt -86.04 -20.61 28.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.94 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 315' ' ' ALA . . . . . 0.497 ' HA ' ' C ' ' A' ' 316' ' ' PRO . . . -47.09 159.96 0.37 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.588 0.708 . . . . 0.0 111.08 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 316' ' ' PRO . . . . . 0.497 ' C ' ' HA ' ' A' ' 315' ' ' ALA . 53.8 Cg_endo -69.78 -21.5 10.2 Favored 'Cis proline' 0 C--O 1.232 0.188 0 C-N-CA 122.677 -1.801 . . . . 0.0 112.357 0.055 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 317' ' ' LEU . . . . . . . . . . . . . 22.2 mt -41.38 139.07 1.11 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.887 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -118.51 110.55 38.88 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.576 0.703 . . . . 0.0 110.876 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 319' ' ' PRO . . . . . 0.451 ' HA ' ' CD2' ' A' ' 340' ' ' PHE . 54.2 Cg_endo -69.71 -178.33 2.27 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.68 2.253 . . . . 0.0 112.384 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 320' ' ' VAL . . . . . 0.411 HG22 ' C ' ' A' ' 340' ' ' PHE . 19.4 t -104.12 -34.14 3.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.151 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -162.73 132.93 4.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.115 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 322' ' ' ILE . . . . . . . . . . . . . 66.2 mt -107.75 117.21 52.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.153 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 19.4 mmt180 -111.47 107.08 16.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.843 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 70.8 mt -84.61 138.21 19.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.156 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . 0.405 HG22 ' CE2' ' A' ' 337' ' ' PHE . 62.1 t . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.095 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 335' ' ' TYR . . . . . 0.552 ' CD1' ' HD3' ' A' ' 297' ' ' LYS . 79.3 m-85 . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.811 0.338 . . . . 0.0 110.957 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 60.0 mt -127.28 121.52 57.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.132 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . 0.456 ' CE1' ' HG3' ' A' ' 297' ' ' LYS . 39.1 m-85 -96.1 136.2 36.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.876 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 25.5 t -134.73 132.17 54.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.105 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -105.69 157.94 17.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.883 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 340' ' ' PHE . . . . . 0.451 ' CD2' ' HA ' ' A' ' 319' ' ' PRO . 53.3 m-85 -133.85 162.06 33.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.879 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 34.4 p -64.73 -66.61 0.52 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.877 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 342' ' ' ASN . . . . . 0.401 ' OD1' ' N ' ' A' ' 342' ' ' ASN . 2.8 p-10 -99.75 170.8 8.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.918 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 343' ' ' GLU . . . . . 0.564 ' HB3' ' CE1' ' A' ' 294' ' ' HIS . 1.4 pp20? -70.14 -51.01 34.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.89 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 344' ' ' GLU . . . . . 0.425 ' N ' ' CD ' ' A' ' 343' ' ' GLU . 10.4 tt0 -40.36 -57.98 1.64 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.906 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -39.74 -36.15 0.4 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.899 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 24.6 t -70.08 -48.27 63.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.106 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 347' ' ' LYS . . . . . 0.42 ' NZ ' ' HB2' ' A' ' 347' ' ' LYS . 5.1 mtmp? -52.87 -39.46 62.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.934 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -73.31 -26.66 61.15 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.933 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -64.03 -35.96 82.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.095 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 350' ' ' LEU . . . . . . . . . . . . . 15.9 mt -73.22 -37.06 66.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.912 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 26.3 mmmt -47.44 -47.18 27.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.901 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 352' ' ' CYS . . . . . . . . . . . . . 15.9 m -70.3 72.55 0.47 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.877 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 14.9 p30 -109.09 162.76 13.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.932 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 20.5 mmt180 61.86 35.63 16.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.848 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 355' ' ' GLU . . . . . 0.46 ' C ' ' CD1' ' A' ' 356' ' ' TYR . 20.9 mm-40 -91.48 173.65 7.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.891 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 356' ' ' TYR . . . . . 0.491 ' CD1' ' N ' ' A' ' 356' ' ' TYR . 1.2 m-85 -136.3 128.06 29.11 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.922 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 357' ' ' MET . . . . . . . . . . . . . 3.6 ptt? -156.6 140.38 16.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.912 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 76.95 -9.29 25.47 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.456 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 102.93 16.85 20.38 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.461 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 360' ' ' ARG . . . . . . . . . . . . . 10.3 mmt180 -144.29 153.36 41.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.801 0.334 . . . . 0.0 110.881 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 361' ' ' TYR . . . . . 0.441 ' CD1' ' C ' ' A' ' 361' ' ' TYR . 1.0 OUTLIER -64.88 166.26 9.4 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.911 -179.84 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 362' ' ' ILE . . . . . 0.409 HG12 ' C ' ' A' ' 361' ' ' TYR . 15.7 mm -146.75 137.54 18.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.136 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 363' ' ' GLU . . . . . 0.567 ' HG3' ' CE2' ' A' ' 365' ' ' PHE . 14.7 pt-20 -133.99 112.07 10.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.895 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 364' ' ' VAL . . . . . 0.533 ' O ' ' CD1' ' A' ' 365' ' ' PHE . 14.2 t -84.51 154.07 3.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.099 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 365' ' ' PHE . . . . . 0.567 ' CE2' ' HG3' ' A' ' 363' ' ' GLU . 28.8 m-85 -145.99 156.46 43.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.851 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 32.8 ttp85 -97.86 120.4 38.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.912 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.881 -179.917 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 294' ' ' HIS . . . . . 0.426 ' HB3' ' CG2' ' A' ' 346' ' ' VAL . 7.8 m-70 . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.878 0.371 . . . . 0.0 110.874 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 295' ' ' THR . . . . . 0.448 HG21 ' N ' ' A' ' 296' ' ' VAL . 24.7 m -136.49 143.5 43.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.148 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 296' ' ' VAL . . . . . 0.448 ' N ' HG21 ' A' ' 295' ' ' THR . 27.0 m -128.92 150.45 34.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.106 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 28.3 ttpp -119.1 132.36 56.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.902 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 7.3 mp -105.95 103.1 12.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.869 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 299' ' ' ARG . . . . . 0.518 ' HD3' ' CE1' ' A' ' 335' ' ' TYR . 38.0 tpt85 -104.45 122.68 46.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.896 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . 0.411 ' C ' ' O ' ' A' ' 361' ' ' TYR . . . 133.36 -25.1 3.67 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.501 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . 0.465 ' HA ' ' CD1' ' A' ' 362' ' ' ILE . . . -59.52 144.11 85.0 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.571 0.7 . . . . 0.0 111.095 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -167.74 0.24 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.665 2.243 . . . . 0.0 112.341 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 303' ' ' PHE . . . . . 0.411 ' CD1' ' C ' ' A' ' 303' ' ' PHE . 1.8 p90 -95.81 -12.8 24.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.87 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -93.33 3.01 56.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.94 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 305' ' ' VAL . . . . . . . . . . . . . 7.5 p -78.39 143.23 12.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.109 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 306' ' ' THR . . . . . . . . . . . . . 16.6 p -131.92 162.73 29.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.115 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -38.93 -49.16 1.66 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.932 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 30.2 ttmt -50.87 -58.69 5.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.86 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -49.91 -43.01 49.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.891 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 99.0 t -60.56 -49.09 85.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.155 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 311' ' ' MET . . . . . . . . . . . . . 3.1 mmt -50.11 -39.09 41.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.822 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -71.7 -35.49 70.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.898 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 313' ' ' PHE . . . . . 0.556 ' CZ ' HG22 ' A' ' 362' ' ' ILE . 1.6 t80 -74.82 -31.06 61.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.86 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 50.5 mt -84.24 -26.18 28.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.95 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 315' ' ' ALA . . . . . 0.47 ' HA ' ' C ' ' A' ' 316' ' ' PRO . . . -51.45 163.3 0.59 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.576 0.703 . . . . 0.0 111.105 179.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 316' ' ' PRO . . . . . 0.47 ' C ' ' HA ' ' A' ' 315' ' ' ALA . 54.1 Cg_endo -69.81 -16.24 12.36 Favored 'Cis proline' 0 C--O 1.232 0.21 0 C-N-CA 122.696 -1.793 . . . . 0.0 112.377 0.005 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 317' ' ' LEU . . . . . 0.44 HD22 ' CB ' ' A' ' 348' ' ' GLN . 23.9 mt -46.7 129.37 11.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.896 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 318' ' ' LYS . . . . . 0.415 ' NZ ' ' HA ' ' A' ' 318' ' ' LYS . 0.2 OUTLIER -105.72 105.75 54.04 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.571 0.701 . . . . 0.0 110.87 179.819 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 319' ' ' PRO . . . . . 0.431 ' HA ' ' CD2' ' A' ' 340' ' ' PHE . 53.2 Cg_endo -69.79 178.46 4.57 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.711 2.274 . . . . 0.0 112.297 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 320' ' ' VAL . . . . . 0.414 HG22 ' C ' ' A' ' 340' ' ' PHE . 61.8 t -100.01 -37.06 5.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.093 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -160.83 137.95 9.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.118 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 322' ' ' ILE . . . . . . . . . . . . . 74.0 mt -110.69 109.31 27.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.13 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 63.8 mmt-85 -107.1 105.12 14.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.898 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 67.1 mt -76.42 126.97 37.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.127 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . 0.448 HG22 ' CD2' ' A' ' 337' ' ' PHE . 48.8 t . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.16 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 335' ' ' TYR . . . . . 0.518 ' CE1' ' HD3' ' A' ' 299' ' ' ARG . 8.4 m-85 . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.905 0.383 . . . . 0.0 110.896 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 336' ' ' ILE . . . . . 0.418 HG13 ' C ' ' A' ' 335' ' ' TYR . 88.7 mt -151.04 116.19 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.103 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . 0.448 ' CD2' HG22 ' A' ' 325' ' ' VAL . 31.6 m-85 -90.55 134.76 34.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.845 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 17.4 t -134.62 141.49 43.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.113 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -113.82 161.33 17.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.849 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 340' ' ' PHE . . . . . 0.431 ' CD2' ' HA ' ' A' ' 319' ' ' PRO . 67.0 m-85 -139.18 167.56 21.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.864 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 22.7 m -72.28 -68.46 0.47 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.828 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 342' ' ' ASN . . . . . 0.548 ' ND2' ' H ' ' A' ' 345' ' ' GLU . 2.3 p-10 -99.11 -176.04 3.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.883 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 343' ' ' GLU . . . . . 0.434 ' O ' ' N ' ' A' ' 346' ' ' VAL . 12.0 pt-20 -83.56 -47.26 11.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.884 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 344' ' ' GLU . . . . . 0.482 ' N ' HD21 ' A' ' 342' ' ' ASN . 7.3 mm-40 -44.01 -30.13 0.69 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.914 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 345' ' ' GLU . . . . . 0.548 ' H ' ' ND2' ' A' ' 342' ' ' ASN . 16.7 mt-10 -73.59 -35.8 65.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.876 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . 0.434 ' N ' ' O ' ' A' ' 343' ' ' GLU . 61.7 t -68.85 -59.12 3.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.163 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.81 -29.04 62.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.893 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 348' ' ' GLN . . . . . 0.44 ' CB ' HD22 ' A' ' 317' ' ' LEU . 29.6 mt-30 -73.11 -32.44 64.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.948 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -62.0 -36.44 81.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.089 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 350' ' ' LEU . . . . . 0.401 HD13 ' CD ' ' A' ' 366' ' ' ARG . 57.1 mt -60.99 -24.78 66.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.913 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 20.8 mmtp -49.72 -44.87 48.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.948 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 352' ' ' CYS . . . . . . . . . . . . . 22.3 m -78.21 72.28 4.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.865 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -109.24 147.71 32.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.883 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 50.4 ttm-85 70.15 30.44 3.49 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.883 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 355' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -88.52 173.74 8.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.936 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 356' ' ' TYR . . . . . 0.425 ' CD1' ' N ' ' A' ' 356' ' ' TYR . 1.7 m-85 -125.31 117.73 24.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.911 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 357' ' ' MET . . . . . 0.444 ' SD ' ' CD2' ' A' ' 313' ' ' PHE . 4.3 ptm -142.26 123.36 14.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.907 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 86.29 -20.37 22.24 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.51 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 117.24 13.45 7.61 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.494 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 360' ' ' ARG . . . . . . . . . . . . . 21.5 mmt-85 -140.75 158.52 43.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.815 0.34 . . . . 0.0 110.823 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 361' ' ' TYR . . . . . 0.411 ' O ' ' C ' ' A' ' 300' ' ' GLY . 13.0 p90 -67.14 163.62 19.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.94 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 362' ' ' ILE . . . . . 0.556 HG22 ' CZ ' ' A' ' 313' ' ' PHE . 15.1 mm -140.57 144.58 27.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.154 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 363' ' ' GLU . . . . . 0.414 ' N ' HG23 ' A' ' 362' ' ' ILE . 31.9 mt-10 -138.42 112.19 8.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.861 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 45.9 t -84.6 134.54 26.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.155 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -131.01 152.94 49.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.913 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . 0.401 ' CD ' HD13 ' A' ' 350' ' ' LEU . 51.6 mtm180 -101.43 113.35 26.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.866 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.87 -179.937 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 31.9 m80 . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.843 0.354 . . . . 0.0 110.886 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 295' ' ' THR . . . . . 0.438 HG22 ' N ' ' A' ' 296' ' ' VAL . 85.0 m -140.55 143.44 35.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.116 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 296' ' ' VAL . . . . . 0.438 ' N ' HG22 ' A' ' 295' ' ' THR . 27.2 m -116.99 147.77 20.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.123 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 13.9 ttmt -125.37 137.38 54.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.921 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . 0.471 HD22 ' CE1' ' A' ' 313' ' ' PHE . 6.8 mp -120.86 118.31 29.63 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.919 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -115.75 155.62 27.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.828 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 86.86 36.58 9.09 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.451 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -102.2 147.72 34.36 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.622 0.725 . . . . 0.0 111.113 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 175.98 7.37 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.713 2.275 . . . . 0.0 112.372 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 56.0 t80 -80.97 -29.26 35.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.876 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -86.89 35.44 0.69 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.903 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 305' ' ' VAL . . . . . . . . . . . . . 11.8 p -98.45 145.05 10.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.116 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 306' ' ' THR . . . . . . . . . . . . . 64.4 p -141.36 164.97 28.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.099 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -44.88 -34.95 2.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.915 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? -57.74 -47.06 83.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.909 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 23.2 m120 -60.19 -59.41 5.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.9 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 85.2 t -48.89 -41.51 13.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.152 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 311' ' ' MET . . . . . . . . . . . . . 2.0 mmt -62.09 -44.76 95.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.861 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -68.24 -26.41 65.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.881 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 313' ' ' PHE . . . . . 0.471 ' CE1' HD22 ' A' ' 298' ' ' LEU . 5.5 t80 -75.33 -40.91 57.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.866 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 57.9 mt -83.1 -24.89 32.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.921 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 315' ' ' ALA . . . . . 0.507 ' HA ' ' C ' ' A' ' 316' ' ' PRO . . . -44.58 156.74 0.33 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.579 0.704 . . . . 0.0 111.133 179.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 316' ' ' PRO . . . . . 0.507 ' C ' ' HA ' ' A' ' 315' ' ' ALA . 53.6 Cg_endo -69.85 -19.09 11.52 Favored 'Cis proline' 0 C--O 1.232 0.21 0 C-N-CA 122.661 -1.808 . . . . 0.0 112.332 0.08 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 317' ' ' LEU . . . . . 0.413 HD23 ' CD ' ' A' ' 345' ' ' GLU . 35.7 mt -39.01 138.4 0.57 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.894 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 12.6 tppt? -119.64 107.49 40.57 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.551 0.691 . . . . 0.0 110.889 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 319' ' ' PRO . . . . . 0.476 ' HA ' ' CD2' ' A' ' 340' ' ' PHE . 54.0 Cg_endo -69.78 -171.02 0.43 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.648 2.232 . . . . 0.0 112.333 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 320' ' ' VAL . . . . . 0.42 HG22 ' C ' ' A' ' 340' ' ' PHE . 65.2 t -106.68 -41.75 6.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.11 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -155.06 129.8 9.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.118 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 322' ' ' ILE . . . . . . . . . . . . . 91.7 mt -100.97 99.8 9.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.152 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 9.5 mmm180 -98.74 103.44 15.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.908 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 324' ' ' ILE . . . . . 0.466 ' CG2' HG12 ' A' ' 336' ' ' ILE . 58.7 mt -81.01 134.86 26.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.128 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . 0.404 HG22 ' CE2' ' A' ' 337' ' ' PHE . 45.5 t . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.16 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 335' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.919 0.39 . . . . 0.0 110.911 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 336' ' ' ILE . . . . . 0.466 HG12 ' CG2' ' A' ' 324' ' ' ILE . 30.2 mt -145.63 143.48 21.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.114 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . 0.404 ' CE2' HG22 ' A' ' 325' ' ' VAL . 27.5 m-85 -110.67 123.52 50.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.859 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 93.8 t -126.0 126.57 69.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.136 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -101.36 160.61 14.27 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.905 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 340' ' ' PHE . . . . . 0.476 ' CD2' ' HA ' ' A' ' 319' ' ' PRO . 35.9 m-85 -134.68 165.86 24.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.862 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 16.9 t -87.79 -55.34 3.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.831 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -89.54 168.04 12.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.895 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -81.96 -43.16 18.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.883 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -56.93 -54.11 50.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.938 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 345' ' ' GLU . . . . . 0.413 ' CD ' HD23 ' A' ' 317' ' ' LEU . 20.8 mm-40 -41.22 -35.81 0.66 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.888 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . 0.429 ' CG2' ' HB2' ' A' ' 340' ' ' PHE . 53.0 t -74.86 -50.28 25.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.11 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 15.5 mtpp -53.71 -35.75 61.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.879 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 35.3 mm-40 -71.46 -44.06 65.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.926 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -43.58 -40.1 3.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.099 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 350' ' ' LEU . . . . . . . . . . . . . 54.6 mt -58.88 -39.0 80.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.923 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 56.1 mmtt -45.12 -36.69 3.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.932 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 352' ' ' CYS . . . . . . . . . . . . . 64.6 m -71.2 71.99 0.62 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.908 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . 0.401 ' O ' ' C ' ' A' ' 354' ' ' ARG . 16.7 p30 -116.85 -176.46 2.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.913 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . 0.401 ' C ' ' O ' ' A' ' 353' ' ' ASN . 54.0 ttt-85 37.29 49.88 0.96 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.83 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 355' ' ' GLU . . . . . 0.438 ' OE1' ' C ' ' A' ' 355' ' ' GLU . 0.0 OUTLIER -135.94 173.38 11.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.899 -179.983 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 356' ' ' TYR . . . . . 0.434 ' CD1' ' N ' ' A' ' 356' ' ' TYR . 2.7 m-85 -131.7 137.14 48.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.902 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 357' ' ' MET . . . . . 0.426 ' CG ' HG13 ' A' ' 362' ' ' ILE . 0.1 OUTLIER -139.04 128.06 23.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.87 179.89 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 83.03 -28.75 3.58 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.479 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 125.26 28.46 1.1 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.5 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 360' ' ' ARG . . . . . . . . . . . . . 33.7 mtt-85 -151.41 156.99 41.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.861 0.363 . . . . 0.0 110.873 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 361' ' ' TYR . . . . . 0.438 ' O ' ' CG ' ' A' ' 361' ' ' TYR . 2.3 p90 -69.66 125.43 26.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.921 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 362' ' ' ILE . . . . . 0.426 HG13 ' CG ' ' A' ' 357' ' ' MET . 17.3 mm -107.18 151.94 8.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.191 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 363' ' ' GLU . . . . . 0.558 ' HB3' ' CZ ' ' A' ' 365' ' ' PHE . 59.9 mm-40 -143.42 112.16 6.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.881 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 15.9 t -87.81 120.85 37.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.151 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 365' ' ' PHE . . . . . 0.558 ' CZ ' ' HB3' ' A' ' 363' ' ' GLU . 70.7 m-85 -124.85 133.32 53.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.847 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 366' ' ' ARG . . . . . 0.417 ' HB3' ' NH1' ' A' ' 366' ' ' ARG . 6.2 ttp-105 -82.25 111.75 18.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.92 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.876 -179.905 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 N-CA-C 112.492 -0.243 . . . . 0.0 112.492 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 22.0 t 61.19 42.3 12.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.874 0.368 . . . . 0.0 110.866 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 1.5 t -95.17 172.24 8.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.833 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 145.68 92.44 0.13 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.438 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 37.4 m -150.06 113.37 4.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.894 0.378 . . . . 0.0 110.835 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 3.8 t -49.95 136.21 18.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.891 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' GLY . . . . . 0.435 ' O ' ' C ' ' A' ' 291' ' ' THR . . . -158.41 111.24 0.47 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.487 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' THR . . . . . 0.435 ' C ' ' O ' ' A' ' 290' ' ' GLY . 93.3 m -34.47 125.06 0.51 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.856 0.36 . . . . 0.0 111.178 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 64.3 p -102.87 164.84 11.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.181 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' CYS . . . . . . . . . . . . . 23.0 m -67.63 102.35 1.17 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.864 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . 0.563 ' CE1' ' HG3' ' A' ' 343' ' ' GLU . 28.5 m-70 -38.85 132.0 1.29 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.866 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 63.0 m -139.66 142.35 36.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.142 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 296' ' ' VAL . . . . . 0.445 ' CG2' ' HB ' ' A' ' 338' ' ' VAL . 29.2 m -118.5 151.06 20.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.145 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 5.5 ttpm? -119.62 138.51 53.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.868 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 7.4 mp -126.36 128.47 47.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.927 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 27.2 ptt180 -131.93 163.39 28.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.839 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 90.99 28.23 16.14 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.527 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -98.22 148.45 34.52 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.545 0.688 . . . . 0.0 111.115 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -165.9 0.17 Allowed 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.702 2.268 . . . . 0.0 112.303 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -93.21 -13.97 27.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.863 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -102.68 27.6 6.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.935 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 305' ' ' VAL . . . . . . . . . . . . . 10.6 p -90.41 141.78 13.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.068 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 306' ' ' THR . . . . . . . . . . . . . 35.2 p -139.26 -179.05 5.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.137 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -55.26 -35.91 65.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.876 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 28.1 tttp -58.13 -59.37 5.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.881 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -46.1 -47.68 17.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.882 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 58.4 t -58.34 -44.94 89.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.098 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 311' ' ' MET . . . . . . . . . . . . . 4.0 mmt -58.49 -52.0 67.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.884 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -64.12 -29.27 70.41 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.86 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 313' ' ' PHE . . . . . 0.475 ' CD1' ' C ' ' A' ' 313' ' ' PHE . 3.1 t80 -75.49 -41.34 55.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.907 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 46.5 mt -81.65 -25.83 35.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.922 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . 0.47 ' HA ' ' N ' ' A' ' 317' ' ' LEU . . . -46.37 166.56 0.16 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.647 0.736 . . . . 0.0 111.084 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 316' ' ' PRO . . . . . 0.466 ' HA ' ' CB ' ' A' ' 315' ' ' ALA . 54.4 Cg_endo -69.68 -3.58 7.67 Favored 'Cis proline' 0 C--O 1.232 0.205 0 C-N-CA 122.66 -1.808 . . . . 0.0 112.386 -0.044 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 317' ' ' LEU . . . . . 0.47 ' N ' ' HA ' ' A' ' 315' ' ' ALA . 20.8 mt -53.19 156.32 2.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.908 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 9.6 tttp -130.83 102.71 16.12 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.593 0.711 . . . . 0.0 110.895 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 319' ' ' PRO . . . . . 0.547 ' HA ' ' CD2' ' A' ' 340' ' ' PHE . 53.5 Cg_endo -69.77 -179.07 2.66 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.691 2.261 . . . . 0.0 112.333 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 21.7 t -100.72 -39.25 6.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.112 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -156.15 129.92 8.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.086 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 322' ' ' ILE . . . . . . . . . . . . . 54.3 mt -105.78 99.79 9.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.124 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 18.6 mtp85 -94.0 118.62 31.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.874 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 51.7 mt -87.06 124.37 40.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.139 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . 0.467 HG23 ' CD2' ' A' ' 337' ' ' PHE . 53.7 t -64.88 109.33 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.152 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 29.6 mmt180 -99.99 103.48 15.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.895 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 327' ' ' ASN . . . . . 0.478 ' OD1' ' N ' ' A' ' 331' ' ' ASN . 5.8 p-10 -47.2 173.43 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.879 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -47.69 -56.36 7.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.105 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 12.1 m80 -86.06 38.14 0.75 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.822 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . 0.429 ' N ' ' OD1' ' A' ' 327' ' ' ASN . . . 44.6 87.93 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.519 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 331' ' ' ASN . . . . . 0.478 ' N ' ' OD1' ' A' ' 327' ' ' ASN . 31.8 t-20 -158.19 132.99 8.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.915 0.388 . . . . 0.0 110.869 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 23.6 mttt -75.49 95.16 3.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.947 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 333' ' ' THR . . . . . 0.414 ' O ' ' CG2' ' A' ' 333' ' ' THR . 8.8 t -98.36 74.27 2.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.12 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . 0.542 ' O ' ' CG ' ' A' ' 335' ' ' TYR . . . 35.91 70.44 0.2 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.502 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 335' ' ' TYR . . . . . 0.542 ' CG ' ' O ' ' A' ' 334' ' ' GLY . 14.9 m-85 -170.07 121.95 0.67 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.833 0.349 . . . . 0.0 110.914 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 67.5 mt -145.27 117.13 2.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.167 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . 0.467 ' CD2' HG23 ' A' ' 325' ' ' VAL . 71.5 m-85 -87.47 121.35 29.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.835 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . 0.445 ' HB ' ' CG2' ' A' ' 296' ' ' VAL . 46.4 t -124.43 132.06 71.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.138 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 43.4 m-20 -107.95 161.01 15.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.866 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 340' ' ' PHE . . . . . 0.547 ' CD2' ' HA ' ' A' ' 319' ' ' PRO . 62.1 m-85 -138.08 168.78 19.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.895 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 9.5 t -85.22 -62.2 1.59 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.829 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -99.51 150.0 22.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.902 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 343' ' ' GLU . . . . . 0.563 ' HG3' ' CE1' ' A' ' 294' ' ' HIS . 23.3 tt0 -54.72 -45.27 74.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.888 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -40.17 -64.19 0.53 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.871 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . 0.537 ' HB3' ' CD2' ' A' ' 340' ' ' PHE . 16.0 mm-40 -39.43 -46.17 1.62 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.875 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 65.9 t -67.38 -52.24 44.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.112 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 20.6 mtpp -50.73 -39.85 52.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.865 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -73.87 -30.07 62.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.931 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -56.68 -35.56 68.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.055 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 350' ' ' LEU . . . . . . . . . . . . . 83.7 mt -65.5 -35.77 81.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.963 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 76.4 mttt -45.92 -50.29 14.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.914 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 352' ' ' CYS . . . . . . . . . . . . . 31.7 m -69.06 72.23 0.26 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.92 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -107.68 158.94 16.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.902 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 70.0 mtt180 54.22 46.72 24.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.907 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 355' ' ' GLU . . . . . 0.478 ' C ' ' CD1' ' A' ' 356' ' ' TYR . 1.5 mm-40 -98.55 173.84 6.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.932 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 356' ' ' TYR . . . . . 0.478 ' CD1' ' C ' ' A' ' 355' ' ' GLU . 2.9 m-85 -139.22 115.98 10.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.958 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 357' ' ' MET . . . . . . . . . . . . . 3.6 ptt? -142.07 145.96 34.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.902 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 78.01 -46.81 2.74 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.487 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 359' ' ' GLY . . . . . 0.433 ' O ' ' CG ' ' A' ' 360' ' ' ARG . . . 141.74 34.89 0.1 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.477 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 360' ' ' ARG . . . . . 0.433 ' CG ' ' O ' ' A' ' 359' ' ' GLY . 56.8 mtt180 -164.3 156.04 16.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.793 0.33 . . . . 0.0 110.897 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 361' ' ' TYR . . . . . 0.519 ' CD1' ' O ' ' A' ' 361' ' ' TYR . 1.8 p90 -70.66 133.48 46.7 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.871 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 27.2 mm -111.98 143.75 21.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.128 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 363' ' ' GLU . . . . . 0.511 ' HB3' ' CZ ' ' A' ' 365' ' ' PHE . 21.1 mm-40 -130.96 113.18 13.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.904 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 21.6 t -88.68 141.85 13.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.129 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 365' ' ' PHE . . . . . 0.511 ' CZ ' ' HB3' ' A' ' 363' ' ' GLU . 56.7 m-85 -141.8 141.49 33.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.906 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 31.7 ttt180 -87.71 114.78 24.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.841 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -80.99 100.22 8.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.869 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 24.7 ttmt -50.82 -53.1 34.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.864 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 26.7 t -50.68 -58.06 6.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.85 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 111.99 -95.79 0.82 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.495 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 144.92 55.36 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.692 2.261 . . . . 0.0 112.327 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 372' ' ' SER . . . . . . . . . . . . . 56.9 p -130.15 -48.8 1.1 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.861 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 3.0 m -59.01 111.58 1.36 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.797 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.442 179.969 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 N-CA-C 112.499 -0.24 . . . . 0.0 112.499 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 3.4 m -110.13 42.09 1.6 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.853 0.359 . . . . 0.0 110.874 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 34.0 t -82.7 114.71 21.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.842 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -122.12 40.58 2.03 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.482 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 7.5 t -95.45 39.09 1.13 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.891 0.377 . . . . 0.0 110.856 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 8.6 t -116.9 106.04 13.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.849 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 174.49 -36.87 0.11 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.532 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 291' ' ' THR . . . . . 0.574 ' O ' ' CE1' ' A' ' 294' ' ' HIS . 52.0 m -37.37 -41.41 0.42 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.851 0.358 . . . . 0.0 111.101 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 30.3 m -69.31 143.98 53.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.122 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 293' ' ' CYS . . . . . . . . . . . . . 5.3 t 67.22 51.28 0.92 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.879 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . 0.574 ' CE1' ' O ' ' A' ' 291' ' ' THR . 22.7 m-70 -55.65 112.83 1.24 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.876 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 6.3 m -134.0 133.85 41.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.121 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 36.0 m -112.05 148.64 15.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.147 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 8.2 ttpm? -117.96 150.6 38.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.884 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . 0.557 HD23 ' CE2' ' A' ' 313' ' ' PHE . 7.0 mp -132.92 152.23 51.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.956 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 13.2 ptt180 -154.16 176.44 12.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.825 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 82.79 -21.36 7.79 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.555 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -58.2 151.78 45.19 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.637 0.732 . . . . 0.0 111.062 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.8 178.6 4.43 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.705 2.27 . . . . 0.0 112.313 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -85.17 -15.66 42.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.902 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 35.7 t-20 -99.24 35.75 1.87 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.904 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 305' ' ' VAL . . . . . . . . . . . . . 6.3 p -100.8 142.55 15.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.155 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 306' ' ' THR . . . . . . . . . . . . . 25.5 p -128.46 164.74 22.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.13 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -44.35 -50.25 9.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.881 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -43.53 -52.12 6.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.865 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -56.13 -43.87 78.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.889 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 92.2 t -61.98 -39.06 82.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.153 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 311' ' ' MET . . . . . . . . . . . . . 4.1 mmt -63.67 -44.17 94.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.858 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -67.96 -29.06 68.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.907 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 313' ' ' PHE . . . . . 0.557 ' CE2' HD23 ' A' ' 298' ' ' LEU . 36.6 t80 -72.64 -47.06 50.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.9 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . 0.433 ' CD1' HG13 ' A' ' 338' ' ' VAL . 49.4 mt -79.04 -18.27 53.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.904 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . 0.468 ' HA ' ' N ' ' A' ' 317' ' ' LEU . . . -51.25 166.78 0.31 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.613 0.72 . . . . 0.0 111.082 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 316' ' ' PRO . . . . . 0.465 ' HA ' ' CB ' ' A' ' 315' ' ' ALA . 54.0 Cg_endo -69.72 -3.81 7.87 Favored 'Cis proline' 0 C--O 1.232 0.204 0 C-N-CA 122.72 -1.783 . . . . 0.0 112.321 -0.004 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 317' ' ' LEU . . . . . 0.468 ' N ' ' HA ' ' A' ' 315' ' ' ALA . 19.4 mt -50.72 165.28 0.11 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.897 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 35.3 tttt -140.4 105.05 6.51 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.609 0.718 . . . . 0.0 110.889 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -177.61 1.94 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.684 2.256 . . . . 0.0 112.359 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 59.1 t -100.58 -41.41 8.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.145 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -158.2 134.57 9.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.079 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 322' ' ' ILE . . . . . . . . . . . . . 60.9 mt -105.6 101.56 12.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.121 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 20.5 mmt85 -96.29 96.79 9.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.847 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . 0.405 HG22 ' NZ ' ' A' ' 332' ' ' LYS . 74.6 mt -68.0 122.14 18.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.124 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 47.0 t -59.39 103.58 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.156 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 53.0 mtt180 -92.16 110.41 21.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.876 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -56.26 -45.4 80.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.887 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . 0.429 ' O ' ' C ' ' A' ' 329' ' ' HIS . . . -169.5 156.26 6.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.11 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 329' ' ' HIS . . . . . 0.429 ' C ' ' O ' ' A' ' 328' ' ' ALA . 5.1 t-160 35.09 50.23 0.47 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.862 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 39.7 77.42 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.536 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -115.84 161.27 19.01 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.922 0.392 . . . . 0.0 110.896 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 332' ' ' LYS . . . . . 0.405 ' NZ ' HG22 ' A' ' 324' ' ' ILE . 0.0 OUTLIER -98.68 78.25 2.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.905 179.881 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 9.9 t -165.54 127.52 2.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.139 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 132.03 -112.8 1.21 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.471 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 335' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -135.34 -179.19 5.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.876 0.369 . . . . 0.0 110.866 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 55.3 mt -137.64 122.96 24.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.158 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -98.05 126.58 43.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.87 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . 0.433 HG13 ' CD1' ' A' ' 314' ' ' LEU . 99.1 t -124.0 131.01 73.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.132 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -105.55 160.41 15.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.879 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -137.94 166.0 25.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.887 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 2.1 m -90.64 -44.19 9.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.891 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -98.63 169.39 9.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.926 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 343' ' ' GLU . . . . . 0.43 ' HB3' ' CE1' ' A' ' 294' ' ' HIS . 2.2 mp0 -85.15 -55.48 4.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.882 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -43.32 -46.72 6.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.863 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . 0.405 ' CD ' HD23 ' A' ' 317' ' ' LEU . 5.7 mm-40 -50.05 -39.04 40.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.912 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . 0.441 ' CG2' ' HB3' ' A' ' 294' ' ' HIS . 46.3 t -70.35 -58.24 5.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.15 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 15.7 mtmt -50.03 -26.21 4.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.91 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 25.2 mm100 -82.54 -38.95 23.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.918 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -47.32 -30.93 3.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.131 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 350' ' ' LEU . . . . . . . . . . . . . 48.0 mt -63.78 -36.96 85.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.873 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -47.19 -44.2 21.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.92 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 352' ' ' CYS . . . . . . . . . . . . . 8.0 m -64.59 83.19 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.922 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . 0.449 ' O ' ' CG ' ' A' ' 354' ' ' ARG . 48.8 t30 -140.43 177.91 7.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.868 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . 0.449 ' CG ' ' O ' ' A' ' 353' ' ' ASN . 7.9 ptp85 44.78 37.22 2.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.904 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 355' ' ' GLU . . . . . 0.423 ' C ' ' CD ' ' A' ' 355' ' ' GLU . 0.0 OUTLIER -125.69 172.63 9.63 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.904 -179.974 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 356' ' ' TYR . . . . . 0.414 ' CD1' ' N ' ' A' ' 356' ' ' TYR . 1.8 m-85 -118.94 146.61 44.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.911 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 357' ' ' MET . . . . . . . . . . . . . 3.2 ptt? -164.24 125.58 2.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.887 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 86.02 -31.75 3.95 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.449 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 359' ' ' GLY . . . . . 0.461 ' O ' ' CG ' ' A' ' 360' ' ' ARG . . . 126.91 30.6 0.8 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.509 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 360' ' ' ARG . . . . . 0.461 ' CG ' ' O ' ' A' ' 359' ' ' GLY . 59.8 mtt180 -164.76 164.59 21.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.743 0.306 . . . . 0.0 110.93 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 361' ' ' TYR . . . . . . . . . . . . . 27.3 p90 -67.05 159.34 28.93 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.891 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 12.5 mm -138.07 125.22 28.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.11 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 363' ' ' GLU . . . . . 0.421 ' HB3' ' CZ ' ' A' ' 365' ' ' PHE . 28.2 mm-40 -118.85 118.23 30.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.824 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 93.8 t -95.15 143.78 11.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.123 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 365' ' ' PHE . . . . . 0.421 ' CZ ' ' HB3' ' A' ' 363' ' ' GLU . 68.6 m-85 -141.97 148.95 39.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.863 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 35.7 ttp85 -96.98 112.18 24.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.884 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -86.39 97.19 10.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.881 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . 0.405 ' HG2' ' N ' ' A' ' 369' ' ' SER . 0.0 OUTLIER -64.16 -31.71 73.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.883 179.972 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 369' ' ' SER . . . . . 0.405 ' N ' ' HG2' ' A' ' 368' ' ' LYS . 62.1 m -78.4 -60.65 2.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.842 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 108.28 -154.72 16.45 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.505 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 1.82 4.13 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.675 2.25 . . . . 0.0 112.287 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 372' ' ' SER . . . . . . . . . . . . . 8.7 t -134.16 133.84 41.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.878 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 47.2 t -97.72 -44.12 6.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.831 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.277 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.472 179.979 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.285 0 N-CA-C 112.469 -0.252 . . . . 0.0 112.469 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 34.4 m -72.01 108.33 5.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.873 0.368 . . . . 0.0 110.868 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 1.3 t -106.12 -58.57 1.9 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.856 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 86.46 178.91 49.47 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.524 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 48.7 m -101.99 109.03 20.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.864 0.364 . . . . 0.0 110.863 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 62.8 p -151.91 145.4 24.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.867 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 137.41 90.83 0.26 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.524 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 66.9 p -46.6 167.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.87 0.367 . . . . 0.0 111.105 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 24.2 m -61.26 127.24 30.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.143 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 293' ' ' CYS . . . . . . . . . . . . . 4.4 t -134.52 151.01 50.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.879 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . 0.412 ' HB3' ' CG2' ' A' ' 346' ' ' VAL . 3.8 m170 -110.64 83.91 1.84 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.838 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 295' ' ' THR . . . . . 0.404 HG23 ' N ' ' A' ' 296' ' ' VAL . 12.1 m -125.64 142.43 51.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.147 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 296' ' ' VAL . . . . . 0.404 ' N ' HG23 ' A' ' 295' ' ' THR . 27.0 m -118.64 147.47 22.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.124 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -120.85 138.78 53.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.925 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 6.9 mp -119.57 141.9 48.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.926 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 299' ' ' ARG . . . . . 0.417 ' HB2' ' CE1' ' A' ' 335' ' ' TYR . 13.3 ptt180 -141.58 151.14 42.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.887 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 96.24 16.66 36.99 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.488 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -78.87 147.29 70.19 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.566 0.698 . . . . 0.0 111.105 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.69 169.79 18.0 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.698 2.265 . . . . 0.0 112.386 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 303' ' ' PHE . . . . . 0.458 ' O ' ' CG ' ' A' ' 303' ' ' PHE . 10.3 t80 -70.93 -8.93 56.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.858 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -111.51 41.42 1.89 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.923 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 305' ' ' VAL . . . . . . . . . . . . . 7.7 p -101.98 149.23 6.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.132 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 306' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -148.31 167.26 25.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.178 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -49.68 -20.41 0.81 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.921 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 9.9 ttmm -74.88 -53.32 9.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.852 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -51.67 -34.16 37.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.87 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 54.2 t -69.74 -46.01 75.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.146 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 311' ' ' MET . . . . . 0.416 ' HG2' ' CD1' ' A' ' 322' ' ' ILE . 4.1 mmt -53.37 -48.25 68.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.87 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -68.17 -25.5 65.28 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.929 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 313' ' ' PHE . . . . . 0.494 ' CD1' ' C ' ' A' ' 313' ' ' PHE . 2.6 t80 -75.58 -46.81 29.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.886 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 65.4 mt -78.01 -25.39 47.94 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.919 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . 0.467 ' HA ' ' N ' ' A' ' 317' ' ' LEU . . . -44.4 166.25 0.12 Allowed Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.585 0.707 . . . . 0.0 111.08 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 316' ' ' PRO . . . . . 0.451 ' C ' ' HA ' ' A' ' 315' ' ' ALA . 53.5 Cg_endo -69.72 -3.77 7.84 Favored 'Cis proline' 0 C--N 1.341 0.178 0 C-N-CA 122.664 -1.806 . . . . 0.0 112.361 0.03 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 317' ' ' LEU . . . . . 0.467 ' N ' ' HA ' ' A' ' 315' ' ' ALA . 27.7 mt -50.03 170.8 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.895 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 33.3 tttt -145.24 105.05 4.38 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.551 0.691 . . . . 0.0 110.923 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 319' ' ' PRO . . . . . 0.545 ' HA ' ' CD2' ' A' ' 340' ' ' PHE . 53.5 Cg_endo -69.79 -175.94 1.33 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.692 2.261 . . . . 0.0 112.33 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 320' ' ' VAL . . . . . 0.4 HG21 ' C ' ' A' ' 340' ' ' PHE . 31.1 t -101.12 -39.78 7.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.12 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -156.84 131.64 8.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.123 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 322' ' ' ILE . . . . . 0.416 ' CD1' ' HG2' ' A' ' 311' ' ' MET . 66.7 mt -110.23 108.74 26.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.131 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 27.7 mmm-85 -108.18 121.85 45.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.877 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 60.8 mt -89.71 120.59 38.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.131 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 20.6 t -47.54 100.53 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.107 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 56.0 mtm-85 -96.43 124.06 40.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.904 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -52.42 178.52 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.87 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -51.02 -56.25 13.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.068 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 4.5 m80 -74.15 -62.55 1.47 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.877 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 159.23 99.4 0.15 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.478 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -172.97 120.32 0.36 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.889 0.376 . . . . 0.0 110.884 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 12.0 mttp -54.38 98.04 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.878 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 333' ' ' THR . . . . . 0.497 ' O ' ' N ' ' A' ' 335' ' ' TYR . 26.8 p -79.48 54.62 1.78 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.116 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . 0.432 ' O ' ' C ' ' A' ' 335' ' ' TYR . . . 58.48 -77.78 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.452 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 335' ' ' TYR . . . . . 0.497 ' N ' ' O ' ' A' ' 333' ' ' THR . 3.6 m-85 -34.54 148.32 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.84 0.352 . . . . 0.0 110.938 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 43.5 mt -145.95 147.51 18.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.169 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -119.89 128.46 53.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.879 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 21.7 t -129.31 136.82 58.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.167 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -113.74 155.46 25.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.857 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 340' ' ' PHE . . . . . 0.545 ' CD2' ' HA ' ' A' ' 319' ' ' PRO . 53.5 m-85 -132.08 166.35 21.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.848 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 36.2 p -88.53 -58.12 2.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.896 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 67.3 m-80 -87.63 159.13 18.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.925 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -78.28 -23.54 47.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.902 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -67.64 -49.25 63.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.894 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -48.58 -50.3 33.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.848 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . 0.43 ' CG2' ' HB2' ' A' ' 340' ' ' PHE . 54.9 t -60.8 -56.01 20.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.143 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 24.9 mtpp -51.38 -32.62 26.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.877 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -83.27 -24.03 32.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.879 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -65.0 -26.25 68.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.075 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 350' ' ' LEU . . . . . . . . . . . . . 42.8 mt -75.34 -7.83 55.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.919 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 1.5 mmmp? -72.95 -32.61 65.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.915 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 352' ' ' CYS . . . . . . . . . . . . . 15.5 m -79.69 72.36 6.37 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.899 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -122.55 174.08 7.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.906 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 23.6 mtt180 53.22 28.42 7.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.847 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 355' ' ' GLU . . . . . 0.411 ' C ' ' OE1' ' A' ' 355' ' ' GLU . 0.0 OUTLIER -117.7 174.45 6.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.906 -179.951 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 356' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -124.8 128.14 48.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.925 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 357' ' ' MET . . . . . 0.422 ' HG3' ' CD1' ' A' ' 362' ' ' ILE . 0.0 OUTLIER -130.77 130.92 44.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.875 179.914 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 83.14 -41.7 2.93 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.462 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 359' ' ' GLY . . . . . 0.447 ' O ' ' CG ' ' A' ' 360' ' ' ARG . . . 141.92 33.27 0.12 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.468 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 360' ' ' ARG . . . . . 0.447 ' CG ' ' O ' ' A' ' 359' ' ' GLY . 71.5 mtt180 -165.19 161.64 19.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.794 0.331 . . . . 0.0 110.924 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 361' ' ' TYR . . . . . . . . . . . . . 13.6 p90 -63.74 144.27 57.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.976 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 362' ' ' ILE . . . . . 0.422 ' CD1' ' HG3' ' A' ' 357' ' ' MET . 6.5 mm -130.72 135.05 61.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.161 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 363' ' ' GLU . . . . . 0.493 ' HB2' ' CZ ' ' A' ' 365' ' ' PHE . 15.7 mt-10 -126.35 112.71 15.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.864 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 57.3 t -88.61 124.0 41.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.129 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 365' ' ' PHE . . . . . 0.493 ' CZ ' ' HB2' ' A' ' 363' ' ' GLU . 21.9 m-85 -121.66 142.74 49.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.856 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . 0.432 ' CZ ' ' HB3' ' A' ' 366' ' ' ARG . 9.8 ttp-105 -84.94 127.98 34.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.871 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -112.54 79.26 1.2 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.921 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.41 -21.69 61.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.881 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 46.9 m -62.41 -42.89 99.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.865 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 107.85 -158.48 14.88 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.483 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -178.84 2.54 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.676 2.251 . . . . 0.0 112.329 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 372' ' ' SER . . . . . 0.415 ' O ' ' C ' ' A' ' 373' ' ' SER . 15.2 m -115.54 -52.99 2.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.838 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 373' ' ' SER . . . . . 0.415 ' C ' ' O ' ' A' ' 372' ' ' SER . 59.6 p -36.12 145.49 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.828 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.496 179.995 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 N-CA-C 112.497 -0.241 . . . . 0.0 112.497 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 45.8 t -79.92 86.09 5.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.861 0.362 . . . . 0.0 110.831 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 4.6 m 39.84 38.93 0.5 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.852 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -126.3 51.01 0.85 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.471 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 97.1 p -50.11 -34.19 21.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.858 0.361 . . . . 0.0 110.831 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 2.0 m -100.9 127.12 47.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.885 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . -179.34 30.78 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.473 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 41.3 p -138.16 172.49 12.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.89 0.376 . . . . 0.0 111.11 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 79.2 p -85.69 107.55 17.62 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.165 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 293' ' ' CYS . . . . . . . . . . . . . 5.7 m -127.63 131.9 49.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.898 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . 0.443 ' CE1' ' HG2' ' A' ' 343' ' ' GLU . 33.6 m80 -129.42 106.12 8.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.9 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 26.5 m -139.42 139.65 37.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.161 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 296' ' ' VAL . . . . . 0.453 ' CG1' HG12 ' A' ' 346' ' ' VAL . 33.2 m -112.27 148.88 15.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.154 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . 0.538 ' HE3' ' CD1' ' A' ' 335' ' ' TYR . 56.4 tttt -122.55 131.19 53.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.931 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 7.9 mp -108.82 154.55 21.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.885 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 299' ' ' ARG . . . . . 0.482 ' HD2' ' CE1' ' A' ' 335' ' ' TYR . 13.0 ttt-85 -162.08 136.02 6.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.878 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 128.6 -18.19 5.74 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.487 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -65.64 151.42 94.69 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.547 0.689 . . . . 0.0 111.117 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -176.4 1.48 Allowed 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.679 2.253 . . . . 0.0 112.347 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 303' ' ' PHE . . . . . 0.484 ' CD1' ' C ' ' A' ' 303' ' ' PHE . 0.5 OUTLIER -76.43 -27.74 56.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.931 179.986 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 23.8 p-10 -92.81 43.76 1.13 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.893 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 305' ' ' VAL . . . . . . . . . . . . . 12.7 p -101.98 141.02 19.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.106 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 306' ' ' THR . . . . . . . . . . . . . 66.8 p -130.93 169.38 15.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.169 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -46.7 -45.91 19.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.903 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 20.9 ttmm -48.29 -57.07 6.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.919 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 25.4 m120 -48.45 -41.76 30.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.904 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 95.9 t -69.33 -42.01 81.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.109 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 311' ' ' MET . . . . . . . . . . . . . 3.6 mmt -58.41 -50.38 73.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.896 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -65.77 -24.83 67.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.883 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 313' ' ' PHE . . . . . 0.602 ' CD1' ' C ' ' A' ' 313' ' ' PHE . 0.5 OUTLIER -83.77 -28.68 28.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.888 -179.938 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 33.1 mt -90.9 -23.66 20.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.865 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . 0.46 ' HA ' ' C ' ' A' ' 316' ' ' PRO . . . -52.1 166.02 0.44 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.546 0.688 . . . . 0.0 111.136 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 316' ' ' PRO . . . . . 0.46 ' C ' ' HA ' ' A' ' 315' ' ' ALA . 53.6 Cg_endo -69.72 -7.6 9.98 Favored 'Cis proline' 0 C--O 1.231 0.161 0 C-N-CA 122.703 -1.791 . . . . 0.0 112.328 -0.031 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 317' ' ' LEU . . . . . . . . . . . . . 47.3 mt -56.04 144.35 29.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.883 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 14.3 tptp -120.42 110.73 35.51 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.563 0.696 . . . . 0.0 110.86 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 319' ' ' PRO . . . . . 0.545 ' HA ' ' CD1' ' A' ' 340' ' ' PHE . 53.7 Cg_endo -69.78 -163.83 0.12 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.694 2.262 . . . . 0.0 112.328 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 21.7 t -118.61 -41.25 2.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.131 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -151.69 124.13 8.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.075 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 322' ' ' ILE . . . . . . . . . . . . . 65.4 mt -98.86 102.39 13.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.141 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 9.2 tpt180 -86.1 116.04 24.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.82 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 72.5 mt -88.63 117.11 31.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.115 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 50.7 t -84.57 89.06 2.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.124 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.47 -179.6 7.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.913 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -117.92 175.16 5.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.878 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -41.07 -70.61 0.1 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.096 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 11.1 m170 -58.42 -51.84 68.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.83 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 142.6 33.74 0.1 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.467 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -111.35 117.45 33.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.893 0.377 . . . . 0.0 110.87 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 8.1 mptt -71.68 107.35 4.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.899 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 333' ' ' THR . . . . . 0.412 ' O ' ' C ' ' A' ' 334' ' ' GLY . 70.7 p -86.07 69.91 10.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.135 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . 0.522 ' O ' ' CG ' ' A' ' 335' ' ' TYR . . . 36.91 77.79 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.499 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 335' ' ' TYR . . . . . 0.538 ' CD1' ' HE3' ' A' ' 297' ' ' LYS . 7.0 m-85 -169.61 122.09 0.73 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.811 0.338 . . . . 0.0 110.995 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 336' ' ' ILE . . . . . 0.411 HG13 ' C ' ' A' ' 335' ' ' TYR . 85.4 mt -149.73 136.93 13.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.188 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . 0.58 ' CD1' ' OE2' ' A' ' 367' ' ' GLU . 55.5 m-85 -108.71 116.08 31.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.889 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . 0.407 ' HB ' ' CG2' ' A' ' 296' ' ' VAL . 87.0 t -112.62 127.67 69.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.117 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -105.36 139.19 40.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.854 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 340' ' ' PHE . . . . . 0.545 ' CD1' ' HA ' ' A' ' 319' ' ' PRO . 64.2 m-85 -117.22 157.86 25.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.887 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 2.4 m -79.11 -56.07 4.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.872 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 47.3 m-20 -91.93 158.3 16.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.871 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 343' ' ' GLU . . . . . 0.443 ' HG2' ' CE1' ' A' ' 294' ' ' HIS . 53.7 mt-10 -71.46 -44.84 64.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.892 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -47.91 -50.5 26.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.874 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -46.19 -45.65 16.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.91 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . 0.453 HG12 ' CG1' ' A' ' 296' ' ' VAL . 66.7 t -68.14 -52.08 41.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.118 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 25.1 mtpp -51.37 -38.44 53.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.903 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 70.4 mm-40 -78.13 -42.85 30.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.886 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -42.8 -42.4 3.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.054 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 350' ' ' LEU . . . . . . . . . . . . . 40.3 mt -58.85 -42.95 90.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.879 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 65.6 mmtt -42.89 -48.05 5.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.893 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 352' ' ' CYS . . . . . . . . . . . . . 19.9 m -69.11 72.68 0.28 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.883 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -112.55 156.01 23.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.923 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 7.6 ttt85 66.72 29.27 8.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.896 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 355' ' ' GLU . . . . . 0.424 ' HB2' ' CE2' ' A' ' 313' ' ' PHE . 4.4 mm-40 -83.87 173.4 11.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.861 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 356' ' ' TYR . . . . . 0.45 ' CD1' ' N ' ' A' ' 356' ' ' TYR . 1.3 m-85 -131.8 127.41 36.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.904 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 357' ' ' MET . . . . . . . . . . . . . 3.9 ptt? -154.74 142.32 19.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.859 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 78.45 -42.86 2.24 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.448 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 135.65 29.76 0.36 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.542 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 360' ' ' ARG . . . . . . . . . . . . . 61.3 mtt-85 -158.67 158.09 33.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.789 0.328 . . . . 0.0 110.929 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 361' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -66.88 157.17 33.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.941 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 9.1 mm -140.15 149.55 21.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.145 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 363' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -137.17 121.0 17.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.907 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 72.0 t -90.48 131.83 36.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.166 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -125.76 138.62 53.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.874 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 18.2 ttp180 -92.67 109.31 20.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.863 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . 0.58 ' OE2' ' CD1' ' A' ' 337' ' ' PHE . 20.1 mt-10 -64.02 81.88 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.866 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 10.5 ptpp? -55.36 -31.24 61.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.863 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 30.5 t -131.75 56.96 1.79 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.84 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . -74.52 145.21 33.98 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.45 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 120.48 7.26 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.646 2.231 . . . . 0.0 112.355 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 372' ' ' SER . . . . . . . . . . . . . 6.6 t -97.33 -45.83 6.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.875 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 13.2 t -112.19 170.46 8.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.835 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.479 -179.999 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 N-CA-C 112.463 -0.255 . . . . 0.0 112.463 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 3.5 m -133.49 111.76 10.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.839 0.352 . . . . 0.0 110.852 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 28.7 t -126.39 148.33 49.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.862 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -176.22 153.59 14.88 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.501 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 50.4 p -61.74 153.39 28.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.895 0.379 . . . . 0.0 110.886 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 28.9 p -128.98 89.28 2.85 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.85 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 100.31 52.95 1.11 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.473 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 85.2 m -152.86 129.82 11.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.92 0.39 . . . . 0.0 111.138 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 67.0 p -118.93 116.15 25.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.111 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 293' ' ' CYS . . . . . . . . . . . . . 9.9 m -104.99 174.89 5.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.882 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . 0.499 ' CE1' ' HB3' ' A' ' 343' ' ' GLU . 33.4 m80 -129.36 84.25 2.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.858 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 25.5 m -121.17 142.65 49.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.182 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 28.2 m -119.15 149.49 21.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.121 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . 0.531 ' HG3' ' CE1' ' A' ' 337' ' ' PHE . 16.8 ttmt -117.37 143.62 45.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.896 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . 0.496 HD23 ' CD2' ' A' ' 313' ' ' PHE . 7.1 mp -122.0 121.43 37.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.917 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 299' ' ' ARG . . . . . 0.618 ' NE ' ' CD2' ' A' ' 365' ' ' PHE . 25.4 mtt180 -122.36 162.01 22.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.896 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 95.12 -23.28 34.07 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.511 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -56.13 152.49 21.93 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.588 0.708 . . . . 0.0 111.11 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.71 -173.14 0.66 Allowed 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.701 2.267 . . . . 0.0 112.376 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -90.7 -26.03 19.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.891 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -95.34 44.44 1.09 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.886 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 305' ' ' VAL . . . . . 0.408 ' CG1' ' NZ ' ' A' ' 332' ' ' LYS . 10.8 p -105.22 139.69 25.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.134 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 306' ' ' THR . . . . . . . . . . . . . 41.6 p -124.33 171.2 10.09 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.151 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -48.61 -54.14 15.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.862 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 21.5 ttmt -41.34 -48.81 3.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.91 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -56.95 -41.06 77.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.908 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 87.2 t -65.7 -51.23 64.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.093 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 311' ' ' MET . . . . . . . . . . . . . 3.2 mmt -51.58 -40.06 59.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.851 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -74.09 -30.81 62.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.885 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 313' ' ' PHE . . . . . 0.555 ' CZ ' HG22 ' A' ' 362' ' ' ILE . 27.2 t80 -73.24 -41.67 63.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.892 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 86.9 mt -80.95 -26.11 36.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.922 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . 0.491 ' HA ' ' C ' ' A' ' 316' ' ' PRO . . . -45.54 161.54 0.24 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.569 0.7 . . . . 0.0 111.097 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 316' ' ' PRO . . . . . 0.491 ' C ' ' HA ' ' A' ' 315' ' ' ALA . 53.9 Cg_endo -69.71 -13.76 12.32 Favored 'Cis proline' 0 C--O 1.232 0.219 0 C-N-CA 122.725 -1.781 . . . . 0.0 112.341 -0.04 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 317' ' ' LEU . . . . . . . . . . . . . 83.1 mt -43.09 135.13 3.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.916 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 4.9 tmtt? -111.71 100.54 48.65 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.574 0.702 . . . . 0.0 110.905 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 319' ' ' PRO . . . . . 0.569 ' HA ' ' CD2' ' A' ' 340' ' ' PHE . 53.9 Cg_endo -69.77 -175.39 1.14 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.644 2.23 . . . . 0.0 112.36 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 39.0 t -100.04 -43.63 11.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.102 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -157.3 144.19 18.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.138 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 322' ' ' ILE . . . . . . . . . . . . . 60.4 mt -116.15 103.41 15.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.112 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 55.2 mtt-85 -98.42 116.3 30.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.862 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 60.0 mt -85.87 124.89 40.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.114 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . 0.554 ' CG2' ' CD2' ' A' ' 337' ' ' PHE . 15.8 t -80.55 118.49 28.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.104 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 3.1 ptp180 -90.26 163.58 14.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.859 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 327' ' ' ASN . . . . . 0.452 ' CB ' ' OD1' ' A' ' 331' ' ' ASN . 1.2 t30 -77.68 150.64 34.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.859 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . 0.428 ' C ' ' O ' ' A' ' 327' ' ' ASN . . . -34.82 -68.93 0.11 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.088 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 9.6 m170 -51.7 -58.78 5.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.845 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 146.04 66.29 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.52 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 331' ' ' ASN . . . . . 0.452 ' OD1' ' CB ' ' A' ' 327' ' ' ASN . 8.9 p30 -144.79 145.81 31.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.923 0.392 . . . . 0.0 110.872 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 332' ' ' LYS . . . . . 0.422 ' HD3' ' C ' ' A' ' 332' ' ' LYS . 5.6 tmtt? -59.7 105.54 0.38 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.928 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 333' ' ' THR . . . . . 0.422 ' CG2' ' O ' ' A' ' 325' ' ' VAL . 2.5 t -95.65 173.5 7.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.147 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . 0.496 ' O ' ' CD1' ' A' ' 335' ' ' TYR . . . -86.36 61.95 4.37 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.474 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 335' ' ' TYR . . . . . 0.496 ' CD1' ' O ' ' A' ' 334' ' ' GLY . 32.2 m-85 -154.28 138.75 16.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.835 0.35 . . . . 0.0 110.897 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 78.5 mt -146.9 149.11 16.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.145 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . 0.554 ' CD2' ' CG2' ' A' ' 325' ' ' VAL . 17.4 m-85 -121.38 122.02 38.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.902 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 38.1 t -121.21 126.02 74.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.114 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -104.14 157.29 17.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.884 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 340' ' ' PHE . . . . . 0.569 ' CD2' ' HA ' ' A' ' 319' ' ' PRO . 69.4 m-85 -134.52 167.96 19.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.881 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 30.8 t -87.65 -57.2 3.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.881 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -89.91 160.18 16.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.893 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 343' ' ' GLU . . . . . 0.499 ' HB3' ' CE1' ' A' ' 294' ' ' HIS . 10.5 pt-20 -78.05 -14.35 59.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.874 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -75.73 -44.51 41.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.906 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . 0.5 ' HB3' ' CD2' ' A' ' 340' ' ' PHE . 45.5 mt-10 -55.4 -40.17 71.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.883 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . 0.476 HG23 ' CD1' ' A' ' 340' ' ' PHE . 67.3 t -74.17 -41.28 51.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.158 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 33.5 mtpt -59.89 -29.54 68.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.882 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -88.16 -28.34 21.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.907 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -55.57 -35.72 66.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.082 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 350' ' ' LEU . . . . . . . . . . . . . 42.6 mt -67.41 -38.63 84.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.905 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 16.8 mmtp -56.63 -25.47 53.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.909 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 352' ' ' CYS . . . . . . . . . . . . . 40.4 t -78.44 57.9 2.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.86 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -110.57 170.64 7.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.906 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 13.4 mmt180 61.85 29.24 17.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.83 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 355' ' ' GLU . . . . . 0.516 ' C ' ' CD1' ' A' ' 356' ' ' TYR . 12.4 mm-40 -97.68 172.5 7.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.908 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 356' ' ' TYR . . . . . 0.516 ' CD1' ' C ' ' A' ' 355' ' ' GLU . 1.3 m-85 -138.44 122.87 18.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.931 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 357' ' ' MET . . . . . . . . . . . . . 1.7 ptt? -148.23 155.74 41.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.878 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 60.57 7.93 8.71 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.449 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 83.76 27.18 39.21 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.517 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 360' ' ' ARG . . . . . . . . . . . . . 15.1 mmm180 -147.68 177.43 9.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.8 0.333 . . . . 0.0 110.893 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 361' ' ' TYR . . . . . . . . . . . . . 29.2 p90 -92.39 149.3 21.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.891 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 362' ' ' ILE . . . . . 0.555 HG22 ' CZ ' ' A' ' 313' ' ' PHE . 14.5 mm -118.64 149.93 20.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.127 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 363' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -141.02 112.67 7.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.891 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 11.2 t -88.23 140.7 15.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.148 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 365' ' ' PHE . . . . . 0.618 ' CD2' ' NE ' ' A' ' 299' ' ' ARG . 72.4 m-85 -139.93 143.7 36.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.891 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 17.7 ttp85 -91.81 122.19 34.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.836 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . 0.411 ' OE1' ' N ' ' A' ' 297' ' ' LYS . 5.7 mp0 -106.73 127.6 53.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.829 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 52.2 tttm -98.02 -33.65 11.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.881 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 1.4 p -84.43 6.87 21.68 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.84 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 59.34 -172.89 4.42 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.481 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.83 114.15 3.62 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.635 2.223 . . . . 0.0 112.325 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 372' ' ' SER . . . . . . . . . . . . . 76.8 p -63.85 119.77 10.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.845 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 2.9 t -88.72 142.43 27.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.849 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.442 179.999 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . 0.44 ' O ' ' C ' ' A' ' 285' ' ' SER . . . . . . . . 0 N--CA 1.451 -0.336 0 N-CA-C 112.504 -0.239 . . . . 0.0 112.504 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 285' ' ' SER . . . . . 0.44 ' C ' ' O ' ' A' ' 284' ' ' GLY . 35.6 p 34.96 43.28 0.1 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.844 0.354 . . . . 0.0 110.865 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 2.3 m -88.35 42.27 1.06 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.846 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -134.32 -54.65 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.437 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 1.4 t -86.5 146.95 26.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.878 0.37 . . . . 0.0 110.894 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 9.1 m -51.56 141.99 15.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.871 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . -173.59 -52.12 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.504 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 13.5 t -90.6 -30.87 16.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.861 0.362 . . . . 0.0 111.167 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 88.5 m -91.21 85.7 5.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.179 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 293' ' ' CYS . . . . . . . . . . . . . 96.9 m -117.33 128.3 54.91 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.897 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -96.6 92.1 6.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.897 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 54.5 m -121.41 150.1 42.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.141 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 296' ' ' VAL . . . . . 0.403 ' CG2' ' HB ' ' A' ' 338' ' ' VAL . 27.3 m -118.02 146.16 22.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.113 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . 0.553 ' HG3' ' CE1' ' A' ' 337' ' ' PHE . 16.3 ttmt -117.67 142.68 46.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.917 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . 0.518 HD22 ' CE2' ' A' ' 313' ' ' PHE . 7.9 mp -123.67 135.63 54.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.913 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 9.7 ttm-85 -144.76 132.94 21.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.877 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 129.18 -19.89 5.38 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.455 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -57.75 152.15 38.28 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.571 0.7 . . . . 0.0 111.1 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.72 177.38 5.61 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.711 2.274 . . . . 0.0 112.338 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -72.37 -24.11 61.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.9 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -98.71 47.78 0.98 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.891 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 305' ' ' VAL . . . . . . . . . . . . . 9.4 p -104.62 141.44 20.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.148 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 306' ' ' THR . . . . . . . . . . . . . 66.6 p -136.3 162.86 31.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.155 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -37.85 -46.74 0.97 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.923 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 36.4 tttm -45.5 -56.83 4.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.886 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 21.2 m120 -50.82 -49.11 59.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.905 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 86.9 t -58.0 -41.54 80.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.082 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 311' ' ' MET . . . . . . . . . . . . . 1.9 mmt -61.12 -53.08 61.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.86 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.64 -36.23 78.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.905 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 313' ' ' PHE . . . . . 0.518 ' CE2' HD22 ' A' ' 298' ' ' LEU . 15.4 t80 -70.67 -44.28 67.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.878 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . 0.472 ' CD1' HG11 ' A' ' 338' ' ' VAL . 32.9 mt -73.41 -25.59 60.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.934 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . 0.461 ' HA ' ' C ' ' A' ' 316' ' ' PRO . . . -51.25 165.4 0.4 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.579 0.704 . . . . 0.0 111.102 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 316' ' ' PRO . . . . . 0.461 ' C ' ' HA ' ' A' ' 315' ' ' ALA . 54.1 Cg_endo -69.75 -9.52 11.04 Favored 'Cis proline' 0 C--O 1.232 0.183 0 C-N-CA 122.673 -1.803 . . . . 0.0 112.367 -0.017 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 317' ' ' LEU . . . . . . . . . . . . . 33.8 mt -54.96 139.03 42.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.888 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.32 109.48 51.47 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.591 0.71 . . . . 0.0 110.904 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 319' ' ' PRO . . . . . 0.519 ' HA ' ' CD2' ' A' ' 340' ' ' PHE . 53.5 Cg_endo -69.78 -171.94 0.53 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.673 2.249 . . . . 0.0 112.329 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 80.2 t -104.51 -39.55 5.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.098 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -164.18 129.09 2.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.118 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 322' ' ' ILE . . . . . . . . . . . . . 50.8 mt -100.53 105.25 17.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.147 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 15.4 mmm180 -99.04 119.98 38.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.856 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . 0.43 ' O ' ' C ' ' A' ' 325' ' ' VAL . 64.0 mt -91.38 117.48 34.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.148 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . 0.447 ' O ' ' C ' ' A' ' 326' ' ' ARG . 22.4 t -35.38 145.14 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.115 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 326' ' ' ARG . . . . . 0.447 ' C ' ' O ' ' A' ' 325' ' ' VAL . 1.6 ptt-85 -34.37 108.7 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.861 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 327' ' ' ASN . . . . . 0.429 ' CG ' ' N ' ' A' ' 328' ' ' ALA . 8.2 p-10 -107.58 -52.23 2.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.923 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . 0.429 ' N ' ' CG ' ' A' ' 327' ' ' ASN . . . -63.42 -63.58 1.14 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.109 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 6.1 m170 -45.43 -47.84 13.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.826 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -104.01 -91.05 2.19 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.502 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 331' ' ' ASN . . . . . 0.4 ' O ' ' C ' ' A' ' 332' ' ' LYS . 5.6 t-20 -166.74 136.25 3.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.843 0.354 . . . . 0.0 110.909 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 332' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' A' ' 331' ' ' ASN . 0.5 OUTLIER -38.17 126.14 1.3 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.882 179.949 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 333' ' ' THR . . . . . 0.423 ' CG2' ' HB ' ' A' ' 325' ' ' VAL . 0.0 OUTLIER -126.34 143.9 51.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.104 179.997 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -62.94 -16.87 57.76 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.521 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 335' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -69.28 137.28 52.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.881 0.372 . . . . 0.0 110.921 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 73.6 mt -147.4 129.3 6.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.126 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . 0.553 ' CE1' ' HG3' ' A' ' 297' ' ' LYS . 61.6 m-85 -104.25 127.52 51.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.893 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . 0.472 HG11 ' CD1' ' A' ' 314' ' ' LEU . 22.5 t -126.07 135.72 63.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.128 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -106.05 161.19 14.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.852 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 340' ' ' PHE . . . . . 0.55 ' CD2' ' HB3' ' A' ' 345' ' ' GLU . 41.6 m-85 -138.06 171.03 15.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.842 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 3.9 m -81.46 -64.35 1.2 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.855 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -95.42 166.04 12.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.863 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -76.11 -16.09 59.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.861 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -70.99 -50.8 30.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.892 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . 0.55 ' HB3' ' CD2' ' A' ' 340' ' ' PHE . 16.5 mm-40 -50.67 -41.03 55.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.904 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 95.0 t -68.1 -53.2 31.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.132 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp -52.31 -44.65 65.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.897 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -64.5 -40.56 95.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.919 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -42.52 -43.06 3.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.15 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 350' ' ' LEU . . . . . . . . . . . . . 21.4 mt -57.42 -36.77 71.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.9 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 1.5 mmmp? -44.73 -50.55 9.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.859 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 352' ' ' CYS . . . . . . . . . . . . . 3.5 m -73.97 80.33 1.68 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.871 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -121.63 149.61 42.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.898 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? 73.18 35.82 0.9 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.907 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 355' ' ' GLU . . . . . 0.431 ' C ' ' CD1' ' A' ' 356' ' ' TYR . 3.1 mm-40 -95.89 173.52 7.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.87 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 356' ' ' TYR . . . . . 0.488 ' CD1' ' N ' ' A' ' 356' ' ' TYR . 1.1 m-85 -134.55 124.22 25.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.93 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 357' ' ' MET . . . . . 0.427 ' HE2' ' CG ' ' A' ' 313' ' ' PHE . 2.4 ptt? -147.82 139.53 23.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.859 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 78.98 -14.37 14.44 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.455 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 113.25 6.08 22.49 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.461 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 360' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -134.03 168.49 18.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.785 0.326 . . . . 0.0 110.899 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 361' ' ' TYR . . . . . . . . . . . . . 8.4 p90 -84.59 157.31 21.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.878 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 10.7 mm -133.69 156.93 41.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.122 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 363' ' ' GLU . . . . . 0.438 ' HB3' ' CZ ' ' A' ' 365' ' ' PHE . 7.4 mm-40 -142.95 123.66 14.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.909 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 364' ' ' VAL . . . . . 0.497 ' O ' ' CD1' ' A' ' 365' ' ' PHE . 53.1 t -98.7 141.65 16.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.101 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 365' ' ' PHE . . . . . 0.497 ' CD1' ' O ' ' A' ' 364' ' ' VAL . 28.5 m-85 -144.37 137.04 26.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.854 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . 0.467 ' CZ ' ' HB3' ' A' ' 366' ' ' ARG . 9.4 ttp-105 -81.65 119.32 23.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.885 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -82.84 100.37 10.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.865 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . 0.409 ' C ' ' HD3' ' A' ' 368' ' ' LYS . 0.0 OUTLIER -63.57 -17.8 63.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.923 179.977 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 78.4 p -111.27 -62.52 1.53 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.851 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 107.06 -158.25 15.19 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.5 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 86.23 0.59 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.68 2.254 . . . . 0.0 112.369 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 372' ' ' SER . . . . . . . . . . . . . 68.8 m -90.73 104.28 16.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.884 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 14.6 m 52.83 39.23 28.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.848 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.364 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.513 -179.987 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.297 0 N-CA-C 112.491 -0.244 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 48.6 m -127.89 111.14 13.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.864 0.364 . . . . 0.0 110.869 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 33.3 m -144.19 130.16 19.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.87 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -88.96 -131.15 3.97 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.49 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 93.7 p -51.49 173.72 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.883 0.373 . . . . 0.0 110.845 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 25.3 m -82.98 -45.9 13.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.834 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 151.41 -125.9 1.97 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.501 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 58.0 m -121.9 83.61 2.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.903 0.383 . . . . 0.0 111.156 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 70.6 p -139.98 146.48 39.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.108 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 293' ' ' CYS . . . . . . . . . . . . . 1.8 t -114.0 175.13 5.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.867 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . 0.559 ' CE1' ' HB3' ' A' ' 343' ' ' GLU . 48.9 m80 -38.81 121.65 1.08 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.895 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 28.1 m -129.28 144.89 51.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.121 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 27.8 m -117.19 147.93 20.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.135 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . 0.487 ' HG3' ' CE1' ' A' ' 337' ' ' PHE . 9.2 ttmm -116.01 135.58 53.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.901 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 6.4 mp -122.92 126.66 47.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.909 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 299' ' ' ARG . . . . . 0.547 ' NH1' ' CZ ' ' A' ' 335' ' ' TYR . 0.7 OUTLIER -127.01 167.96 15.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.873 179.945 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 76.82 38.32 31.59 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.477 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -104.64 152.31 39.41 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.568 0.699 . . . . 0.0 111.099 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 -172.79 0.62 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.669 2.246 . . . . 0.0 112.312 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -87.21 -31.18 20.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.88 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -87.42 39.98 0.9 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.907 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 305' ' ' VAL . . . . . . . . . . . . . 7.2 p -102.37 136.99 32.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.144 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 306' ' ' THR . . . . . . . . . . . . . 52.8 p -136.73 173.5 11.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.13 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -46.62 -30.8 2.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.881 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -69.18 -59.21 3.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.913 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -44.11 -34.4 1.79 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.909 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 22.0 t -74.6 -46.05 43.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.12 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 311' ' ' MET . . . . . . . . . . . . . 5.5 mmt -53.68 -44.45 69.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.892 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -67.47 -30.69 70.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.903 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 313' ' ' PHE . . . . . 0.527 ' CE2' HG22 ' A' ' 362' ' ' ILE . 2.4 t80 -74.68 -39.05 62.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.919 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 34.5 mt -81.01 -21.6 40.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.913 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . 0.467 ' CB ' ' HA ' ' A' ' 316' ' ' PRO . . . -51.93 166.57 0.38 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.561 0.696 . . . . 0.0 111.142 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 316' ' ' PRO . . . . . 0.467 ' HA ' ' CB ' ' A' ' 315' ' ' ALA . 53.9 Cg_endo -69.75 -8.49 10.51 Favored 'Cis proline' 0 C--O 1.232 0.194 0 C-N-CA 122.694 -1.794 . . . . 0.0 112.342 -0.005 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 317' ' ' LEU . . . . . . . . . . . . . 46.0 mt -48.09 165.72 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.943 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 6.7 tttp -140.31 104.96 6.56 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.59 0.71 . . . . 0.0 110.91 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 319' ' ' PRO . . . . . 0.475 ' HA ' ' CD2' ' A' ' 340' ' ' PHE . 53.1 Cg_endo -69.75 -168.64 0.28 Allowed 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.72 2.28 . . . . 0.0 112.345 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 25.6 t -111.23 -38.07 3.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.127 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -156.06 140.6 16.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.119 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 322' ' ' ILE . . . . . . . . . . . . . 53.1 mt -118.57 115.26 47.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.128 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -105.56 128.19 53.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.887 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 73.2 mt -94.06 136.89 24.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.089 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . 0.453 HG21 ' CE2' ' A' ' 337' ' ' PHE . 43.4 t -98.94 113.69 34.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.109 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 12.5 mtt85 -99.95 131.03 46.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.844 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -44.9 165.68 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.921 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -55.15 -55.76 27.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.085 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 46.1 m80 -57.88 -59.59 5.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.935 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 152.1 43.93 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.518 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -118.56 156.59 28.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.888 0.375 . . . . 0.0 110.868 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 25.5 mttm -82.48 86.79 6.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.877 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 9.3 t -77.53 155.61 31.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.117 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . 0.436 ' O ' ' CG ' ' A' ' 335' ' ' TYR . . . -70.36 81.43 0.38 Allowed Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.441 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 335' ' ' TYR . . . . . 0.547 ' CZ ' ' NH1' ' A' ' 299' ' ' ARG . 8.7 m-85 -166.99 124.73 1.28 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.819 0.343 . . . . 0.0 110.959 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 96.9 mt -144.98 144.99 21.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.146 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . 0.487 ' CE1' ' HG3' ' A' ' 297' ' ' LYS . 68.7 m-85 -120.51 131.78 54.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.86 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 46.7 t -130.58 140.66 48.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.103 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -110.62 159.22 17.76 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.878 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 340' ' ' PHE . . . . . 0.475 ' CD2' ' HA ' ' A' ' 319' ' ' PRO . 71.3 m-85 -134.72 172.02 13.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.875 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 40.8 t -79.33 -66.36 0.88 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.874 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 342' ' ' ASN . . . . . 0.553 ' ND2' ' H ' ' A' ' 342' ' ' ASN . 0.0 OUTLIER -98.7 176.94 5.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.908 -179.992 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 343' ' ' GLU . . . . . 0.559 ' HB3' ' CE1' ' A' ' 294' ' ' HIS . 3.1 pm0 -84.81 -16.25 42.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.863 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -68.91 -33.36 73.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.86 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . 0.405 ' HB3' ' CD2' ' A' ' 340' ' ' PHE . 52.0 mt-10 -68.55 -51.01 47.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.834 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 87.1 t -58.63 -52.16 63.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.104 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 33.4 mtpt -46.95 -45.49 20.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.884 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 22.5 mm-40 -67.78 -33.5 74.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.9 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -55.19 -36.06 65.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.107 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 350' ' ' LEU . . . . . . . . . . . . . 69.2 mt -64.66 -42.58 95.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.898 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 58.1 mmtt -42.57 -48.55 5.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.858 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 352' ' ' CYS . . . . . . . . . . . . . 16.1 m -70.68 73.95 0.57 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.869 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -110.65 152.9 25.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.923 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 22.0 mtt85 61.78 37.6 15.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.893 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 355' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -92.47 174.17 7.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.865 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 356' ' ' TYR . . . . . 0.454 ' CD1' ' N ' ' A' ' 356' ' ' TYR . 1.4 m-85 -126.58 105.62 8.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.937 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 357' ' ' MET . . . . . 0.403 ' O ' ' CG ' ' A' ' 357' ' ' MET . 0.1 OUTLIER -127.37 118.82 24.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.914 179.923 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 90.09 -36.99 3.42 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.468 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 131.03 29.53 0.61 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.497 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 360' ' ' ARG . . . . . . . . . . . . . 47.0 mtt-85 -152.99 140.42 19.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.782 0.325 . . . . 0.0 110.878 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 361' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -54.1 129.95 36.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.962 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 362' ' ' ILE . . . . . 0.527 HG22 ' CE2' ' A' ' 313' ' ' PHE . 32.4 mm -109.14 146.12 15.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.113 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 363' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -138.26 112.14 8.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.87 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 58.8 t -86.56 136.15 23.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.148 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -131.82 129.73 40.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.909 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 18.8 ttt180 -78.46 115.98 18.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.897 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -97.19 104.82 16.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.89 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.3 -43.83 73.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.898 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 3.9 m -70.0 -58.57 3.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.88 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 109.48 -161.87 12.92 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.498 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.76 2.61 3.38 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.74 2.294 . . . . 0.0 112.286 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 372' ' ' SER . . . . . . . . . . . . . 19.8 p -38.38 -39.06 0.41 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.813 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 373' ' ' SER . . . . . 0.421 ' O ' ' C ' ' A' ' 374' ' ' GLY . 63.9 p -100.4 121.01 40.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.869 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 374' ' ' GLY . . . . . 0.421 ' C ' ' O ' ' A' ' 373' ' ' SER . . . . . . . . 0 N--CA 1.451 -0.342 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.493 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.366 0 N-CA-C 112.539 -0.224 . . . . 0.0 112.539 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 16.0 m -105.12 92.23 4.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.852 0.358 . . . . 0.0 110.825 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 23.3 t -122.95 114.49 20.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.835 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -152.54 -96.95 0.14 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.462 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 40.9 t -73.3 132.49 43.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.913 0.387 . . . . 0.0 110.857 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 60.9 p -41.58 -49.52 4.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.86 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 176.77 -43.48 0.1 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.487 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 9.7 t -81.56 128.3 33.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.866 0.365 . . . . 0.0 111.115 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 67.2 p -72.86 135.29 45.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.116 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 293' ' ' CYS . . . . . . . . . . . . . 1.9 t -114.42 150.31 34.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.884 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 39.4 m-70 -101.94 95.41 6.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.891 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 38.9 m -137.45 139.35 40.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.18 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 14.4 m -118.64 153.92 20.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.137 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . 0.563 ' HE2' ' CE1' ' A' ' 337' ' ' PHE . 2.1 tppp? -112.38 145.94 39.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.875 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . 0.465 ' N ' ' HG3' ' A' ' 297' ' ' LYS . 6.9 mp -132.78 108.57 9.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.902 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 21.9 ptt180 -119.14 146.9 44.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.909 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 114.29 -9.13 22.58 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.447 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -68.48 151.51 97.18 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.572 0.701 . . . . 0.0 111.095 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.71 173.35 11.06 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.676 2.25 . . . . 0.0 112.317 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 303' ' ' PHE . . . . . 0.437 ' C ' ' CD1' ' A' ' 303' ' ' PHE . 6.1 t80 -74.07 -33.23 63.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.854 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 55.7 m-20 -90.44 48.51 1.56 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.861 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 305' ' ' VAL . . . . . . . . . . . . . 9.5 p -105.07 164.22 4.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.165 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 306' ' ' THR . . . . . 0.435 ' OG1' ' N ' ' A' ' 307' ' ' GLU . 0.0 OUTLIER -149.19 171.06 17.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.169 -179.968 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 307' ' ' GLU . . . . . 0.435 ' N ' ' OG1' ' A' ' 306' ' ' THR . 38.6 mt-10 -54.98 -23.38 18.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.914 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 53.6 tttp -70.74 -65.52 0.72 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.926 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -40.14 -37.88 0.68 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.876 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 46.9 t -65.64 -50.47 71.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.144 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 311' ' ' MET . . . . . . . . . . . . . 3.4 mmt -51.38 -39.24 56.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.875 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -66.53 -39.72 88.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.913 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -70.46 -46.24 64.19 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.836 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 29.9 mt -72.83 -26.16 61.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.956 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . 0.481 ' HA ' ' C ' ' A' ' 316' ' ' PRO . . . -48.49 162.89 0.33 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.616 0.722 . . . . 0.0 111.074 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 316' ' ' PRO . . . . . 0.481 ' C ' ' HA ' ' A' ' 315' ' ' ALA . 53.9 Cg_endo -69.74 -10.61 11.54 Favored 'Cis proline' 0 C--N 1.342 0.195 0 C-N-CA 122.693 -1.794 . . . . 0.0 112.383 -0.036 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 317' ' ' LEU . . . . . . . . . . . . . 33.9 mt -39.48 157.97 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.963 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 36.6 tttm -135.05 96.77 14.09 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.602 0.715 . . . . 0.0 110.877 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 319' ' ' PRO . . . . . 0.562 ' HA ' ' CD2' ' A' ' 340' ' ' PHE . 54.3 Cg_endo -69.76 -175.67 1.23 Allowed 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.666 2.244 . . . . 0.0 112.355 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 38.8 t -100.1 -43.62 11.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.112 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -155.74 141.07 17.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.083 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 322' ' ' ILE . . . . . . . . . . . . . 56.8 mt -117.13 100.72 10.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.123 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -100.22 105.06 16.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.89 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 83.5 mt -69.69 114.0 6.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.162 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 59.8 t -49.56 106.46 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.075 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 75.3 mtm180 -90.03 137.96 31.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.838 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 327' ' ' ASN . . . . . 0.437 ' O ' ' C ' ' A' ' 328' ' ' ALA . 28.2 t30 -73.27 157.54 36.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.883 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . 0.437 ' C ' ' O ' ' A' ' 327' ' ' ASN . . . -34.7 -56.65 0.54 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.084 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 9.3 m-70 -69.44 -48.68 60.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.882 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 134.59 74.78 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.49 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 12.1 m-80 -148.33 -178.18 6.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.861 0.362 . . . . 0.0 110.88 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 20.1 mttp -118.73 121.1 39.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.906 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 333' ' ' THR . . . . . 0.44 ' O ' ' C ' ' A' ' 334' ' ' GLY . 61.6 p -125.89 74.96 1.46 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.171 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . 0.476 ' O ' ' CG ' ' A' ' 335' ' ' TYR . . . 34.7 67.44 0.27 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.462 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 335' ' ' TYR . . . . . 0.476 ' CG ' ' O ' ' A' ' 334' ' ' GLY . 5.8 m-85 -168.45 120.03 0.8 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.838 0.351 . . . . 0.0 110.971 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 336' ' ' ILE . . . . . 0.412 HG13 ' C ' ' A' ' 335' ' ' TYR . 28.5 mt -144.54 143.27 23.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.109 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . 0.563 ' CE1' ' HE2' ' A' ' 297' ' ' LYS . 15.7 m-85 -108.32 120.99 43.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.875 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 39.3 t -121.03 124.27 71.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.124 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -103.58 159.12 15.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.851 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 340' ' ' PHE . . . . . 0.562 ' CD2' ' HA ' ' A' ' 319' ' ' PRO . 66.7 m-85 -134.93 160.57 37.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.877 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 17.7 t -83.41 -50.43 8.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.808 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 60.5 m-20 -98.32 159.8 14.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.909 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -74.53 -43.57 55.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.929 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -48.38 -41.37 28.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.863 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . 0.423 ' HB3' ' CD2' ' A' ' 340' ' ' PHE . 29.6 mt-10 -56.46 -47.17 79.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.885 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 48.8 t -57.64 -56.87 12.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.113 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.59 -38.19 20.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.929 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 17.9 mm100 -72.84 -37.69 67.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.946 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -52.54 -39.52 61.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.115 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 350' ' ' LEU . . . . . . . . . . . . . 81.4 mt -67.38 -25.13 65.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.958 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 6.5 mmpt? -60.73 -59.7 4.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.895 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 352' ' ' CYS . . . . . . . . . . . . . 69.5 m -65.71 74.05 0.07 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.886 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 55.9 p30 -118.16 168.58 10.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.877 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 19.7 mtt180 61.54 28.96 18.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.908 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 355' ' ' GLU . . . . . 0.42 ' C ' ' CD1' ' A' ' 356' ' ' TYR . 7.0 mm-40 -86.71 174.2 8.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.859 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 356' ' ' TYR . . . . . 0.51 ' CD1' ' N ' ' A' ' 356' ' ' TYR . 0.9 OUTLIER -133.92 99.7 4.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.893 -179.825 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 357' ' ' MET . . . . . . . . . . . . . 5.3 ptt? -126.61 141.93 51.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.936 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 79.22 -43.37 2.48 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.452 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 359' ' ' GLY . . . . . 0.472 ' O ' ' CG ' ' A' ' 360' ' ' ARG . . . 140.92 32.67 0.14 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.481 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 360' ' ' ARG . . . . . 0.472 ' CG ' ' O ' ' A' ' 359' ' ' GLY . 58.1 mtt-85 -164.85 158.15 17.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.802 0.334 . . . . 0.0 110.879 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 361' ' ' TYR . . . . . . . . . . . . . 27.0 p90 -71.83 144.1 49.23 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.908 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 31.2 mm -115.09 142.46 27.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.13 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 363' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -131.15 113.68 14.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.856 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 20.1 t -89.32 134.43 28.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.181 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -131.43 140.82 49.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.886 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 2.1 tmm_? -85.88 124.49 32.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.906 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . 0.412 ' OE1' ' CE1' ' A' ' 337' ' ' PHE . 16.3 mt-10 -106.1 134.02 49.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.935 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 24.2 mtpt -91.48 -53.77 4.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.873 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 22.9 m -63.38 -52.55 61.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.84 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 118.51 -75.99 0.29 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.465 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 142.88 49.18 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.685 2.257 . . . . 0.0 112.368 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 372' ' ' SER . . . . . . . . . . . . . 81.3 p -38.86 154.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.852 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 43.5 m -72.83 159.0 34.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.886 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.474 179.984 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 N-CA-C 112.442 -0.263 . . . . 0.0 112.442 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 3.5 m -99.84 120.63 40.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.854 0.359 . . . . 0.0 110.879 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 78.3 p -136.54 120.41 17.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.878 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -111.15 84.5 0.36 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.459 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 18.2 m -42.07 -55.8 3.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.889 0.376 . . . . 0.0 110.855 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 49.9 m -97.33 -52.51 3.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.875 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 79.54 134.28 1.1 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.502 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 75.0 p -44.14 164.18 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.84 0.352 . . . . 0.0 111.178 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 292' ' ' THR . . . . . 0.568 HG22 ' CE1' ' A' ' 294' ' ' HIS . 32.4 m -57.38 98.66 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.142 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 293' ' ' CYS . . . . . . . . . . . . . 25.0 m -123.65 98.58 5.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.844 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . 0.568 ' CE1' HG22 ' A' ' 292' ' ' THR . 34.6 m80 -109.11 122.51 47.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.856 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 5.0 m -137.12 136.62 38.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.189 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 296' ' ' VAL . . . . . 0.468 ' CG1' HG12 ' A' ' 346' ' ' VAL . 26.8 m -118.13 146.79 22.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.162 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . 0.494 ' HG3' ' CE1' ' A' ' 337' ' ' PHE . 8.3 ttmm -114.2 141.85 47.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.87 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . 0.515 ' CD2' ' CE2' ' A' ' 313' ' ' PHE . 7.4 mp -123.0 149.93 43.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.915 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 64.0 mtt180 -143.91 165.41 27.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.906 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 87.71 -21.25 23.59 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.5 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -58.28 152.09 44.48 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.571 0.701 . . . . 0.0 111.13 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.8 179.25 3.85 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.667 2.244 . . . . 0.0 112.323 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 303' ' ' PHE . . . . . 0.539 ' CD2' ' O ' ' A' ' 332' ' ' LYS . 93.1 m-85 -86.45 -38.09 17.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.864 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -85.4 46.28 1.28 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.929 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 305' ' ' VAL . . . . . . . . . . . . . 12.3 p -103.09 141.39 19.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.14 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 306' ' ' THR . . . . . . . . . . . . . 41.6 p -121.99 169.94 10.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.173 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 41.7 mp0 -50.3 -51.47 44.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.823 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 12.2 tttp -45.02 -45.13 10.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.89 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -61.02 -49.12 78.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.901 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 78.5 t -59.5 -48.58 86.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.14 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 311' ' ' MET . . . . . . . . . . . . . 4.4 mmt -51.08 -42.78 60.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.84 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -69.69 -25.56 63.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.93 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 313' ' ' PHE . . . . . 0.54 ' CZ ' ' CG2' ' A' ' 362' ' ' ILE . 37.1 t80 -76.26 -45.86 30.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.869 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 89.4 mt -79.24 -20.46 48.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.905 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . 0.484 ' HA ' ' C ' ' A' ' 316' ' ' PRO . . . -49.86 162.62 0.46 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.571 0.7 . . . . 0.0 111.095 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 316' ' ' PRO . . . . . 0.484 ' C ' ' HA ' ' A' ' 315' ' ' ALA . 53.2 Cg_endo -69.8 -8.51 10.62 Favored 'Cis proline' 0 C--O 1.232 0.198 0 C-N-CA 122.675 -1.802 . . . . 0.0 112.305 0.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 317' ' ' LEU . . . . . . . . . . . . . 17.5 mt -46.7 156.69 0.18 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.893 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 18.0 ttpt -133.44 105.51 12.07 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.604 0.716 . . . . 0.0 110.89 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -174.65 0.95 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.688 2.259 . . . . 0.0 112.345 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 320' ' ' VAL . . . . . 0.413 HG23 ' C ' ' A' ' 340' ' ' PHE . 21.8 t -108.08 -31.64 2.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.126 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -161.27 130.3 4.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.126 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 322' ' ' ILE . . . . . . . . . . . . . 68.2 mt -107.21 106.82 21.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.139 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 32.7 mmt180 -104.75 101.95 11.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.848 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 66.0 mt -74.68 131.99 34.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.136 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . 0.544 HG23 ' CE2' ' A' ' 337' ' ' PHE . 46.5 t -72.44 90.54 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.127 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 12.5 ptt-85 -87.25 126.63 34.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.907 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 10.2 m-20 -118.15 169.17 9.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.857 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . 50.89 39.07 21.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.107 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 6.8 m80 61.44 41.83 12.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.902 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 116.03 83.16 1.03 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.451 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -170.68 112.68 0.41 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.924 0.392 . . . . 0.0 110.9 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 332' ' ' LYS . . . . . 0.539 ' O ' ' CD2' ' A' ' 303' ' ' PHE . 0.1 OUTLIER -74.52 98.83 3.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.894 179.935 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 24.2 p -90.74 68.28 6.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.132 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . 0.597 ' O ' ' CD1' ' A' ' 335' ' ' TYR . . . 40.21 52.15 3.5 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.469 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 335' ' ' TYR . . . . . 0.597 ' CD1' ' O ' ' A' ' 334' ' ' GLY . 17.2 m-85 -155.88 134.68 11.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.839 0.352 . . . . 0.0 110.93 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 336' ' ' ILE . . . . . 0.467 HG23 ' N ' ' A' ' 337' ' ' PHE . 84.7 mt -149.18 138.11 15.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.145 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . 0.544 ' CE2' HG23 ' A' ' 325' ' ' VAL . 30.9 m-85 -110.51 125.28 53.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.863 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . 0.466 ' HB ' ' CG2' ' A' ' 296' ' ' VAL . 24.2 t -125.5 143.02 40.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.12 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 339' ' ' ASP . . . . . 0.405 ' N ' HG11 ' A' ' 338' ' ' VAL . 4.5 m-20 -119.37 156.68 29.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.905 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 340' ' ' PHE . . . . . 0.511 ' CD2' ' HB3' ' A' ' 345' ' ' GLU . 57.0 m-85 -134.88 166.23 23.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.86 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 1.9 m -85.41 -55.41 4.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.86 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -99.6 162.86 12.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.877 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 343' ' ' GLU . . . . . 0.562 ' HB3' ' CE1' ' A' ' 294' ' ' HIS . 1.2 pm0 -81.13 -15.28 56.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.864 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -71.15 -34.13 70.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.884 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . 0.511 ' HB3' ' CD2' ' A' ' 340' ' ' PHE . 27.1 mt-10 -68.23 -44.84 74.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.932 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . 0.468 HG12 ' CG1' ' A' ' 296' ' ' VAL . 55.4 t -63.66 -47.22 92.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.155 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 32.0 mttm -49.53 -38.89 32.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.914 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 3.7 mm100 -71.88 -46.09 59.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.892 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -49.45 -36.44 22.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.12 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 350' ' ' LEU . . . . . . . . . . . . . 55.5 mt -66.62 -42.77 86.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.938 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 66.6 mttt -58.1 -38.39 76.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.878 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 352' ' ' CYS . . . . . 0.42 ' HB3' ' CD ' ' A' ' 355' ' ' GLU . 72.3 m -76.11 83.9 2.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.873 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -120.71 169.99 9.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.865 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 27.9 mmm180 53.85 39.18 30.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.896 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 355' ' ' GLU . . . . . 0.439 ' OE2' ' CE1' ' A' ' 313' ' ' PHE . 12.3 mt-10 -95.39 174.73 6.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.884 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 356' ' ' TYR . . . . . 0.418 ' CD1' ' N ' ' A' ' 356' ' ' TYR . 1.6 m-85 -122.88 105.38 9.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.928 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 357' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.31 123.69 30.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.904 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 85.13 -33.06 3.42 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.471 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 129.72 29.15 0.71 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.481 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 360' ' ' ARG . . . . . . . . . . . . . 36.6 mtt85 -162.32 145.38 11.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.836 0.35 . . . . 0.0 110.83 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 361' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -47.01 165.93 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.91 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 362' ' ' ILE . . . . . 0.54 ' CG2' ' CZ ' ' A' ' 313' ' ' PHE . 42.7 mm -139.93 145.79 25.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.136 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 363' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -134.63 115.71 14.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.842 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 50.6 t -96.61 142.81 13.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.092 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -144.07 126.75 16.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.868 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 8.1 ttp-105 -68.82 139.09 55.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.862 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -129.08 166.92 18.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.883 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 19.6 mttp -118.29 82.02 1.77 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.861 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 3.3 t 52.8 52.21 14.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.84 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 92.67 153.16 29.86 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.476 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 88.83 0.53 Allowed 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.645 2.23 . . . . 0.0 112.339 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 372' ' ' SER . . . . . . . . . . . . . 18.2 m 41.93 41.87 2.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.91 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 23.3 t -101.6 148.54 25.1 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.858 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.478 -179.975 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . 0.441 ' O ' ' C ' ' A' ' 285' ' ' SER . . . . . . . . 0 N--CA 1.452 -0.296 0 N-CA-C 112.505 -0.238 . . . . 0.0 112.505 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 285' ' ' SER . . . . . 0.441 ' C ' ' O ' ' A' ' 284' ' ' GLY . 53.1 p 35.32 41.38 0.08 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.862 0.363 . . . . 0.0 110.85 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 66.7 m 39.8 50.74 2.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.799 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -93.19 158.33 23.75 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.485 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 16.9 m -96.91 -58.58 1.99 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.875 0.369 . . . . 0.0 110.881 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 7.0 t -52.42 163.57 0.4 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.925 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 144.26 173.38 15.62 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.49 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 9.0 t -100.7 144.27 29.87 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.875 0.369 . . . . 0.0 111.136 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 64.2 p -83.08 101.79 11.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.121 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 293' ' ' CYS . . . . . . . . . . . . . 4.4 m -123.63 150.55 44.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.903 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 25.3 m80 -128.37 107.31 9.65 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.851 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 50.1 m -132.69 151.73 51.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.127 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 296' ' ' VAL . . . . . 0.42 ' CG1' HG12 ' A' ' 346' ' ' VAL . 26.3 m -129.65 157.37 42.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.167 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . 0.416 ' HG3' ' CE1' ' A' ' 337' ' ' PHE . 4.5 ttpm? -125.89 152.4 45.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.899 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . 0.606 ' CD2' ' CE2' ' A' ' 313' ' ' PHE . 6.8 mp -126.35 131.3 51.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.844 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 34.1 ttp85 -136.44 127.78 28.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.872 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 125.41 -8.68 7.85 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.459 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -69.73 150.14 96.67 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.592 0.71 . . . . 0.0 111.092 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 174.32 9.7 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.669 2.246 . . . . 0.0 112.366 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 303' ' ' PHE . . . . . 0.489 ' CD1' ' C ' ' A' ' 303' ' ' PHE . 2.4 t80 -75.54 -27.07 58.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.876 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 25.6 p30 -92.86 46.38 1.23 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.891 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 305' ' ' VAL . . . . . 0.465 ' CG1' ' HE3' ' A' ' 332' ' ' LYS . 9.8 p -106.93 144.27 16.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.151 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 306' ' ' THR . . . . . . . . . . . . . 61.1 p -132.76 167.52 20.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.182 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -43.89 -52.59 6.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.9 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 36.7 tttt -41.25 -55.91 2.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.899 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -50.91 -48.83 60.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.908 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 61.9 t -57.87 -42.36 82.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.133 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 311' ' ' MET . . . . . 0.463 ' HG2' ' CD1' ' A' ' 322' ' ' ILE . 2.6 mmt -61.17 -52.69 63.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.833 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -65.5 -28.0 68.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.892 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 313' ' ' PHE . . . . . 0.606 ' CE2' ' CD2' ' A' ' 298' ' ' LEU . 14.9 t80 -71.11 -43.81 66.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.875 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 61.6 mt -80.86 -26.12 37.16 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.953 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . 0.491 ' HA ' ' C ' ' A' ' 316' ' ' PRO . . . -41.31 161.06 0.13 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.553 0.692 . . . . 0.0 111.108 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 316' ' ' PRO . . . . . 0.491 ' C ' ' HA ' ' A' ' 315' ' ' ALA . 53.5 Cg_endo -69.86 -9.43 11.21 Favored 'Cis proline' 0 C--O 1.232 0.183 0 C-N-CA 122.657 -1.81 . . . . 0.0 112.348 0.071 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 317' ' ' LEU . . . . . . . . . . . . . 73.0 mt -44.62 149.77 0.38 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.944 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 26.2 tttp -127.54 101.33 24.38 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.596 0.712 . . . . 0.0 110.964 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 319' ' ' PRO . . . . . 0.557 ' HA ' ' CD2' ' A' ' 340' ' ' PHE . 53.2 Cg_endo -69.76 -169.96 0.36 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.718 2.278 . . . . 0.0 112.301 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 53.0 t -110.27 -37.18 3.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.137 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -159.18 134.61 8.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.097 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 322' ' ' ILE . . . . . 0.463 ' CD1' ' HG2' ' A' ' 311' ' ' MET . 48.6 mt -110.52 100.52 10.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.106 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -96.03 108.3 20.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.89 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 95.9 mt -74.14 118.43 19.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.132 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . 0.423 ' HB ' ' CB ' ' A' ' 335' ' ' TYR . 25.5 t -62.02 102.05 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.131 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -98.26 152.8 19.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.836 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -94.53 177.27 5.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.924 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -44.94 -69.52 0.13 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.096 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 6.5 m80 -84.78 49.01 1.63 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.895 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 44.97 59.31 4.5 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.488 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -123.34 75.03 1.28 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.886 0.374 . . . . 0.0 110.868 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 332' ' ' LYS . . . . . 0.465 ' HE3' ' CG1' ' A' ' 305' ' ' VAL . 43.7 tttm -51.15 112.98 0.81 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.894 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 333' ' ' THR . . . . . 0.435 ' O ' ' C ' ' A' ' 334' ' ' GLY . 24.0 p -103.53 79.56 1.7 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.144 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . 0.529 ' O ' ' CG ' ' A' ' 335' ' ' TYR . . . 34.99 78.52 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.495 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 335' ' ' TYR . . . . . 0.529 ' CG ' ' O ' ' A' ' 334' ' ' GLY . 9.1 m-85 -168.82 117.96 0.7 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.843 0.354 . . . . 0.0 110.927 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 53.4 mt -138.0 124.94 27.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.12 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . 0.416 ' CE1' ' HG3' ' A' ' 297' ' ' LYS . 25.1 m-85 -99.29 122.3 42.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.864 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 44.1 t -119.7 134.34 63.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.102 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -109.88 164.74 12.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.859 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 340' ' ' PHE . . . . . 0.557 ' CD2' ' HA ' ' A' ' 319' ' ' PRO . 76.1 m-85 -143.37 170.95 14.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.854 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 3.0 p -96.32 -45.99 6.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.872 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -92.43 163.55 13.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.879 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 -87.62 -33.93 18.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.909 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -63.98 -41.05 97.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.901 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -56.34 -49.26 74.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.917 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . 0.42 HG12 ' CG1' ' A' ' 296' ' ' VAL . 71.9 t -58.77 -41.74 83.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.1 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 9.9 mtpm? -58.11 -43.25 87.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.892 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -65.53 -37.71 87.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.907 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -54.46 -17.17 2.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.141 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 350' ' ' LEU . . . . . . . . . . . . . 32.1 mt -92.33 -23.21 19.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.921 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.96 -7.81 9.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.866 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 352' ' ' CYS . . . . . . . . . . . . . 75.7 m -112.24 98.34 7.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.854 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . 0.487 ' O ' ' C ' ' A' ' 354' ' ' ARG . 6.9 p-10 -118.54 -179.64 3.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.907 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . 0.487 ' C ' ' O ' ' A' ' 353' ' ' ASN . 0.0 OUTLIER 31.44 38.25 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.843 179.969 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 355' ' ' GLU . . . . . 0.486 ' N ' ' O ' ' A' ' 353' ' ' ASN . 3.9 mm-40 -81.2 174.67 11.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.877 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 356' ' ' TYR . . . . . 0.494 ' CD1' ' N ' ' A' ' 356' ' ' TYR . 1.0 OUTLIER -134.05 110.28 9.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.929 -179.912 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 357' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.02 124.98 22.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.891 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 87.53 -37.28 3.24 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.515 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 133.92 29.78 0.45 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.495 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 360' ' ' ARG . . . . . . . . . . . . . 55.5 mtt180 -159.63 145.56 15.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.829 0.347 . . . . 0.0 110.884 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 361' ' ' TYR . . . . . . . . . . . . . 48.6 p90 -50.56 159.65 0.49 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.906 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 4.6 mm -143.35 129.15 16.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.137 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 363' ' ' GLU . . . . . 0.473 ' HB3' ' CZ ' ' A' ' 365' ' ' PHE . 6.5 mm-40 -119.3 112.21 19.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.895 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 38.4 t -88.03 131.83 34.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.104 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 365' ' ' PHE . . . . . 0.473 ' CZ ' ' HB3' ' A' ' 363' ' ' GLU . 25.7 m-85 -130.25 150.99 51.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.848 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 28.5 ttt180 -95.57 122.33 38.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.836 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -101.75 156.95 17.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.919 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.6 95.59 5.22 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.911 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 18.3 t 56.59 41.41 28.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.934 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 44.53 74.72 0.2 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.529 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 108.17 2.01 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.695 2.264 . . . . 0.0 112.354 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 372' ' ' SER . . . . . . . . . . . . . 1.5 t -114.49 -45.47 3.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.866 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 25.7 m -118.84 118.66 32.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.903 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.492 -179.957 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 N-CA-C 112.53 -0.228 . . . . 0.0 112.53 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 30.8 m -157.62 139.87 14.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.861 0.363 . . . . 0.0 110.888 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 97.6 p -88.51 42.11 1.05 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.87 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 164.91 54.9 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.457 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 5.1 t -84.33 -48.11 10.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.844 0.354 . . . . 0.0 110.854 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 11.0 t -90.36 86.12 6.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.844 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . -163.49 -58.21 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.519 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 70.8 p -104.41 109.98 22.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.877 0.37 . . . . 0.0 111.125 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 38.3 p -122.05 40.21 3.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.173 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 293' ' ' CYS . . . . . . . . . . . . . 20.0 p -60.27 165.43 3.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.839 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . 0.531 ' CE1' ' HB2' ' A' ' 343' ' ' GLU . 13.9 m-70 -118.76 133.78 55.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.89 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 32.3 m -138.89 116.37 11.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.129 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 29.6 m -98.13 160.67 3.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.138 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . 0.562 ' HD3' ' CE1' ' A' ' 337' ' ' PHE . 31.3 ttpt -139.34 150.14 45.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.892 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . 0.566 HD22 ' CE1' ' A' ' 313' ' ' PHE . 6.8 mp -124.71 135.51 53.09 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.931 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 18.0 ttt-85 -133.56 138.42 46.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.9 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 110.23 10.57 21.93 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.511 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -75.96 143.65 74.6 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.57 0.7 . . . . 0.0 111.09 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 -170.08 0.37 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.667 2.245 . . . . 0.0 112.339 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -90.67 -10.56 42.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.84 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -101.42 25.98 7.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.895 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 305' ' ' VAL . . . . . . . . . . . . . 9.2 p -94.66 140.23 17.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.103 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 306' ' ' THR . . . . . 0.401 ' O ' ' N ' ' A' ' 308' ' ' LYS . 21.3 p -137.03 160.69 38.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.132 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -38.1 -32.61 0.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.877 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 308' ' ' LYS . . . . . 0.444 ' O ' ' N ' ' A' ' 311' ' ' MET . 23.6 ttmt -63.38 -67.7 0.4 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.921 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . 0.41 ' C ' ' O ' ' A' ' 308' ' ' LYS . 9.4 m-80 -37.65 -45.66 0.8 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.92 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 61.7 t -57.82 -43.55 84.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.116 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 311' ' ' MET . . . . . 0.444 ' N ' ' O ' ' A' ' 308' ' ' LYS . 4.7 mmt -59.73 -50.67 72.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.893 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 15.2 mp0 -62.31 -36.38 81.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.906 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 313' ' ' PHE . . . . . 0.566 ' CE1' HD22 ' A' ' 298' ' ' LEU . 3.5 t80 -65.09 -44.63 88.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.873 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . 0.462 ' CD1' HG12 ' A' ' 338' ' ' VAL . 54.6 mt -78.43 -21.07 49.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.905 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . 0.472 ' CB ' ' HA ' ' A' ' 316' ' ' PRO . . . -51.58 166.84 0.34 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.573 0.702 . . . . 0.0 111.143 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 316' ' ' PRO . . . . . 0.472 ' HA ' ' CB ' ' A' ' 315' ' ' ALA . 54.1 Cg_endo -69.73 -4.58 8.33 Favored 'Cis proline' 0 C--O 1.232 0.202 0 C-N-CA 122.66 -1.809 . . . . 0.0 112.348 -0.028 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 317' ' ' LEU . . . . . 0.449 ' N ' ' HA ' ' A' ' 315' ' ' ALA . 21.1 mt -54.1 161.1 1.35 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.885 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 46.2 tttt -134.46 107.19 11.01 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.586 0.708 . . . . 0.0 110.925 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 319' ' ' PRO . . . . . 0.525 ' HA ' ' CD2' ' A' ' 340' ' ' PHE . 53.7 Cg_endo -69.79 -175.76 1.27 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.713 2.275 . . . . 0.0 112.358 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 42.3 t -102.4 -35.74 4.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.107 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -164.14 138.12 5.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.092 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 322' ' ' ILE . . . . . . . . . . . . . 80.5 mt -112.22 111.51 36.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.121 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 87.0 mtt180 -110.01 103.33 12.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.849 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 94.4 mt -64.26 118.24 6.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.141 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . 0.501 ' CG2' ' CD2' ' A' ' 337' ' ' PHE . 27.1 t -57.67 92.23 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.157 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 18.1 ptt-85 -99.94 113.18 25.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.854 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -51.36 -70.43 0.09 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.907 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -158.72 153.11 24.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.079 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 24.7 m170 43.68 29.24 0.27 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.852 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 73.17 74.42 0.8 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.44 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -129.75 84.62 2.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.88 0.371 . . . . 0.0 110.85 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -57.04 114.82 2.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.882 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 333' ' ' THR . . . . . 0.422 ' O ' ' C ' ' A' ' 334' ' ' GLY . 34.7 p -113.71 69.28 0.7 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.108 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 333' ' ' THR . . . 36.37 61.55 0.83 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.462 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 335' ' ' TYR . . . . . 0.458 ' CE1' ' HE3' ' A' ' 297' ' ' LYS . 10.6 m-85 -162.3 131.15 4.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.854 0.359 . . . . 0.0 110.915 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 58.7 mt -141.54 113.79 3.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.158 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . 0.562 ' CE1' ' HD3' ' A' ' 297' ' ' LYS . 18.0 m-85 -87.88 129.85 35.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.893 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . 0.462 HG12 ' CD1' ' A' ' 314' ' ' LEU . 22.0 t -134.33 135.34 54.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.174 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -111.75 162.68 14.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.877 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 340' ' ' PHE . . . . . 0.525 ' CD2' ' HA ' ' A' ' 319' ' ' PRO . 60.3 m-85 -136.64 172.3 13.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.882 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 29.3 t -79.42 -67.6 0.74 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.878 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -100.05 173.25 6.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.876 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 343' ' ' GLU . . . . . 0.531 ' HB2' ' CE1' ' A' ' 294' ' ' HIS . 11.0 pt-20 -75.19 -40.36 59.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.923 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 344' ' ' GLU . . . . . 0.402 ' N ' ' HG3' ' A' ' 343' ' ' GLU . 34.5 tt0 -44.23 -50.75 8.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.913 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -53.96 -61.81 2.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.897 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . 0.484 HG21 ' CD1' ' A' ' 340' ' ' PHE . 60.5 t -50.21 -47.04 25.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.086 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 45.2 mtpt -50.95 -39.3 54.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.946 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -79.44 -29.11 41.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.903 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -57.54 -27.05 62.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.074 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 350' ' ' LEU . . . . . . . . . . . . . 92.6 mt -77.21 -34.99 56.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.912 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 18.3 mmtp -46.33 -43.35 15.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.886 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 352' ' ' CYS . . . . . . . . . . . . . 8.3 m -62.05 85.04 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.897 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . 0.483 ' O ' ' C ' ' A' ' 354' ' ' ARG . 33.7 p-10 -122.9 -176.9 3.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.873 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . 0.483 ' C ' ' O ' ' A' ' 353' ' ' ASN . 2.9 ppt_? 30.59 44.59 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.894 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 355' ' ' GLU . . . . . 0.446 ' C ' ' OE1' ' A' ' 355' ' ' GLU . 0.0 OUTLIER -118.1 173.1 6.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.891 -179.906 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 356' ' ' TYR . . . . . 0.476 ' CD1' ' N ' ' A' ' 356' ' ' TYR . 1.3 m-85 -128.47 149.29 50.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.902 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 357' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -166.66 125.79 1.48 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.868 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 87.74 -15.2 56.12 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.476 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 105.15 19.77 10.39 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.483 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 360' ' ' ARG . . . . . . . . . . . . . 10.5 mmt180 -146.03 158.86 43.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.828 0.347 . . . . 0.0 110.875 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 361' ' ' TYR . . . . . . . . . . . . . 9.1 p90 -66.22 151.51 46.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.905 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 15.7 mm -135.3 155.27 37.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.145 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 363' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 -147.57 114.82 6.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.842 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 58.4 t -88.22 140.12 16.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.114 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -137.37 154.79 49.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.831 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 3.0 tmm_? -101.87 109.05 20.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.849 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -93.28 130.62 38.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.892 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 10.7 ptpp? -81.67 128.56 34.09 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.911 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 77.9 p 38.28 40.43 0.34 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.841 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 61.92 -171.85 9.19 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.496 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.83 177.5 5.57 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.674 2.249 . . . . 0.0 112.343 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 372' ' ' SER . . . . . . . . . . . . . 74.9 m -140.4 148.01 40.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.844 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 33.1 p -108.51 108.12 18.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.912 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.285 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.437 -179.985 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 N-CA-C 112.479 -0.249 . . . . 0.0 112.479 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 2.7 m -171.91 176.91 3.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.847 0.356 . . . . 0.0 110.882 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 63.3 p -141.36 110.08 6.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.912 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -78.69 -139.43 1.59 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.508 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 34.9 p -90.0 43.45 1.15 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.833 0.349 . . . . 0.0 110.841 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 85.1 p -39.8 133.83 1.5 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.854 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 290' ' ' GLY . . . . . 0.438 ' O ' ' C ' ' A' ' 291' ' ' THR . . . 50.05 -117.23 4.62 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.487 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 291' ' ' THR . . . . . 0.438 ' C ' ' O ' ' A' ' 290' ' ' GLY . 77.2 p 35.06 45.02 0.15 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.885 0.374 . . . . 0.0 111.124 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 9.7 t -132.05 172.61 12.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.102 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 293' ' ' CYS . . . . . . . . . . . . . 21.6 m 41.77 47.16 3.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.861 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . 0.55 ' CE1' ' HB3' ' A' ' 343' ' ' GLU . 75.1 m80 -47.28 122.45 4.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.83 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 69.0 m -135.45 149.81 49.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.13 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 30.8 m -125.74 156.73 35.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.115 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . 0.558 ' HD3' ' CE1' ' A' ' 337' ' ' PHE . 13.4 ttpt -130.35 143.67 50.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.877 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 6.8 mp -118.23 151.86 36.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.9 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 299' ' ' ARG . . . . . 0.496 ' HB2' ' CE1' ' A' ' 335' ' ' TYR . 8.8 ttm-85 -146.42 136.37 23.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.901 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 98.9 48.13 1.81 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.454 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -114.61 148.36 40.14 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.601 0.715 . . . . 0.0 111.05 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 153.3 69.16 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.681 2.254 . . . . 0.0 112.306 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -58.49 -30.47 67.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.905 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -85.0 34.41 0.55 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.847 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 305' ' ' VAL . . . . . . . . . . . . . 9.0 p -96.02 139.64 18.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.126 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 306' ' ' THR . . . . . 0.45 ' O ' ' C ' ' A' ' 307' ' ' GLU . 70.7 p -136.2 155.51 50.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.171 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 307' ' ' GLU . . . . . 0.45 ' C ' ' O ' ' A' ' 306' ' ' THR . 30.2 mt-10 -34.46 -38.48 0.07 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.884 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 29.7 ttmt -57.43 -55.52 33.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.916 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -49.79 -46.7 51.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.906 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 85.0 t -61.55 -40.79 87.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.155 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 311' ' ' MET . . . . . . . . . . . . . 4.1 mmt -58.71 -40.75 84.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.896 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -68.94 -31.55 70.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.909 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 313' ' ' PHE . . . . . 0.536 ' CE2' HG22 ' A' ' 362' ' ' ILE . 1.9 t80 -74.13 -48.93 26.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.919 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . 0.409 ' CD1' ' CG1' ' A' ' 338' ' ' VAL . 27.8 mt -72.45 -24.95 61.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.944 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . 0.466 ' HA ' ' C ' ' A' ' 316' ' ' PRO . . . -49.73 164.52 0.34 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.577 0.703 . . . . 0.0 111.127 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 316' ' ' PRO . . . . . 0.466 ' C ' ' HA ' ' A' ' 315' ' ' ALA . 54.0 Cg_endo -69.79 -7.43 10.02 Favored 'Cis proline' 0 C--O 1.232 0.188 0 C-N-CA 122.701 -1.791 . . . . 0.0 112.358 0.067 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 317' ' ' LEU . . . . . . . . . . . . . 33.0 mt -57.57 134.29 56.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.926 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.88 111.7 56.32 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.56 0.695 . . . . 0.0 110.906 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 319' ' ' PRO . . . . . 0.43 ' HA ' ' CD2' ' A' ' 340' ' ' PHE . 53.7 Cg_endo -69.75 -176.62 1.54 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.707 2.271 . . . . 0.0 112.327 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 320' ' ' VAL . . . . . 0.405 HG21 ' C ' ' A' ' 340' ' ' PHE . 93.0 t -100.52 -40.27 7.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.092 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -160.56 131.67 5.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.095 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 322' ' ' ILE . . . . . . . . . . . . . 86.5 mt -102.11 119.96 51.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.122 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 61.5 mtm180 -115.54 98.69 6.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.884 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 41.8 mt -74.72 125.0 33.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.108 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 88.0 t -58.14 112.98 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.126 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 19.4 mmt85 -87.31 119.56 27.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.893 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -75.3 -55.62 5.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.922 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -118.26 -68.95 0.88 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.083 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 21.3 m80 -121.51 -67.37 0.97 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.858 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -148.77 31.64 1.22 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.464 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -79.46 115.71 19.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.894 0.378 . . . . 0.0 110.889 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 8.0 mptt -75.05 95.16 2.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.898 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 8.9 t -173.11 148.09 1.66 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.131 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 109.17 -87.85 0.5 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.513 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 335' ' ' TYR . . . . . 0.496 ' CE1' ' HB2' ' A' ' 299' ' ' ARG . 18.2 m-85 -143.59 160.57 40.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.842 0.354 . . . . 0.0 110.937 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 85.5 mt -138.91 113.75 8.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.171 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . 0.558 ' CE1' ' HD3' ' A' ' 297' ' ' LYS . 77.0 m-85 -84.95 135.87 33.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.91 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . 0.409 ' CG1' ' CD1' ' A' ' 314' ' ' LEU . 58.0 t -137.64 120.15 19.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.15 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -97.38 158.06 15.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.838 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 340' ' ' PHE . . . . . 0.43 ' CD2' ' HA ' ' A' ' 319' ' ' PRO . 41.8 m-85 -133.18 172.19 13.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.874 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 48.5 t -83.23 -63.08 1.43 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.872 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -96.02 159.8 14.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.891 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 343' ' ' GLU . . . . . 0.55 ' HB3' ' CE1' ' A' ' 294' ' ' HIS . 10.7 pt-20 -68.64 -47.25 67.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.875 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -45.87 -55.34 6.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.931 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -41.92 -44.83 3.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.879 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 83.8 t -69.86 -48.57 63.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.159 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 18.8 mtpp -46.07 -42.47 13.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.921 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 348' ' ' GLN . . . . . 0.401 ' O ' ' N ' ' A' ' 351' ' ' LYS . 15.7 mm100 -70.44 -41.43 72.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.873 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -40.49 -43.47 1.85 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.048 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 350' ' ' LEU . . . . . . . . . . . . . 22.6 mt -64.08 -40.72 96.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.913 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 351' ' ' LYS . . . . . 0.401 ' N ' ' O ' ' A' ' 348' ' ' GLN . 15.6 mmtp -54.38 -25.55 25.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.881 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 352' ' ' CYS . . . . . . . . . . . . . 85.6 m -95.93 52.17 1.3 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.864 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . 0.408 ' CG ' ' N ' ' A' ' 354' ' ' ARG . 1.8 t30 -100.38 164.05 12.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.907 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . 0.408 ' N ' ' CG ' ' A' ' 353' ' ' ASN . 11.2 ttm180 68.99 33.33 3.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.886 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 355' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -102.57 174.01 6.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.909 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 356' ' ' TYR . . . . . 0.462 ' CD1' ' N ' ' A' ' 356' ' ' TYR . 1.3 m-85 -124.62 135.3 52.98 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.952 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 357' ' ' MET . . . . . 0.465 ' CG ' HG13 ' A' ' 362' ' ' ILE . 0.0 OUTLIER -148.59 123.33 9.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.867 179.98 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 82.87 -13.59 42.44 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.478 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 110.56 5.22 28.02 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.487 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 360' ' ' ARG . . . . . 0.436 ' HB3' ' NH1' ' A' ' 360' ' ' ARG . 5.1 mmm180 -123.8 130.67 52.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.836 0.35 . . . . 0.0 110.886 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 361' ' ' TYR . . . . . . . . . . . . . 20.4 p90 -49.38 128.5 17.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.915 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 362' ' ' ILE . . . . . 0.536 HG22 ' CE2' ' A' ' 313' ' ' PHE . 37.1 mm -106.51 144.96 14.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.136 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 363' ' ' GLU . . . . . . . . . . . . . 56.0 mm-40 -139.67 112.29 7.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.841 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 364' ' ' VAL . . . . . 0.436 ' O ' ' CD1' ' A' ' 365' ' ' PHE . 15.0 t -85.25 149.57 4.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.117 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 365' ' ' PHE . . . . . 0.436 ' CD1' ' O ' ' A' ' 364' ' ' VAL . 43.0 m-85 -148.64 121.62 8.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.886 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 1.3 tmm_? -69.17 127.78 34.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.888 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -103.46 150.92 23.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.9 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . 0.405 ' O ' ' C ' ' A' ' 369' ' ' SER . 0.0 OUTLIER -91.88 67.49 5.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.876 179.954 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 369' ' ' SER . . . . . 0.405 ' C ' ' O ' ' A' ' 368' ' ' LYS . 80.8 p 36.79 54.5 1.15 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.814 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . -171.4 158.49 29.71 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.472 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 0.74 5.22 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.657 2.238 . . . . 0.0 112.34 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 372' ' ' SER . . . . . . . . . . . . . 1.7 t 74.34 54.03 0.09 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.869 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 26.8 t -101.51 170.21 8.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.876 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.466 179.983 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.35 0 N-CA-C 112.509 -0.237 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 88.8 p -111.93 145.66 39.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.879 0.371 . . . . 0.0 110.884 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 23.2 t -50.43 -48.8 56.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.816 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 92.21 -98.82 2.47 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.512 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 71.7 m -63.32 90.09 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.877 0.37 . . . . 0.0 110.874 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 80.2 p -63.85 -49.36 73.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.912 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 109.96 -82.42 0.3 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.501 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 291' ' ' THR . . . . . 0.496 ' CG2' ' O ' ' A' ' 369' ' ' SER . 12.2 t -78.32 127.53 32.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.891 0.377 . . . . 0.0 111.158 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 21.7 m -90.7 96.86 10.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.141 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 293' ' ' CYS . . . . . . . . . . . . . 29.3 p -145.9 167.16 23.95 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.878 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . 0.564 ' CE1' ' HB3' ' A' ' 343' ' ' GLU . 1.5 m-70 -126.93 105.1 8.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.884 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 36.6 m -132.06 142.42 49.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.171 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 31.6 m -115.68 150.05 17.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.127 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 17.0 ttpt -120.59 138.11 54.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.875 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . 0.439 HD21 ' CE2' ' A' ' 313' ' ' PHE . 6.1 mp -120.23 141.38 49.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.897 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 20.3 ptt180 -149.82 145.94 26.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.931 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 107.18 14.22 19.19 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.512 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -83.85 151.59 61.24 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.607 0.718 . . . . 0.0 111.088 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -165.97 0.17 Allowed 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.724 2.283 . . . . 0.0 112.365 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -90.35 -17.79 26.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.849 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -93.3 14.58 17.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.892 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 305' ' ' VAL . . . . . . . . . . . . . 11.8 p -78.84 138.55 19.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.108 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 306' ' ' THR . . . . . . . . . . . . . 39.0 p -145.35 177.45 8.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.128 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -49.42 -31.61 10.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.897 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 20.1 ttpt -67.78 -60.98 2.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.914 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -46.57 -38.62 9.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.866 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 53.6 t -69.47 -46.76 75.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.172 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 311' ' ' MET . . . . . . . . . . . . . 2.8 mmt -56.66 -49.65 74.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.908 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -66.52 -24.72 66.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.882 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 313' ' ' PHE . . . . . 0.439 ' CE2' HD21 ' A' ' 298' ' ' LEU . 24.4 t80 -74.57 -38.75 62.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.91 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . 0.405 ' CD1' HG11 ' A' ' 338' ' ' VAL . 27.1 mt -88.12 -24.37 23.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.882 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . 0.488 ' HA ' ' C ' ' A' ' 316' ' ' PRO . . . -48.4 161.95 0.37 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.561 0.696 . . . . 0.0 111.15 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 316' ' ' PRO . . . . . 0.488 ' C ' ' HA ' ' A' ' 315' ' ' ALA . 53.0 Cg_endo -69.83 -2.45 7.25 Favored 'Cis proline' 0 C--N 1.342 0.198 0 C-N-CA 122.621 -1.825 . . . . 0.0 112.299 0.054 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 317' ' ' LEU . . . . . 0.466 ' N ' ' HA ' ' A' ' 315' ' ' ALA . 24.7 mt -55.62 124.59 17.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.864 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -102.65 105.29 43.62 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.517 0.675 . . . . 0.0 110.895 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 319' ' ' PRO . . . . . 0.437 ' HA ' ' CD2' ' A' ' 340' ' ' PHE . 54.1 Cg_endo -69.74 -175.54 1.18 Allowed 'Trans proline' 0 N--CA 1.465 -0.155 0 C-N-CA 122.728 2.285 . . . . 0.0 112.36 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 97.7 t -100.03 -43.45 11.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.147 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -156.88 139.67 15.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.14 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 322' ' ' ILE . . . . . . . . . . . . . 90.6 mt -108.39 108.49 25.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.084 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -103.12 98.08 8.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.878 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 71.9 mt -70.38 118.22 14.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.105 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . 0.509 HG22 ' CE2' ' A' ' 337' ' ' PHE . 35.2 t -81.8 120.09 32.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.125 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 87.9 mtt180 -99.39 37.95 1.49 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.853 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 49.3 t30 47.19 50.66 14.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.923 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . 43.67 37.69 1.66 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.085 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 14.3 m80 -159.79 174.66 14.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.881 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -80.81 53.12 4.54 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.522 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -144.05 111.84 6.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.87 0.367 . . . . 0.0 110.903 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -68.15 103.88 1.66 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.915 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 333' ' ' THR . . . . . 0.418 ' OG1' ' N ' ' A' ' 334' ' ' GLY . 2.8 t -103.99 175.97 5.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.174 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . 0.418 ' N ' ' OG1' ' A' ' 333' ' ' THR . . . -58.02 -39.54 92.11 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.502 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 335' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -44.7 118.5 1.61 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.895 0.379 . . . . 0.0 110.932 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 73.7 mt -143.72 124.44 9.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.126 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . 0.509 ' CE2' HG22 ' A' ' 325' ' ' VAL . 25.9 m-85 -100.24 126.82 46.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.907 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . 0.405 HG11 ' CD1' ' A' ' 314' ' ' LEU . 31.2 t -126.83 132.79 69.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.147 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -106.2 162.14 13.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.853 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 340' ' ' PHE . . . . . 0.437 ' CD2' ' HA ' ' A' ' 319' ' ' PRO . 67.0 m-85 -136.62 161.0 37.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.86 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 46.0 m -76.83 -61.02 2.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.825 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -92.3 157.98 16.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.872 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 343' ' ' GLU . . . . . 0.564 ' HB3' ' CE1' ' A' ' 294' ' ' HIS . 8.3 pt-20 -70.22 -41.8 73.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.852 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 344' ' ' GLU . . . . . 0.41 ' O ' ' C ' ' A' ' 345' ' ' GLU . 36.3 mm-40 -47.07 -61.01 2.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.917 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 344' ' ' GLU . 30.2 mt-10 -37.47 -44.44 0.65 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.878 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 39.6 t -58.81 -54.11 38.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.133 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -49.78 -37.08 28.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.914 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -71.65 -46.23 59.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.902 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -46.1 -34.72 4.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.071 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 350' ' ' LEU . . . . . . . . . . . . . 65.5 mt -71.36 -41.01 70.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.935 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 27.5 mmtp -40.25 -52.41 2.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.879 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 352' ' ' CYS . . . . . . . . . . . . . 89.7 m -74.27 80.23 1.83 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.903 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -107.83 171.25 7.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.87 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 10.6 ptm180 41.99 50.43 4.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.907 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 355' ' ' GLU . . . . . 0.506 ' C ' ' CD1' ' A' ' 356' ' ' TYR . 9.8 mm-40 -98.08 174.38 6.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.916 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 356' ' ' TYR . . . . . 0.506 ' CD1' ' C ' ' A' ' 355' ' ' GLU . 1.0 OUTLIER -137.96 117.91 13.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.922 -179.862 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 357' ' ' MET . . . . . . . . . . . . . 4.4 ptt? -143.71 139.61 29.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.89 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 82.02 -33.76 2.63 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.5 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 129.14 15.89 2.01 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.499 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 360' ' ' ARG . . . . . . . . . . . . . 15.7 mmm180 -142.67 148.98 38.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.78 0.324 . . . . 0.0 110.889 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 361' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -61.0 152.7 27.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.961 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 8.5 mm -135.55 145.26 31.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.17 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 363' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -135.7 119.18 16.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.893 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 4.1 t -91.68 128.57 43.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.106 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -125.9 139.38 53.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.861 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 15.9 ttt-85 -88.17 114.02 24.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.835 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 64.4 mm-40 -82.52 121.58 26.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.872 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 13.9 pttm -95.03 -41.6 9.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.874 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 369' ' ' SER . . . . . 0.496 ' O ' ' CG2' ' A' ' 291' ' ' THR . 45.6 t -51.58 -49.41 62.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.871 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 104.18 -164.97 14.96 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.477 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 176.82 6.26 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.717 2.278 . . . . 0.0 112.375 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 372' ' ' SER . . . . . . . . . . . . . 1.4 t -134.45 85.55 2.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.848 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 40.0 m -110.54 133.96 52.82 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.86 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.521 179.997 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.274 0 N-CA-C 112.482 -0.247 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 63.6 m -51.4 149.7 4.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.87 0.367 . . . . 0.0 110.895 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 11.3 t -114.07 -45.55 3.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.848 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 106.76 98.55 2.57 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.508 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 27.6 t -119.59 105.56 11.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.874 0.368 . . . . 0.0 110.859 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 67.3 m -129.69 116.69 19.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.854 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . -165.84 -45.84 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.463 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 40.2 p -155.25 138.01 15.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.896 0.379 . . . . 0.0 111.145 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 10.1 m -126.28 88.66 2.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.154 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 293' ' ' CYS . . . . . . . . . . . . . 27.0 p -105.9 169.66 8.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.856 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . 0.545 ' CE1' ' CG ' ' A' ' 343' ' ' GLU . 12.3 m-70 -80.35 120.41 24.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.824 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 96.5 m -139.38 147.19 41.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.098 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 29.9 m -127.59 146.81 32.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.176 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . 0.562 ' HD3' ' CE1' ' A' ' 337' ' ' PHE . 30.6 ttpt -117.02 145.99 43.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.936 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . 0.482 HD23 ' CE2' ' A' ' 313' ' ' PHE . 6.4 mp -117.17 129.08 55.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.897 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 6.4 ttt85 -129.13 150.09 50.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.876 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 91.06 36.83 6.51 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.494 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -109.84 152.36 42.91 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.519 0.676 . . . . 0.0 111.105 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 -178.51 2.38 Favored 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.692 2.261 . . . . 0.0 112.316 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -89.51 -4.21 58.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.901 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -100.34 3.28 43.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.907 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 305' ' ' VAL . . . . . . . . . . . . . 4.1 p -65.11 153.13 8.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.088 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 306' ' ' THR . . . . . 0.439 ' OG1' ' N ' ' A' ' 307' ' ' GLU . 0.0 OUTLIER -149.12 170.84 17.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.104 -179.93 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 307' ' ' GLU . . . . . 0.439 ' N ' ' OG1' ' A' ' 306' ' ' THR . 30.7 mt-10 -54.71 -24.38 21.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.864 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 21.4 tttm -74.78 -51.44 14.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.881 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -54.23 -32.84 56.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.881 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 30.0 t -70.81 -45.83 71.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.126 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 311' ' ' MET . . . . . . . . . . . . . 4.1 mmt -57.58 -53.13 61.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.919 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -63.41 -24.39 67.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.901 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 313' ' ' PHE . . . . . 0.542 ' CZ ' HG21 ' A' ' 362' ' ' ILE . 31.2 t80 -77.6 -49.75 13.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.879 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . 0.407 ' CD1' HG11 ' A' ' 338' ' ' VAL . 74.2 mt -74.44 -22.65 59.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.913 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . 0.479 ' HA ' ' C ' ' A' ' 316' ' ' PRO . . . -46.22 163.33 0.23 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.551 0.691 . . . . 0.0 111.149 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 316' ' ' PRO . . . . . 0.479 ' C ' ' HA ' ' A' ' 315' ' ' ALA . 53.5 Cg_endo -69.79 -6.55 9.54 Favored 'Cis proline' 0 C--O 1.232 0.195 0 C-N-CA 122.68 -1.8 . . . . 0.0 112.316 0.027 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 317' ' ' LEU . . . . . . . . . . . . . 81.6 mt -52.66 135.6 34.52 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.875 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 14.6 tptm -113.96 103.39 55.22 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.539 0.685 . . . . 0.0 110.892 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 319' ' ' PRO . . . . . 0.412 ' HA ' ' CD2' ' A' ' 340' ' ' PHE . 53.8 Cg_endo -69.76 -169.9 0.36 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.636 2.224 . . . . 0.0 112.361 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 47.2 t -103.34 -46.24 10.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.093 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -156.06 138.28 14.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.062 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 322' ' ' ILE . . . . . . . . . . . . . 66.2 mt -114.21 122.86 69.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.135 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 65.9 mmt-85 -118.05 107.78 14.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.832 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 52.3 mt -77.56 119.97 27.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.133 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . 0.424 HG21 ' CE2' ' A' ' 337' ' ' PHE . 18.8 t -80.72 113.09 19.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.132 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 -85.7 163.38 18.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.907 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -76.32 159.73 30.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.894 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -52.46 -54.59 30.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.105 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -52.51 -43.63 65.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.827 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . 0.445 ' O ' ' C ' ' A' ' 331' ' ' ASN . . . 141.53 -46.23 0.91 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.513 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 331' ' ' ASN . . . . . 0.445 ' C ' ' O ' ' A' ' 330' ' ' GLY . 95.6 m-20 -34.77 132.38 0.32 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.924 0.392 . . . . 0.0 110.908 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 11.7 tttp -66.8 83.83 0.11 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.88 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 10.0 t -158.72 132.5 7.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.143 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 155.44 -138.97 6.33 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.491 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 335' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -101.28 175.84 5.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.828 0.347 . . . . 0.0 110.947 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 54.2 mt -144.49 123.75 6.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.141 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . 0.562 ' CE1' ' HD3' ' A' ' 297' ' ' LYS . 62.1 m-85 -93.65 135.99 34.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.863 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . 0.464 HG12 ' CE1' ' A' ' 340' ' ' PHE . 41.5 t -134.96 122.92 39.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.14 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -98.24 160.52 14.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.853 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 340' ' ' PHE . . . . . 0.464 ' CE1' HG12 ' A' ' 338' ' ' VAL . 60.7 m-85 -139.79 162.92 33.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.912 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 2.8 m -98.88 -42.3 7.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.851 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 342' ' ' ASN . . . . . 0.408 ' O ' ' C ' ' A' ' 343' ' ' GLU . 19.5 m-80 -99.56 111.08 23.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.86 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 343' ' ' GLU . . . . . 0.545 ' CG ' ' CE1' ' A' ' 294' ' ' HIS . 0.5 OUTLIER -37.37 -60.61 0.66 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.85 -179.97 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 344' ' ' GLU . . . . . 0.454 ' C ' ' O ' ' A' ' 343' ' ' GLU . 13.1 tt0 -34.3 -51.37 0.45 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.873 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -47.48 -45.56 26.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.892 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . 0.459 ' N ' ' O ' ' A' ' 343' ' ' GLU . 23.7 t -57.49 -51.67 66.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.14 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 49.3 mtpt -54.46 -43.14 71.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.896 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 60.0 mm-40 -65.29 -39.18 92.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.943 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -48.02 -40.87 24.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.072 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 350' ' ' LEU . . . . . . . . . . . . . 39.7 mt -65.0 -40.91 95.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.913 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 34.2 mmtm -46.18 -46.22 17.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.916 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 352' ' ' CYS . . . . . . . . . . . . . 58.0 m -69.76 69.42 0.29 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.893 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 14.6 p30 -109.83 171.84 7.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.851 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? 55.75 33.22 20.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.851 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 355' ' ' GLU . . . . . 0.47 ' C ' ' CD1' ' A' ' 356' ' ' TYR . 2.5 mm-40 -97.09 173.68 7.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.903 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 356' ' ' TYR . . . . . 0.521 ' CD1' ' N ' ' A' ' 356' ' ' TYR . 0.9 OUTLIER -138.65 130.29 27.65 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.953 -179.877 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 357' ' ' MET . . . . . 0.457 ' HG2' ' CG1' ' A' ' 362' ' ' ILE . 5.8 ptt? -152.16 120.13 6.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.865 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 92.56 -23.29 28.75 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.522 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 125.96 -5.52 7.86 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.446 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 360' ' ' ARG . . . . . . . . . . . . . 15.4 mmm180 -119.34 158.52 25.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.873 0.368 . . . . 0.0 110.864 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 361' ' ' TYR . . . . . 0.547 ' CG ' ' O ' ' A' ' 361' ' ' TYR . 3.0 p90 -77.2 117.48 18.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.951 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 362' ' ' ILE . . . . . 0.542 HG21 ' CZ ' ' A' ' 313' ' ' PHE . 45.9 mm -83.23 117.01 28.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.112 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 363' ' ' GLU . . . . . 0.566 ' HG3' ' CZ ' ' A' ' 365' ' ' PHE . 4.2 tp10 -111.23 112.06 23.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.919 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 7.0 t -87.16 144.72 8.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.131 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 365' ' ' PHE . . . . . 0.566 ' CZ ' ' HG3' ' A' ' 363' ' ' GLU . 58.0 m-85 -140.85 133.24 28.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.916 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 6.0 ttm180 -84.73 115.51 22.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.907 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -104.19 46.79 0.9 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.877 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -39.33 -44.07 1.25 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.904 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 369' ' ' SER . . . . . 0.444 ' O ' ' C ' ' A' ' 370' ' ' GLY . 95.6 p -79.48 -37.02 37.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.885 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . 0.444 ' C ' ' O ' ' A' ' 369' ' ' SER . . . -32.84 96.31 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.465 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 371' ' ' PRO . . . . . 0.419 ' N ' ' O ' ' A' ' 369' ' ' SER . 54.1 Cg_endo -69.74 -0.7 7.27 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.71 2.273 . . . . 0.0 112.388 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 372' ' ' SER . . . . . . . . . . . . . 7.6 t -47.67 118.87 2.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.888 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 8.2 t -136.21 125.46 24.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.873 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.521 179.977 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.288 0 N-CA-C 112.466 -0.254 . . . . 0.0 112.466 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 44.3 m -81.04 106.04 12.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.9 0.381 . . . . 0.0 110.847 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 21.1 m -126.79 169.72 12.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.902 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -69.26 165.19 49.7 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.495 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 44.0 t -143.01 156.12 44.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.876 0.369 . . . . 0.0 110.86 -179.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 2.9 t -156.98 154.58 29.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.871 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . -173.67 -69.03 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.489 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 72.0 p -123.66 107.74 11.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.876 0.369 . . . . 0.0 111.151 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 14.8 t -104.61 39.77 1.62 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.142 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 293' ' ' CYS . . . . . . . . . . . . . 15.0 m -52.05 120.84 5.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.875 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 34.2 m80 -82.82 90.92 6.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.879 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 19.5 m -131.01 132.14 44.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.129 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 296' ' ' VAL . . . . . 0.462 ' CG2' ' HB ' ' A' ' 338' ' ' VAL . 34.9 m -104.01 154.72 5.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.133 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . 0.562 ' HE2' ' CZ ' ' A' ' 337' ' ' PHE . 2.1 tppp? -113.26 142.34 45.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.94 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . 0.567 HD21 ' CD2' ' A' ' 313' ' ' PHE . 6.9 mp -128.69 119.78 25.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.906 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 19.2 ptt85 -127.68 165.65 19.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.868 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 94.36 -24.08 29.0 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.497 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -57.36 151.78 36.13 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.558 0.694 . . . . 0.0 111.103 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 163.11 39.49 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.703 2.269 . . . . 0.0 112.37 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 303' ' ' PHE . . . . . 0.557 ' CD1' ' C ' ' A' ' 303' ' ' PHE . 0.5 OUTLIER -69.05 -24.52 64.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.877 -179.979 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -93.58 36.72 1.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.916 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 305' ' ' VAL . . . . . . . . . . . . . 9.9 p -94.8 146.15 7.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.16 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 306' ' ' THR . . . . . . . . . . . . . 7.1 p -128.27 159.87 33.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.159 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -43.17 -43.45 4.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.885 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 56.1 tttt -52.89 -61.79 2.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.885 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -41.48 -46.81 3.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.864 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 92.4 t -60.2 -55.9 21.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.142 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 311' ' ' MET . . . . . . . . . . . . . 3.6 mmt -43.14 -45.55 5.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.885 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -62.33 -41.66 98.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.855 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 313' ' ' PHE . . . . . 0.567 ' CD2' HD21 ' A' ' 298' ' ' LEU . 21.2 t80 -67.05 -44.24 80.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.833 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 94.3 mt -75.99 -25.7 56.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.914 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . 0.497 ' HA ' ' C ' ' A' ' 316' ' ' PRO . . . -50.65 158.48 1.08 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.613 0.72 . . . . 0.0 111.076 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 316' ' ' PRO . . . . . 0.497 ' C ' ' HA ' ' A' ' 315' ' ' ALA . 54.2 Cg_endo -69.72 -19.55 11.14 Favored 'Cis proline' 0 C--N 1.342 0.185 0 C-N-CA 122.702 -1.791 . . . . 0.0 112.362 -0.031 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 317' ' ' LEU . . . . . . . . . . . . . 60.3 mt -38.33 125.34 1.31 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.915 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 318' ' ' LYS . . . . . 0.442 ' CE ' ' HA ' ' A' ' 318' ' ' LYS . 0.6 OUTLIER -105.44 103.37 42.53 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.625 0.726 . . . . 0.0 110.905 179.83 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 319' ' ' PRO . . . . . 0.418 ' HA ' ' CD2' ' A' ' 340' ' ' PHE . 52.8 Cg_endo -69.81 -172.07 0.54 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.698 2.265 . . . . 0.0 112.301 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 79.6 t -103.45 -44.52 9.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.149 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -157.6 134.45 10.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.079 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 322' ' ' ILE . . . . . . . . . . . . . 64.5 mt -105.99 105.09 18.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.111 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 73.9 mtt-85 -108.69 107.98 18.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.849 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . 0.459 ' CG2' ' HG3' ' A' ' 332' ' ' LYS . 59.9 mt -72.22 128.02 34.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.125 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . 0.556 ' CG2' ' CD2' ' A' ' 337' ' ' PHE . 66.8 t -74.03 128.41 36.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.143 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 62.7 mtm-85 -96.03 -177.81 4.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.905 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -109.88 -58.71 2.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.936 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -131.79 -69.23 0.61 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.119 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 8.3 m-70 -112.81 -28.3 7.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.892 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 168.85 41.9 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.507 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 34.5 m-20 -105.92 79.71 1.45 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.901 0.382 . . . . 0.0 110.899 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 332' ' ' LYS . . . . . 0.459 ' HG3' ' CG2' ' A' ' 324' ' ' ILE . 0.6 OUTLIER -47.3 124.67 6.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.903 179.921 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 333' ' ' THR . . . . . 0.458 ' O ' ' C ' ' A' ' 334' ' ' GLY . 27.6 p -125.29 76.62 1.56 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.141 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . 0.516 ' O ' ' CG ' ' A' ' 335' ' ' TYR . . . 33.92 69.74 0.16 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.461 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 335' ' ' TYR . . . . . 0.516 ' CG ' ' O ' ' A' ' 334' ' ' GLY . 13.7 m-85 -167.39 112.88 0.73 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.891 0.377 . . . . 0.0 110.882 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 42.6 mt -134.39 130.16 53.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.134 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . 0.562 ' CZ ' ' HE2' ' A' ' 297' ' ' LYS . 7.2 m-85 -98.15 127.86 44.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.9 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . 0.462 ' HB ' ' CG2' ' A' ' 296' ' ' VAL . 75.0 t -127.38 120.65 55.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.129 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -95.86 156.01 16.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.876 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 340' ' ' PHE . . . . . 0.422 ' CE1' HG13 ' A' ' 338' ' ' VAL . 61.3 m-85 -134.42 165.42 25.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.921 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 2.0 m -93.98 -53.34 4.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.858 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 35.8 m-20 -95.16 128.49 42.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.87 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -49.45 -43.46 44.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.903 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -45.5 -55.82 5.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.858 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 62.1 mt-10 -43.76 -53.68 5.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.876 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 66.7 t -54.55 -50.5 58.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.17 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -54.34 -33.67 59.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.895 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -78.45 -36.63 45.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.894 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -47.1 -38.67 11.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.054 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 350' ' ' LEU . . . . . . . . . . . . . 49.5 mt -63.35 -39.43 94.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.898 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 18.9 mmtm -47.31 -45.4 24.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.886 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 352' ' ' CYS . . . . . . . . . . . . . 4.1 m -75.21 64.94 1.5 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.915 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -108.71 160.83 15.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.871 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 25.0 ttp180 63.09 34.72 13.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.865 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 355' ' ' GLU . . . . . 0.455 ' C ' ' CD1' ' A' ' 356' ' ' TYR . 3.9 mm-40 -94.82 172.78 7.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.886 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 356' ' ' TYR . . . . . 0.473 ' CD1' ' N ' ' A' ' 356' ' ' TYR . 1.3 m-85 -135.68 120.05 17.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.912 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 357' ' ' MET . . . . . . . . . . . . . 3.3 ptt? -145.45 143.9 30.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.857 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 75.98 -9.96 16.25 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.492 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 106.4 18.33 11.21 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.483 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 360' ' ' ARG . . . . . . . . . . . . . 20.2 mmt180 -145.46 178.11 8.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.836 0.35 . . . . 0.0 110.862 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 361' ' ' TYR . . . . . . . . . . . . . 18.9 p90 -90.67 163.83 14.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.932 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 8.0 mm -141.6 155.34 20.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.112 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 363' ' ' GLU . . . . . 0.527 ' HB3' ' CZ ' ' A' ' 365' ' ' PHE . 13.8 mt-10 -147.47 119.45 8.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.851 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 20.0 t -89.01 140.06 16.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.139 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 365' ' ' PHE . . . . . 0.527 ' CZ ' ' HB3' ' A' ' 363' ' ' GLU . 16.8 m-85 -140.92 128.3 21.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.889 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 36.4 mtp180 -73.21 143.0 47.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.865 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -130.6 78.09 1.82 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.939 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -55.36 -46.0 76.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.936 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 39.8 m -72.38 -51.42 20.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.874 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 67.55 87.8 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.512 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -4.96 15.07 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.71 2.273 . . . . 0.0 112.306 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 372' ' ' SER . . . . . 0.551 ' OG ' ' CE2' ' A' ' 337' ' ' PHE . 3.3 m -76.48 106.04 7.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.888 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 53.3 p -55.97 121.48 9.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.866 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.519 179.994 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.268 0 N-CA-C 112.452 -0.259 . . . . 0.0 112.452 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 71.0 p -130.2 104.16 7.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.901 0.381 . . . . 0.0 110.872 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 82.9 p -112.09 135.72 52.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.87 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 168.89 -58.23 0.2 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.447 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 72.4 p 41.14 41.87 1.48 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.873 0.368 . . . . 0.0 110.87 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 83.9 p -158.9 119.92 3.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.857 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . -148.75 -120.84 1.11 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.492 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 74.0 p -121.66 128.85 52.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.848 0.356 . . . . 0.0 111.11 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 18.4 p 39.63 47.01 1.61 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.149 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 293' ' ' CYS . . . . . . . . . . . . . 68.8 m -50.43 130.21 23.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.879 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . 0.47 ' CE1' ' HB3' ' A' ' 343' ' ' GLU . 6.1 m80 -85.16 123.06 30.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.889 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 95.4 m -138.44 137.29 37.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.146 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 296' ' ' VAL . . . . . 0.425 ' CG2' ' HB ' ' A' ' 338' ' ' VAL . 35.9 m -110.69 152.24 12.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.158 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . 0.541 ' HG3' ' CE1' ' A' ' 337' ' ' PHE . 0.2 OUTLIER -118.08 136.01 53.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.848 179.992 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . 0.558 HD22 ' CE2' ' A' ' 313' ' ' PHE . 6.7 mp -113.98 142.28 46.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.89 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 299' ' ' ARG . . . . . 0.531 ' HD3' ' CE2' ' A' ' 335' ' ' TYR . 25.1 tpt85 -148.79 134.14 18.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.868 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 126.07 -23.88 5.77 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.446 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -56.62 147.55 50.46 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.568 0.699 . . . . 0.0 111.105 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 -172.45 0.57 Allowed 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.673 2.249 . . . . 0.0 112.325 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 303' ' ' PHE . . . . . 0.429 ' O ' ' CG ' ' A' ' 303' ' ' PHE . 73.1 t80 -89.56 -3.41 58.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.895 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 36.3 t30 -110.41 29.34 7.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.871 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 305' ' ' VAL . . . . . . . . . . . . . 9.1 p -97.04 148.91 5.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.12 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 306' ' ' THR . . . . . . . . . . . . . 23.5 p -134.89 161.23 35.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.129 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -39.77 -49.28 2.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.868 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 33.1 ttmt -46.84 -58.87 3.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.92 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 32.7 m120 -45.17 -45.17 11.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.899 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 61.6 t -57.81 -43.6 84.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.149 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 311' ' ' MET . . . . . . . . . . . . . 3.3 mmt -59.28 -50.49 73.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.869 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -64.28 -29.74 70.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.917 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 313' ' ' PHE . . . . . 0.558 ' CE2' HD22 ' A' ' 298' ' ' LEU . 4.4 t80 -72.27 -31.78 66.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.893 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 92.1 mt -90.93 -22.95 20.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.906 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . 0.502 ' HA ' ' C ' ' A' ' 316' ' ' PRO . . . -44.06 159.32 0.24 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.557 0.694 . . . . 0.0 111.127 179.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 316' ' ' PRO . . . . . 0.502 ' C ' ' HA ' ' A' ' 315' ' ' ALA . 53.6 Cg_endo -69.73 -8.98 10.73 Favored 'Cis proline' 0 C--N 1.341 0.183 0 C-N-CA 122.662 -1.807 . . . . 0.0 112.357 -0.034 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 317' ' ' LEU . . . . . . . . . . . . . 26.4 mt -46.72 161.15 0.07 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.899 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 29.2 tttm -143.79 105.0 4.91 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.563 0.697 . . . . 0.0 110.884 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 319' ' ' PRO . . . . . 0.469 ' HA ' ' CD2' ' A' ' 340' ' ' PHE . 53.8 Cg_endo -69.71 -173.6 0.74 Allowed 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.706 2.271 . . . . 0.0 112.36 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 93.7 t -103.18 -41.11 7.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.136 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -157.47 139.08 13.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.109 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 322' ' ' ILE . . . . . . . . . . . . . 92.0 mt -106.79 106.77 21.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.151 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 45.2 mtt180 -102.47 105.29 15.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.884 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 55.8 mt -73.93 119.85 21.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.122 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . 0.409 HG21 ' CD2' ' A' ' 337' ' ' PHE . 94.4 t -57.6 123.94 10.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.13 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 49.3 mtt180 -83.63 178.77 7.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.848 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -133.04 -64.94 0.72 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.854 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -113.22 -63.44 1.45 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.114 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 7.1 m-70 -111.35 -72.47 0.72 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.865 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -170.48 32.11 0.15 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.52 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -89.55 136.37 33.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.925 0.393 . . . . 0.0 110.883 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 2.7 tmtt? -59.93 105.17 0.36 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.932 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 4.0 t -173.47 132.15 0.46 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.15 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 118.49 -110.92 2.03 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.494 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 335' ' ' TYR . . . . . 0.531 ' CE2' ' HD3' ' A' ' 299' ' ' ARG . 2.8 m-85 -124.41 -177.93 3.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.855 0.36 . . . . 0.0 110.919 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 72.8 mt -142.45 114.34 3.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.123 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . 0.541 ' CE1' ' HG3' ' A' ' 297' ' ' LYS . 15.6 m-85 -88.5 135.35 33.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.918 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . 0.425 ' HB ' ' CG2' ' A' ' 296' ' ' VAL . 63.3 t -132.5 129.91 59.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.11 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -103.18 161.8 13.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.886 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 340' ' ' PHE . . . . . 0.469 ' CD2' ' HA ' ' A' ' 319' ' ' PRO . 55.6 m-85 -139.57 166.53 24.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.868 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 32.2 m -82.59 -62.06 1.71 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.874 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 21.1 m-80 -91.87 158.01 16.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.893 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 343' ' ' GLU . . . . . 0.47 ' HB3' ' CE1' ' A' ' 294' ' ' HIS . 1.7 pp20? -73.92 -28.56 61.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.85 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 45.7 mm-40 -59.3 -53.05 62.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.91 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -46.27 -51.74 13.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.907 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 21.2 t -49.96 -50.64 18.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.146 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 6.2 mtpm? -51.61 -48.76 63.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.875 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -62.38 -26.13 68.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.914 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -63.23 -35.92 81.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.101 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 350' ' ' LEU . . . . . . . . . . . . . 57.6 mt -63.74 -40.94 97.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.978 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 5.4 mtmp? -46.63 -51.15 16.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.934 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 352' ' ' CYS . . . . . . . . . . . . . 4.2 m -69.36 85.19 0.4 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.897 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . 0.452 ' O ' ' C ' ' A' ' 354' ' ' ARG . 1.1 p30 -124.91 -176.37 3.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.91 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . 0.482 ' O ' ' CD ' ' A' ' 354' ' ' ARG . 0.0 OUTLIER 32.44 38.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.883 -179.925 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 355' ' ' GLU . . . . . 0.469 ' C ' ' CD1' ' A' ' 356' ' ' TYR . 57.1 mm-40 -86.95 176.16 7.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.87 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 356' ' ' TYR . . . . . 0.469 ' CD1' ' C ' ' A' ' 355' ' ' GLU . 1.2 m-85 -135.31 107.95 7.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.964 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 357' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -138.38 145.83 41.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.918 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 72.89 -6.13 14.48 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.494 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 102.96 21.91 9.78 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.479 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 360' ' ' ARG . . . . . . . . . . . . . 14.2 mmt180 -148.71 175.7 10.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.807 0.337 . . . . 0.0 110.9 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 361' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -82.59 172.21 13.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.924 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 25.7 mm -142.27 155.53 18.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.11 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 363' ' ' GLU . . . . . 0.532 ' HB3' ' CZ ' ' A' ' 365' ' ' PHE . 7.0 mm-40 -147.87 112.92 5.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.888 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 17.2 t -91.46 143.53 11.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.078 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 365' ' ' PHE . . . . . 0.532 ' CZ ' ' HB3' ' A' ' 363' ' ' GLU . 32.0 m-85 -143.09 122.38 13.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.898 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 35.2 ttp85 -75.84 112.69 12.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.847 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -85.64 98.24 10.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.854 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . 0.406 ' C ' ' HD3' ' A' ' 368' ' ' LYS . 0.0 OUTLIER -70.03 -32.66 70.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.928 179.936 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 7.8 t -75.33 -51.4 13.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.873 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 76.85 -156.33 45.84 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.477 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 175.02 8.69 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.667 2.245 . . . . 0.0 112.369 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 372' ' ' SER . . . . . . . . . . . . . 4.4 m -43.14 122.18 2.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.829 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 3.6 m -84.23 42.0 0.86 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.915 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.494 -179.961 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . 0.442 ' O ' ' C ' ' A' ' 285' ' ' SER . . . . . . . . 0 N--CA 1.451 -0.321 0 N-CA-C 112.506 -0.238 . . . . 0.0 112.506 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 285' ' ' SER . . . . . 0.442 ' C ' ' O ' ' A' ' 284' ' ' GLY . 3.9 m 34.89 51.16 0.5 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.873 0.368 . . . . 0.0 110.888 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 21.5 t -66.03 -67.27 0.46 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.833 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 156.14 106.91 0.26 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.456 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 66.7 p -119.73 120.07 35.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.897 0.38 . . . . 0.0 110.89 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 10.2 m -131.99 100.14 4.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.832 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 104.61 112.47 3.71 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.474 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 31.1 p -100.37 143.92 29.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.889 0.376 . . . . 0.0 111.153 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 7.2 t -125.06 -39.09 2.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.17 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 293' ' ' CYS . . . . . . . . . . . . . 91.9 m -122.52 165.84 15.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.88 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . 0.568 ' CE1' ' HB3' ' A' ' 343' ' ' GLU . 3.0 m-70 -126.82 104.3 7.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.869 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 87.4 m -126.34 144.57 50.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.106 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 19.6 m -121.72 157.65 25.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.136 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 8.8 ttpp -128.43 142.34 51.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.873 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . 0.416 HD23 ' CE1' ' A' ' 313' ' ' PHE . 7.6 mp -114.93 149.83 36.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.89 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 7.7 ttt180 -150.41 140.2 21.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.893 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 103.43 44.94 1.62 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.474 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -113.84 151.42 44.71 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.597 0.713 . . . . 0.0 111.091 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -171.95 0.53 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.637 2.225 . . . . 0.0 112.319 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -87.55 -7.69 57.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.897 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 33.0 m120 -108.97 32.01 5.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.88 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 305' ' ' VAL . . . . . . . . . . . . . 4.5 p -96.2 139.89 18.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.139 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 306' ' ' THR . . . . . . . . . . . . . 67.7 p -142.97 170.63 15.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.146 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -46.68 -35.35 5.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.883 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 11.4 tmtt? -59.7 -50.32 74.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.884 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 34.8 m120 -55.09 -48.89 72.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.944 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 310' ' ' VAL . . . . . 0.438 ' CG1' HD11 ' A' ' 314' ' ' LEU . 76.6 t -58.17 -55.31 22.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.14 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 311' ' ' MET . . . . . . . . . . . . . 2.3 mmt -46.35 -44.47 16.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.889 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -73.99 -26.28 60.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.875 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 313' ' ' PHE . . . . . 0.591 ' CD2' ' SD ' ' A' ' 357' ' ' MET . 1.9 t80 -78.37 -30.9 48.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.822 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . 0.438 HD11 ' CG1' ' A' ' 310' ' ' VAL . 93.9 mt -91.5 -24.53 19.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.952 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . 0.475 ' HA ' ' C ' ' A' ' 316' ' ' PRO . . . -48.68 163.87 0.3 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.592 0.711 . . . . 0.0 111.098 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 316' ' ' PRO . . . . . 0.475 ' C ' ' HA ' ' A' ' 315' ' ' ALA . 53.7 Cg_endo -69.72 -3.2 7.5 Favored 'Cis proline' 0 C--O 1.231 0.165 0 C-N-CA 122.713 -1.786 . . . . 0.0 112.341 -0.026 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 317' ' ' LEU . . . . . 0.467 ' N ' ' HA ' ' A' ' 315' ' ' ALA . 13.5 mt -55.63 142.95 31.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.93 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -120.52 106.31 40.21 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.588 0.708 . . . . 0.0 110.883 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 -164.54 0.13 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.72 2.28 . . . . 0.0 112.369 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 24.5 t -113.62 -45.04 4.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.104 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -153.59 128.94 9.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.09 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 322' ' ' ILE . . . . . . . . . . . . . 49.3 mt -107.67 99.86 9.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.144 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -100.19 104.73 16.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.875 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 58.4 mt -73.73 118.34 19.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.104 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . 0.414 HG22 ' CE2' ' A' ' 337' ' ' PHE . 84.5 t -52.64 107.68 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.109 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 7.2 ptp180 -96.61 166.19 11.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.883 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -116.79 -175.77 2.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.891 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -46.29 -43.44 15.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.116 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 34.5 m80 -110.83 39.0 2.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.868 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 48.24 51.41 20.62 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.46 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 22.7 m-20 -107.11 106.21 16.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.856 0.36 . . . . 0.0 110.865 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 55.4 mttp -57.41 123.91 17.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.918 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 333' ' ' THR . . . . . 0.519 ' O ' ' CD2' ' A' ' 335' ' ' TYR . 64.5 p -118.69 72.52 0.88 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.113 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . 0.463 ' O ' ' CD1' ' A' ' 335' ' ' TYR . . . 34.52 53.12 0.78 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.466 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 335' ' ' TYR . . . . . 0.519 ' CD2' ' O ' ' A' ' 333' ' ' THR . 19.2 m-85 -152.34 120.69 6.34 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.915 0.388 . . . . 0.0 110.928 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 42.6 mt -139.93 132.02 33.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.137 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . 0.414 ' CE2' HG22 ' A' ' 325' ' ' VAL . 22.7 m-85 -99.52 142.78 30.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.849 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 27.6 t -146.33 131.53 12.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.181 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -103.22 168.09 9.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.856 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 340' ' ' PHE . . . . . 0.472 ' HB2' ' CG2' ' A' ' 346' ' ' VAL . 65.6 m-85 -148.22 157.56 43.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.852 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 13.1 t -70.16 -64.6 0.86 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.856 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -99.39 177.43 5.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.863 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 343' ' ' GLU . . . . . 0.568 ' HB3' ' CE1' ' A' ' 294' ' ' HIS . 20.1 pt-20 -78.22 -45.84 21.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.868 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -42.26 -60.03 1.61 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.892 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . 0.419 ' CD ' HD22 ' A' ' 317' ' ' LEU . 19.5 mm-40 -45.3 -32.45 1.99 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.873 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . 0.472 ' CG2' ' HB2' ' A' ' 340' ' ' PHE . 74.9 t -82.6 -36.75 13.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.114 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -64.22 -35.43 80.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.915 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 45.9 mm-40 -76.03 -40.01 54.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.92 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -51.82 -33.53 36.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.141 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 350' ' ' LEU . . . . . . . . . . . . . 96.8 mt -72.48 -40.15 67.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.935 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 46.7 mttm -46.27 -40.69 11.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.885 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 352' ' ' CYS . . . . . . . . . . . . . 33.1 m -78.77 80.45 5.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.915 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . 0.438 ' O ' ' C ' ' A' ' 354' ' ' ARG . 31.5 p-10 -109.28 178.56 4.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.86 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . 0.438 ' C ' ' O ' ' A' ' 353' ' ' ASN . 20.7 ptt180 35.42 42.86 0.13 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.922 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 355' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -89.45 173.9 8.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.85 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 356' ' ' TYR . . . . . 0.497 ' CD1' ' N ' ' A' ' 356' ' ' TYR . 1.1 m-85 -128.13 115.56 18.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.952 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 357' ' ' MET . . . . . 0.591 ' SD ' ' CD2' ' A' ' 313' ' ' PHE . 4.6 ptt? -145.81 127.52 15.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.866 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 81.36 -17.94 12.11 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.526 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 113.25 19.03 6.89 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.467 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 360' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -143.87 134.71 25.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.812 0.339 . . . . 0.0 110.9 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 361' ' ' TYR . . . . . 0.557 ' CD1' ' O ' ' A' ' 361' ' ' TYR . 12.6 p90 -56.27 127.23 29.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.897 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 362' ' ' ILE . . . . . 0.429 ' CD1' ' HG2' ' A' ' 357' ' ' MET . 4.2 mm -106.31 151.57 8.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.163 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 363' ' ' GLU . . . . . 0.413 ' CB ' ' CZ ' ' A' ' 365' ' ' PHE . 28.1 mm-40 -143.4 116.93 9.14 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.846 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 364' ' ' VAL . . . . . 0.442 ' O ' ' CD1' ' A' ' 365' ' ' PHE . 21.7 t -88.82 142.53 12.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.15 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 365' ' ' PHE . . . . . 0.442 ' CD1' ' O ' ' A' ' 364' ' ' VAL . 10.3 m-85 -139.93 146.87 39.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.909 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.68 109.36 19.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.878 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -87.8 79.92 8.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.888 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . 0.446 ' HG2' ' N ' ' A' ' 369' ' ' SER . 0.0 OUTLIER -42.16 -28.98 0.21 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.948 179.946 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 369' ' ' SER . . . . . 0.446 ' N ' ' HG2' ' A' ' 368' ' ' LYS . 44.5 t -86.74 -62.7 1.45 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.856 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 122.93 -157.21 17.45 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.498 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 135.52 30.54 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.704 2.269 . . . . 0.0 112.332 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 372' ' ' SER . . . . . . . . . . . . . 31.3 t -95.32 82.56 3.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.86 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 76.5 p -134.62 159.52 40.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.866 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.492 179.999 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 N-CA-C 112.535 -0.226 . . . . 0.0 112.535 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 41.9 p 38.34 42.15 0.5 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.856 0.36 . . . . 0.0 110.83 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 2.5 t -136.84 114.47 11.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.858 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 101.35 -43.8 1.66 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.498 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 84.1 p -64.72 -48.13 75.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.866 0.365 . . . . 0.0 110.848 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 23.5 t -93.26 -46.51 7.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.83 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 60.5 -137.11 48.96 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.444 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 291' ' ' THR . . . . . 0.415 ' O ' ' C ' ' A' ' 292' ' ' THR . 30.1 m -135.77 111.53 9.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.852 0.358 . . . . 0.0 111.151 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 292' ' ' THR . . . . . 0.415 ' C ' ' O ' ' A' ' 291' ' ' THR . 9.4 t -35.49 128.26 0.59 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.162 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 293' ' ' CYS . . . . . . . . . . . . . 40.1 t -131.94 146.52 52.15 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.91 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . 0.564 ' CE1' ' HB3' ' A' ' 343' ' ' GLU . 11.3 m80 -96.73 99.17 10.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.861 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 63.1 m -136.17 145.36 45.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.178 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 29.8 m -118.86 147.21 22.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.154 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . 0.552 ' HD3' ' CD1' ' A' ' 335' ' ' TYR . 8.8 ttmm -116.87 146.33 42.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.944 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 6.9 mp -115.55 157.55 23.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.917 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -158.02 130.22 7.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.859 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 123.1 -23.2 6.96 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.484 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -57.17 147.71 55.4 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.594 0.711 . . . . 0.0 111.066 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 -176.54 1.52 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.71 2.273 . . . . 0.0 112.301 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 303' ' ' PHE . . . . . 0.413 ' O ' ' CB ' ' A' ' 332' ' ' LYS . 34.5 p90 -78.1 -35.74 48.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.904 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -88.59 48.46 1.64 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.858 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 305' ' ' VAL . . . . . . . . . . . . . 11.4 p -99.24 141.38 16.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.163 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 306' ' ' THR . . . . . 0.414 ' O ' ' C ' ' A' ' 307' ' ' GLU . 69.2 p -132.43 153.27 51.01 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.096 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 307' ' ' GLU . . . . . 0.414 ' C ' ' O ' ' A' ' 306' ' ' THR . 26.1 mt-10 -35.68 -52.17 0.68 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.891 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 14.7 ttpt -40.83 -47.25 2.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.892 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -57.85 -54.87 42.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.873 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 56.2 t -55.9 -50.4 69.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.159 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 311' ' ' MET . . . . . . . . . . . . . 2.7 mmt -48.91 -52.46 24.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.866 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -67.31 -24.73 65.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.871 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 313' ' ' PHE . . . . . 0.402 ' CZ ' HG23 ' A' ' 362' ' ' ILE . 11.2 t80 -77.34 -35.66 54.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.848 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 85.9 mt -86.04 -20.61 28.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.94 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . 0.497 ' HA ' ' C ' ' A' ' 316' ' ' PRO . . . -47.09 159.96 0.37 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.588 0.708 . . . . 0.0 111.08 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 316' ' ' PRO . . . . . 0.497 ' C ' ' HA ' ' A' ' 315' ' ' ALA . 53.8 Cg_endo -69.78 -21.5 10.2 Favored 'Cis proline' 0 C--O 1.232 0.188 0 C-N-CA 122.677 -1.801 . . . . 0.0 112.357 0.055 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 317' ' ' LEU . . . . . . . . . . . . . 22.2 mt -41.38 139.07 1.11 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.887 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -118.51 110.55 38.88 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.576 0.703 . . . . 0.0 110.876 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 319' ' ' PRO . . . . . 0.451 ' HA ' ' CD2' ' A' ' 340' ' ' PHE . 54.2 Cg_endo -69.71 -178.33 2.27 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.68 2.253 . . . . 0.0 112.384 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 320' ' ' VAL . . . . . 0.411 HG22 ' C ' ' A' ' 340' ' ' PHE . 19.4 t -104.12 -34.14 3.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.151 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -162.73 132.93 4.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.115 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 322' ' ' ILE . . . . . . . . . . . . . 66.2 mt -107.75 117.21 52.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.153 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 19.4 mmt180 -111.47 107.08 16.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.843 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 70.8 mt -84.61 138.21 19.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.156 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . 0.405 HG22 ' CE2' ' A' ' 337' ' ' PHE . 62.1 t -106.82 145.28 14.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.095 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 6.7 ptp85 -95.94 172.66 7.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.89 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 327' ' ' ASN . . . . . 0.41 ' O ' ' C ' ' A' ' 328' ' ' ALA . 52.1 t30 -92.86 155.45 17.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.875 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . 0.41 ' C ' ' O ' ' A' ' 327' ' ' ASN . . . -36.52 -54.67 0.86 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.056 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 7.7 m170 -62.36 -61.03 2.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.816 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 145.52 63.94 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.485 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -138.88 158.48 44.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.921 0.391 . . . . 0.0 110.904 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 332' ' ' LYS . . . . . 0.413 ' CB ' ' O ' ' A' ' 303' ' ' PHE . 0.0 OUTLIER -55.11 -59.24 5.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.876 179.908 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 9.3 t -39.43 145.23 0.12 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.143 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 148.76 -98.49 0.19 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.461 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 335' ' ' TYR . . . . . 0.552 ' CD1' ' HD3' ' A' ' 297' ' ' LYS . 79.3 m-85 -150.51 145.9 26.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.811 0.338 . . . . 0.0 110.957 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 60.0 mt -127.28 121.52 57.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.132 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . 0.456 ' CE1' ' HG3' ' A' ' 297' ' ' LYS . 39.1 m-85 -96.1 136.2 36.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.876 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 25.5 t -134.73 132.17 54.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.105 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -105.69 157.94 17.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.883 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 340' ' ' PHE . . . . . 0.451 ' CD2' ' HA ' ' A' ' 319' ' ' PRO . 53.3 m-85 -133.85 162.06 33.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.879 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 34.4 p -64.73 -66.61 0.52 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.877 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 342' ' ' ASN . . . . . 0.401 ' OD1' ' N ' ' A' ' 342' ' ' ASN . 2.8 p-10 -99.75 170.8 8.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.918 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 343' ' ' GLU . . . . . 0.564 ' HB3' ' CE1' ' A' ' 294' ' ' HIS . 1.4 pp20? -70.14 -51.01 34.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.89 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 344' ' ' GLU . . . . . 0.425 ' N ' ' CD ' ' A' ' 343' ' ' GLU . 10.4 tt0 -40.36 -57.98 1.64 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.906 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -39.74 -36.15 0.4 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.899 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 24.6 t -70.08 -48.27 63.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.106 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 347' ' ' LYS . . . . . 0.42 ' HB2' ' NZ ' ' A' ' 347' ' ' LYS . 5.1 mtmp? -52.87 -39.46 62.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.934 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -73.31 -26.66 61.15 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.933 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -64.03 -35.96 82.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.095 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 350' ' ' LEU . . . . . . . . . . . . . 15.9 mt -73.22 -37.06 66.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.912 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 26.3 mmmt -47.44 -47.18 27.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.901 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 352' ' ' CYS . . . . . . . . . . . . . 15.9 m -70.3 72.55 0.47 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.877 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 14.9 p30 -109.09 162.76 13.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.932 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 20.5 mmt180 61.86 35.63 16.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.848 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 355' ' ' GLU . . . . . 0.46 ' C ' ' CD1' ' A' ' 356' ' ' TYR . 20.9 mm-40 -91.48 173.65 7.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.891 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 356' ' ' TYR . . . . . 0.491 ' CD1' ' N ' ' A' ' 356' ' ' TYR . 1.2 m-85 -136.3 128.06 29.11 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.922 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 357' ' ' MET . . . . . . . . . . . . . 3.6 ptt? -156.6 140.38 16.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.912 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 76.95 -9.29 25.47 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.456 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 102.93 16.85 20.38 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.461 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 360' ' ' ARG . . . . . . . . . . . . . 10.3 mmt180 -144.29 153.36 41.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.801 0.334 . . . . 0.0 110.881 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 361' ' ' TYR . . . . . 0.441 ' CD1' ' C ' ' A' ' 361' ' ' TYR . 1.0 OUTLIER -64.88 166.26 9.4 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.911 -179.84 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 362' ' ' ILE . . . . . 0.409 HG12 ' C ' ' A' ' 361' ' ' TYR . 15.7 mm -146.75 137.54 18.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.136 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 363' ' ' GLU . . . . . 0.567 ' HG3' ' CE2' ' A' ' 365' ' ' PHE . 14.7 pt-20 -133.99 112.07 10.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.895 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 364' ' ' VAL . . . . . 0.533 ' O ' ' CD1' ' A' ' 365' ' ' PHE . 14.2 t -84.51 154.07 3.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.099 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 365' ' ' PHE . . . . . 0.567 ' CE2' ' HG3' ' A' ' 363' ' ' GLU . 28.8 m-85 -145.99 156.46 43.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.851 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 32.8 ttp85 -97.86 120.4 38.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.912 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -101.61 74.37 1.51 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.881 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . 0.419 ' HD3' ' C ' ' A' ' 368' ' ' LYS . 0.0 OUTLIER -49.91 -24.49 2.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.9 179.958 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 15.1 m -71.92 -60.97 1.96 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.878 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 96.85 -157.87 21.24 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.464 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 171.86 13.69 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.7 2.267 . . . . 0.0 112.335 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 372' ' ' SER . . . . . . . . . . . . . 30.8 t -109.31 95.91 5.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.808 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 5.6 m -50.19 150.02 2.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.858 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.472 -179.952 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 N-CA-C 112.488 -0.245 . . . . 0.0 112.488 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 285' ' ' SER . . . . . 0.425 ' O ' ' C ' ' A' ' 286' ' ' SER . 1.2 t -153.6 158.89 41.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.86 0.362 . . . . 0.0 110.855 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 286' ' ' SER . . . . . 0.425 ' C ' ' O ' ' A' ' 285' ' ' SER . 1.7 t -36.6 -58.67 0.71 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.882 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 134.21 77.2 0.1 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.495 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 96.8 p -158.5 119.64 3.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.894 0.378 . . . . 0.0 110.86 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 1.7 t -108.75 143.75 37.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.886 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 101.79 136.67 9.35 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.514 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 23.7 m -101.65 131.1 48.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.821 0.343 . . . . 0.0 111.151 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 87.5 m -97.61 -45.42 6.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.177 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 293' ' ' CYS . . . . . . . . . . . . . 35.9 m -97.08 115.51 27.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.846 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . 0.426 ' HB3' ' CG2' ' A' ' 346' ' ' VAL . 7.8 m-70 -84.13 97.26 9.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.874 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 295' ' ' THR . . . . . 0.448 HG21 ' N ' ' A' ' 296' ' ' VAL . 24.7 m -136.49 143.5 43.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.148 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 296' ' ' VAL . . . . . 0.448 ' N ' HG21 ' A' ' 295' ' ' THR . 27.0 m -128.92 150.45 34.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.106 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 28.3 ttpp -119.1 132.36 56.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.902 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 7.3 mp -105.95 103.1 12.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.869 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 299' ' ' ARG . . . . . 0.518 ' HD3' ' CE1' ' A' ' 335' ' ' TYR . 38.0 tpt85 -104.45 122.68 46.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.896 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . 0.411 ' C ' ' O ' ' A' ' 361' ' ' TYR . . . 133.36 -25.1 3.67 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.501 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . 0.465 ' HA ' ' CD1' ' A' ' 362' ' ' ILE . . . -59.52 144.11 85.0 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.571 0.7 . . . . 0.0 111.095 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -167.74 0.24 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.665 2.243 . . . . 0.0 112.341 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 303' ' ' PHE . . . . . 0.411 ' CD1' ' C ' ' A' ' 303' ' ' PHE . 1.8 p90 -95.81 -12.8 24.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.87 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -93.33 3.01 56.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.94 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 305' ' ' VAL . . . . . . . . . . . . . 7.5 p -78.39 143.23 12.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.109 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 306' ' ' THR . . . . . . . . . . . . . 16.6 p -131.92 162.73 29.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.115 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -38.93 -49.16 1.66 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.932 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 30.2 ttmt -50.87 -58.69 5.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.86 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -49.91 -43.01 49.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.891 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 99.0 t -60.56 -49.09 85.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.155 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 311' ' ' MET . . . . . . . . . . . . . 3.1 mmt -50.11 -39.09 41.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.822 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -71.7 -35.49 70.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.898 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 313' ' ' PHE . . . . . 0.556 ' CZ ' HG22 ' A' ' 362' ' ' ILE . 1.6 t80 -74.82 -31.06 61.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.86 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 50.5 mt -84.24 -26.18 28.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.95 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . 0.47 ' HA ' ' C ' ' A' ' 316' ' ' PRO . . . -51.45 163.3 0.59 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.576 0.703 . . . . 0.0 111.105 179.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 316' ' ' PRO . . . . . 0.47 ' C ' ' HA ' ' A' ' 315' ' ' ALA . 54.1 Cg_endo -69.81 -16.24 12.36 Favored 'Cis proline' 0 C--O 1.232 0.21 0 C-N-CA 122.696 -1.793 . . . . 0.0 112.377 0.005 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 317' ' ' LEU . . . . . 0.44 HD22 ' CB ' ' A' ' 348' ' ' GLN . 23.9 mt -46.7 129.37 11.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.896 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 318' ' ' LYS . . . . . 0.415 ' NZ ' ' HA ' ' A' ' 318' ' ' LYS . 0.2 OUTLIER -105.72 105.75 54.04 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.571 0.701 . . . . 0.0 110.87 179.819 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 319' ' ' PRO . . . . . 0.431 ' HA ' ' CD2' ' A' ' 340' ' ' PHE . 53.2 Cg_endo -69.79 178.46 4.57 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.711 2.274 . . . . 0.0 112.297 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 320' ' ' VAL . . . . . 0.414 HG22 ' C ' ' A' ' 340' ' ' PHE . 61.8 t -100.01 -37.06 5.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.093 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -160.83 137.95 9.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.118 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 322' ' ' ILE . . . . . . . . . . . . . 74.0 mt -110.69 109.31 27.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.13 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 63.8 mmt-85 -107.1 105.12 14.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.898 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 67.1 mt -76.42 126.97 37.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.127 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . 0.448 HG22 ' CD2' ' A' ' 337' ' ' PHE . 48.8 t -64.07 125.29 20.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.16 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 21.3 mtm-85 -97.15 127.95 43.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.874 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -91.38 -58.11 2.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.866 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -99.64 -73.57 0.63 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.116 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 33.0 m80 -124.28 -71.42 0.71 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.855 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -146.41 63.91 0.44 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.513 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -126.87 172.1 10.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.942 0.401 . . . . 0.0 110.898 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 332' ' ' LYS . . . . . 0.457 ' HD2' ' N ' ' A' ' 332' ' ' LYS . 6.7 mptt -102.29 93.84 5.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.92 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 2.2 t -84.46 67.64 9.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.161 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 38.81 39.18 0.82 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.548 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 335' ' ' TYR . . . . . 0.518 ' CE1' ' HD3' ' A' ' 299' ' ' ARG . 8.4 m-85 -151.94 133.38 14.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.905 0.383 . . . . 0.0 110.896 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 336' ' ' ILE . . . . . 0.418 HG13 ' C ' ' A' ' 335' ' ' TYR . 88.7 mt -151.04 116.19 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.103 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . 0.448 ' CD2' HG22 ' A' ' 325' ' ' VAL . 31.6 m-85 -90.55 134.76 34.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.845 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 17.4 t -134.62 141.49 43.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.113 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -113.82 161.33 17.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.849 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 340' ' ' PHE . . . . . 0.431 ' CD2' ' HA ' ' A' ' 319' ' ' PRO . 67.0 m-85 -139.18 167.56 21.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.864 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 22.7 m -72.28 -68.46 0.47 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.828 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 342' ' ' ASN . . . . . 0.548 ' ND2' ' H ' ' A' ' 345' ' ' GLU . 2.3 p-10 -99.11 -176.04 3.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.883 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 343' ' ' GLU . . . . . 0.434 ' O ' ' N ' ' A' ' 346' ' ' VAL . 12.0 pt-20 -83.56 -47.26 11.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.884 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 344' ' ' GLU . . . . . 0.482 ' N ' HD21 ' A' ' 342' ' ' ASN . 7.3 mm-40 -44.01 -30.13 0.69 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.914 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . 0.548 ' H ' ' ND2' ' A' ' 342' ' ' ASN . 16.7 mt-10 -73.59 -35.8 65.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.876 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . 0.434 ' N ' ' O ' ' A' ' 343' ' ' GLU . 61.7 t -68.85 -59.12 3.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.163 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.81 -29.04 62.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.893 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 348' ' ' GLN . . . . . 0.44 ' CB ' HD22 ' A' ' 317' ' ' LEU . 29.6 mt-30 -73.11 -32.44 64.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.948 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -62.0 -36.44 81.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.089 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 350' ' ' LEU . . . . . 0.401 HD13 ' CD ' ' A' ' 366' ' ' ARG . 57.1 mt -60.99 -24.78 66.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.913 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 20.8 mmtp -49.72 -44.87 48.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.948 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 352' ' ' CYS . . . . . . . . . . . . . 22.3 m -78.21 72.28 4.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.865 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -109.24 147.71 32.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.883 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 50.4 ttm-85 70.15 30.44 3.49 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.883 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 355' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -88.52 173.74 8.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.936 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 356' ' ' TYR . . . . . 0.425 ' CD1' ' N ' ' A' ' 356' ' ' TYR . 1.7 m-85 -125.31 117.73 24.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.911 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 357' ' ' MET . . . . . 0.444 ' SD ' ' CD2' ' A' ' 313' ' ' PHE . 4.3 ptm -142.26 123.36 14.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.907 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 86.29 -20.37 22.24 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.51 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 117.24 13.45 7.61 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.494 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 360' ' ' ARG . . . . . . . . . . . . . 21.5 mmt-85 -140.75 158.52 43.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.815 0.34 . . . . 0.0 110.823 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 361' ' ' TYR . . . . . 0.411 ' O ' ' C ' ' A' ' 300' ' ' GLY . 13.0 p90 -67.14 163.62 19.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.94 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 362' ' ' ILE . . . . . 0.556 HG22 ' CZ ' ' A' ' 313' ' ' PHE . 15.1 mm -140.57 144.58 27.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.154 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 363' ' ' GLU . . . . . 0.414 ' N ' HG23 ' A' ' 362' ' ' ILE . 31.9 mt-10 -138.42 112.19 8.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.861 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 45.9 t -84.6 134.54 26.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.155 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -131.01 152.94 49.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.913 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . 0.401 ' CD ' HD13 ' A' ' 350' ' ' LEU . 51.6 mtm180 -101.43 113.35 26.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.866 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -92.04 104.7 17.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.87 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 44.3 mttm -48.04 -55.51 9.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.9 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 33.8 m -99.99 -49.55 4.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.876 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 65.43 144.92 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.473 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 371' ' ' PRO . . . . . 0.417 ' O ' ' C ' ' A' ' 372' ' ' SER . 54.1 Cg_endo -69.73 -37.01 9.82 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.708 2.272 . . . . 0.0 112.373 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 372' ' ' SER . . . . . 0.417 ' C ' ' O ' ' A' ' 371' ' ' PRO . 23.0 t -37.13 -53.3 1.02 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.908 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 55.5 p -164.19 141.26 6.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.857 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.339 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.524 179.985 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 N-CA-C 112.519 -0.232 . . . . 0.0 112.519 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 285' ' ' SER . . . . . 0.446 ' O ' ' C ' ' A' ' 286' ' ' SER . 1.5 t -131.65 -51.54 0.99 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.864 0.364 . . . . 0.0 110.87 -179.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 286' ' ' SER . . . . . 0.446 ' C ' ' O ' ' A' ' 285' ' ' SER . 51.3 p 34.52 42.32 0.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.901 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -134.44 -99.56 0.64 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.486 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 13.9 t -59.06 117.64 4.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.898 0.38 . . . . 0.0 110.864 -179.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 61.9 p -64.67 149.67 48.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.83 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 121.63 -153.43 16.72 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.469 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 1.3 m 64.01 54.32 1.72 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.909 0.385 . . . . 0.0 111.119 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 72.6 p -108.74 111.07 22.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.134 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 293' ' ' CYS . . . . . . . . . . . . . 37.8 m -122.29 137.12 54.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.858 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 31.9 m80 -122.65 118.19 27.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.886 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 295' ' ' THR . . . . . 0.438 HG22 ' N ' ' A' ' 296' ' ' VAL . 85.0 m -140.55 143.44 35.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.116 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 296' ' ' VAL . . . . . 0.438 ' N ' HG22 ' A' ' 295' ' ' THR . 27.2 m -116.99 147.77 20.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.123 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 13.9 ttmt -125.37 137.38 54.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.921 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . 0.471 HD22 ' CE1' ' A' ' 313' ' ' PHE . 6.8 mp -120.86 118.31 29.63 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.919 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -115.75 155.62 27.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.828 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 86.86 36.58 9.09 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.451 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -102.2 147.72 34.36 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.622 0.725 . . . . 0.0 111.113 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 175.98 7.37 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.713 2.275 . . . . 0.0 112.372 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 56.0 t80 -80.97 -29.26 35.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.876 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -86.89 35.44 0.69 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.903 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 305' ' ' VAL . . . . . . . . . . . . . 11.8 p -98.45 145.05 10.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.116 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 306' ' ' THR . . . . . . . . . . . . . 64.4 p -141.36 164.97 28.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.099 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -44.88 -34.95 2.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.915 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? -57.74 -47.06 83.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.909 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 23.2 m120 -60.19 -59.41 5.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.9 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 85.2 t -48.89 -41.51 13.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.152 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 311' ' ' MET . . . . . . . . . . . . . 2.0 mmt -62.09 -44.76 95.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.861 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -68.24 -26.41 65.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.881 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 313' ' ' PHE . . . . . 0.471 ' CE1' HD22 ' A' ' 298' ' ' LEU . 5.5 t80 -75.33 -40.91 57.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.866 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 57.9 mt -83.1 -24.89 32.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.921 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . 0.507 ' HA ' ' C ' ' A' ' 316' ' ' PRO . . . -44.58 156.74 0.33 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.579 0.704 . . . . 0.0 111.133 179.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 316' ' ' PRO . . . . . 0.507 ' C ' ' HA ' ' A' ' 315' ' ' ALA . 53.6 Cg_endo -69.85 -19.09 11.52 Favored 'Cis proline' 0 C--O 1.232 0.21 0 C-N-CA 122.661 -1.808 . . . . 0.0 112.332 0.08 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 317' ' ' LEU . . . . . 0.413 HD23 ' CD ' ' A' ' 345' ' ' GLU . 35.7 mt -39.01 138.4 0.57 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.894 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 12.6 tppt? -119.64 107.49 40.57 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.551 0.691 . . . . 0.0 110.889 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 319' ' ' PRO . . . . . 0.476 ' HA ' ' CD2' ' A' ' 340' ' ' PHE . 54.0 Cg_endo -69.78 -171.02 0.43 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.648 2.232 . . . . 0.0 112.333 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 320' ' ' VAL . . . . . 0.42 HG22 ' C ' ' A' ' 340' ' ' PHE . 65.2 t -106.68 -41.75 6.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.11 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -155.06 129.8 9.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.118 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 322' ' ' ILE . . . . . . . . . . . . . 91.7 mt -100.97 99.8 9.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.152 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 9.5 mmm180 -98.74 103.44 15.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.908 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . 0.466 ' CG2' HG12 ' A' ' 336' ' ' ILE . 58.7 mt -81.01 134.86 26.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.128 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . 0.404 HG22 ' CE2' ' A' ' 337' ' ' PHE . 45.5 t -64.56 80.83 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.16 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 25.6 ptt180 -87.63 139.75 30.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.919 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 28.3 m120 -57.04 -179.31 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.87 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -51.94 -54.12 33.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.122 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -65.13 -54.57 27.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.904 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 144.02 66.64 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.469 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -133.81 129.68 36.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.913 0.387 . . . . 0.0 110.901 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 332' ' ' LYS . . . . . 0.43 ' HG2' ' CG2' ' A' ' 324' ' ' ILE . 33.2 mttt -59.76 131.4 50.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.933 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 333' ' ' THR . . . . . 0.501 ' O ' ' N ' ' A' ' 335' ' ' TYR . 81.0 p -125.88 74.75 1.44 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.12 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . 0.45 ' O ' ' C ' ' A' ' 335' ' ' TYR . . . 46.2 -89.0 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.484 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 335' ' ' TYR . . . . . 0.501 ' N ' ' O ' ' A' ' 333' ' ' THR . 93.2 m-85 -34.24 140.29 0.07 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.919 0.39 . . . . 0.0 110.911 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 336' ' ' ILE . . . . . 0.466 HG12 ' CG2' ' A' ' 324' ' ' ILE . 30.2 mt -145.63 143.48 21.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.114 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . 0.404 ' CE2' HG22 ' A' ' 325' ' ' VAL . 27.5 m-85 -110.67 123.52 50.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.859 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 93.8 t -126.0 126.57 69.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.136 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -101.36 160.61 14.27 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.905 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 340' ' ' PHE . . . . . 0.476 ' CD2' ' HA ' ' A' ' 319' ' ' PRO . 35.9 m-85 -134.68 165.86 24.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.862 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 16.9 t -87.79 -55.34 3.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.831 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -89.54 168.04 12.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.895 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -81.96 -43.16 18.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.883 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -56.93 -54.11 50.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.938 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . 0.413 ' CD ' HD23 ' A' ' 317' ' ' LEU . 20.8 mm-40 -41.22 -35.81 0.66 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.888 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . 0.429 ' CG2' ' HB2' ' A' ' 340' ' ' PHE . 53.0 t -74.86 -50.28 25.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.11 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 15.5 mtpp -53.71 -35.75 61.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.879 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 35.3 mm-40 -71.46 -44.06 65.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.926 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -43.58 -40.1 3.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.099 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 350' ' ' LEU . . . . . . . . . . . . . 54.6 mt -58.88 -39.0 80.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.923 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 56.1 mmtt -45.12 -36.69 3.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.932 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 352' ' ' CYS . . . . . . . . . . . . . 64.6 m -71.2 71.99 0.62 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.908 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . 0.401 ' O ' ' C ' ' A' ' 354' ' ' ARG . 16.7 p30 -116.85 -176.46 2.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.913 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . 0.401 ' C ' ' O ' ' A' ' 353' ' ' ASN . 54.0 ttt-85 37.29 49.88 0.96 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.83 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 355' ' ' GLU . . . . . 0.438 ' C ' ' OE1' ' A' ' 355' ' ' GLU . 0.0 OUTLIER -135.94 173.38 11.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.899 -179.983 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 356' ' ' TYR . . . . . 0.434 ' CD1' ' N ' ' A' ' 356' ' ' TYR . 2.7 m-85 -131.7 137.14 48.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.902 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 357' ' ' MET . . . . . 0.426 ' CG ' HG13 ' A' ' 362' ' ' ILE . 0.1 OUTLIER -139.04 128.06 23.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.87 179.89 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 83.03 -28.75 3.58 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.479 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 125.26 28.46 1.1 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.5 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 360' ' ' ARG . . . . . . . . . . . . . 33.7 mtt-85 -151.41 156.99 41.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.861 0.363 . . . . 0.0 110.873 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 361' ' ' TYR . . . . . 0.438 ' CG ' ' O ' ' A' ' 361' ' ' TYR . 2.3 p90 -69.66 125.43 26.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.921 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 362' ' ' ILE . . . . . 0.426 HG13 ' CG ' ' A' ' 357' ' ' MET . 17.3 mm -107.18 151.94 8.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.191 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 363' ' ' GLU . . . . . 0.558 ' HB3' ' CZ ' ' A' ' 365' ' ' PHE . 59.9 mm-40 -143.42 112.16 6.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.881 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 15.9 t -87.81 120.85 37.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.151 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 365' ' ' PHE . . . . . 0.558 ' CZ ' ' HB3' ' A' ' 363' ' ' GLU . 70.7 m-85 -124.85 133.32 53.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.847 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . 0.417 ' NH1' ' HB3' ' A' ' 366' ' ' ARG . 6.2 ttp-105 -82.25 111.75 18.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.92 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -82.07 106.01 13.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.876 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 2.2 ttmp? -59.44 -46.87 87.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.881 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 65.3 p -93.41 -48.69 6.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.836 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 82.48 -168.39 47.97 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.518 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.69 95.0 0.53 Allowed 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.733 2.289 . . . . 0.0 112.331 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 372' ' ' SER . . . . . . . . . . . . . 1.6 t -112.71 126.84 55.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.863 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 48.3 t -165.17 124.4 1.77 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.883 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.382 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.498 -179.973 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 294' ' ' HIS . . . . . 0.679 ' HB2' HG21 ' A' ' 346' ' ' VAL . 28.5 m-70 . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.865 0.364 . . . . 0.0 110.866 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 63.0 m -139.66 142.35 36.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.142 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 296' ' ' VAL . . . . . 0.542 ' CG1' HG13 ' A' ' 346' ' ' VAL . 29.2 m -118.5 151.06 20.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.145 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 297' ' ' LYS . . . . . 0.429 ' C ' HD12 ' A' ' 298' ' ' LEU . 5.5 ttpm? -119.62 138.51 53.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.868 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 298' ' ' LEU . . . . . 0.429 HD12 ' C ' ' A' ' 297' ' ' LYS . 7.4 mp -126.36 128.47 47.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.927 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 27.2 ptt180 -131.93 163.39 28.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.839 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 300' ' ' GLY . . . . . 0.472 ' C ' HD13 ' A' ' 362' ' ' ILE . . . 90.99 28.23 16.14 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.527 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -98.22 148.45 34.52 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.545 0.688 . . . . 0.0 111.115 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -165.9 0.17 Allowed 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.702 2.268 . . . . 0.0 112.303 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -93.21 -13.97 27.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.863 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -102.68 27.6 6.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.935 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 305' ' ' VAL . . . . . . . . . . . . . 10.6 p -90.41 141.78 13.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.068 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 306' ' ' THR . . . . . . . . . . . . . 35.2 p -139.26 -179.05 5.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.137 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -55.26 -35.91 65.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.876 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 28.1 tttp -58.13 -59.37 5.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.881 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -46.1 -47.68 17.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.882 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 58.4 t -58.34 -44.94 89.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.098 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 311' ' ' MET . . . . . . . . . . . . . 4.0 mmt -58.49 -52.0 67.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.884 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -64.12 -29.27 70.41 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.86 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 313' ' ' PHE . . . . . 0.475 ' CD1' ' C ' ' A' ' 313' ' ' PHE . 3.1 t80 -75.49 -41.34 55.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.907 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.452 ' CD1' HG11 ' A' ' 338' ' ' VAL . 46.5 mt -81.65 -25.83 35.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.922 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 315' ' ' ALA . . . . . 0.852 ' HB1' ' HA ' ' A' ' 316' ' ' PRO . . . -46.37 166.56 0.16 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.647 0.736 . . . . 0.0 111.084 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 316' ' ' PRO . . . . . 0.852 ' HA ' ' HB1' ' A' ' 315' ' ' ALA . 54.4 Cg_endo -69.68 -3.58 7.67 Favored 'Cis proline' 0 C--O 1.232 0.205 0 C-N-CA 122.66 -1.808 . . . . 0.0 112.386 -0.044 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 317' ' ' LEU . . . . . 0.668 HD22 ' HA ' ' A' ' 345' ' ' GLU . 20.8 mt -53.19 156.32 2.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.908 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 9.6 tttp -130.83 102.71 16.12 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.593 0.711 . . . . 0.0 110.895 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 319' ' ' PRO . . . . . 0.506 ' HA ' ' CD2' ' A' ' 340' ' ' PHE . 53.5 Cg_endo -69.77 -179.07 2.66 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.691 2.261 . . . . 0.0 112.333 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 320' ' ' VAL . . . . . 0.415 HG23 ' HA ' ' A' ' 340' ' ' PHE . 21.7 t -100.72 -39.25 6.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.112 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -156.15 129.92 8.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.086 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 322' ' ' ILE . . . . . 0.49 HG23 HG22 ' A' ' 338' ' ' VAL . 54.3 mt -105.78 99.79 9.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.124 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 18.6 mtp85 -94.0 118.62 31.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.874 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 51.7 mt -87.06 124.37 40.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.139 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 325' ' ' VAL . . . . . 0.687 HG21 ' HB3' ' A' ' 335' ' ' TYR . 53.7 t . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.152 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 335' ' ' TYR . . . . . 0.687 ' HB3' HG21 ' A' ' 325' ' ' VAL . 14.9 m-85 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.833 0.349 . . . . 0.0 110.914 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 67.5 mt -145.27 117.13 2.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.167 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 337' ' ' PHE . . . . . 0.664 ' CE2' HG22 ' A' ' 325' ' ' VAL . 71.5 m-85 -87.47 121.35 29.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.835 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 338' ' ' VAL . . . . . 0.49 HG22 HG23 ' A' ' 322' ' ' ILE . 46.4 t -124.43 132.06 71.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.138 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 43.4 m-20 -107.95 161.01 15.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.866 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 340' ' ' PHE . . . . . 0.555 ' CD2' ' HB3' ' A' ' 345' ' ' GLU . 62.1 m-85 -138.08 168.78 19.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.895 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 9.5 t -85.22 -62.2 1.59 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.829 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -99.51 150.0 22.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.902 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 343' ' ' GLU . . . . . 0.56 ' HG3' ' CE1' ' A' ' 294' ' ' HIS . 23.3 tt0 -54.72 -45.27 74.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.888 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -40.17 -64.19 0.53 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.871 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 345' ' ' GLU . . . . . 0.668 ' HA ' HD22 ' A' ' 317' ' ' LEU . 16.0 mm-40 -39.43 -46.17 1.62 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.875 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 346' ' ' VAL . . . . . 0.679 HG21 ' HB2' ' A' ' 294' ' ' HIS . 65.9 t -67.38 -52.24 44.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.112 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 20.6 mtpp -50.73 -39.85 52.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.865 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -73.87 -30.07 62.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.931 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -56.68 -35.56 68.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.055 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 350' ' ' LEU . . . . . . . . . . . . . 83.7 mt -65.5 -35.77 81.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.963 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 76.4 mttt -45.92 -50.29 14.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.914 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 352' ' ' CYS . . . . . . . . . . . . . 31.7 m -69.06 72.23 0.26 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.92 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -107.68 158.94 16.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.902 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 70.0 mtt180 54.22 46.72 24.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.907 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 355' ' ' GLU . . . . . 0.478 ' C ' ' CD1' ' A' ' 356' ' ' TYR . 1.5 mm-40 -98.55 173.84 6.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.932 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 356' ' ' TYR . . . . . 0.478 ' CD1' ' C ' ' A' ' 355' ' ' GLU . 2.9 m-85 -139.22 115.98 10.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.958 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 357' ' ' MET . . . . . . . . . . . . . 3.6 ptt? -142.07 145.96 34.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.902 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 78.01 -46.81 2.74 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.487 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 359' ' ' GLY . . . . . 0.433 ' O ' ' CG ' ' A' ' 360' ' ' ARG . . . 141.74 34.89 0.1 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.477 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 360' ' ' ARG . . . . . 0.433 ' CG ' ' O ' ' A' ' 359' ' ' GLY . 56.8 mtt180 -164.3 156.04 16.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.793 0.33 . . . . 0.0 110.897 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 361' ' ' TYR . . . . . 0.519 ' CD1' ' O ' ' A' ' 361' ' ' TYR . 1.8 p90 -70.66 133.48 46.7 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.871 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 362' ' ' ILE . . . . . 0.472 HD13 ' C ' ' A' ' 300' ' ' GLY . 27.2 mm -111.98 143.75 21.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.128 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 363' ' ' GLU . . . . . 0.53 ' HB3' ' CZ ' ' A' ' 365' ' ' PHE . 21.1 mm-40 -130.96 113.18 13.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.904 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 21.6 t -88.68 141.85 13.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.129 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 365' ' ' PHE . . . . . 0.53 ' CZ ' ' HB3' ' A' ' 363' ' ' GLU . 56.7 m-85 -141.8 141.49 33.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.906 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 31.7 ttt180 -87.71 114.78 24.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.841 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.869 -179.956 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 294' ' ' HIS . . . . . 0.946 ' CB ' HG21 ' A' ' 346' ' ' VAL . 17.6 m80 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.88 0.371 . . . . 0.0 110.876 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 6.3 m -134.0 133.85 41.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.121 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 296' ' ' VAL . . . . . 0.453 HG13 HG13 ' A' ' 346' ' ' VAL . 36.0 m -112.05 148.64 15.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.147 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 297' ' ' LYS . . . . . 0.56 ' C ' HD12 ' A' ' 298' ' ' LEU . 8.2 ttpm? -117.96 150.6 38.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.884 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 298' ' ' LEU . . . . . 0.56 HD12 ' C ' ' A' ' 297' ' ' LYS . 7.0 mp -132.92 152.23 51.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.956 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 13.2 ptt180 -154.16 176.44 12.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.825 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 82.79 -21.36 7.79 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.555 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -58.2 151.78 45.19 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.637 0.732 . . . . 0.0 111.062 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.8 178.6 4.43 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.705 2.27 . . . . 0.0 112.313 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -85.17 -15.66 42.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.902 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 35.7 t-20 -99.24 35.75 1.87 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.904 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 305' ' ' VAL . . . . . . . . . . . . . 6.3 p -100.8 142.55 15.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.155 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 306' ' ' THR . . . . . . . . . . . . . 25.5 p -128.46 164.74 22.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.13 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -44.35 -50.25 9.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.881 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -43.53 -52.12 6.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.865 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -56.13 -43.87 78.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.889 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 92.2 t -61.98 -39.06 82.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.153 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 311' ' ' MET . . . . . . . . . . . . . 4.1 mmt -63.67 -44.17 94.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.858 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -67.96 -29.06 68.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.907 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 313' ' ' PHE . . . . . 0.437 ' CE2' HD21 ' A' ' 298' ' ' LEU . 36.6 t80 -72.64 -47.06 50.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.9 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.447 ' CD1' HG11 ' A' ' 338' ' ' VAL . 49.4 mt -79.04 -18.27 53.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.904 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 315' ' ' ALA . . . . . 0.872 ' HB1' ' HA ' ' A' ' 316' ' ' PRO . . . -51.25 166.78 0.31 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.613 0.72 . . . . 0.0 111.082 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 316' ' ' PRO . . . . . 0.872 ' HA ' ' HB1' ' A' ' 315' ' ' ALA . 54.0 Cg_endo -69.72 -3.81 7.87 Favored 'Cis proline' 0 C--O 1.232 0.204 0 C-N-CA 122.72 -1.783 . . . . 0.0 112.321 -0.004 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 317' ' ' LEU . . . . . 0.487 ' N ' ' HA ' ' A' ' 315' ' ' ALA . 19.4 mt -50.72 165.28 0.11 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.897 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 35.3 tttt -140.4 105.05 6.51 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.609 0.718 . . . . 0.0 110.889 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -177.61 1.94 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.684 2.256 . . . . 0.0 112.359 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 59.1 t -100.58 -41.41 8.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.145 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -158.2 134.57 9.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.079 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 322' ' ' ILE . . . . . . . . . . . . . 60.9 mt -105.6 101.56 12.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.121 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 20.5 mmt85 -96.29 96.79 9.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.847 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 74.6 mt -68.0 122.14 18.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.124 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 325' ' ' VAL . . . . . 0.494 HG22 ' CD2' ' A' ' 337' ' ' PHE . 47.0 t . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.156 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 335' ' ' TYR . . . . . 0.4 ' HB2' HG21 ' A' ' 325' ' ' VAL . 11.7 m-85 . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.876 0.369 . . . . 0.0 110.866 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 55.3 mt -137.64 122.96 24.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.158 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 337' ' ' PHE . . . . . 0.494 ' CD2' HG22 ' A' ' 325' ' ' VAL . 30.8 m-85 -98.05 126.58 43.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.87 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 338' ' ' VAL . . . . . 0.447 HG11 ' CD1' ' A' ' 314' ' ' LEU . 99.1 t -124.0 131.01 73.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.132 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -105.55 160.41 15.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.879 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -137.94 166.0 25.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.887 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 2.1 m -90.64 -44.19 9.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.891 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -98.63 169.39 9.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.926 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -85.15 -55.48 4.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.882 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -43.32 -46.72 6.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.863 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -50.05 -39.04 40.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.912 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 346' ' ' VAL . . . . . 0.946 HG21 ' CB ' ' A' ' 294' ' ' HIS . 46.3 t -70.35 -58.24 5.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.15 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 15.7 mtmt -50.03 -26.21 4.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.91 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 25.2 mm100 -82.54 -38.95 23.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.918 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -47.32 -30.93 3.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.131 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 350' ' ' LEU . . . . . 0.476 HD23 HG12 ' A' ' 364' ' ' VAL . 48.0 mt -63.78 -36.96 85.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.873 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -47.19 -44.2 21.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.92 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 352' ' ' CYS . . . . . . . . . . . . . 8.0 m -64.59 83.19 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.922 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 353' ' ' ASN . . . . . 0.449 ' O ' ' CG ' ' A' ' 354' ' ' ARG . 48.8 t30 -140.43 177.91 7.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.868 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 354' ' ' ARG . . . . . 0.449 ' CG ' ' O ' ' A' ' 353' ' ' ASN . 7.9 ptp85 44.78 37.22 2.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.904 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 355' ' ' GLU . . . . . 0.423 ' C ' ' CD ' ' A' ' 355' ' ' GLU . 0.0 OUTLIER -125.69 172.63 9.63 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.904 -179.974 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 356' ' ' TYR . . . . . 0.414 ' CD1' ' N ' ' A' ' 356' ' ' TYR . 1.8 m-85 -118.94 146.61 44.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.911 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 357' ' ' MET . . . . . . . . . . . . . 3.2 ptt? -164.24 125.58 2.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.887 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 86.02 -31.75 3.95 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.449 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 359' ' ' GLY . . . . . 0.461 ' O ' ' CG ' ' A' ' 360' ' ' ARG . . . 126.91 30.6 0.8 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.509 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 360' ' ' ARG . . . . . 0.461 ' CG ' ' O ' ' A' ' 359' ' ' GLY . 59.8 mtt180 -164.76 164.59 21.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.743 0.306 . . . . 0.0 110.93 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 361' ' ' TYR . . . . . . . . . . . . . 27.3 p90 -67.05 159.34 28.93 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.891 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 12.5 mm -138.07 125.22 28.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.11 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 363' ' ' GLU . . . . . 0.438 ' HB3' ' CZ ' ' A' ' 365' ' ' PHE . 28.2 mm-40 -118.85 118.23 30.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.824 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 364' ' ' VAL . . . . . 0.476 HG12 HD23 ' A' ' 350' ' ' LEU . 93.8 t -95.15 143.78 11.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.123 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 365' ' ' PHE . . . . . 0.438 ' CZ ' ' HB3' ' A' ' 363' ' ' GLU . 68.6 m-85 -141.97 148.95 39.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.863 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 35.7 ttp85 -96.98 112.18 24.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.884 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.881 -179.934 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 294' ' ' HIS . . . . . 0.705 ' HB3' HG21 ' A' ' 346' ' ' VAL . 3.8 m170 . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.864 0.364 . . . . 0.0 110.838 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 12.1 m -125.64 142.43 51.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.147 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 27.0 m -118.64 147.47 22.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.124 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 297' ' ' LYS . . . . . 0.402 ' NZ ' ' HB3' ' A' ' 297' ' ' LYS . 0.2 OUTLIER -120.85 138.78 53.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.925 179.858 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 6.9 mp -119.57 141.9 48.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.926 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 299' ' ' ARG . . . . . 0.435 ' HB2' ' CE1' ' A' ' 335' ' ' TYR . 13.3 ptt180 -141.58 151.14 42.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.887 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 96.24 16.66 36.99 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.488 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -78.87 147.29 70.19 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.566 0.698 . . . . 0.0 111.105 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.69 169.79 18.0 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.698 2.265 . . . . 0.0 112.386 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 303' ' ' PHE . . . . . 0.458 ' O ' ' CG ' ' A' ' 303' ' ' PHE . 10.3 t80 -70.93 -8.93 56.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.858 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -111.51 41.42 1.89 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.923 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 305' ' ' VAL . . . . . . . . . . . . . 7.7 p -101.98 149.23 6.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.132 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 306' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -148.31 167.26 25.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.178 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -49.68 -20.41 0.81 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.921 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 9.9 ttmm -74.88 -53.32 9.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.852 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -51.67 -34.16 37.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.87 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 54.2 t -69.74 -46.01 75.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.146 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 311' ' ' MET . . . . . 0.43 ' HG2' ' CD1' ' A' ' 322' ' ' ILE . 4.1 mmt -53.37 -48.25 68.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.87 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -68.17 -25.5 65.28 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.929 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 313' ' ' PHE . . . . . 0.494 ' CD1' ' C ' ' A' ' 313' ' ' PHE . 2.6 t80 -75.58 -46.81 29.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.886 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.544 ' CD1' HG11 ' A' ' 338' ' ' VAL . 65.4 mt -78.01 -25.39 47.94 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.919 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 315' ' ' ALA . . . . . 0.859 ' HB1' ' HA ' ' A' ' 316' ' ' PRO . . . -44.4 166.25 0.12 Allowed Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.585 0.707 . . . . 0.0 111.08 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 316' ' ' PRO . . . . . 0.859 ' HA ' ' HB1' ' A' ' 315' ' ' ALA . 53.5 Cg_endo -69.72 -3.77 7.84 Favored 'Cis proline' 0 C--N 1.341 0.178 0 C-N-CA 122.664 -1.806 . . . . 0.0 112.361 0.03 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 317' ' ' LEU . . . . . 0.485 ' N ' ' HA ' ' A' ' 315' ' ' ALA . 27.7 mt -50.03 170.8 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.895 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 33.3 tttt -145.24 105.05 4.38 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.551 0.691 . . . . 0.0 110.923 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 319' ' ' PRO . . . . . 0.498 ' HA ' ' CD2' ' A' ' 340' ' ' PHE . 53.5 Cg_endo -69.79 -175.94 1.33 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.692 2.261 . . . . 0.0 112.33 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 31.1 t -101.12 -39.78 7.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.12 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -156.84 131.64 8.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.123 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 322' ' ' ILE . . . . . 0.548 HG12 HG13 ' A' ' 338' ' ' VAL . 66.7 mt -110.23 108.74 26.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.131 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 27.7 mmm-85 -108.18 121.85 45.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.877 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 324' ' ' ILE . . . . . 0.412 HG23 HG12 ' A' ' 336' ' ' ILE . 60.8 mt -89.71 120.59 38.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.131 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 325' ' ' VAL . . . . . 0.432 HG21 ' HB3' ' A' ' 335' ' ' TYR . 20.6 t . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.107 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 335' ' ' TYR . . . . . 0.435 ' CE1' ' HB2' ' A' ' 299' ' ' ARG . 3.6 m-85 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.84 0.352 . . . . 0.0 110.938 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 336' ' ' ILE . . . . . 0.412 HG12 HG23 ' A' ' 324' ' ' ILE . 43.5 mt -145.95 147.51 18.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.169 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -119.89 128.46 53.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.879 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 338' ' ' VAL . . . . . 0.548 HG13 HG12 ' A' ' 322' ' ' ILE . 21.7 t -129.31 136.82 58.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.167 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -113.74 155.46 25.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.857 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 340' ' ' PHE . . . . . 0.499 ' HB2' HG23 ' A' ' 346' ' ' VAL . 53.5 m-85 -132.08 166.35 21.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.848 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 36.2 p -88.53 -58.12 2.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.896 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 67.3 m-80 -87.63 159.13 18.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.925 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -78.28 -23.54 47.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.902 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -67.64 -49.25 63.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.894 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -48.58 -50.3 33.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.848 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 346' ' ' VAL . . . . . 0.705 HG21 ' HB3' ' A' ' 294' ' ' HIS . 54.9 t -60.8 -56.01 20.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.143 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 24.9 mtpp -51.38 -32.62 26.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.877 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -83.27 -24.03 32.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.879 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -65.0 -26.25 68.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.075 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 350' ' ' LEU . . . . . 0.615 HD23 HG12 ' A' ' 364' ' ' VAL . 42.8 mt -75.34 -7.83 55.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.919 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 1.5 mmmp? -72.95 -32.61 65.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.915 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 352' ' ' CYS . . . . . . . . . . . . . 15.5 m -79.69 72.36 6.37 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.899 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 6.8 p-10 -122.55 174.08 7.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.906 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 23.6 mtt180 53.22 28.42 7.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.847 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 355' ' ' GLU . . . . . 0.411 ' C ' ' OE1' ' A' ' 355' ' ' GLU . 0.0 OUTLIER -117.7 174.45 6.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.906 -179.951 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 356' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -124.8 128.14 48.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.925 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 357' ' ' MET . . . . . 0.445 ' HG3' ' CD1' ' A' ' 362' ' ' ILE . 0.0 OUTLIER -130.77 130.92 44.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.875 179.914 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 83.14 -41.7 2.93 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.462 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 359' ' ' GLY . . . . . 0.447 ' O ' ' CG ' ' A' ' 360' ' ' ARG . . . 141.92 33.27 0.12 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.468 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 360' ' ' ARG . . . . . 0.447 ' CG ' ' O ' ' A' ' 359' ' ' GLY . 71.5 mtt180 -165.19 161.64 19.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.794 0.331 . . . . 0.0 110.924 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 361' ' ' TYR . . . . . 0.443 ' O ' HD13 ' A' ' 362' ' ' ILE . 13.6 p90 -63.74 144.27 57.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.976 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 362' ' ' ILE . . . . . 0.445 ' CD1' ' HG3' ' A' ' 357' ' ' MET . 6.5 mm -130.72 135.05 61.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.161 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 363' ' ' GLU . . . . . 0.513 ' HB2' ' CZ ' ' A' ' 365' ' ' PHE . 15.7 mt-10 -126.35 112.71 15.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.864 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 364' ' ' VAL . . . . . 0.615 HG12 HD23 ' A' ' 350' ' ' LEU . 57.3 t -88.61 124.0 41.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.129 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 365' ' ' PHE . . . . . 0.513 ' CZ ' ' HB2' ' A' ' 363' ' ' GLU . 21.9 m-85 -121.66 142.74 49.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.856 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 366' ' ' ARG . . . . . 0.438 ' CZ ' ' HB3' ' A' ' 366' ' ' ARG . 9.8 ttp-105 -84.94 127.98 34.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.871 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.921 -179.934 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 294' ' ' HIS . . . . . 0.841 ' HB3' HG21 ' A' ' 346' ' ' VAL . 33.6 m80 . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.907 0.384 . . . . 0.0 110.9 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 26.5 m -139.42 139.65 37.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.161 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 296' ' ' VAL . . . . . 0.501 ' CG1' HG13 ' A' ' 346' ' ' VAL . 33.2 m -112.27 148.88 15.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.154 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 297' ' ' LYS . . . . . 0.563 ' HE3' ' CD1' ' A' ' 335' ' ' TYR . 56.4 tttt -122.55 131.19 53.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.931 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 7.9 mp -108.82 154.55 21.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.885 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 299' ' ' ARG . . . . . 0.507 ' HD2' ' CE1' ' A' ' 335' ' ' TYR . 13.0 ttt-85 -162.08 136.02 6.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.878 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 128.6 -18.19 5.74 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.487 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -65.64 151.42 94.69 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.547 0.689 . . . . 0.0 111.117 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -176.4 1.48 Allowed 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.679 2.253 . . . . 0.0 112.347 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 303' ' ' PHE . . . . . 0.484 ' CD1' ' C ' ' A' ' 303' ' ' PHE . 0.5 OUTLIER -76.43 -27.74 56.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.931 179.986 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 23.8 p-10 -92.81 43.76 1.13 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.893 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 305' ' ' VAL . . . . . . . . . . . . . 12.7 p -101.98 141.02 19.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.106 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 306' ' ' THR . . . . . . . . . . . . . 66.8 p -130.93 169.38 15.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.169 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -46.7 -45.91 19.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.903 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 20.9 ttmm -48.29 -57.07 6.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.919 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 25.4 m120 -48.45 -41.76 30.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.904 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 310' ' ' VAL . . . . . 0.443 HG21 HD13 ' A' ' 336' ' ' ILE . 95.9 t -69.33 -42.01 81.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.109 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 311' ' ' MET . . . . . . . . . . . . . 3.6 mmt -58.41 -50.38 73.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.896 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -65.77 -24.83 67.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.883 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 313' ' ' PHE . . . . . 0.602 ' CD1' ' C ' ' A' ' 313' ' ' PHE . 0.5 OUTLIER -83.77 -28.68 28.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.888 -179.938 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.598 HD11 HG21 ' A' ' 338' ' ' VAL . 33.1 mt -90.9 -23.66 20.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.865 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 315' ' ' ALA . . . . . 0.825 ' HB1' ' HA ' ' A' ' 316' ' ' PRO . . . -52.1 166.02 0.44 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.546 0.688 . . . . 0.0 111.136 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 316' ' ' PRO . . . . . 0.825 ' HA ' ' HB1' ' A' ' 315' ' ' ALA . 53.6 Cg_endo -69.72 -7.6 9.98 Favored 'Cis proline' 0 C--O 1.231 0.161 0 C-N-CA 122.703 -1.791 . . . . 0.0 112.328 -0.031 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 317' ' ' LEU . . . . . 0.413 ' N ' ' HA ' ' A' ' 315' ' ' ALA . 47.3 mt -56.04 144.35 29.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.883 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 14.3 tptp -120.42 110.73 35.51 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.563 0.696 . . . . 0.0 110.86 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 319' ' ' PRO . . . . . 0.513 ' HA ' ' CD1' ' A' ' 340' ' ' PHE . 53.7 Cg_endo -69.78 -163.83 0.12 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.694 2.262 . . . . 0.0 112.328 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 21.7 t -118.61 -41.25 2.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.131 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -151.69 124.13 8.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.075 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 322' ' ' ILE . . . . . . . . . . . . . 65.4 mt -98.86 102.39 13.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.141 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 9.2 tpt180 -86.1 116.04 24.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.82 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 72.5 mt -88.63 117.11 31.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.115 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 50.7 t . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.124 179.811 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 335' ' ' TYR . . . . . 0.563 ' CD1' ' HE3' ' A' ' 297' ' ' LYS . 7.0 m-85 . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.811 0.338 . . . . 0.0 110.995 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 336' ' ' ILE . . . . . 0.443 HD13 HG21 ' A' ' 310' ' ' VAL . 85.4 mt -149.73 136.93 13.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.188 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 337' ' ' PHE . . . . . 0.58 ' CD1' ' OE2' ' A' ' 367' ' ' GLU . 55.5 m-85 -108.71 116.08 31.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.889 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 338' ' ' VAL . . . . . 0.598 HG21 HD11 ' A' ' 314' ' ' LEU . 87.0 t -112.62 127.67 69.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.117 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -105.36 139.19 40.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.854 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 340' ' ' PHE . . . . . 0.513 ' CD1' ' HA ' ' A' ' 319' ' ' PRO . 64.2 m-85 -117.22 157.86 25.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.887 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 2.4 m -79.11 -56.07 4.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.872 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 47.3 m-20 -91.93 158.3 16.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.871 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 343' ' ' GLU . . . . . 0.429 ' HG2' ' CE1' ' A' ' 294' ' ' HIS . 53.7 mt-10 -71.46 -44.84 64.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.892 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -47.91 -50.5 26.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.874 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -46.19 -45.65 16.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.91 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 346' ' ' VAL . . . . . 0.841 HG21 ' HB3' ' A' ' 294' ' ' HIS . 66.7 t -68.14 -52.08 41.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.118 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 25.1 mtpp -51.37 -38.44 53.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.903 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 70.4 mm-40 -78.13 -42.85 30.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.886 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -42.8 -42.4 3.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.054 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 350' ' ' LEU . . . . . 0.602 HD23 HG12 ' A' ' 364' ' ' VAL . 40.3 mt -58.85 -42.95 90.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.879 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 65.6 mmtt -42.89 -48.05 5.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.893 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 352' ' ' CYS . . . . . . . . . . . . . 19.9 m -69.11 72.68 0.28 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.883 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -112.55 156.01 23.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.923 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 7.6 ttt85 66.72 29.27 8.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.896 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 355' ' ' GLU . . . . . 0.428 ' HB2' ' CE2' ' A' ' 313' ' ' PHE . 4.4 mm-40 -83.87 173.4 11.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.861 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 356' ' ' TYR . . . . . 0.45 ' CD1' ' N ' ' A' ' 356' ' ' TYR . 1.3 m-85 -131.8 127.41 36.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.904 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 357' ' ' MET . . . . . . . . . . . . . 3.9 ptt? -154.74 142.32 19.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.859 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 78.45 -42.86 2.24 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.448 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 135.65 29.76 0.36 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.542 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 360' ' ' ARG . . . . . . . . . . . . . 61.3 mtt-85 -158.67 158.09 33.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.789 0.328 . . . . 0.0 110.929 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 361' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -66.88 157.17 33.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.941 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 9.1 mm -140.15 149.55 21.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.145 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 363' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -137.17 121.0 17.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.907 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 364' ' ' VAL . . . . . 0.602 HG12 HD23 ' A' ' 350' ' ' LEU . 72.0 t -90.48 131.83 36.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.166 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -125.76 138.62 53.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.874 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 366' ' ' ARG . . . . . 0.554 ' HB2' HD21 ' A' ' 350' ' ' LEU . 18.2 ttp180 -92.67 109.31 20.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.863 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 367' ' ' GLU . . . . . 0.58 ' OE2' ' CD1' ' A' ' 337' ' ' PHE . 20.1 mt-10 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.866 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 294' ' ' HIS . . . . . 0.84 ' HB3' HG21 ' A' ' 346' ' ' VAL . 76.5 m-70 . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.818 0.342 . . . . 0.0 110.858 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 25.5 m -121.17 142.65 49.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.182 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 296' ' ' VAL . . . . . 0.548 HG22 ' O ' ' A' ' 338' ' ' VAL . 28.2 m -119.15 149.49 21.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.121 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 297' ' ' LYS . . . . . 0.527 ' HG3' ' CE1' ' A' ' 337' ' ' PHE . 16.8 ttmt -117.37 143.62 45.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.896 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 298' ' ' LEU . . . . . 0.445 HD12 ' C ' ' A' ' 297' ' ' LYS . 7.1 mp -122.0 121.43 37.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.917 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 299' ' ' ARG . . . . . 0.618 ' NE ' ' CD2' ' A' ' 365' ' ' PHE . 25.4 mtt180 -122.36 162.01 22.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.896 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 95.12 -23.28 34.07 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.511 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -56.13 152.49 21.93 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.588 0.708 . . . . 0.0 111.11 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.71 -173.14 0.66 Allowed 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.701 2.267 . . . . 0.0 112.376 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -90.7 -26.03 19.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.891 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -95.34 44.44 1.09 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.886 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 305' ' ' VAL . . . . . . . . . . . . . 10.8 p -105.22 139.69 25.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.134 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 306' ' ' THR . . . . . . . . . . . . . 41.6 p -124.33 171.2 10.09 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.151 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -48.61 -54.14 15.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.862 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 21.5 ttmt -41.34 -48.81 3.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.91 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -56.95 -41.06 77.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.908 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 87.2 t -65.7 -51.23 64.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.093 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 311' ' ' MET . . . . . . . . . . . . . 3.2 mmt -51.58 -40.06 59.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.851 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -74.09 -30.81 62.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.885 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 313' ' ' PHE . . . . . 0.607 ' CZ ' HG21 ' A' ' 362' ' ' ILE . 27.2 t80 -73.24 -41.67 63.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.892 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.785 ' CD1' HG11 ' A' ' 338' ' ' VAL . 86.9 mt -80.95 -26.11 36.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.922 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 315' ' ' ALA . . . . . 0.677 ' HB1' ' HA ' ' A' ' 316' ' ' PRO . . . -45.54 161.54 0.24 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.569 0.7 . . . . 0.0 111.097 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 316' ' ' PRO . . . . . 0.677 ' HA ' ' HB1' ' A' ' 315' ' ' ALA . 53.9 Cg_endo -69.71 -13.76 12.32 Favored 'Cis proline' 0 C--O 1.232 0.219 0 C-N-CA 122.725 -1.781 . . . . 0.0 112.341 -0.04 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 317' ' ' LEU . . . . . 0.406 HD13 ' O ' ' A' ' 345' ' ' GLU . 83.1 mt -43.09 135.13 3.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.916 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 4.9 tmtt? -111.71 100.54 48.65 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.574 0.702 . . . . 0.0 110.905 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 319' ' ' PRO . . . . . 0.514 ' HA ' ' CD2' ' A' ' 340' ' ' PHE . 53.9 Cg_endo -69.77 -175.39 1.14 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.644 2.23 . . . . 0.0 112.36 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 39.0 t -100.04 -43.63 11.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.102 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -157.3 144.19 18.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.138 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 322' ' ' ILE . . . . . 0.46 HG23 HG22 ' A' ' 338' ' ' VAL . 60.4 mt -116.15 103.41 15.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.112 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 55.2 mtt-85 -98.42 116.3 30.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.862 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 60.0 mt -85.87 124.89 40.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.114 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 325' ' ' VAL . . . . . 0.554 ' CG2' ' CD2' ' A' ' 337' ' ' PHE . 15.8 t . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.104 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 335' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.835 0.35 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 78.5 mt -146.9 149.11 16.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.145 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 337' ' ' PHE . . . . . 0.554 ' CD2' ' CG2' ' A' ' 325' ' ' VAL . 17.4 m-85 -121.38 122.02 38.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.902 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 338' ' ' VAL . . . . . 0.785 HG11 ' CD1' ' A' ' 314' ' ' LEU . 38.1 t -121.21 126.02 74.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.114 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -104.14 157.29 17.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.884 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 340' ' ' PHE . . . . . 0.607 ' HB2' HG23 ' A' ' 346' ' ' VAL . 69.4 m-85 -134.52 167.96 19.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.881 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 30.8 t -87.65 -57.2 3.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.881 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -89.91 160.18 16.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.893 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -78.05 -14.35 59.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.874 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -75.73 -44.51 41.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.906 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 345' ' ' GLU . . . . . 0.521 ' HB3' ' CD2' ' A' ' 340' ' ' PHE . 45.5 mt-10 -55.4 -40.17 71.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.883 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 346' ' ' VAL . . . . . 0.84 HG21 ' HB3' ' A' ' 294' ' ' HIS . 67.3 t -74.17 -41.28 51.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.158 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 33.5 mtpt -59.89 -29.54 68.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.882 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -88.16 -28.34 21.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.907 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -55.57 -35.72 66.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.082 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 350' ' ' LEU . . . . . 0.602 HD23 HG12 ' A' ' 364' ' ' VAL . 42.6 mt -67.41 -38.63 84.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.905 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 16.8 mmtp -56.63 -25.47 53.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.909 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 352' ' ' CYS . . . . . . . . . . . . . 40.4 t -78.44 57.9 2.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.86 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -110.57 170.64 7.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.906 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 13.4 mmt180 61.85 29.24 17.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.83 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 355' ' ' GLU . . . . . 0.516 ' C ' ' CD1' ' A' ' 356' ' ' TYR . 12.4 mm-40 -97.68 172.5 7.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.908 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 356' ' ' TYR . . . . . 0.516 ' CD1' ' C ' ' A' ' 355' ' ' GLU . 1.3 m-85 -138.44 122.87 18.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.931 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 357' ' ' MET . . . . . . . . . . . . . 1.7 ptt? -148.23 155.74 41.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.878 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 60.57 7.93 8.71 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.449 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 83.76 27.18 39.21 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.517 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 360' ' ' ARG . . . . . . . . . . . . . 15.1 mmm180 -147.68 177.43 9.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.8 0.333 . . . . 0.0 110.893 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 361' ' ' TYR . . . . . . . . . . . . . 29.2 p90 -92.39 149.3 21.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.891 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 362' ' ' ILE . . . . . 0.607 HG21 ' CZ ' ' A' ' 313' ' ' PHE . 14.5 mm -118.64 149.93 20.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.127 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 363' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -141.02 112.67 7.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.891 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 364' ' ' VAL . . . . . 0.602 HG12 HD23 ' A' ' 350' ' ' LEU . 11.2 t -88.23 140.7 15.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.148 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 365' ' ' PHE . . . . . 0.618 ' CD2' ' NE ' ' A' ' 299' ' ' ARG . 72.4 m-85 -139.93 143.7 36.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.891 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 17.7 ttp85 -91.81 122.19 34.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.836 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 367' ' ' GLU . . . . . 0.411 ' OE1' ' N ' ' A' ' 297' ' ' LYS . 5.7 mp0 . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.829 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 294' ' ' HIS . . . . . 0.417 ' CB ' HG21 ' A' ' 346' ' ' VAL . 15.4 m-70 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.9 0.381 . . . . 0.0 110.897 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 54.5 m -121.41 150.1 42.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.141 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 296' ' ' VAL . . . . . 0.669 HG13 HG13 ' A' ' 346' ' ' VAL . 27.3 m -118.02 146.16 22.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.113 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 297' ' ' LYS . . . . . 0.558 ' HG3' ' CE1' ' A' ' 337' ' ' PHE . 16.3 ttmt -117.67 142.68 46.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.917 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 298' ' ' LEU . . . . . 0.473 HD12 ' C ' ' A' ' 297' ' ' LYS . 7.9 mp -123.67 135.63 54.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.913 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 9.7 ttm-85 -144.76 132.94 21.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.877 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 129.18 -19.89 5.38 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.455 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -57.75 152.15 38.28 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.571 0.7 . . . . 0.0 111.1 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.72 177.38 5.61 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.711 2.274 . . . . 0.0 112.338 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -72.37 -24.11 61.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.9 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -98.71 47.78 0.98 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.891 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 305' ' ' VAL . . . . . . . . . . . . . 9.4 p -104.62 141.44 20.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.148 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 306' ' ' THR . . . . . . . . . . . . . 66.6 p -136.3 162.86 31.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.155 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -37.85 -46.74 0.97 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.923 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 36.4 tttm -45.5 -56.83 4.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.886 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 21.2 m120 -50.82 -49.11 59.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.905 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 86.9 t -58.0 -41.54 80.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.082 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 311' ' ' MET . . . . . . . . . . . . . 1.9 mmt -61.12 -53.08 61.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.86 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.64 -36.23 78.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.905 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -70.67 -44.28 67.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.878 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.481 ' CD1' HG11 ' A' ' 338' ' ' VAL . 32.9 mt -73.41 -25.59 60.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.934 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 315' ' ' ALA . . . . . 0.811 ' HB1' ' HA ' ' A' ' 316' ' ' PRO . . . -51.25 165.4 0.4 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.579 0.704 . . . . 0.0 111.102 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 316' ' ' PRO . . . . . 0.811 ' HA ' ' HB1' ' A' ' 315' ' ' ALA . 54.1 Cg_endo -69.75 -9.52 11.04 Favored 'Cis proline' 0 C--O 1.232 0.183 0 C-N-CA 122.673 -1.803 . . . . 0.0 112.367 -0.017 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 317' ' ' LEU . . . . . 0.447 HD22 ' CD ' ' A' ' 345' ' ' GLU . 33.8 mt -54.96 139.03 42.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.888 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 318' ' ' LYS . . . . . 0.401 ' HA ' ' HD2' ' A' ' 319' ' ' PRO . 0.0 OUTLIER -113.32 109.48 51.47 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.591 0.71 . . . . 0.0 110.904 179.866 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 319' ' ' PRO . . . . . 0.492 ' HA ' ' CD2' ' A' ' 340' ' ' PHE . 53.5 Cg_endo -69.78 -171.94 0.53 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.673 2.249 . . . . 0.0 112.329 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 80.2 t -104.51 -39.55 5.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.098 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -164.18 129.09 2.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.118 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 322' ' ' ILE . . . . . 0.591 HG23 HG22 ' A' ' 338' ' ' VAL . 50.8 mt -100.53 105.25 17.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.147 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 15.4 mmm180 -99.04 119.98 38.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.856 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 324' ' ' ILE . . . . . 0.43 ' O ' ' C ' ' A' ' 325' ' ' VAL . 64.0 mt -91.38 117.48 34.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.148 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 325' ' ' VAL . . . . . 0.607 HG21 ' HB3' ' A' ' 335' ' ' TYR . 22.4 t . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.115 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 335' ' ' TYR . . . . . 0.607 ' HB3' HG21 ' A' ' 325' ' ' VAL . 3.9 m-85 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.881 0.372 . . . . 0.0 110.921 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 73.6 mt -147.4 129.3 6.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.126 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 337' ' ' PHE . . . . . 0.558 ' CE1' ' HG3' ' A' ' 297' ' ' LYS . 61.6 m-85 -104.25 127.52 51.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.893 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 338' ' ' VAL . . . . . 0.591 HG22 HG23 ' A' ' 322' ' ' ILE . 22.5 t -126.07 135.72 63.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.128 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -106.05 161.19 14.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.852 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 340' ' ' PHE . . . . . 0.57 ' CD2' ' HB3' ' A' ' 345' ' ' GLU . 41.6 m-85 -138.06 171.03 15.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.842 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 3.9 m -81.46 -64.35 1.2 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.855 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -95.42 166.04 12.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.863 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 343' ' ' GLU . . . . . 0.401 ' H ' ' CD ' ' A' ' 343' ' ' GLU . 1.0 OUTLIER -76.11 -16.09 59.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.861 -179.956 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -70.99 -50.8 30.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.892 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 345' ' ' GLU . . . . . 0.57 ' HB3' ' CD2' ' A' ' 340' ' ' PHE . 16.5 mm-40 -50.67 -41.03 55.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.904 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 346' ' ' VAL . . . . . 0.669 HG13 HG13 ' A' ' 296' ' ' VAL . 95.0 t -68.1 -53.2 31.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.132 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp -52.31 -44.65 65.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.897 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -64.5 -40.56 95.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.919 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -42.52 -43.06 3.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.15 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 350' ' ' LEU . . . . . . . . . . . . . 21.4 mt -57.42 -36.77 71.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.9 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 1.5 mmmp? -44.73 -50.55 9.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.859 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 352' ' ' CYS . . . . . . . . . . . . . 3.5 m -73.97 80.33 1.68 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.871 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -121.63 149.61 42.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.898 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? 73.18 35.82 0.9 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.907 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 355' ' ' GLU . . . . . 0.431 ' C ' ' CD1' ' A' ' 356' ' ' TYR . 3.1 mm-40 -95.89 173.52 7.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.87 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 356' ' ' TYR . . . . . 0.488 ' CD1' ' N ' ' A' ' 356' ' ' TYR . 1.1 m-85 -134.55 124.22 25.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.93 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 357' ' ' MET . . . . . . . . . . . . . 2.4 ptt? -147.82 139.53 23.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.859 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 78.98 -14.37 14.44 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.455 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 113.25 6.08 22.49 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.461 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 360' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -134.03 168.49 18.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.785 0.326 . . . . 0.0 110.899 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 361' ' ' TYR . . . . . . . . . . . . . 8.4 p90 -84.59 157.31 21.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.878 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 362' ' ' ILE . . . . . 0.437 HG22 ' N ' ' A' ' 363' ' ' GLU . 10.7 mm -133.69 156.93 41.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.122 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 363' ' ' GLU . . . . . 0.458 ' HB3' ' CZ ' ' A' ' 365' ' ' PHE . 7.4 mm-40 -142.95 123.66 14.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.909 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 364' ' ' VAL . . . . . 0.497 ' O ' ' CD1' ' A' ' 365' ' ' PHE . 53.1 t -98.7 141.65 16.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.101 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 365' ' ' PHE . . . . . 0.497 ' CD1' ' O ' ' A' ' 364' ' ' VAL . 28.5 m-85 -144.37 137.04 26.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.854 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 366' ' ' ARG . . . . . 0.474 ' CZ ' ' HB3' ' A' ' 366' ' ' ARG . 9.4 ttp-105 -81.65 119.32 23.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.885 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.865 -179.885 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 294' ' ' HIS . . . . . 0.737 ' CB ' HG21 ' A' ' 346' ' ' VAL . 48.9 m80 . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.885 0.374 . . . . 0.0 110.895 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 28.1 m -129.28 144.89 51.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.121 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 296' ' ' VAL . . . . . 0.602 ' CG1' HG13 ' A' ' 346' ' ' VAL . 27.8 m -117.19 147.93 20.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.135 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 297' ' ' LYS . . . . . 0.486 ' HG3' ' CE1' ' A' ' 337' ' ' PHE . 9.2 ttmm -116.01 135.58 53.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.901 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 6.4 mp -122.92 126.66 47.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.909 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 299' ' ' ARG . . . . . 0.547 ' NH1' ' CZ ' ' A' ' 335' ' ' TYR . 0.7 OUTLIER -127.01 167.96 15.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.873 179.945 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 76.82 38.32 31.59 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.477 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -104.64 152.31 39.41 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.568 0.699 . . . . 0.0 111.099 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 -172.79 0.62 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.669 2.246 . . . . 0.0 112.312 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -87.21 -31.18 20.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.88 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -87.42 39.98 0.9 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.907 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 305' ' ' VAL . . . . . . . . . . . . . 7.2 p -102.37 136.99 32.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.144 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 306' ' ' THR . . . . . . . . . . . . . 52.8 p -136.73 173.5 11.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.13 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -46.62 -30.8 2.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.881 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -69.18 -59.21 3.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.913 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -44.11 -34.4 1.79 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.909 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 22.0 t -74.6 -46.05 43.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.12 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 311' ' ' MET . . . . . . . . . . . . . 5.5 mmt -53.68 -44.45 69.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.892 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -67.47 -30.69 70.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.903 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 313' ' ' PHE . . . . . 0.624 ' CE2' HG21 ' A' ' 362' ' ' ILE . 2.4 t80 -74.68 -39.05 62.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.919 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 34.5 mt -81.01 -21.6 40.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.913 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 315' ' ' ALA . . . . . 0.865 ' HB1' ' HA ' ' A' ' 316' ' ' PRO . . . -51.93 166.57 0.38 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.561 0.696 . . . . 0.0 111.142 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 316' ' ' PRO . . . . . 0.865 ' HA ' ' HB1' ' A' ' 315' ' ' ALA . 53.9 Cg_endo -69.75 -8.49 10.51 Favored 'Cis proline' 0 C--O 1.232 0.194 0 C-N-CA 122.694 -1.794 . . . . 0.0 112.342 -0.005 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 317' ' ' LEU . . . . . . . . . . . . . 46.0 mt -48.09 165.72 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.943 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 318' ' ' LYS . . . . . 0.401 ' HA ' ' HD2' ' A' ' 319' ' ' PRO . 6.7 tttp -140.31 104.96 6.56 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.59 0.71 . . . . 0.0 110.91 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 319' ' ' PRO . . . . . 0.427 ' HA ' ' CD2' ' A' ' 340' ' ' PHE . 53.1 Cg_endo -69.75 -168.64 0.28 Allowed 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.72 2.28 . . . . 0.0 112.345 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 25.6 t -111.23 -38.07 3.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.127 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -156.06 140.6 16.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.119 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 322' ' ' ILE . . . . . 0.539 HG23 HG22 ' A' ' 338' ' ' VAL . 53.1 mt -118.57 115.26 47.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.128 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -105.56 128.19 53.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.887 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 73.2 mt -94.06 136.89 24.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.089 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 325' ' ' VAL . . . . . 0.458 HG21 ' CE2' ' A' ' 337' ' ' PHE . 43.4 t . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.109 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 335' ' ' TYR . . . . . 0.547 ' CZ ' ' NH1' ' A' ' 299' ' ' ARG . 8.7 m-85 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.819 0.343 . . . . 0.0 110.959 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 96.9 mt -144.98 144.99 21.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.146 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 337' ' ' PHE . . . . . 0.486 ' CE1' ' HG3' ' A' ' 297' ' ' LYS . 68.7 m-85 -120.51 131.78 54.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.86 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 338' ' ' VAL . . . . . 0.539 HG22 HG23 ' A' ' 322' ' ' ILE . 46.7 t -130.58 140.66 48.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.103 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -110.62 159.22 17.76 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.878 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 340' ' ' PHE . . . . . 0.427 ' CD2' ' HA ' ' A' ' 319' ' ' PRO . 71.3 m-85 -134.72 172.02 13.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.875 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 40.8 t -79.33 -66.36 0.88 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.874 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 342' ' ' ASN . . . . . 0.613 ' H ' ' ND2' ' A' ' 342' ' ' ASN . 0.0 OUTLIER -98.7 176.94 5.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.908 -179.992 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 343' ' ' GLU . . . . . 0.572 ' HB3' ' CE1' ' A' ' 294' ' ' HIS . 3.1 pm0 -84.81 -16.25 42.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.863 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -68.91 -33.36 73.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.86 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 345' ' ' GLU . . . . . 0.424 ' HB3' ' CD2' ' A' ' 340' ' ' PHE . 52.0 mt-10 -68.55 -51.01 47.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.834 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 346' ' ' VAL . . . . . 0.737 HG21 ' CB ' ' A' ' 294' ' ' HIS . 87.1 t -58.63 -52.16 63.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.104 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 33.4 mtpt -46.95 -45.49 20.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.884 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 22.5 mm-40 -67.78 -33.5 74.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.9 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 349' ' ' ALA . . . . . 0.405 ' HB3' ' O ' ' A' ' 346' ' ' VAL . . . -55.19 -36.06 65.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.107 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 350' ' ' LEU . . . . . 0.525 HD11 ' HB2' ' A' ' 366' ' ' ARG . 69.2 mt -64.66 -42.58 95.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.898 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 58.1 mmtt -42.57 -48.55 5.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.858 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 352' ' ' CYS . . . . . . . . . . . . . 16.1 m -70.68 73.95 0.57 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.869 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -110.65 152.9 25.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.923 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 22.0 mtt85 61.78 37.6 15.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.893 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 355' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -92.47 174.17 7.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.865 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 356' ' ' TYR . . . . . 0.454 ' CD1' ' N ' ' A' ' 356' ' ' TYR . 1.4 m-85 -126.58 105.62 8.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.937 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 357' ' ' MET . . . . . 0.403 ' O ' ' CG ' ' A' ' 357' ' ' MET . 0.1 OUTLIER -127.37 118.82 24.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.914 179.923 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 90.09 -36.99 3.42 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.468 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 131.03 29.53 0.61 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.497 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 360' ' ' ARG . . . . . . . . . . . . . 47.0 mtt-85 -152.99 140.42 19.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.782 0.325 . . . . 0.0 110.878 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 361' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -54.1 129.95 36.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.962 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 362' ' ' ILE . . . . . 0.624 HG21 ' CE2' ' A' ' 313' ' ' PHE . 32.4 mm -109.14 146.12 15.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.113 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 363' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -138.26 112.14 8.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.87 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 364' ' ' VAL . . . . . 0.42 HG12 HD23 ' A' ' 350' ' ' LEU . 58.8 t -86.56 136.15 23.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.148 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -131.82 129.73 40.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.909 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 366' ' ' ARG . . . . . 0.525 ' HB2' HD11 ' A' ' 350' ' ' LEU . 18.8 ttt180 -78.46 115.98 18.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.897 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.89 -179.927 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 294' ' ' HIS . . . . . 0.583 ' HB3' HG21 ' A' ' 346' ' ' VAL . 39.4 m-70 . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.877 0.37 . . . . 0.0 110.891 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 38.9 m -137.45 139.35 40.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.18 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 296' ' ' VAL . . . . . 0.505 HG22 ' O ' ' A' ' 338' ' ' VAL . 14.4 m -118.64 153.92 20.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.137 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 297' ' ' LYS . . . . . 0.572 ' HE2' ' CE1' ' A' ' 337' ' ' PHE . 2.1 tppp? -112.38 145.94 39.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.875 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 298' ' ' LEU . . . . . 0.473 HD12 ' C ' ' A' ' 297' ' ' LYS . 6.9 mp -132.78 108.57 9.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.902 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 21.9 ptt180 -119.14 146.9 44.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.909 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 114.29 -9.13 22.58 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.447 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -68.48 151.51 97.18 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.572 0.701 . . . . 0.0 111.095 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.71 173.35 11.06 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.676 2.25 . . . . 0.0 112.317 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 303' ' ' PHE . . . . . 0.437 ' CD1' ' C ' ' A' ' 303' ' ' PHE . 6.1 t80 -74.07 -33.23 63.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.854 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 55.7 m-20 -90.44 48.51 1.56 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.861 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 305' ' ' VAL . . . . . 0.542 HG22 ' N ' ' A' ' 306' ' ' THR . 9.5 p -105.07 164.22 4.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.165 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 306' ' ' THR . . . . . 0.542 ' N ' HG22 ' A' ' 305' ' ' VAL . 0.0 OUTLIER -149.19 171.06 17.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.169 -179.968 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 307' ' ' GLU . . . . . 0.435 ' N ' ' OG1' ' A' ' 306' ' ' THR . 38.6 mt-10 -54.98 -23.38 18.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.914 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 53.6 tttp -70.74 -65.52 0.72 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.926 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -40.14 -37.88 0.68 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.876 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 310' ' ' VAL . . . . . 0.462 HG13 HD22 ' A' ' 298' ' ' LEU . 46.9 t -65.64 -50.47 71.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.144 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 311' ' ' MET . . . . . 0.429 ' O ' ' HB2' ' A' ' 315' ' ' ALA . 3.4 mmt -51.38 -39.24 56.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.875 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -66.53 -39.72 88.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.913 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -70.46 -46.24 64.19 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.836 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.755 ' CD1' HG11 ' A' ' 338' ' ' VAL . 29.9 mt -72.83 -26.16 61.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.956 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 315' ' ' ALA . . . . . 0.726 ' HB1' ' HA ' ' A' ' 316' ' ' PRO . . . -48.49 162.89 0.33 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.616 0.722 . . . . 0.0 111.074 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 316' ' ' PRO . . . . . 0.726 ' HA ' ' HB1' ' A' ' 315' ' ' ALA . 53.9 Cg_endo -69.74 -10.61 11.54 Favored 'Cis proline' 0 C--N 1.342 0.195 0 C-N-CA 122.693 -1.794 . . . . 0.0 112.383 -0.036 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 317' ' ' LEU . . . . . . . . . . . . . 33.9 mt -39.48 157.97 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.963 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 36.6 tttm -135.05 96.77 14.09 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.602 0.715 . . . . 0.0 110.877 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 319' ' ' PRO . . . . . 0.519 ' HA ' ' CD2' ' A' ' 340' ' ' PHE . 54.3 Cg_endo -69.76 -175.67 1.23 Allowed 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.666 2.244 . . . . 0.0 112.355 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 38.8 t -100.1 -43.62 11.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.112 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -155.74 141.07 17.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.083 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 322' ' ' ILE . . . . . 0.471 HG23 HG22 ' A' ' 338' ' ' VAL . 56.8 mt -117.13 100.72 10.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.123 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -100.22 105.06 16.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.89 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 324' ' ' ILE . . . . . 0.697 ' HA ' HG23 ' A' ' 336' ' ' ILE . 83.5 mt -69.69 114.0 6.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.162 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 325' ' ' VAL . . . . . 0.453 HG22 ' CD2' ' A' ' 337' ' ' PHE . 59.8 t . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.075 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 335' ' ' TYR . . . . . 0.434 ' C ' HG13 ' A' ' 336' ' ' ILE . 5.8 m-85 . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.838 0.351 . . . . 0.0 110.971 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 336' ' ' ILE . . . . . 0.697 HG23 ' HA ' ' A' ' 324' ' ' ILE . 28.5 mt -144.54 143.27 23.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.109 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 337' ' ' PHE . . . . . 0.572 ' CE1' ' HE2' ' A' ' 297' ' ' LYS . 15.7 m-85 -108.32 120.99 43.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.875 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 338' ' ' VAL . . . . . 0.755 HG11 ' CD1' ' A' ' 314' ' ' LEU . 39.3 t -121.03 124.27 71.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.124 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -103.58 159.12 15.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.851 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 340' ' ' PHE . . . . . 0.519 ' CD2' ' HA ' ' A' ' 319' ' ' PRO . 66.7 m-85 -134.93 160.57 37.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.877 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 17.7 t -83.41 -50.43 8.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.808 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 60.5 m-20 -98.32 159.8 14.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.909 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -74.53 -43.57 55.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.929 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -48.38 -41.37 28.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.863 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 345' ' ' GLU . . . . . 0.439 ' HB3' ' CD2' ' A' ' 340' ' ' PHE . 29.6 mt-10 -56.46 -47.17 79.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.885 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 346' ' ' VAL . . . . . 0.583 HG21 ' HB3' ' A' ' 294' ' ' HIS . 48.8 t -57.64 -56.87 12.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.113 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.59 -38.19 20.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.929 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 17.9 mm100 -72.84 -37.69 67.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.946 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -52.54 -39.52 61.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.115 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 350' ' ' LEU . . . . . 0.422 HD23 HG12 ' A' ' 364' ' ' VAL . 81.4 mt -67.38 -25.13 65.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.958 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 6.5 mmpt? -60.73 -59.7 4.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.895 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 352' ' ' CYS . . . . . . . . . . . . . 69.5 m -65.71 74.05 0.07 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.886 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 55.9 p30 -118.16 168.58 10.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.877 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 19.7 mtt180 61.54 28.96 18.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.908 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 355' ' ' GLU . . . . . 0.42 ' C ' ' CD1' ' A' ' 356' ' ' TYR . 7.0 mm-40 -86.71 174.2 8.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.859 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 356' ' ' TYR . . . . . 0.51 ' CD1' ' N ' ' A' ' 356' ' ' TYR . 0.9 OUTLIER -133.92 99.7 4.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.893 -179.825 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 357' ' ' MET . . . . . . . . . . . . . 5.3 ptt? -126.61 141.93 51.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.936 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 79.22 -43.37 2.48 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.452 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 359' ' ' GLY . . . . . 0.472 ' O ' ' CG ' ' A' ' 360' ' ' ARG . . . 140.92 32.67 0.14 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.481 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 360' ' ' ARG . . . . . 0.472 ' CG ' ' O ' ' A' ' 359' ' ' GLY . 58.1 mtt-85 -164.85 158.15 17.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.802 0.334 . . . . 0.0 110.879 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 361' ' ' TYR . . . . . . . . . . . . . 27.0 p90 -71.83 144.1 49.23 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.908 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 31.2 mm -115.09 142.46 27.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.13 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 363' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -131.15 113.68 14.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.856 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 364' ' ' VAL . . . . . 0.422 HG12 HD23 ' A' ' 350' ' ' LEU . 20.1 t -89.32 134.43 28.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.181 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -131.43 140.82 49.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.886 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 2.1 tmm_? -85.88 124.49 32.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.906 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 367' ' ' GLU . . . . . 0.412 ' OE1' ' CE1' ' A' ' 337' ' ' PHE . 16.3 mt-10 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.935 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 294' ' ' HIS . . . . . 0.837 ' HB3' HG21 ' A' ' 346' ' ' VAL . 79.0 m-70 . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.833 0.349 . . . . 0.0 110.856 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 295' ' ' THR . . . . . 0.592 HG23 ' OD1' ' A' ' 339' ' ' ASP . 5.0 m -137.12 136.62 38.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.189 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 296' ' ' VAL . . . . . 0.71 ' CG1' HG13 ' A' ' 346' ' ' VAL . 26.8 m -118.13 146.79 22.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.162 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 297' ' ' LYS . . . . . 0.494 ' HG3' ' CE1' ' A' ' 337' ' ' PHE . 8.3 ttmm -114.2 141.85 47.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.87 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 298' ' ' LEU . . . . . 0.759 HD21 ' CE2' ' A' ' 313' ' ' PHE . 7.4 mp -123.0 149.93 43.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.915 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 64.0 mtt180 -143.91 165.41 27.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.906 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 87.71 -21.25 23.59 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.5 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -58.28 152.09 44.48 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.571 0.701 . . . . 0.0 111.13 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.8 179.25 3.85 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.667 2.244 . . . . 0.0 112.323 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -86.45 -38.09 17.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.864 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -85.4 46.28 1.28 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.929 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 305' ' ' VAL . . . . . . . . . . . . . 12.3 p -103.09 141.39 19.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.14 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 306' ' ' THR . . . . . . . . . . . . . 41.6 p -121.99 169.94 10.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.173 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 41.7 mp0 -50.3 -51.47 44.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.823 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 12.2 tttp -45.02 -45.13 10.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.89 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -61.02 -49.12 78.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.901 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 78.5 t -59.5 -48.58 86.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.14 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 311' ' ' MET . . . . . . . . . . . . . 4.4 mmt -51.08 -42.78 60.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.84 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -69.69 -25.56 63.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.93 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 313' ' ' PHE . . . . . 0.873 ' CZ ' HG21 ' A' ' 362' ' ' ILE . 37.1 t80 -76.26 -45.86 30.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.869 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.682 ' CD1' HG11 ' A' ' 338' ' ' VAL . 89.4 mt -79.24 -20.46 48.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.905 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 315' ' ' ALA . . . . . 0.725 ' HB1' ' HA ' ' A' ' 316' ' ' PRO . . . -49.86 162.62 0.46 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.571 0.7 . . . . 0.0 111.095 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 316' ' ' PRO . . . . . 0.725 ' HA ' ' HB1' ' A' ' 315' ' ' ALA . 53.2 Cg_endo -69.8 -8.51 10.62 Favored 'Cis proline' 0 C--O 1.232 0.198 0 C-N-CA 122.675 -1.802 . . . . 0.0 112.305 0.037 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 317' ' ' LEU . . . . . . . . . . . . . 17.5 mt -46.7 156.69 0.18 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.893 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 318' ' ' LYS . . . . . 0.401 ' HA ' ' HD2' ' A' ' 319' ' ' PRO . 18.0 ttpt -133.44 105.51 12.07 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.604 0.716 . . . . 0.0 110.89 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 319' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 318' ' ' LYS . 53.6 Cg_endo -69.76 -174.65 0.95 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.688 2.259 . . . . 0.0 112.345 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 21.8 t -108.08 -31.64 2.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.126 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -161.27 130.3 4.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.126 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 322' ' ' ILE . . . . . . . . . . . . . 68.2 mt -107.21 106.82 21.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.139 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 32.7 mmt180 -104.75 101.95 11.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.848 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 66.0 mt -74.68 131.99 34.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.136 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 325' ' ' VAL . . . . . 0.541 HG22 ' CE2' ' A' ' 337' ' ' PHE . 46.5 t . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.127 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 335' ' ' TYR . . . . . 0.43 ' C ' HG13 ' A' ' 336' ' ' ILE . 17.2 m-85 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.839 0.352 . . . . 0.0 110.93 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 336' ' ' ILE . . . . . 0.43 HG13 ' C ' ' A' ' 335' ' ' TYR . 84.7 mt -149.18 138.11 15.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.145 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 337' ' ' PHE . . . . . 0.541 ' CE2' HG22 ' A' ' 325' ' ' VAL . 30.9 m-85 -110.51 125.28 53.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.863 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 338' ' ' VAL . . . . . 0.682 HG11 ' CD1' ' A' ' 314' ' ' LEU . 24.2 t -125.5 143.02 40.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.12 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 339' ' ' ASP . . . . . 0.592 ' OD1' HG23 ' A' ' 295' ' ' THR . 4.5 m-20 -119.37 156.68 29.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.905 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 340' ' ' PHE . . . . . 0.528 ' CD2' ' HB3' ' A' ' 345' ' ' GLU . 57.0 m-85 -134.88 166.23 23.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.86 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 1.9 m -85.41 -55.41 4.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.86 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -99.6 162.86 12.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.877 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 343' ' ' GLU . . . . . 0.417 ' HB3' ' CE1' ' A' ' 294' ' ' HIS . 1.2 pm0 -81.13 -15.28 56.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.864 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -71.15 -34.13 70.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.884 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 345' ' ' GLU . . . . . 0.528 ' HB3' ' CD2' ' A' ' 340' ' ' PHE . 27.1 mt-10 -68.23 -44.84 74.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.932 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 346' ' ' VAL . . . . . 0.837 HG21 ' HB3' ' A' ' 294' ' ' HIS . 55.4 t -63.66 -47.22 92.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.155 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 32.0 mttm -49.53 -38.89 32.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.914 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 3.7 mm100 -71.88 -46.09 59.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.892 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -49.45 -36.44 22.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.12 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 350' ' ' LEU . . . . . 0.599 HD11 ' HD3' ' A' ' 366' ' ' ARG . 55.5 mt -66.62 -42.77 86.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.938 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 66.6 mttt -58.1 -38.39 76.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.878 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 352' ' ' CYS . . . . . 0.438 ' HB3' ' CD ' ' A' ' 355' ' ' GLU . 72.3 m -76.11 83.9 2.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.873 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -120.71 169.99 9.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.865 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 27.9 mmm180 53.85 39.18 30.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.896 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 355' ' ' GLU . . . . . 0.439 ' OE2' ' CE1' ' A' ' 313' ' ' PHE . 12.3 mt-10 -95.39 174.73 6.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.884 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 356' ' ' TYR . . . . . 0.418 ' CD1' ' N ' ' A' ' 356' ' ' TYR . 1.6 m-85 -122.88 105.38 9.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.928 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 357' ' ' MET . . . . . 0.651 ' HG3' HD11 ' A' ' 362' ' ' ILE . 0.0 OUTLIER -130.31 123.69 30.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.904 179.884 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 85.13 -33.06 3.42 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.471 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 129.72 29.15 0.71 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.481 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 360' ' ' ARG . . . . . . . . . . . . . 36.6 mtt85 -162.32 145.38 11.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.836 0.35 . . . . 0.0 110.83 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 361' ' ' TYR . . . . . 0.636 ' O ' HD13 ' A' ' 362' ' ' ILE . 37.1 p90 -47.01 165.93 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.91 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 362' ' ' ILE . . . . . 0.873 HG21 ' CZ ' ' A' ' 313' ' ' PHE . 42.7 mm -139.93 145.79 25.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.136 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 363' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -134.63 115.71 14.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.842 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 50.6 t -96.61 142.81 13.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.092 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -144.07 126.75 16.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.868 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 366' ' ' ARG . . . . . 0.599 ' HD3' HD11 ' A' ' 350' ' ' LEU . 8.1 ttp-105 -68.82 139.09 55.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.862 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.883 -179.941 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 294' ' ' HIS . . . . . 0.688 ' HB3' HG21 ' A' ' 346' ' ' VAL . 70.2 m-70 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.896 0.379 . . . . 0.0 110.851 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 50.1 m -132.69 151.73 51.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.127 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 296' ' ' VAL . . . . . 0.485 ' CG1' HG13 ' A' ' 346' ' ' VAL . 26.3 m -129.65 157.37 42.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.167 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 4.5 ttpm? -125.89 152.4 45.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.899 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 298' ' ' LEU . . . . . 0.754 HD21 ' CE2' ' A' ' 313' ' ' PHE . 6.8 mp -126.35 131.3 51.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.844 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 34.1 ttp85 -136.44 127.78 28.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.872 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 125.41 -8.68 7.85 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.459 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -69.73 150.14 96.67 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.592 0.71 . . . . 0.0 111.092 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 174.32 9.7 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.669 2.246 . . . . 0.0 112.366 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 303' ' ' PHE . . . . . 0.489 ' CD1' ' C ' ' A' ' 303' ' ' PHE . 2.4 t80 -75.54 -27.07 58.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.876 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 25.6 p30 -92.86 46.38 1.23 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.891 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 305' ' ' VAL . . . . . . . . . . . . . 9.8 p -106.93 144.27 16.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.151 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 306' ' ' THR . . . . . . . . . . . . . 61.1 p -132.76 167.52 20.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.182 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -43.89 -52.59 6.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.9 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 36.7 tttt -41.25 -55.91 2.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.899 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -50.91 -48.83 60.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.908 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 310' ' ' VAL . . . . . 0.475 HG21 HG21 ' A' ' 336' ' ' ILE . 61.9 t -57.87 -42.36 82.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.133 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 311' ' ' MET . . . . . 0.468 ' HG2' ' CD1' ' A' ' 322' ' ' ILE . 2.6 mmt -61.17 -52.69 63.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.833 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -65.5 -28.0 68.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.892 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 313' ' ' PHE . . . . . 0.754 ' CE2' HD21 ' A' ' 298' ' ' LEU . 14.9 t80 -71.11 -43.81 66.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.875 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.628 HD11 HG21 ' A' ' 338' ' ' VAL . 61.6 mt -80.86 -26.12 37.16 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.953 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 315' ' ' ALA . . . . . 0.671 ' HB1' ' HA ' ' A' ' 316' ' ' PRO . . . -41.31 161.06 0.13 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.553 0.692 . . . . 0.0 111.108 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 316' ' ' PRO . . . . . 0.671 ' HA ' ' HB1' ' A' ' 315' ' ' ALA . 53.5 Cg_endo -69.86 -9.43 11.21 Favored 'Cis proline' 0 C--O 1.232 0.183 0 C-N-CA 122.657 -1.81 . . . . 0.0 112.348 0.071 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 317' ' ' LEU . . . . . . . . . . . . . 73.0 mt -44.62 149.77 0.38 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.944 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 26.2 tttp -127.54 101.33 24.38 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.596 0.712 . . . . 0.0 110.964 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 319' ' ' PRO . . . . . 0.511 ' HA ' ' CD2' ' A' ' 340' ' ' PHE . 53.2 Cg_endo -69.76 -169.96 0.36 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.718 2.278 . . . . 0.0 112.301 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 320' ' ' VAL . . . . . 0.41 HG23 ' HA ' ' A' ' 340' ' ' PHE . 53.0 t -110.27 -37.18 3.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.137 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -159.18 134.61 8.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.097 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 322' ' ' ILE . . . . . 0.468 ' CD1' ' HG2' ' A' ' 311' ' ' MET . 48.6 mt -110.52 100.52 10.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.106 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -96.03 108.3 20.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.89 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 95.9 mt -74.14 118.43 19.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.132 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 325' ' ' VAL . . . . . 0.485 HG21 ' HB3' ' A' ' 335' ' ' TYR . 25.5 t . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.131 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 335' ' ' TYR . . . . . 0.485 ' HB3' HG21 ' A' ' 325' ' ' VAL . 9.1 m-85 . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.843 0.354 . . . . 0.0 110.927 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 336' ' ' ILE . . . . . 0.475 HG21 HG21 ' A' ' 310' ' ' VAL . 53.4 mt -138.0 124.94 27.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.12 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -99.29 122.3 42.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.864 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 338' ' ' VAL . . . . . 0.628 HG21 HD11 ' A' ' 314' ' ' LEU . 44.1 t -119.7 134.34 63.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.102 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -109.88 164.74 12.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.859 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 340' ' ' PHE . . . . . 0.511 ' CD2' ' HA ' ' A' ' 319' ' ' PRO . 76.1 m-85 -143.37 170.95 14.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.854 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 3.0 p -96.32 -45.99 6.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.872 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -92.43 163.55 13.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.879 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 -87.62 -33.93 18.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.909 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -63.98 -41.05 97.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.901 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -56.34 -49.26 74.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.917 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 346' ' ' VAL . . . . . 0.688 HG21 ' HB3' ' A' ' 294' ' ' HIS . 71.9 t -58.77 -41.74 83.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.1 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 9.9 mtpm? -58.11 -43.25 87.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.892 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -65.53 -37.71 87.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.907 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 349' ' ' ALA . . . . . 0.567 ' O ' HG11 ' A' ' 364' ' ' VAL . . . -54.46 -17.17 2.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.141 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 350' ' ' LEU . . . . . 0.428 HD23 HG12 ' A' ' 364' ' ' VAL . 32.1 mt -92.33 -23.21 19.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.921 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.96 -7.81 9.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.866 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 352' ' ' CYS . . . . . . . . . . . . . 75.7 m -112.24 98.34 7.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.854 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 353' ' ' ASN . . . . . 0.487 ' O ' ' C ' ' A' ' 354' ' ' ARG . 6.9 p-10 -118.54 -179.64 3.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.907 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 354' ' ' ARG . . . . . 0.487 ' C ' ' O ' ' A' ' 353' ' ' ASN . 0.0 OUTLIER 31.44 38.25 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.843 179.969 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 355' ' ' GLU . . . . . 0.486 ' N ' ' O ' ' A' ' 353' ' ' ASN . 3.9 mm-40 -81.2 174.67 11.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.877 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 356' ' ' TYR . . . . . 0.494 ' CD1' ' N ' ' A' ' 356' ' ' TYR . 1.0 OUTLIER -134.05 110.28 9.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.929 -179.912 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 357' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.02 124.98 22.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.891 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 87.53 -37.28 3.24 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.515 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 133.92 29.78 0.45 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.495 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 360' ' ' ARG . . . . . . . . . . . . . 55.5 mtt180 -159.63 145.56 15.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.829 0.347 . . . . 0.0 110.884 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 361' ' ' TYR . . . . . 0.499 ' O ' HD13 ' A' ' 362' ' ' ILE . 48.6 p90 -50.56 159.65 0.49 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.906 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 362' ' ' ILE . . . . . 0.499 HD13 ' O ' ' A' ' 361' ' ' TYR . 4.6 mm -143.35 129.15 16.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.137 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 363' ' ' GLU . . . . . 0.494 ' HB3' ' CZ ' ' A' ' 365' ' ' PHE . 6.5 mm-40 -119.3 112.21 19.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.895 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 364' ' ' VAL . . . . . 0.567 HG11 ' O ' ' A' ' 349' ' ' ALA . 38.4 t -88.03 131.83 34.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.104 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 365' ' ' PHE . . . . . 0.494 ' CZ ' ' HB3' ' A' ' 363' ' ' GLU . 25.7 m-85 -130.25 150.99 51.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.848 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 28.5 ttt180 -95.57 122.33 38.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.836 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.919 -179.964 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 294' ' ' HIS . . . . . 0.726 ' HB2' HG21 ' A' ' 346' ' ' VAL . 13.9 m-70 . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.847 0.356 . . . . 0.0 110.89 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 295' ' ' THR . . . . . 0.443 HG23 ' OD1' ' A' ' 339' ' ' ASP . 32.3 m -138.89 116.37 11.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.129 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 296' ' ' VAL . . . . . 0.658 ' CG1' HG13 ' A' ' 346' ' ' VAL . 29.6 m -98.13 160.67 3.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.138 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 297' ' ' LYS . . . . . 0.578 ' HD3' ' CE1' ' A' ' 337' ' ' PHE . 31.3 ttpt -139.34 150.14 45.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.892 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 298' ' ' LEU . . . . . 0.475 HD21 ' CE1' ' A' ' 313' ' ' PHE . 6.8 mp -124.71 135.51 53.09 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.931 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 18.0 ttt-85 -133.56 138.42 46.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.9 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 110.23 10.57 21.93 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.511 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -75.96 143.65 74.6 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.57 0.7 . . . . 0.0 111.09 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 -170.08 0.37 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.667 2.245 . . . . 0.0 112.339 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -90.67 -10.56 42.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.84 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -101.42 25.98 7.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.895 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 305' ' ' VAL . . . . . . . . . . . . . 9.2 p -94.66 140.23 17.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.103 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 306' ' ' THR . . . . . 0.401 ' O ' ' N ' ' A' ' 308' ' ' LYS . 21.3 p -137.03 160.69 38.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.132 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -38.1 -32.61 0.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.877 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 308' ' ' LYS . . . . . 0.444 ' O ' ' N ' ' A' ' 311' ' ' MET . 23.6 ttmt -63.38 -67.7 0.4 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.921 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 309' ' ' ASN . . . . . 0.41 ' C ' ' O ' ' A' ' 308' ' ' LYS . 9.4 m-80 -37.65 -45.66 0.8 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.92 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 61.7 t -57.82 -43.55 84.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.116 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 311' ' ' MET . . . . . 0.444 ' N ' ' O ' ' A' ' 308' ' ' LYS . 4.7 mmt -59.73 -50.67 72.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.893 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 15.2 mp0 -62.31 -36.38 81.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.906 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 313' ' ' PHE . . . . . 0.475 ' CE1' HD21 ' A' ' 298' ' ' LEU . 3.5 t80 -65.09 -44.63 88.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.873 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.585 ' CD1' HG11 ' A' ' 338' ' ' VAL . 54.6 mt -78.43 -21.07 49.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.905 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 315' ' ' ALA . . . . . 0.871 ' HB1' ' HA ' ' A' ' 316' ' ' PRO . . . -51.58 166.84 0.34 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.573 0.702 . . . . 0.0 111.143 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 316' ' ' PRO . . . . . 0.871 ' HA ' ' HB1' ' A' ' 315' ' ' ALA . 54.1 Cg_endo -69.73 -4.58 8.33 Favored 'Cis proline' 0 C--O 1.232 0.202 0 C-N-CA 122.66 -1.809 . . . . 0.0 112.348 -0.028 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 317' ' ' LEU . . . . . 0.468 ' N ' ' HA ' ' A' ' 315' ' ' ALA . 21.1 mt -54.1 161.1 1.35 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.885 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 46.2 tttt -134.46 107.19 11.01 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.586 0.708 . . . . 0.0 110.925 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 319' ' ' PRO . . . . . 0.476 ' HA ' ' CD2' ' A' ' 340' ' ' PHE . 53.7 Cg_endo -69.79 -175.76 1.27 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.713 2.275 . . . . 0.0 112.358 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 320' ' ' VAL . . . . . 0.459 HG23 ' C ' ' A' ' 340' ' ' PHE . 42.3 t -102.4 -35.74 4.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.107 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -164.14 138.12 5.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.092 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 322' ' ' ILE . . . . . 0.48 HG23 HG22 ' A' ' 338' ' ' VAL . 80.5 mt -112.22 111.51 36.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.121 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 87.0 mtt180 -110.01 103.33 12.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.849 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 94.4 mt -64.26 118.24 6.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.141 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 325' ' ' VAL . . . . . 0.915 HG22 ' CD2' ' A' ' 337' ' ' PHE . 27.1 t . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.157 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 335' ' ' TYR . . . . . 0.555 ' HB3' HG21 ' A' ' 325' ' ' VAL . 10.6 m-85 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.854 0.359 . . . . 0.0 110.915 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 58.7 mt -141.54 113.79 3.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.158 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 337' ' ' PHE . . . . . 0.915 ' CD2' HG22 ' A' ' 325' ' ' VAL . 18.0 m-85 -87.88 129.85 35.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.893 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 338' ' ' VAL . . . . . 0.585 HG11 ' CD1' ' A' ' 314' ' ' LEU . 22.0 t -134.33 135.34 54.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.174 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 339' ' ' ASP . . . . . 0.443 ' OD1' HG23 ' A' ' 295' ' ' THR . 7.0 m-20 -111.75 162.68 14.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.877 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 340' ' ' PHE . . . . . 0.562 ' HB2' HG23 ' A' ' 346' ' ' VAL . 60.3 m-85 -136.64 172.3 13.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.882 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 29.3 t -79.42 -67.6 0.74 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.878 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -100.05 173.25 6.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.876 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 343' ' ' GLU . . . . . 0.551 ' HB2' ' CE1' ' A' ' 294' ' ' HIS . 11.0 pt-20 -75.19 -40.36 59.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.923 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 344' ' ' GLU . . . . . 0.413 ' N ' ' HG3' ' A' ' 343' ' ' GLU . 34.5 tt0 -44.23 -50.75 8.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.913 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -53.96 -61.81 2.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.897 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 346' ' ' VAL . . . . . 0.726 HG21 ' HB2' ' A' ' 294' ' ' HIS . 60.5 t -50.21 -47.04 25.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.086 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 45.2 mtpt -50.95 -39.3 54.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.946 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -79.44 -29.11 41.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.903 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -57.54 -27.05 62.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.074 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 350' ' ' LEU . . . . . 0.56 HD23 HG12 ' A' ' 364' ' ' VAL . 92.6 mt -77.21 -34.99 56.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.912 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 18.3 mmtp -46.33 -43.35 15.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.886 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 352' ' ' CYS . . . . . . . . . . . . . 8.3 m -62.05 85.04 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.897 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 353' ' ' ASN . . . . . 0.483 ' O ' ' C ' ' A' ' 354' ' ' ARG . 33.7 p-10 -122.9 -176.9 3.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.873 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 354' ' ' ARG . . . . . 0.483 ' C ' ' O ' ' A' ' 353' ' ' ASN . 2.9 ppt_? 30.59 44.59 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.894 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 355' ' ' GLU . . . . . 0.446 ' C ' ' OE1' ' A' ' 355' ' ' GLU . 0.0 OUTLIER -118.1 173.1 6.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.891 -179.906 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 356' ' ' TYR . . . . . 0.476 ' CD1' ' N ' ' A' ' 356' ' ' TYR . 1.3 m-85 -128.47 149.29 50.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.902 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 357' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -166.66 125.79 1.48 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.868 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 87.74 -15.2 56.12 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.476 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 105.15 19.77 10.39 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.483 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 360' ' ' ARG . . . . . . . . . . . . . 10.5 mmt180 -146.03 158.86 43.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.828 0.347 . . . . 0.0 110.875 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 361' ' ' TYR . . . . . . . . . . . . . 9.1 p90 -66.22 151.51 46.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.905 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 362' ' ' ILE . . . . . 0.462 HG22 ' N ' ' A' ' 363' ' ' GLU . 15.7 mm -135.3 155.27 37.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.145 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 363' ' ' GLU . . . . . 0.462 ' N ' HG22 ' A' ' 362' ' ' ILE . 49.5 mm-40 -147.57 114.82 6.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.842 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 364' ' ' VAL . . . . . 0.56 HG12 HD23 ' A' ' 350' ' ' LEU . 58.4 t -88.22 140.12 16.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.114 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -137.37 154.79 49.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.831 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 3.0 tmm_? -101.87 109.05 20.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.849 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.892 -179.935 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 294' ' ' HIS . . . . . 0.499 ' CB ' HG21 ' A' ' 346' ' ' VAL . 69.2 m-70 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.867 0.365 . . . . 0.0 110.83 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 69.0 m -135.45 149.81 49.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.13 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 296' ' ' VAL . . . . . 0.511 HG13 HG13 ' A' ' 346' ' ' VAL . 30.8 m -125.74 156.73 35.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.115 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 297' ' ' LYS . . . . . 0.579 ' HD3' ' CE1' ' A' ' 337' ' ' PHE . 13.4 ttpt -130.35 143.67 50.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.877 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 6.8 mp -118.23 151.86 36.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.9 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 299' ' ' ARG . . . . . 0.513 ' HB2' ' CE1' ' A' ' 335' ' ' TYR . 8.8 ttm-85 -146.42 136.37 23.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.901 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 98.9 48.13 1.81 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.454 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -114.61 148.36 40.14 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.601 0.715 . . . . 0.0 111.05 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 153.3 69.16 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.681 2.254 . . . . 0.0 112.306 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -58.49 -30.47 67.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.905 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -85.0 34.41 0.55 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.847 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 305' ' ' VAL . . . . . . . . . . . . . 9.0 p -96.02 139.64 18.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.126 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 306' ' ' THR . . . . . 0.45 ' O ' ' C ' ' A' ' 307' ' ' GLU . 70.7 p -136.2 155.51 50.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.171 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 307' ' ' GLU . . . . . 0.45 ' C ' ' O ' ' A' ' 306' ' ' THR . 30.2 mt-10 -34.46 -38.48 0.07 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.884 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 29.7 ttmt -57.43 -55.52 33.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.916 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -49.79 -46.7 51.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.906 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 85.0 t -61.55 -40.79 87.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.155 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 311' ' ' MET . . . . . 0.404 ' O ' ' HB2' ' A' ' 315' ' ' ALA . 4.1 mmt -58.71 -40.75 84.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.896 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -68.94 -31.55 70.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.909 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 313' ' ' PHE . . . . . 0.72 ' CE2' HG21 ' A' ' 362' ' ' ILE . 1.9 t80 -74.13 -48.93 26.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.919 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.91 ' CD1' HG11 ' A' ' 338' ' ' VAL . 27.8 mt -72.45 -24.95 61.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.944 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 315' ' ' ALA . . . . . 0.791 ' HB1' ' HA ' ' A' ' 316' ' ' PRO . . . -49.73 164.52 0.34 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.577 0.703 . . . . 0.0 111.127 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 316' ' ' PRO . . . . . 0.791 ' HA ' ' HB1' ' A' ' 315' ' ' ALA . 54.0 Cg_endo -69.79 -7.43 10.02 Favored 'Cis proline' 0 C--O 1.232 0.188 0 C-N-CA 122.701 -1.791 . . . . 0.0 112.358 0.067 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 317' ' ' LEU . . . . . 0.642 HD13 ' O ' ' A' ' 345' ' ' GLU . 33.0 mt -57.57 134.29 56.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.926 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.88 111.7 56.32 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.56 0.695 . . . . 0.0 110.906 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -176.62 1.54 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.707 2.271 . . . . 0.0 112.327 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 320' ' ' VAL . . . . . 0.417 HG23 ' C ' ' A' ' 340' ' ' PHE . 93.0 t -100.52 -40.27 7.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.092 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -160.56 131.67 5.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.095 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 322' ' ' ILE . . . . . . . . . . . . . 86.5 mt -102.11 119.96 51.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.122 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 61.5 mtm180 -115.54 98.69 6.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.884 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 324' ' ' ILE . . . . . 0.708 HG23 HG12 ' A' ' 336' ' ' ILE . 41.8 mt -74.72 125.0 33.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.108 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 325' ' ' VAL . . . . . 0.524 HG22 ' CE2' ' A' ' 337' ' ' PHE . 88.0 t . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.126 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 335' ' ' TYR . . . . . 0.513 ' CE1' ' HB2' ' A' ' 299' ' ' ARG . 18.2 m-85 . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.842 0.354 . . . . 0.0 110.937 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 336' ' ' ILE . . . . . 0.708 HG12 HG23 ' A' ' 324' ' ' ILE . 85.5 mt -138.91 113.75 8.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.171 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 337' ' ' PHE . . . . . 0.579 ' CE1' ' HD3' ' A' ' 297' ' ' LYS . 77.0 m-85 -84.95 135.87 33.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.91 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 338' ' ' VAL . . . . . 0.91 HG11 ' CD1' ' A' ' 314' ' ' LEU . 58.0 t -137.64 120.15 19.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.15 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -97.38 158.06 15.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.838 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 340' ' ' PHE . . . . . 0.517 ' CZ ' HD13 ' A' ' 314' ' ' LEU . 41.8 m-85 -133.18 172.19 13.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.874 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 48.5 t -83.23 -63.08 1.43 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.872 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -96.02 159.8 14.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.891 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 343' ' ' GLU . . . . . 0.47 ' HB2' ' CE1' ' A' ' 294' ' ' HIS . 10.7 pt-20 -68.64 -47.25 67.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.875 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -45.87 -55.34 6.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.931 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 345' ' ' GLU . . . . . 0.642 ' O ' HD13 ' A' ' 317' ' ' LEU . 35.6 mt-10 -41.92 -44.83 3.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.879 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 346' ' ' VAL . . . . . 0.511 HG13 HG13 ' A' ' 296' ' ' VAL . 83.8 t -69.86 -48.57 63.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.159 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 18.8 mtpp -46.07 -42.47 13.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.921 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 348' ' ' GLN . . . . . 0.401 ' O ' ' N ' ' A' ' 351' ' ' LYS . 15.7 mm100 -70.44 -41.43 72.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.873 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -40.49 -43.47 1.85 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.048 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 350' ' ' LEU . . . . . 0.566 HD21 ' HB2' ' A' ' 366' ' ' ARG . 22.6 mt -64.08 -40.72 96.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.913 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 351' ' ' LYS . . . . . 0.401 ' N ' ' O ' ' A' ' 348' ' ' GLN . 15.6 mmtp -54.38 -25.55 25.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.881 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 352' ' ' CYS . . . . . . . . . . . . . 85.6 m -95.93 52.17 1.3 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.864 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 353' ' ' ASN . . . . . 0.408 ' CG ' ' N ' ' A' ' 354' ' ' ARG . 8.4 t-20 -100.38 164.05 12.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.907 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 354' ' ' ARG . . . . . 0.408 ' N ' ' CG ' ' A' ' 353' ' ' ASN . 11.2 ttm180 68.99 33.33 3.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.886 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 355' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -102.57 174.01 6.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.909 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 356' ' ' TYR . . . . . 0.462 ' CD1' ' N ' ' A' ' 356' ' ' TYR . 1.3 m-85 -124.62 135.3 52.98 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.952 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 357' ' ' MET . . . . . 0.637 ' HG3' HD11 ' A' ' 362' ' ' ILE . 0.0 OUTLIER -148.59 123.33 9.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.867 179.98 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 82.87 -13.59 42.44 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.478 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 110.56 5.22 28.02 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.487 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 360' ' ' ARG . . . . . 0.426 ' HB3' ' NH1' ' A' ' 360' ' ' ARG . 5.1 mmm180 -123.8 130.67 52.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.836 0.35 . . . . 0.0 110.886 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 361' ' ' TYR . . . . . . . . . . . . . 20.4 p90 -49.38 128.5 17.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.915 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 362' ' ' ILE . . . . . 0.72 HG21 ' CE2' ' A' ' 313' ' ' PHE . 37.1 mm -106.51 144.96 14.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.136 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 363' ' ' GLU . . . . . . . . . . . . . 56.0 mm-40 -139.67 112.29 7.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.841 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 364' ' ' VAL . . . . . 0.436 ' O ' ' CD1' ' A' ' 365' ' ' PHE . 15.0 t -85.25 149.57 4.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.117 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 365' ' ' PHE . . . . . 0.436 ' CD1' ' O ' ' A' ' 364' ' ' VAL . 43.0 m-85 -148.64 121.62 8.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.886 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 366' ' ' ARG . . . . . 0.566 ' HB2' HD21 ' A' ' 350' ' ' LEU . 1.3 tmm_? -69.17 127.78 34.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.888 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.9 -179.926 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 294' ' ' HIS . . . . . 0.9 ' CB ' HG21 ' A' ' 346' ' ' VAL . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.893 0.378 . . . . 0.0 110.884 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 36.6 m -132.06 142.42 49.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.171 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 31.6 m -115.68 150.05 17.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.127 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 297' ' ' LYS . . . . . 0.58 ' C ' HD12 ' A' ' 298' ' ' LEU . 17.0 ttpt -120.59 138.11 54.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.875 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 298' ' ' LEU . . . . . 0.58 HD12 ' C ' ' A' ' 297' ' ' LYS . 6.1 mp -120.23 141.38 49.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.897 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 20.3 ptt180 -149.82 145.94 26.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.931 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 107.18 14.22 19.19 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.512 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -83.85 151.59 61.24 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.607 0.718 . . . . 0.0 111.088 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -165.97 0.17 Allowed 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.724 2.283 . . . . 0.0 112.365 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -90.35 -17.79 26.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.849 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -93.3 14.58 17.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.892 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 305' ' ' VAL . . . . . . . . . . . . . 11.8 p -78.84 138.55 19.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.108 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 306' ' ' THR . . . . . . . . . . . . . 39.0 p -145.35 177.45 8.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.128 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -49.42 -31.61 10.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.897 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 20.1 ttpt -67.78 -60.98 2.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.914 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -46.57 -38.62 9.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.866 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 53.6 t -69.47 -46.76 75.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.172 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 311' ' ' MET . . . . . 0.427 ' HG2' HD11 ' A' ' 322' ' ' ILE . 2.8 mmt -56.66 -49.65 74.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.908 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -66.52 -24.72 66.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.882 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -74.57 -38.75 62.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.91 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.474 ' CD1' HG11 ' A' ' 338' ' ' VAL . 27.1 mt -88.12 -24.37 23.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.882 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 315' ' ' ALA . . . . . 0.695 ' HB1' ' HA ' ' A' ' 316' ' ' PRO . . . -48.4 161.95 0.37 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.561 0.696 . . . . 0.0 111.15 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 316' ' ' PRO . . . . . 0.695 ' HA ' ' HB1' ' A' ' 315' ' ' ALA . 53.0 Cg_endo -69.83 -2.45 7.25 Favored 'Cis proline' 0 C--N 1.342 0.198 0 C-N-CA 122.621 -1.825 . . . . 0.0 112.299 0.054 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 317' ' ' LEU . . . . . 0.487 ' N ' ' HA ' ' A' ' 315' ' ' ALA . 24.7 mt -55.62 124.59 17.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.864 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -102.65 105.29 43.62 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.517 0.675 . . . . 0.0 110.895 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 -175.54 1.18 Allowed 'Trans proline' 0 N--CA 1.465 -0.155 0 C-N-CA 122.728 2.285 . . . . 0.0 112.36 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 97.7 t -100.03 -43.45 11.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.147 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -156.88 139.67 15.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.14 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 322' ' ' ILE . . . . . 0.427 HD11 ' HG2' ' A' ' 311' ' ' MET . 90.6 mt -108.39 108.49 25.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.084 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -103.12 98.08 8.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.878 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 71.9 mt -70.38 118.22 14.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.105 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 325' ' ' VAL . . . . . 0.504 ' CG2' ' CD2' ' A' ' 337' ' ' PHE . 35.2 t . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.125 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 335' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.895 0.379 . . . . 0.0 110.932 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 73.7 mt -143.72 124.44 9.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.126 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 337' ' ' PHE . . . . . 0.504 ' CD2' ' CG2' ' A' ' 325' ' ' VAL . 25.9 m-85 -100.24 126.82 46.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.907 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 338' ' ' VAL . . . . . 0.474 HG11 ' CD1' ' A' ' 314' ' ' LEU . 31.2 t -126.83 132.79 69.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.147 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -106.2 162.14 13.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.853 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -136.62 161.0 37.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.86 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 46.0 m -76.83 -61.02 2.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.825 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -92.3 157.98 16.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.872 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -70.22 -41.8 73.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.852 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 344' ' ' GLU . . . . . 0.41 ' O ' ' C ' ' A' ' 345' ' ' GLU . 36.3 mm-40 -47.07 -61.01 2.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.917 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 345' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 344' ' ' GLU . 30.2 mt-10 -37.47 -44.44 0.65 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.878 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 346' ' ' VAL . . . . . 0.9 HG21 ' CB ' ' A' ' 294' ' ' HIS . 39.6 t -58.81 -54.11 38.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.133 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -49.78 -37.08 28.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.914 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -71.65 -46.23 59.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.902 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -46.1 -34.72 4.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.071 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 350' ' ' LEU . . . . . . . . . . . . . 65.5 mt -71.36 -41.01 70.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.935 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 27.5 mmtp -40.25 -52.41 2.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.879 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 352' ' ' CYS . . . . . . . . . . . . . 89.7 m -74.27 80.23 1.83 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.903 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 12.3 t30 -107.83 171.25 7.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.87 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 10.6 ptm180 41.99 50.43 4.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.907 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 355' ' ' GLU . . . . . 0.506 ' C ' ' CD1' ' A' ' 356' ' ' TYR . 9.8 mm-40 -98.08 174.38 6.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.916 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 356' ' ' TYR . . . . . 0.506 ' CD1' ' C ' ' A' ' 355' ' ' GLU . 1.0 OUTLIER -137.96 117.91 13.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.922 -179.862 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 357' ' ' MET . . . . . . . . . . . . . 4.4 ptt? -143.71 139.61 29.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.89 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 82.02 -33.76 2.63 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.5 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 129.14 15.89 2.01 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.499 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 360' ' ' ARG . . . . . . . . . . . . . 15.7 mmm180 -142.67 148.98 38.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.78 0.324 . . . . 0.0 110.889 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 361' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -61.0 152.7 27.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.961 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 8.5 mm -135.55 145.26 31.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.17 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 363' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -135.7 119.18 16.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.893 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 4.1 t -91.68 128.57 43.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.106 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -125.9 139.38 53.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.861 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 15.9 ttt-85 -88.17 114.02 24.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.835 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 64.4 mm-40 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.872 -179.946 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 294' ' ' HIS . . . . . 0.948 ' CB ' HG21 ' A' ' 346' ' ' VAL . 6.4 m80 . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.914 0.388 . . . . 0.0 110.824 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 96.5 m -139.38 147.19 41.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.098 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 296' ' ' VAL . . . . . 0.428 HG13 HG13 ' A' ' 346' ' ' VAL . 29.9 m -127.59 146.81 32.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.176 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 297' ' ' LYS . . . . . 0.567 ' HD3' ' CE1' ' A' ' 337' ' ' PHE . 30.6 ttpt -117.02 145.99 43.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.936 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 6.4 mp -117.17 129.08 55.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.897 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 6.4 ttt85 -129.13 150.09 50.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.876 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 91.06 36.83 6.51 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.494 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -109.84 152.36 42.91 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.519 0.676 . . . . 0.0 111.105 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 -178.51 2.38 Favored 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.692 2.261 . . . . 0.0 112.316 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -89.51 -4.21 58.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.901 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -100.34 3.28 43.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.907 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 305' ' ' VAL . . . . . . . . . . . . . 4.1 p -65.11 153.13 8.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.088 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 306' ' ' THR . . . . . 0.439 ' OG1' ' N ' ' A' ' 307' ' ' GLU . 0.0 OUTLIER -149.12 170.84 17.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.104 -179.93 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 307' ' ' GLU . . . . . 0.439 ' N ' ' OG1' ' A' ' 306' ' ' THR . 30.7 mt-10 -54.71 -24.38 21.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.864 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 21.4 tttm -74.78 -51.44 14.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.881 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -54.23 -32.84 56.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.881 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 310' ' ' VAL . . . . . 0.51 ' HB ' HD13 ' A' ' 322' ' ' ILE . 30.0 t -70.81 -45.83 71.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.126 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 311' ' ' MET . . . . . . . . . . . . . 4.1 mmt -57.58 -53.13 61.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.919 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -63.41 -24.39 67.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.901 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 313' ' ' PHE . . . . . 0.812 ' CZ ' HG21 ' A' ' 362' ' ' ILE . 31.2 t80 -77.6 -49.75 13.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.879 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.579 ' CD1' HG11 ' A' ' 338' ' ' VAL . 74.2 mt -74.44 -22.65 59.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.913 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 315' ' ' ALA . . . . . 0.737 ' HB1' ' HA ' ' A' ' 316' ' ' PRO . . . -46.22 163.33 0.23 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.551 0.691 . . . . 0.0 111.149 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 316' ' ' PRO . . . . . 0.737 ' HA ' ' HB1' ' A' ' 315' ' ' ALA . 53.5 Cg_endo -69.79 -6.55 9.54 Favored 'Cis proline' 0 C--O 1.232 0.195 0 C-N-CA 122.68 -1.8 . . . . 0.0 112.316 0.027 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 317' ' ' LEU . . . . . 0.419 ' N ' ' HA ' ' A' ' 315' ' ' ALA . 81.6 mt -52.66 135.6 34.52 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.875 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 14.6 tptm -113.96 103.39 55.22 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.539 0.685 . . . . 0.0 110.892 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -169.9 0.36 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.636 2.224 . . . . 0.0 112.361 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 47.2 t -103.34 -46.24 10.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.093 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -156.06 138.28 14.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.062 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 322' ' ' ILE . . . . . 0.51 HD13 ' HB ' ' A' ' 310' ' ' VAL . 66.2 mt -114.21 122.86 69.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.135 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 65.9 mmt-85 -118.05 107.78 14.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.832 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 324' ' ' ILE . . . . . 0.577 HG23 HG12 ' A' ' 336' ' ' ILE . 52.3 mt -77.56 119.97 27.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.133 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 18.8 t . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.132 179.869 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 335' ' ' TYR . . . . . 0.415 ' C ' HG13 ' A' ' 336' ' ' ILE . 6.9 m-85 . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.828 0.347 . . . . 0.0 110.947 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 336' ' ' ILE . . . . . 0.577 HG12 HG23 ' A' ' 324' ' ' ILE . 54.2 mt -144.49 123.75 6.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.141 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 337' ' ' PHE . . . . . 0.567 ' CE1' ' HD3' ' A' ' 297' ' ' LYS . 62.1 m-85 -93.65 135.99 34.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.863 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 338' ' ' VAL . . . . . 0.579 HG11 ' CD1' ' A' ' 314' ' ' LEU . 41.5 t -134.96 122.92 39.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.14 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -98.24 160.52 14.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.853 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -139.79 162.92 33.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.912 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 2.8 m -98.88 -42.3 7.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.851 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 342' ' ' ASN . . . . . 0.408 ' O ' ' C ' ' A' ' 343' ' ' GLU . 19.5 m-80 -99.56 111.08 23.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.86 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 343' ' ' GLU . . . . . 0.459 ' O ' ' N ' ' A' ' 346' ' ' VAL . 0.5 OUTLIER -37.37 -60.61 0.66 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.85 -179.97 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 344' ' ' GLU . . . . . 0.454 ' C ' ' O ' ' A' ' 343' ' ' GLU . 13.1 tt0 -34.3 -51.37 0.45 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.873 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -47.48 -45.56 26.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.892 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 346' ' ' VAL . . . . . 0.948 HG21 ' CB ' ' A' ' 294' ' ' HIS . 23.7 t -57.49 -51.67 66.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.14 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 49.3 mtpt -54.46 -43.14 71.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.896 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 60.0 mm-40 -65.29 -39.18 92.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.943 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -48.02 -40.87 24.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.072 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 350' ' ' LEU . . . . . 0.53 HD11 ' HE ' ' A' ' 366' ' ' ARG . 39.7 mt -65.0 -40.91 95.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.913 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 34.2 mmtm -46.18 -46.22 17.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.916 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 352' ' ' CYS . . . . . . . . . . . . . 58.0 m -69.76 69.42 0.29 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.893 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 14.6 p30 -109.83 171.84 7.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.851 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? 55.75 33.22 20.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.851 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 355' ' ' GLU . . . . . 0.47 ' C ' ' CD1' ' A' ' 356' ' ' TYR . 2.5 mm-40 -97.09 173.68 7.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.903 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 356' ' ' TYR . . . . . 0.521 ' CD1' ' N ' ' A' ' 356' ' ' TYR . 0.9 OUTLIER -138.65 130.29 27.65 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.953 -179.877 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 357' ' ' MET . . . . . 0.608 ' HG2' HD11 ' A' ' 362' ' ' ILE . 5.8 ptt? -152.16 120.13 6.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.865 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 92.56 -23.29 28.75 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.522 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 125.96 -5.52 7.86 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.446 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 360' ' ' ARG . . . . . . . . . . . . . 15.4 mmm180 -119.34 158.52 25.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.873 0.368 . . . . 0.0 110.864 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 361' ' ' TYR . . . . . 0.547 ' CG ' ' O ' ' A' ' 361' ' ' TYR . 3.0 p90 -77.2 117.48 18.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.951 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 362' ' ' ILE . . . . . 0.812 HG21 ' CZ ' ' A' ' 313' ' ' PHE . 45.9 mm -83.23 117.01 28.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.112 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 363' ' ' GLU . . . . . 0.588 ' HG3' ' CZ ' ' A' ' 365' ' ' PHE . 4.2 tp10 -111.23 112.06 23.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.919 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 7.0 t -87.16 144.72 8.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.131 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 365' ' ' PHE . . . . . 0.588 ' CZ ' ' HG3' ' A' ' 363' ' ' GLU . 58.0 m-85 -140.85 133.24 28.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.916 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 366' ' ' ARG . . . . . 0.53 ' HE ' HD11 ' A' ' 350' ' ' LEU . 6.0 ttm180 -84.73 115.51 22.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.907 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.877 -179.901 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 294' ' ' HIS . . . . . 0.838 ' HB3' HG21 ' A' ' 346' ' ' VAL . 34.2 m80 . . . . . 0 C--O 1.233 0.191 0 CA-C-O 120.856 0.36 . . . . 0.0 110.879 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 19.5 m -131.01 132.14 44.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.129 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 296' ' ' VAL . . . . . 0.472 ' CG1' HG13 ' A' ' 346' ' ' VAL . 34.9 m -104.01 154.72 5.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.133 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 297' ' ' LYS . . . . . 0.571 ' HE2' ' CZ ' ' A' ' 337' ' ' PHE . 2.1 tppp? -113.26 142.34 45.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.94 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 6.9 mp -128.69 119.78 25.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.906 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 19.2 ptt85 -127.68 165.65 19.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.868 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 94.36 -24.08 29.0 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.497 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -57.36 151.78 36.13 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.558 0.694 . . . . 0.0 111.103 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 163.11 39.49 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.703 2.269 . . . . 0.0 112.37 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 303' ' ' PHE . . . . . 0.557 ' CD1' ' C ' ' A' ' 303' ' ' PHE . 0.5 OUTLIER -69.05 -24.52 64.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.877 -179.979 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 304' ' ' ASN . . . . . 0.47 ' ND2' ' O ' ' A' ' 304' ' ' ASN . 2.3 t30 -93.58 36.72 1.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.916 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 305' ' ' VAL . . . . . . . . . . . . . 9.9 p -94.8 146.15 7.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.16 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 306' ' ' THR . . . . . . . . . . . . . 7.1 p -128.27 159.87 33.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.159 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -43.17 -43.45 4.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.885 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 56.1 tttt -52.89 -61.79 2.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.885 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -41.48 -46.81 3.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.864 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 92.4 t -60.2 -55.9 21.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.142 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 311' ' ' MET . . . . . . . . . . . . . 3.6 mmt -43.14 -45.55 5.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.885 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -62.33 -41.66 98.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.855 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -67.05 -44.24 80.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.833 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.637 HD13 HG11 ' A' ' 338' ' ' VAL . 94.3 mt -75.99 -25.7 56.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.914 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 315' ' ' ALA . . . . . 0.594 ' HB1' ' HA ' ' A' ' 316' ' ' PRO . . . -50.65 158.48 1.08 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.613 0.72 . . . . 0.0 111.076 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 316' ' ' PRO . . . . . 0.594 ' HA ' ' HB1' ' A' ' 315' ' ' ALA . 54.2 Cg_endo -69.72 -19.55 11.14 Favored 'Cis proline' 0 C--N 1.342 0.185 0 C-N-CA 122.702 -1.791 . . . . 0.0 112.362 -0.031 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 317' ' ' LEU . . . . . 0.591 HD21 ' OE1' ' A' ' 348' ' ' GLN . 60.3 mt -38.33 125.34 1.31 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.915 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 318' ' ' LYS . . . . . 0.446 ' CE ' ' HA ' ' A' ' 318' ' ' LYS . 0.6 OUTLIER -105.44 103.37 42.53 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.625 0.726 . . . . 0.0 110.905 179.83 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.81 -172.07 0.54 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.698 2.265 . . . . 0.0 112.301 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 79.6 t -103.45 -44.52 9.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.149 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -157.6 134.45 10.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.079 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 322' ' ' ILE . . . . . 0.477 HG23 HG22 ' A' ' 338' ' ' VAL . 64.5 mt -105.99 105.09 18.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.111 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 73.9 mtt-85 -108.69 107.98 18.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.849 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 324' ' ' ILE . . . . . 0.599 HG23 HG12 ' A' ' 336' ' ' ILE . 59.9 mt -72.22 128.02 34.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.125 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 325' ' ' VAL . . . . . 0.556 ' CG2' ' CD2' ' A' ' 337' ' ' PHE . 66.8 t . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.143 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 335' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.891 0.377 . . . . 0.0 110.882 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 336' ' ' ILE . . . . . 0.599 HG12 HG23 ' A' ' 324' ' ' ILE . 42.6 mt -134.39 130.16 53.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.134 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 337' ' ' PHE . . . . . 0.571 ' CZ ' ' HE2' ' A' ' 297' ' ' LYS . 7.2 m-85 -98.15 127.86 44.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.9 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 338' ' ' VAL . . . . . 0.637 HG11 HD13 ' A' ' 314' ' ' LEU . 75.0 t -127.38 120.65 55.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.129 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -95.86 156.01 16.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.876 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -134.42 165.42 25.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.921 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 2.0 m -93.98 -53.34 4.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.858 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 35.8 m-20 -95.16 128.49 42.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.87 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -49.45 -43.46 44.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.903 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -45.5 -55.82 5.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.858 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 345' ' ' GLU . . . . . 0.5 ' HA ' HD22 ' A' ' 317' ' ' LEU . 62.1 mt-10 -43.76 -53.68 5.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.876 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 346' ' ' VAL . . . . . 0.838 HG21 ' HB3' ' A' ' 294' ' ' HIS . 66.7 t -54.55 -50.5 58.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.17 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -54.34 -33.67 59.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.895 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 348' ' ' GLN . . . . . 0.591 ' OE1' HD21 ' A' ' 317' ' ' LEU . 68.2 mt-30 -78.45 -36.63 45.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.894 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -47.1 -38.67 11.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.054 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 350' ' ' LEU . . . . . 0.532 HD11 ' HG3' ' A' ' 366' ' ' ARG . 49.5 mt -63.35 -39.43 94.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.898 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 18.9 mmtm -47.31 -45.4 24.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.886 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 352' ' ' CYS . . . . . . . . . . . . . 4.1 m -75.21 64.94 1.5 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.915 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -108.71 160.83 15.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.871 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 25.0 ttp180 63.09 34.72 13.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.865 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 355' ' ' GLU . . . . . 0.455 ' C ' ' CD1' ' A' ' 356' ' ' TYR . 3.9 mm-40 -94.82 172.78 7.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.886 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 356' ' ' TYR . . . . . 0.473 ' CD1' ' N ' ' A' ' 356' ' ' TYR . 1.3 m-85 -135.68 120.05 17.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.912 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 357' ' ' MET . . . . . . . . . . . . . 3.3 ptt? -145.45 143.9 30.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.857 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 75.98 -9.96 16.25 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.492 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 106.4 18.33 11.21 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.483 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 360' ' ' ARG . . . . . . . . . . . . . 20.2 mmt180 -145.46 178.11 8.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.836 0.35 . . . . 0.0 110.862 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 361' ' ' TYR . . . . . . . . . . . . . 18.9 p90 -90.67 163.83 14.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.932 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 362' ' ' ILE . . . . . 0.417 HG22 ' N ' ' A' ' 363' ' ' GLU . 8.0 mm -141.6 155.34 20.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.112 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 363' ' ' GLU . . . . . 0.549 ' HB3' ' CZ ' ' A' ' 365' ' ' PHE . 13.8 mt-10 -147.47 119.45 8.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.851 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 20.0 t -89.01 140.06 16.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.139 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 365' ' ' PHE . . . . . 0.549 ' CZ ' ' HB3' ' A' ' 363' ' ' GLU . 16.8 m-85 -140.92 128.3 21.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.889 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 366' ' ' ARG . . . . . 0.532 ' HG3' HD11 ' A' ' 350' ' ' LEU . 36.4 mtp180 -73.21 143.0 47.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.865 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.939 -179.996 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 294' ' ' HIS . . . . . 0.777 ' CB ' HG21 ' A' ' 346' ' ' VAL . 6.1 m80 . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.875 0.369 . . . . 0.0 110.889 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 95.4 m -138.44 137.29 37.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.146 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 296' ' ' VAL . . . . . 0.434 ' CG2' ' HB ' ' A' ' 338' ' ' VAL . 35.9 m -110.69 152.24 12.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.158 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 297' ' ' LYS . . . . . 0.539 ' HG3' ' CE1' ' A' ' 337' ' ' PHE . 0.2 OUTLIER -118.08 136.01 53.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.848 179.992 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 298' ' ' LEU . . . . . 0.438 HD21 ' CE2' ' A' ' 313' ' ' PHE . 6.7 mp -113.98 142.28 46.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.89 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 299' ' ' ARG . . . . . 0.535 ' HD3' ' CE2' ' A' ' 335' ' ' TYR . 25.1 tpt85 -148.79 134.14 18.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.868 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 126.07 -23.88 5.77 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.446 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -56.62 147.55 50.46 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.568 0.699 . . . . 0.0 111.105 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 -172.45 0.57 Allowed 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.673 2.249 . . . . 0.0 112.325 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 303' ' ' PHE . . . . . 0.429 ' O ' ' CG ' ' A' ' 303' ' ' PHE . 73.1 t80 -89.56 -3.41 58.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.895 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 36.3 t30 -110.41 29.34 7.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.871 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 305' ' ' VAL . . . . . . . . . . . . . 9.1 p -97.04 148.91 5.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.12 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 306' ' ' THR . . . . . . . . . . . . . 23.5 p -134.89 161.23 35.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.129 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -39.77 -49.28 2.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.868 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 33.1 ttmt -46.84 -58.87 3.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.92 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 32.7 m120 -45.17 -45.17 11.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.899 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 61.6 t -57.81 -43.6 84.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.149 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 311' ' ' MET . . . . . 0.405 ' HG2' HD11 ' A' ' 322' ' ' ILE . 3.3 mmt -59.28 -50.49 73.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.869 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -64.28 -29.74 70.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.917 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 313' ' ' PHE . . . . . 0.438 ' CE2' HD21 ' A' ' 298' ' ' LEU . 4.4 t80 -72.27 -31.78 66.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.893 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.482 HD13 ' HZ ' ' A' ' 340' ' ' PHE . 92.1 mt -90.93 -22.95 20.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.906 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 315' ' ' ALA . . . . . 0.614 ' HB1' ' HA ' ' A' ' 316' ' ' PRO . . . -44.06 159.32 0.24 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.557 0.694 . . . . 0.0 111.127 179.776 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 316' ' ' PRO . . . . . 0.614 ' HA ' ' HB1' ' A' ' 315' ' ' ALA . 53.6 Cg_endo -69.73 -8.98 10.73 Favored 'Cis proline' 0 C--N 1.341 0.183 0 C-N-CA 122.662 -1.807 . . . . 0.0 112.357 -0.034 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 317' ' ' LEU . . . . . 0.521 HD21 ' OE1' ' A' ' 348' ' ' GLN . 26.4 mt -46.72 161.15 0.07 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.899 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 29.2 tttm -143.79 105.0 4.91 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.563 0.697 . . . . 0.0 110.884 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 319' ' ' PRO . . . . . 0.425 ' HA ' ' CD2' ' A' ' 340' ' ' PHE . 53.8 Cg_endo -69.71 -173.6 0.74 Allowed 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.706 2.271 . . . . 0.0 112.36 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 93.7 t -103.18 -41.11 7.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.136 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -157.47 139.08 13.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.109 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 322' ' ' ILE . . . . . 0.405 HD11 ' HG2' ' A' ' 311' ' ' MET . 92.0 mt -106.79 106.77 21.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.151 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 45.2 mtt180 -102.47 105.29 15.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.884 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 55.8 mt -73.93 119.85 21.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.122 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 325' ' ' VAL . . . . . 0.482 HG22 ' CD2' ' A' ' 337' ' ' PHE . 94.4 t . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.13 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 335' ' ' TYR . . . . . 0.535 ' CE2' ' HD3' ' A' ' 299' ' ' ARG . 2.8 m-85 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.855 0.36 . . . . 0.0 110.919 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 72.8 mt -142.45 114.34 3.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.123 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 337' ' ' PHE . . . . . 0.539 ' CE1' ' HG3' ' A' ' 297' ' ' LYS . 15.6 m-85 -88.5 135.35 33.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.918 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 338' ' ' VAL . . . . . 0.434 ' HB ' ' CG2' ' A' ' 296' ' ' VAL . 63.3 t -132.5 129.91 59.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.11 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -103.18 161.8 13.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.886 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 340' ' ' PHE . . . . . 0.482 ' HZ ' HD13 ' A' ' 314' ' ' LEU . 55.6 m-85 -139.57 166.53 24.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.868 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 32.2 m -82.59 -62.06 1.71 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.874 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 21.1 m-80 -91.87 158.01 16.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.893 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 343' ' ' GLU . . . . . 0.483 ' HB3' ' CE1' ' A' ' 294' ' ' HIS . 1.7 pp20? -73.92 -28.56 61.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.85 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 45.7 mm-40 -59.3 -53.05 62.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.91 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -46.27 -51.74 13.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.907 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 346' ' ' VAL . . . . . 0.777 HG21 ' CB ' ' A' ' 294' ' ' HIS . 21.2 t -49.96 -50.64 18.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.146 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 6.2 mtpm? -51.61 -48.76 63.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.875 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 348' ' ' GLN . . . . . 0.521 ' OE1' HD21 ' A' ' 317' ' ' LEU . 75.4 mt-30 -62.38 -26.13 68.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.914 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 349' ' ' ALA . . . . . 0.511 ' HB3' ' O ' ' A' ' 346' ' ' VAL . . . -63.23 -35.92 81.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.101 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 350' ' ' LEU . . . . . 0.455 HD21 ' HB2' ' A' ' 366' ' ' ARG . 57.6 mt -63.74 -40.94 97.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.978 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 5.4 mtmp? -46.63 -51.15 16.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.934 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 352' ' ' CYS . . . . . . . . . . . . . 4.2 m -69.36 85.19 0.4 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.897 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 353' ' ' ASN . . . . . 0.452 ' O ' ' C ' ' A' ' 354' ' ' ARG . 1.1 p30 -124.91 -176.37 3.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.91 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 354' ' ' ARG . . . . . 0.482 ' O ' ' CD ' ' A' ' 354' ' ' ARG . 0.0 OUTLIER 32.44 38.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.883 -179.925 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 355' ' ' GLU . . . . . 0.469 ' C ' ' CD1' ' A' ' 356' ' ' TYR . 57.1 mm-40 -86.95 176.16 7.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.87 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 356' ' ' TYR . . . . . 0.469 ' CD1' ' C ' ' A' ' 355' ' ' GLU . 1.2 m-85 -135.31 107.95 7.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.964 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 357' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -138.38 145.83 41.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.918 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 72.89 -6.13 14.48 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.494 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 102.96 21.91 9.78 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.479 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 360' ' ' ARG . . . . . . . . . . . . . 14.2 mmt180 -148.71 175.7 10.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.807 0.337 . . . . 0.0 110.9 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 361' ' ' TYR . . . . . 0.73 ' O ' HD13 ' A' ' 362' ' ' ILE . 10.8 p90 -82.59 172.21 13.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.924 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 362' ' ' ILE . . . . . 0.73 HD13 ' O ' ' A' ' 361' ' ' TYR . 25.7 mm -142.27 155.53 18.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.11 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 363' ' ' GLU . . . . . 0.553 ' HB3' ' CZ ' ' A' ' 365' ' ' PHE . 7.0 mm-40 -147.87 112.92 5.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.888 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 17.2 t -91.46 143.53 11.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.078 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 365' ' ' PHE . . . . . 0.553 ' CZ ' ' HB3' ' A' ' 363' ' ' GLU . 32.0 m-85 -143.09 122.38 13.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.898 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 366' ' ' ARG . . . . . 0.455 ' HB2' HD21 ' A' ' 350' ' ' LEU . 35.2 ttp85 -75.84 112.69 12.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.847 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.854 -179.91 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 294' ' ' HIS . . . . . 0.584 ' CB ' HG21 ' A' ' 346' ' ' VAL . 3.0 m-70 . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.883 0.373 . . . . 0.0 110.869 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 87.4 m -126.34 144.57 50.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.106 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 296' ' ' VAL . . . . . 0.763 ' CG1' HG13 ' A' ' 346' ' ' VAL . 19.6 m -121.72 157.65 25.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.136 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 8.8 ttpp -128.43 142.34 51.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.873 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 298' ' ' LEU . . . . . 0.491 HD21 ' CE1' ' A' ' 313' ' ' PHE . 7.6 mp -114.93 149.83 36.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.89 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 7.7 ttt180 -150.41 140.2 21.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.893 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 300' ' ' GLY . . . . . 0.685 ' O ' HD13 ' A' ' 362' ' ' ILE . . . 103.43 44.94 1.62 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.474 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -113.84 151.42 44.71 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.597 0.713 . . . . 0.0 111.091 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -171.95 0.53 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.637 2.225 . . . . 0.0 112.319 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -87.55 -7.69 57.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.897 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 33.0 m120 -108.97 32.01 5.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.88 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 305' ' ' VAL . . . . . . . . . . . . . 4.5 p -96.2 139.89 18.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.139 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 306' ' ' THR . . . . . . . . . . . . . 67.7 p -142.97 170.63 15.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.146 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -46.68 -35.35 5.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.883 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 11.4 tmtt? -59.7 -50.32 74.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.884 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 34.8 m120 -55.09 -48.89 72.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.944 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 76.6 t -58.17 -55.31 22.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.14 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 311' ' ' MET . . . . . . . . . . . . . 2.3 mmt -46.35 -44.47 16.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.889 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -73.99 -26.28 60.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.875 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 313' ' ' PHE . . . . . 0.591 ' CD2' ' SD ' ' A' ' 357' ' ' MET . 1.9 t80 -78.37 -30.9 48.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.822 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.463 ' CD1' HG11 ' A' ' 338' ' ' VAL . 93.9 mt -91.5 -24.53 19.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.952 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 315' ' ' ALA . . . . . 0.756 ' HB1' ' HA ' ' A' ' 316' ' ' PRO . . . -48.68 163.87 0.3 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.592 0.711 . . . . 0.0 111.098 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 316' ' ' PRO . . . . . 0.756 ' HA ' ' HB1' ' A' ' 315' ' ' ALA . 53.7 Cg_endo -69.72 -3.2 7.5 Favored 'Cis proline' 0 C--O 1.231 0.165 0 C-N-CA 122.713 -1.786 . . . . 0.0 112.341 -0.026 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 317' ' ' LEU . . . . . 0.485 ' N ' ' HA ' ' A' ' 315' ' ' ALA . 13.5 mt -55.63 142.95 31.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.93 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -120.52 106.31 40.21 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.588 0.708 . . . . 0.0 110.883 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 -164.54 0.13 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.72 2.28 . . . . 0.0 112.369 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 24.5 t -113.62 -45.04 4.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.104 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -153.59 128.94 9.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.09 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 322' ' ' ILE . . . . . 0.583 HG23 HG22 ' A' ' 338' ' ' VAL . 49.3 mt -107.67 99.86 9.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.144 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -100.19 104.73 16.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.875 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 324' ' ' ILE . . . . . 0.51 HG12 HG23 ' A' ' 336' ' ' ILE . 58.4 mt -73.73 118.34 19.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.104 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 325' ' ' VAL . . . . . 0.441 HG22 ' CE2' ' A' ' 337' ' ' PHE . 84.5 t . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.109 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 335' ' ' TYR . . . . . 0.409 ' HB3' HG21 ' A' ' 325' ' ' VAL . 19.2 m-85 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.915 0.388 . . . . 0.0 110.928 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 336' ' ' ILE . . . . . 0.51 HG23 HG12 ' A' ' 324' ' ' ILE . 42.6 mt -139.93 132.02 33.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.137 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 337' ' ' PHE . . . . . 0.441 ' CE2' HG22 ' A' ' 325' ' ' VAL . 22.7 m-85 -99.52 142.78 30.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.849 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 338' ' ' VAL . . . . . 0.583 HG22 HG23 ' A' ' 322' ' ' ILE . 27.6 t -146.33 131.53 12.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.181 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -103.22 168.09 9.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.856 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 340' ' ' PHE . . . . . 0.477 ' HB2' ' CG2' ' A' ' 346' ' ' VAL . 65.6 m-85 -148.22 157.56 43.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.852 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 13.1 t -70.16 -64.6 0.86 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.856 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -99.39 177.43 5.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.863 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 343' ' ' GLU . . . . . 0.583 ' HB3' ' CE1' ' A' ' 294' ' ' HIS . 20.1 pt-20 -78.22 -45.84 21.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.868 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 344' ' ' GLU . . . . . 0.403 ' N ' ' HG3' ' A' ' 343' ' ' GLU . 19.0 mt-10 -42.26 -60.03 1.61 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.892 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -45.3 -32.45 1.99 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.873 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 346' ' ' VAL . . . . . 0.763 HG13 ' CG1' ' A' ' 296' ' ' VAL . 74.9 t -82.6 -36.75 13.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.114 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -64.22 -35.43 80.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.915 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 45.9 mm-40 -76.03 -40.01 54.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.92 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -51.82 -33.53 36.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.141 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 350' ' ' LEU . . . . . 0.61 HD23 HG12 ' A' ' 364' ' ' VAL . 96.8 mt -72.48 -40.15 67.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.935 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 46.7 mttm -46.27 -40.69 11.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.885 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 352' ' ' CYS . . . . . . . . . . . . . 33.1 m -78.77 80.45 5.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.915 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 353' ' ' ASN . . . . . 0.438 ' O ' ' C ' ' A' ' 354' ' ' ARG . 31.5 p-10 -109.28 178.56 4.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.86 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 354' ' ' ARG . . . . . 0.438 ' C ' ' O ' ' A' ' 353' ' ' ASN . 20.7 ptt180 35.42 42.86 0.13 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.922 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 355' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -89.45 173.9 8.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.85 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 356' ' ' TYR . . . . . 0.497 ' CD1' ' N ' ' A' ' 356' ' ' TYR . 1.1 m-85 -128.13 115.56 18.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.952 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 357' ' ' MET . . . . . 0.591 ' SD ' ' CD2' ' A' ' 313' ' ' PHE . 4.6 ptt? -145.81 127.52 15.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.866 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 81.36 -17.94 12.11 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.526 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 113.25 19.03 6.89 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.467 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 360' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -143.87 134.71 25.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.812 0.339 . . . . 0.0 110.9 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 361' ' ' TYR . . . . . 0.557 ' CD1' ' O ' ' A' ' 361' ' ' TYR . 12.6 p90 -56.27 127.23 29.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.897 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 362' ' ' ILE . . . . . 0.685 HD13 ' O ' ' A' ' 300' ' ' GLY . 4.2 mm -106.31 151.57 8.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.163 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 363' ' ' GLU . . . . . 0.421 ' HB3' ' CZ ' ' A' ' 365' ' ' PHE . 28.1 mm-40 -143.4 116.93 9.14 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.846 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 364' ' ' VAL . . . . . 0.61 HG12 HD23 ' A' ' 350' ' ' LEU . 21.7 t -88.82 142.53 12.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.15 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 365' ' ' PHE . . . . . 0.442 ' CD1' ' O ' ' A' ' 364' ' ' VAL . 10.3 m-85 -139.93 146.87 39.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.909 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 366' ' ' ARG . . . . . 0.506 ' HB2' HD11 ' A' ' 350' ' ' LEU . 0.0 OUTLIER -86.68 109.36 19.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.878 -179.896 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.888 -179.922 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 294' ' ' HIS . . . . . 0.632 ' HB3' HG21 ' A' ' 346' ' ' VAL . 11.3 m80 . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.864 0.364 . . . . 0.0 110.861 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 63.1 m -136.17 145.36 45.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.178 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 296' ' ' VAL . . . . . 0.52 ' CG1' HG13 ' A' ' 346' ' ' VAL . 29.8 m -118.86 147.21 22.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.154 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 297' ' ' LYS . . . . . 0.568 ' HD3' ' CD1' ' A' ' 335' ' ' TYR . 8.8 ttmm -116.87 146.33 42.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.944 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 298' ' ' LEU . . . . . 0.465 HD21 ' CD2' ' A' ' 313' ' ' PHE . 6.9 mp -115.55 157.55 23.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.917 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -158.02 130.22 7.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.859 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 123.1 -23.2 6.96 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.484 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -57.17 147.71 55.4 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.594 0.711 . . . . 0.0 111.066 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 -176.54 1.52 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.71 2.273 . . . . 0.0 112.301 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -78.1 -35.74 48.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.904 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -88.59 48.46 1.64 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.858 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 305' ' ' VAL . . . . . . . . . . . . . 11.4 p -99.24 141.38 16.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.163 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 306' ' ' THR . . . . . 0.414 ' O ' ' C ' ' A' ' 307' ' ' GLU . 69.2 p -132.43 153.27 51.01 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.096 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 307' ' ' GLU . . . . . 0.414 ' C ' ' O ' ' A' ' 306' ' ' THR . 26.1 mt-10 -35.68 -52.17 0.68 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.891 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 14.7 ttpt -40.83 -47.25 2.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.892 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -57.85 -54.87 42.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.873 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 56.2 t -55.9 -50.4 69.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.159 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 311' ' ' MET . . . . . . . . . . . . . 2.7 mmt -48.91 -52.46 24.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.866 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -67.31 -24.73 65.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.871 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 313' ' ' PHE . . . . . 0.465 ' CD2' HD21 ' A' ' 298' ' ' LEU . 11.2 t80 -77.34 -35.66 54.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.848 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.482 ' CD1' HG11 ' A' ' 338' ' ' VAL . 85.9 mt -86.04 -20.61 28.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.94 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 315' ' ' ALA . . . . . 0.641 ' HB1' ' HA ' ' A' ' 316' ' ' PRO . . . -47.09 159.96 0.37 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.588 0.708 . . . . 0.0 111.08 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 316' ' ' PRO . . . . . 0.641 ' HA ' ' HB1' ' A' ' 315' ' ' ALA . 53.8 Cg_endo -69.78 -21.5 10.2 Favored 'Cis proline' 0 C--O 1.232 0.188 0 C-N-CA 122.677 -1.801 . . . . 0.0 112.357 0.055 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 317' ' ' LEU . . . . . 0.588 HD11 ' CB ' ' A' ' 348' ' ' GLN . 22.2 mt -41.38 139.07 1.11 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.887 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -118.51 110.55 38.88 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.576 0.703 . . . . 0.0 110.876 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 319' ' ' PRO . . . . . 0.405 ' HA ' ' CD2' ' A' ' 340' ' ' PHE . 54.2 Cg_endo -69.71 -178.33 2.27 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.68 2.253 . . . . 0.0 112.384 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 19.4 t -104.12 -34.14 3.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.151 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -162.73 132.93 4.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.115 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 322' ' ' ILE . . . . . 0.414 HG23 HG22 ' A' ' 338' ' ' VAL . 66.2 mt -107.75 117.21 52.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.153 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 19.4 mmt180 -111.47 107.08 16.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.843 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 324' ' ' ILE . . . . . 0.625 HG23 HG12 ' A' ' 336' ' ' ILE . 70.8 mt -84.61 138.21 19.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.156 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 325' ' ' VAL . . . . . 0.523 HG21 ' CE2' ' A' ' 337' ' ' PHE . 62.1 t . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.095 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 335' ' ' TYR . . . . . 0.568 ' CD1' ' HD3' ' A' ' 297' ' ' LYS . 79.3 m-85 . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.811 0.338 . . . . 0.0 110.957 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 336' ' ' ILE . . . . . 0.625 HG12 HG23 ' A' ' 324' ' ' ILE . 60.0 mt -127.28 121.52 57.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.132 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 337' ' ' PHE . . . . . 0.523 ' CE2' HG21 ' A' ' 325' ' ' VAL . 39.1 m-85 -96.1 136.2 36.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.876 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 338' ' ' VAL . . . . . 0.482 HG11 ' CD1' ' A' ' 314' ' ' LEU . 25.5 t -134.73 132.17 54.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.105 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -105.69 157.94 17.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.883 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 340' ' ' PHE . . . . . 0.405 ' CD2' ' HA ' ' A' ' 319' ' ' PRO . 53.3 m-85 -133.85 162.06 33.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.879 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 34.4 p -64.73 -66.61 0.52 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.877 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 342' ' ' ASN . . . . . 0.401 ' OD1' ' N ' ' A' ' 342' ' ' ASN . 2.8 p-10 -99.75 170.8 8.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.918 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 343' ' ' GLU . . . . . 0.586 ' HB3' ' CE1' ' A' ' 294' ' ' HIS . 1.4 pp20? -70.14 -51.01 34.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.89 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 344' ' ' GLU . . . . . 0.425 ' N ' ' CD ' ' A' ' 343' ' ' GLU . 10.4 tt0 -40.36 -57.98 1.64 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.906 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -39.74 -36.15 0.4 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.899 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 346' ' ' VAL . . . . . 0.632 HG21 ' HB3' ' A' ' 294' ' ' HIS . 24.6 t -70.08 -48.27 63.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.106 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 347' ' ' LYS . . . . . 0.423 ' HB2' ' NZ ' ' A' ' 347' ' ' LYS . 5.1 mtmp? -52.87 -39.46 62.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.934 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 348' ' ' GLN . . . . . 0.588 ' CB ' HD11 ' A' ' 317' ' ' LEU . 85.5 mt-30 -73.31 -26.66 61.15 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.933 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -64.03 -35.96 82.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.095 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 350' ' ' LEU . . . . . . . . . . . . . 15.9 mt -73.22 -37.06 66.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.912 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 26.3 mmmt -47.44 -47.18 27.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.901 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 352' ' ' CYS . . . . . . . . . . . . . 15.9 m -70.3 72.55 0.47 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.877 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 14.9 p30 -109.09 162.76 13.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.932 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 20.5 mmt180 61.86 35.63 16.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.848 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 355' ' ' GLU . . . . . 0.46 ' C ' ' CD1' ' A' ' 356' ' ' TYR . 20.9 mm-40 -91.48 173.65 7.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.891 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 356' ' ' TYR . . . . . 0.491 ' CD1' ' N ' ' A' ' 356' ' ' TYR . 1.2 m-85 -136.3 128.06 29.11 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.922 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 357' ' ' MET . . . . . . . . . . . . . 3.6 ptt? -156.6 140.38 16.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.912 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 76.95 -9.29 25.47 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.456 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 102.93 16.85 20.38 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.461 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 360' ' ' ARG . . . . . . . . . . . . . 10.3 mmt180 -144.29 153.36 41.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.801 0.334 . . . . 0.0 110.881 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 361' ' ' TYR . . . . . 0.441 ' CD1' ' C ' ' A' ' 361' ' ' TYR . 1.0 OUTLIER -64.88 166.26 9.4 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.911 -179.84 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 362' ' ' ILE . . . . . 0.401 HG12 ' C ' ' A' ' 361' ' ' TYR . 15.7 mm -146.75 137.54 18.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.136 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 363' ' ' GLU . . . . . 0.565 ' HG3' ' CE2' ' A' ' 365' ' ' PHE . 14.7 pt-20 -133.99 112.07 10.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.895 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 364' ' ' VAL . . . . . 0.533 ' O ' ' CD1' ' A' ' 365' ' ' PHE . 14.2 t -84.51 154.07 3.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.099 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 365' ' ' PHE . . . . . 0.565 ' CE2' ' HG3' ' A' ' 363' ' ' GLU . 28.8 m-85 -145.99 156.46 43.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.851 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 32.8 ttp85 -97.86 120.4 38.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.912 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.881 -179.917 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 294' ' ' HIS . . . . . 0.553 ' HB3' HG21 ' A' ' 346' ' ' VAL . 7.8 m-70 . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.878 0.371 . . . . 0.0 110.874 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 24.7 m -136.49 143.5 43.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.148 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 296' ' ' VAL . . . . . 0.521 ' CG1' HG13 ' A' ' 346' ' ' VAL . 27.0 m -128.92 150.45 34.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.106 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 28.3 ttpp -119.1 132.36 56.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.902 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 7.3 mp -105.95 103.1 12.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.869 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 299' ' ' ARG . . . . . 0.541 ' HD3' ' CE1' ' A' ' 335' ' ' TYR . 38.0 tpt85 -104.45 122.68 46.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.896 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 300' ' ' GLY . . . . . 0.411 ' C ' ' O ' ' A' ' 361' ' ' TYR . . . 133.36 -25.1 3.67 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.501 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 301' ' ' ALA . . . . . 0.456 ' HA ' ' CD1' ' A' ' 362' ' ' ILE . . . -59.52 144.11 85.0 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.571 0.7 . . . . 0.0 111.095 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -167.74 0.24 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.665 2.243 . . . . 0.0 112.341 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 303' ' ' PHE . . . . . 0.411 ' CD1' ' C ' ' A' ' 303' ' ' PHE . 1.8 p90 -95.81 -12.8 24.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.87 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -93.33 3.01 56.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.94 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 305' ' ' VAL . . . . . 0.4 HG11 ' HB1' ' A' ' 301' ' ' ALA . 7.5 p -78.39 143.23 12.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.109 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 306' ' ' THR . . . . . . . . . . . . . 16.6 p -131.92 162.73 29.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.115 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -38.93 -49.16 1.66 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.932 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 30.2 ttmt -50.87 -58.69 5.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.86 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -49.91 -43.01 49.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.891 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 310' ' ' VAL . . . . . 0.525 HG12 HD12 ' A' ' 314' ' ' LEU . 99.0 t -60.56 -49.09 85.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.155 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 311' ' ' MET . . . . . . . . . . . . . 3.1 mmt -50.11 -39.09 41.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.822 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -71.7 -35.49 70.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.898 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 313' ' ' PHE . . . . . 0.449 ' CD1' ' C ' ' A' ' 313' ' ' PHE . 1.6 t80 -74.82 -31.06 61.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.86 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.758 HD11 HG21 ' A' ' 338' ' ' VAL . 50.5 mt -84.24 -26.18 28.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.95 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 315' ' ' ALA . . . . . 0.756 ' HB1' ' HA ' ' A' ' 316' ' ' PRO . . . -51.45 163.3 0.59 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.576 0.703 . . . . 0.0 111.105 179.789 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 316' ' ' PRO . . . . . 0.756 ' HA ' ' HB1' ' A' ' 315' ' ' ALA . 54.1 Cg_endo -69.81 -16.24 12.36 Favored 'Cis proline' 0 C--O 1.232 0.21 0 C-N-CA 122.696 -1.793 . . . . 0.0 112.377 0.005 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 317' ' ' LEU . . . . . 0.576 HD11 ' HB3' ' A' ' 348' ' ' GLN . 23.9 mt -46.7 129.37 11.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.896 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 318' ' ' LYS . . . . . 0.416 ' NZ ' ' HA ' ' A' ' 318' ' ' LYS . 0.2 OUTLIER -105.72 105.75 54.04 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.571 0.701 . . . . 0.0 110.87 179.819 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 178.46 4.57 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.711 2.274 . . . . 0.0 112.297 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 61.8 t -100.01 -37.06 5.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.093 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -160.83 137.95 9.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.118 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 322' ' ' ILE . . . . . 0.49 HG23 HG22 ' A' ' 338' ' ' VAL . 74.0 mt -110.69 109.31 27.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.13 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 63.8 mmt-85 -107.1 105.12 14.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.898 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 324' ' ' ILE . . . . . 0.513 HG23 HG12 ' A' ' 336' ' ' ILE . 67.1 mt -76.42 126.97 37.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.127 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 325' ' ' VAL . . . . . 0.466 HG22 ' CD2' ' A' ' 337' ' ' PHE . 48.8 t . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.16 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 335' ' ' TYR . . . . . 0.541 ' CE1' ' HD3' ' A' ' 299' ' ' ARG . 8.4 m-85 . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.905 0.383 . . . . 0.0 110.896 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 336' ' ' ILE . . . . . 0.513 HG12 HG23 ' A' ' 324' ' ' ILE . 88.7 mt -151.04 116.19 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.103 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 337' ' ' PHE . . . . . 0.466 ' CD2' HG22 ' A' ' 325' ' ' VAL . 31.6 m-85 -90.55 134.76 34.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.845 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 338' ' ' VAL . . . . . 0.758 HG21 HD11 ' A' ' 314' ' ' LEU . 17.4 t -134.62 141.49 43.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.113 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -113.82 161.33 17.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.849 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -139.18 167.56 21.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.864 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 22.7 m -72.28 -68.46 0.47 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.828 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 342' ' ' ASN . . . . . 0.526 ' ND2' ' HG3' ' A' ' 345' ' ' GLU . 9.1 p30 -99.11 -176.04 3.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.883 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 343' ' ' GLU . . . . . 0.428 ' O ' ' N ' ' A' ' 346' ' ' VAL . 12.0 pt-20 -83.56 -47.26 11.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.884 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -44.01 -30.13 0.69 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.914 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 345' ' ' GLU . . . . . 0.526 ' HG3' ' ND2' ' A' ' 342' ' ' ASN . 16.7 mt-10 -73.59 -35.8 65.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.876 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 346' ' ' VAL . . . . . 0.553 HG21 ' HB3' ' A' ' 294' ' ' HIS . 61.7 t -68.85 -59.12 3.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.163 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.81 -29.04 62.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.893 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 348' ' ' GLN . . . . . 0.576 ' HB3' HD11 ' A' ' 317' ' ' LEU . 29.6 mt-30 -73.11 -32.44 64.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.948 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -62.0 -36.44 81.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.089 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 350' ' ' LEU . . . . . 0.687 HD23 HG12 ' A' ' 364' ' ' VAL . 57.1 mt -60.99 -24.78 66.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.913 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 20.8 mmtp -49.72 -44.87 48.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.948 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 352' ' ' CYS . . . . . . . . . . . . . 22.3 m -78.21 72.28 4.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.865 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -109.24 147.71 32.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.883 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 50.4 ttm-85 70.15 30.44 3.49 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.883 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 355' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -88.52 173.74 8.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.936 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 356' ' ' TYR . . . . . 0.425 ' CD1' ' N ' ' A' ' 356' ' ' TYR . 1.7 m-85 -125.31 117.73 24.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.911 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 357' ' ' MET . . . . . 0.444 ' SD ' ' CD2' ' A' ' 313' ' ' PHE . 4.3 ptm -142.26 123.36 14.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.907 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 86.29 -20.37 22.24 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.51 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 117.24 13.45 7.61 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.494 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 360' ' ' ARG . . . . . . . . . . . . . 21.5 mmt-85 -140.75 158.52 43.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.815 0.34 . . . . 0.0 110.823 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 361' ' ' TYR . . . . . 0.731 ' O ' HD13 ' A' ' 362' ' ' ILE . 13.0 p90 -67.14 163.62 19.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.94 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 362' ' ' ILE . . . . . 0.731 HD13 ' O ' ' A' ' 361' ' ' TYR . 15.1 mm -140.57 144.58 27.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.154 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 363' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -138.42 112.19 8.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.861 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 364' ' ' VAL . . . . . 0.687 HG12 HD23 ' A' ' 350' ' ' LEU . 45.9 t -84.6 134.54 26.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.155 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -131.01 152.94 49.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.913 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 366' ' ' ARG . . . . . 0.403 ' HG3' HD11 ' A' ' 350' ' ' LEU . 51.6 mtm180 -101.43 113.35 26.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.866 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.87 -179.937 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 31.9 m80 . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.843 0.354 . . . . 0.0 110.886 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 85.0 m -140.55 143.44 35.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.116 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 296' ' ' VAL . . . . . 0.454 HG23 ' HB ' ' A' ' 338' ' ' VAL . 27.2 m -116.99 147.77 20.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.123 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 13.9 ttmt -125.37 137.38 54.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.921 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 6.8 mp -120.86 118.31 29.63 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.919 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -115.75 155.62 27.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.828 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 86.86 36.58 9.09 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.451 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -102.2 147.72 34.36 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.622 0.725 . . . . 0.0 111.113 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 175.98 7.37 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.713 2.275 . . . . 0.0 112.372 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 56.0 t80 -80.97 -29.26 35.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.876 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -86.89 35.44 0.69 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.903 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 305' ' ' VAL . . . . . . . . . . . . . 11.8 p -98.45 145.05 10.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.116 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 306' ' ' THR . . . . . . . . . . . . . 64.4 p -141.36 164.97 28.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.099 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -44.88 -34.95 2.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.915 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? -57.74 -47.06 83.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.909 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 23.2 m120 -60.19 -59.41 5.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.9 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 85.2 t -48.89 -41.51 13.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.152 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 311' ' ' MET . . . . . . . . . . . . . 2.0 mmt -62.09 -44.76 95.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.861 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -68.24 -26.41 65.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.881 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 313' ' ' PHE . . . . . 0.424 ' CD1' ' C ' ' A' ' 313' ' ' PHE . 5.5 t80 -75.33 -40.91 57.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.866 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.579 ' CD1' HG11 ' A' ' 338' ' ' VAL . 57.9 mt -83.1 -24.89 32.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.921 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 315' ' ' ALA . . . . . 0.533 ' HB1' ' HA ' ' A' ' 316' ' ' PRO . . . -44.58 156.74 0.33 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.579 0.704 . . . . 0.0 111.133 179.76 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 316' ' ' PRO . . . . . 0.533 ' HA ' ' HB1' ' A' ' 315' ' ' ALA . 53.6 Cg_endo -69.85 -19.09 11.52 Favored 'Cis proline' 0 C--O 1.232 0.21 0 C-N-CA 122.661 -1.808 . . . . 0.0 112.332 0.08 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 317' ' ' LEU . . . . . 0.558 HD22 ' HA ' ' A' ' 345' ' ' GLU . 35.7 mt -39.01 138.4 0.57 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.894 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 12.6 tppt? -119.64 107.49 40.57 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.551 0.691 . . . . 0.0 110.889 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 319' ' ' PRO . . . . . 0.426 ' HA ' ' CD2' ' A' ' 340' ' ' PHE . 54.0 Cg_endo -69.78 -171.02 0.43 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.648 2.232 . . . . 0.0 112.333 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 65.2 t -106.68 -41.75 6.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.11 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -155.06 129.8 9.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.118 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 322' ' ' ILE . . . . . 0.495 HG23 HG22 ' A' ' 338' ' ' VAL . 91.7 mt -100.97 99.8 9.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.152 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 9.5 mmm180 -98.74 103.44 15.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.908 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 324' ' ' ILE . . . . . 0.891 HG23 HG12 ' A' ' 336' ' ' ILE . 58.7 mt -81.01 134.86 26.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.128 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 325' ' ' VAL . . . . . 0.407 HG22 ' CE2' ' A' ' 337' ' ' PHE . 45.5 t . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.16 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 335' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.919 0.39 . . . . 0.0 110.911 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 336' ' ' ILE . . . . . 0.891 HG12 HG23 ' A' ' 324' ' ' ILE . 30.2 mt -145.63 143.48 21.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.114 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 337' ' ' PHE . . . . . 0.407 ' CE2' HG22 ' A' ' 325' ' ' VAL . 27.5 m-85 -110.67 123.52 50.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.859 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 338' ' ' VAL . . . . . 0.579 HG11 ' CD1' ' A' ' 314' ' ' LEU . 93.8 t -126.0 126.57 69.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.136 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -101.36 160.61 14.27 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.905 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 340' ' ' PHE . . . . . 0.439 ' HB2' ' CG2' ' A' ' 346' ' ' VAL . 35.9 m-85 -134.68 165.86 24.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.862 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 16.9 t -87.79 -55.34 3.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.831 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -89.54 168.04 12.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.895 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -81.96 -43.16 18.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.883 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -56.93 -54.11 50.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.938 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 345' ' ' GLU . . . . . 0.558 ' HA ' HD22 ' A' ' 317' ' ' LEU . 20.8 mm-40 -41.22 -35.81 0.66 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.888 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 346' ' ' VAL . . . . . 0.439 ' CG2' ' HB2' ' A' ' 340' ' ' PHE . 53.0 t -74.86 -50.28 25.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.11 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 15.5 mtpp -53.71 -35.75 61.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.879 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 35.3 mm-40 -71.46 -44.06 65.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.926 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -43.58 -40.1 3.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.099 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 350' ' ' LEU . . . . . . . . . . . . . 54.6 mt -58.88 -39.0 80.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.923 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 56.1 mmtt -45.12 -36.69 3.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.932 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 352' ' ' CYS . . . . . . . . . . . . . 64.6 m -71.2 71.99 0.62 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.908 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 353' ' ' ASN . . . . . 0.401 ' O ' ' C ' ' A' ' 354' ' ' ARG . 16.7 p30 -116.85 -176.46 2.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.913 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 354' ' ' ARG . . . . . 0.401 ' C ' ' O ' ' A' ' 353' ' ' ASN . 54.0 ttt-85 37.29 49.88 0.96 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.83 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 355' ' ' GLU . . . . . 0.438 ' C ' ' OE1' ' A' ' 355' ' ' GLU . 0.0 OUTLIER -135.94 173.38 11.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.899 -179.983 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 356' ' ' TYR . . . . . 0.434 ' CD1' ' N ' ' A' ' 356' ' ' TYR . 2.7 m-85 -131.7 137.14 48.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.902 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 357' ' ' MET . . . . . 0.425 ' CG ' HG13 ' A' ' 362' ' ' ILE . 0.1 OUTLIER -139.04 128.06 23.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.87 179.89 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 83.03 -28.75 3.58 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.479 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 125.26 28.46 1.1 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.5 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 360' ' ' ARG . . . . . . . . . . . . . 33.7 mtt-85 -151.41 156.99 41.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.861 0.363 . . . . 0.0 110.873 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 361' ' ' TYR . . . . . 0.438 ' CG ' ' O ' ' A' ' 361' ' ' TYR . 2.3 p90 -69.66 125.43 26.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.921 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 362' ' ' ILE . . . . . 0.425 HG13 ' CG ' ' A' ' 357' ' ' MET . 17.3 mm -107.18 151.94 8.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.191 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 363' ' ' GLU . . . . . 0.577 ' HB3' ' CZ ' ' A' ' 365' ' ' PHE . 59.9 mm-40 -143.42 112.16 6.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.881 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 15.9 t -87.81 120.85 37.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.151 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 365' ' ' PHE . . . . . 0.577 ' CZ ' ' HB3' ' A' ' 363' ' ' GLU . 70.7 m-85 -124.85 133.32 53.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.847 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 366' ' ' ARG . . . . . 0.43 ' NH1' ' HB3' ' A' ' 366' ' ' ARG . 6.2 ttp-105 -82.25 111.75 18.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.92 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.876 -179.905 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 N-CA-C 112.492 -0.243 . . . . 0.0 112.492 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 22.0 t 61.19 42.3 12.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.874 0.368 . . . . 0.0 110.866 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 1.5 t -95.17 172.24 8.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.833 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 145.68 92.44 0.13 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.438 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 37.4 m -150.06 113.37 4.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.894 0.378 . . . . 0.0 110.835 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 3.8 t -49.95 136.21 18.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.891 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 290' ' ' GLY . . . . . 0.435 ' O ' ' C ' ' A' ' 291' ' ' THR . . . -158.41 111.24 0.47 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.487 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 291' ' ' THR . . . . . 0.435 ' C ' ' O ' ' A' ' 290' ' ' GLY . 93.3 m -34.47 125.06 0.51 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.856 0.36 . . . . 0.0 111.178 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 64.3 p -102.87 164.84 11.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.181 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 293' ' ' CYS . . . . . . . . . . . . . 23.0 m -67.63 102.35 1.17 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.864 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 294' ' ' HIS . . . . . 0.679 ' HB2' HG21 ' A' ' 346' ' ' VAL . 28.5 m-70 -38.85 132.0 1.29 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.866 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 63.0 m -139.66 142.35 36.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.142 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 296' ' ' VAL . . . . . 0.542 ' CG1' HG13 ' A' ' 346' ' ' VAL . 29.2 m -118.5 151.06 20.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.145 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 297' ' ' LYS . . . . . 0.429 ' C ' HD12 ' A' ' 298' ' ' LEU . 5.5 ttpm? -119.62 138.51 53.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.868 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 298' ' ' LEU . . . . . 0.429 HD12 ' C ' ' A' ' 297' ' ' LYS . 7.4 mp -126.36 128.47 47.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.927 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 27.2 ptt180 -131.93 163.39 28.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.839 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 300' ' ' GLY . . . . . 0.472 ' C ' HD13 ' A' ' 362' ' ' ILE . . . 90.99 28.23 16.14 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.527 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -98.22 148.45 34.52 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.545 0.688 . . . . 0.0 111.115 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -165.9 0.17 Allowed 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.702 2.268 . . . . 0.0 112.303 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -93.21 -13.97 27.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.863 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -102.68 27.6 6.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.935 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 305' ' ' VAL . . . . . . . . . . . . . 10.6 p -90.41 141.78 13.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.068 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 306' ' ' THR . . . . . . . . . . . . . 35.2 p -139.26 -179.05 5.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.137 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -55.26 -35.91 65.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.876 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 28.1 tttp -58.13 -59.37 5.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.881 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -46.1 -47.68 17.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.882 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 58.4 t -58.34 -44.94 89.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.098 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 311' ' ' MET . . . . . . . . . . . . . 4.0 mmt -58.49 -52.0 67.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.884 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -64.12 -29.27 70.41 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.86 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 313' ' ' PHE . . . . . 0.475 ' CD1' ' C ' ' A' ' 313' ' ' PHE . 3.1 t80 -75.49 -41.34 55.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.907 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.452 ' CD1' HG11 ' A' ' 338' ' ' VAL . 46.5 mt -81.65 -25.83 35.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.922 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 315' ' ' ALA . . . . . 0.852 ' HB1' ' HA ' ' A' ' 316' ' ' PRO . . . -46.37 166.56 0.16 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.647 0.736 . . . . 0.0 111.084 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 316' ' ' PRO . . . . . 0.852 ' HA ' ' HB1' ' A' ' 315' ' ' ALA . 54.4 Cg_endo -69.68 -3.58 7.67 Favored 'Cis proline' 0 C--O 1.232 0.205 0 C-N-CA 122.66 -1.808 . . . . 0.0 112.386 -0.044 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 317' ' ' LEU . . . . . 0.668 HD22 ' HA ' ' A' ' 345' ' ' GLU . 20.8 mt -53.19 156.32 2.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.908 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 9.6 tttp -130.83 102.71 16.12 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.593 0.711 . . . . 0.0 110.895 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 319' ' ' PRO . . . . . 0.506 ' HA ' ' CD2' ' A' ' 340' ' ' PHE . 53.5 Cg_endo -69.77 -179.07 2.66 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.691 2.261 . . . . 0.0 112.333 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 320' ' ' VAL . . . . . 0.415 HG23 ' HA ' ' A' ' 340' ' ' PHE . 21.7 t -100.72 -39.25 6.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.112 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -156.15 129.92 8.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.086 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 322' ' ' ILE . . . . . 0.49 HG23 HG22 ' A' ' 338' ' ' VAL . 54.3 mt -105.78 99.79 9.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.124 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 18.6 mtp85 -94.0 118.62 31.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.874 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 51.7 mt -87.06 124.37 40.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.139 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 325' ' ' VAL . . . . . 0.687 HG21 ' HB3' ' A' ' 335' ' ' TYR . 53.7 t -64.88 109.33 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.152 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 29.6 mmt180 -99.99 103.48 15.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.895 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 327' ' ' ASN . . . . . 0.478 ' OD1' ' N ' ' A' ' 331' ' ' ASN . 5.8 p-10 -47.2 173.43 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.879 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -47.69 -56.36 7.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.105 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 12.1 m80 -86.06 38.14 0.75 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.822 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 330' ' ' GLY . . . . . 0.429 ' N ' ' OD1' ' A' ' 327' ' ' ASN . . . 44.6 87.93 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.519 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 331' ' ' ASN . . . . . 0.478 ' N ' ' OD1' ' A' ' 327' ' ' ASN . 31.8 t-20 -158.19 132.99 8.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.915 0.388 . . . . 0.0 110.869 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 23.6 mttt -75.49 95.16 3.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.947 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 333' ' ' THR . . . . . 0.661 HG23 ' O ' ' A' ' 333' ' ' THR . 8.8 t -98.36 74.27 2.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.12 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 334' ' ' GLY . . . . . 0.542 ' O ' ' CG ' ' A' ' 335' ' ' TYR . . . 35.91 70.44 0.2 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.502 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 335' ' ' TYR . . . . . 0.687 ' HB3' HG21 ' A' ' 325' ' ' VAL . 14.9 m-85 -170.07 121.95 0.67 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.833 0.349 . . . . 0.0 110.914 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 67.5 mt -145.27 117.13 2.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.167 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 337' ' ' PHE . . . . . 0.664 ' CE2' HG22 ' A' ' 325' ' ' VAL . 71.5 m-85 -87.47 121.35 29.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.835 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 338' ' ' VAL . . . . . 0.49 HG22 HG23 ' A' ' 322' ' ' ILE . 46.4 t -124.43 132.06 71.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.138 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 43.4 m-20 -107.95 161.01 15.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.866 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 340' ' ' PHE . . . . . 0.555 ' CD2' ' HB3' ' A' ' 345' ' ' GLU . 62.1 m-85 -138.08 168.78 19.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.895 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 9.5 t -85.22 -62.2 1.59 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.829 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -99.51 150.0 22.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.902 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 343' ' ' GLU . . . . . 0.56 ' HG3' ' CE1' ' A' ' 294' ' ' HIS . 23.3 tt0 -54.72 -45.27 74.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.888 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -40.17 -64.19 0.53 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.871 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 345' ' ' GLU . . . . . 0.668 ' HA ' HD22 ' A' ' 317' ' ' LEU . 16.0 mm-40 -39.43 -46.17 1.62 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.875 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 346' ' ' VAL . . . . . 0.679 HG21 ' HB2' ' A' ' 294' ' ' HIS . 65.9 t -67.38 -52.24 44.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.112 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 20.6 mtpp -50.73 -39.85 52.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.865 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -73.87 -30.07 62.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.931 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -56.68 -35.56 68.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.055 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 350' ' ' LEU . . . . . . . . . . . . . 83.7 mt -65.5 -35.77 81.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.963 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 76.4 mttt -45.92 -50.29 14.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.914 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 352' ' ' CYS . . . . . . . . . . . . . 31.7 m -69.06 72.23 0.26 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.92 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -107.68 158.94 16.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.902 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 70.0 mtt180 54.22 46.72 24.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.907 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 355' ' ' GLU . . . . . 0.478 ' C ' ' CD1' ' A' ' 356' ' ' TYR . 1.5 mm-40 -98.55 173.84 6.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.932 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 356' ' ' TYR . . . . . 0.478 ' CD1' ' C ' ' A' ' 355' ' ' GLU . 2.9 m-85 -139.22 115.98 10.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.958 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 357' ' ' MET . . . . . . . . . . . . . 3.6 ptt? -142.07 145.96 34.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.902 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 78.01 -46.81 2.74 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.487 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 359' ' ' GLY . . . . . 0.433 ' O ' ' CG ' ' A' ' 360' ' ' ARG . . . 141.74 34.89 0.1 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.477 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 360' ' ' ARG . . . . . 0.433 ' CG ' ' O ' ' A' ' 359' ' ' GLY . 56.8 mtt180 -164.3 156.04 16.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.793 0.33 . . . . 0.0 110.897 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 361' ' ' TYR . . . . . 0.519 ' CD1' ' O ' ' A' ' 361' ' ' TYR . 1.8 p90 -70.66 133.48 46.7 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.871 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 362' ' ' ILE . . . . . 0.472 HD13 ' C ' ' A' ' 300' ' ' GLY . 27.2 mm -111.98 143.75 21.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.128 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 363' ' ' GLU . . . . . 0.53 ' HB3' ' CZ ' ' A' ' 365' ' ' PHE . 21.1 mm-40 -130.96 113.18 13.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.904 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 21.6 t -88.68 141.85 13.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.129 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 365' ' ' PHE . . . . . 0.53 ' CZ ' ' HB3' ' A' ' 363' ' ' GLU . 56.7 m-85 -141.8 141.49 33.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.906 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 31.7 ttt180 -87.71 114.78 24.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.841 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -80.99 100.22 8.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.869 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 24.7 ttmt -50.82 -53.1 34.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.864 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 26.7 t -50.68 -58.06 6.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.85 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 111.99 -95.79 0.82 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.495 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 144.92 55.36 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.692 2.261 . . . . 0.0 112.327 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 372' ' ' SER . . . . . . . . . . . . . 56.9 p -130.15 -48.8 1.1 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.861 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 3.0 m -59.01 111.58 1.36 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.797 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.442 179.969 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 N-CA-C 112.499 -0.24 . . . . 0.0 112.499 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 3.4 m -110.13 42.09 1.6 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.853 0.359 . . . . 0.0 110.874 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 34.0 t -82.7 114.71 21.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.842 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -122.12 40.58 2.03 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.482 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 7.5 t -95.45 39.09 1.13 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.891 0.377 . . . . 0.0 110.856 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 8.6 t -116.9 106.04 13.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.849 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 174.49 -36.87 0.11 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.532 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 291' ' ' THR . . . . . 0.466 ' O ' ' CE1' ' A' ' 294' ' ' HIS . 52.0 m -37.37 -41.41 0.42 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.851 0.358 . . . . 0.0 111.101 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 30.3 m -69.31 143.98 53.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.122 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 293' ' ' CYS . . . . . . . . . . . . . 5.3 t 67.22 51.28 0.92 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.879 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 294' ' ' HIS . . . . . 0.946 ' CB ' HG21 ' A' ' 346' ' ' VAL . 17.6 m80 -55.65 112.83 1.24 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.876 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 6.3 m -134.0 133.85 41.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.121 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 296' ' ' VAL . . . . . 0.453 HG13 HG13 ' A' ' 346' ' ' VAL . 36.0 m -112.05 148.64 15.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.147 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 297' ' ' LYS . . . . . 0.56 ' C ' HD12 ' A' ' 298' ' ' LEU . 8.2 ttpm? -117.96 150.6 38.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.884 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 298' ' ' LEU . . . . . 0.56 HD12 ' C ' ' A' ' 297' ' ' LYS . 7.0 mp -132.92 152.23 51.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.956 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 13.2 ptt180 -154.16 176.44 12.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.825 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 82.79 -21.36 7.79 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.555 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -58.2 151.78 45.19 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.637 0.732 . . . . 0.0 111.062 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.8 178.6 4.43 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.705 2.27 . . . . 0.0 112.313 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -85.17 -15.66 42.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.902 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 35.7 t-20 -99.24 35.75 1.87 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.904 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 305' ' ' VAL . . . . . . . . . . . . . 6.3 p -100.8 142.55 15.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.155 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 306' ' ' THR . . . . . . . . . . . . . 25.5 p -128.46 164.74 22.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.13 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -44.35 -50.25 9.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.881 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -43.53 -52.12 6.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.865 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -56.13 -43.87 78.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.889 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 92.2 t -61.98 -39.06 82.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.153 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 311' ' ' MET . . . . . . . . . . . . . 4.1 mmt -63.67 -44.17 94.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.858 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -67.96 -29.06 68.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.907 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 313' ' ' PHE . . . . . 0.437 ' CE2' HD21 ' A' ' 298' ' ' LEU . 36.6 t80 -72.64 -47.06 50.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.9 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.447 ' CD1' HG11 ' A' ' 338' ' ' VAL . 49.4 mt -79.04 -18.27 53.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.904 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 315' ' ' ALA . . . . . 0.872 ' HB1' ' HA ' ' A' ' 316' ' ' PRO . . . -51.25 166.78 0.31 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.613 0.72 . . . . 0.0 111.082 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 316' ' ' PRO . . . . . 0.872 ' HA ' ' HB1' ' A' ' 315' ' ' ALA . 54.0 Cg_endo -69.72 -3.81 7.87 Favored 'Cis proline' 0 C--O 1.232 0.204 0 C-N-CA 122.72 -1.783 . . . . 0.0 112.321 -0.004 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 317' ' ' LEU . . . . . 0.487 ' N ' ' HA ' ' A' ' 315' ' ' ALA . 19.4 mt -50.72 165.28 0.11 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.897 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 35.3 tttt -140.4 105.05 6.51 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.609 0.718 . . . . 0.0 110.889 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -177.61 1.94 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.684 2.256 . . . . 0.0 112.359 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 59.1 t -100.58 -41.41 8.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.145 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -158.2 134.57 9.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.079 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 322' ' ' ILE . . . . . . . . . . . . . 60.9 mt -105.6 101.56 12.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.121 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 20.5 mmt85 -96.29 96.79 9.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.847 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 324' ' ' ILE . . . . . 0.808 HG21 ' HZ1' ' A' ' 332' ' ' LYS . 74.6 mt -68.0 122.14 18.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.124 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 325' ' ' VAL . . . . . 0.494 HG22 ' CD2' ' A' ' 337' ' ' PHE . 47.0 t -59.39 103.58 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.156 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 53.0 mtt180 -92.16 110.41 21.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.876 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -56.26 -45.4 80.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.887 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 328' ' ' ALA . . . . . 0.429 ' O ' ' C ' ' A' ' 329' ' ' HIS . . . -169.5 156.26 6.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.11 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 329' ' ' HIS . . . . . 0.429 ' C ' ' O ' ' A' ' 328' ' ' ALA . 5.1 t-160 35.09 50.23 0.47 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.862 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 39.7 77.42 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.536 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -115.84 161.27 19.01 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.922 0.392 . . . . 0.0 110.896 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 332' ' ' LYS . . . . . 0.808 ' HZ1' HG21 ' A' ' 324' ' ' ILE . 0.0 OUTLIER -98.68 78.25 2.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.905 179.881 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 9.9 t -165.54 127.52 2.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.139 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 132.03 -112.8 1.21 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.471 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 335' ' ' TYR . . . . . 0.4 ' HB2' HG21 ' A' ' 325' ' ' VAL . 11.7 m-85 -135.34 -179.19 5.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.876 0.369 . . . . 0.0 110.866 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 55.3 mt -137.64 122.96 24.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.158 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 337' ' ' PHE . . . . . 0.494 ' CD2' HG22 ' A' ' 325' ' ' VAL . 30.8 m-85 -98.05 126.58 43.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.87 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 338' ' ' VAL . . . . . 0.447 HG11 ' CD1' ' A' ' 314' ' ' LEU . 99.1 t -124.0 131.01 73.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.132 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -105.55 160.41 15.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.879 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -137.94 166.0 25.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.887 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 2.1 m -90.64 -44.19 9.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.891 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -98.63 169.39 9.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.926 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -85.15 -55.48 4.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.882 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -43.32 -46.72 6.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.863 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -50.05 -39.04 40.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.912 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 346' ' ' VAL . . . . . 0.946 HG21 ' CB ' ' A' ' 294' ' ' HIS . 46.3 t -70.35 -58.24 5.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.15 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 15.7 mtmt -50.03 -26.21 4.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.91 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 25.2 mm100 -82.54 -38.95 23.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.918 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -47.32 -30.93 3.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.131 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 350' ' ' LEU . . . . . 0.476 HD23 HG12 ' A' ' 364' ' ' VAL . 48.0 mt -63.78 -36.96 85.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.873 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -47.19 -44.2 21.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.92 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 352' ' ' CYS . . . . . . . . . . . . . 8.0 m -64.59 83.19 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.922 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 353' ' ' ASN . . . . . 0.449 ' O ' ' CG ' ' A' ' 354' ' ' ARG . 48.8 t30 -140.43 177.91 7.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.868 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 354' ' ' ARG . . . . . 0.449 ' CG ' ' O ' ' A' ' 353' ' ' ASN . 7.9 ptp85 44.78 37.22 2.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.904 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 355' ' ' GLU . . . . . 0.423 ' C ' ' CD ' ' A' ' 355' ' ' GLU . 0.0 OUTLIER -125.69 172.63 9.63 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.904 -179.974 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 356' ' ' TYR . . . . . 0.414 ' CD1' ' N ' ' A' ' 356' ' ' TYR . 1.8 m-85 -118.94 146.61 44.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.911 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 357' ' ' MET . . . . . . . . . . . . . 3.2 ptt? -164.24 125.58 2.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.887 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 86.02 -31.75 3.95 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.449 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 359' ' ' GLY . . . . . 0.461 ' O ' ' CG ' ' A' ' 360' ' ' ARG . . . 126.91 30.6 0.8 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.509 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 360' ' ' ARG . . . . . 0.461 ' CG ' ' O ' ' A' ' 359' ' ' GLY . 59.8 mtt180 -164.76 164.59 21.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.743 0.306 . . . . 0.0 110.93 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 361' ' ' TYR . . . . . . . . . . . . . 27.3 p90 -67.05 159.34 28.93 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.891 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 12.5 mm -138.07 125.22 28.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.11 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 363' ' ' GLU . . . . . 0.438 ' HB3' ' CZ ' ' A' ' 365' ' ' PHE . 28.2 mm-40 -118.85 118.23 30.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.824 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 364' ' ' VAL . . . . . 0.476 HG12 HD23 ' A' ' 350' ' ' LEU . 93.8 t -95.15 143.78 11.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.123 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 365' ' ' PHE . . . . . 0.438 ' CZ ' ' HB3' ' A' ' 363' ' ' GLU . 68.6 m-85 -141.97 148.95 39.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.863 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 35.7 ttp85 -96.98 112.18 24.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.884 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -86.39 97.19 10.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.881 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.16 -31.71 73.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.883 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 62.1 m -78.4 -60.65 2.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.842 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 108.28 -154.72 16.45 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.505 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 1.82 4.13 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.675 2.25 . . . . 0.0 112.287 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 372' ' ' SER . . . . . . . . . . . . . 8.7 t -134.16 133.84 41.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.878 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 47.2 t -97.72 -44.12 6.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.831 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.277 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.472 179.979 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.285 0 N-CA-C 112.469 -0.252 . . . . 0.0 112.469 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 34.4 m -72.01 108.33 5.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.873 0.368 . . . . 0.0 110.868 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 1.3 t -106.12 -58.57 1.9 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.856 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 86.46 178.91 49.47 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.524 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 48.7 m -101.99 109.03 20.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.864 0.364 . . . . 0.0 110.863 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 62.8 p -151.91 145.4 24.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.867 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 137.41 90.83 0.26 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.524 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 66.9 p -46.6 167.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.87 0.367 . . . . 0.0 111.105 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 24.2 m -61.26 127.24 30.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.143 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 293' ' ' CYS . . . . . . . . . . . . . 4.4 t -134.52 151.01 50.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.879 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 294' ' ' HIS . . . . . 0.705 ' HB3' HG21 ' A' ' 346' ' ' VAL . 3.8 m170 -110.64 83.91 1.84 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.838 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 12.1 m -125.64 142.43 51.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.147 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 27.0 m -118.64 147.47 22.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.124 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 297' ' ' LYS . . . . . 0.402 ' NZ ' ' HB3' ' A' ' 297' ' ' LYS . 0.2 OUTLIER -120.85 138.78 53.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.925 179.858 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 6.9 mp -119.57 141.9 48.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.926 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 299' ' ' ARG . . . . . 0.435 ' HB2' ' CE1' ' A' ' 335' ' ' TYR . 13.3 ptt180 -141.58 151.14 42.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.887 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 96.24 16.66 36.99 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.488 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -78.87 147.29 70.19 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.566 0.698 . . . . 0.0 111.105 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.69 169.79 18.0 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.698 2.265 . . . . 0.0 112.386 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 303' ' ' PHE . . . . . 0.458 ' O ' ' CG ' ' A' ' 303' ' ' PHE . 10.3 t80 -70.93 -8.93 56.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.858 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -111.51 41.42 1.89 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.923 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 305' ' ' VAL . . . . . . . . . . . . . 7.7 p -101.98 149.23 6.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.132 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 306' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -148.31 167.26 25.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.178 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -49.68 -20.41 0.81 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.921 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 9.9 ttmm -74.88 -53.32 9.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.852 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -51.67 -34.16 37.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.87 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 54.2 t -69.74 -46.01 75.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.146 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 311' ' ' MET . . . . . 0.43 ' HG2' ' CD1' ' A' ' 322' ' ' ILE . 4.1 mmt -53.37 -48.25 68.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.87 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -68.17 -25.5 65.28 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.929 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 313' ' ' PHE . . . . . 0.494 ' CD1' ' C ' ' A' ' 313' ' ' PHE . 2.6 t80 -75.58 -46.81 29.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.886 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.544 ' CD1' HG11 ' A' ' 338' ' ' VAL . 65.4 mt -78.01 -25.39 47.94 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.919 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 315' ' ' ALA . . . . . 0.859 ' HB1' ' HA ' ' A' ' 316' ' ' PRO . . . -44.4 166.25 0.12 Allowed Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.585 0.707 . . . . 0.0 111.08 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 316' ' ' PRO . . . . . 0.859 ' HA ' ' HB1' ' A' ' 315' ' ' ALA . 53.5 Cg_endo -69.72 -3.77 7.84 Favored 'Cis proline' 0 C--N 1.341 0.178 0 C-N-CA 122.664 -1.806 . . . . 0.0 112.361 0.03 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 317' ' ' LEU . . . . . 0.485 ' N ' ' HA ' ' A' ' 315' ' ' ALA . 27.7 mt -50.03 170.8 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.895 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 33.3 tttt -145.24 105.05 4.38 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.551 0.691 . . . . 0.0 110.923 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 319' ' ' PRO . . . . . 0.498 ' HA ' ' CD2' ' A' ' 340' ' ' PHE . 53.5 Cg_endo -69.79 -175.94 1.33 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.692 2.261 . . . . 0.0 112.33 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 31.1 t -101.12 -39.78 7.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.12 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -156.84 131.64 8.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.123 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 322' ' ' ILE . . . . . 0.548 HG12 HG13 ' A' ' 338' ' ' VAL . 66.7 mt -110.23 108.74 26.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.131 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 27.7 mmm-85 -108.18 121.85 45.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.877 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 324' ' ' ILE . . . . . 0.429 HG21 ' HG2' ' A' ' 332' ' ' LYS . 60.8 mt -89.71 120.59 38.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.131 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 325' ' ' VAL . . . . . 0.432 HG21 ' HB3' ' A' ' 335' ' ' TYR . 20.6 t -47.54 100.53 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.107 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 56.0 mtm-85 -96.43 124.06 40.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.904 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -52.42 178.52 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.87 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -51.02 -56.25 13.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.068 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 4.5 m80 -74.15 -62.55 1.47 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.877 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 159.23 99.4 0.15 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.478 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -172.97 120.32 0.36 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.889 0.376 . . . . 0.0 110.884 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 332' ' ' LYS . . . . . 0.429 ' HG2' HG21 ' A' ' 324' ' ' ILE . 12.0 mttp -54.38 98.04 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.878 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 333' ' ' THR . . . . . 0.497 ' O ' ' N ' ' A' ' 335' ' ' TYR . 26.8 p -79.48 54.62 1.78 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.116 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 334' ' ' GLY . . . . . 0.432 ' O ' ' C ' ' A' ' 335' ' ' TYR . . . 58.48 -77.78 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.452 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 335' ' ' TYR . . . . . 0.497 ' N ' ' O ' ' A' ' 333' ' ' THR . 3.6 m-85 -34.54 148.32 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.84 0.352 . . . . 0.0 110.938 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 336' ' ' ILE . . . . . 0.412 HG12 HG23 ' A' ' 324' ' ' ILE . 43.5 mt -145.95 147.51 18.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.169 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -119.89 128.46 53.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.879 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 338' ' ' VAL . . . . . 0.548 HG13 HG12 ' A' ' 322' ' ' ILE . 21.7 t -129.31 136.82 58.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.167 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -113.74 155.46 25.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.857 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 340' ' ' PHE . . . . . 0.499 ' HB2' HG23 ' A' ' 346' ' ' VAL . 53.5 m-85 -132.08 166.35 21.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.848 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 36.2 p -88.53 -58.12 2.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.896 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 67.3 m-80 -87.63 159.13 18.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.925 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -78.28 -23.54 47.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.902 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -67.64 -49.25 63.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.894 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -48.58 -50.3 33.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.848 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 346' ' ' VAL . . . . . 0.705 HG21 ' HB3' ' A' ' 294' ' ' HIS . 54.9 t -60.8 -56.01 20.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.143 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 24.9 mtpp -51.38 -32.62 26.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.877 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -83.27 -24.03 32.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.879 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -65.0 -26.25 68.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.075 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 350' ' ' LEU . . . . . 0.615 HD23 HG12 ' A' ' 364' ' ' VAL . 42.8 mt -75.34 -7.83 55.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.919 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 1.5 mmmp? -72.95 -32.61 65.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.915 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 352' ' ' CYS . . . . . . . . . . . . . 15.5 m -79.69 72.36 6.37 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.899 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 6.8 p-10 -122.55 174.08 7.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.906 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 23.6 mtt180 53.22 28.42 7.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.847 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 355' ' ' GLU . . . . . 0.411 ' C ' ' OE1' ' A' ' 355' ' ' GLU . 0.0 OUTLIER -117.7 174.45 6.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.906 -179.951 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 356' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -124.8 128.14 48.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.925 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 357' ' ' MET . . . . . 0.445 ' HG3' ' CD1' ' A' ' 362' ' ' ILE . 0.0 OUTLIER -130.77 130.92 44.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.875 179.914 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 83.14 -41.7 2.93 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.462 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 359' ' ' GLY . . . . . 0.447 ' O ' ' CG ' ' A' ' 360' ' ' ARG . . . 141.92 33.27 0.12 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.468 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 360' ' ' ARG . . . . . 0.447 ' CG ' ' O ' ' A' ' 359' ' ' GLY . 71.5 mtt180 -165.19 161.64 19.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.794 0.331 . . . . 0.0 110.924 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 361' ' ' TYR . . . . . 0.443 ' O ' HD13 ' A' ' 362' ' ' ILE . 13.6 p90 -63.74 144.27 57.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.976 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 362' ' ' ILE . . . . . 0.445 ' CD1' ' HG3' ' A' ' 357' ' ' MET . 6.5 mm -130.72 135.05 61.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.161 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 363' ' ' GLU . . . . . 0.513 ' HB2' ' CZ ' ' A' ' 365' ' ' PHE . 15.7 mt-10 -126.35 112.71 15.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.864 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 364' ' ' VAL . . . . . 0.615 HG12 HD23 ' A' ' 350' ' ' LEU . 57.3 t -88.61 124.0 41.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.129 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 365' ' ' PHE . . . . . 0.513 ' CZ ' ' HB2' ' A' ' 363' ' ' GLU . 21.9 m-85 -121.66 142.74 49.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.856 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 366' ' ' ARG . . . . . 0.438 ' CZ ' ' HB3' ' A' ' 366' ' ' ARG . 9.8 ttp-105 -84.94 127.98 34.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.871 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -112.54 79.26 1.2 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.921 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.41 -21.69 61.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.881 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 46.9 m -62.41 -42.89 99.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.865 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 107.85 -158.48 14.88 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.483 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -178.84 2.54 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.676 2.251 . . . . 0.0 112.329 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 372' ' ' SER . . . . . 0.415 ' O ' ' C ' ' A' ' 373' ' ' SER . 15.2 m -115.54 -52.99 2.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.838 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 373' ' ' SER . . . . . 0.415 ' C ' ' O ' ' A' ' 372' ' ' SER . 59.6 p -36.12 145.49 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.828 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.496 179.995 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 N-CA-C 112.497 -0.241 . . . . 0.0 112.497 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 45.8 t -79.92 86.09 5.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.861 0.362 . . . . 0.0 110.831 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 4.6 m 39.84 38.93 0.5 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.852 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -126.3 51.01 0.85 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.471 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 97.1 p -50.11 -34.19 21.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.858 0.361 . . . . 0.0 110.831 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 2.0 m -100.9 127.12 47.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.885 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . -179.34 30.78 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.473 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 41.3 p -138.16 172.49 12.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.89 0.376 . . . . 0.0 111.11 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 79.2 p -85.69 107.55 17.62 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.165 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 293' ' ' CYS . . . . . . . . . . . . . 5.7 m -127.63 131.9 49.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.898 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 294' ' ' HIS . . . . . 0.841 ' HB3' HG21 ' A' ' 346' ' ' VAL . 33.6 m80 -129.42 106.12 8.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.9 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 26.5 m -139.42 139.65 37.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.161 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 296' ' ' VAL . . . . . 0.501 ' CG1' HG13 ' A' ' 346' ' ' VAL . 33.2 m -112.27 148.88 15.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.154 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 297' ' ' LYS . . . . . 0.563 ' HE3' ' CD1' ' A' ' 335' ' ' TYR . 56.4 tttt -122.55 131.19 53.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.931 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 7.9 mp -108.82 154.55 21.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.885 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 299' ' ' ARG . . . . . 0.507 ' HD2' ' CE1' ' A' ' 335' ' ' TYR . 13.0 ttt-85 -162.08 136.02 6.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.878 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 128.6 -18.19 5.74 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.487 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -65.64 151.42 94.69 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.547 0.689 . . . . 0.0 111.117 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -176.4 1.48 Allowed 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.679 2.253 . . . . 0.0 112.347 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 303' ' ' PHE . . . . . 0.484 ' CD1' ' C ' ' A' ' 303' ' ' PHE . 0.5 OUTLIER -76.43 -27.74 56.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.931 179.986 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 23.8 p-10 -92.81 43.76 1.13 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.893 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 305' ' ' VAL . . . . . . . . . . . . . 12.7 p -101.98 141.02 19.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.106 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 306' ' ' THR . . . . . . . . . . . . . 66.8 p -130.93 169.38 15.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.169 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -46.7 -45.91 19.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.903 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 20.9 ttmm -48.29 -57.07 6.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.919 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 25.4 m120 -48.45 -41.76 30.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.904 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 310' ' ' VAL . . . . . 0.443 HG21 HD13 ' A' ' 336' ' ' ILE . 95.9 t -69.33 -42.01 81.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.109 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 311' ' ' MET . . . . . . . . . . . . . 3.6 mmt -58.41 -50.38 73.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.896 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -65.77 -24.83 67.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.883 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 313' ' ' PHE . . . . . 0.602 ' CD1' ' C ' ' A' ' 313' ' ' PHE . 0.5 OUTLIER -83.77 -28.68 28.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.888 -179.938 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.598 HD11 HG21 ' A' ' 338' ' ' VAL . 33.1 mt -90.9 -23.66 20.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.865 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 315' ' ' ALA . . . . . 0.825 ' HB1' ' HA ' ' A' ' 316' ' ' PRO . . . -52.1 166.02 0.44 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.546 0.688 . . . . 0.0 111.136 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 316' ' ' PRO . . . . . 0.825 ' HA ' ' HB1' ' A' ' 315' ' ' ALA . 53.6 Cg_endo -69.72 -7.6 9.98 Favored 'Cis proline' 0 C--O 1.231 0.161 0 C-N-CA 122.703 -1.791 . . . . 0.0 112.328 -0.031 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 317' ' ' LEU . . . . . 0.413 ' N ' ' HA ' ' A' ' 315' ' ' ALA . 47.3 mt -56.04 144.35 29.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.883 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 14.3 tptp -120.42 110.73 35.51 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.563 0.696 . . . . 0.0 110.86 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 319' ' ' PRO . . . . . 0.513 ' HA ' ' CD1' ' A' ' 340' ' ' PHE . 53.7 Cg_endo -69.78 -163.83 0.12 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.694 2.262 . . . . 0.0 112.328 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 21.7 t -118.61 -41.25 2.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.131 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -151.69 124.13 8.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.075 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 322' ' ' ILE . . . . . . . . . . . . . 65.4 mt -98.86 102.39 13.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.141 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 9.2 tpt180 -86.1 116.04 24.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.82 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 324' ' ' ILE . . . . . 0.665 HG21 ' HE3' ' A' ' 332' ' ' LYS . 72.5 mt -88.63 117.11 31.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.115 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 50.7 t -84.57 89.06 2.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.124 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.47 -179.6 7.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.913 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -117.92 175.16 5.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.878 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -41.07 -70.61 0.1 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.096 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 11.1 m170 -58.42 -51.84 68.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.83 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 142.6 33.74 0.1 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.467 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -111.35 117.45 33.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.893 0.377 . . . . 0.0 110.87 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 332' ' ' LYS . . . . . 0.665 ' HE3' HG21 ' A' ' 324' ' ' ILE . 8.1 mptt -71.68 107.35 4.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.899 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 333' ' ' THR . . . . . 0.412 ' O ' ' C ' ' A' ' 334' ' ' GLY . 70.7 p -86.07 69.91 10.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.135 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 334' ' ' GLY . . . . . 0.522 ' O ' ' CG ' ' A' ' 335' ' ' TYR . . . 36.91 77.79 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.499 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 335' ' ' TYR . . . . . 0.563 ' CD1' ' HE3' ' A' ' 297' ' ' LYS . 7.0 m-85 -169.61 122.09 0.73 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.811 0.338 . . . . 0.0 110.995 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 336' ' ' ILE . . . . . 0.443 HD13 HG21 ' A' ' 310' ' ' VAL . 85.4 mt -149.73 136.93 13.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.188 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 337' ' ' PHE . . . . . 0.58 ' CD1' ' OE2' ' A' ' 367' ' ' GLU . 55.5 m-85 -108.71 116.08 31.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.889 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 338' ' ' VAL . . . . . 0.598 HG21 HD11 ' A' ' 314' ' ' LEU . 87.0 t -112.62 127.67 69.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.117 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -105.36 139.19 40.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.854 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 340' ' ' PHE . . . . . 0.513 ' CD1' ' HA ' ' A' ' 319' ' ' PRO . 64.2 m-85 -117.22 157.86 25.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.887 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 2.4 m -79.11 -56.07 4.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.872 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 47.3 m-20 -91.93 158.3 16.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.871 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 343' ' ' GLU . . . . . 0.429 ' HG2' ' CE1' ' A' ' 294' ' ' HIS . 53.7 mt-10 -71.46 -44.84 64.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.892 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -47.91 -50.5 26.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.874 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -46.19 -45.65 16.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.91 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 346' ' ' VAL . . . . . 0.841 HG21 ' HB3' ' A' ' 294' ' ' HIS . 66.7 t -68.14 -52.08 41.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.118 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 25.1 mtpp -51.37 -38.44 53.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.903 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 70.4 mm-40 -78.13 -42.85 30.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.886 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -42.8 -42.4 3.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.054 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 350' ' ' LEU . . . . . 0.602 HD23 HG12 ' A' ' 364' ' ' VAL . 40.3 mt -58.85 -42.95 90.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.879 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 65.6 mmtt -42.89 -48.05 5.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.893 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 352' ' ' CYS . . . . . . . . . . . . . 19.9 m -69.11 72.68 0.28 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.883 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -112.55 156.01 23.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.923 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 7.6 ttt85 66.72 29.27 8.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.896 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 355' ' ' GLU . . . . . 0.428 ' HB2' ' CE2' ' A' ' 313' ' ' PHE . 4.4 mm-40 -83.87 173.4 11.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.861 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 356' ' ' TYR . . . . . 0.45 ' CD1' ' N ' ' A' ' 356' ' ' TYR . 1.3 m-85 -131.8 127.41 36.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.904 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 357' ' ' MET . . . . . . . . . . . . . 3.9 ptt? -154.74 142.32 19.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.859 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 78.45 -42.86 2.24 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.448 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 135.65 29.76 0.36 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.542 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 360' ' ' ARG . . . . . . . . . . . . . 61.3 mtt-85 -158.67 158.09 33.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.789 0.328 . . . . 0.0 110.929 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 361' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -66.88 157.17 33.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.941 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 9.1 mm -140.15 149.55 21.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.145 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 363' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -137.17 121.0 17.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.907 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 364' ' ' VAL . . . . . 0.602 HG12 HD23 ' A' ' 350' ' ' LEU . 72.0 t -90.48 131.83 36.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.166 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -125.76 138.62 53.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.874 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 366' ' ' ARG . . . . . 0.554 ' HB2' HD21 ' A' ' 350' ' ' LEU . 18.2 ttp180 -92.67 109.31 20.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.863 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 367' ' ' GLU . . . . . 0.58 ' OE2' ' CD1' ' A' ' 337' ' ' PHE . 20.1 mt-10 -64.02 81.88 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.866 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 10.5 ptpp? -55.36 -31.24 61.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.863 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 30.5 t -131.75 56.96 1.79 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.84 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . -74.52 145.21 33.98 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.45 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 120.48 7.26 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.646 2.231 . . . . 0.0 112.355 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 372' ' ' SER . . . . . . . . . . . . . 6.6 t -97.33 -45.83 6.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.875 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 13.2 t -112.19 170.46 8.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.835 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.479 -179.999 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 N-CA-C 112.463 -0.255 . . . . 0.0 112.463 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 3.5 m -133.49 111.76 10.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.839 0.352 . . . . 0.0 110.852 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 28.7 t -126.39 148.33 49.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.862 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -176.22 153.59 14.88 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.501 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 50.4 p -61.74 153.39 28.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.895 0.379 . . . . 0.0 110.886 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 28.9 p -128.98 89.28 2.85 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.85 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 100.31 52.95 1.11 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.473 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 85.2 m -152.86 129.82 11.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.92 0.39 . . . . 0.0 111.138 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 67.0 p -118.93 116.15 25.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.111 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 293' ' ' CYS . . . . . . . . . . . . . 9.9 m -104.99 174.89 5.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.882 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 294' ' ' HIS . . . . . 0.84 ' HB3' HG21 ' A' ' 346' ' ' VAL . 76.5 m-70 -129.36 84.25 2.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.858 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 25.5 m -121.17 142.65 49.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.182 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 296' ' ' VAL . . . . . 0.548 HG22 ' O ' ' A' ' 338' ' ' VAL . 28.2 m -119.15 149.49 21.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.121 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 297' ' ' LYS . . . . . 0.527 ' HG3' ' CE1' ' A' ' 337' ' ' PHE . 16.8 ttmt -117.37 143.62 45.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.896 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 298' ' ' LEU . . . . . 0.445 HD12 ' C ' ' A' ' 297' ' ' LYS . 7.1 mp -122.0 121.43 37.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.917 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 299' ' ' ARG . . . . . 0.618 ' NE ' ' CD2' ' A' ' 365' ' ' PHE . 25.4 mtt180 -122.36 162.01 22.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.896 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 95.12 -23.28 34.07 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.511 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -56.13 152.49 21.93 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.588 0.708 . . . . 0.0 111.11 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.71 -173.14 0.66 Allowed 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.701 2.267 . . . . 0.0 112.376 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -90.7 -26.03 19.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.891 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -95.34 44.44 1.09 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.886 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 305' ' ' VAL . . . . . 0.408 ' CG1' ' NZ ' ' A' ' 332' ' ' LYS . 10.8 p -105.22 139.69 25.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.134 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 306' ' ' THR . . . . . . . . . . . . . 41.6 p -124.33 171.2 10.09 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.151 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -48.61 -54.14 15.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.862 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 21.5 ttmt -41.34 -48.81 3.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.91 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -56.95 -41.06 77.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.908 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 87.2 t -65.7 -51.23 64.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.093 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 311' ' ' MET . . . . . . . . . . . . . 3.2 mmt -51.58 -40.06 59.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.851 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -74.09 -30.81 62.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.885 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 313' ' ' PHE . . . . . 0.607 ' CZ ' HG21 ' A' ' 362' ' ' ILE . 27.2 t80 -73.24 -41.67 63.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.892 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.785 ' CD1' HG11 ' A' ' 338' ' ' VAL . 86.9 mt -80.95 -26.11 36.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.922 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 315' ' ' ALA . . . . . 0.677 ' HB1' ' HA ' ' A' ' 316' ' ' PRO . . . -45.54 161.54 0.24 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.569 0.7 . . . . 0.0 111.097 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 316' ' ' PRO . . . . . 0.677 ' HA ' ' HB1' ' A' ' 315' ' ' ALA . 53.9 Cg_endo -69.71 -13.76 12.32 Favored 'Cis proline' 0 C--O 1.232 0.219 0 C-N-CA 122.725 -1.781 . . . . 0.0 112.341 -0.04 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 317' ' ' LEU . . . . . 0.406 HD13 ' O ' ' A' ' 345' ' ' GLU . 83.1 mt -43.09 135.13 3.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.916 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 4.9 tmtt? -111.71 100.54 48.65 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.574 0.702 . . . . 0.0 110.905 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 319' ' ' PRO . . . . . 0.514 ' HA ' ' CD2' ' A' ' 340' ' ' PHE . 53.9 Cg_endo -69.77 -175.39 1.14 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.644 2.23 . . . . 0.0 112.36 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 39.0 t -100.04 -43.63 11.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.102 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -157.3 144.19 18.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.138 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 322' ' ' ILE . . . . . 0.46 HG23 HG22 ' A' ' 338' ' ' VAL . 60.4 mt -116.15 103.41 15.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.112 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 55.2 mtt-85 -98.42 116.3 30.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.862 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 324' ' ' ILE . . . . . 0.409 HG21 ' HE2' ' A' ' 332' ' ' LYS . 60.0 mt -85.87 124.89 40.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.114 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 325' ' ' VAL . . . . . 0.554 ' CG2' ' CD2' ' A' ' 337' ' ' PHE . 15.8 t -80.55 118.49 28.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.104 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 3.1 ptp180 -90.26 163.58 14.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.859 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 327' ' ' ASN . . . . . 0.452 ' CB ' ' OD1' ' A' ' 331' ' ' ASN . 18.3 t-20 -77.68 150.64 34.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.859 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 328' ' ' ALA . . . . . 0.428 ' C ' ' O ' ' A' ' 327' ' ' ASN . . . -34.82 -68.93 0.11 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.088 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 9.6 m170 -51.7 -58.78 5.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.845 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 146.04 66.29 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.52 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 331' ' ' ASN . . . . . 0.452 ' OD1' ' CB ' ' A' ' 327' ' ' ASN . 8.9 p30 -144.79 145.81 31.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.923 0.392 . . . . 0.0 110.872 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 332' ' ' LYS . . . . . 0.429 ' HD3' ' C ' ' A' ' 332' ' ' LYS . 5.6 tmtt? -59.7 105.54 0.38 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.928 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 333' ' ' THR . . . . . 0.422 ' CG2' ' O ' ' A' ' 325' ' ' VAL . 2.5 t -95.65 173.5 7.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.147 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 334' ' ' GLY . . . . . 0.496 ' O ' ' CD1' ' A' ' 335' ' ' TYR . . . -86.36 61.95 4.37 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.474 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 335' ' ' TYR . . . . . 0.496 ' CD1' ' O ' ' A' ' 334' ' ' GLY . 32.2 m-85 -154.28 138.75 16.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.835 0.35 . . . . 0.0 110.897 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 78.5 mt -146.9 149.11 16.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.145 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 337' ' ' PHE . . . . . 0.554 ' CD2' ' CG2' ' A' ' 325' ' ' VAL . 17.4 m-85 -121.38 122.02 38.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.902 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 338' ' ' VAL . . . . . 0.785 HG11 ' CD1' ' A' ' 314' ' ' LEU . 38.1 t -121.21 126.02 74.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.114 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -104.14 157.29 17.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.884 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 340' ' ' PHE . . . . . 0.607 ' HB2' HG23 ' A' ' 346' ' ' VAL . 69.4 m-85 -134.52 167.96 19.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.881 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 30.8 t -87.65 -57.2 3.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.881 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -89.91 160.18 16.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.893 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -78.05 -14.35 59.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.874 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -75.73 -44.51 41.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.906 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 345' ' ' GLU . . . . . 0.521 ' HB3' ' CD2' ' A' ' 340' ' ' PHE . 45.5 mt-10 -55.4 -40.17 71.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.883 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 346' ' ' VAL . . . . . 0.84 HG21 ' HB3' ' A' ' 294' ' ' HIS . 67.3 t -74.17 -41.28 51.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.158 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 33.5 mtpt -59.89 -29.54 68.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.882 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -88.16 -28.34 21.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.907 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -55.57 -35.72 66.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.082 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 350' ' ' LEU . . . . . 0.602 HD23 HG12 ' A' ' 364' ' ' VAL . 42.6 mt -67.41 -38.63 84.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.905 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 16.8 mmtp -56.63 -25.47 53.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.909 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 352' ' ' CYS . . . . . . . . . . . . . 40.4 t -78.44 57.9 2.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.86 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -110.57 170.64 7.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.906 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 13.4 mmt180 61.85 29.24 17.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.83 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 355' ' ' GLU . . . . . 0.516 ' C ' ' CD1' ' A' ' 356' ' ' TYR . 12.4 mm-40 -97.68 172.5 7.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.908 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 356' ' ' TYR . . . . . 0.516 ' CD1' ' C ' ' A' ' 355' ' ' GLU . 1.3 m-85 -138.44 122.87 18.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.931 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 357' ' ' MET . . . . . . . . . . . . . 1.7 ptt? -148.23 155.74 41.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.878 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 60.57 7.93 8.71 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.449 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 83.76 27.18 39.21 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.517 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 360' ' ' ARG . . . . . . . . . . . . . 15.1 mmm180 -147.68 177.43 9.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.8 0.333 . . . . 0.0 110.893 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 361' ' ' TYR . . . . . . . . . . . . . 29.2 p90 -92.39 149.3 21.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.891 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 362' ' ' ILE . . . . . 0.607 HG21 ' CZ ' ' A' ' 313' ' ' PHE . 14.5 mm -118.64 149.93 20.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.127 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 363' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -141.02 112.67 7.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.891 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 364' ' ' VAL . . . . . 0.602 HG12 HD23 ' A' ' 350' ' ' LEU . 11.2 t -88.23 140.7 15.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.148 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 365' ' ' PHE . . . . . 0.618 ' CD2' ' NE ' ' A' ' 299' ' ' ARG . 72.4 m-85 -139.93 143.7 36.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.891 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 17.7 ttp85 -91.81 122.19 34.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.836 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 367' ' ' GLU . . . . . 0.411 ' OE1' ' N ' ' A' ' 297' ' ' LYS . 5.7 mp0 -106.73 127.6 53.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.829 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 52.2 tttm -98.02 -33.65 11.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.881 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 1.4 p -84.43 6.87 21.68 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.84 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 59.34 -172.89 4.42 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.481 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.83 114.15 3.62 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.635 2.223 . . . . 0.0 112.325 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 372' ' ' SER . . . . . . . . . . . . . 76.8 p -63.85 119.77 10.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.845 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 2.9 t -88.72 142.43 27.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.849 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.442 179.999 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 284' ' ' GLY . . . . . 0.44 ' O ' ' C ' ' A' ' 285' ' ' SER . . . . . . . . 0 N--CA 1.451 -0.336 0 N-CA-C 112.504 -0.239 . . . . 0.0 112.504 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 285' ' ' SER . . . . . 0.44 ' C ' ' O ' ' A' ' 284' ' ' GLY . 35.6 p 34.96 43.28 0.1 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.844 0.354 . . . . 0.0 110.865 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 2.3 m -88.35 42.27 1.06 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.846 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -134.32 -54.65 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.437 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 1.4 t -86.5 146.95 26.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.878 0.37 . . . . 0.0 110.894 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 9.1 m -51.56 141.99 15.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.871 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . -173.59 -52.12 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.504 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 13.5 t -90.6 -30.87 16.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.861 0.362 . . . . 0.0 111.167 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 88.5 m -91.21 85.7 5.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.179 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 293' ' ' CYS . . . . . . . . . . . . . 96.9 m -117.33 128.3 54.91 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.897 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 294' ' ' HIS . . . . . 0.417 ' CB ' HG21 ' A' ' 346' ' ' VAL . 15.4 m-70 -96.6 92.1 6.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.897 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 54.5 m -121.41 150.1 42.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.141 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 296' ' ' VAL . . . . . 0.669 HG13 HG13 ' A' ' 346' ' ' VAL . 27.3 m -118.02 146.16 22.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.113 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 297' ' ' LYS . . . . . 0.558 ' HG3' ' CE1' ' A' ' 337' ' ' PHE . 16.3 ttmt -117.67 142.68 46.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.917 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 298' ' ' LEU . . . . . 0.473 HD12 ' C ' ' A' ' 297' ' ' LYS . 7.9 mp -123.67 135.63 54.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.913 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 9.7 ttm-85 -144.76 132.94 21.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.877 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 129.18 -19.89 5.38 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.455 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -57.75 152.15 38.28 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.571 0.7 . . . . 0.0 111.1 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.72 177.38 5.61 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.711 2.274 . . . . 0.0 112.338 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -72.37 -24.11 61.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.9 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -98.71 47.78 0.98 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.891 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 305' ' ' VAL . . . . . . . . . . . . . 9.4 p -104.62 141.44 20.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.148 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 306' ' ' THR . . . . . . . . . . . . . 66.6 p -136.3 162.86 31.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.155 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -37.85 -46.74 0.97 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.923 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 36.4 tttm -45.5 -56.83 4.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.886 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 21.2 m120 -50.82 -49.11 59.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.905 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 86.9 t -58.0 -41.54 80.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.082 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 311' ' ' MET . . . . . . . . . . . . . 1.9 mmt -61.12 -53.08 61.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.86 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.64 -36.23 78.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.905 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -70.67 -44.28 67.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.878 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.481 ' CD1' HG11 ' A' ' 338' ' ' VAL . 32.9 mt -73.41 -25.59 60.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.934 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 315' ' ' ALA . . . . . 0.811 ' HB1' ' HA ' ' A' ' 316' ' ' PRO . . . -51.25 165.4 0.4 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.579 0.704 . . . . 0.0 111.102 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 316' ' ' PRO . . . . . 0.811 ' HA ' ' HB1' ' A' ' 315' ' ' ALA . 54.1 Cg_endo -69.75 -9.52 11.04 Favored 'Cis proline' 0 C--O 1.232 0.183 0 C-N-CA 122.673 -1.803 . . . . 0.0 112.367 -0.017 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 317' ' ' LEU . . . . . 0.447 HD22 ' CD ' ' A' ' 345' ' ' GLU . 33.8 mt -54.96 139.03 42.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.888 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 318' ' ' LYS . . . . . 0.401 ' HA ' ' HD2' ' A' ' 319' ' ' PRO . 0.0 OUTLIER -113.32 109.48 51.47 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.591 0.71 . . . . 0.0 110.904 179.866 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 319' ' ' PRO . . . . . 0.492 ' HA ' ' CD2' ' A' ' 340' ' ' PHE . 53.5 Cg_endo -69.78 -171.94 0.53 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.673 2.249 . . . . 0.0 112.329 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 80.2 t -104.51 -39.55 5.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.098 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -164.18 129.09 2.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.118 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 322' ' ' ILE . . . . . 0.591 HG23 HG22 ' A' ' 338' ' ' VAL . 50.8 mt -100.53 105.25 17.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.147 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 15.4 mmm180 -99.04 119.98 38.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.856 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 324' ' ' ILE . . . . . 0.43 ' O ' ' C ' ' A' ' 325' ' ' VAL . 64.0 mt -91.38 117.48 34.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.148 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 325' ' ' VAL . . . . . 0.607 HG21 ' HB3' ' A' ' 335' ' ' TYR . 22.4 t -35.38 145.14 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.115 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 326' ' ' ARG . . . . . 0.447 ' C ' ' O ' ' A' ' 325' ' ' VAL . 1.6 ptt-85 -34.37 108.7 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.861 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 327' ' ' ASN . . . . . 0.429 ' CG ' ' N ' ' A' ' 328' ' ' ALA . 8.2 p-10 -107.58 -52.23 2.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.923 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 328' ' ' ALA . . . . . 0.429 ' N ' ' CG ' ' A' ' 327' ' ' ASN . . . -63.42 -63.58 1.14 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.109 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 6.1 m170 -45.43 -47.84 13.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.826 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -104.01 -91.05 2.19 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.502 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 331' ' ' ASN . . . . . 0.4 ' O ' ' C ' ' A' ' 332' ' ' LYS . 5.6 t-20 -166.74 136.25 3.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.843 0.354 . . . . 0.0 110.909 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 332' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' A' ' 331' ' ' ASN . 0.5 OUTLIER -38.17 126.14 1.3 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.882 179.949 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 333' ' ' THR . . . . . 0.432 ' CG2' ' HB ' ' A' ' 325' ' ' VAL . 0.0 OUTLIER -126.34 143.9 51.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.104 179.997 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -62.94 -16.87 57.76 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.521 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 335' ' ' TYR . . . . . 0.607 ' HB3' HG21 ' A' ' 325' ' ' VAL . 3.9 m-85 -69.28 137.28 52.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.881 0.372 . . . . 0.0 110.921 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 73.6 mt -147.4 129.3 6.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.126 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 337' ' ' PHE . . . . . 0.558 ' CE1' ' HG3' ' A' ' 297' ' ' LYS . 61.6 m-85 -104.25 127.52 51.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.893 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 338' ' ' VAL . . . . . 0.591 HG22 HG23 ' A' ' 322' ' ' ILE . 22.5 t -126.07 135.72 63.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.128 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -106.05 161.19 14.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.852 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 340' ' ' PHE . . . . . 0.57 ' CD2' ' HB3' ' A' ' 345' ' ' GLU . 41.6 m-85 -138.06 171.03 15.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.842 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 3.9 m -81.46 -64.35 1.2 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.855 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -95.42 166.04 12.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.863 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 343' ' ' GLU . . . . . 0.401 ' H ' ' CD ' ' A' ' 343' ' ' GLU . 1.0 OUTLIER -76.11 -16.09 59.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.861 -179.956 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -70.99 -50.8 30.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.892 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 345' ' ' GLU . . . . . 0.57 ' HB3' ' CD2' ' A' ' 340' ' ' PHE . 16.5 mm-40 -50.67 -41.03 55.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.904 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 346' ' ' VAL . . . . . 0.669 HG13 HG13 ' A' ' 296' ' ' VAL . 95.0 t -68.1 -53.2 31.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.132 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp -52.31 -44.65 65.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.897 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -64.5 -40.56 95.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.919 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -42.52 -43.06 3.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.15 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 350' ' ' LEU . . . . . . . . . . . . . 21.4 mt -57.42 -36.77 71.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.9 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 1.5 mmmp? -44.73 -50.55 9.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.859 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 352' ' ' CYS . . . . . . . . . . . . . 3.5 m -73.97 80.33 1.68 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.871 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -121.63 149.61 42.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.898 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? 73.18 35.82 0.9 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.907 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 355' ' ' GLU . . . . . 0.431 ' C ' ' CD1' ' A' ' 356' ' ' TYR . 3.1 mm-40 -95.89 173.52 7.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.87 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 356' ' ' TYR . . . . . 0.488 ' CD1' ' N ' ' A' ' 356' ' ' TYR . 1.1 m-85 -134.55 124.22 25.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.93 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 357' ' ' MET . . . . . . . . . . . . . 2.4 ptt? -147.82 139.53 23.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.859 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 78.98 -14.37 14.44 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.455 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 113.25 6.08 22.49 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.461 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 360' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -134.03 168.49 18.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.785 0.326 . . . . 0.0 110.899 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 361' ' ' TYR . . . . . . . . . . . . . 8.4 p90 -84.59 157.31 21.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.878 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 362' ' ' ILE . . . . . 0.437 HG22 ' N ' ' A' ' 363' ' ' GLU . 10.7 mm -133.69 156.93 41.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.122 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 363' ' ' GLU . . . . . 0.458 ' HB3' ' CZ ' ' A' ' 365' ' ' PHE . 7.4 mm-40 -142.95 123.66 14.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.909 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 364' ' ' VAL . . . . . 0.497 ' O ' ' CD1' ' A' ' 365' ' ' PHE . 53.1 t -98.7 141.65 16.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.101 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 365' ' ' PHE . . . . . 0.497 ' CD1' ' O ' ' A' ' 364' ' ' VAL . 28.5 m-85 -144.37 137.04 26.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.854 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 366' ' ' ARG . . . . . 0.474 ' CZ ' ' HB3' ' A' ' 366' ' ' ARG . 9.4 ttp-105 -81.65 119.32 23.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.885 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -82.84 100.37 10.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.865 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 368' ' ' LYS . . . . . 0.413 ' C ' ' HD3' ' A' ' 368' ' ' LYS . 0.0 OUTLIER -63.57 -17.8 63.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.923 179.977 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 78.4 p -111.27 -62.52 1.53 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.851 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 107.06 -158.25 15.19 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.5 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 86.23 0.59 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.68 2.254 . . . . 0.0 112.369 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 372' ' ' SER . . . . . . . . . . . . . 68.8 m -90.73 104.28 16.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.884 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 14.6 m 52.83 39.23 28.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.848 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.364 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.513 -179.987 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.297 0 N-CA-C 112.491 -0.244 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 48.6 m -127.89 111.14 13.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.864 0.364 . . . . 0.0 110.869 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 33.3 m -144.19 130.16 19.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.87 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -88.96 -131.15 3.97 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.49 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 93.7 p -51.49 173.72 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.883 0.373 . . . . 0.0 110.845 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 25.3 m -82.98 -45.9 13.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.834 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 151.41 -125.9 1.97 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.501 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 58.0 m -121.9 83.61 2.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.903 0.383 . . . . 0.0 111.156 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 70.6 p -139.98 146.48 39.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.108 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 293' ' ' CYS . . . . . . . . . . . . . 1.8 t -114.0 175.13 5.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.867 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 294' ' ' HIS . . . . . 0.737 ' CB ' HG21 ' A' ' 346' ' ' VAL . 48.9 m80 -38.81 121.65 1.08 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.895 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 28.1 m -129.28 144.89 51.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.121 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 296' ' ' VAL . . . . . 0.602 ' CG1' HG13 ' A' ' 346' ' ' VAL . 27.8 m -117.19 147.93 20.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.135 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 297' ' ' LYS . . . . . 0.486 ' HG3' ' CE1' ' A' ' 337' ' ' PHE . 9.2 ttmm -116.01 135.58 53.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.901 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 6.4 mp -122.92 126.66 47.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.909 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 299' ' ' ARG . . . . . 0.547 ' NH1' ' CZ ' ' A' ' 335' ' ' TYR . 0.7 OUTLIER -127.01 167.96 15.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.873 179.945 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 76.82 38.32 31.59 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.477 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -104.64 152.31 39.41 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.568 0.699 . . . . 0.0 111.099 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 -172.79 0.62 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.669 2.246 . . . . 0.0 112.312 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -87.21 -31.18 20.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.88 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -87.42 39.98 0.9 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.907 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 305' ' ' VAL . . . . . . . . . . . . . 7.2 p -102.37 136.99 32.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.144 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 306' ' ' THR . . . . . . . . . . . . . 52.8 p -136.73 173.5 11.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.13 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -46.62 -30.8 2.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.881 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -69.18 -59.21 3.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.913 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -44.11 -34.4 1.79 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.909 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 22.0 t -74.6 -46.05 43.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.12 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 311' ' ' MET . . . . . . . . . . . . . 5.5 mmt -53.68 -44.45 69.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.892 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -67.47 -30.69 70.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.903 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 313' ' ' PHE . . . . . 0.624 ' CE2' HG21 ' A' ' 362' ' ' ILE . 2.4 t80 -74.68 -39.05 62.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.919 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 34.5 mt -81.01 -21.6 40.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.913 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 315' ' ' ALA . . . . . 0.865 ' HB1' ' HA ' ' A' ' 316' ' ' PRO . . . -51.93 166.57 0.38 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.561 0.696 . . . . 0.0 111.142 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 316' ' ' PRO . . . . . 0.865 ' HA ' ' HB1' ' A' ' 315' ' ' ALA . 53.9 Cg_endo -69.75 -8.49 10.51 Favored 'Cis proline' 0 C--O 1.232 0.194 0 C-N-CA 122.694 -1.794 . . . . 0.0 112.342 -0.005 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 317' ' ' LEU . . . . . . . . . . . . . 46.0 mt -48.09 165.72 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.943 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 318' ' ' LYS . . . . . 0.401 ' HA ' ' HD2' ' A' ' 319' ' ' PRO . 6.7 tttp -140.31 104.96 6.56 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.59 0.71 . . . . 0.0 110.91 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 319' ' ' PRO . . . . . 0.427 ' HA ' ' CD2' ' A' ' 340' ' ' PHE . 53.1 Cg_endo -69.75 -168.64 0.28 Allowed 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.72 2.28 . . . . 0.0 112.345 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 25.6 t -111.23 -38.07 3.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.127 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -156.06 140.6 16.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.119 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 322' ' ' ILE . . . . . 0.539 HG23 HG22 ' A' ' 338' ' ' VAL . 53.1 mt -118.57 115.26 47.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.128 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -105.56 128.19 53.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.887 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 73.2 mt -94.06 136.89 24.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.089 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 325' ' ' VAL . . . . . 0.458 HG21 ' CE2' ' A' ' 337' ' ' PHE . 43.4 t -98.94 113.69 34.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.109 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 12.5 mtt85 -99.95 131.03 46.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.844 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -44.9 165.68 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.921 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -55.15 -55.76 27.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.085 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 46.1 m80 -57.88 -59.59 5.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.935 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 152.1 43.93 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.518 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -118.56 156.59 28.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.888 0.375 . . . . 0.0 110.868 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 25.5 mttm -82.48 86.79 6.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.877 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 9.3 t -77.53 155.61 31.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.117 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 334' ' ' GLY . . . . . 0.436 ' O ' ' CG ' ' A' ' 335' ' ' TYR . . . -70.36 81.43 0.38 Allowed Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.441 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 335' ' ' TYR . . . . . 0.547 ' CZ ' ' NH1' ' A' ' 299' ' ' ARG . 8.7 m-85 -166.99 124.73 1.28 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.819 0.343 . . . . 0.0 110.959 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 96.9 mt -144.98 144.99 21.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.146 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 337' ' ' PHE . . . . . 0.486 ' CE1' ' HG3' ' A' ' 297' ' ' LYS . 68.7 m-85 -120.51 131.78 54.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.86 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 338' ' ' VAL . . . . . 0.539 HG22 HG23 ' A' ' 322' ' ' ILE . 46.7 t -130.58 140.66 48.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.103 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -110.62 159.22 17.76 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.878 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 340' ' ' PHE . . . . . 0.427 ' CD2' ' HA ' ' A' ' 319' ' ' PRO . 71.3 m-85 -134.72 172.02 13.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.875 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 40.8 t -79.33 -66.36 0.88 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.874 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 342' ' ' ASN . . . . . 0.613 ' H ' ' ND2' ' A' ' 342' ' ' ASN . 0.0 OUTLIER -98.7 176.94 5.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.908 -179.992 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 343' ' ' GLU . . . . . 0.572 ' HB3' ' CE1' ' A' ' 294' ' ' HIS . 3.1 pm0 -84.81 -16.25 42.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.863 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -68.91 -33.36 73.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.86 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 345' ' ' GLU . . . . . 0.424 ' HB3' ' CD2' ' A' ' 340' ' ' PHE . 52.0 mt-10 -68.55 -51.01 47.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.834 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 346' ' ' VAL . . . . . 0.737 HG21 ' CB ' ' A' ' 294' ' ' HIS . 87.1 t -58.63 -52.16 63.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.104 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 33.4 mtpt -46.95 -45.49 20.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.884 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 22.5 mm-40 -67.78 -33.5 74.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.9 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 349' ' ' ALA . . . . . 0.405 ' HB3' ' O ' ' A' ' 346' ' ' VAL . . . -55.19 -36.06 65.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.107 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 350' ' ' LEU . . . . . 0.525 HD11 ' HB2' ' A' ' 366' ' ' ARG . 69.2 mt -64.66 -42.58 95.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.898 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 58.1 mmtt -42.57 -48.55 5.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.858 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 352' ' ' CYS . . . . . . . . . . . . . 16.1 m -70.68 73.95 0.57 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.869 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -110.65 152.9 25.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.923 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 22.0 mtt85 61.78 37.6 15.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.893 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 355' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -92.47 174.17 7.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.865 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 356' ' ' TYR . . . . . 0.454 ' CD1' ' N ' ' A' ' 356' ' ' TYR . 1.4 m-85 -126.58 105.62 8.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.937 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 357' ' ' MET . . . . . 0.403 ' O ' ' CG ' ' A' ' 357' ' ' MET . 0.1 OUTLIER -127.37 118.82 24.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.914 179.923 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 90.09 -36.99 3.42 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.468 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 131.03 29.53 0.61 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.497 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 360' ' ' ARG . . . . . . . . . . . . . 47.0 mtt-85 -152.99 140.42 19.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.782 0.325 . . . . 0.0 110.878 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 361' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -54.1 129.95 36.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.962 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 362' ' ' ILE . . . . . 0.624 HG21 ' CE2' ' A' ' 313' ' ' PHE . 32.4 mm -109.14 146.12 15.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.113 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 363' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -138.26 112.14 8.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.87 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 364' ' ' VAL . . . . . 0.42 HG12 HD23 ' A' ' 350' ' ' LEU . 58.8 t -86.56 136.15 23.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.148 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -131.82 129.73 40.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.909 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 366' ' ' ARG . . . . . 0.525 ' HB2' HD11 ' A' ' 350' ' ' LEU . 18.8 ttt180 -78.46 115.98 18.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.897 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -97.19 104.82 16.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.89 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.3 -43.83 73.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.898 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 3.9 m -70.0 -58.57 3.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.88 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 109.48 -161.87 12.92 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.498 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.76 2.61 3.38 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.74 2.294 . . . . 0.0 112.286 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 372' ' ' SER . . . . . . . . . . . . . 19.8 p -38.38 -39.06 0.41 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.813 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 373' ' ' SER . . . . . 0.421 ' O ' ' C ' ' A' ' 374' ' ' GLY . 63.9 p -100.4 121.01 40.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.869 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 374' ' ' GLY . . . . . 0.421 ' C ' ' O ' ' A' ' 373' ' ' SER . . . . . . . . 0 N--CA 1.451 -0.342 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.493 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.366 0 N-CA-C 112.539 -0.224 . . . . 0.0 112.539 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 16.0 m -105.12 92.23 4.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.852 0.358 . . . . 0.0 110.825 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 23.3 t -122.95 114.49 20.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.835 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -152.54 -96.95 0.14 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.462 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 40.9 t -73.3 132.49 43.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.913 0.387 . . . . 0.0 110.857 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 60.9 p -41.58 -49.52 4.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.86 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 176.77 -43.48 0.1 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.487 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 9.7 t -81.56 128.3 33.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.866 0.365 . . . . 0.0 111.115 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 67.2 p -72.86 135.29 45.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.116 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 293' ' ' CYS . . . . . . . . . . . . . 1.9 t -114.42 150.31 34.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.884 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 294' ' ' HIS . . . . . 0.583 ' HB3' HG21 ' A' ' 346' ' ' VAL . 39.4 m-70 -101.94 95.41 6.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.891 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 38.9 m -137.45 139.35 40.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.18 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 296' ' ' VAL . . . . . 0.505 HG22 ' O ' ' A' ' 338' ' ' VAL . 14.4 m -118.64 153.92 20.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.137 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 297' ' ' LYS . . . . . 0.572 ' HE2' ' CE1' ' A' ' 337' ' ' PHE . 2.1 tppp? -112.38 145.94 39.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.875 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 298' ' ' LEU . . . . . 0.473 HD12 ' C ' ' A' ' 297' ' ' LYS . 6.9 mp -132.78 108.57 9.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.902 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 21.9 ptt180 -119.14 146.9 44.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.909 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 114.29 -9.13 22.58 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.447 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -68.48 151.51 97.18 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.572 0.701 . . . . 0.0 111.095 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.71 173.35 11.06 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.676 2.25 . . . . 0.0 112.317 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 303' ' ' PHE . . . . . 0.437 ' CD1' ' C ' ' A' ' 303' ' ' PHE . 6.1 t80 -74.07 -33.23 63.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.854 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 55.7 m-20 -90.44 48.51 1.56 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.861 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 305' ' ' VAL . . . . . 0.542 HG22 ' N ' ' A' ' 306' ' ' THR . 9.5 p -105.07 164.22 4.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.165 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 306' ' ' THR . . . . . 0.542 ' N ' HG22 ' A' ' 305' ' ' VAL . 0.0 OUTLIER -149.19 171.06 17.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.169 -179.968 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 307' ' ' GLU . . . . . 0.435 ' N ' ' OG1' ' A' ' 306' ' ' THR . 38.6 mt-10 -54.98 -23.38 18.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.914 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 53.6 tttp -70.74 -65.52 0.72 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.926 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -40.14 -37.88 0.68 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.876 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 310' ' ' VAL . . . . . 0.462 HG13 HD22 ' A' ' 298' ' ' LEU . 46.9 t -65.64 -50.47 71.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.144 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 311' ' ' MET . . . . . 0.429 ' O ' ' HB2' ' A' ' 315' ' ' ALA . 3.4 mmt -51.38 -39.24 56.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.875 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -66.53 -39.72 88.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.913 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -70.46 -46.24 64.19 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.836 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.755 ' CD1' HG11 ' A' ' 338' ' ' VAL . 29.9 mt -72.83 -26.16 61.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.956 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 315' ' ' ALA . . . . . 0.726 ' HB1' ' HA ' ' A' ' 316' ' ' PRO . . . -48.49 162.89 0.33 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.616 0.722 . . . . 0.0 111.074 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 316' ' ' PRO . . . . . 0.726 ' HA ' ' HB1' ' A' ' 315' ' ' ALA . 53.9 Cg_endo -69.74 -10.61 11.54 Favored 'Cis proline' 0 C--N 1.342 0.195 0 C-N-CA 122.693 -1.794 . . . . 0.0 112.383 -0.036 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 317' ' ' LEU . . . . . . . . . . . . . 33.9 mt -39.48 157.97 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.963 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 36.6 tttm -135.05 96.77 14.09 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.602 0.715 . . . . 0.0 110.877 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 319' ' ' PRO . . . . . 0.519 ' HA ' ' CD2' ' A' ' 340' ' ' PHE . 54.3 Cg_endo -69.76 -175.67 1.23 Allowed 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.666 2.244 . . . . 0.0 112.355 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 38.8 t -100.1 -43.62 11.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.112 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -155.74 141.07 17.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.083 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 322' ' ' ILE . . . . . 0.471 HG23 HG22 ' A' ' 338' ' ' VAL . 56.8 mt -117.13 100.72 10.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.123 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -100.22 105.06 16.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.89 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 324' ' ' ILE . . . . . 0.697 ' HA ' HG23 ' A' ' 336' ' ' ILE . 83.5 mt -69.69 114.0 6.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.162 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 325' ' ' VAL . . . . . 0.453 HG22 ' CD2' ' A' ' 337' ' ' PHE . 59.8 t -49.56 106.46 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.075 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 75.3 mtm180 -90.03 137.96 31.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.838 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 327' ' ' ASN . . . . . 0.437 ' O ' ' C ' ' A' ' 328' ' ' ALA . 28.2 t30 -73.27 157.54 36.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.883 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 328' ' ' ALA . . . . . 0.437 ' C ' ' O ' ' A' ' 327' ' ' ASN . . . -34.7 -56.65 0.54 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.084 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 9.3 m-70 -69.44 -48.68 60.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.882 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 134.59 74.78 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.49 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 12.1 m-80 -148.33 -178.18 6.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.861 0.362 . . . . 0.0 110.88 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 332' ' ' LYS . . . . . 0.402 ' HG2' HG21 ' A' ' 324' ' ' ILE . 20.1 mttp -118.73 121.1 39.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.906 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 333' ' ' THR . . . . . 0.44 ' O ' ' C ' ' A' ' 334' ' ' GLY . 61.6 p -125.89 74.96 1.46 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.171 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 334' ' ' GLY . . . . . 0.476 ' O ' ' CG ' ' A' ' 335' ' ' TYR . . . 34.7 67.44 0.27 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.462 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 335' ' ' TYR . . . . . 0.476 ' CG ' ' O ' ' A' ' 334' ' ' GLY . 5.8 m-85 -168.45 120.03 0.8 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.838 0.351 . . . . 0.0 110.971 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 336' ' ' ILE . . . . . 0.697 HG23 ' HA ' ' A' ' 324' ' ' ILE . 28.5 mt -144.54 143.27 23.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.109 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 337' ' ' PHE . . . . . 0.572 ' CE1' ' HE2' ' A' ' 297' ' ' LYS . 15.7 m-85 -108.32 120.99 43.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.875 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 338' ' ' VAL . . . . . 0.755 HG11 ' CD1' ' A' ' 314' ' ' LEU . 39.3 t -121.03 124.27 71.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.124 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -103.58 159.12 15.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.851 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 340' ' ' PHE . . . . . 0.519 ' CD2' ' HA ' ' A' ' 319' ' ' PRO . 66.7 m-85 -134.93 160.57 37.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.877 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 17.7 t -83.41 -50.43 8.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.808 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 60.5 m-20 -98.32 159.8 14.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.909 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -74.53 -43.57 55.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.929 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -48.38 -41.37 28.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.863 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 345' ' ' GLU . . . . . 0.439 ' HB3' ' CD2' ' A' ' 340' ' ' PHE . 29.6 mt-10 -56.46 -47.17 79.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.885 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 346' ' ' VAL . . . . . 0.583 HG21 ' HB3' ' A' ' 294' ' ' HIS . 48.8 t -57.64 -56.87 12.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.113 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.59 -38.19 20.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.929 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 17.9 mm100 -72.84 -37.69 67.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.946 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -52.54 -39.52 61.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.115 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 350' ' ' LEU . . . . . 0.422 HD23 HG12 ' A' ' 364' ' ' VAL . 81.4 mt -67.38 -25.13 65.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.958 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 6.5 mmpt? -60.73 -59.7 4.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.895 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 352' ' ' CYS . . . . . . . . . . . . . 69.5 m -65.71 74.05 0.07 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.886 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 55.9 p30 -118.16 168.58 10.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.877 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 19.7 mtt180 61.54 28.96 18.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.908 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 355' ' ' GLU . . . . . 0.42 ' C ' ' CD1' ' A' ' 356' ' ' TYR . 7.0 mm-40 -86.71 174.2 8.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.859 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 356' ' ' TYR . . . . . 0.51 ' CD1' ' N ' ' A' ' 356' ' ' TYR . 0.9 OUTLIER -133.92 99.7 4.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.893 -179.825 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 357' ' ' MET . . . . . . . . . . . . . 5.3 ptt? -126.61 141.93 51.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.936 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 79.22 -43.37 2.48 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.452 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 359' ' ' GLY . . . . . 0.472 ' O ' ' CG ' ' A' ' 360' ' ' ARG . . . 140.92 32.67 0.14 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.481 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 360' ' ' ARG . . . . . 0.472 ' CG ' ' O ' ' A' ' 359' ' ' GLY . 58.1 mtt-85 -164.85 158.15 17.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.802 0.334 . . . . 0.0 110.879 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 361' ' ' TYR . . . . . . . . . . . . . 27.0 p90 -71.83 144.1 49.23 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.908 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 31.2 mm -115.09 142.46 27.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.13 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 363' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -131.15 113.68 14.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.856 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 364' ' ' VAL . . . . . 0.422 HG12 HD23 ' A' ' 350' ' ' LEU . 20.1 t -89.32 134.43 28.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.181 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -131.43 140.82 49.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.886 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 2.1 tmm_? -85.88 124.49 32.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.906 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 367' ' ' GLU . . . . . 0.412 ' OE1' ' CE1' ' A' ' 337' ' ' PHE . 16.3 mt-10 -106.1 134.02 49.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.935 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 24.2 mtpt -91.48 -53.77 4.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.873 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 369' ' ' SER . . . . . 0.41 ' C ' ' HD2' ' A' ' 371' ' ' PRO . 22.9 m -63.38 -52.55 61.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.84 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 118.51 -75.99 0.29 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.465 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 371' ' ' PRO . . . . . 0.41 ' HD2' ' C ' ' A' ' 369' ' ' SER . 53.7 Cg_endo -69.75 142.88 49.18 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.685 2.257 . . . . 0.0 112.368 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 372' ' ' SER . . . . . . . . . . . . . 81.3 p -38.86 154.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.852 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 43.5 m -72.83 159.0 34.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.886 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.474 179.984 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 N-CA-C 112.442 -0.263 . . . . 0.0 112.442 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 3.5 m -99.84 120.63 40.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.854 0.359 . . . . 0.0 110.879 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 78.3 p -136.54 120.41 17.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.878 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -111.15 84.5 0.36 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.459 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 18.2 m -42.07 -55.8 3.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.889 0.376 . . . . 0.0 110.855 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 49.9 m -97.33 -52.51 3.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.875 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 79.54 134.28 1.1 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.502 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 75.0 p -44.14 164.18 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.84 0.352 . . . . 0.0 111.178 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 32.4 m -57.38 98.66 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.142 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 293' ' ' CYS . . . . . . . . . . . . . 25.0 m -123.65 98.58 5.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.844 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 294' ' ' HIS . . . . . 0.837 ' HB3' HG21 ' A' ' 346' ' ' VAL . 79.0 m-70 -109.11 122.51 47.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.856 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 295' ' ' THR . . . . . 0.592 HG23 ' OD1' ' A' ' 339' ' ' ASP . 5.0 m -137.12 136.62 38.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.189 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 296' ' ' VAL . . . . . 0.71 ' CG1' HG13 ' A' ' 346' ' ' VAL . 26.8 m -118.13 146.79 22.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.162 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 297' ' ' LYS . . . . . 0.494 ' HG3' ' CE1' ' A' ' 337' ' ' PHE . 8.3 ttmm -114.2 141.85 47.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.87 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 298' ' ' LEU . . . . . 0.759 HD21 ' CE2' ' A' ' 313' ' ' PHE . 7.4 mp -123.0 149.93 43.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.915 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 64.0 mtt180 -143.91 165.41 27.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.906 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 87.71 -21.25 23.59 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.5 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -58.28 152.09 44.48 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.571 0.701 . . . . 0.0 111.13 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.8 179.25 3.85 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.667 2.244 . . . . 0.0 112.323 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 303' ' ' PHE . . . . . 0.539 ' CD2' ' O ' ' A' ' 332' ' ' LYS . 93.1 m-85 -86.45 -38.09 17.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.864 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -85.4 46.28 1.28 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.929 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 305' ' ' VAL . . . . . . . . . . . . . 12.3 p -103.09 141.39 19.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.14 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 306' ' ' THR . . . . . . . . . . . . . 41.6 p -121.99 169.94 10.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.173 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 41.7 mp0 -50.3 -51.47 44.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.823 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 12.2 tttp -45.02 -45.13 10.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.89 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -61.02 -49.12 78.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.901 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 78.5 t -59.5 -48.58 86.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.14 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 311' ' ' MET . . . . . . . . . . . . . 4.4 mmt -51.08 -42.78 60.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.84 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -69.69 -25.56 63.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.93 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 313' ' ' PHE . . . . . 0.873 ' CZ ' HG21 ' A' ' 362' ' ' ILE . 37.1 t80 -76.26 -45.86 30.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.869 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.682 ' CD1' HG11 ' A' ' 338' ' ' VAL . 89.4 mt -79.24 -20.46 48.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.905 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 315' ' ' ALA . . . . . 0.725 ' HB1' ' HA ' ' A' ' 316' ' ' PRO . . . -49.86 162.62 0.46 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.571 0.7 . . . . 0.0 111.095 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 316' ' ' PRO . . . . . 0.725 ' HA ' ' HB1' ' A' ' 315' ' ' ALA . 53.2 Cg_endo -69.8 -8.51 10.62 Favored 'Cis proline' 0 C--O 1.232 0.198 0 C-N-CA 122.675 -1.802 . . . . 0.0 112.305 0.037 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 317' ' ' LEU . . . . . . . . . . . . . 17.5 mt -46.7 156.69 0.18 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.893 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 318' ' ' LYS . . . . . 0.401 ' HA ' ' HD2' ' A' ' 319' ' ' PRO . 18.0 ttpt -133.44 105.51 12.07 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.604 0.716 . . . . 0.0 110.89 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 319' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 318' ' ' LYS . 53.6 Cg_endo -69.76 -174.65 0.95 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.688 2.259 . . . . 0.0 112.345 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 21.8 t -108.08 -31.64 2.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.126 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -161.27 130.3 4.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.126 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 322' ' ' ILE . . . . . . . . . . . . . 68.2 mt -107.21 106.82 21.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.139 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 32.7 mmt180 -104.75 101.95 11.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.848 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 66.0 mt -74.68 131.99 34.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.136 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 325' ' ' VAL . . . . . 0.541 HG22 ' CE2' ' A' ' 337' ' ' PHE . 46.5 t -72.44 90.54 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.127 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 12.5 ptt-85 -87.25 126.63 34.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.907 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 10.2 m-20 -118.15 169.17 9.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.857 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . 50.89 39.07 21.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.107 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 6.8 m80 61.44 41.83 12.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.902 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 116.03 83.16 1.03 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.451 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -170.68 112.68 0.41 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.924 0.392 . . . . 0.0 110.9 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 332' ' ' LYS . . . . . 0.539 ' O ' ' CD2' ' A' ' 303' ' ' PHE . 0.1 OUTLIER -74.52 98.83 3.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.894 179.935 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 24.2 p -90.74 68.28 6.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.132 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 334' ' ' GLY . . . . . 0.597 ' O ' ' CD1' ' A' ' 335' ' ' TYR . . . 40.21 52.15 3.5 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.469 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 335' ' ' TYR . . . . . 0.597 ' CD1' ' O ' ' A' ' 334' ' ' GLY . 17.2 m-85 -155.88 134.68 11.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.839 0.352 . . . . 0.0 110.93 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 336' ' ' ILE . . . . . 0.43 HG13 ' C ' ' A' ' 335' ' ' TYR . 84.7 mt -149.18 138.11 15.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.145 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 337' ' ' PHE . . . . . 0.541 ' CE2' HG22 ' A' ' 325' ' ' VAL . 30.9 m-85 -110.51 125.28 53.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.863 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 338' ' ' VAL . . . . . 0.682 HG11 ' CD1' ' A' ' 314' ' ' LEU . 24.2 t -125.5 143.02 40.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.12 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 339' ' ' ASP . . . . . 0.592 ' OD1' HG23 ' A' ' 295' ' ' THR . 4.5 m-20 -119.37 156.68 29.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.905 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 340' ' ' PHE . . . . . 0.528 ' CD2' ' HB3' ' A' ' 345' ' ' GLU . 57.0 m-85 -134.88 166.23 23.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.86 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 1.9 m -85.41 -55.41 4.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.86 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -99.6 162.86 12.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.877 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 343' ' ' GLU . . . . . 0.417 ' HB3' ' CE1' ' A' ' 294' ' ' HIS . 1.2 pm0 -81.13 -15.28 56.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.864 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -71.15 -34.13 70.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.884 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 345' ' ' GLU . . . . . 0.528 ' HB3' ' CD2' ' A' ' 340' ' ' PHE . 27.1 mt-10 -68.23 -44.84 74.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.932 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 346' ' ' VAL . . . . . 0.837 HG21 ' HB3' ' A' ' 294' ' ' HIS . 55.4 t -63.66 -47.22 92.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.155 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 32.0 mttm -49.53 -38.89 32.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.914 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 3.7 mm100 -71.88 -46.09 59.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.892 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -49.45 -36.44 22.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.12 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 350' ' ' LEU . . . . . 0.599 HD11 ' HD3' ' A' ' 366' ' ' ARG . 55.5 mt -66.62 -42.77 86.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.938 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 66.6 mttt -58.1 -38.39 76.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.878 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 352' ' ' CYS . . . . . 0.438 ' HB3' ' CD ' ' A' ' 355' ' ' GLU . 72.3 m -76.11 83.9 2.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.873 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -120.71 169.99 9.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.865 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 27.9 mmm180 53.85 39.18 30.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.896 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 355' ' ' GLU . . . . . 0.439 ' OE2' ' CE1' ' A' ' 313' ' ' PHE . 12.3 mt-10 -95.39 174.73 6.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.884 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 356' ' ' TYR . . . . . 0.418 ' CD1' ' N ' ' A' ' 356' ' ' TYR . 1.6 m-85 -122.88 105.38 9.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.928 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 357' ' ' MET . . . . . 0.651 ' HG3' HD11 ' A' ' 362' ' ' ILE . 0.0 OUTLIER -130.31 123.69 30.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.904 179.884 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 85.13 -33.06 3.42 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.471 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 129.72 29.15 0.71 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.481 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 360' ' ' ARG . . . . . . . . . . . . . 36.6 mtt85 -162.32 145.38 11.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.836 0.35 . . . . 0.0 110.83 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 361' ' ' TYR . . . . . 0.636 ' O ' HD13 ' A' ' 362' ' ' ILE . 37.1 p90 -47.01 165.93 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.91 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 362' ' ' ILE . . . . . 0.873 HG21 ' CZ ' ' A' ' 313' ' ' PHE . 42.7 mm -139.93 145.79 25.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.136 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 363' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -134.63 115.71 14.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.842 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 50.6 t -96.61 142.81 13.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.092 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -144.07 126.75 16.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.868 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 366' ' ' ARG . . . . . 0.599 ' HD3' HD11 ' A' ' 350' ' ' LEU . 8.1 ttp-105 -68.82 139.09 55.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.862 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -129.08 166.92 18.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.883 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 19.6 mttp -118.29 82.02 1.77 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.861 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 3.3 t 52.8 52.21 14.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.84 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 92.67 153.16 29.86 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.476 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 88.83 0.53 Allowed 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.645 2.23 . . . . 0.0 112.339 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 372' ' ' SER . . . . . . . . . . . . . 18.2 m 41.93 41.87 2.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.91 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 23.3 t -101.6 148.54 25.1 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.858 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.478 -179.975 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 284' ' ' GLY . . . . . 0.441 ' O ' ' C ' ' A' ' 285' ' ' SER . . . . . . . . 0 N--CA 1.452 -0.296 0 N-CA-C 112.505 -0.238 . . . . 0.0 112.505 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 285' ' ' SER . . . . . 0.441 ' C ' ' O ' ' A' ' 284' ' ' GLY . 53.1 p 35.32 41.38 0.08 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.862 0.363 . . . . 0.0 110.85 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 66.7 m 39.8 50.74 2.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.799 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -93.19 158.33 23.75 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.485 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 16.9 m -96.91 -58.58 1.99 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.875 0.369 . . . . 0.0 110.881 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 7.0 t -52.42 163.57 0.4 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.925 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 144.26 173.38 15.62 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.49 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 9.0 t -100.7 144.27 29.87 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.875 0.369 . . . . 0.0 111.136 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 64.2 p -83.08 101.79 11.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.121 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 293' ' ' CYS . . . . . . . . . . . . . 4.4 m -123.63 150.55 44.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.903 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 294' ' ' HIS . . . . . 0.688 ' HB3' HG21 ' A' ' 346' ' ' VAL . 70.2 m-70 -128.37 107.31 9.65 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.851 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 50.1 m -132.69 151.73 51.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.127 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 296' ' ' VAL . . . . . 0.485 ' CG1' HG13 ' A' ' 346' ' ' VAL . 26.3 m -129.65 157.37 42.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.167 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 4.5 ttpm? -125.89 152.4 45.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.899 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 298' ' ' LEU . . . . . 0.754 HD21 ' CE2' ' A' ' 313' ' ' PHE . 6.8 mp -126.35 131.3 51.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.844 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 34.1 ttp85 -136.44 127.78 28.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.872 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 125.41 -8.68 7.85 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.459 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -69.73 150.14 96.67 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.592 0.71 . . . . 0.0 111.092 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 174.32 9.7 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.669 2.246 . . . . 0.0 112.366 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 303' ' ' PHE . . . . . 0.489 ' CD1' ' C ' ' A' ' 303' ' ' PHE . 2.4 t80 -75.54 -27.07 58.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.876 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 25.6 p30 -92.86 46.38 1.23 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.891 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 305' ' ' VAL . . . . . 0.452 ' CG1' ' HE3' ' A' ' 332' ' ' LYS . 9.8 p -106.93 144.27 16.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.151 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 306' ' ' THR . . . . . . . . . . . . . 61.1 p -132.76 167.52 20.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.182 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -43.89 -52.59 6.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.9 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 36.7 tttt -41.25 -55.91 2.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.899 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -50.91 -48.83 60.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.908 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 310' ' ' VAL . . . . . 0.475 HG21 HG21 ' A' ' 336' ' ' ILE . 61.9 t -57.87 -42.36 82.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.133 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 311' ' ' MET . . . . . 0.468 ' HG2' ' CD1' ' A' ' 322' ' ' ILE . 2.6 mmt -61.17 -52.69 63.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.833 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -65.5 -28.0 68.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.892 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 313' ' ' PHE . . . . . 0.754 ' CE2' HD21 ' A' ' 298' ' ' LEU . 14.9 t80 -71.11 -43.81 66.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.875 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.628 HD11 HG21 ' A' ' 338' ' ' VAL . 61.6 mt -80.86 -26.12 37.16 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.953 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 315' ' ' ALA . . . . . 0.671 ' HB1' ' HA ' ' A' ' 316' ' ' PRO . . . -41.31 161.06 0.13 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.553 0.692 . . . . 0.0 111.108 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 316' ' ' PRO . . . . . 0.671 ' HA ' ' HB1' ' A' ' 315' ' ' ALA . 53.5 Cg_endo -69.86 -9.43 11.21 Favored 'Cis proline' 0 C--O 1.232 0.183 0 C-N-CA 122.657 -1.81 . . . . 0.0 112.348 0.071 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 317' ' ' LEU . . . . . . . . . . . . . 73.0 mt -44.62 149.77 0.38 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.944 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 26.2 tttp -127.54 101.33 24.38 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.596 0.712 . . . . 0.0 110.964 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 319' ' ' PRO . . . . . 0.511 ' HA ' ' CD2' ' A' ' 340' ' ' PHE . 53.2 Cg_endo -69.76 -169.96 0.36 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.718 2.278 . . . . 0.0 112.301 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 320' ' ' VAL . . . . . 0.41 HG23 ' HA ' ' A' ' 340' ' ' PHE . 53.0 t -110.27 -37.18 3.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.137 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -159.18 134.61 8.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.097 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 322' ' ' ILE . . . . . 0.468 ' CD1' ' HG2' ' A' ' 311' ' ' MET . 48.6 mt -110.52 100.52 10.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.106 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -96.03 108.3 20.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.89 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 95.9 mt -74.14 118.43 19.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.132 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 325' ' ' VAL . . . . . 0.485 HG21 ' HB3' ' A' ' 335' ' ' TYR . 25.5 t -62.02 102.05 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.131 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -98.26 152.8 19.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.836 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -94.53 177.27 5.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.924 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -44.94 -69.52 0.13 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.096 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 6.5 m80 -84.78 49.01 1.63 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.895 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 44.97 59.31 4.5 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.488 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -123.34 75.03 1.28 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.886 0.374 . . . . 0.0 110.868 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 332' ' ' LYS . . . . . 0.452 ' HE3' ' CG1' ' A' ' 305' ' ' VAL . 43.7 tttm -51.15 112.98 0.81 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.894 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 333' ' ' THR . . . . . 0.435 ' O ' ' C ' ' A' ' 334' ' ' GLY . 24.0 p -103.53 79.56 1.7 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.144 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 334' ' ' GLY . . . . . 0.529 ' O ' ' CG ' ' A' ' 335' ' ' TYR . . . 34.99 78.52 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.495 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 335' ' ' TYR . . . . . 0.529 ' CG ' ' O ' ' A' ' 334' ' ' GLY . 9.1 m-85 -168.82 117.96 0.7 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.843 0.354 . . . . 0.0 110.927 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 336' ' ' ILE . . . . . 0.475 HG21 HG21 ' A' ' 310' ' ' VAL . 53.4 mt -138.0 124.94 27.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.12 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -99.29 122.3 42.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.864 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 338' ' ' VAL . . . . . 0.628 HG21 HD11 ' A' ' 314' ' ' LEU . 44.1 t -119.7 134.34 63.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.102 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -109.88 164.74 12.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.859 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 340' ' ' PHE . . . . . 0.511 ' CD2' ' HA ' ' A' ' 319' ' ' PRO . 76.1 m-85 -143.37 170.95 14.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.854 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 3.0 p -96.32 -45.99 6.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.872 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -92.43 163.55 13.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.879 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 -87.62 -33.93 18.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.909 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -63.98 -41.05 97.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.901 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -56.34 -49.26 74.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.917 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 346' ' ' VAL . . . . . 0.688 HG21 ' HB3' ' A' ' 294' ' ' HIS . 71.9 t -58.77 -41.74 83.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.1 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 9.9 mtpm? -58.11 -43.25 87.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.892 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -65.53 -37.71 87.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.907 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 349' ' ' ALA . . . . . 0.567 ' O ' HG11 ' A' ' 364' ' ' VAL . . . -54.46 -17.17 2.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.141 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 350' ' ' LEU . . . . . 0.428 HD23 HG12 ' A' ' 364' ' ' VAL . 32.1 mt -92.33 -23.21 19.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.921 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.96 -7.81 9.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.866 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 352' ' ' CYS . . . . . . . . . . . . . 75.7 m -112.24 98.34 7.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.854 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 353' ' ' ASN . . . . . 0.487 ' O ' ' C ' ' A' ' 354' ' ' ARG . 6.9 p-10 -118.54 -179.64 3.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.907 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 354' ' ' ARG . . . . . 0.487 ' C ' ' O ' ' A' ' 353' ' ' ASN . 0.0 OUTLIER 31.44 38.25 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.843 179.969 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 355' ' ' GLU . . . . . 0.486 ' N ' ' O ' ' A' ' 353' ' ' ASN . 3.9 mm-40 -81.2 174.67 11.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.877 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 356' ' ' TYR . . . . . 0.494 ' CD1' ' N ' ' A' ' 356' ' ' TYR . 1.0 OUTLIER -134.05 110.28 9.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.929 -179.912 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 357' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.02 124.98 22.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.891 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 87.53 -37.28 3.24 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.515 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 133.92 29.78 0.45 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.495 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 360' ' ' ARG . . . . . . . . . . . . . 55.5 mtt180 -159.63 145.56 15.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.829 0.347 . . . . 0.0 110.884 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 361' ' ' TYR . . . . . 0.499 ' O ' HD13 ' A' ' 362' ' ' ILE . 48.6 p90 -50.56 159.65 0.49 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.906 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 362' ' ' ILE . . . . . 0.499 HD13 ' O ' ' A' ' 361' ' ' TYR . 4.6 mm -143.35 129.15 16.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.137 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 363' ' ' GLU . . . . . 0.494 ' HB3' ' CZ ' ' A' ' 365' ' ' PHE . 6.5 mm-40 -119.3 112.21 19.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.895 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 364' ' ' VAL . . . . . 0.567 HG11 ' O ' ' A' ' 349' ' ' ALA . 38.4 t -88.03 131.83 34.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.104 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 365' ' ' PHE . . . . . 0.494 ' CZ ' ' HB3' ' A' ' 363' ' ' GLU . 25.7 m-85 -130.25 150.99 51.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.848 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 28.5 ttt180 -95.57 122.33 38.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.836 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -101.75 156.95 17.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.919 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.6 95.59 5.22 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.911 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 18.3 t 56.59 41.41 28.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.934 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 44.53 74.72 0.2 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.529 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 108.17 2.01 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.695 2.264 . . . . 0.0 112.354 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 372' ' ' SER . . . . . . . . . . . . . 1.5 t -114.49 -45.47 3.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.866 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 25.7 m -118.84 118.66 32.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.903 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.492 -179.957 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 N-CA-C 112.53 -0.228 . . . . 0.0 112.53 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 30.8 m -157.62 139.87 14.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.861 0.363 . . . . 0.0 110.888 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 97.6 p -88.51 42.11 1.05 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.87 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 164.91 54.9 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.457 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 5.1 t -84.33 -48.11 10.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.844 0.354 . . . . 0.0 110.854 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 11.0 t -90.36 86.12 6.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.844 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . -163.49 -58.21 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.519 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 70.8 p -104.41 109.98 22.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.877 0.37 . . . . 0.0 111.125 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 38.3 p -122.05 40.21 3.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.173 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 293' ' ' CYS . . . . . . . . . . . . . 20.0 p -60.27 165.43 3.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.839 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 294' ' ' HIS . . . . . 0.726 ' HB2' HG21 ' A' ' 346' ' ' VAL . 13.9 m-70 -118.76 133.78 55.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.89 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 295' ' ' THR . . . . . 0.443 HG23 ' OD1' ' A' ' 339' ' ' ASP . 32.3 m -138.89 116.37 11.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.129 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 296' ' ' VAL . . . . . 0.658 ' CG1' HG13 ' A' ' 346' ' ' VAL . 29.6 m -98.13 160.67 3.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.138 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 297' ' ' LYS . . . . . 0.578 ' HD3' ' CE1' ' A' ' 337' ' ' PHE . 31.3 ttpt -139.34 150.14 45.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.892 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 298' ' ' LEU . . . . . 0.475 HD21 ' CE1' ' A' ' 313' ' ' PHE . 6.8 mp -124.71 135.51 53.09 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.931 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 18.0 ttt-85 -133.56 138.42 46.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.9 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 110.23 10.57 21.93 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.511 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -75.96 143.65 74.6 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.57 0.7 . . . . 0.0 111.09 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 -170.08 0.37 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.667 2.245 . . . . 0.0 112.339 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -90.67 -10.56 42.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.84 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -101.42 25.98 7.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.895 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 305' ' ' VAL . . . . . 0.408 ' CG1' ' HE3' ' A' ' 332' ' ' LYS . 9.2 p -94.66 140.23 17.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.103 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 306' ' ' THR . . . . . 0.401 ' O ' ' N ' ' A' ' 308' ' ' LYS . 21.3 p -137.03 160.69 38.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.132 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -38.1 -32.61 0.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.877 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 308' ' ' LYS . . . . . 0.444 ' O ' ' N ' ' A' ' 311' ' ' MET . 23.6 ttmt -63.38 -67.7 0.4 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.921 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 309' ' ' ASN . . . . . 0.41 ' C ' ' O ' ' A' ' 308' ' ' LYS . 9.4 m-80 -37.65 -45.66 0.8 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.92 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 61.7 t -57.82 -43.55 84.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.116 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 311' ' ' MET . . . . . 0.444 ' N ' ' O ' ' A' ' 308' ' ' LYS . 4.7 mmt -59.73 -50.67 72.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.893 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 15.2 mp0 -62.31 -36.38 81.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.906 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 313' ' ' PHE . . . . . 0.475 ' CE1' HD21 ' A' ' 298' ' ' LEU . 3.5 t80 -65.09 -44.63 88.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.873 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.585 ' CD1' HG11 ' A' ' 338' ' ' VAL . 54.6 mt -78.43 -21.07 49.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.905 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 315' ' ' ALA . . . . . 0.871 ' HB1' ' HA ' ' A' ' 316' ' ' PRO . . . -51.58 166.84 0.34 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.573 0.702 . . . . 0.0 111.143 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 316' ' ' PRO . . . . . 0.871 ' HA ' ' HB1' ' A' ' 315' ' ' ALA . 54.1 Cg_endo -69.73 -4.58 8.33 Favored 'Cis proline' 0 C--O 1.232 0.202 0 C-N-CA 122.66 -1.809 . . . . 0.0 112.348 -0.028 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 317' ' ' LEU . . . . . 0.468 ' N ' ' HA ' ' A' ' 315' ' ' ALA . 21.1 mt -54.1 161.1 1.35 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.885 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 46.2 tttt -134.46 107.19 11.01 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.586 0.708 . . . . 0.0 110.925 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 319' ' ' PRO . . . . . 0.476 ' HA ' ' CD2' ' A' ' 340' ' ' PHE . 53.7 Cg_endo -69.79 -175.76 1.27 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.713 2.275 . . . . 0.0 112.358 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 320' ' ' VAL . . . . . 0.459 HG23 ' C ' ' A' ' 340' ' ' PHE . 42.3 t -102.4 -35.74 4.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.107 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -164.14 138.12 5.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.092 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 322' ' ' ILE . . . . . 0.48 HG23 HG22 ' A' ' 338' ' ' VAL . 80.5 mt -112.22 111.51 36.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.121 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 87.0 mtt180 -110.01 103.33 12.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.849 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 94.4 mt -64.26 118.24 6.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.141 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 325' ' ' VAL . . . . . 0.915 HG22 ' CD2' ' A' ' 337' ' ' PHE . 27.1 t -57.67 92.23 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.157 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 18.1 ptt-85 -99.94 113.18 25.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.854 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -51.36 -70.43 0.09 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.907 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -158.72 153.11 24.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.079 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 24.7 m170 43.68 29.24 0.27 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.852 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 73.17 74.42 0.8 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.44 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -129.75 84.62 2.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.88 0.371 . . . . 0.0 110.85 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 332' ' ' LYS . . . . . 0.408 ' HE3' ' CG1' ' A' ' 305' ' ' VAL . 9.7 mtpm? -57.04 114.82 2.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.882 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 333' ' ' THR . . . . . 0.422 ' O ' ' C ' ' A' ' 334' ' ' GLY . 34.7 p -113.71 69.28 0.7 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.108 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 334' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 333' ' ' THR . . . 36.37 61.55 0.83 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.462 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 335' ' ' TYR . . . . . 0.555 ' HB3' HG21 ' A' ' 325' ' ' VAL . 10.6 m-85 -162.3 131.15 4.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.854 0.359 . . . . 0.0 110.915 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 58.7 mt -141.54 113.79 3.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.158 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 337' ' ' PHE . . . . . 0.915 ' CD2' HG22 ' A' ' 325' ' ' VAL . 18.0 m-85 -87.88 129.85 35.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.893 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 338' ' ' VAL . . . . . 0.585 HG11 ' CD1' ' A' ' 314' ' ' LEU . 22.0 t -134.33 135.34 54.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.174 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 339' ' ' ASP . . . . . 0.443 ' OD1' HG23 ' A' ' 295' ' ' THR . 7.0 m-20 -111.75 162.68 14.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.877 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 340' ' ' PHE . . . . . 0.562 ' HB2' HG23 ' A' ' 346' ' ' VAL . 60.3 m-85 -136.64 172.3 13.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.882 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 29.3 t -79.42 -67.6 0.74 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.878 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -100.05 173.25 6.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.876 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 343' ' ' GLU . . . . . 0.551 ' HB2' ' CE1' ' A' ' 294' ' ' HIS . 11.0 pt-20 -75.19 -40.36 59.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.923 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 344' ' ' GLU . . . . . 0.413 ' N ' ' HG3' ' A' ' 343' ' ' GLU . 34.5 tt0 -44.23 -50.75 8.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.913 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -53.96 -61.81 2.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.897 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 346' ' ' VAL . . . . . 0.726 HG21 ' HB2' ' A' ' 294' ' ' HIS . 60.5 t -50.21 -47.04 25.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.086 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 45.2 mtpt -50.95 -39.3 54.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.946 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -79.44 -29.11 41.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.903 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -57.54 -27.05 62.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.074 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 350' ' ' LEU . . . . . 0.56 HD23 HG12 ' A' ' 364' ' ' VAL . 92.6 mt -77.21 -34.99 56.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.912 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 18.3 mmtp -46.33 -43.35 15.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.886 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 352' ' ' CYS . . . . . . . . . . . . . 8.3 m -62.05 85.04 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.897 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 353' ' ' ASN . . . . . 0.483 ' O ' ' C ' ' A' ' 354' ' ' ARG . 33.7 p-10 -122.9 -176.9 3.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.873 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 354' ' ' ARG . . . . . 0.483 ' C ' ' O ' ' A' ' 353' ' ' ASN . 2.9 ppt_? 30.59 44.59 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.894 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 355' ' ' GLU . . . . . 0.446 ' C ' ' OE1' ' A' ' 355' ' ' GLU . 0.0 OUTLIER -118.1 173.1 6.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.891 -179.906 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 356' ' ' TYR . . . . . 0.476 ' CD1' ' N ' ' A' ' 356' ' ' TYR . 1.3 m-85 -128.47 149.29 50.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.902 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 357' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -166.66 125.79 1.48 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.868 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 87.74 -15.2 56.12 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.476 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 105.15 19.77 10.39 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.483 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 360' ' ' ARG . . . . . . . . . . . . . 10.5 mmt180 -146.03 158.86 43.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.828 0.347 . . . . 0.0 110.875 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 361' ' ' TYR . . . . . . . . . . . . . 9.1 p90 -66.22 151.51 46.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.905 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 362' ' ' ILE . . . . . 0.462 HG22 ' N ' ' A' ' 363' ' ' GLU . 15.7 mm -135.3 155.27 37.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.145 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 363' ' ' GLU . . . . . 0.462 ' N ' HG22 ' A' ' 362' ' ' ILE . 49.5 mm-40 -147.57 114.82 6.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.842 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 364' ' ' VAL . . . . . 0.56 HG12 HD23 ' A' ' 350' ' ' LEU . 58.4 t -88.22 140.12 16.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.114 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -137.37 154.79 49.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.831 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 3.0 tmm_? -101.87 109.05 20.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.849 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -93.28 130.62 38.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.892 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 10.7 ptpp? -81.67 128.56 34.09 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.911 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 77.9 p 38.28 40.43 0.34 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.841 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 61.92 -171.85 9.19 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.496 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.83 177.5 5.57 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.674 2.249 . . . . 0.0 112.343 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 372' ' ' SER . . . . . . . . . . . . . 74.9 m -140.4 148.01 40.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.844 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 33.1 p -108.51 108.12 18.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.912 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.285 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.437 -179.985 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 N-CA-C 112.479 -0.249 . . . . 0.0 112.479 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 2.7 m -171.91 176.91 3.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.847 0.356 . . . . 0.0 110.882 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 63.3 p -141.36 110.08 6.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.912 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -78.69 -139.43 1.59 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.508 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 34.9 p -90.0 43.45 1.15 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.833 0.349 . . . . 0.0 110.841 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 85.1 p -39.8 133.83 1.5 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.854 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 290' ' ' GLY . . . . . 0.438 ' O ' ' C ' ' A' ' 291' ' ' THR . . . 50.05 -117.23 4.62 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.487 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 291' ' ' THR . . . . . 0.438 ' C ' ' O ' ' A' ' 290' ' ' GLY . 77.2 p 35.06 45.02 0.15 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.885 0.374 . . . . 0.0 111.124 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 9.7 t -132.05 172.61 12.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.102 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 293' ' ' CYS . . . . . . . . . . . . . 21.6 m 41.77 47.16 3.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.861 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 294' ' ' HIS . . . . . 0.573 ' CE1' ' HB3' ' A' ' 343' ' ' GLU . 75.1 m80 -47.28 122.45 4.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.83 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 69.0 m -135.45 149.81 49.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.13 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 296' ' ' VAL . . . . . 0.511 HG13 HG13 ' A' ' 346' ' ' VAL . 30.8 m -125.74 156.73 35.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.115 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 297' ' ' LYS . . . . . 0.579 ' HD3' ' CE1' ' A' ' 337' ' ' PHE . 13.4 ttpt -130.35 143.67 50.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.877 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 6.8 mp -118.23 151.86 36.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.9 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 299' ' ' ARG . . . . . 0.513 ' HB2' ' CE1' ' A' ' 335' ' ' TYR . 8.8 ttm-85 -146.42 136.37 23.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.901 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 98.9 48.13 1.81 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.454 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -114.61 148.36 40.14 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.601 0.715 . . . . 0.0 111.05 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 153.3 69.16 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.681 2.254 . . . . 0.0 112.306 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -58.49 -30.47 67.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.905 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -85.0 34.41 0.55 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.847 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 305' ' ' VAL . . . . . 0.479 HG12 ' HB3' ' A' ' 332' ' ' LYS . 9.0 p -96.02 139.64 18.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.126 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 306' ' ' THR . . . . . 0.45 ' O ' ' C ' ' A' ' 307' ' ' GLU . 70.7 p -136.2 155.51 50.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.171 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 307' ' ' GLU . . . . . 0.45 ' C ' ' O ' ' A' ' 306' ' ' THR . 30.2 mt-10 -34.46 -38.48 0.07 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.884 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 29.7 ttmt -57.43 -55.52 33.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.916 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -49.79 -46.7 51.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.906 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 85.0 t -61.55 -40.79 87.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.155 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 311' ' ' MET . . . . . 0.404 ' O ' ' HB2' ' A' ' 315' ' ' ALA . 4.1 mmt -58.71 -40.75 84.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.896 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -68.94 -31.55 70.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.909 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 313' ' ' PHE . . . . . 0.72 ' CE2' HG21 ' A' ' 362' ' ' ILE . 1.9 t80 -74.13 -48.93 26.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.919 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.91 ' CD1' HG11 ' A' ' 338' ' ' VAL . 27.8 mt -72.45 -24.95 61.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.944 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 315' ' ' ALA . . . . . 0.791 ' HB1' ' HA ' ' A' ' 316' ' ' PRO . . . -49.73 164.52 0.34 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.577 0.703 . . . . 0.0 111.127 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 316' ' ' PRO . . . . . 0.791 ' HA ' ' HB1' ' A' ' 315' ' ' ALA . 54.0 Cg_endo -69.79 -7.43 10.02 Favored 'Cis proline' 0 C--O 1.232 0.188 0 C-N-CA 122.701 -1.791 . . . . 0.0 112.358 0.067 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 317' ' ' LEU . . . . . 0.642 HD13 ' O ' ' A' ' 345' ' ' GLU . 33.0 mt -57.57 134.29 56.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.926 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.88 111.7 56.32 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.56 0.695 . . . . 0.0 110.906 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -176.62 1.54 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.707 2.271 . . . . 0.0 112.327 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 320' ' ' VAL . . . . . 0.417 HG23 ' C ' ' A' ' 340' ' ' PHE . 93.0 t -100.52 -40.27 7.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.092 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -160.56 131.67 5.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.095 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 322' ' ' ILE . . . . . . . . . . . . . 86.5 mt -102.11 119.96 51.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.122 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 61.5 mtm180 -115.54 98.69 6.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.884 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 324' ' ' ILE . . . . . 0.708 HG23 HG12 ' A' ' 336' ' ' ILE . 41.8 mt -74.72 125.0 33.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.108 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 325' ' ' VAL . . . . . 0.524 HG22 ' CE2' ' A' ' 337' ' ' PHE . 88.0 t -58.14 112.98 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.126 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 19.4 mmt85 -87.31 119.56 27.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.893 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -75.3 -55.62 5.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.922 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -118.26 -68.95 0.88 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.083 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 21.3 m80 -121.51 -67.37 0.97 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.858 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -148.77 31.64 1.22 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.464 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -79.46 115.71 19.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.894 0.378 . . . . 0.0 110.889 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 332' ' ' LYS . . . . . 0.479 ' HB3' HG12 ' A' ' 305' ' ' VAL . 8.0 mptt -75.05 95.16 2.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.898 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 8.9 t -173.11 148.09 1.66 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.131 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 109.17 -87.85 0.5 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.513 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 335' ' ' TYR . . . . . 0.513 ' CE1' ' HB2' ' A' ' 299' ' ' ARG . 18.2 m-85 -143.59 160.57 40.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.842 0.354 . . . . 0.0 110.937 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 336' ' ' ILE . . . . . 0.708 HG12 HG23 ' A' ' 324' ' ' ILE . 85.5 mt -138.91 113.75 8.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.171 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 337' ' ' PHE . . . . . 0.579 ' CE1' ' HD3' ' A' ' 297' ' ' LYS . 77.0 m-85 -84.95 135.87 33.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.91 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 338' ' ' VAL . . . . . 0.91 HG11 ' CD1' ' A' ' 314' ' ' LEU . 58.0 t -137.64 120.15 19.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.15 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -97.38 158.06 15.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.838 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 340' ' ' PHE . . . . . 0.517 ' CZ ' HD13 ' A' ' 314' ' ' LEU . 41.8 m-85 -133.18 172.19 13.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.874 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 48.5 t -83.23 -63.08 1.43 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.872 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -96.02 159.8 14.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.891 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 343' ' ' GLU . . . . . 0.573 ' HB3' ' CE1' ' A' ' 294' ' ' HIS . 10.7 pt-20 -68.64 -47.25 67.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.875 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -45.87 -55.34 6.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.931 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 345' ' ' GLU . . . . . 0.642 ' O ' HD13 ' A' ' 317' ' ' LEU . 35.6 mt-10 -41.92 -44.83 3.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.879 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 346' ' ' VAL . . . . . 0.511 HG13 HG13 ' A' ' 296' ' ' VAL . 83.8 t -69.86 -48.57 63.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.159 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 18.8 mtpp -46.07 -42.47 13.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.921 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 348' ' ' GLN . . . . . 0.401 ' O ' ' N ' ' A' ' 351' ' ' LYS . 15.7 mm100 -70.44 -41.43 72.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.873 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -40.49 -43.47 1.85 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.048 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 350' ' ' LEU . . . . . 0.566 HD21 ' HB2' ' A' ' 366' ' ' ARG . 22.6 mt -64.08 -40.72 96.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.913 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 351' ' ' LYS . . . . . 0.401 ' N ' ' O ' ' A' ' 348' ' ' GLN . 15.6 mmtp -54.38 -25.55 25.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.881 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 352' ' ' CYS . . . . . . . . . . . . . 85.6 m -95.93 52.17 1.3 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.864 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 353' ' ' ASN . . . . . 0.408 ' CG ' ' N ' ' A' ' 354' ' ' ARG . 8.4 t-20 -100.38 164.05 12.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.907 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 354' ' ' ARG . . . . . 0.408 ' N ' ' CG ' ' A' ' 353' ' ' ASN . 11.2 ttm180 68.99 33.33 3.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.886 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 355' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -102.57 174.01 6.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.909 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 356' ' ' TYR . . . . . 0.462 ' CD1' ' N ' ' A' ' 356' ' ' TYR . 1.3 m-85 -124.62 135.3 52.98 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.952 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 357' ' ' MET . . . . . 0.637 ' HG3' HD11 ' A' ' 362' ' ' ILE . 0.0 OUTLIER -148.59 123.33 9.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.867 179.98 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 82.87 -13.59 42.44 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.478 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 110.56 5.22 28.02 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.487 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 360' ' ' ARG . . . . . 0.426 ' HB3' ' NH1' ' A' ' 360' ' ' ARG . 5.1 mmm180 -123.8 130.67 52.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.836 0.35 . . . . 0.0 110.886 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 361' ' ' TYR . . . . . . . . . . . . . 20.4 p90 -49.38 128.5 17.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.915 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 362' ' ' ILE . . . . . 0.72 HG21 ' CE2' ' A' ' 313' ' ' PHE . 37.1 mm -106.51 144.96 14.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.136 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 363' ' ' GLU . . . . . . . . . . . . . 56.0 mm-40 -139.67 112.29 7.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.841 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 364' ' ' VAL . . . . . 0.436 ' O ' ' CD1' ' A' ' 365' ' ' PHE . 15.0 t -85.25 149.57 4.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.117 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 365' ' ' PHE . . . . . 0.436 ' CD1' ' O ' ' A' ' 364' ' ' VAL . 43.0 m-85 -148.64 121.62 8.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.886 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 366' ' ' ARG . . . . . 0.566 ' HB2' HD21 ' A' ' 350' ' ' LEU . 1.3 tmm_? -69.17 127.78 34.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.888 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -103.46 150.92 23.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.9 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 368' ' ' LYS . . . . . 0.405 ' O ' ' C ' ' A' ' 369' ' ' SER . 0.0 OUTLIER -91.88 67.49 5.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.876 179.954 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 369' ' ' SER . . . . . 0.405 ' C ' ' O ' ' A' ' 368' ' ' LYS . 80.8 p 36.79 54.5 1.15 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.814 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . -171.4 158.49 29.71 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.472 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 0.74 5.22 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.657 2.238 . . . . 0.0 112.34 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 372' ' ' SER . . . . . . . . . . . . . 1.7 t 74.34 54.03 0.09 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.869 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 26.8 t -101.51 170.21 8.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.876 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.466 179.983 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.35 0 N-CA-C 112.509 -0.237 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 88.8 p -111.93 145.66 39.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.879 0.371 . . . . 0.0 110.884 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 23.2 t -50.43 -48.8 56.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.816 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 92.21 -98.82 2.47 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.512 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 71.7 m -63.32 90.09 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.877 0.37 . . . . 0.0 110.874 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 80.2 p -63.85 -49.36 73.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.912 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 109.96 -82.42 0.3 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.501 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 291' ' ' THR . . . . . 0.496 ' CG2' ' O ' ' A' ' 369' ' ' SER . 12.2 t -78.32 127.53 32.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.891 0.377 . . . . 0.0 111.158 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 21.7 m -90.7 96.86 10.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.141 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 293' ' ' CYS . . . . . . . . . . . . . 29.3 p -145.9 167.16 23.95 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.878 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 294' ' ' HIS . . . . . 0.9 ' CB ' HG21 ' A' ' 346' ' ' VAL . 1.0 OUTLIER -126.93 105.1 8.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.884 -179.966 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 36.6 m -132.06 142.42 49.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.171 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 31.6 m -115.68 150.05 17.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.127 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 297' ' ' LYS . . . . . 0.58 ' C ' HD12 ' A' ' 298' ' ' LEU . 17.0 ttpt -120.59 138.11 54.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.875 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 298' ' ' LEU . . . . . 0.58 HD12 ' C ' ' A' ' 297' ' ' LYS . 6.1 mp -120.23 141.38 49.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.897 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 20.3 ptt180 -149.82 145.94 26.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.931 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 107.18 14.22 19.19 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.512 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -83.85 151.59 61.24 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.607 0.718 . . . . 0.0 111.088 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -165.97 0.17 Allowed 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.724 2.283 . . . . 0.0 112.365 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -90.35 -17.79 26.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.849 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -93.3 14.58 17.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.892 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 305' ' ' VAL . . . . . . . . . . . . . 11.8 p -78.84 138.55 19.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.108 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 306' ' ' THR . . . . . . . . . . . . . 39.0 p -145.35 177.45 8.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.128 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -49.42 -31.61 10.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.897 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 20.1 ttpt -67.78 -60.98 2.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.914 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -46.57 -38.62 9.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.866 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 53.6 t -69.47 -46.76 75.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.172 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 311' ' ' MET . . . . . 0.427 ' HG2' HD11 ' A' ' 322' ' ' ILE . 2.8 mmt -56.66 -49.65 74.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.908 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -66.52 -24.72 66.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.882 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -74.57 -38.75 62.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.91 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.474 ' CD1' HG11 ' A' ' 338' ' ' VAL . 27.1 mt -88.12 -24.37 23.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.882 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 315' ' ' ALA . . . . . 0.695 ' HB1' ' HA ' ' A' ' 316' ' ' PRO . . . -48.4 161.95 0.37 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.561 0.696 . . . . 0.0 111.15 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 316' ' ' PRO . . . . . 0.695 ' HA ' ' HB1' ' A' ' 315' ' ' ALA . 53.0 Cg_endo -69.83 -2.45 7.25 Favored 'Cis proline' 0 C--N 1.342 0.198 0 C-N-CA 122.621 -1.825 . . . . 0.0 112.299 0.054 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 317' ' ' LEU . . . . . 0.487 ' N ' ' HA ' ' A' ' 315' ' ' ALA . 24.7 mt -55.62 124.59 17.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.864 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -102.65 105.29 43.62 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.517 0.675 . . . . 0.0 110.895 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 -175.54 1.18 Allowed 'Trans proline' 0 N--CA 1.465 -0.155 0 C-N-CA 122.728 2.285 . . . . 0.0 112.36 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 97.7 t -100.03 -43.45 11.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.147 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -156.88 139.67 15.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.14 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 322' ' ' ILE . . . . . 0.427 HD11 ' HG2' ' A' ' 311' ' ' MET . 90.6 mt -108.39 108.49 25.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.084 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -103.12 98.08 8.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.878 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 71.9 mt -70.38 118.22 14.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.105 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 325' ' ' VAL . . . . . 0.504 ' CG2' ' CD2' ' A' ' 337' ' ' PHE . 35.2 t -81.8 120.09 32.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.125 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 87.9 mtt180 -99.39 37.95 1.49 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.853 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 327' ' ' ASN . . . . . 0.467 ' H ' HG12 ' A' ' 325' ' ' VAL . 49.3 t30 47.19 50.66 14.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.923 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . 43.67 37.69 1.66 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.085 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 14.3 m80 -159.79 174.66 14.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.881 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -80.81 53.12 4.54 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.522 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -144.05 111.84 6.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.87 0.367 . . . . 0.0 110.903 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -68.15 103.88 1.66 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.915 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 333' ' ' THR . . . . . 0.418 ' OG1' ' N ' ' A' ' 334' ' ' GLY . 2.8 t -103.99 175.97 5.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.174 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 334' ' ' GLY . . . . . 0.418 ' N ' ' OG1' ' A' ' 333' ' ' THR . . . -58.02 -39.54 92.11 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.502 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 335' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -44.7 118.5 1.61 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.895 0.379 . . . . 0.0 110.932 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 73.7 mt -143.72 124.44 9.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.126 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 337' ' ' PHE . . . . . 0.504 ' CD2' ' CG2' ' A' ' 325' ' ' VAL . 25.9 m-85 -100.24 126.82 46.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.907 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 338' ' ' VAL . . . . . 0.474 HG11 ' CD1' ' A' ' 314' ' ' LEU . 31.2 t -126.83 132.79 69.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.147 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -106.2 162.14 13.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.853 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -136.62 161.0 37.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.86 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 46.0 m -76.83 -61.02 2.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.825 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -92.3 157.98 16.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.872 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -70.22 -41.8 73.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.852 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 344' ' ' GLU . . . . . 0.41 ' O ' ' C ' ' A' ' 345' ' ' GLU . 36.3 mm-40 -47.07 -61.01 2.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.917 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 345' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 344' ' ' GLU . 30.2 mt-10 -37.47 -44.44 0.65 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.878 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 346' ' ' VAL . . . . . 0.9 HG21 ' CB ' ' A' ' 294' ' ' HIS . 39.6 t -58.81 -54.11 38.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.133 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -49.78 -37.08 28.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.914 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -71.65 -46.23 59.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.902 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -46.1 -34.72 4.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.071 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 350' ' ' LEU . . . . . . . . . . . . . 65.5 mt -71.36 -41.01 70.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.935 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 27.5 mmtp -40.25 -52.41 2.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.879 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 352' ' ' CYS . . . . . . . . . . . . . 89.7 m -74.27 80.23 1.83 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.903 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 12.3 t30 -107.83 171.25 7.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.87 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 10.6 ptm180 41.99 50.43 4.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.907 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 355' ' ' GLU . . . . . 0.506 ' C ' ' CD1' ' A' ' 356' ' ' TYR . 9.8 mm-40 -98.08 174.38 6.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.916 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 356' ' ' TYR . . . . . 0.506 ' CD1' ' C ' ' A' ' 355' ' ' GLU . 1.0 OUTLIER -137.96 117.91 13.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.922 -179.862 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 357' ' ' MET . . . . . . . . . . . . . 4.4 ptt? -143.71 139.61 29.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.89 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 82.02 -33.76 2.63 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.5 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 129.14 15.89 2.01 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.499 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 360' ' ' ARG . . . . . . . . . . . . . 15.7 mmm180 -142.67 148.98 38.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.78 0.324 . . . . 0.0 110.889 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 361' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -61.0 152.7 27.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.961 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 8.5 mm -135.55 145.26 31.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.17 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 363' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -135.7 119.18 16.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.893 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 4.1 t -91.68 128.57 43.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.106 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -125.9 139.38 53.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.861 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 15.9 ttt-85 -88.17 114.02 24.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.835 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 64.4 mm-40 -82.52 121.58 26.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.872 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 13.9 pttm -95.03 -41.6 9.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.874 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 369' ' ' SER . . . . . 0.496 ' O ' ' CG2' ' A' ' 291' ' ' THR . 45.6 t -51.58 -49.41 62.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.871 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 104.18 -164.97 14.96 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.477 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 176.82 6.26 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.717 2.278 . . . . 0.0 112.375 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 372' ' ' SER . . . . . . . . . . . . . 1.4 t -134.45 85.55 2.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.848 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 40.0 m -110.54 133.96 52.82 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.86 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.521 179.997 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.274 0 N-CA-C 112.482 -0.247 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 63.6 m -51.4 149.7 4.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.87 0.367 . . . . 0.0 110.895 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 11.3 t -114.07 -45.55 3.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.848 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 106.76 98.55 2.57 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.508 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 27.6 t -119.59 105.56 11.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.874 0.368 . . . . 0.0 110.859 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 67.3 m -129.69 116.69 19.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.854 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . -165.84 -45.84 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.463 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 40.2 p -155.25 138.01 15.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.896 0.379 . . . . 0.0 111.145 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 10.1 m -126.28 88.66 2.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.154 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 293' ' ' CYS . . . . . . . . . . . . . 27.0 p -105.9 169.66 8.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.856 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 294' ' ' HIS . . . . . 0.948 ' CB ' HG21 ' A' ' 346' ' ' VAL . 6.4 m80 -80.35 120.41 24.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.824 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 96.5 m -139.38 147.19 41.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.098 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 296' ' ' VAL . . . . . 0.428 HG13 HG13 ' A' ' 346' ' ' VAL . 29.9 m -127.59 146.81 32.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.176 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 297' ' ' LYS . . . . . 0.567 ' HD3' ' CE1' ' A' ' 337' ' ' PHE . 30.6 ttpt -117.02 145.99 43.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.936 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 6.4 mp -117.17 129.08 55.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.897 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 6.4 ttt85 -129.13 150.09 50.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.876 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 91.06 36.83 6.51 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.494 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -109.84 152.36 42.91 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.519 0.676 . . . . 0.0 111.105 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 -178.51 2.38 Favored 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.692 2.261 . . . . 0.0 112.316 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -89.51 -4.21 58.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.901 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -100.34 3.28 43.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.907 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 305' ' ' VAL . . . . . . . . . . . . . 4.1 p -65.11 153.13 8.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.088 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 306' ' ' THR . . . . . 0.439 ' OG1' ' N ' ' A' ' 307' ' ' GLU . 0.0 OUTLIER -149.12 170.84 17.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.104 -179.93 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 307' ' ' GLU . . . . . 0.439 ' N ' ' OG1' ' A' ' 306' ' ' THR . 30.7 mt-10 -54.71 -24.38 21.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.864 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 21.4 tttm -74.78 -51.44 14.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.881 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -54.23 -32.84 56.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.881 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 310' ' ' VAL . . . . . 0.51 ' HB ' HD13 ' A' ' 322' ' ' ILE . 30.0 t -70.81 -45.83 71.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.126 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 311' ' ' MET . . . . . . . . . . . . . 4.1 mmt -57.58 -53.13 61.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.919 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -63.41 -24.39 67.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.901 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 313' ' ' PHE . . . . . 0.812 ' CZ ' HG21 ' A' ' 362' ' ' ILE . 31.2 t80 -77.6 -49.75 13.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.879 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.579 ' CD1' HG11 ' A' ' 338' ' ' VAL . 74.2 mt -74.44 -22.65 59.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.913 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 315' ' ' ALA . . . . . 0.737 ' HB1' ' HA ' ' A' ' 316' ' ' PRO . . . -46.22 163.33 0.23 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.551 0.691 . . . . 0.0 111.149 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 316' ' ' PRO . . . . . 0.737 ' HA ' ' HB1' ' A' ' 315' ' ' ALA . 53.5 Cg_endo -69.79 -6.55 9.54 Favored 'Cis proline' 0 C--O 1.232 0.195 0 C-N-CA 122.68 -1.8 . . . . 0.0 112.316 0.027 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 317' ' ' LEU . . . . . 0.419 ' N ' ' HA ' ' A' ' 315' ' ' ALA . 81.6 mt -52.66 135.6 34.52 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.875 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 14.6 tptm -113.96 103.39 55.22 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.539 0.685 . . . . 0.0 110.892 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -169.9 0.36 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.636 2.224 . . . . 0.0 112.361 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 47.2 t -103.34 -46.24 10.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.093 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -156.06 138.28 14.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.062 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 322' ' ' ILE . . . . . 0.51 HD13 ' HB ' ' A' ' 310' ' ' VAL . 66.2 mt -114.21 122.86 69.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.135 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 65.9 mmt-85 -118.05 107.78 14.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.832 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 324' ' ' ILE . . . . . 0.577 HG23 HG12 ' A' ' 336' ' ' ILE . 52.3 mt -77.56 119.97 27.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.133 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 18.8 t -80.72 113.09 19.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.132 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 -85.7 163.38 18.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.907 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -76.32 159.73 30.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.894 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -52.46 -54.59 30.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.105 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -52.51 -43.63 65.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.827 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 330' ' ' GLY . . . . . 0.445 ' O ' ' C ' ' A' ' 331' ' ' ASN . . . 141.53 -46.23 0.91 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.513 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 331' ' ' ASN . . . . . 0.445 ' C ' ' O ' ' A' ' 330' ' ' GLY . 95.6 m-20 -34.77 132.38 0.32 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.924 0.392 . . . . 0.0 110.908 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 11.7 tttp -66.8 83.83 0.11 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.88 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 10.0 t -158.72 132.5 7.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.143 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 155.44 -138.97 6.33 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.491 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 335' ' ' TYR . . . . . 0.415 ' C ' HG13 ' A' ' 336' ' ' ILE . 6.9 m-85 -101.28 175.84 5.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.828 0.347 . . . . 0.0 110.947 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 336' ' ' ILE . . . . . 0.577 HG12 HG23 ' A' ' 324' ' ' ILE . 54.2 mt -144.49 123.75 6.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.141 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 337' ' ' PHE . . . . . 0.567 ' CE1' ' HD3' ' A' ' 297' ' ' LYS . 62.1 m-85 -93.65 135.99 34.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.863 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 338' ' ' VAL . . . . . 0.579 HG11 ' CD1' ' A' ' 314' ' ' LEU . 41.5 t -134.96 122.92 39.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.14 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -98.24 160.52 14.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.853 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -139.79 162.92 33.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.912 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 2.8 m -98.88 -42.3 7.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.851 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 342' ' ' ASN . . . . . 0.408 ' O ' ' C ' ' A' ' 343' ' ' GLU . 19.5 m-80 -99.56 111.08 23.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.86 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 343' ' ' GLU . . . . . 0.459 ' O ' ' N ' ' A' ' 346' ' ' VAL . 0.5 OUTLIER -37.37 -60.61 0.66 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.85 -179.97 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 344' ' ' GLU . . . . . 0.454 ' C ' ' O ' ' A' ' 343' ' ' GLU . 13.1 tt0 -34.3 -51.37 0.45 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.873 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -47.48 -45.56 26.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.892 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 346' ' ' VAL . . . . . 0.948 HG21 ' CB ' ' A' ' 294' ' ' HIS . 23.7 t -57.49 -51.67 66.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.14 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 49.3 mtpt -54.46 -43.14 71.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.896 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 60.0 mm-40 -65.29 -39.18 92.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.943 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -48.02 -40.87 24.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.072 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 350' ' ' LEU . . . . . 0.53 HD11 ' HE ' ' A' ' 366' ' ' ARG . 39.7 mt -65.0 -40.91 95.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.913 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 34.2 mmtm -46.18 -46.22 17.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.916 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 352' ' ' CYS . . . . . . . . . . . . . 58.0 m -69.76 69.42 0.29 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.893 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 14.6 p30 -109.83 171.84 7.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.851 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? 55.75 33.22 20.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.851 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 355' ' ' GLU . . . . . 0.47 ' C ' ' CD1' ' A' ' 356' ' ' TYR . 2.5 mm-40 -97.09 173.68 7.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.903 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 356' ' ' TYR . . . . . 0.521 ' CD1' ' N ' ' A' ' 356' ' ' TYR . 0.9 OUTLIER -138.65 130.29 27.65 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.953 -179.877 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 357' ' ' MET . . . . . 0.608 ' HG2' HD11 ' A' ' 362' ' ' ILE . 5.8 ptt? -152.16 120.13 6.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.865 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 92.56 -23.29 28.75 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.522 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 125.96 -5.52 7.86 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.446 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 360' ' ' ARG . . . . . . . . . . . . . 15.4 mmm180 -119.34 158.52 25.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.873 0.368 . . . . 0.0 110.864 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 361' ' ' TYR . . . . . 0.547 ' CG ' ' O ' ' A' ' 361' ' ' TYR . 3.0 p90 -77.2 117.48 18.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.951 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 362' ' ' ILE . . . . . 0.812 HG21 ' CZ ' ' A' ' 313' ' ' PHE . 45.9 mm -83.23 117.01 28.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.112 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 363' ' ' GLU . . . . . 0.588 ' HG3' ' CZ ' ' A' ' 365' ' ' PHE . 4.2 tp10 -111.23 112.06 23.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.919 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 7.0 t -87.16 144.72 8.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.131 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 365' ' ' PHE . . . . . 0.588 ' CZ ' ' HG3' ' A' ' 363' ' ' GLU . 58.0 m-85 -140.85 133.24 28.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.916 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 366' ' ' ARG . . . . . 0.53 ' HE ' HD11 ' A' ' 350' ' ' LEU . 6.0 ttm180 -84.73 115.51 22.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.907 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -104.19 46.79 0.9 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.877 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -39.33 -44.07 1.25 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.904 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 369' ' ' SER . . . . . 0.444 ' O ' ' C ' ' A' ' 370' ' ' GLY . 95.6 p -79.48 -37.02 37.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.885 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 370' ' ' GLY . . . . . 0.444 ' C ' ' O ' ' A' ' 369' ' ' SER . . . -32.84 96.31 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.465 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 371' ' ' PRO . . . . . 0.419 ' N ' ' O ' ' A' ' 369' ' ' SER . 54.1 Cg_endo -69.74 -0.7 7.27 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.71 2.273 . . . . 0.0 112.388 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 372' ' ' SER . . . . . . . . . . . . . 7.6 t -47.67 118.87 2.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.888 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 8.2 t -136.21 125.46 24.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.873 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.521 179.977 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.288 0 N-CA-C 112.466 -0.254 . . . . 0.0 112.466 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 44.3 m -81.04 106.04 12.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.9 0.381 . . . . 0.0 110.847 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 21.1 m -126.79 169.72 12.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.902 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -69.26 165.19 49.7 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.495 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 44.0 t -143.01 156.12 44.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.876 0.369 . . . . 0.0 110.86 -179.711 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 2.9 t -156.98 154.58 29.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.871 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . -173.67 -69.03 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.489 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 72.0 p -123.66 107.74 11.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.876 0.369 . . . . 0.0 111.151 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 292' ' ' THR . . . . . 0.439 HG23 ' O ' ' A' ' 292' ' ' THR . 14.8 t -104.61 39.77 1.62 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.142 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 293' ' ' CYS . . . . . . . . . . . . . 15.0 m -52.05 120.84 5.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.875 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 294' ' ' HIS . . . . . 0.838 ' HB3' HG21 ' A' ' 346' ' ' VAL . 34.2 m80 -82.82 90.92 6.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.879 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 19.5 m -131.01 132.14 44.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.129 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 296' ' ' VAL . . . . . 0.472 ' CG1' HG13 ' A' ' 346' ' ' VAL . 34.9 m -104.01 154.72 5.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.133 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 297' ' ' LYS . . . . . 0.571 ' HE2' ' CZ ' ' A' ' 337' ' ' PHE . 2.1 tppp? -113.26 142.34 45.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.94 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 6.9 mp -128.69 119.78 25.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.906 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 19.2 ptt85 -127.68 165.65 19.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.868 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 94.36 -24.08 29.0 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.497 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -57.36 151.78 36.13 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.558 0.694 . . . . 0.0 111.103 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 163.11 39.49 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.703 2.269 . . . . 0.0 112.37 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 303' ' ' PHE . . . . . 0.557 ' CD1' ' C ' ' A' ' 303' ' ' PHE . 0.5 OUTLIER -69.05 -24.52 64.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.877 -179.979 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 304' ' ' ASN . . . . . 0.47 ' ND2' ' O ' ' A' ' 304' ' ' ASN . 2.3 t30 -93.58 36.72 1.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.916 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 305' ' ' VAL . . . . . . . . . . . . . 9.9 p -94.8 146.15 7.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.16 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 306' ' ' THR . . . . . . . . . . . . . 7.1 p -128.27 159.87 33.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.159 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -43.17 -43.45 4.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.885 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 56.1 tttt -52.89 -61.79 2.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.885 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -41.48 -46.81 3.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.864 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 92.4 t -60.2 -55.9 21.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.142 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 311' ' ' MET . . . . . . . . . . . . . 3.6 mmt -43.14 -45.55 5.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.885 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -62.33 -41.66 98.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.855 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -67.05 -44.24 80.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.833 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.637 HD13 HG11 ' A' ' 338' ' ' VAL . 94.3 mt -75.99 -25.7 56.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.914 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 315' ' ' ALA . . . . . 0.594 ' HB1' ' HA ' ' A' ' 316' ' ' PRO . . . -50.65 158.48 1.08 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.613 0.72 . . . . 0.0 111.076 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 316' ' ' PRO . . . . . 0.594 ' HA ' ' HB1' ' A' ' 315' ' ' ALA . 54.2 Cg_endo -69.72 -19.55 11.14 Favored 'Cis proline' 0 C--N 1.342 0.185 0 C-N-CA 122.702 -1.791 . . . . 0.0 112.362 -0.031 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 317' ' ' LEU . . . . . 0.591 HD21 ' OE1' ' A' ' 348' ' ' GLN . 60.3 mt -38.33 125.34 1.31 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.915 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 318' ' ' LYS . . . . . 0.446 ' CE ' ' HA ' ' A' ' 318' ' ' LYS . 0.6 OUTLIER -105.44 103.37 42.53 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.625 0.726 . . . . 0.0 110.905 179.83 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.81 -172.07 0.54 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.698 2.265 . . . . 0.0 112.301 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 79.6 t -103.45 -44.52 9.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.149 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -157.6 134.45 10.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.079 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 322' ' ' ILE . . . . . 0.477 HG23 HG22 ' A' ' 338' ' ' VAL . 64.5 mt -105.99 105.09 18.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.111 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 73.9 mtt-85 -108.69 107.98 18.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.849 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 324' ' ' ILE . . . . . 0.599 HG23 HG12 ' A' ' 336' ' ' ILE . 59.9 mt -72.22 128.02 34.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.125 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 325' ' ' VAL . . . . . 0.556 ' CG2' ' CD2' ' A' ' 337' ' ' PHE . 66.8 t -74.03 128.41 36.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.143 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 62.7 mtm-85 -96.03 -177.81 4.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.905 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -109.88 -58.71 2.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.936 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -131.79 -69.23 0.61 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.119 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 8.3 m-70 -112.81 -28.3 7.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.892 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 168.85 41.9 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.507 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 331' ' ' ASN . . . . . 0.472 ' O ' HG23 ' A' ' 333' ' ' THR . 34.5 m-20 -105.92 79.71 1.45 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.901 0.382 . . . . 0.0 110.899 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 332' ' ' LYS . . . . . 0.532 ' HG3' HG21 ' A' ' 324' ' ' ILE . 0.6 OUTLIER -47.3 124.67 6.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.903 179.921 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 333' ' ' THR . . . . . 0.472 HG23 ' O ' ' A' ' 331' ' ' ASN . 27.6 p -125.29 76.62 1.56 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.141 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 334' ' ' GLY . . . . . 0.516 ' O ' ' CG ' ' A' ' 335' ' ' TYR . . . 33.92 69.74 0.16 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.461 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 335' ' ' TYR . . . . . 0.516 ' CG ' ' O ' ' A' ' 334' ' ' GLY . 13.7 m-85 -167.39 112.88 0.73 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.891 0.377 . . . . 0.0 110.882 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 336' ' ' ILE . . . . . 0.599 HG12 HG23 ' A' ' 324' ' ' ILE . 42.6 mt -134.39 130.16 53.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.134 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 337' ' ' PHE . . . . . 0.571 ' CZ ' ' HE2' ' A' ' 297' ' ' LYS . 7.2 m-85 -98.15 127.86 44.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.9 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 338' ' ' VAL . . . . . 0.637 HG11 HD13 ' A' ' 314' ' ' LEU . 75.0 t -127.38 120.65 55.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.129 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -95.86 156.01 16.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.876 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -134.42 165.42 25.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.921 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 2.0 m -93.98 -53.34 4.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.858 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 35.8 m-20 -95.16 128.49 42.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.87 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -49.45 -43.46 44.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.903 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -45.5 -55.82 5.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.858 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 345' ' ' GLU . . . . . 0.5 ' HA ' HD22 ' A' ' 317' ' ' LEU . 62.1 mt-10 -43.76 -53.68 5.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.876 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 346' ' ' VAL . . . . . 0.838 HG21 ' HB3' ' A' ' 294' ' ' HIS . 66.7 t -54.55 -50.5 58.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.17 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -54.34 -33.67 59.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.895 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 348' ' ' GLN . . . . . 0.591 ' OE1' HD21 ' A' ' 317' ' ' LEU . 68.2 mt-30 -78.45 -36.63 45.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.894 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -47.1 -38.67 11.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.054 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 350' ' ' LEU . . . . . 0.532 HD11 ' HG3' ' A' ' 366' ' ' ARG . 49.5 mt -63.35 -39.43 94.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.898 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 18.9 mmtm -47.31 -45.4 24.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.886 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 352' ' ' CYS . . . . . . . . . . . . . 4.1 m -75.21 64.94 1.5 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.915 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -108.71 160.83 15.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.871 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 25.0 ttp180 63.09 34.72 13.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.865 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 355' ' ' GLU . . . . . 0.455 ' C ' ' CD1' ' A' ' 356' ' ' TYR . 3.9 mm-40 -94.82 172.78 7.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.886 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 356' ' ' TYR . . . . . 0.473 ' CD1' ' N ' ' A' ' 356' ' ' TYR . 1.3 m-85 -135.68 120.05 17.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.912 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 357' ' ' MET . . . . . . . . . . . . . 3.3 ptt? -145.45 143.9 30.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.857 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 75.98 -9.96 16.25 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.492 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 106.4 18.33 11.21 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.483 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 360' ' ' ARG . . . . . . . . . . . . . 20.2 mmt180 -145.46 178.11 8.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.836 0.35 . . . . 0.0 110.862 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 361' ' ' TYR . . . . . . . . . . . . . 18.9 p90 -90.67 163.83 14.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.932 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 362' ' ' ILE . . . . . 0.417 HG22 ' N ' ' A' ' 363' ' ' GLU . 8.0 mm -141.6 155.34 20.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.112 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 363' ' ' GLU . . . . . 0.549 ' HB3' ' CZ ' ' A' ' 365' ' ' PHE . 13.8 mt-10 -147.47 119.45 8.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.851 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 20.0 t -89.01 140.06 16.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.139 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 365' ' ' PHE . . . . . 0.549 ' CZ ' ' HB3' ' A' ' 363' ' ' GLU . 16.8 m-85 -140.92 128.3 21.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.889 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 366' ' ' ARG . . . . . 0.532 ' HG3' HD11 ' A' ' 350' ' ' LEU . 36.4 mtp180 -73.21 143.0 47.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.865 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -130.6 78.09 1.82 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.939 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -55.36 -46.0 76.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.936 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 39.8 m -72.38 -51.42 20.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.874 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 67.55 87.8 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.512 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -4.96 15.07 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.71 2.273 . . . . 0.0 112.306 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 372' ' ' SER . . . . . 0.551 ' OG ' ' CE2' ' A' ' 337' ' ' PHE . 3.3 m -76.48 106.04 7.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.888 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 53.3 p -55.97 121.48 9.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.866 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.519 179.994 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.268 0 N-CA-C 112.452 -0.259 . . . . 0.0 112.452 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 71.0 p -130.2 104.16 7.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.901 0.381 . . . . 0.0 110.872 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 82.9 p -112.09 135.72 52.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.87 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 168.89 -58.23 0.2 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.447 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 72.4 p 41.14 41.87 1.48 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.873 0.368 . . . . 0.0 110.87 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 83.9 p -158.9 119.92 3.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.857 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . -148.75 -120.84 1.11 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.492 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 74.0 p -121.66 128.85 52.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.848 0.356 . . . . 0.0 111.11 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 18.4 p 39.63 47.01 1.61 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.149 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 293' ' ' CYS . . . . . . . . . . . . . 68.8 m -50.43 130.21 23.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.879 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 294' ' ' HIS . . . . . 0.777 ' CB ' HG21 ' A' ' 346' ' ' VAL . 6.1 m80 -85.16 123.06 30.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.889 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 95.4 m -138.44 137.29 37.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.146 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 296' ' ' VAL . . . . . 0.434 ' CG2' ' HB ' ' A' ' 338' ' ' VAL . 35.9 m -110.69 152.24 12.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.158 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 297' ' ' LYS . . . . . 0.539 ' HG3' ' CE1' ' A' ' 337' ' ' PHE . 0.2 OUTLIER -118.08 136.01 53.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.848 179.992 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 298' ' ' LEU . . . . . 0.438 HD21 ' CE2' ' A' ' 313' ' ' PHE . 6.7 mp -113.98 142.28 46.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.89 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 299' ' ' ARG . . . . . 0.535 ' HD3' ' CE2' ' A' ' 335' ' ' TYR . 25.1 tpt85 -148.79 134.14 18.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.868 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 126.07 -23.88 5.77 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.446 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -56.62 147.55 50.46 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.568 0.699 . . . . 0.0 111.105 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 -172.45 0.57 Allowed 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.673 2.249 . . . . 0.0 112.325 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 303' ' ' PHE . . . . . 0.429 ' O ' ' CG ' ' A' ' 303' ' ' PHE . 73.1 t80 -89.56 -3.41 58.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.895 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 36.3 t30 -110.41 29.34 7.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.871 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 305' ' ' VAL . . . . . . . . . . . . . 9.1 p -97.04 148.91 5.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.12 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 306' ' ' THR . . . . . . . . . . . . . 23.5 p -134.89 161.23 35.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.129 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -39.77 -49.28 2.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.868 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 33.1 ttmt -46.84 -58.87 3.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.92 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 32.7 m120 -45.17 -45.17 11.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.899 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 61.6 t -57.81 -43.6 84.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.149 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 311' ' ' MET . . . . . 0.405 ' HG2' HD11 ' A' ' 322' ' ' ILE . 3.3 mmt -59.28 -50.49 73.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.869 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -64.28 -29.74 70.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.917 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 313' ' ' PHE . . . . . 0.438 ' CE2' HD21 ' A' ' 298' ' ' LEU . 4.4 t80 -72.27 -31.78 66.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.893 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.482 HD13 ' HZ ' ' A' ' 340' ' ' PHE . 92.1 mt -90.93 -22.95 20.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.906 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 315' ' ' ALA . . . . . 0.614 ' HB1' ' HA ' ' A' ' 316' ' ' PRO . . . -44.06 159.32 0.24 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.557 0.694 . . . . 0.0 111.127 179.776 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 316' ' ' PRO . . . . . 0.614 ' HA ' ' HB1' ' A' ' 315' ' ' ALA . 53.6 Cg_endo -69.73 -8.98 10.73 Favored 'Cis proline' 0 C--N 1.341 0.183 0 C-N-CA 122.662 -1.807 . . . . 0.0 112.357 -0.034 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 317' ' ' LEU . . . . . 0.521 HD21 ' OE1' ' A' ' 348' ' ' GLN . 26.4 mt -46.72 161.15 0.07 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.899 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 29.2 tttm -143.79 105.0 4.91 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.563 0.697 . . . . 0.0 110.884 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 319' ' ' PRO . . . . . 0.425 ' HA ' ' CD2' ' A' ' 340' ' ' PHE . 53.8 Cg_endo -69.71 -173.6 0.74 Allowed 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.706 2.271 . . . . 0.0 112.36 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 93.7 t -103.18 -41.11 7.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.136 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -157.47 139.08 13.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.109 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 322' ' ' ILE . . . . . 0.405 HD11 ' HG2' ' A' ' 311' ' ' MET . 92.0 mt -106.79 106.77 21.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.151 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 45.2 mtt180 -102.47 105.29 15.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.884 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 55.8 mt -73.93 119.85 21.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.122 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 325' ' ' VAL . . . . . 0.482 HG22 ' CD2' ' A' ' 337' ' ' PHE . 94.4 t -57.6 123.94 10.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.13 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 49.3 mtt180 -83.63 178.77 7.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.848 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -133.04 -64.94 0.72 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.854 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -113.22 -63.44 1.45 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.114 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 7.1 m-70 -111.35 -72.47 0.72 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.865 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -170.48 32.11 0.15 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.52 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 331' ' ' ASN . . . . . 0.564 ' O ' HG22 ' A' ' 333' ' ' THR . 1.4 p-10 -89.55 136.37 33.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.925 0.393 . . . . 0.0 110.883 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 2.7 tmtt? -59.93 105.17 0.36 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.932 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 333' ' ' THR . . . . . 0.564 HG22 ' O ' ' A' ' 331' ' ' ASN . 4.0 t -173.47 132.15 0.46 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.15 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 118.49 -110.92 2.03 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.494 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 335' ' ' TYR . . . . . 0.535 ' CE2' ' HD3' ' A' ' 299' ' ' ARG . 2.8 m-85 -124.41 -177.93 3.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.855 0.36 . . . . 0.0 110.919 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 72.8 mt -142.45 114.34 3.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.123 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 337' ' ' PHE . . . . . 0.539 ' CE1' ' HG3' ' A' ' 297' ' ' LYS . 15.6 m-85 -88.5 135.35 33.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.918 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 338' ' ' VAL . . . . . 0.434 ' HB ' ' CG2' ' A' ' 296' ' ' VAL . 63.3 t -132.5 129.91 59.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.11 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -103.18 161.8 13.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.886 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 340' ' ' PHE . . . . . 0.482 ' HZ ' HD13 ' A' ' 314' ' ' LEU . 55.6 m-85 -139.57 166.53 24.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.868 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 32.2 m -82.59 -62.06 1.71 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.874 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 21.1 m-80 -91.87 158.01 16.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.893 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 343' ' ' GLU . . . . . 0.483 ' HB3' ' CE1' ' A' ' 294' ' ' HIS . 1.7 pp20? -73.92 -28.56 61.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.85 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 45.7 mm-40 -59.3 -53.05 62.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.91 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -46.27 -51.74 13.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.907 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 346' ' ' VAL . . . . . 0.777 HG21 ' CB ' ' A' ' 294' ' ' HIS . 21.2 t -49.96 -50.64 18.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.146 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 6.2 mtpm? -51.61 -48.76 63.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.875 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 348' ' ' GLN . . . . . 0.521 ' OE1' HD21 ' A' ' 317' ' ' LEU . 75.4 mt-30 -62.38 -26.13 68.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.914 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 349' ' ' ALA . . . . . 0.511 ' HB3' ' O ' ' A' ' 346' ' ' VAL . . . -63.23 -35.92 81.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.101 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 350' ' ' LEU . . . . . 0.455 HD21 ' HB2' ' A' ' 366' ' ' ARG . 57.6 mt -63.74 -40.94 97.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.978 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 5.4 mtmp? -46.63 -51.15 16.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.934 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 352' ' ' CYS . . . . . . . . . . . . . 4.2 m -69.36 85.19 0.4 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.897 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 353' ' ' ASN . . . . . 0.452 ' O ' ' C ' ' A' ' 354' ' ' ARG . 1.1 p30 -124.91 -176.37 3.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.91 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 354' ' ' ARG . . . . . 0.482 ' O ' ' CD ' ' A' ' 354' ' ' ARG . 0.0 OUTLIER 32.44 38.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.883 -179.925 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 355' ' ' GLU . . . . . 0.469 ' C ' ' CD1' ' A' ' 356' ' ' TYR . 57.1 mm-40 -86.95 176.16 7.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.87 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 356' ' ' TYR . . . . . 0.469 ' CD1' ' C ' ' A' ' 355' ' ' GLU . 1.2 m-85 -135.31 107.95 7.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.964 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 357' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -138.38 145.83 41.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.918 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 72.89 -6.13 14.48 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.494 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 102.96 21.91 9.78 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.479 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 360' ' ' ARG . . . . . . . . . . . . . 14.2 mmt180 -148.71 175.7 10.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.807 0.337 . . . . 0.0 110.9 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 361' ' ' TYR . . . . . 0.73 ' O ' HD13 ' A' ' 362' ' ' ILE . 10.8 p90 -82.59 172.21 13.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.924 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 362' ' ' ILE . . . . . 0.73 HD13 ' O ' ' A' ' 361' ' ' TYR . 25.7 mm -142.27 155.53 18.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.11 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 363' ' ' GLU . . . . . 0.553 ' HB3' ' CZ ' ' A' ' 365' ' ' PHE . 7.0 mm-40 -147.87 112.92 5.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.888 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 17.2 t -91.46 143.53 11.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.078 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 365' ' ' PHE . . . . . 0.553 ' CZ ' ' HB3' ' A' ' 363' ' ' GLU . 32.0 m-85 -143.09 122.38 13.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.898 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 366' ' ' ARG . . . . . 0.455 ' HB2' HD21 ' A' ' 350' ' ' LEU . 35.2 ttp85 -75.84 112.69 12.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.847 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -85.64 98.24 10.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.854 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 368' ' ' LYS . . . . . 0.412 ' HD3' ' C ' ' A' ' 368' ' ' LYS . 0.0 OUTLIER -70.03 -32.66 70.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.928 179.936 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 7.8 t -75.33 -51.4 13.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.873 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 76.85 -156.33 45.84 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.477 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 175.02 8.69 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.667 2.245 . . . . 0.0 112.369 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 372' ' ' SER . . . . . . . . . . . . . 4.4 m -43.14 122.18 2.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.829 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 3.6 m -84.23 42.0 0.86 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.915 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.494 -179.961 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 284' ' ' GLY . . . . . 0.442 ' O ' ' C ' ' A' ' 285' ' ' SER . . . . . . . . 0 N--CA 1.451 -0.321 0 N-CA-C 112.506 -0.238 . . . . 0.0 112.506 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 285' ' ' SER . . . . . 0.442 ' C ' ' O ' ' A' ' 284' ' ' GLY . 3.9 m 34.89 51.16 0.5 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.873 0.368 . . . . 0.0 110.888 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 21.5 t -66.03 -67.27 0.46 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.833 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 156.14 106.91 0.26 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.456 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 66.7 p -119.73 120.07 35.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.897 0.38 . . . . 0.0 110.89 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 10.2 m -131.99 100.14 4.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.832 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 104.61 112.47 3.71 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.474 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 31.1 p -100.37 143.92 29.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.889 0.376 . . . . 0.0 111.153 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 7.2 t -125.06 -39.09 2.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.17 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 293' ' ' CYS . . . . . . . . . . . . . 91.9 m -122.52 165.84 15.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.88 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 294' ' ' HIS . . . . . 0.584 ' CB ' HG21 ' A' ' 346' ' ' VAL . 3.0 m-70 -126.82 104.3 7.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.869 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 87.4 m -126.34 144.57 50.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.106 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 296' ' ' VAL . . . . . 0.763 ' CG1' HG13 ' A' ' 346' ' ' VAL . 19.6 m -121.72 157.65 25.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.136 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 8.8 ttpp -128.43 142.34 51.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.873 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 298' ' ' LEU . . . . . 0.491 HD21 ' CE1' ' A' ' 313' ' ' PHE . 7.6 mp -114.93 149.83 36.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.89 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 7.7 ttt180 -150.41 140.2 21.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.893 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 300' ' ' GLY . . . . . 0.685 ' O ' HD13 ' A' ' 362' ' ' ILE . . . 103.43 44.94 1.62 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.474 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -113.84 151.42 44.71 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.597 0.713 . . . . 0.0 111.091 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -171.95 0.53 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.637 2.225 . . . . 0.0 112.319 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -87.55 -7.69 57.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.897 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 33.0 m120 -108.97 32.01 5.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.88 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 305' ' ' VAL . . . . . . . . . . . . . 4.5 p -96.2 139.89 18.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.139 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 306' ' ' THR . . . . . . . . . . . . . 67.7 p -142.97 170.63 15.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.146 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -46.68 -35.35 5.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.883 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 11.4 tmtt? -59.7 -50.32 74.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.884 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 34.8 m120 -55.09 -48.89 72.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.944 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 76.6 t -58.17 -55.31 22.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.14 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 311' ' ' MET . . . . . . . . . . . . . 2.3 mmt -46.35 -44.47 16.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.889 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -73.99 -26.28 60.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.875 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 313' ' ' PHE . . . . . 0.591 ' CD2' ' SD ' ' A' ' 357' ' ' MET . 1.9 t80 -78.37 -30.9 48.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.822 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.463 ' CD1' HG11 ' A' ' 338' ' ' VAL . 93.9 mt -91.5 -24.53 19.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.952 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 315' ' ' ALA . . . . . 0.756 ' HB1' ' HA ' ' A' ' 316' ' ' PRO . . . -48.68 163.87 0.3 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.592 0.711 . . . . 0.0 111.098 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 316' ' ' PRO . . . . . 0.756 ' HA ' ' HB1' ' A' ' 315' ' ' ALA . 53.7 Cg_endo -69.72 -3.2 7.5 Favored 'Cis proline' 0 C--O 1.231 0.165 0 C-N-CA 122.713 -1.786 . . . . 0.0 112.341 -0.026 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 317' ' ' LEU . . . . . 0.485 ' N ' ' HA ' ' A' ' 315' ' ' ALA . 13.5 mt -55.63 142.95 31.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.93 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -120.52 106.31 40.21 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.588 0.708 . . . . 0.0 110.883 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 -164.54 0.13 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.72 2.28 . . . . 0.0 112.369 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 24.5 t -113.62 -45.04 4.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.104 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -153.59 128.94 9.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.09 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 322' ' ' ILE . . . . . 0.583 HG23 HG22 ' A' ' 338' ' ' VAL . 49.3 mt -107.67 99.86 9.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.144 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -100.19 104.73 16.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.875 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 324' ' ' ILE . . . . . 0.51 HG12 HG23 ' A' ' 336' ' ' ILE . 58.4 mt -73.73 118.34 19.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.104 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 325' ' ' VAL . . . . . 0.441 HG22 ' CE2' ' A' ' 337' ' ' PHE . 84.5 t -52.64 107.68 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.109 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 7.2 ptp180 -96.61 166.19 11.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.883 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -116.79 -175.77 2.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.891 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -46.29 -43.44 15.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.116 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 34.5 m80 -110.83 39.0 2.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.868 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 48.24 51.41 20.62 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.46 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 22.7 m-20 -107.11 106.21 16.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.856 0.36 . . . . 0.0 110.865 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 55.4 mttp -57.41 123.91 17.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.918 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 333' ' ' THR . . . . . 0.519 ' O ' ' CD2' ' A' ' 335' ' ' TYR . 64.5 p -118.69 72.52 0.88 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.113 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 334' ' ' GLY . . . . . 0.463 ' O ' ' CD1' ' A' ' 335' ' ' TYR . . . 34.52 53.12 0.78 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.466 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 335' ' ' TYR . . . . . 0.519 ' CD2' ' O ' ' A' ' 333' ' ' THR . 19.2 m-85 -152.34 120.69 6.34 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.915 0.388 . . . . 0.0 110.928 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 336' ' ' ILE . . . . . 0.51 HG23 HG12 ' A' ' 324' ' ' ILE . 42.6 mt -139.93 132.02 33.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.137 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 337' ' ' PHE . . . . . 0.441 ' CE2' HG22 ' A' ' 325' ' ' VAL . 22.7 m-85 -99.52 142.78 30.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.849 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 338' ' ' VAL . . . . . 0.583 HG22 HG23 ' A' ' 322' ' ' ILE . 27.6 t -146.33 131.53 12.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.181 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -103.22 168.09 9.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.856 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 340' ' ' PHE . . . . . 0.477 ' HB2' ' CG2' ' A' ' 346' ' ' VAL . 65.6 m-85 -148.22 157.56 43.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.852 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 13.1 t -70.16 -64.6 0.86 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.856 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -99.39 177.43 5.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.863 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 343' ' ' GLU . . . . . 0.583 ' HB3' ' CE1' ' A' ' 294' ' ' HIS . 20.1 pt-20 -78.22 -45.84 21.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.868 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 344' ' ' GLU . . . . . 0.403 ' N ' ' HG3' ' A' ' 343' ' ' GLU . 19.0 mt-10 -42.26 -60.03 1.61 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.892 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -45.3 -32.45 1.99 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.873 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 346' ' ' VAL . . . . . 0.763 HG13 ' CG1' ' A' ' 296' ' ' VAL . 74.9 t -82.6 -36.75 13.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.114 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -64.22 -35.43 80.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.915 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 45.9 mm-40 -76.03 -40.01 54.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.92 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -51.82 -33.53 36.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.141 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 350' ' ' LEU . . . . . 0.61 HD23 HG12 ' A' ' 364' ' ' VAL . 96.8 mt -72.48 -40.15 67.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.935 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 46.7 mttm -46.27 -40.69 11.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.885 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 352' ' ' CYS . . . . . . . . . . . . . 33.1 m -78.77 80.45 5.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.915 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 353' ' ' ASN . . . . . 0.438 ' O ' ' C ' ' A' ' 354' ' ' ARG . 31.5 p-10 -109.28 178.56 4.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.86 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 354' ' ' ARG . . . . . 0.438 ' C ' ' O ' ' A' ' 353' ' ' ASN . 20.7 ptt180 35.42 42.86 0.13 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.922 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 355' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -89.45 173.9 8.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.85 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 356' ' ' TYR . . . . . 0.497 ' CD1' ' N ' ' A' ' 356' ' ' TYR . 1.1 m-85 -128.13 115.56 18.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.952 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 357' ' ' MET . . . . . 0.591 ' SD ' ' CD2' ' A' ' 313' ' ' PHE . 4.6 ptt? -145.81 127.52 15.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.866 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 81.36 -17.94 12.11 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.526 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 113.25 19.03 6.89 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.467 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 360' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -143.87 134.71 25.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.812 0.339 . . . . 0.0 110.9 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 361' ' ' TYR . . . . . 0.557 ' CD1' ' O ' ' A' ' 361' ' ' TYR . 12.6 p90 -56.27 127.23 29.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.897 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 362' ' ' ILE . . . . . 0.685 HD13 ' O ' ' A' ' 300' ' ' GLY . 4.2 mm -106.31 151.57 8.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.163 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 363' ' ' GLU . . . . . 0.421 ' HB3' ' CZ ' ' A' ' 365' ' ' PHE . 28.1 mm-40 -143.4 116.93 9.14 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.846 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 364' ' ' VAL . . . . . 0.61 HG12 HD23 ' A' ' 350' ' ' LEU . 21.7 t -88.82 142.53 12.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.15 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 365' ' ' PHE . . . . . 0.442 ' CD1' ' O ' ' A' ' 364' ' ' VAL . 10.3 m-85 -139.93 146.87 39.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.909 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 366' ' ' ARG . . . . . 0.506 ' HB2' HD11 ' A' ' 350' ' ' LEU . 0.0 OUTLIER -86.68 109.36 19.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.878 -179.896 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -87.8 79.92 8.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.888 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 368' ' ' LYS . . . . . 0.435 ' HG2' ' N ' ' A' ' 369' ' ' SER . 0.0 OUTLIER -42.16 -28.98 0.21 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.948 179.946 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 369' ' ' SER . . . . . 0.435 ' N ' ' HG2' ' A' ' 368' ' ' LYS . 44.5 t -86.74 -62.7 1.45 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.856 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 122.93 -157.21 17.45 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.498 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 135.52 30.54 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.704 2.269 . . . . 0.0 112.332 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 372' ' ' SER . . . . . . . . . . . . . 31.3 t -95.32 82.56 3.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.86 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 76.5 p -134.62 159.52 40.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.866 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.492 179.999 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 N-CA-C 112.535 -0.226 . . . . 0.0 112.535 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 41.9 p 38.34 42.15 0.5 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.856 0.36 . . . . 0.0 110.83 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 2.5 t -136.84 114.47 11.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.858 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 101.35 -43.8 1.66 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.498 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 84.1 p -64.72 -48.13 75.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.866 0.365 . . . . 0.0 110.848 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 23.5 t -93.26 -46.51 7.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.83 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 60.5 -137.11 48.96 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.444 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 291' ' ' THR . . . . . 0.415 ' O ' ' C ' ' A' ' 292' ' ' THR . 30.1 m -135.77 111.53 9.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.852 0.358 . . . . 0.0 111.151 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 292' ' ' THR . . . . . 0.415 ' C ' ' O ' ' A' ' 291' ' ' THR . 9.4 t -35.49 128.26 0.59 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.162 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 293' ' ' CYS . . . . . . . . . . . . . 40.1 t -131.94 146.52 52.15 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.91 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 294' ' ' HIS . . . . . 0.632 ' HB3' HG21 ' A' ' 346' ' ' VAL . 11.3 m80 -96.73 99.17 10.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.861 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 63.1 m -136.17 145.36 45.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.178 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 296' ' ' VAL . . . . . 0.52 ' CG1' HG13 ' A' ' 346' ' ' VAL . 29.8 m -118.86 147.21 22.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.154 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 297' ' ' LYS . . . . . 0.568 ' HD3' ' CD1' ' A' ' 335' ' ' TYR . 8.8 ttmm -116.87 146.33 42.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.944 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 298' ' ' LEU . . . . . 0.465 HD21 ' CD2' ' A' ' 313' ' ' PHE . 6.9 mp -115.55 157.55 23.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.917 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -158.02 130.22 7.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.859 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 123.1 -23.2 6.96 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.484 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -57.17 147.71 55.4 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.594 0.711 . . . . 0.0 111.066 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 -176.54 1.52 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.71 2.273 . . . . 0.0 112.301 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 303' ' ' PHE . . . . . 0.413 ' O ' ' CB ' ' A' ' 332' ' ' LYS . 34.5 p90 -78.1 -35.74 48.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.904 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -88.59 48.46 1.64 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.858 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 305' ' ' VAL . . . . . 0.458 HG12 ' HG2' ' A' ' 332' ' ' LYS . 11.4 p -99.24 141.38 16.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.163 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 306' ' ' THR . . . . . 0.414 ' O ' ' C ' ' A' ' 307' ' ' GLU . 69.2 p -132.43 153.27 51.01 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.096 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 307' ' ' GLU . . . . . 0.414 ' C ' ' O ' ' A' ' 306' ' ' THR . 26.1 mt-10 -35.68 -52.17 0.68 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.891 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 14.7 ttpt -40.83 -47.25 2.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.892 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -57.85 -54.87 42.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.873 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 56.2 t -55.9 -50.4 69.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.159 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 311' ' ' MET . . . . . . . . . . . . . 2.7 mmt -48.91 -52.46 24.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.866 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -67.31 -24.73 65.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.871 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 313' ' ' PHE . . . . . 0.465 ' CD2' HD21 ' A' ' 298' ' ' LEU . 11.2 t80 -77.34 -35.66 54.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.848 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.482 ' CD1' HG11 ' A' ' 338' ' ' VAL . 85.9 mt -86.04 -20.61 28.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.94 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 315' ' ' ALA . . . . . 0.641 ' HB1' ' HA ' ' A' ' 316' ' ' PRO . . . -47.09 159.96 0.37 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.588 0.708 . . . . 0.0 111.08 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 316' ' ' PRO . . . . . 0.641 ' HA ' ' HB1' ' A' ' 315' ' ' ALA . 53.8 Cg_endo -69.78 -21.5 10.2 Favored 'Cis proline' 0 C--O 1.232 0.188 0 C-N-CA 122.677 -1.801 . . . . 0.0 112.357 0.055 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 317' ' ' LEU . . . . . 0.588 HD11 ' CB ' ' A' ' 348' ' ' GLN . 22.2 mt -41.38 139.07 1.11 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.887 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -118.51 110.55 38.88 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.576 0.703 . . . . 0.0 110.876 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 319' ' ' PRO . . . . . 0.405 ' HA ' ' CD2' ' A' ' 340' ' ' PHE . 54.2 Cg_endo -69.71 -178.33 2.27 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.68 2.253 . . . . 0.0 112.384 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 19.4 t -104.12 -34.14 3.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.151 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -162.73 132.93 4.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.115 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 322' ' ' ILE . . . . . 0.414 HG23 HG22 ' A' ' 338' ' ' VAL . 66.2 mt -107.75 117.21 52.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.153 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 19.4 mmt180 -111.47 107.08 16.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.843 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 324' ' ' ILE . . . . . 0.625 HG23 HG12 ' A' ' 336' ' ' ILE . 70.8 mt -84.61 138.21 19.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.156 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 325' ' ' VAL . . . . . 0.523 HG21 ' CE2' ' A' ' 337' ' ' PHE . 62.1 t -106.82 145.28 14.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.095 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 6.7 ptp85 -95.94 172.66 7.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.89 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 327' ' ' ASN . . . . . 0.41 ' O ' ' C ' ' A' ' 328' ' ' ALA . 52.1 t30 -92.86 155.45 17.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.875 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 328' ' ' ALA . . . . . 0.41 ' C ' ' O ' ' A' ' 327' ' ' ASN . . . -36.52 -54.67 0.86 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.056 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 7.7 m170 -62.36 -61.03 2.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.816 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 145.52 63.94 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.485 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -138.88 158.48 44.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.921 0.391 . . . . 0.0 110.904 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 332' ' ' LYS . . . . . 0.458 ' HG2' HG12 ' A' ' 305' ' ' VAL . 0.0 OUTLIER -55.11 -59.24 5.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.876 179.908 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 9.3 t -39.43 145.23 0.12 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.143 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 148.76 -98.49 0.19 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.461 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 335' ' ' TYR . . . . . 0.568 ' CD1' ' HD3' ' A' ' 297' ' ' LYS . 79.3 m-85 -150.51 145.9 26.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.811 0.338 . . . . 0.0 110.957 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 336' ' ' ILE . . . . . 0.625 HG12 HG23 ' A' ' 324' ' ' ILE . 60.0 mt -127.28 121.52 57.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.132 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 337' ' ' PHE . . . . . 0.523 ' CE2' HG21 ' A' ' 325' ' ' VAL . 39.1 m-85 -96.1 136.2 36.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.876 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 338' ' ' VAL . . . . . 0.482 HG11 ' CD1' ' A' ' 314' ' ' LEU . 25.5 t -134.73 132.17 54.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.105 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -105.69 157.94 17.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.883 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 340' ' ' PHE . . . . . 0.405 ' CD2' ' HA ' ' A' ' 319' ' ' PRO . 53.3 m-85 -133.85 162.06 33.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.879 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 34.4 p -64.73 -66.61 0.52 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.877 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 342' ' ' ASN . . . . . 0.401 ' OD1' ' N ' ' A' ' 342' ' ' ASN . 2.8 p-10 -99.75 170.8 8.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.918 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 343' ' ' GLU . . . . . 0.586 ' HB3' ' CE1' ' A' ' 294' ' ' HIS . 1.4 pp20? -70.14 -51.01 34.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.89 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 344' ' ' GLU . . . . . 0.425 ' N ' ' CD ' ' A' ' 343' ' ' GLU . 10.4 tt0 -40.36 -57.98 1.64 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.906 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -39.74 -36.15 0.4 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.899 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 346' ' ' VAL . . . . . 0.632 HG21 ' HB3' ' A' ' 294' ' ' HIS . 24.6 t -70.08 -48.27 63.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.106 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 347' ' ' LYS . . . . . 0.423 ' HB2' ' NZ ' ' A' ' 347' ' ' LYS . 5.1 mtmp? -52.87 -39.46 62.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.934 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 348' ' ' GLN . . . . . 0.588 ' CB ' HD11 ' A' ' 317' ' ' LEU . 85.5 mt-30 -73.31 -26.66 61.15 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.933 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -64.03 -35.96 82.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.095 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 350' ' ' LEU . . . . . . . . . . . . . 15.9 mt -73.22 -37.06 66.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.912 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 26.3 mmmt -47.44 -47.18 27.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.901 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 352' ' ' CYS . . . . . . . . . . . . . 15.9 m -70.3 72.55 0.47 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.877 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 14.9 p30 -109.09 162.76 13.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.932 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 20.5 mmt180 61.86 35.63 16.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.848 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 355' ' ' GLU . . . . . 0.46 ' C ' ' CD1' ' A' ' 356' ' ' TYR . 20.9 mm-40 -91.48 173.65 7.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.891 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 356' ' ' TYR . . . . . 0.491 ' CD1' ' N ' ' A' ' 356' ' ' TYR . 1.2 m-85 -136.3 128.06 29.11 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.922 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 357' ' ' MET . . . . . . . . . . . . . 3.6 ptt? -156.6 140.38 16.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.912 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 76.95 -9.29 25.47 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.456 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 102.93 16.85 20.38 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.461 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 360' ' ' ARG . . . . . . . . . . . . . 10.3 mmt180 -144.29 153.36 41.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.801 0.334 . . . . 0.0 110.881 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 361' ' ' TYR . . . . . 0.441 ' CD1' ' C ' ' A' ' 361' ' ' TYR . 1.0 OUTLIER -64.88 166.26 9.4 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.911 -179.84 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 362' ' ' ILE . . . . . 0.401 HG12 ' C ' ' A' ' 361' ' ' TYR . 15.7 mm -146.75 137.54 18.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.136 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 363' ' ' GLU . . . . . 0.565 ' HG3' ' CE2' ' A' ' 365' ' ' PHE . 14.7 pt-20 -133.99 112.07 10.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.895 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 364' ' ' VAL . . . . . 0.533 ' O ' ' CD1' ' A' ' 365' ' ' PHE . 14.2 t -84.51 154.07 3.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.099 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 365' ' ' PHE . . . . . 0.565 ' CE2' ' HG3' ' A' ' 363' ' ' GLU . 28.8 m-85 -145.99 156.46 43.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.851 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 32.8 ttp85 -97.86 120.4 38.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.912 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -101.61 74.37 1.51 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.881 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 368' ' ' LYS . . . . . 0.419 ' HD3' ' C ' ' A' ' 368' ' ' LYS . 0.0 OUTLIER -49.91 -24.49 2.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.9 179.958 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 15.1 m -71.92 -60.97 1.96 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.878 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 96.85 -157.87 21.24 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.464 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 171.86 13.69 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.7 2.267 . . . . 0.0 112.335 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 372' ' ' SER . . . . . . . . . . . . . 30.8 t -109.31 95.91 5.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.808 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 5.6 m -50.19 150.02 2.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.858 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.472 -179.952 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 N-CA-C 112.488 -0.245 . . . . 0.0 112.488 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 285' ' ' SER . . . . . 0.425 ' O ' ' C ' ' A' ' 286' ' ' SER . 1.2 t -153.6 158.89 41.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.86 0.362 . . . . 0.0 110.855 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 286' ' ' SER . . . . . 0.425 ' C ' ' O ' ' A' ' 285' ' ' SER . 1.7 t -36.6 -58.67 0.71 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.882 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 134.21 77.2 0.1 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.495 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 96.8 p -158.5 119.64 3.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.894 0.378 . . . . 0.0 110.86 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 1.7 t -108.75 143.75 37.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.886 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 101.79 136.67 9.35 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.514 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 23.7 m -101.65 131.1 48.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.821 0.343 . . . . 0.0 111.151 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 87.5 m -97.61 -45.42 6.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.177 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 293' ' ' CYS . . . . . . . . . . . . . 35.9 m -97.08 115.51 27.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.846 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 294' ' ' HIS . . . . . 0.553 ' HB3' HG21 ' A' ' 346' ' ' VAL . 7.8 m-70 -84.13 97.26 9.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.874 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 24.7 m -136.49 143.5 43.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.148 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 296' ' ' VAL . . . . . 0.521 ' CG1' HG13 ' A' ' 346' ' ' VAL . 27.0 m -128.92 150.45 34.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.106 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 28.3 ttpp -119.1 132.36 56.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.902 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 7.3 mp -105.95 103.1 12.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.869 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 299' ' ' ARG . . . . . 0.541 ' HD3' ' CE1' ' A' ' 335' ' ' TYR . 38.0 tpt85 -104.45 122.68 46.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.896 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 300' ' ' GLY . . . . . 0.411 ' C ' ' O ' ' A' ' 361' ' ' TYR . . . 133.36 -25.1 3.67 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.501 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 301' ' ' ALA . . . . . 0.456 ' HA ' ' CD1' ' A' ' 362' ' ' ILE . . . -59.52 144.11 85.0 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.571 0.7 . . . . 0.0 111.095 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -167.74 0.24 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.665 2.243 . . . . 0.0 112.341 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 303' ' ' PHE . . . . . 0.411 ' CD1' ' C ' ' A' ' 303' ' ' PHE . 1.8 p90 -95.81 -12.8 24.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.87 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -93.33 3.01 56.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.94 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 305' ' ' VAL . . . . . 0.4 HG11 ' HB1' ' A' ' 301' ' ' ALA . 7.5 p -78.39 143.23 12.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.109 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 306' ' ' THR . . . . . . . . . . . . . 16.6 p -131.92 162.73 29.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.115 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -38.93 -49.16 1.66 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.932 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 30.2 ttmt -50.87 -58.69 5.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.86 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -49.91 -43.01 49.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.891 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 310' ' ' VAL . . . . . 0.525 HG12 HD12 ' A' ' 314' ' ' LEU . 99.0 t -60.56 -49.09 85.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.155 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 311' ' ' MET . . . . . . . . . . . . . 3.1 mmt -50.11 -39.09 41.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.822 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -71.7 -35.49 70.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.898 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 313' ' ' PHE . . . . . 0.449 ' CD1' ' C ' ' A' ' 313' ' ' PHE . 1.6 t80 -74.82 -31.06 61.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.86 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.758 HD11 HG21 ' A' ' 338' ' ' VAL . 50.5 mt -84.24 -26.18 28.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.95 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 315' ' ' ALA . . . . . 0.756 ' HB1' ' HA ' ' A' ' 316' ' ' PRO . . . -51.45 163.3 0.59 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.576 0.703 . . . . 0.0 111.105 179.789 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 316' ' ' PRO . . . . . 0.756 ' HA ' ' HB1' ' A' ' 315' ' ' ALA . 54.1 Cg_endo -69.81 -16.24 12.36 Favored 'Cis proline' 0 C--O 1.232 0.21 0 C-N-CA 122.696 -1.793 . . . . 0.0 112.377 0.005 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 317' ' ' LEU . . . . . 0.576 HD11 ' HB3' ' A' ' 348' ' ' GLN . 23.9 mt -46.7 129.37 11.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.896 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 318' ' ' LYS . . . . . 0.416 ' NZ ' ' HA ' ' A' ' 318' ' ' LYS . 0.2 OUTLIER -105.72 105.75 54.04 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.571 0.701 . . . . 0.0 110.87 179.819 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 178.46 4.57 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.711 2.274 . . . . 0.0 112.297 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 61.8 t -100.01 -37.06 5.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.093 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -160.83 137.95 9.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.118 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 322' ' ' ILE . . . . . 0.49 HG23 HG22 ' A' ' 338' ' ' VAL . 74.0 mt -110.69 109.31 27.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.13 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 63.8 mmt-85 -107.1 105.12 14.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.898 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 324' ' ' ILE . . . . . 0.555 HG21 ' HG3' ' A' ' 332' ' ' LYS . 67.1 mt -76.42 126.97 37.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.127 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 325' ' ' VAL . . . . . 0.466 HG22 ' CD2' ' A' ' 337' ' ' PHE . 48.8 t -64.07 125.29 20.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.16 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 21.3 mtm-85 -97.15 127.95 43.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.874 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -91.38 -58.11 2.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.866 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -99.64 -73.57 0.63 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.116 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 33.0 m80 -124.28 -71.42 0.71 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.855 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -146.41 63.91 0.44 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.513 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -126.87 172.1 10.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.942 0.401 . . . . 0.0 110.898 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 332' ' ' LYS . . . . . 0.555 ' HG3' HG21 ' A' ' 324' ' ' ILE . 6.7 mptt -102.29 93.84 5.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.92 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 2.2 t -84.46 67.64 9.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.161 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 38.81 39.18 0.82 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.548 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 335' ' ' TYR . . . . . 0.541 ' CE1' ' HD3' ' A' ' 299' ' ' ARG . 8.4 m-85 -151.94 133.38 14.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.905 0.383 . . . . 0.0 110.896 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 336' ' ' ILE . . . . . 0.513 HG12 HG23 ' A' ' 324' ' ' ILE . 88.7 mt -151.04 116.19 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.103 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 337' ' ' PHE . . . . . 0.466 ' CD2' HG22 ' A' ' 325' ' ' VAL . 31.6 m-85 -90.55 134.76 34.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.845 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 338' ' ' VAL . . . . . 0.758 HG21 HD11 ' A' ' 314' ' ' LEU . 17.4 t -134.62 141.49 43.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.113 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -113.82 161.33 17.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.849 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -139.18 167.56 21.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.864 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 22.7 m -72.28 -68.46 0.47 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.828 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 342' ' ' ASN . . . . . 0.526 ' ND2' ' HG3' ' A' ' 345' ' ' GLU . 9.1 p30 -99.11 -176.04 3.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.883 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 343' ' ' GLU . . . . . 0.428 ' O ' ' N ' ' A' ' 346' ' ' VAL . 12.0 pt-20 -83.56 -47.26 11.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.884 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -44.01 -30.13 0.69 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.914 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 345' ' ' GLU . . . . . 0.526 ' HG3' ' ND2' ' A' ' 342' ' ' ASN . 16.7 mt-10 -73.59 -35.8 65.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.876 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 346' ' ' VAL . . . . . 0.553 HG21 ' HB3' ' A' ' 294' ' ' HIS . 61.7 t -68.85 -59.12 3.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.163 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.81 -29.04 62.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.893 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 348' ' ' GLN . . . . . 0.576 ' HB3' HD11 ' A' ' 317' ' ' LEU . 29.6 mt-30 -73.11 -32.44 64.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.948 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -62.0 -36.44 81.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.089 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 350' ' ' LEU . . . . . 0.687 HD23 HG12 ' A' ' 364' ' ' VAL . 57.1 mt -60.99 -24.78 66.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.913 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 20.8 mmtp -49.72 -44.87 48.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.948 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 352' ' ' CYS . . . . . . . . . . . . . 22.3 m -78.21 72.28 4.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.865 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -109.24 147.71 32.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.883 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 50.4 ttm-85 70.15 30.44 3.49 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.883 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 355' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -88.52 173.74 8.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.936 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 356' ' ' TYR . . . . . 0.425 ' CD1' ' N ' ' A' ' 356' ' ' TYR . 1.7 m-85 -125.31 117.73 24.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.911 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 357' ' ' MET . . . . . 0.444 ' SD ' ' CD2' ' A' ' 313' ' ' PHE . 4.3 ptm -142.26 123.36 14.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.907 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 86.29 -20.37 22.24 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.51 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 117.24 13.45 7.61 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.494 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 360' ' ' ARG . . . . . . . . . . . . . 21.5 mmt-85 -140.75 158.52 43.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.815 0.34 . . . . 0.0 110.823 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 361' ' ' TYR . . . . . 0.731 ' O ' HD13 ' A' ' 362' ' ' ILE . 13.0 p90 -67.14 163.62 19.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.94 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 362' ' ' ILE . . . . . 0.731 HD13 ' O ' ' A' ' 361' ' ' TYR . 15.1 mm -140.57 144.58 27.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.154 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 363' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -138.42 112.19 8.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.861 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 364' ' ' VAL . . . . . 0.687 HG12 HD23 ' A' ' 350' ' ' LEU . 45.9 t -84.6 134.54 26.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.155 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -131.01 152.94 49.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.913 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 366' ' ' ARG . . . . . 0.403 ' HG3' HD11 ' A' ' 350' ' ' LEU . 51.6 mtm180 -101.43 113.35 26.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.866 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -92.04 104.7 17.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.87 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 44.3 mttm -48.04 -55.51 9.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.9 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 33.8 m -99.99 -49.55 4.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.876 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 65.43 144.92 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.473 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 371' ' ' PRO . . . . . 0.417 ' O ' ' C ' ' A' ' 372' ' ' SER . 54.1 Cg_endo -69.73 -37.01 9.82 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.708 2.272 . . . . 0.0 112.373 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 372' ' ' SER . . . . . 0.417 ' C ' ' O ' ' A' ' 371' ' ' PRO . 23.0 t -37.13 -53.3 1.02 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.908 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 55.5 p -164.19 141.26 6.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.857 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.339 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.524 179.985 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 N-CA-C 112.519 -0.232 . . . . 0.0 112.519 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 285' ' ' SER . . . . . 0.446 ' O ' ' C ' ' A' ' 286' ' ' SER . 1.5 t -131.65 -51.54 0.99 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.864 0.364 . . . . 0.0 110.87 -179.749 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 286' ' ' SER . . . . . 0.446 ' C ' ' O ' ' A' ' 285' ' ' SER . 51.3 p 34.52 42.32 0.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.901 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -134.44 -99.56 0.64 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.486 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 13.9 t -59.06 117.64 4.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.898 0.38 . . . . 0.0 110.864 -179.773 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 61.9 p -64.67 149.67 48.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.83 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 121.63 -153.43 16.72 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.469 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 1.3 m 64.01 54.32 1.72 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.909 0.385 . . . . 0.0 111.119 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 72.6 p -108.74 111.07 22.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.134 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 293' ' ' CYS . . . . . . . . . . . . . 37.8 m -122.29 137.12 54.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.858 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 31.9 m80 -122.65 118.19 27.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.886 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 85.0 m -140.55 143.44 35.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.116 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 296' ' ' VAL . . . . . 0.454 HG23 ' HB ' ' A' ' 338' ' ' VAL . 27.2 m -116.99 147.77 20.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.123 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 13.9 ttmt -125.37 137.38 54.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.921 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 6.8 mp -120.86 118.31 29.63 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.919 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -115.75 155.62 27.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.828 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 86.86 36.58 9.09 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.451 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -102.2 147.72 34.36 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.622 0.725 . . . . 0.0 111.113 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 175.98 7.37 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.713 2.275 . . . . 0.0 112.372 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 56.0 t80 -80.97 -29.26 35.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.876 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -86.89 35.44 0.69 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.903 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 305' ' ' VAL . . . . . . . . . . . . . 11.8 p -98.45 145.05 10.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.116 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 306' ' ' THR . . . . . . . . . . . . . 64.4 p -141.36 164.97 28.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.099 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -44.88 -34.95 2.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.915 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? -57.74 -47.06 83.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.909 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 23.2 m120 -60.19 -59.41 5.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.9 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 85.2 t -48.89 -41.51 13.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.152 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 311' ' ' MET . . . . . . . . . . . . . 2.0 mmt -62.09 -44.76 95.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.861 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -68.24 -26.41 65.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.881 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 313' ' ' PHE . . . . . 0.424 ' CD1' ' C ' ' A' ' 313' ' ' PHE . 5.5 t80 -75.33 -40.91 57.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.866 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.579 ' CD1' HG11 ' A' ' 338' ' ' VAL . 57.9 mt -83.1 -24.89 32.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.921 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 315' ' ' ALA . . . . . 0.533 ' HB1' ' HA ' ' A' ' 316' ' ' PRO . . . -44.58 156.74 0.33 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.579 0.704 . . . . 0.0 111.133 179.76 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 316' ' ' PRO . . . . . 0.533 ' HA ' ' HB1' ' A' ' 315' ' ' ALA . 53.6 Cg_endo -69.85 -19.09 11.52 Favored 'Cis proline' 0 C--O 1.232 0.21 0 C-N-CA 122.661 -1.808 . . . . 0.0 112.332 0.08 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 317' ' ' LEU . . . . . 0.558 HD22 ' HA ' ' A' ' 345' ' ' GLU . 35.7 mt -39.01 138.4 0.57 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.894 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 12.6 tppt? -119.64 107.49 40.57 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.551 0.691 . . . . 0.0 110.889 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 319' ' ' PRO . . . . . 0.426 ' HA ' ' CD2' ' A' ' 340' ' ' PHE . 54.0 Cg_endo -69.78 -171.02 0.43 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.648 2.232 . . . . 0.0 112.333 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 65.2 t -106.68 -41.75 6.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.11 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -155.06 129.8 9.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.118 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 322' ' ' ILE . . . . . 0.495 HG23 HG22 ' A' ' 338' ' ' VAL . 91.7 mt -100.97 99.8 9.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.152 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 9.5 mmm180 -98.74 103.44 15.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.908 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 324' ' ' ILE . . . . . 0.947 HG21 ' HG2' ' A' ' 332' ' ' LYS . 58.7 mt -81.01 134.86 26.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.128 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 325' ' ' VAL . . . . . 0.407 HG22 ' CE2' ' A' ' 337' ' ' PHE . 45.5 t -64.56 80.83 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.16 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 25.6 ptt180 -87.63 139.75 30.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.919 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 327' ' ' ASN . . . . . 0.58 HD21 HG21 ' A' ' 333' ' ' THR . 28.3 m120 -57.04 -179.31 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.87 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -51.94 -54.12 33.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.122 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -65.13 -54.57 27.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.904 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 144.02 66.64 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.469 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -133.81 129.68 36.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.913 0.387 . . . . 0.0 110.901 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 332' ' ' LYS . . . . . 0.947 ' HG2' HG21 ' A' ' 324' ' ' ILE . 33.2 mttt -59.76 131.4 50.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.933 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 333' ' ' THR . . . . . 0.58 HG21 HD21 ' A' ' 327' ' ' ASN . 81.0 p -125.88 74.75 1.44 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.12 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 334' ' ' GLY . . . . . 0.45 ' O ' ' C ' ' A' ' 335' ' ' TYR . . . 46.2 -89.0 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.484 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 335' ' ' TYR . . . . . 0.501 ' N ' ' O ' ' A' ' 333' ' ' THR . 93.2 m-85 -34.24 140.29 0.07 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.919 0.39 . . . . 0.0 110.911 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 336' ' ' ILE . . . . . 0.891 HG12 HG23 ' A' ' 324' ' ' ILE . 30.2 mt -145.63 143.48 21.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.114 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 337' ' ' PHE . . . . . 0.407 ' CE2' HG22 ' A' ' 325' ' ' VAL . 27.5 m-85 -110.67 123.52 50.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.859 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 338' ' ' VAL . . . . . 0.579 HG11 ' CD1' ' A' ' 314' ' ' LEU . 93.8 t -126.0 126.57 69.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.136 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -101.36 160.61 14.27 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.905 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 340' ' ' PHE . . . . . 0.439 ' HB2' ' CG2' ' A' ' 346' ' ' VAL . 35.9 m-85 -134.68 165.86 24.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.862 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 16.9 t -87.79 -55.34 3.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.831 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -89.54 168.04 12.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.895 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -81.96 -43.16 18.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.883 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -56.93 -54.11 50.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.938 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 345' ' ' GLU . . . . . 0.558 ' HA ' HD22 ' A' ' 317' ' ' LEU . 20.8 mm-40 -41.22 -35.81 0.66 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.888 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 346' ' ' VAL . . . . . 0.439 ' CG2' ' HB2' ' A' ' 340' ' ' PHE . 53.0 t -74.86 -50.28 25.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.11 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 15.5 mtpp -53.71 -35.75 61.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.879 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 35.3 mm-40 -71.46 -44.06 65.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.926 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -43.58 -40.1 3.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.099 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 350' ' ' LEU . . . . . . . . . . . . . 54.6 mt -58.88 -39.0 80.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.923 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 56.1 mmtt -45.12 -36.69 3.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.932 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 352' ' ' CYS . . . . . . . . . . . . . 64.6 m -71.2 71.99 0.62 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.908 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 353' ' ' ASN . . . . . 0.401 ' O ' ' C ' ' A' ' 354' ' ' ARG . 16.7 p30 -116.85 -176.46 2.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.913 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 354' ' ' ARG . . . . . 0.401 ' C ' ' O ' ' A' ' 353' ' ' ASN . 54.0 ttt-85 37.29 49.88 0.96 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.83 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 355' ' ' GLU . . . . . 0.438 ' C ' ' OE1' ' A' ' 355' ' ' GLU . 0.0 OUTLIER -135.94 173.38 11.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.899 -179.983 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 356' ' ' TYR . . . . . 0.434 ' CD1' ' N ' ' A' ' 356' ' ' TYR . 2.7 m-85 -131.7 137.14 48.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.902 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 357' ' ' MET . . . . . 0.425 ' CG ' HG13 ' A' ' 362' ' ' ILE . 0.1 OUTLIER -139.04 128.06 23.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.87 179.89 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 83.03 -28.75 3.58 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.479 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 125.26 28.46 1.1 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.5 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 360' ' ' ARG . . . . . . . . . . . . . 33.7 mtt-85 -151.41 156.99 41.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.861 0.363 . . . . 0.0 110.873 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 361' ' ' TYR . . . . . 0.438 ' CG ' ' O ' ' A' ' 361' ' ' TYR . 2.3 p90 -69.66 125.43 26.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.921 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 362' ' ' ILE . . . . . 0.425 HG13 ' CG ' ' A' ' 357' ' ' MET . 17.3 mm -107.18 151.94 8.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.191 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 363' ' ' GLU . . . . . 0.577 ' HB3' ' CZ ' ' A' ' 365' ' ' PHE . 59.9 mm-40 -143.42 112.16 6.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.881 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 15.9 t -87.81 120.85 37.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.151 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 365' ' ' PHE . . . . . 0.577 ' CZ ' ' HB3' ' A' ' 363' ' ' GLU . 70.7 m-85 -124.85 133.32 53.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.847 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 366' ' ' ARG . . . . . 0.43 ' NH1' ' HB3' ' A' ' 366' ' ' ARG . 6.2 ttp-105 -82.25 111.75 18.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.92 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -82.07 106.01 13.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.876 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 2.2 ttmp? -59.44 -46.87 87.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.881 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 65.3 p -93.41 -48.69 6.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.836 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 82.48 -168.39 47.97 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.518 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.69 95.0 0.53 Allowed 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.733 2.289 . . . . 0.0 112.331 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 372' ' ' SER . . . . . . . . . . . . . 1.6 t -112.71 126.84 55.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.863 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 48.3 t -165.17 124.4 1.77 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.883 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.382 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.498 -179.973 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 294' ' ' HIS . . . . . 0.679 ' HB2' HG21 ' A' ' 346' ' ' VAL . 28.5 m-70 . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.865 0.364 . . . . 0.0 110.866 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 63.0 m -139.66 142.35 36.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.142 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 296' ' ' VAL . . . . . 0.542 ' CG1' HG13 ' A' ' 346' ' ' VAL . 29.2 m -118.5 151.06 20.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.145 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . 0.429 ' C ' HD12 ' A' ' 298' ' ' LEU . 5.5 ttpm? -119.62 138.51 53.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.868 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . 0.429 HD12 ' C ' ' A' ' 297' ' ' LYS . 7.4 mp -126.36 128.47 47.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.927 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 27.2 ptt180 -131.93 163.39 28.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.839 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . 0.472 ' C ' HD13 ' A' ' 362' ' ' ILE . . . 90.99 28.23 16.14 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.527 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -98.22 148.45 34.52 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.545 0.688 . . . . 0.0 111.115 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -165.9 0.17 Allowed 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.702 2.268 . . . . 0.0 112.303 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -93.21 -13.97 27.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.863 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -102.68 27.6 6.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.935 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 305' ' ' VAL . . . . . . . . . . . . . 10.6 p -90.41 141.78 13.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.068 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 306' ' ' THR . . . . . . . . . . . . . 35.2 p -139.26 -179.05 5.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.137 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -55.26 -35.91 65.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.876 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 28.1 tttp -58.13 -59.37 5.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.881 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -46.1 -47.68 17.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.882 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 58.4 t -58.34 -44.94 89.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.098 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 311' ' ' MET . . . . . . . . . . . . . 4.0 mmt -58.49 -52.0 67.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.884 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -64.12 -29.27 70.41 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.86 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 313' ' ' PHE . . . . . 0.475 ' C ' ' CD1' ' A' ' 313' ' ' PHE . 3.1 t80 -75.49 -41.34 55.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.907 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.452 ' CD1' HG11 ' A' ' 338' ' ' VAL . 46.5 mt -81.65 -25.83 35.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.922 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 315' ' ' ALA . . . . . 0.852 ' HB1' ' HA ' ' A' ' 316' ' ' PRO . . . -46.37 166.56 0.16 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.647 0.736 . . . . 0.0 111.084 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 316' ' ' PRO . . . . . 0.852 ' HA ' ' HB1' ' A' ' 315' ' ' ALA . 54.4 Cg_endo -69.68 -3.58 7.67 Favored 'Cis proline' 0 C--O 1.232 0.205 0 C-N-CA 122.66 -1.808 . . . . 0.0 112.386 -0.044 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 317' ' ' LEU . . . . . 0.668 HD22 ' HA ' ' A' ' 345' ' ' GLU . 20.8 mt -53.19 156.32 2.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.908 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 9.6 tttp -130.83 102.71 16.12 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.593 0.711 . . . . 0.0 110.895 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 319' ' ' PRO . . . . . 0.506 ' HA ' ' CD2' ' A' ' 340' ' ' PHE . 53.5 Cg_endo -69.77 -179.07 2.66 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.691 2.261 . . . . 0.0 112.333 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 320' ' ' VAL . . . . . 0.415 HG23 ' HA ' ' A' ' 340' ' ' PHE . 21.7 t -100.72 -39.25 6.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.112 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -156.15 129.92 8.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.086 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 322' ' ' ILE . . . . . 0.49 HG23 HG22 ' A' ' 338' ' ' VAL . 54.3 mt -105.78 99.79 9.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.124 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 18.6 mtp85 -94.0 118.62 31.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.874 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 51.7 mt -87.06 124.37 40.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.139 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . 0.687 HG21 ' HB3' ' A' ' 335' ' ' TYR . 53.7 t . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.152 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 335' ' ' TYR . . . . . 0.687 ' HB3' HG21 ' A' ' 325' ' ' VAL . 14.9 m-85 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.833 0.349 . . . . 0.0 110.914 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 67.5 mt -145.27 117.13 2.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.167 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . 0.664 ' CE2' HG22 ' A' ' 325' ' ' VAL . 71.5 m-85 -87.47 121.35 29.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.835 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . 0.49 HG22 HG23 ' A' ' 322' ' ' ILE . 46.4 t -124.43 132.06 71.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.138 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 43.4 m-20 -107.95 161.01 15.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.866 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 340' ' ' PHE . . . . . 0.555 ' CD2' ' HB3' ' A' ' 345' ' ' GLU . 62.1 m-85 -138.08 168.78 19.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.895 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 9.5 t -85.22 -62.2 1.59 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.829 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -99.51 150.0 22.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.902 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 343' ' ' GLU . . . . . 0.56 ' HG3' ' CE1' ' A' ' 294' ' ' HIS . 23.3 tt0 -54.72 -45.27 74.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.888 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -40.17 -64.19 0.53 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.871 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 345' ' ' GLU . . . . . 0.668 ' HA ' HD22 ' A' ' 317' ' ' LEU . 16.0 mm-40 -39.43 -46.17 1.62 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.875 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . 0.679 HG21 ' HB2' ' A' ' 294' ' ' HIS . 65.9 t -67.38 -52.24 44.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.112 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 20.6 mtpp -50.73 -39.85 52.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.865 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -73.87 -30.07 62.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.931 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -56.68 -35.56 68.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.055 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 350' ' ' LEU . . . . . . . . . . . . . 83.7 mt -65.5 -35.77 81.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.963 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 76.4 mttt -45.92 -50.29 14.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.914 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 352' ' ' CYS . . . . . . . . . . . . . 31.7 m -69.06 72.23 0.26 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.92 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -107.68 158.94 16.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.902 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 70.0 mtt180 54.22 46.72 24.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.907 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 355' ' ' GLU . . . . . 0.478 ' C ' ' CD1' ' A' ' 356' ' ' TYR . 1.5 mm-40 -98.55 173.84 6.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.932 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 356' ' ' TYR . . . . . 0.478 ' CD1' ' C ' ' A' ' 355' ' ' GLU . 2.9 m-85 -139.22 115.98 10.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.958 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 357' ' ' MET . . . . . . . . . . . . . 3.6 ptt? -142.07 145.96 34.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.902 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 78.01 -46.81 2.74 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.487 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 359' ' ' GLY . . . . . 0.433 ' O ' ' CG ' ' A' ' 360' ' ' ARG . . . 141.74 34.89 0.1 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.477 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 360' ' ' ARG . . . . . 0.433 ' CG ' ' O ' ' A' ' 359' ' ' GLY . 56.8 mtt180 -164.3 156.04 16.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.793 0.33 . . . . 0.0 110.897 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 361' ' ' TYR . . . . . 0.519 ' O ' ' CD1' ' A' ' 361' ' ' TYR . 1.8 p90 -70.66 133.48 46.7 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.871 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 362' ' ' ILE . . . . . 0.472 HD13 ' C ' ' A' ' 300' ' ' GLY . 27.2 mm -111.98 143.75 21.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.128 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 363' ' ' GLU . . . . . 0.53 ' HB3' ' CZ ' ' A' ' 365' ' ' PHE . 21.1 mm-40 -130.96 113.18 13.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.904 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 21.6 t -88.68 141.85 13.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.129 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 365' ' ' PHE . . . . . 0.53 ' CZ ' ' HB3' ' A' ' 363' ' ' GLU . 56.7 m-85 -141.8 141.49 33.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.906 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 31.7 ttt180 -87.71 114.78 24.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.841 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.869 -179.956 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 294' ' ' HIS . . . . . 0.946 ' CB ' HG21 ' A' ' 346' ' ' VAL . 22.7 m-70 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.88 0.371 . . . . 0.0 110.876 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 6.3 m -134.0 133.85 41.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.121 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 296' ' ' VAL . . . . . 0.453 HG13 HG13 ' A' ' 346' ' ' VAL . 36.0 m -112.05 148.64 15.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.147 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . 0.56 ' C ' HD12 ' A' ' 298' ' ' LEU . 8.2 ttpm? -117.96 150.6 38.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.884 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . 0.56 HD12 ' C ' ' A' ' 297' ' ' LYS . 7.0 mp -132.92 152.23 51.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.956 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 13.2 ptt180 -154.16 176.44 12.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.825 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 82.79 -21.36 7.79 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.555 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -58.2 151.78 45.19 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.637 0.732 . . . . 0.0 111.062 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.8 178.6 4.43 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.705 2.27 . . . . 0.0 112.313 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -85.17 -15.66 42.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.902 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 35.7 t-20 -99.24 35.75 1.87 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.904 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 305' ' ' VAL . . . . . . . . . . . . . 6.3 p -100.8 142.55 15.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.155 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 306' ' ' THR . . . . . . . . . . . . . 25.5 p -128.46 164.74 22.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.13 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -44.35 -50.25 9.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.881 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -43.53 -52.12 6.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.865 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -56.13 -43.87 78.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.889 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 92.2 t -61.98 -39.06 82.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.153 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 311' ' ' MET . . . . . . . . . . . . . 4.1 mmt -63.67 -44.17 94.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.858 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -67.96 -29.06 68.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.907 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 313' ' ' PHE . . . . . 0.437 ' CE2' HD21 ' A' ' 298' ' ' LEU . 36.6 t80 -72.64 -47.06 50.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.9 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.447 ' CD1' HG11 ' A' ' 338' ' ' VAL . 49.4 mt -79.04 -18.27 53.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.904 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 315' ' ' ALA . . . . . 0.872 ' HB1' ' HA ' ' A' ' 316' ' ' PRO . . . -51.25 166.78 0.31 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.613 0.72 . . . . 0.0 111.082 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 316' ' ' PRO . . . . . 0.872 ' HA ' ' HB1' ' A' ' 315' ' ' ALA . 54.0 Cg_endo -69.72 -3.81 7.87 Favored 'Cis proline' 0 C--O 1.232 0.204 0 C-N-CA 122.72 -1.783 . . . . 0.0 112.321 -0.004 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 317' ' ' LEU . . . . . 0.487 ' N ' ' HA ' ' A' ' 315' ' ' ALA . 19.4 mt -50.72 165.28 0.11 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.897 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 35.3 tttt -140.4 105.05 6.51 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.609 0.718 . . . . 0.0 110.889 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -177.61 1.94 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.684 2.256 . . . . 0.0 112.359 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 59.1 t -100.58 -41.41 8.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.145 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -158.2 134.57 9.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.079 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 322' ' ' ILE . . . . . . . . . . . . . 60.9 mt -105.6 101.56 12.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.121 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 20.5 mmt85 -96.29 96.79 9.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.847 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 74.6 mt -68.0 122.14 18.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.124 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . 0.494 HG22 ' CD2' ' A' ' 337' ' ' PHE . 47.0 t . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.156 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 335' ' ' TYR . . . . . 0.4 ' HB2' HG21 ' A' ' 325' ' ' VAL . 11.7 m-85 . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.876 0.369 . . . . 0.0 110.866 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 55.3 mt -137.64 122.96 24.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.158 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . 0.494 ' CD2' HG22 ' A' ' 325' ' ' VAL . 30.8 m-85 -98.05 126.58 43.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.87 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . 0.447 HG11 ' CD1' ' A' ' 314' ' ' LEU . 99.1 t -124.0 131.01 73.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.132 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -105.55 160.41 15.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.879 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -137.94 166.0 25.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.887 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 2.1 m -90.64 -44.19 9.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.891 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -98.63 169.39 9.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.926 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 343' ' ' GLU . . . . . 0.422 ' HB3' ' CE1' ' A' ' 294' ' ' HIS . 2.2 mp0 -85.15 -55.48 4.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.882 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -43.32 -46.72 6.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.863 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -50.05 -39.04 40.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.912 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . 0.946 HG21 ' CB ' ' A' ' 294' ' ' HIS . 46.3 t -70.35 -58.24 5.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.15 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 15.7 mtmt -50.03 -26.21 4.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.91 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 25.2 mm100 -82.54 -38.95 23.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.918 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -47.32 -30.93 3.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.131 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 350' ' ' LEU . . . . . 0.476 HD23 HG12 ' A' ' 364' ' ' VAL . 48.0 mt -63.78 -36.96 85.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.873 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -47.19 -44.2 21.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.92 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 352' ' ' CYS . . . . . . . . . . . . . 8.0 m -64.59 83.19 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.922 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . 0.449 ' O ' ' CG ' ' A' ' 354' ' ' ARG . 48.8 t30 -140.43 177.91 7.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.868 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . 0.449 ' CG ' ' O ' ' A' ' 353' ' ' ASN . 7.9 ptp85 44.78 37.22 2.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.904 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 355' ' ' GLU . . . . . 0.423 ' C ' ' CD ' ' A' ' 355' ' ' GLU . 0.0 OUTLIER -125.69 172.63 9.63 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.904 -179.974 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 356' ' ' TYR . . . . . 0.414 ' N ' ' CD1' ' A' ' 356' ' ' TYR . 1.8 m-85 -118.94 146.61 44.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.911 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 357' ' ' MET . . . . . . . . . . . . . 3.2 ptt? -164.24 125.58 2.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.887 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 86.02 -31.75 3.95 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.449 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 359' ' ' GLY . . . . . 0.461 ' O ' ' CG ' ' A' ' 360' ' ' ARG . . . 126.91 30.6 0.8 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.509 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 360' ' ' ARG . . . . . 0.461 ' CG ' ' O ' ' A' ' 359' ' ' GLY . 59.8 mtt180 -164.76 164.59 21.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.743 0.306 . . . . 0.0 110.93 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 361' ' ' TYR . . . . . . . . . . . . . 27.3 p90 -67.05 159.34 28.93 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.891 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 12.5 mm -138.07 125.22 28.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.11 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 363' ' ' GLU . . . . . 0.438 ' HB3' ' CZ ' ' A' ' 365' ' ' PHE . 28.2 mm-40 -118.85 118.23 30.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.824 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 364' ' ' VAL . . . . . 0.476 HG12 HD23 ' A' ' 350' ' ' LEU . 93.8 t -95.15 143.78 11.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.123 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 365' ' ' PHE . . . . . 0.438 ' CZ ' ' HB3' ' A' ' 363' ' ' GLU . 68.6 m-85 -141.97 148.95 39.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.863 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 35.7 ttp85 -96.98 112.18 24.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.884 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.881 -179.934 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 294' ' ' HIS . . . . . 0.705 ' HB3' HG21 ' A' ' 346' ' ' VAL . 3.8 m170 . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.864 0.364 . . . . 0.0 110.838 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 12.1 m -125.64 142.43 51.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.147 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 27.0 m -118.64 147.47 22.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.124 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . 0.402 ' NZ ' ' HB3' ' A' ' 297' ' ' LYS . 0.2 OUTLIER -120.85 138.78 53.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.925 179.858 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 6.9 mp -119.57 141.9 48.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.926 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 299' ' ' ARG . . . . . 0.435 ' HB2' ' CE1' ' A' ' 335' ' ' TYR . 13.3 ptt180 -141.58 151.14 42.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.887 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 96.24 16.66 36.99 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.488 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -78.87 147.29 70.19 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.566 0.698 . . . . 0.0 111.105 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.69 169.79 18.0 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.698 2.265 . . . . 0.0 112.386 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 303' ' ' PHE . . . . . 0.458 ' O ' ' CG ' ' A' ' 303' ' ' PHE . 10.3 t80 -70.93 -8.93 56.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.858 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -111.51 41.42 1.89 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.923 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 305' ' ' VAL . . . . . . . . . . . . . 7.7 p -101.98 149.23 6.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.132 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 306' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -148.31 167.26 25.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.178 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -49.68 -20.41 0.81 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.921 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 9.9 ttmm -74.88 -53.32 9.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.852 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -51.67 -34.16 37.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.87 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 54.2 t -69.74 -46.01 75.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.146 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 311' ' ' MET . . . . . 0.43 ' HG2' ' CD1' ' A' ' 322' ' ' ILE . 4.1 mmt -53.37 -48.25 68.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.87 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -68.17 -25.5 65.28 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.929 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 313' ' ' PHE . . . . . 0.494 ' C ' ' CD1' ' A' ' 313' ' ' PHE . 2.6 t80 -75.58 -46.81 29.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.886 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.544 ' CD1' HG11 ' A' ' 338' ' ' VAL . 65.4 mt -78.01 -25.39 47.94 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.919 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 315' ' ' ALA . . . . . 0.859 ' HB1' ' HA ' ' A' ' 316' ' ' PRO . . . -44.4 166.25 0.12 Allowed Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.585 0.707 . . . . 0.0 111.08 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 316' ' ' PRO . . . . . 0.859 ' HA ' ' HB1' ' A' ' 315' ' ' ALA . 53.5 Cg_endo -69.72 -3.77 7.84 Favored 'Cis proline' 0 C--N 1.341 0.178 0 C-N-CA 122.664 -1.806 . . . . 0.0 112.361 0.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 317' ' ' LEU . . . . . 0.485 ' N ' ' HA ' ' A' ' 315' ' ' ALA . 27.7 mt -50.03 170.8 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.895 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 33.3 tttt -145.24 105.05 4.38 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.551 0.691 . . . . 0.0 110.923 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 319' ' ' PRO . . . . . 0.498 ' HA ' ' CD2' ' A' ' 340' ' ' PHE . 53.5 Cg_endo -69.79 -175.94 1.33 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.692 2.261 . . . . 0.0 112.33 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 31.1 t -101.12 -39.78 7.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.12 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -156.84 131.64 8.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.123 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 322' ' ' ILE . . . . . 0.548 HG12 HG13 ' A' ' 338' ' ' VAL . 66.7 mt -110.23 108.74 26.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.131 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 27.7 mmm-85 -108.18 121.85 45.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.877 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 324' ' ' ILE . . . . . 0.412 HG23 HG12 ' A' ' 336' ' ' ILE . 60.8 mt -89.71 120.59 38.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.131 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . 0.432 HG21 ' HB3' ' A' ' 335' ' ' TYR . 20.6 t . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.107 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 335' ' ' TYR . . . . . 0.435 ' CE1' ' HB2' ' A' ' 299' ' ' ARG . 3.6 m-85 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.84 0.352 . . . . 0.0 110.938 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 336' ' ' ILE . . . . . 0.412 HG12 HG23 ' A' ' 324' ' ' ILE . 43.5 mt -145.95 147.51 18.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.169 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -119.89 128.46 53.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.879 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . 0.548 HG13 HG12 ' A' ' 322' ' ' ILE . 21.7 t -129.31 136.82 58.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.167 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -113.74 155.46 25.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.857 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 340' ' ' PHE . . . . . 0.499 ' HB2' HG23 ' A' ' 346' ' ' VAL . 53.5 m-85 -132.08 166.35 21.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.848 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 36.2 p -88.53 -58.12 2.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.896 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 67.3 m-80 -87.63 159.13 18.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.925 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -78.28 -23.54 47.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.902 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -67.64 -49.25 63.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.894 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -48.58 -50.3 33.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.848 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . 0.705 HG21 ' HB3' ' A' ' 294' ' ' HIS . 54.9 t -60.8 -56.01 20.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.143 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 24.9 mtpp -51.38 -32.62 26.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.877 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -83.27 -24.03 32.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.879 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -65.0 -26.25 68.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.075 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 350' ' ' LEU . . . . . 0.615 HD23 HG12 ' A' ' 364' ' ' VAL . 42.8 mt -75.34 -7.83 55.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.919 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 1.5 mmmp? -72.95 -32.61 65.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.915 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 352' ' ' CYS . . . . . . . . . . . . . 15.5 m -79.69 72.36 6.37 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.899 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -122.55 174.08 7.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.906 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 23.6 mtt180 53.22 28.42 7.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.847 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 355' ' ' GLU . . . . . 0.411 ' C ' ' OE1' ' A' ' 355' ' ' GLU . 0.0 OUTLIER -117.7 174.45 6.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.906 -179.951 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 356' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -124.8 128.14 48.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.925 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 357' ' ' MET . . . . . 0.445 ' HG3' ' CD1' ' A' ' 362' ' ' ILE . 0.0 OUTLIER -130.77 130.92 44.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.875 179.914 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 83.14 -41.7 2.93 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.462 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 359' ' ' GLY . . . . . 0.447 ' O ' ' CG ' ' A' ' 360' ' ' ARG . . . 141.92 33.27 0.12 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.468 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 360' ' ' ARG . . . . . 0.447 ' CG ' ' O ' ' A' ' 359' ' ' GLY . 71.5 mtt180 -165.19 161.64 19.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.794 0.331 . . . . 0.0 110.924 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 361' ' ' TYR . . . . . 0.443 ' O ' HD13 ' A' ' 362' ' ' ILE . 13.6 p90 -63.74 144.27 57.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.976 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 362' ' ' ILE . . . . . 0.445 ' CD1' ' HG3' ' A' ' 357' ' ' MET . 6.5 mm -130.72 135.05 61.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.161 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 363' ' ' GLU . . . . . 0.513 ' HB2' ' CZ ' ' A' ' 365' ' ' PHE . 15.7 mt-10 -126.35 112.71 15.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.864 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 364' ' ' VAL . . . . . 0.615 HG12 HD23 ' A' ' 350' ' ' LEU . 57.3 t -88.61 124.0 41.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.129 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 365' ' ' PHE . . . . . 0.513 ' CZ ' ' HB2' ' A' ' 363' ' ' GLU . 21.9 m-85 -121.66 142.74 49.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.856 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . 0.438 ' HB3' ' CZ ' ' A' ' 366' ' ' ARG . 9.8 ttp-105 -84.94 127.98 34.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.871 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.921 -179.934 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 294' ' ' HIS . . . . . 0.841 ' HB3' HG21 ' A' ' 346' ' ' VAL . 33.6 m80 . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.907 0.384 . . . . 0.0 110.9 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 26.5 m -139.42 139.65 37.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.161 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 296' ' ' VAL . . . . . 0.501 ' CG1' HG13 ' A' ' 346' ' ' VAL . 33.2 m -112.27 148.88 15.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.154 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . 0.563 ' HE3' ' CD1' ' A' ' 335' ' ' TYR . 56.4 tttt -122.55 131.19 53.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.931 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 7.9 mp -108.82 154.55 21.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.885 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 299' ' ' ARG . . . . . 0.507 ' HD2' ' CE1' ' A' ' 335' ' ' TYR . 13.0 ttt-85 -162.08 136.02 6.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.878 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 128.6 -18.19 5.74 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.487 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -65.64 151.42 94.69 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.547 0.689 . . . . 0.0 111.117 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -176.4 1.48 Allowed 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.679 2.253 . . . . 0.0 112.347 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 303' ' ' PHE . . . . . 0.484 ' C ' ' CD1' ' A' ' 303' ' ' PHE . 0.5 OUTLIER -76.43 -27.74 56.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.931 179.986 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 23.8 p-10 -92.81 43.76 1.13 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.893 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 305' ' ' VAL . . . . . . . . . . . . . 12.7 p -101.98 141.02 19.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.106 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 306' ' ' THR . . . . . . . . . . . . . 66.8 p -130.93 169.38 15.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.169 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -46.7 -45.91 19.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.903 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 20.9 ttmm -48.29 -57.07 6.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.919 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 25.4 m120 -48.45 -41.76 30.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.904 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 310' ' ' VAL . . . . . 0.443 HG21 HD13 ' A' ' 336' ' ' ILE . 95.9 t -69.33 -42.01 81.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.109 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 311' ' ' MET . . . . . . . . . . . . . 3.6 mmt -58.41 -50.38 73.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.896 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -65.77 -24.83 67.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.883 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 313' ' ' PHE . . . . . 0.602 ' C ' ' CD1' ' A' ' 313' ' ' PHE . 0.5 OUTLIER -83.77 -28.68 28.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.888 -179.938 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.598 HD11 HG21 ' A' ' 338' ' ' VAL . 33.1 mt -90.9 -23.66 20.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.865 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 315' ' ' ALA . . . . . 0.825 ' HB1' ' HA ' ' A' ' 316' ' ' PRO . . . -52.1 166.02 0.44 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.546 0.688 . . . . 0.0 111.136 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 316' ' ' PRO . . . . . 0.825 ' HA ' ' HB1' ' A' ' 315' ' ' ALA . 53.6 Cg_endo -69.72 -7.6 9.98 Favored 'Cis proline' 0 C--O 1.231 0.161 0 C-N-CA 122.703 -1.791 . . . . 0.0 112.328 -0.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 317' ' ' LEU . . . . . 0.413 ' N ' ' HA ' ' A' ' 315' ' ' ALA . 47.3 mt -56.04 144.35 29.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.883 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 14.3 tptp -120.42 110.73 35.51 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.563 0.696 . . . . 0.0 110.86 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 319' ' ' PRO . . . . . 0.513 ' HA ' ' CD1' ' A' ' 340' ' ' PHE . 53.7 Cg_endo -69.78 -163.83 0.12 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.694 2.262 . . . . 0.0 112.328 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 21.7 t -118.61 -41.25 2.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.131 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -151.69 124.13 8.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.075 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 322' ' ' ILE . . . . . . . . . . . . . 65.4 mt -98.86 102.39 13.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.141 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 9.2 tpt180 -86.1 116.04 24.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.82 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 72.5 mt -88.63 117.11 31.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.115 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 50.7 t . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.124 179.811 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 335' ' ' TYR . . . . . 0.563 ' CD1' ' HE3' ' A' ' 297' ' ' LYS . 7.0 m-85 . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.811 0.338 . . . . 0.0 110.995 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 336' ' ' ILE . . . . . 0.443 HD13 HG21 ' A' ' 310' ' ' VAL . 85.4 mt -149.73 136.93 13.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.188 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . 0.58 ' CD1' ' OE2' ' A' ' 367' ' ' GLU . 55.5 m-85 -108.71 116.08 31.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.889 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . 0.598 HG21 HD11 ' A' ' 314' ' ' LEU . 87.0 t -112.62 127.67 69.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.117 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -105.36 139.19 40.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.854 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 340' ' ' PHE . . . . . 0.513 ' CD1' ' HA ' ' A' ' 319' ' ' PRO . 64.2 m-85 -117.22 157.86 25.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.887 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 2.4 m -79.11 -56.07 4.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.872 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 47.3 m-20 -91.93 158.3 16.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.871 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 343' ' ' GLU . . . . . 0.429 ' HG2' ' CE1' ' A' ' 294' ' ' HIS . 53.7 mt-10 -71.46 -44.84 64.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.892 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -47.91 -50.5 26.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.874 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -46.19 -45.65 16.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.91 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . 0.841 HG21 ' HB3' ' A' ' 294' ' ' HIS . 66.7 t -68.14 -52.08 41.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.118 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 25.1 mtpp -51.37 -38.44 53.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.903 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 70.4 mm-40 -78.13 -42.85 30.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.886 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -42.8 -42.4 3.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.054 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 350' ' ' LEU . . . . . 0.602 HD23 HG12 ' A' ' 364' ' ' VAL . 40.3 mt -58.85 -42.95 90.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.879 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 65.6 mmtt -42.89 -48.05 5.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.893 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 352' ' ' CYS . . . . . . . . . . . . . 19.9 m -69.11 72.68 0.28 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.883 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -112.55 156.01 23.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.923 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 7.6 ttt85 66.72 29.27 8.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.896 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 355' ' ' GLU . . . . . 0.428 ' HB2' ' CE2' ' A' ' 313' ' ' PHE . 4.4 mm-40 -83.87 173.4 11.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.861 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 356' ' ' TYR . . . . . 0.45 ' N ' ' CD1' ' A' ' 356' ' ' TYR . 1.3 m-85 -131.8 127.41 36.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.904 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 357' ' ' MET . . . . . . . . . . . . . 3.9 ptt? -154.74 142.32 19.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.859 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 78.45 -42.86 2.24 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.448 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 135.65 29.76 0.36 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.542 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 360' ' ' ARG . . . . . . . . . . . . . 61.3 mtt-85 -158.67 158.09 33.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.789 0.328 . . . . 0.0 110.929 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 361' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -66.88 157.17 33.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.941 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 9.1 mm -140.15 149.55 21.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.145 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 363' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -137.17 121.0 17.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.907 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 364' ' ' VAL . . . . . 0.602 HG12 HD23 ' A' ' 350' ' ' LEU . 72.0 t -90.48 131.83 36.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.166 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -125.76 138.62 53.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.874 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . 0.554 ' HB2' HD21 ' A' ' 350' ' ' LEU . 18.2 ttp180 -92.67 109.31 20.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.863 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 367' ' ' GLU . . . . . 0.58 ' OE2' ' CD1' ' A' ' 337' ' ' PHE . 20.1 mt-10 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.866 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 294' ' ' HIS . . . . . 0.84 ' HB3' HG21 ' A' ' 346' ' ' VAL . 33.4 m80 . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.818 0.342 . . . . 0.0 110.858 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 25.5 m -121.17 142.65 49.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.182 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 296' ' ' VAL . . . . . 0.548 HG22 ' O ' ' A' ' 338' ' ' VAL . 28.2 m -119.15 149.49 21.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.121 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . 0.527 ' HG3' ' CE1' ' A' ' 337' ' ' PHE . 16.8 ttmt -117.37 143.62 45.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.896 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . 0.445 HD12 ' C ' ' A' ' 297' ' ' LYS . 7.1 mp -122.0 121.43 37.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.917 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 299' ' ' ARG . . . . . 0.618 ' NE ' ' CD2' ' A' ' 365' ' ' PHE . 25.4 mtt180 -122.36 162.01 22.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.896 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 95.12 -23.28 34.07 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.511 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -56.13 152.49 21.93 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.588 0.708 . . . . 0.0 111.11 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.71 -173.14 0.66 Allowed 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.701 2.267 . . . . 0.0 112.376 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -90.7 -26.03 19.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.891 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -95.34 44.44 1.09 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.886 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 305' ' ' VAL . . . . . . . . . . . . . 10.8 p -105.22 139.69 25.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.134 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 306' ' ' THR . . . . . . . . . . . . . 41.6 p -124.33 171.2 10.09 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.151 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -48.61 -54.14 15.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.862 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 21.5 ttmt -41.34 -48.81 3.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.91 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -56.95 -41.06 77.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.908 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 87.2 t -65.7 -51.23 64.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.093 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 311' ' ' MET . . . . . . . . . . . . . 3.2 mmt -51.58 -40.06 59.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.851 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -74.09 -30.81 62.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.885 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 313' ' ' PHE . . . . . 0.607 ' CZ ' HG21 ' A' ' 362' ' ' ILE . 27.2 t80 -73.24 -41.67 63.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.892 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.785 ' CD1' HG11 ' A' ' 338' ' ' VAL . 86.9 mt -80.95 -26.11 36.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.922 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 315' ' ' ALA . . . . . 0.677 ' HB1' ' HA ' ' A' ' 316' ' ' PRO . . . -45.54 161.54 0.24 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.569 0.7 . . . . 0.0 111.097 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 316' ' ' PRO . . . . . 0.677 ' HA ' ' HB1' ' A' ' 315' ' ' ALA . 53.9 Cg_endo -69.71 -13.76 12.32 Favored 'Cis proline' 0 C--O 1.232 0.219 0 C-N-CA 122.725 -1.781 . . . . 0.0 112.341 -0.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 317' ' ' LEU . . . . . 0.406 HD13 ' O ' ' A' ' 345' ' ' GLU . 83.1 mt -43.09 135.13 3.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.916 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 4.9 tmtt? -111.71 100.54 48.65 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.574 0.702 . . . . 0.0 110.905 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 319' ' ' PRO . . . . . 0.514 ' HA ' ' CD2' ' A' ' 340' ' ' PHE . 53.9 Cg_endo -69.77 -175.39 1.14 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.644 2.23 . . . . 0.0 112.36 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 39.0 t -100.04 -43.63 11.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.102 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -157.3 144.19 18.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.138 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 322' ' ' ILE . . . . . 0.46 HG23 HG22 ' A' ' 338' ' ' VAL . 60.4 mt -116.15 103.41 15.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.112 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 55.2 mtt-85 -98.42 116.3 30.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.862 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 60.0 mt -85.87 124.89 40.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.114 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . 0.554 ' CG2' ' CD2' ' A' ' 337' ' ' PHE . 15.8 t . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.104 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 335' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.835 0.35 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 78.5 mt -146.9 149.11 16.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.145 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . 0.554 ' CD2' ' CG2' ' A' ' 325' ' ' VAL . 17.4 m-85 -121.38 122.02 38.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.902 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . 0.785 HG11 ' CD1' ' A' ' 314' ' ' LEU . 38.1 t -121.21 126.02 74.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.114 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -104.14 157.29 17.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.884 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 340' ' ' PHE . . . . . 0.607 ' HB2' HG23 ' A' ' 346' ' ' VAL . 69.4 m-85 -134.52 167.96 19.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.881 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 30.8 t -87.65 -57.2 3.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.881 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -89.91 160.18 16.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.893 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 343' ' ' GLU . . . . . 0.516 ' HB3' ' CE1' ' A' ' 294' ' ' HIS . 10.5 pt-20 -78.05 -14.35 59.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.874 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -75.73 -44.51 41.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.906 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 345' ' ' GLU . . . . . 0.521 ' HB3' ' CD2' ' A' ' 340' ' ' PHE . 45.5 mt-10 -55.4 -40.17 71.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.883 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . 0.84 HG21 ' HB3' ' A' ' 294' ' ' HIS . 67.3 t -74.17 -41.28 51.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.158 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 33.5 mtpt -59.89 -29.54 68.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.882 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -88.16 -28.34 21.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.907 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -55.57 -35.72 66.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.082 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 350' ' ' LEU . . . . . 0.602 HD23 HG12 ' A' ' 364' ' ' VAL . 42.6 mt -67.41 -38.63 84.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.905 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 16.8 mmtp -56.63 -25.47 53.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.909 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 352' ' ' CYS . . . . . . . . . . . . . 40.4 t -78.44 57.9 2.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.86 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -110.57 170.64 7.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.906 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 13.4 mmt180 61.85 29.24 17.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.83 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 355' ' ' GLU . . . . . 0.516 ' C ' ' CD1' ' A' ' 356' ' ' TYR . 12.4 mm-40 -97.68 172.5 7.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.908 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 356' ' ' TYR . . . . . 0.516 ' CD1' ' C ' ' A' ' 355' ' ' GLU . 1.3 m-85 -138.44 122.87 18.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.931 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 357' ' ' MET . . . . . . . . . . . . . 1.7 ptt? -148.23 155.74 41.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.878 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 60.57 7.93 8.71 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.449 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 83.76 27.18 39.21 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.517 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 360' ' ' ARG . . . . . . . . . . . . . 15.1 mmm180 -147.68 177.43 9.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.8 0.333 . . . . 0.0 110.893 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 361' ' ' TYR . . . . . . . . . . . . . 29.2 p90 -92.39 149.3 21.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.891 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 362' ' ' ILE . . . . . 0.607 HG21 ' CZ ' ' A' ' 313' ' ' PHE . 14.5 mm -118.64 149.93 20.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.127 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 363' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -141.02 112.67 7.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.891 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 364' ' ' VAL . . . . . 0.602 HG12 HD23 ' A' ' 350' ' ' LEU . 11.2 t -88.23 140.7 15.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.148 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 365' ' ' PHE . . . . . 0.618 ' CD2' ' NE ' ' A' ' 299' ' ' ARG . 72.4 m-85 -139.93 143.7 36.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.891 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 17.7 ttp85 -91.81 122.19 34.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.836 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 367' ' ' GLU . . . . . 0.411 ' OE1' ' N ' ' A' ' 297' ' ' LYS . 5.7 mp0 . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.829 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 294' ' ' HIS . . . . . 0.417 ' CB ' HG21 ' A' ' 346' ' ' VAL . 15.4 m-70 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.9 0.381 . . . . 0.0 110.897 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 54.5 m -121.41 150.1 42.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.141 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 296' ' ' VAL . . . . . 0.669 HG13 HG13 ' A' ' 346' ' ' VAL . 27.3 m -118.02 146.16 22.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.113 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . 0.558 ' HG3' ' CE1' ' A' ' 337' ' ' PHE . 16.3 ttmt -117.67 142.68 46.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.917 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . 0.473 HD12 ' C ' ' A' ' 297' ' ' LYS . 7.9 mp -123.67 135.63 54.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.913 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 9.7 ttm-85 -144.76 132.94 21.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.877 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 129.18 -19.89 5.38 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.455 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -57.75 152.15 38.28 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.571 0.7 . . . . 0.0 111.1 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.72 177.38 5.61 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.711 2.274 . . . . 0.0 112.338 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -72.37 -24.11 61.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.9 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -98.71 47.78 0.98 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.891 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 305' ' ' VAL . . . . . . . . . . . . . 9.4 p -104.62 141.44 20.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.148 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 306' ' ' THR . . . . . . . . . . . . . 66.6 p -136.3 162.86 31.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.155 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -37.85 -46.74 0.97 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.923 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 36.4 tttm -45.5 -56.83 4.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.886 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 21.2 m120 -50.82 -49.11 59.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.905 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 86.9 t -58.0 -41.54 80.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.082 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 311' ' ' MET . . . . . . . . . . . . . 1.9 mmt -61.12 -53.08 61.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.86 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.64 -36.23 78.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.905 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -70.67 -44.28 67.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.878 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.481 ' CD1' HG11 ' A' ' 338' ' ' VAL . 32.9 mt -73.41 -25.59 60.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.934 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 315' ' ' ALA . . . . . 0.811 ' HB1' ' HA ' ' A' ' 316' ' ' PRO . . . -51.25 165.4 0.4 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.579 0.704 . . . . 0.0 111.102 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 316' ' ' PRO . . . . . 0.811 ' HA ' ' HB1' ' A' ' 315' ' ' ALA . 54.1 Cg_endo -69.75 -9.52 11.04 Favored 'Cis proline' 0 C--O 1.232 0.183 0 C-N-CA 122.673 -1.803 . . . . 0.0 112.367 -0.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 317' ' ' LEU . . . . . 0.447 HD22 ' CD ' ' A' ' 345' ' ' GLU . 33.8 mt -54.96 139.03 42.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.888 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 318' ' ' LYS . . . . . 0.401 ' HA ' ' HD2' ' A' ' 319' ' ' PRO . 0.0 OUTLIER -113.32 109.48 51.47 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.591 0.71 . . . . 0.0 110.904 179.866 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 319' ' ' PRO . . . . . 0.492 ' HA ' ' CD2' ' A' ' 340' ' ' PHE . 53.5 Cg_endo -69.78 -171.94 0.53 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.673 2.249 . . . . 0.0 112.329 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 80.2 t -104.51 -39.55 5.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.098 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -164.18 129.09 2.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.118 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 322' ' ' ILE . . . . . 0.591 HG23 HG22 ' A' ' 338' ' ' VAL . 50.8 mt -100.53 105.25 17.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.147 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 15.4 mmm180 -99.04 119.98 38.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.856 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 324' ' ' ILE . . . . . 0.43 ' O ' ' C ' ' A' ' 325' ' ' VAL . 64.0 mt -91.38 117.48 34.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.148 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . 0.607 HG21 ' HB3' ' A' ' 335' ' ' TYR . 22.4 t . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.115 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 335' ' ' TYR . . . . . 0.607 ' HB3' HG21 ' A' ' 325' ' ' VAL . 3.9 m-85 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.881 0.372 . . . . 0.0 110.921 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 73.6 mt -147.4 129.3 6.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.126 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . 0.558 ' CE1' ' HG3' ' A' ' 297' ' ' LYS . 61.6 m-85 -104.25 127.52 51.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.893 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . 0.591 HG22 HG23 ' A' ' 322' ' ' ILE . 22.5 t -126.07 135.72 63.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.128 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -106.05 161.19 14.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.852 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 340' ' ' PHE . . . . . 0.57 ' CD2' ' HB3' ' A' ' 345' ' ' GLU . 41.6 m-85 -138.06 171.03 15.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.842 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 3.9 m -81.46 -64.35 1.2 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.855 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -95.42 166.04 12.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.863 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 343' ' ' GLU . . . . . 0.401 ' H ' ' CD ' ' A' ' 343' ' ' GLU . 1.0 OUTLIER -76.11 -16.09 59.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.861 -179.956 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -70.99 -50.8 30.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.892 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 345' ' ' GLU . . . . . 0.57 ' HB3' ' CD2' ' A' ' 340' ' ' PHE . 16.5 mm-40 -50.67 -41.03 55.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.904 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . 0.669 HG13 HG13 ' A' ' 296' ' ' VAL . 95.0 t -68.1 -53.2 31.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.132 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp -52.31 -44.65 65.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.897 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -64.5 -40.56 95.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.919 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -42.52 -43.06 3.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.15 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 350' ' ' LEU . . . . . . . . . . . . . 21.4 mt -57.42 -36.77 71.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.9 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 1.5 mmmp? -44.73 -50.55 9.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.859 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 352' ' ' CYS . . . . . . . . . . . . . 3.5 m -73.97 80.33 1.68 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.871 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -121.63 149.61 42.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.898 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? 73.18 35.82 0.9 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.907 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 355' ' ' GLU . . . . . 0.431 ' C ' ' CD1' ' A' ' 356' ' ' TYR . 3.1 mm-40 -95.89 173.52 7.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.87 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 356' ' ' TYR . . . . . 0.488 ' N ' ' CD1' ' A' ' 356' ' ' TYR . 1.1 m-85 -134.55 124.22 25.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.93 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 357' ' ' MET . . . . . . . . . . . . . 2.4 ptt? -147.82 139.53 23.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.859 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 78.98 -14.37 14.44 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.455 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 113.25 6.08 22.49 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.461 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 360' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -134.03 168.49 18.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.785 0.326 . . . . 0.0 110.899 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 361' ' ' TYR . . . . . . . . . . . . . 8.4 p90 -84.59 157.31 21.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.878 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 362' ' ' ILE . . . . . 0.437 HG22 ' N ' ' A' ' 363' ' ' GLU . 10.7 mm -133.69 156.93 41.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.122 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 363' ' ' GLU . . . . . 0.458 ' HB3' ' CZ ' ' A' ' 365' ' ' PHE . 7.4 mm-40 -142.95 123.66 14.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.909 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 364' ' ' VAL . . . . . 0.497 ' O ' ' CD1' ' A' ' 365' ' ' PHE . 53.1 t -98.7 141.65 16.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.101 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 365' ' ' PHE . . . . . 0.497 ' CD1' ' O ' ' A' ' 364' ' ' VAL . 28.5 m-85 -144.37 137.04 26.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.854 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . 0.474 ' HB3' ' CZ ' ' A' ' 366' ' ' ARG . 9.4 ttp-105 -81.65 119.32 23.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.885 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.865 -179.885 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 294' ' ' HIS . . . . . 0.737 ' CB ' HG21 ' A' ' 346' ' ' VAL . 48.9 m80 . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.885 0.374 . . . . 0.0 110.895 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 28.1 m -129.28 144.89 51.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.121 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 296' ' ' VAL . . . . . 0.602 ' CG1' HG13 ' A' ' 346' ' ' VAL . 27.8 m -117.19 147.93 20.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.135 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . 0.486 ' HG3' ' CE1' ' A' ' 337' ' ' PHE . 9.2 ttmm -116.01 135.58 53.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.901 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 6.4 mp -122.92 126.66 47.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.909 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 299' ' ' ARG . . . . . 0.547 ' NH1' ' CZ ' ' A' ' 335' ' ' TYR . 0.7 OUTLIER -127.01 167.96 15.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.873 179.945 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 76.82 38.32 31.59 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.477 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -104.64 152.31 39.41 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.568 0.699 . . . . 0.0 111.099 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 -172.79 0.62 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.669 2.246 . . . . 0.0 112.312 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -87.21 -31.18 20.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.88 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -87.42 39.98 0.9 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.907 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 305' ' ' VAL . . . . . . . . . . . . . 7.2 p -102.37 136.99 32.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.144 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 306' ' ' THR . . . . . . . . . . . . . 52.8 p -136.73 173.5 11.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.13 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -46.62 -30.8 2.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.881 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -69.18 -59.21 3.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.913 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -44.11 -34.4 1.79 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.909 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 22.0 t -74.6 -46.05 43.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.12 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 311' ' ' MET . . . . . . . . . . . . . 5.5 mmt -53.68 -44.45 69.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.892 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -67.47 -30.69 70.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.903 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 313' ' ' PHE . . . . . 0.624 ' CE2' HG21 ' A' ' 362' ' ' ILE . 2.4 t80 -74.68 -39.05 62.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.919 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 34.5 mt -81.01 -21.6 40.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.913 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 315' ' ' ALA . . . . . 0.865 ' HB1' ' HA ' ' A' ' 316' ' ' PRO . . . -51.93 166.57 0.38 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.561 0.696 . . . . 0.0 111.142 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 316' ' ' PRO . . . . . 0.865 ' HA ' ' HB1' ' A' ' 315' ' ' ALA . 53.9 Cg_endo -69.75 -8.49 10.51 Favored 'Cis proline' 0 C--O 1.232 0.194 0 C-N-CA 122.694 -1.794 . . . . 0.0 112.342 -0.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 317' ' ' LEU . . . . . . . . . . . . . 46.0 mt -48.09 165.72 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.943 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 318' ' ' LYS . . . . . 0.401 ' HA ' ' HD2' ' A' ' 319' ' ' PRO . 6.7 tttp -140.31 104.96 6.56 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.59 0.71 . . . . 0.0 110.91 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 319' ' ' PRO . . . . . 0.427 ' HA ' ' CD2' ' A' ' 340' ' ' PHE . 53.1 Cg_endo -69.75 -168.64 0.28 Allowed 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.72 2.28 . . . . 0.0 112.345 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 25.6 t -111.23 -38.07 3.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.127 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -156.06 140.6 16.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.119 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 322' ' ' ILE . . . . . 0.539 HG23 HG22 ' A' ' 338' ' ' VAL . 53.1 mt -118.57 115.26 47.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.128 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -105.56 128.19 53.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.887 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 73.2 mt -94.06 136.89 24.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.089 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . 0.458 HG21 ' CE2' ' A' ' 337' ' ' PHE . 43.4 t . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.109 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 335' ' ' TYR . . . . . 0.547 ' CZ ' ' NH1' ' A' ' 299' ' ' ARG . 8.7 m-85 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.819 0.343 . . . . 0.0 110.959 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 96.9 mt -144.98 144.99 21.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.146 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . 0.486 ' CE1' ' HG3' ' A' ' 297' ' ' LYS . 68.7 m-85 -120.51 131.78 54.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.86 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . 0.539 HG22 HG23 ' A' ' 322' ' ' ILE . 46.7 t -130.58 140.66 48.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.103 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -110.62 159.22 17.76 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.878 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 340' ' ' PHE . . . . . 0.427 ' CD2' ' HA ' ' A' ' 319' ' ' PRO . 71.3 m-85 -134.72 172.02 13.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.875 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 40.8 t -79.33 -66.36 0.88 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.874 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 342' ' ' ASN . . . . . 0.613 ' ND2' ' H ' ' A' ' 342' ' ' ASN . 0.0 OUTLIER -98.7 176.94 5.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.908 -179.992 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 343' ' ' GLU . . . . . 0.572 ' HB3' ' CE1' ' A' ' 294' ' ' HIS . 3.1 pm0 -84.81 -16.25 42.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.863 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -68.91 -33.36 73.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.86 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 345' ' ' GLU . . . . . 0.424 ' HB3' ' CD2' ' A' ' 340' ' ' PHE . 52.0 mt-10 -68.55 -51.01 47.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.834 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . 0.737 HG21 ' CB ' ' A' ' 294' ' ' HIS . 87.1 t -58.63 -52.16 63.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.104 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 33.4 mtpt -46.95 -45.49 20.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.884 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 22.5 mm-40 -67.78 -33.5 74.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.9 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 349' ' ' ALA . . . . . 0.405 ' HB3' ' O ' ' A' ' 346' ' ' VAL . . . -55.19 -36.06 65.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.107 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 350' ' ' LEU . . . . . 0.525 HD11 ' HB2' ' A' ' 366' ' ' ARG . 69.2 mt -64.66 -42.58 95.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.898 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 58.1 mmtt -42.57 -48.55 5.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.858 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 352' ' ' CYS . . . . . . . . . . . . . 16.1 m -70.68 73.95 0.57 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.869 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -110.65 152.9 25.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.923 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 22.0 mtt85 61.78 37.6 15.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.893 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 355' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -92.47 174.17 7.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.865 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 356' ' ' TYR . . . . . 0.454 ' N ' ' CD1' ' A' ' 356' ' ' TYR . 1.4 m-85 -126.58 105.62 8.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.937 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 357' ' ' MET . . . . . 0.403 ' O ' ' CG ' ' A' ' 357' ' ' MET . 0.1 OUTLIER -127.37 118.82 24.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.914 179.923 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 90.09 -36.99 3.42 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.468 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 131.03 29.53 0.61 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.497 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 360' ' ' ARG . . . . . . . . . . . . . 47.0 mtt-85 -152.99 140.42 19.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.782 0.325 . . . . 0.0 110.878 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 361' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -54.1 129.95 36.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.962 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 362' ' ' ILE . . . . . 0.624 HG21 ' CE2' ' A' ' 313' ' ' PHE . 32.4 mm -109.14 146.12 15.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.113 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 363' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -138.26 112.14 8.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.87 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 364' ' ' VAL . . . . . 0.42 HG12 HD23 ' A' ' 350' ' ' LEU . 58.8 t -86.56 136.15 23.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.148 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -131.82 129.73 40.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.909 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . 0.525 ' HB2' HD11 ' A' ' 350' ' ' LEU . 18.8 ttt180 -78.46 115.98 18.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.897 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.89 -179.927 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 294' ' ' HIS . . . . . 0.583 ' HB3' HG21 ' A' ' 346' ' ' VAL . 39.4 m-70 . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.877 0.37 . . . . 0.0 110.891 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 38.9 m -137.45 139.35 40.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.18 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 296' ' ' VAL . . . . . 0.505 HG22 ' O ' ' A' ' 338' ' ' VAL . 14.4 m -118.64 153.92 20.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.137 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . 0.572 ' HE2' ' CE1' ' A' ' 337' ' ' PHE . 2.1 tppp? -112.38 145.94 39.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.875 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . 0.473 HD12 ' C ' ' A' ' 297' ' ' LYS . 6.9 mp -132.78 108.57 9.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.902 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 21.9 ptt180 -119.14 146.9 44.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.909 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 114.29 -9.13 22.58 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.447 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -68.48 151.51 97.18 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.572 0.701 . . . . 0.0 111.095 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.71 173.35 11.06 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.676 2.25 . . . . 0.0 112.317 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 303' ' ' PHE . . . . . 0.437 ' C ' ' CD1' ' A' ' 303' ' ' PHE . 6.1 t80 -74.07 -33.23 63.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.854 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 55.7 m-20 -90.44 48.51 1.56 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.861 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 305' ' ' VAL . . . . . 0.542 HG22 ' N ' ' A' ' 306' ' ' THR . 9.5 p -105.07 164.22 4.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.165 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 306' ' ' THR . . . . . 0.542 ' N ' HG22 ' A' ' 305' ' ' VAL . 0.0 OUTLIER -149.19 171.06 17.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.169 -179.968 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 307' ' ' GLU . . . . . 0.435 ' N ' ' OG1' ' A' ' 306' ' ' THR . 38.6 mt-10 -54.98 -23.38 18.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.914 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 53.6 tttp -70.74 -65.52 0.72 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.926 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -40.14 -37.88 0.68 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.876 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 310' ' ' VAL . . . . . 0.462 HG13 HD22 ' A' ' 298' ' ' LEU . 46.9 t -65.64 -50.47 71.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.144 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 311' ' ' MET . . . . . 0.429 ' O ' ' HB2' ' A' ' 315' ' ' ALA . 3.4 mmt -51.38 -39.24 56.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.875 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -66.53 -39.72 88.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.913 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -70.46 -46.24 64.19 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.836 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.755 ' CD1' HG11 ' A' ' 338' ' ' VAL . 29.9 mt -72.83 -26.16 61.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.956 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 315' ' ' ALA . . . . . 0.726 ' HB1' ' HA ' ' A' ' 316' ' ' PRO . . . -48.49 162.89 0.33 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.616 0.722 . . . . 0.0 111.074 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 316' ' ' PRO . . . . . 0.726 ' HA ' ' HB1' ' A' ' 315' ' ' ALA . 53.9 Cg_endo -69.74 -10.61 11.54 Favored 'Cis proline' 0 C--N 1.342 0.195 0 C-N-CA 122.693 -1.794 . . . . 0.0 112.383 -0.036 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 317' ' ' LEU . . . . . . . . . . . . . 33.9 mt -39.48 157.97 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.963 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 36.6 tttm -135.05 96.77 14.09 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.602 0.715 . . . . 0.0 110.877 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 319' ' ' PRO . . . . . 0.519 ' HA ' ' CD2' ' A' ' 340' ' ' PHE . 54.3 Cg_endo -69.76 -175.67 1.23 Allowed 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.666 2.244 . . . . 0.0 112.355 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 38.8 t -100.1 -43.62 11.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.112 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -155.74 141.07 17.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.083 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 322' ' ' ILE . . . . . 0.471 HG23 HG22 ' A' ' 338' ' ' VAL . 56.8 mt -117.13 100.72 10.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.123 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -100.22 105.06 16.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.89 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 324' ' ' ILE . . . . . 0.697 ' HA ' HG23 ' A' ' 336' ' ' ILE . 83.5 mt -69.69 114.0 6.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.162 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . 0.453 HG22 ' CD2' ' A' ' 337' ' ' PHE . 59.8 t . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.075 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 335' ' ' TYR . . . . . 0.434 ' C ' HG13 ' A' ' 336' ' ' ILE . 5.8 m-85 . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.838 0.351 . . . . 0.0 110.971 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 336' ' ' ILE . . . . . 0.697 HG23 ' HA ' ' A' ' 324' ' ' ILE . 28.5 mt -144.54 143.27 23.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.109 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . 0.572 ' CE1' ' HE2' ' A' ' 297' ' ' LYS . 15.7 m-85 -108.32 120.99 43.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.875 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . 0.755 HG11 ' CD1' ' A' ' 314' ' ' LEU . 39.3 t -121.03 124.27 71.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.124 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -103.58 159.12 15.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.851 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 340' ' ' PHE . . . . . 0.519 ' CD2' ' HA ' ' A' ' 319' ' ' PRO . 66.7 m-85 -134.93 160.57 37.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.877 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 17.7 t -83.41 -50.43 8.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.808 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 60.5 m-20 -98.32 159.8 14.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.909 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -74.53 -43.57 55.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.929 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -48.38 -41.37 28.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.863 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 345' ' ' GLU . . . . . 0.439 ' HB3' ' CD2' ' A' ' 340' ' ' PHE . 29.6 mt-10 -56.46 -47.17 79.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.885 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . 0.583 HG21 ' HB3' ' A' ' 294' ' ' HIS . 48.8 t -57.64 -56.87 12.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.113 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.59 -38.19 20.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.929 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 17.9 mm100 -72.84 -37.69 67.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.946 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -52.54 -39.52 61.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.115 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 350' ' ' LEU . . . . . 0.422 HD23 HG12 ' A' ' 364' ' ' VAL . 81.4 mt -67.38 -25.13 65.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.958 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 6.5 mmpt? -60.73 -59.7 4.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.895 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 352' ' ' CYS . . . . . . . . . . . . . 69.5 m -65.71 74.05 0.07 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.886 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 55.9 p30 -118.16 168.58 10.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.877 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 19.7 mtt180 61.54 28.96 18.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.908 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 355' ' ' GLU . . . . . 0.42 ' C ' ' CD1' ' A' ' 356' ' ' TYR . 7.0 mm-40 -86.71 174.2 8.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.859 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 356' ' ' TYR . . . . . 0.51 ' N ' ' CD1' ' A' ' 356' ' ' TYR . 0.9 OUTLIER -133.92 99.7 4.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.893 -179.825 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 357' ' ' MET . . . . . . . . . . . . . 5.3 ptt? -126.61 141.93 51.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.936 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 79.22 -43.37 2.48 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.452 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 359' ' ' GLY . . . . . 0.472 ' O ' ' CG ' ' A' ' 360' ' ' ARG . . . 140.92 32.67 0.14 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.481 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 360' ' ' ARG . . . . . 0.472 ' CG ' ' O ' ' A' ' 359' ' ' GLY . 58.1 mtt-85 -164.85 158.15 17.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.802 0.334 . . . . 0.0 110.879 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 361' ' ' TYR . . . . . . . . . . . . . 27.0 p90 -71.83 144.1 49.23 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.908 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 31.2 mm -115.09 142.46 27.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.13 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 363' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -131.15 113.68 14.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.856 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 364' ' ' VAL . . . . . 0.422 HG12 HD23 ' A' ' 350' ' ' LEU . 20.1 t -89.32 134.43 28.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.181 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -131.43 140.82 49.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.886 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 2.1 tmm_? -85.88 124.49 32.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.906 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 367' ' ' GLU . . . . . 0.412 ' OE1' ' CE1' ' A' ' 337' ' ' PHE . 16.3 mt-10 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.935 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 294' ' ' HIS . . . . . 0.837 ' HB3' HG21 ' A' ' 346' ' ' VAL . 34.6 m80 . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.833 0.349 . . . . 0.0 110.856 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 295' ' ' THR . . . . . 0.592 HG23 ' OD1' ' A' ' 339' ' ' ASP . 5.0 m -137.12 136.62 38.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.189 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 296' ' ' VAL . . . . . 0.71 ' CG1' HG13 ' A' ' 346' ' ' VAL . 26.8 m -118.13 146.79 22.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.162 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . 0.494 ' HG3' ' CE1' ' A' ' 337' ' ' PHE . 8.3 ttmm -114.2 141.85 47.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.87 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . 0.759 HD21 ' CE2' ' A' ' 313' ' ' PHE . 7.4 mp -123.0 149.93 43.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.915 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 64.0 mtt180 -143.91 165.41 27.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.906 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 87.71 -21.25 23.59 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.5 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -58.28 152.09 44.48 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.571 0.701 . . . . 0.0 111.13 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.8 179.25 3.85 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.667 2.244 . . . . 0.0 112.323 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -86.45 -38.09 17.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.864 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -85.4 46.28 1.28 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.929 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 305' ' ' VAL . . . . . . . . . . . . . 12.3 p -103.09 141.39 19.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.14 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 306' ' ' THR . . . . . . . . . . . . . 41.6 p -121.99 169.94 10.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.173 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 41.7 mp0 -50.3 -51.47 44.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.823 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 12.2 tttp -45.02 -45.13 10.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.89 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -61.02 -49.12 78.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.901 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 78.5 t -59.5 -48.58 86.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.14 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 311' ' ' MET . . . . . . . . . . . . . 4.4 mmt -51.08 -42.78 60.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.84 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -69.69 -25.56 63.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.93 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 313' ' ' PHE . . . . . 0.873 ' CZ ' HG21 ' A' ' 362' ' ' ILE . 37.1 t80 -76.26 -45.86 30.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.869 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.682 ' CD1' HG11 ' A' ' 338' ' ' VAL . 89.4 mt -79.24 -20.46 48.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.905 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 315' ' ' ALA . . . . . 0.725 ' HB1' ' HA ' ' A' ' 316' ' ' PRO . . . -49.86 162.62 0.46 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.571 0.7 . . . . 0.0 111.095 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 316' ' ' PRO . . . . . 0.725 ' HA ' ' HB1' ' A' ' 315' ' ' ALA . 53.2 Cg_endo -69.8 -8.51 10.62 Favored 'Cis proline' 0 C--O 1.232 0.198 0 C-N-CA 122.675 -1.802 . . . . 0.0 112.305 0.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 317' ' ' LEU . . . . . . . . . . . . . 17.5 mt -46.7 156.69 0.18 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.893 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 318' ' ' LYS . . . . . 0.401 ' HA ' ' HD2' ' A' ' 319' ' ' PRO . 18.0 ttpt -133.44 105.51 12.07 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.604 0.716 . . . . 0.0 110.89 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 319' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 318' ' ' LYS . 53.6 Cg_endo -69.76 -174.65 0.95 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.688 2.259 . . . . 0.0 112.345 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 21.8 t -108.08 -31.64 2.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.126 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -161.27 130.3 4.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.126 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 322' ' ' ILE . . . . . . . . . . . . . 68.2 mt -107.21 106.82 21.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.139 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 32.7 mmt180 -104.75 101.95 11.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.848 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 66.0 mt -74.68 131.99 34.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.136 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . 0.541 HG22 ' CE2' ' A' ' 337' ' ' PHE . 46.5 t . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.127 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 335' ' ' TYR . . . . . 0.43 ' C ' HG13 ' A' ' 336' ' ' ILE . 17.2 m-85 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.839 0.352 . . . . 0.0 110.93 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 336' ' ' ILE . . . . . 0.43 HG13 ' C ' ' A' ' 335' ' ' TYR . 84.7 mt -149.18 138.11 15.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.145 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . 0.541 ' CE2' HG22 ' A' ' 325' ' ' VAL . 30.9 m-85 -110.51 125.28 53.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.863 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . 0.682 HG11 ' CD1' ' A' ' 314' ' ' LEU . 24.2 t -125.5 143.02 40.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.12 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 339' ' ' ASP . . . . . 0.592 ' OD1' HG23 ' A' ' 295' ' ' THR . 4.5 m-20 -119.37 156.68 29.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.905 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 340' ' ' PHE . . . . . 0.528 ' CD2' ' HB3' ' A' ' 345' ' ' GLU . 57.0 m-85 -134.88 166.23 23.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.86 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 1.9 m -85.41 -55.41 4.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.86 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -99.6 162.86 12.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.877 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 343' ' ' GLU . . . . . 0.574 ' HB3' ' CE1' ' A' ' 294' ' ' HIS . 1.2 pm0 -81.13 -15.28 56.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.864 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -71.15 -34.13 70.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.884 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 345' ' ' GLU . . . . . 0.528 ' HB3' ' CD2' ' A' ' 340' ' ' PHE . 27.1 mt-10 -68.23 -44.84 74.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.932 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . 0.837 HG21 ' HB3' ' A' ' 294' ' ' HIS . 55.4 t -63.66 -47.22 92.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.155 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 32.0 mttm -49.53 -38.89 32.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.914 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 3.7 mm100 -71.88 -46.09 59.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.892 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -49.45 -36.44 22.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.12 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 350' ' ' LEU . . . . . 0.599 HD11 ' HD3' ' A' ' 366' ' ' ARG . 55.5 mt -66.62 -42.77 86.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.938 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 66.6 mttt -58.1 -38.39 76.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.878 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 352' ' ' CYS . . . . . 0.438 ' HB3' ' CD ' ' A' ' 355' ' ' GLU . 72.3 m -76.11 83.9 2.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.873 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -120.71 169.99 9.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.865 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 27.9 mmm180 53.85 39.18 30.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.896 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 355' ' ' GLU . . . . . 0.439 ' OE2' ' CE1' ' A' ' 313' ' ' PHE . 12.3 mt-10 -95.39 174.73 6.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.884 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 356' ' ' TYR . . . . . 0.418 ' N ' ' CD1' ' A' ' 356' ' ' TYR . 1.6 m-85 -122.88 105.38 9.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.928 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 357' ' ' MET . . . . . 0.651 ' HG3' HD11 ' A' ' 362' ' ' ILE . 0.0 OUTLIER -130.31 123.69 30.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.904 179.884 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 85.13 -33.06 3.42 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.471 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 129.72 29.15 0.71 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.481 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 360' ' ' ARG . . . . . . . . . . . . . 36.6 mtt85 -162.32 145.38 11.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.836 0.35 . . . . 0.0 110.83 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 361' ' ' TYR . . . . . 0.636 ' O ' HD13 ' A' ' 362' ' ' ILE . 37.1 p90 -47.01 165.93 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.91 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 362' ' ' ILE . . . . . 0.873 HG21 ' CZ ' ' A' ' 313' ' ' PHE . 42.7 mm -139.93 145.79 25.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.136 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 363' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -134.63 115.71 14.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.842 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 50.6 t -96.61 142.81 13.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.092 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -144.07 126.75 16.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.868 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . 0.599 ' HD3' HD11 ' A' ' 350' ' ' LEU . 8.1 ttp-105 -68.82 139.09 55.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.862 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.883 -179.941 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 294' ' ' HIS . . . . . 0.688 ' HB3' HG21 ' A' ' 346' ' ' VAL . 25.3 m80 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.896 0.379 . . . . 0.0 110.851 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 50.1 m -132.69 151.73 51.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.127 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 296' ' ' VAL . . . . . 0.485 ' CG1' HG13 ' A' ' 346' ' ' VAL . 26.3 m -129.65 157.37 42.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.167 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 4.5 ttpm? -125.89 152.4 45.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.899 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . 0.754 HD21 ' CE2' ' A' ' 313' ' ' PHE . 6.8 mp -126.35 131.3 51.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.844 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 34.1 ttp85 -136.44 127.78 28.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.872 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 125.41 -8.68 7.85 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.459 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -69.73 150.14 96.67 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.592 0.71 . . . . 0.0 111.092 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 174.32 9.7 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.669 2.246 . . . . 0.0 112.366 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 303' ' ' PHE . . . . . 0.489 ' C ' ' CD1' ' A' ' 303' ' ' PHE . 2.4 t80 -75.54 -27.07 58.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.876 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 25.6 p30 -92.86 46.38 1.23 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.891 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 305' ' ' VAL . . . . . . . . . . . . . 9.8 p -106.93 144.27 16.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.151 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 306' ' ' THR . . . . . . . . . . . . . 61.1 p -132.76 167.52 20.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.182 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -43.89 -52.59 6.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.9 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 36.7 tttt -41.25 -55.91 2.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.899 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -50.91 -48.83 60.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.908 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 310' ' ' VAL . . . . . 0.475 HG21 HG21 ' A' ' 336' ' ' ILE . 61.9 t -57.87 -42.36 82.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.133 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 311' ' ' MET . . . . . 0.468 ' HG2' ' CD1' ' A' ' 322' ' ' ILE . 2.6 mmt -61.17 -52.69 63.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.833 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -65.5 -28.0 68.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.892 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 313' ' ' PHE . . . . . 0.754 ' CE2' HD21 ' A' ' 298' ' ' LEU . 14.9 t80 -71.11 -43.81 66.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.875 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.628 HD11 HG21 ' A' ' 338' ' ' VAL . 61.6 mt -80.86 -26.12 37.16 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.953 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 315' ' ' ALA . . . . . 0.671 ' HB1' ' HA ' ' A' ' 316' ' ' PRO . . . -41.31 161.06 0.13 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.553 0.692 . . . . 0.0 111.108 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 316' ' ' PRO . . . . . 0.671 ' HA ' ' HB1' ' A' ' 315' ' ' ALA . 53.5 Cg_endo -69.86 -9.43 11.21 Favored 'Cis proline' 0 C--O 1.232 0.183 0 C-N-CA 122.657 -1.81 . . . . 0.0 112.348 0.071 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 317' ' ' LEU . . . . . . . . . . . . . 73.0 mt -44.62 149.77 0.38 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.944 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 26.2 tttp -127.54 101.33 24.38 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.596 0.712 . . . . 0.0 110.964 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 319' ' ' PRO . . . . . 0.511 ' HA ' ' CD2' ' A' ' 340' ' ' PHE . 53.2 Cg_endo -69.76 -169.96 0.36 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.718 2.278 . . . . 0.0 112.301 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 320' ' ' VAL . . . . . 0.41 HG23 ' HA ' ' A' ' 340' ' ' PHE . 53.0 t -110.27 -37.18 3.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.137 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -159.18 134.61 8.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.097 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 322' ' ' ILE . . . . . 0.468 ' CD1' ' HG2' ' A' ' 311' ' ' MET . 48.6 mt -110.52 100.52 10.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.106 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -96.03 108.3 20.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.89 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 95.9 mt -74.14 118.43 19.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.132 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . 0.485 HG21 ' HB3' ' A' ' 335' ' ' TYR . 25.5 t . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.131 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 335' ' ' TYR . . . . . 0.485 ' HB3' HG21 ' A' ' 325' ' ' VAL . 9.1 m-85 . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.843 0.354 . . . . 0.0 110.927 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 336' ' ' ILE . . . . . 0.475 HG21 HG21 ' A' ' 310' ' ' VAL . 53.4 mt -138.0 124.94 27.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.12 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -99.29 122.3 42.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.864 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . 0.628 HG21 HD11 ' A' ' 314' ' ' LEU . 44.1 t -119.7 134.34 63.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.102 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -109.88 164.74 12.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.859 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 340' ' ' PHE . . . . . 0.511 ' CD2' ' HA ' ' A' ' 319' ' ' PRO . 76.1 m-85 -143.37 170.95 14.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.854 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 3.0 p -96.32 -45.99 6.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.872 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -92.43 163.55 13.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.879 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 -87.62 -33.93 18.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.909 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -63.98 -41.05 97.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.901 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -56.34 -49.26 74.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.917 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . 0.688 HG21 ' HB3' ' A' ' 294' ' ' HIS . 71.9 t -58.77 -41.74 83.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.1 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 9.9 mtpm? -58.11 -43.25 87.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.892 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -65.53 -37.71 87.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.907 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 349' ' ' ALA . . . . . 0.567 ' O ' HG11 ' A' ' 364' ' ' VAL . . . -54.46 -17.17 2.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.141 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 350' ' ' LEU . . . . . 0.428 HD23 HG12 ' A' ' 364' ' ' VAL . 32.1 mt -92.33 -23.21 19.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.921 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.96 -7.81 9.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.866 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 352' ' ' CYS . . . . . . . . . . . . . 75.7 m -112.24 98.34 7.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.854 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . 0.487 ' O ' ' C ' ' A' ' 354' ' ' ARG . 6.9 p-10 -118.54 -179.64 3.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.907 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . 0.487 ' C ' ' O ' ' A' ' 353' ' ' ASN . 0.0 OUTLIER 31.44 38.25 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.843 179.969 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 355' ' ' GLU . . . . . 0.486 ' N ' ' O ' ' A' ' 353' ' ' ASN . 3.9 mm-40 -81.2 174.67 11.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.877 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 356' ' ' TYR . . . . . 0.494 ' N ' ' CD1' ' A' ' 356' ' ' TYR . 1.0 OUTLIER -134.05 110.28 9.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.929 -179.912 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 357' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.02 124.98 22.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.891 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 87.53 -37.28 3.24 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.515 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 133.92 29.78 0.45 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.495 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 360' ' ' ARG . . . . . . . . . . . . . 55.5 mtt180 -159.63 145.56 15.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.829 0.347 . . . . 0.0 110.884 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 361' ' ' TYR . . . . . 0.499 ' O ' HD13 ' A' ' 362' ' ' ILE . 48.6 p90 -50.56 159.65 0.49 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.906 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 362' ' ' ILE . . . . . 0.499 HD13 ' O ' ' A' ' 361' ' ' TYR . 4.6 mm -143.35 129.15 16.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.137 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 363' ' ' GLU . . . . . 0.494 ' HB3' ' CZ ' ' A' ' 365' ' ' PHE . 6.5 mm-40 -119.3 112.21 19.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.895 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 364' ' ' VAL . . . . . 0.567 HG11 ' O ' ' A' ' 349' ' ' ALA . 38.4 t -88.03 131.83 34.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.104 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 365' ' ' PHE . . . . . 0.494 ' CZ ' ' HB3' ' A' ' 363' ' ' GLU . 25.7 m-85 -130.25 150.99 51.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.848 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 28.5 ttt180 -95.57 122.33 38.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.836 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.919 -179.964 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 294' ' ' HIS . . . . . 0.726 ' HB2' HG21 ' A' ' 346' ' ' VAL . 13.9 m-70 . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.847 0.356 . . . . 0.0 110.89 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 295' ' ' THR . . . . . 0.443 HG23 ' OD1' ' A' ' 339' ' ' ASP . 32.3 m -138.89 116.37 11.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.129 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 296' ' ' VAL . . . . . 0.658 ' CG1' HG13 ' A' ' 346' ' ' VAL . 29.6 m -98.13 160.67 3.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.138 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . 0.578 ' HD3' ' CE1' ' A' ' 337' ' ' PHE . 31.3 ttpt -139.34 150.14 45.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.892 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . 0.475 HD21 ' CE1' ' A' ' 313' ' ' PHE . 6.8 mp -124.71 135.51 53.09 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.931 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 18.0 ttt-85 -133.56 138.42 46.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.9 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 110.23 10.57 21.93 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.511 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -75.96 143.65 74.6 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.57 0.7 . . . . 0.0 111.09 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 -170.08 0.37 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.667 2.245 . . . . 0.0 112.339 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -90.67 -10.56 42.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.84 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -101.42 25.98 7.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.895 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 305' ' ' VAL . . . . . . . . . . . . . 9.2 p -94.66 140.23 17.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.103 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 306' ' ' THR . . . . . 0.401 ' O ' ' N ' ' A' ' 308' ' ' LYS . 21.3 p -137.03 160.69 38.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.132 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -38.1 -32.61 0.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.877 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 308' ' ' LYS . . . . . 0.444 ' O ' ' N ' ' A' ' 311' ' ' MET . 23.6 ttmt -63.38 -67.7 0.4 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.921 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . 0.41 ' C ' ' O ' ' A' ' 308' ' ' LYS . 9.4 m-80 -37.65 -45.66 0.8 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.92 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 61.7 t -57.82 -43.55 84.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.116 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 311' ' ' MET . . . . . 0.444 ' N ' ' O ' ' A' ' 308' ' ' LYS . 4.7 mmt -59.73 -50.67 72.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.893 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 15.2 mp0 -62.31 -36.38 81.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.906 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 313' ' ' PHE . . . . . 0.475 ' CE1' HD21 ' A' ' 298' ' ' LEU . 3.5 t80 -65.09 -44.63 88.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.873 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.585 ' CD1' HG11 ' A' ' 338' ' ' VAL . 54.6 mt -78.43 -21.07 49.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.905 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 315' ' ' ALA . . . . . 0.871 ' HB1' ' HA ' ' A' ' 316' ' ' PRO . . . -51.58 166.84 0.34 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.573 0.702 . . . . 0.0 111.143 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 316' ' ' PRO . . . . . 0.871 ' HA ' ' HB1' ' A' ' 315' ' ' ALA . 54.1 Cg_endo -69.73 -4.58 8.33 Favored 'Cis proline' 0 C--O 1.232 0.202 0 C-N-CA 122.66 -1.809 . . . . 0.0 112.348 -0.028 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 317' ' ' LEU . . . . . 0.468 ' N ' ' HA ' ' A' ' 315' ' ' ALA . 21.1 mt -54.1 161.1 1.35 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.885 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 46.2 tttt -134.46 107.19 11.01 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.586 0.708 . . . . 0.0 110.925 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 319' ' ' PRO . . . . . 0.476 ' HA ' ' CD2' ' A' ' 340' ' ' PHE . 53.7 Cg_endo -69.79 -175.76 1.27 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.713 2.275 . . . . 0.0 112.358 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 320' ' ' VAL . . . . . 0.459 HG23 ' C ' ' A' ' 340' ' ' PHE . 42.3 t -102.4 -35.74 4.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.107 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -164.14 138.12 5.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.092 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 322' ' ' ILE . . . . . 0.48 HG23 HG22 ' A' ' 338' ' ' VAL . 80.5 mt -112.22 111.51 36.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.121 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 87.0 mtt180 -110.01 103.33 12.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.849 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 94.4 mt -64.26 118.24 6.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.141 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . 0.915 HG22 ' CD2' ' A' ' 337' ' ' PHE . 27.1 t . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.157 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 335' ' ' TYR . . . . . 0.555 ' HB3' HG21 ' A' ' 325' ' ' VAL . 10.6 m-85 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.854 0.359 . . . . 0.0 110.915 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 58.7 mt -141.54 113.79 3.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.158 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . 0.915 ' CD2' HG22 ' A' ' 325' ' ' VAL . 18.0 m-85 -87.88 129.85 35.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.893 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . 0.585 HG11 ' CD1' ' A' ' 314' ' ' LEU . 22.0 t -134.33 135.34 54.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.174 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 339' ' ' ASP . . . . . 0.443 ' OD1' HG23 ' A' ' 295' ' ' THR . 7.0 m-20 -111.75 162.68 14.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.877 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 340' ' ' PHE . . . . . 0.562 ' HB2' HG23 ' A' ' 346' ' ' VAL . 60.3 m-85 -136.64 172.3 13.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.882 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 29.3 t -79.42 -67.6 0.74 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.878 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -100.05 173.25 6.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.876 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 343' ' ' GLU . . . . . 0.551 ' HB2' ' CE1' ' A' ' 294' ' ' HIS . 11.0 pt-20 -75.19 -40.36 59.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.923 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 344' ' ' GLU . . . . . 0.413 ' N ' ' HG3' ' A' ' 343' ' ' GLU . 34.5 tt0 -44.23 -50.75 8.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.913 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -53.96 -61.81 2.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.897 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . 0.726 HG21 ' HB2' ' A' ' 294' ' ' HIS . 60.5 t -50.21 -47.04 25.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.086 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 45.2 mtpt -50.95 -39.3 54.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.946 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -79.44 -29.11 41.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.903 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -57.54 -27.05 62.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.074 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 350' ' ' LEU . . . . . 0.56 HD23 HG12 ' A' ' 364' ' ' VAL . 92.6 mt -77.21 -34.99 56.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.912 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 18.3 mmtp -46.33 -43.35 15.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.886 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 352' ' ' CYS . . . . . . . . . . . . . 8.3 m -62.05 85.04 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.897 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . 0.483 ' O ' ' C ' ' A' ' 354' ' ' ARG . 33.7 p-10 -122.9 -176.9 3.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.873 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . 0.483 ' C ' ' O ' ' A' ' 353' ' ' ASN . 2.9 ppt_? 30.59 44.59 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.894 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 355' ' ' GLU . . . . . 0.446 ' C ' ' OE1' ' A' ' 355' ' ' GLU . 0.0 OUTLIER -118.1 173.1 6.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.891 -179.906 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 356' ' ' TYR . . . . . 0.476 ' N ' ' CD1' ' A' ' 356' ' ' TYR . 1.3 m-85 -128.47 149.29 50.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.902 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 357' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -166.66 125.79 1.48 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.868 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 87.74 -15.2 56.12 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.476 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 105.15 19.77 10.39 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.483 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 360' ' ' ARG . . . . . . . . . . . . . 10.5 mmt180 -146.03 158.86 43.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.828 0.347 . . . . 0.0 110.875 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 361' ' ' TYR . . . . . . . . . . . . . 9.1 p90 -66.22 151.51 46.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.905 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 362' ' ' ILE . . . . . 0.462 HG22 ' N ' ' A' ' 363' ' ' GLU . 15.7 mm -135.3 155.27 37.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.145 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 363' ' ' GLU . . . . . 0.462 ' N ' HG22 ' A' ' 362' ' ' ILE . 49.5 mm-40 -147.57 114.82 6.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.842 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 364' ' ' VAL . . . . . 0.56 HG12 HD23 ' A' ' 350' ' ' LEU . 58.4 t -88.22 140.12 16.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.114 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -137.37 154.79 49.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.831 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 3.0 tmm_? -101.87 109.05 20.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.849 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.892 -179.935 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 294' ' ' HIS . . . . . 0.573 ' CE1' ' HB3' ' A' ' 343' ' ' GLU . 75.1 m80 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.867 0.365 . . . . 0.0 110.83 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 69.0 m -135.45 149.81 49.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.13 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 296' ' ' VAL . . . . . 0.511 HG13 HG13 ' A' ' 346' ' ' VAL . 30.8 m -125.74 156.73 35.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.115 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . 0.579 ' HD3' ' CE1' ' A' ' 337' ' ' PHE . 13.4 ttpt -130.35 143.67 50.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.877 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 6.8 mp -118.23 151.86 36.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.9 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 299' ' ' ARG . . . . . 0.513 ' HB2' ' CE1' ' A' ' 335' ' ' TYR . 8.8 ttm-85 -146.42 136.37 23.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.901 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 98.9 48.13 1.81 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.454 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -114.61 148.36 40.14 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.601 0.715 . . . . 0.0 111.05 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 153.3 69.16 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.681 2.254 . . . . 0.0 112.306 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -58.49 -30.47 67.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.905 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -85.0 34.41 0.55 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.847 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 305' ' ' VAL . . . . . . . . . . . . . 9.0 p -96.02 139.64 18.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.126 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 306' ' ' THR . . . . . 0.45 ' O ' ' C ' ' A' ' 307' ' ' GLU . 70.7 p -136.2 155.51 50.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.171 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 307' ' ' GLU . . . . . 0.45 ' C ' ' O ' ' A' ' 306' ' ' THR . 30.2 mt-10 -34.46 -38.48 0.07 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.884 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 29.7 ttmt -57.43 -55.52 33.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.916 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -49.79 -46.7 51.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.906 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 85.0 t -61.55 -40.79 87.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.155 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 311' ' ' MET . . . . . 0.404 ' O ' ' HB2' ' A' ' 315' ' ' ALA . 4.1 mmt -58.71 -40.75 84.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.896 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -68.94 -31.55 70.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.909 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 313' ' ' PHE . . . . . 0.72 ' CE2' HG21 ' A' ' 362' ' ' ILE . 1.9 t80 -74.13 -48.93 26.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.919 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.91 ' CD1' HG11 ' A' ' 338' ' ' VAL . 27.8 mt -72.45 -24.95 61.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.944 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 315' ' ' ALA . . . . . 0.791 ' HB1' ' HA ' ' A' ' 316' ' ' PRO . . . -49.73 164.52 0.34 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.577 0.703 . . . . 0.0 111.127 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 316' ' ' PRO . . . . . 0.791 ' HA ' ' HB1' ' A' ' 315' ' ' ALA . 54.0 Cg_endo -69.79 -7.43 10.02 Favored 'Cis proline' 0 C--O 1.232 0.188 0 C-N-CA 122.701 -1.791 . . . . 0.0 112.358 0.067 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 317' ' ' LEU . . . . . 0.642 HD13 ' O ' ' A' ' 345' ' ' GLU . 33.0 mt -57.57 134.29 56.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.926 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.88 111.7 56.32 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.56 0.695 . . . . 0.0 110.906 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -176.62 1.54 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.707 2.271 . . . . 0.0 112.327 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 320' ' ' VAL . . . . . 0.417 HG23 ' C ' ' A' ' 340' ' ' PHE . 93.0 t -100.52 -40.27 7.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.092 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -160.56 131.67 5.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.095 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 322' ' ' ILE . . . . . . . . . . . . . 86.5 mt -102.11 119.96 51.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.122 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 61.5 mtm180 -115.54 98.69 6.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.884 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 324' ' ' ILE . . . . . 0.708 HG23 HG12 ' A' ' 336' ' ' ILE . 41.8 mt -74.72 125.0 33.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.108 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . 0.524 HG22 ' CE2' ' A' ' 337' ' ' PHE . 88.0 t . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.126 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 335' ' ' TYR . . . . . 0.513 ' CE1' ' HB2' ' A' ' 299' ' ' ARG . 18.2 m-85 . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.842 0.354 . . . . 0.0 110.937 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 336' ' ' ILE . . . . . 0.708 HG12 HG23 ' A' ' 324' ' ' ILE . 85.5 mt -138.91 113.75 8.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.171 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . 0.579 ' CE1' ' HD3' ' A' ' 297' ' ' LYS . 77.0 m-85 -84.95 135.87 33.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.91 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . 0.91 HG11 ' CD1' ' A' ' 314' ' ' LEU . 58.0 t -137.64 120.15 19.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.15 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -97.38 158.06 15.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.838 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 340' ' ' PHE . . . . . 0.517 ' CZ ' HD13 ' A' ' 314' ' ' LEU . 41.8 m-85 -133.18 172.19 13.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.874 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 48.5 t -83.23 -63.08 1.43 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.872 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -96.02 159.8 14.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.891 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 343' ' ' GLU . . . . . 0.573 ' HB3' ' CE1' ' A' ' 294' ' ' HIS . 10.7 pt-20 -68.64 -47.25 67.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.875 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -45.87 -55.34 6.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.931 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 345' ' ' GLU . . . . . 0.642 ' O ' HD13 ' A' ' 317' ' ' LEU . 35.6 mt-10 -41.92 -44.83 3.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.879 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . 0.511 HG13 HG13 ' A' ' 296' ' ' VAL . 83.8 t -69.86 -48.57 63.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.159 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 18.8 mtpp -46.07 -42.47 13.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.921 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 348' ' ' GLN . . . . . 0.401 ' O ' ' N ' ' A' ' 351' ' ' LYS . 15.7 mm100 -70.44 -41.43 72.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.873 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -40.49 -43.47 1.85 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.048 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 350' ' ' LEU . . . . . 0.566 HD21 ' HB2' ' A' ' 366' ' ' ARG . 22.6 mt -64.08 -40.72 96.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.913 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 351' ' ' LYS . . . . . 0.401 ' N ' ' O ' ' A' ' 348' ' ' GLN . 15.6 mmtp -54.38 -25.55 25.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.881 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 352' ' ' CYS . . . . . . . . . . . . . 85.6 m -95.93 52.17 1.3 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.864 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . 0.408 ' CG ' ' N ' ' A' ' 354' ' ' ARG . 1.8 t30 -100.38 164.05 12.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.907 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . 0.408 ' N ' ' CG ' ' A' ' 353' ' ' ASN . 11.2 ttm180 68.99 33.33 3.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.886 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 355' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -102.57 174.01 6.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.909 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 356' ' ' TYR . . . . . 0.462 ' N ' ' CD1' ' A' ' 356' ' ' TYR . 1.3 m-85 -124.62 135.3 52.98 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.952 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 357' ' ' MET . . . . . 0.637 ' HG3' HD11 ' A' ' 362' ' ' ILE . 0.0 OUTLIER -148.59 123.33 9.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.867 179.98 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 82.87 -13.59 42.44 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.478 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 110.56 5.22 28.02 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.487 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 360' ' ' ARG . . . . . 0.426 ' NH1' ' HB3' ' A' ' 360' ' ' ARG . 5.1 mmm180 -123.8 130.67 52.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.836 0.35 . . . . 0.0 110.886 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 361' ' ' TYR . . . . . . . . . . . . . 20.4 p90 -49.38 128.5 17.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.915 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 362' ' ' ILE . . . . . 0.72 HG21 ' CE2' ' A' ' 313' ' ' PHE . 37.1 mm -106.51 144.96 14.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.136 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 363' ' ' GLU . . . . . . . . . . . . . 56.0 mm-40 -139.67 112.29 7.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.841 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 364' ' ' VAL . . . . . 0.436 ' O ' ' CD1' ' A' ' 365' ' ' PHE . 15.0 t -85.25 149.57 4.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.117 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 365' ' ' PHE . . . . . 0.436 ' CD1' ' O ' ' A' ' 364' ' ' VAL . 43.0 m-85 -148.64 121.62 8.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.886 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . 0.566 ' HB2' HD21 ' A' ' 350' ' ' LEU . 1.3 tmm_? -69.17 127.78 34.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.888 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.9 -179.926 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 294' ' ' HIS . . . . . 0.9 ' CB ' HG21 ' A' ' 346' ' ' VAL . 1.5 m-70 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.893 0.378 . . . . 0.0 110.884 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 36.6 m -132.06 142.42 49.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.171 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 31.6 m -115.68 150.05 17.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.127 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . 0.58 ' C ' HD12 ' A' ' 298' ' ' LEU . 17.0 ttpt -120.59 138.11 54.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.875 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . 0.58 HD12 ' C ' ' A' ' 297' ' ' LYS . 6.1 mp -120.23 141.38 49.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.897 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 20.3 ptt180 -149.82 145.94 26.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.931 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 107.18 14.22 19.19 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.512 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -83.85 151.59 61.24 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.607 0.718 . . . . 0.0 111.088 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -165.97 0.17 Allowed 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.724 2.283 . . . . 0.0 112.365 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -90.35 -17.79 26.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.849 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -93.3 14.58 17.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.892 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 305' ' ' VAL . . . . . . . . . . . . . 11.8 p -78.84 138.55 19.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.108 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 306' ' ' THR . . . . . . . . . . . . . 39.0 p -145.35 177.45 8.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.128 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -49.42 -31.61 10.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.897 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 20.1 ttpt -67.78 -60.98 2.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.914 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -46.57 -38.62 9.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.866 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 53.6 t -69.47 -46.76 75.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.172 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 311' ' ' MET . . . . . 0.427 ' HG2' HD11 ' A' ' 322' ' ' ILE . 2.8 mmt -56.66 -49.65 74.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.908 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -66.52 -24.72 66.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.882 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -74.57 -38.75 62.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.91 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.474 ' CD1' HG11 ' A' ' 338' ' ' VAL . 27.1 mt -88.12 -24.37 23.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.882 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 315' ' ' ALA . . . . . 0.695 ' HB1' ' HA ' ' A' ' 316' ' ' PRO . . . -48.4 161.95 0.37 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.561 0.696 . . . . 0.0 111.15 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 316' ' ' PRO . . . . . 0.695 ' HA ' ' HB1' ' A' ' 315' ' ' ALA . 53.0 Cg_endo -69.83 -2.45 7.25 Favored 'Cis proline' 0 C--N 1.342 0.198 0 C-N-CA 122.621 -1.825 . . . . 0.0 112.299 0.054 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 317' ' ' LEU . . . . . 0.487 ' N ' ' HA ' ' A' ' 315' ' ' ALA . 24.7 mt -55.62 124.59 17.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.864 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -102.65 105.29 43.62 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.517 0.675 . . . . 0.0 110.895 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 -175.54 1.18 Allowed 'Trans proline' 0 N--CA 1.465 -0.155 0 C-N-CA 122.728 2.285 . . . . 0.0 112.36 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 97.7 t -100.03 -43.45 11.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.147 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -156.88 139.67 15.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.14 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 322' ' ' ILE . . . . . 0.427 HD11 ' HG2' ' A' ' 311' ' ' MET . 90.6 mt -108.39 108.49 25.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.084 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -103.12 98.08 8.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.878 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 71.9 mt -70.38 118.22 14.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.105 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . 0.504 ' CG2' ' CD2' ' A' ' 337' ' ' PHE . 35.2 t . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.125 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 335' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.895 0.379 . . . . 0.0 110.932 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 73.7 mt -143.72 124.44 9.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.126 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . 0.504 ' CD2' ' CG2' ' A' ' 325' ' ' VAL . 25.9 m-85 -100.24 126.82 46.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.907 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . 0.474 HG11 ' CD1' ' A' ' 314' ' ' LEU . 31.2 t -126.83 132.79 69.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.147 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -106.2 162.14 13.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.853 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -136.62 161.0 37.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.86 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 46.0 m -76.83 -61.02 2.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.825 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -92.3 157.98 16.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.872 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 343' ' ' GLU . . . . . 0.587 ' HB3' ' CE1' ' A' ' 294' ' ' HIS . 8.3 pt-20 -70.22 -41.8 73.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.852 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 344' ' ' GLU . . . . . 0.41 ' O ' ' C ' ' A' ' 345' ' ' GLU . 36.3 mm-40 -47.07 -61.01 2.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.917 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 345' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 344' ' ' GLU . 30.2 mt-10 -37.47 -44.44 0.65 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.878 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . 0.9 HG21 ' CB ' ' A' ' 294' ' ' HIS . 39.6 t -58.81 -54.11 38.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.133 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -49.78 -37.08 28.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.914 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -71.65 -46.23 59.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.902 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -46.1 -34.72 4.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.071 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 350' ' ' LEU . . . . . . . . . . . . . 65.5 mt -71.36 -41.01 70.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.935 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 27.5 mmtp -40.25 -52.41 2.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.879 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 352' ' ' CYS . . . . . . . . . . . . . 89.7 m -74.27 80.23 1.83 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.903 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -107.83 171.25 7.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.87 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 10.6 ptm180 41.99 50.43 4.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.907 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 355' ' ' GLU . . . . . 0.506 ' C ' ' CD1' ' A' ' 356' ' ' TYR . 9.8 mm-40 -98.08 174.38 6.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.916 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 356' ' ' TYR . . . . . 0.506 ' CD1' ' C ' ' A' ' 355' ' ' GLU . 1.0 OUTLIER -137.96 117.91 13.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.922 -179.862 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 357' ' ' MET . . . . . . . . . . . . . 4.4 ptt? -143.71 139.61 29.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.89 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 82.02 -33.76 2.63 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.5 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 129.14 15.89 2.01 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.499 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 360' ' ' ARG . . . . . . . . . . . . . 15.7 mmm180 -142.67 148.98 38.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.78 0.324 . . . . 0.0 110.889 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 361' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -61.0 152.7 27.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.961 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 8.5 mm -135.55 145.26 31.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.17 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 363' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -135.7 119.18 16.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.893 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 4.1 t -91.68 128.57 43.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.106 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -125.9 139.38 53.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.861 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 15.9 ttt-85 -88.17 114.02 24.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.835 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 64.4 mm-40 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.872 -179.946 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 294' ' ' HIS . . . . . 0.948 ' CB ' HG21 ' A' ' 346' ' ' VAL . 12.3 m-70 . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.914 0.388 . . . . 0.0 110.824 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 96.5 m -139.38 147.19 41.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.098 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 296' ' ' VAL . . . . . 0.428 HG13 HG13 ' A' ' 346' ' ' VAL . 29.9 m -127.59 146.81 32.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.176 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . 0.567 ' HD3' ' CE1' ' A' ' 337' ' ' PHE . 30.6 ttpt -117.02 145.99 43.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.936 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 6.4 mp -117.17 129.08 55.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.897 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 6.4 ttt85 -129.13 150.09 50.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.876 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 91.06 36.83 6.51 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.494 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -109.84 152.36 42.91 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.519 0.676 . . . . 0.0 111.105 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 -178.51 2.38 Favored 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.692 2.261 . . . . 0.0 112.316 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -89.51 -4.21 58.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.901 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -100.34 3.28 43.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.907 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 305' ' ' VAL . . . . . . . . . . . . . 4.1 p -65.11 153.13 8.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.088 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 306' ' ' THR . . . . . 0.439 ' OG1' ' N ' ' A' ' 307' ' ' GLU . 0.0 OUTLIER -149.12 170.84 17.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.104 -179.93 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 307' ' ' GLU . . . . . 0.439 ' N ' ' OG1' ' A' ' 306' ' ' THR . 30.7 mt-10 -54.71 -24.38 21.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.864 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 21.4 tttm -74.78 -51.44 14.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.881 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -54.23 -32.84 56.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.881 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 310' ' ' VAL . . . . . 0.51 ' HB ' HD13 ' A' ' 322' ' ' ILE . 30.0 t -70.81 -45.83 71.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.126 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 311' ' ' MET . . . . . . . . . . . . . 4.1 mmt -57.58 -53.13 61.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.919 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -63.41 -24.39 67.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.901 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 313' ' ' PHE . . . . . 0.812 ' CZ ' HG21 ' A' ' 362' ' ' ILE . 31.2 t80 -77.6 -49.75 13.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.879 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.579 ' CD1' HG11 ' A' ' 338' ' ' VAL . 74.2 mt -74.44 -22.65 59.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.913 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 315' ' ' ALA . . . . . 0.737 ' HB1' ' HA ' ' A' ' 316' ' ' PRO . . . -46.22 163.33 0.23 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.551 0.691 . . . . 0.0 111.149 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 316' ' ' PRO . . . . . 0.737 ' HA ' ' HB1' ' A' ' 315' ' ' ALA . 53.5 Cg_endo -69.79 -6.55 9.54 Favored 'Cis proline' 0 C--O 1.232 0.195 0 C-N-CA 122.68 -1.8 . . . . 0.0 112.316 0.027 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 317' ' ' LEU . . . . . 0.419 ' N ' ' HA ' ' A' ' 315' ' ' ALA . 81.6 mt -52.66 135.6 34.52 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.875 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 14.6 tptm -113.96 103.39 55.22 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.539 0.685 . . . . 0.0 110.892 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -169.9 0.36 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.636 2.224 . . . . 0.0 112.361 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 47.2 t -103.34 -46.24 10.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.093 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -156.06 138.28 14.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.062 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 322' ' ' ILE . . . . . 0.51 HD13 ' HB ' ' A' ' 310' ' ' VAL . 66.2 mt -114.21 122.86 69.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.135 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 65.9 mmt-85 -118.05 107.78 14.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.832 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 324' ' ' ILE . . . . . 0.577 HG23 HG12 ' A' ' 336' ' ' ILE . 52.3 mt -77.56 119.97 27.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.133 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 18.8 t . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.132 179.869 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 335' ' ' TYR . . . . . 0.415 ' C ' HG13 ' A' ' 336' ' ' ILE . 6.9 m-85 . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.828 0.347 . . . . 0.0 110.947 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 336' ' ' ILE . . . . . 0.577 HG12 HG23 ' A' ' 324' ' ' ILE . 54.2 mt -144.49 123.75 6.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.141 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . 0.567 ' CE1' ' HD3' ' A' ' 297' ' ' LYS . 62.1 m-85 -93.65 135.99 34.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.863 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . 0.579 HG11 ' CD1' ' A' ' 314' ' ' LEU . 41.5 t -134.96 122.92 39.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.14 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -98.24 160.52 14.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.853 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -139.79 162.92 33.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.912 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 2.8 m -98.88 -42.3 7.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.851 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 342' ' ' ASN . . . . . 0.408 ' O ' ' C ' ' A' ' 343' ' ' GLU . 19.5 m-80 -99.56 111.08 23.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.86 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 343' ' ' GLU . . . . . 0.545 ' CG ' ' CE1' ' A' ' 294' ' ' HIS . 0.5 OUTLIER -37.37 -60.61 0.66 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.85 -179.97 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 344' ' ' GLU . . . . . 0.454 ' C ' ' O ' ' A' ' 343' ' ' GLU . 13.1 tt0 -34.3 -51.37 0.45 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.873 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -47.48 -45.56 26.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.892 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . 0.948 HG21 ' CB ' ' A' ' 294' ' ' HIS . 23.7 t -57.49 -51.67 66.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.14 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 49.3 mtpt -54.46 -43.14 71.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.896 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 60.0 mm-40 -65.29 -39.18 92.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.943 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -48.02 -40.87 24.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.072 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 350' ' ' LEU . . . . . 0.53 HD11 ' HE ' ' A' ' 366' ' ' ARG . 39.7 mt -65.0 -40.91 95.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.913 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 34.2 mmtm -46.18 -46.22 17.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.916 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 352' ' ' CYS . . . . . . . . . . . . . 58.0 m -69.76 69.42 0.29 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.893 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 14.6 p30 -109.83 171.84 7.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.851 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? 55.75 33.22 20.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.851 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 355' ' ' GLU . . . . . 0.47 ' C ' ' CD1' ' A' ' 356' ' ' TYR . 2.5 mm-40 -97.09 173.68 7.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.903 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 356' ' ' TYR . . . . . 0.521 ' N ' ' CD1' ' A' ' 356' ' ' TYR . 0.9 OUTLIER -138.65 130.29 27.65 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.953 -179.877 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 357' ' ' MET . . . . . 0.608 ' HG2' HD11 ' A' ' 362' ' ' ILE . 5.8 ptt? -152.16 120.13 6.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.865 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 92.56 -23.29 28.75 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.522 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 125.96 -5.52 7.86 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.446 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 360' ' ' ARG . . . . . . . . . . . . . 15.4 mmm180 -119.34 158.52 25.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.873 0.368 . . . . 0.0 110.864 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 361' ' ' TYR . . . . . 0.547 ' CG ' ' O ' ' A' ' 361' ' ' TYR . 3.0 p90 -77.2 117.48 18.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.951 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 362' ' ' ILE . . . . . 0.812 HG21 ' CZ ' ' A' ' 313' ' ' PHE . 45.9 mm -83.23 117.01 28.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.112 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 363' ' ' GLU . . . . . 0.588 ' HG3' ' CZ ' ' A' ' 365' ' ' PHE . 4.2 tp10 -111.23 112.06 23.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.919 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 7.0 t -87.16 144.72 8.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.131 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 365' ' ' PHE . . . . . 0.588 ' CZ ' ' HG3' ' A' ' 363' ' ' GLU . 58.0 m-85 -140.85 133.24 28.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.916 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . 0.53 ' HE ' HD11 ' A' ' 350' ' ' LEU . 6.0 ttm180 -84.73 115.51 22.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.907 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.877 -179.901 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 294' ' ' HIS . . . . . 0.838 ' HB3' HG21 ' A' ' 346' ' ' VAL . 34.2 m80 . . . . . 0 C--O 1.233 0.191 0 CA-C-O 120.856 0.36 . . . . 0.0 110.879 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 19.5 m -131.01 132.14 44.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.129 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 296' ' ' VAL . . . . . 0.472 ' CG1' HG13 ' A' ' 346' ' ' VAL . 34.9 m -104.01 154.72 5.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.133 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . 0.571 ' HE2' ' CZ ' ' A' ' 337' ' ' PHE . 2.1 tppp? -113.26 142.34 45.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.94 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 6.9 mp -128.69 119.78 25.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.906 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 19.2 ptt85 -127.68 165.65 19.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.868 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 94.36 -24.08 29.0 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.497 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -57.36 151.78 36.13 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.558 0.694 . . . . 0.0 111.103 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 163.11 39.49 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.703 2.269 . . . . 0.0 112.37 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 303' ' ' PHE . . . . . 0.557 ' C ' ' CD1' ' A' ' 303' ' ' PHE . 0.5 OUTLIER -69.05 -24.52 64.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.877 -179.979 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -93.58 36.72 1.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.916 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 305' ' ' VAL . . . . . . . . . . . . . 9.9 p -94.8 146.15 7.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.16 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 306' ' ' THR . . . . . . . . . . . . . 7.1 p -128.27 159.87 33.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.159 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -43.17 -43.45 4.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.885 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 56.1 tttt -52.89 -61.79 2.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.885 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -41.48 -46.81 3.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.864 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 92.4 t -60.2 -55.9 21.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.142 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 311' ' ' MET . . . . . . . . . . . . . 3.6 mmt -43.14 -45.55 5.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.885 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -62.33 -41.66 98.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.855 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -67.05 -44.24 80.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.833 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.637 HD13 HG11 ' A' ' 338' ' ' VAL . 94.3 mt -75.99 -25.7 56.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.914 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 315' ' ' ALA . . . . . 0.594 ' HB1' ' HA ' ' A' ' 316' ' ' PRO . . . -50.65 158.48 1.08 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.613 0.72 . . . . 0.0 111.076 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 316' ' ' PRO . . . . . 0.594 ' HA ' ' HB1' ' A' ' 315' ' ' ALA . 54.2 Cg_endo -69.72 -19.55 11.14 Favored 'Cis proline' 0 C--N 1.342 0.185 0 C-N-CA 122.702 -1.791 . . . . 0.0 112.362 -0.031 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 317' ' ' LEU . . . . . 0.591 HD21 ' OE1' ' A' ' 348' ' ' GLN . 60.3 mt -38.33 125.34 1.31 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.915 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 318' ' ' LYS . . . . . 0.446 ' CE ' ' HA ' ' A' ' 318' ' ' LYS . 0.6 OUTLIER -105.44 103.37 42.53 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.625 0.726 . . . . 0.0 110.905 179.83 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.81 -172.07 0.54 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.698 2.265 . . . . 0.0 112.301 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 79.6 t -103.45 -44.52 9.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.149 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -157.6 134.45 10.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.079 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 322' ' ' ILE . . . . . 0.477 HG23 HG22 ' A' ' 338' ' ' VAL . 64.5 mt -105.99 105.09 18.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.111 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 73.9 mtt-85 -108.69 107.98 18.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.849 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 324' ' ' ILE . . . . . 0.599 HG23 HG12 ' A' ' 336' ' ' ILE . 59.9 mt -72.22 128.02 34.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.125 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . 0.556 ' CG2' ' CD2' ' A' ' 337' ' ' PHE . 66.8 t . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.143 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 335' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.891 0.377 . . . . 0.0 110.882 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 336' ' ' ILE . . . . . 0.599 HG12 HG23 ' A' ' 324' ' ' ILE . 42.6 mt -134.39 130.16 53.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.134 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . 0.571 ' CZ ' ' HE2' ' A' ' 297' ' ' LYS . 7.2 m-85 -98.15 127.86 44.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.9 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . 0.637 HG11 HD13 ' A' ' 314' ' ' LEU . 75.0 t -127.38 120.65 55.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.129 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -95.86 156.01 16.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.876 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -134.42 165.42 25.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.921 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 2.0 m -93.98 -53.34 4.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.858 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 35.8 m-20 -95.16 128.49 42.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.87 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -49.45 -43.46 44.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.903 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -45.5 -55.82 5.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.858 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 345' ' ' GLU . . . . . 0.5 ' HA ' HD22 ' A' ' 317' ' ' LEU . 62.1 mt-10 -43.76 -53.68 5.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.876 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . 0.838 HG21 ' HB3' ' A' ' 294' ' ' HIS . 66.7 t -54.55 -50.5 58.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.17 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -54.34 -33.67 59.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.895 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 348' ' ' GLN . . . . . 0.591 ' OE1' HD21 ' A' ' 317' ' ' LEU . 68.2 mt-30 -78.45 -36.63 45.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.894 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -47.1 -38.67 11.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.054 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 350' ' ' LEU . . . . . 0.532 HD11 ' HG3' ' A' ' 366' ' ' ARG . 49.5 mt -63.35 -39.43 94.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.898 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 18.9 mmtm -47.31 -45.4 24.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.886 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 352' ' ' CYS . . . . . . . . . . . . . 4.1 m -75.21 64.94 1.5 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.915 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -108.71 160.83 15.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.871 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 25.0 ttp180 63.09 34.72 13.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.865 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 355' ' ' GLU . . . . . 0.455 ' C ' ' CD1' ' A' ' 356' ' ' TYR . 3.9 mm-40 -94.82 172.78 7.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.886 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 356' ' ' TYR . . . . . 0.473 ' N ' ' CD1' ' A' ' 356' ' ' TYR . 1.3 m-85 -135.68 120.05 17.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.912 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 357' ' ' MET . . . . . . . . . . . . . 3.3 ptt? -145.45 143.9 30.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.857 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 75.98 -9.96 16.25 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.492 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 106.4 18.33 11.21 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.483 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 360' ' ' ARG . . . . . . . . . . . . . 20.2 mmt180 -145.46 178.11 8.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.836 0.35 . . . . 0.0 110.862 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 361' ' ' TYR . . . . . . . . . . . . . 18.9 p90 -90.67 163.83 14.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.932 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 362' ' ' ILE . . . . . 0.417 HG22 ' N ' ' A' ' 363' ' ' GLU . 8.0 mm -141.6 155.34 20.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.112 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 363' ' ' GLU . . . . . 0.549 ' HB3' ' CZ ' ' A' ' 365' ' ' PHE . 13.8 mt-10 -147.47 119.45 8.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.851 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 20.0 t -89.01 140.06 16.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.139 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 365' ' ' PHE . . . . . 0.549 ' CZ ' ' HB3' ' A' ' 363' ' ' GLU . 16.8 m-85 -140.92 128.3 21.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.889 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . 0.532 ' HG3' HD11 ' A' ' 350' ' ' LEU . 36.4 mtp180 -73.21 143.0 47.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.865 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.939 -179.996 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 294' ' ' HIS . . . . . 0.777 ' CB ' HG21 ' A' ' 346' ' ' VAL . 6.1 m80 . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.875 0.369 . . . . 0.0 110.889 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 95.4 m -138.44 137.29 37.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.146 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 296' ' ' VAL . . . . . 0.434 ' CG2' ' HB ' ' A' ' 338' ' ' VAL . 35.9 m -110.69 152.24 12.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.158 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . 0.539 ' HG3' ' CE1' ' A' ' 337' ' ' PHE . 0.2 OUTLIER -118.08 136.01 53.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.848 179.992 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . 0.438 HD21 ' CE2' ' A' ' 313' ' ' PHE . 6.7 mp -113.98 142.28 46.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.89 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 299' ' ' ARG . . . . . 0.535 ' HD3' ' CE2' ' A' ' 335' ' ' TYR . 25.1 tpt85 -148.79 134.14 18.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.868 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 126.07 -23.88 5.77 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.446 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -56.62 147.55 50.46 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.568 0.699 . . . . 0.0 111.105 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 -172.45 0.57 Allowed 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.673 2.249 . . . . 0.0 112.325 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 303' ' ' PHE . . . . . 0.429 ' O ' ' CG ' ' A' ' 303' ' ' PHE . 73.1 t80 -89.56 -3.41 58.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.895 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 36.3 t30 -110.41 29.34 7.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.871 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 305' ' ' VAL . . . . . . . . . . . . . 9.1 p -97.04 148.91 5.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.12 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 306' ' ' THR . . . . . . . . . . . . . 23.5 p -134.89 161.23 35.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.129 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -39.77 -49.28 2.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.868 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 33.1 ttmt -46.84 -58.87 3.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.92 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 32.7 m120 -45.17 -45.17 11.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.899 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 61.6 t -57.81 -43.6 84.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.149 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 311' ' ' MET . . . . . 0.405 ' HG2' HD11 ' A' ' 322' ' ' ILE . 3.3 mmt -59.28 -50.49 73.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.869 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -64.28 -29.74 70.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.917 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 313' ' ' PHE . . . . . 0.438 ' CE2' HD21 ' A' ' 298' ' ' LEU . 4.4 t80 -72.27 -31.78 66.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.893 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.482 HD13 ' HZ ' ' A' ' 340' ' ' PHE . 92.1 mt -90.93 -22.95 20.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.906 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 315' ' ' ALA . . . . . 0.614 ' HB1' ' HA ' ' A' ' 316' ' ' PRO . . . -44.06 159.32 0.24 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.557 0.694 . . . . 0.0 111.127 179.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 316' ' ' PRO . . . . . 0.614 ' HA ' ' HB1' ' A' ' 315' ' ' ALA . 53.6 Cg_endo -69.73 -8.98 10.73 Favored 'Cis proline' 0 C--N 1.341 0.183 0 C-N-CA 122.662 -1.807 . . . . 0.0 112.357 -0.034 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 317' ' ' LEU . . . . . 0.521 HD21 ' OE1' ' A' ' 348' ' ' GLN . 26.4 mt -46.72 161.15 0.07 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.899 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 29.2 tttm -143.79 105.0 4.91 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.563 0.697 . . . . 0.0 110.884 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 319' ' ' PRO . . . . . 0.425 ' HA ' ' CD2' ' A' ' 340' ' ' PHE . 53.8 Cg_endo -69.71 -173.6 0.74 Allowed 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.706 2.271 . . . . 0.0 112.36 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 93.7 t -103.18 -41.11 7.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.136 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -157.47 139.08 13.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.109 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 322' ' ' ILE . . . . . 0.405 HD11 ' HG2' ' A' ' 311' ' ' MET . 92.0 mt -106.79 106.77 21.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.151 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 45.2 mtt180 -102.47 105.29 15.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.884 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 55.8 mt -73.93 119.85 21.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.122 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . 0.482 HG22 ' CD2' ' A' ' 337' ' ' PHE . 94.4 t . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.13 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 335' ' ' TYR . . . . . 0.535 ' CE2' ' HD3' ' A' ' 299' ' ' ARG . 2.8 m-85 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.855 0.36 . . . . 0.0 110.919 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 72.8 mt -142.45 114.34 3.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.123 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . 0.539 ' CE1' ' HG3' ' A' ' 297' ' ' LYS . 15.6 m-85 -88.5 135.35 33.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.918 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . 0.434 ' HB ' ' CG2' ' A' ' 296' ' ' VAL . 63.3 t -132.5 129.91 59.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.11 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -103.18 161.8 13.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.886 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 340' ' ' PHE . . . . . 0.482 ' HZ ' HD13 ' A' ' 314' ' ' LEU . 55.6 m-85 -139.57 166.53 24.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.868 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 32.2 m -82.59 -62.06 1.71 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.874 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 21.1 m-80 -91.87 158.01 16.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.893 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 343' ' ' GLU . . . . . 0.483 ' HB3' ' CE1' ' A' ' 294' ' ' HIS . 1.7 pp20? -73.92 -28.56 61.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.85 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 45.7 mm-40 -59.3 -53.05 62.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.91 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -46.27 -51.74 13.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.907 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . 0.777 HG21 ' CB ' ' A' ' 294' ' ' HIS . 21.2 t -49.96 -50.64 18.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.146 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 6.2 mtpm? -51.61 -48.76 63.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.875 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 348' ' ' GLN . . . . . 0.521 ' OE1' HD21 ' A' ' 317' ' ' LEU . 75.4 mt-30 -62.38 -26.13 68.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.914 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 349' ' ' ALA . . . . . 0.511 ' HB3' ' O ' ' A' ' 346' ' ' VAL . . . -63.23 -35.92 81.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.101 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 350' ' ' LEU . . . . . 0.455 HD21 ' HB2' ' A' ' 366' ' ' ARG . 57.6 mt -63.74 -40.94 97.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.978 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 5.4 mtmp? -46.63 -51.15 16.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.934 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 352' ' ' CYS . . . . . . . . . . . . . 4.2 m -69.36 85.19 0.4 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.897 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . 0.452 ' O ' ' C ' ' A' ' 354' ' ' ARG . 1.1 p30 -124.91 -176.37 3.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.91 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . 0.482 ' CD ' ' O ' ' A' ' 354' ' ' ARG . 0.0 OUTLIER 32.44 38.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.883 -179.925 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 355' ' ' GLU . . . . . 0.469 ' C ' ' CD1' ' A' ' 356' ' ' TYR . 57.1 mm-40 -86.95 176.16 7.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.87 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 356' ' ' TYR . . . . . 0.469 ' CD1' ' C ' ' A' ' 355' ' ' GLU . 1.2 m-85 -135.31 107.95 7.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.964 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 357' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -138.38 145.83 41.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.918 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 72.89 -6.13 14.48 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.494 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 102.96 21.91 9.78 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.479 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 360' ' ' ARG . . . . . . . . . . . . . 14.2 mmt180 -148.71 175.7 10.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.807 0.337 . . . . 0.0 110.9 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 361' ' ' TYR . . . . . 0.73 ' O ' HD13 ' A' ' 362' ' ' ILE . 10.8 p90 -82.59 172.21 13.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.924 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 362' ' ' ILE . . . . . 0.73 HD13 ' O ' ' A' ' 361' ' ' TYR . 25.7 mm -142.27 155.53 18.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.11 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 363' ' ' GLU . . . . . 0.553 ' HB3' ' CZ ' ' A' ' 365' ' ' PHE . 7.0 mm-40 -147.87 112.92 5.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.888 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 17.2 t -91.46 143.53 11.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.078 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 365' ' ' PHE . . . . . 0.553 ' CZ ' ' HB3' ' A' ' 363' ' ' GLU . 32.0 m-85 -143.09 122.38 13.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.898 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . 0.455 ' HB2' HD21 ' A' ' 350' ' ' LEU . 35.2 ttp85 -75.84 112.69 12.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.847 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.854 -179.91 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 294' ' ' HIS . . . . . 0.584 ' CB ' HG21 ' A' ' 346' ' ' VAL . 3.0 m-70 . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.883 0.373 . . . . 0.0 110.869 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 87.4 m -126.34 144.57 50.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.106 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 296' ' ' VAL . . . . . 0.763 ' CG1' HG13 ' A' ' 346' ' ' VAL . 19.6 m -121.72 157.65 25.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.136 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 8.8 ttpp -128.43 142.34 51.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.873 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . 0.491 HD21 ' CE1' ' A' ' 313' ' ' PHE . 7.6 mp -114.93 149.83 36.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.89 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 7.7 ttt180 -150.41 140.2 21.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.893 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . 0.685 ' O ' HD13 ' A' ' 362' ' ' ILE . . . 103.43 44.94 1.62 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.474 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -113.84 151.42 44.71 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.597 0.713 . . . . 0.0 111.091 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -171.95 0.53 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.637 2.225 . . . . 0.0 112.319 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -87.55 -7.69 57.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.897 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 33.0 m120 -108.97 32.01 5.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.88 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 305' ' ' VAL . . . . . . . . . . . . . 4.5 p -96.2 139.89 18.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.139 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 306' ' ' THR . . . . . . . . . . . . . 67.7 p -142.97 170.63 15.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.146 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -46.68 -35.35 5.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.883 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 11.4 tmtt? -59.7 -50.32 74.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.884 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 34.8 m120 -55.09 -48.89 72.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.944 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 76.6 t -58.17 -55.31 22.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.14 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 311' ' ' MET . . . . . . . . . . . . . 2.3 mmt -46.35 -44.47 16.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.889 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -73.99 -26.28 60.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.875 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 313' ' ' PHE . . . . . 0.591 ' CD2' ' SD ' ' A' ' 357' ' ' MET . 1.9 t80 -78.37 -30.9 48.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.822 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.463 ' CD1' HG11 ' A' ' 338' ' ' VAL . 93.9 mt -91.5 -24.53 19.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.952 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 315' ' ' ALA . . . . . 0.756 ' HB1' ' HA ' ' A' ' 316' ' ' PRO . . . -48.68 163.87 0.3 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.592 0.711 . . . . 0.0 111.098 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 316' ' ' PRO . . . . . 0.756 ' HA ' ' HB1' ' A' ' 315' ' ' ALA . 53.7 Cg_endo -69.72 -3.2 7.5 Favored 'Cis proline' 0 C--O 1.231 0.165 0 C-N-CA 122.713 -1.786 . . . . 0.0 112.341 -0.026 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 317' ' ' LEU . . . . . 0.485 ' N ' ' HA ' ' A' ' 315' ' ' ALA . 13.5 mt -55.63 142.95 31.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.93 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -120.52 106.31 40.21 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.588 0.708 . . . . 0.0 110.883 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 -164.54 0.13 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.72 2.28 . . . . 0.0 112.369 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 24.5 t -113.62 -45.04 4.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.104 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -153.59 128.94 9.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.09 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 322' ' ' ILE . . . . . 0.583 HG23 HG22 ' A' ' 338' ' ' VAL . 49.3 mt -107.67 99.86 9.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.144 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -100.19 104.73 16.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.875 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 324' ' ' ILE . . . . . 0.51 HG12 HG23 ' A' ' 336' ' ' ILE . 58.4 mt -73.73 118.34 19.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.104 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . 0.441 HG22 ' CE2' ' A' ' 337' ' ' PHE . 84.5 t . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.109 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 335' ' ' TYR . . . . . 0.409 ' HB3' HG21 ' A' ' 325' ' ' VAL . 19.2 m-85 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.915 0.388 . . . . 0.0 110.928 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 336' ' ' ILE . . . . . 0.51 HG23 HG12 ' A' ' 324' ' ' ILE . 42.6 mt -139.93 132.02 33.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.137 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . 0.441 ' CE2' HG22 ' A' ' 325' ' ' VAL . 22.7 m-85 -99.52 142.78 30.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.849 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . 0.583 HG22 HG23 ' A' ' 322' ' ' ILE . 27.6 t -146.33 131.53 12.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.181 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -103.22 168.09 9.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.856 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 340' ' ' PHE . . . . . 0.477 ' HB2' ' CG2' ' A' ' 346' ' ' VAL . 65.6 m-85 -148.22 157.56 43.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.852 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 13.1 t -70.16 -64.6 0.86 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.856 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -99.39 177.43 5.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.863 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 343' ' ' GLU . . . . . 0.583 ' HB3' ' CE1' ' A' ' 294' ' ' HIS . 20.1 pt-20 -78.22 -45.84 21.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.868 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 344' ' ' GLU . . . . . 0.403 ' N ' ' HG3' ' A' ' 343' ' ' GLU . 19.0 mt-10 -42.26 -60.03 1.61 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.892 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -45.3 -32.45 1.99 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.873 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . 0.763 HG13 ' CG1' ' A' ' 296' ' ' VAL . 74.9 t -82.6 -36.75 13.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.114 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -64.22 -35.43 80.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.915 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 45.9 mm-40 -76.03 -40.01 54.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.92 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -51.82 -33.53 36.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.141 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 350' ' ' LEU . . . . . 0.61 HD23 HG12 ' A' ' 364' ' ' VAL . 96.8 mt -72.48 -40.15 67.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.935 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 46.7 mttm -46.27 -40.69 11.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.885 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 352' ' ' CYS . . . . . . . . . . . . . 33.1 m -78.77 80.45 5.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.915 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . 0.438 ' O ' ' C ' ' A' ' 354' ' ' ARG . 31.5 p-10 -109.28 178.56 4.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.86 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . 0.438 ' C ' ' O ' ' A' ' 353' ' ' ASN . 20.7 ptt180 35.42 42.86 0.13 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.922 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 355' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -89.45 173.9 8.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.85 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 356' ' ' TYR . . . . . 0.497 ' N ' ' CD1' ' A' ' 356' ' ' TYR . 1.1 m-85 -128.13 115.56 18.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.952 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 357' ' ' MET . . . . . 0.591 ' SD ' ' CD2' ' A' ' 313' ' ' PHE . 4.6 ptt? -145.81 127.52 15.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.866 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 81.36 -17.94 12.11 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.526 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 113.25 19.03 6.89 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.467 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 360' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -143.87 134.71 25.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.812 0.339 . . . . 0.0 110.9 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 361' ' ' TYR . . . . . 0.557 ' O ' ' CD1' ' A' ' 361' ' ' TYR . 12.6 p90 -56.27 127.23 29.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.897 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 362' ' ' ILE . . . . . 0.685 HD13 ' O ' ' A' ' 300' ' ' GLY . 4.2 mm -106.31 151.57 8.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.163 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 363' ' ' GLU . . . . . 0.421 ' HB3' ' CZ ' ' A' ' 365' ' ' PHE . 28.1 mm-40 -143.4 116.93 9.14 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.846 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 364' ' ' VAL . . . . . 0.61 HG12 HD23 ' A' ' 350' ' ' LEU . 21.7 t -88.82 142.53 12.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.15 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 365' ' ' PHE . . . . . 0.442 ' CD1' ' O ' ' A' ' 364' ' ' VAL . 10.3 m-85 -139.93 146.87 39.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.909 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . 0.506 ' HB2' HD11 ' A' ' 350' ' ' LEU . 0.0 OUTLIER -86.68 109.36 19.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.878 -179.896 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.888 -179.922 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 294' ' ' HIS . . . . . 0.632 ' HB3' HG21 ' A' ' 346' ' ' VAL . 11.3 m80 . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.864 0.364 . . . . 0.0 110.861 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 63.1 m -136.17 145.36 45.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.178 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 296' ' ' VAL . . . . . 0.52 ' CG1' HG13 ' A' ' 346' ' ' VAL . 29.8 m -118.86 147.21 22.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.154 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . 0.568 ' HD3' ' CD1' ' A' ' 335' ' ' TYR . 8.8 ttmm -116.87 146.33 42.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.944 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . 0.465 HD21 ' CD2' ' A' ' 313' ' ' PHE . 6.9 mp -115.55 157.55 23.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.917 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -158.02 130.22 7.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.859 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 123.1 -23.2 6.96 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.484 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -57.17 147.71 55.4 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.594 0.711 . . . . 0.0 111.066 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 -176.54 1.52 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.71 2.273 . . . . 0.0 112.301 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -78.1 -35.74 48.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.904 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -88.59 48.46 1.64 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.858 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 305' ' ' VAL . . . . . . . . . . . . . 11.4 p -99.24 141.38 16.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.163 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 306' ' ' THR . . . . . 0.414 ' O ' ' C ' ' A' ' 307' ' ' GLU . 69.2 p -132.43 153.27 51.01 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.096 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 307' ' ' GLU . . . . . 0.414 ' C ' ' O ' ' A' ' 306' ' ' THR . 26.1 mt-10 -35.68 -52.17 0.68 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.891 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 14.7 ttpt -40.83 -47.25 2.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.892 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -57.85 -54.87 42.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.873 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 56.2 t -55.9 -50.4 69.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.159 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 311' ' ' MET . . . . . . . . . . . . . 2.7 mmt -48.91 -52.46 24.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.866 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -67.31 -24.73 65.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.871 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 313' ' ' PHE . . . . . 0.465 ' CD2' HD21 ' A' ' 298' ' ' LEU . 11.2 t80 -77.34 -35.66 54.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.848 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.482 ' CD1' HG11 ' A' ' 338' ' ' VAL . 85.9 mt -86.04 -20.61 28.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.94 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 315' ' ' ALA . . . . . 0.641 ' HB1' ' HA ' ' A' ' 316' ' ' PRO . . . -47.09 159.96 0.37 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.588 0.708 . . . . 0.0 111.08 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 316' ' ' PRO . . . . . 0.641 ' HA ' ' HB1' ' A' ' 315' ' ' ALA . 53.8 Cg_endo -69.78 -21.5 10.2 Favored 'Cis proline' 0 C--O 1.232 0.188 0 C-N-CA 122.677 -1.801 . . . . 0.0 112.357 0.055 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 317' ' ' LEU . . . . . 0.588 HD11 ' CB ' ' A' ' 348' ' ' GLN . 22.2 mt -41.38 139.07 1.11 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.887 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -118.51 110.55 38.88 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.576 0.703 . . . . 0.0 110.876 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 319' ' ' PRO . . . . . 0.405 ' HA ' ' CD2' ' A' ' 340' ' ' PHE . 54.2 Cg_endo -69.71 -178.33 2.27 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.68 2.253 . . . . 0.0 112.384 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 19.4 t -104.12 -34.14 3.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.151 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -162.73 132.93 4.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.115 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 322' ' ' ILE . . . . . 0.414 HG23 HG22 ' A' ' 338' ' ' VAL . 66.2 mt -107.75 117.21 52.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.153 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 19.4 mmt180 -111.47 107.08 16.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.843 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 324' ' ' ILE . . . . . 0.625 HG23 HG12 ' A' ' 336' ' ' ILE . 70.8 mt -84.61 138.21 19.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.156 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . 0.523 HG21 ' CE2' ' A' ' 337' ' ' PHE . 62.1 t . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.095 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 335' ' ' TYR . . . . . 0.568 ' CD1' ' HD3' ' A' ' 297' ' ' LYS . 79.3 m-85 . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.811 0.338 . . . . 0.0 110.957 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 336' ' ' ILE . . . . . 0.625 HG12 HG23 ' A' ' 324' ' ' ILE . 60.0 mt -127.28 121.52 57.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.132 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . 0.523 ' CE2' HG21 ' A' ' 325' ' ' VAL . 39.1 m-85 -96.1 136.2 36.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.876 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . 0.482 HG11 ' CD1' ' A' ' 314' ' ' LEU . 25.5 t -134.73 132.17 54.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.105 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -105.69 157.94 17.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.883 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 340' ' ' PHE . . . . . 0.405 ' CD2' ' HA ' ' A' ' 319' ' ' PRO . 53.3 m-85 -133.85 162.06 33.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.879 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 34.4 p -64.73 -66.61 0.52 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.877 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 342' ' ' ASN . . . . . 0.401 ' OD1' ' N ' ' A' ' 342' ' ' ASN . 2.8 p-10 -99.75 170.8 8.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.918 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 343' ' ' GLU . . . . . 0.586 ' HB3' ' CE1' ' A' ' 294' ' ' HIS . 1.4 pp20? -70.14 -51.01 34.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.89 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 344' ' ' GLU . . . . . 0.425 ' N ' ' CD ' ' A' ' 343' ' ' GLU . 10.4 tt0 -40.36 -57.98 1.64 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.906 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -39.74 -36.15 0.4 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.899 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . 0.632 HG21 ' HB3' ' A' ' 294' ' ' HIS . 24.6 t -70.08 -48.27 63.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.106 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 347' ' ' LYS . . . . . 0.423 ' NZ ' ' HB2' ' A' ' 347' ' ' LYS . 5.1 mtmp? -52.87 -39.46 62.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.934 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 348' ' ' GLN . . . . . 0.588 ' CB ' HD11 ' A' ' 317' ' ' LEU . 85.5 mt-30 -73.31 -26.66 61.15 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.933 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -64.03 -35.96 82.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.095 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 350' ' ' LEU . . . . . . . . . . . . . 15.9 mt -73.22 -37.06 66.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.912 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 26.3 mmmt -47.44 -47.18 27.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.901 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 352' ' ' CYS . . . . . . . . . . . . . 15.9 m -70.3 72.55 0.47 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.877 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 14.9 p30 -109.09 162.76 13.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.932 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 20.5 mmt180 61.86 35.63 16.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.848 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 355' ' ' GLU . . . . . 0.46 ' C ' ' CD1' ' A' ' 356' ' ' TYR . 20.9 mm-40 -91.48 173.65 7.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.891 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 356' ' ' TYR . . . . . 0.491 ' N ' ' CD1' ' A' ' 356' ' ' TYR . 1.2 m-85 -136.3 128.06 29.11 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.922 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 357' ' ' MET . . . . . . . . . . . . . 3.6 ptt? -156.6 140.38 16.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.912 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 76.95 -9.29 25.47 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.456 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 102.93 16.85 20.38 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.461 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 360' ' ' ARG . . . . . . . . . . . . . 10.3 mmt180 -144.29 153.36 41.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.801 0.334 . . . . 0.0 110.881 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 361' ' ' TYR . . . . . 0.441 ' CD1' ' C ' ' A' ' 361' ' ' TYR . 1.0 OUTLIER -64.88 166.26 9.4 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.911 -179.84 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 362' ' ' ILE . . . . . 0.401 HG12 ' C ' ' A' ' 361' ' ' TYR . 15.7 mm -146.75 137.54 18.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.136 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 363' ' ' GLU . . . . . 0.565 ' HG3' ' CE2' ' A' ' 365' ' ' PHE . 14.7 pt-20 -133.99 112.07 10.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.895 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 364' ' ' VAL . . . . . 0.533 ' O ' ' CD1' ' A' ' 365' ' ' PHE . 14.2 t -84.51 154.07 3.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.099 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 365' ' ' PHE . . . . . 0.565 ' CE2' ' HG3' ' A' ' 363' ' ' GLU . 28.8 m-85 -145.99 156.46 43.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.851 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 32.8 ttp85 -97.86 120.4 38.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.912 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.881 -179.917 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 294' ' ' HIS . . . . . 0.553 ' HB3' HG21 ' A' ' 346' ' ' VAL . 7.8 m-70 . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.878 0.371 . . . . 0.0 110.874 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 24.7 m -136.49 143.5 43.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.148 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 296' ' ' VAL . . . . . 0.521 ' CG1' HG13 ' A' ' 346' ' ' VAL . 27.0 m -128.92 150.45 34.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.106 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 28.3 ttpp -119.1 132.36 56.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.902 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 7.3 mp -105.95 103.1 12.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.869 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 299' ' ' ARG . . . . . 0.541 ' HD3' ' CE1' ' A' ' 335' ' ' TYR . 38.0 tpt85 -104.45 122.68 46.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.896 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . 0.411 ' C ' ' O ' ' A' ' 361' ' ' TYR . . . 133.36 -25.1 3.67 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.501 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . 0.456 ' HA ' ' CD1' ' A' ' 362' ' ' ILE . . . -59.52 144.11 85.0 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.571 0.7 . . . . 0.0 111.095 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -167.74 0.24 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.665 2.243 . . . . 0.0 112.341 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 303' ' ' PHE . . . . . 0.411 ' CD1' ' C ' ' A' ' 303' ' ' PHE . 1.8 p90 -95.81 -12.8 24.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.87 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -93.33 3.01 56.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.94 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 305' ' ' VAL . . . . . 0.4 HG11 ' HB1' ' A' ' 301' ' ' ALA . 7.5 p -78.39 143.23 12.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.109 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 306' ' ' THR . . . . . . . . . . . . . 16.6 p -131.92 162.73 29.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.115 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -38.93 -49.16 1.66 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.932 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 30.2 ttmt -50.87 -58.69 5.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.86 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -49.91 -43.01 49.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.891 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 310' ' ' VAL . . . . . 0.525 HG12 HD12 ' A' ' 314' ' ' LEU . 99.0 t -60.56 -49.09 85.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.155 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 311' ' ' MET . . . . . . . . . . . . . 3.1 mmt -50.11 -39.09 41.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.822 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -71.7 -35.49 70.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.898 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 313' ' ' PHE . . . . . 0.449 ' C ' ' CD1' ' A' ' 313' ' ' PHE . 1.6 t80 -74.82 -31.06 61.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.86 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.758 HD11 HG21 ' A' ' 338' ' ' VAL . 50.5 mt -84.24 -26.18 28.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.95 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 315' ' ' ALA . . . . . 0.756 ' HB1' ' HA ' ' A' ' 316' ' ' PRO . . . -51.45 163.3 0.59 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.576 0.703 . . . . 0.0 111.105 179.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 316' ' ' PRO . . . . . 0.756 ' HA ' ' HB1' ' A' ' 315' ' ' ALA . 54.1 Cg_endo -69.81 -16.24 12.36 Favored 'Cis proline' 0 C--O 1.232 0.21 0 C-N-CA 122.696 -1.793 . . . . 0.0 112.377 0.005 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 317' ' ' LEU . . . . . 0.576 HD11 ' HB3' ' A' ' 348' ' ' GLN . 23.9 mt -46.7 129.37 11.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.896 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 318' ' ' LYS . . . . . 0.416 ' NZ ' ' HA ' ' A' ' 318' ' ' LYS . 0.2 OUTLIER -105.72 105.75 54.04 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.571 0.701 . . . . 0.0 110.87 179.819 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 178.46 4.57 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.711 2.274 . . . . 0.0 112.297 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 61.8 t -100.01 -37.06 5.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.093 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -160.83 137.95 9.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.118 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 322' ' ' ILE . . . . . 0.49 HG23 HG22 ' A' ' 338' ' ' VAL . 74.0 mt -110.69 109.31 27.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.13 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 63.8 mmt-85 -107.1 105.12 14.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.898 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 324' ' ' ILE . . . . . 0.513 HG23 HG12 ' A' ' 336' ' ' ILE . 67.1 mt -76.42 126.97 37.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.127 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . 0.466 HG22 ' CD2' ' A' ' 337' ' ' PHE . 48.8 t . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.16 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 335' ' ' TYR . . . . . 0.541 ' CE1' ' HD3' ' A' ' 299' ' ' ARG . 8.4 m-85 . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.905 0.383 . . . . 0.0 110.896 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 336' ' ' ILE . . . . . 0.513 HG12 HG23 ' A' ' 324' ' ' ILE . 88.7 mt -151.04 116.19 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.103 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . 0.466 ' CD2' HG22 ' A' ' 325' ' ' VAL . 31.6 m-85 -90.55 134.76 34.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.845 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . 0.758 HG21 HD11 ' A' ' 314' ' ' LEU . 17.4 t -134.62 141.49 43.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.113 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -113.82 161.33 17.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.849 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -139.18 167.56 21.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.864 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 22.7 m -72.28 -68.46 0.47 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.828 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 342' ' ' ASN . . . . . 0.571 ' ND2' ' H ' ' A' ' 345' ' ' GLU . 2.3 p-10 -99.11 -176.04 3.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.883 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 343' ' ' GLU . . . . . 0.428 ' O ' ' N ' ' A' ' 346' ' ' VAL . 12.0 pt-20 -83.56 -47.26 11.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.884 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 344' ' ' GLU . . . . . 0.533 ' N ' HD22 ' A' ' 342' ' ' ASN . 7.3 mm-40 -44.01 -30.13 0.69 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.914 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 345' ' ' GLU . . . . . 0.571 ' H ' ' ND2' ' A' ' 342' ' ' ASN . 16.7 mt-10 -73.59 -35.8 65.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.876 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . 0.553 HG21 ' HB3' ' A' ' 294' ' ' HIS . 61.7 t -68.85 -59.12 3.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.163 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.81 -29.04 62.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.893 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 348' ' ' GLN . . . . . 0.576 ' HB3' HD11 ' A' ' 317' ' ' LEU . 29.6 mt-30 -73.11 -32.44 64.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.948 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -62.0 -36.44 81.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.089 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 350' ' ' LEU . . . . . 0.687 HD23 HG12 ' A' ' 364' ' ' VAL . 57.1 mt -60.99 -24.78 66.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.913 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 20.8 mmtp -49.72 -44.87 48.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.948 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 352' ' ' CYS . . . . . . . . . . . . . 22.3 m -78.21 72.28 4.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.865 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -109.24 147.71 32.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.883 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 50.4 ttm-85 70.15 30.44 3.49 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.883 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 355' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -88.52 173.74 8.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.936 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 356' ' ' TYR . . . . . 0.425 ' N ' ' CD1' ' A' ' 356' ' ' TYR . 1.7 m-85 -125.31 117.73 24.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.911 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 357' ' ' MET . . . . . 0.444 ' SD ' ' CD2' ' A' ' 313' ' ' PHE . 4.3 ptm -142.26 123.36 14.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.907 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 86.29 -20.37 22.24 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.51 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 117.24 13.45 7.61 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.494 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 360' ' ' ARG . . . . . . . . . . . . . 21.5 mmt-85 -140.75 158.52 43.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.815 0.34 . . . . 0.0 110.823 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 361' ' ' TYR . . . . . 0.731 ' O ' HD13 ' A' ' 362' ' ' ILE . 13.0 p90 -67.14 163.62 19.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.94 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 362' ' ' ILE . . . . . 0.731 HD13 ' O ' ' A' ' 361' ' ' TYR . 15.1 mm -140.57 144.58 27.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.154 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 363' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -138.42 112.19 8.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.861 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 364' ' ' VAL . . . . . 0.687 HG12 HD23 ' A' ' 350' ' ' LEU . 45.9 t -84.6 134.54 26.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.155 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -131.01 152.94 49.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.913 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . 0.403 ' HG3' HD11 ' A' ' 350' ' ' LEU . 51.6 mtm180 -101.43 113.35 26.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.866 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.87 -179.937 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 31.9 m80 . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.843 0.354 . . . . 0.0 110.886 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 85.0 m -140.55 143.44 35.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.116 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 296' ' ' VAL . . . . . 0.454 HG23 ' HB ' ' A' ' 338' ' ' VAL . 27.2 m -116.99 147.77 20.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.123 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 13.9 ttmt -125.37 137.38 54.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.921 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 6.8 mp -120.86 118.31 29.63 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.919 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -115.75 155.62 27.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.828 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 86.86 36.58 9.09 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.451 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -102.2 147.72 34.36 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.622 0.725 . . . . 0.0 111.113 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 175.98 7.37 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.713 2.275 . . . . 0.0 112.372 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 56.0 t80 -80.97 -29.26 35.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.876 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -86.89 35.44 0.69 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.903 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 305' ' ' VAL . . . . . . . . . . . . . 11.8 p -98.45 145.05 10.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.116 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 306' ' ' THR . . . . . . . . . . . . . 64.4 p -141.36 164.97 28.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.099 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -44.88 -34.95 2.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.915 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? -57.74 -47.06 83.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.909 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 23.2 m120 -60.19 -59.41 5.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.9 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 85.2 t -48.89 -41.51 13.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.152 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 311' ' ' MET . . . . . . . . . . . . . 2.0 mmt -62.09 -44.76 95.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.861 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -68.24 -26.41 65.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.881 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 313' ' ' PHE . . . . . 0.424 ' CD1' ' C ' ' A' ' 313' ' ' PHE . 5.5 t80 -75.33 -40.91 57.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.866 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.579 ' CD1' HG11 ' A' ' 338' ' ' VAL . 57.9 mt -83.1 -24.89 32.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.921 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 315' ' ' ALA . . . . . 0.533 ' HB1' ' HA ' ' A' ' 316' ' ' PRO . . . -44.58 156.74 0.33 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.579 0.704 . . . . 0.0 111.133 179.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 316' ' ' PRO . . . . . 0.533 ' HA ' ' HB1' ' A' ' 315' ' ' ALA . 53.6 Cg_endo -69.85 -19.09 11.52 Favored 'Cis proline' 0 C--O 1.232 0.21 0 C-N-CA 122.661 -1.808 . . . . 0.0 112.332 0.08 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 317' ' ' LEU . . . . . 0.558 HD22 ' HA ' ' A' ' 345' ' ' GLU . 35.7 mt -39.01 138.4 0.57 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.894 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 12.6 tppt? -119.64 107.49 40.57 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.551 0.691 . . . . 0.0 110.889 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 319' ' ' PRO . . . . . 0.426 ' HA ' ' CD2' ' A' ' 340' ' ' PHE . 54.0 Cg_endo -69.78 -171.02 0.43 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.648 2.232 . . . . 0.0 112.333 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 65.2 t -106.68 -41.75 6.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.11 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -155.06 129.8 9.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.118 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 322' ' ' ILE . . . . . 0.495 HG23 HG22 ' A' ' 338' ' ' VAL . 91.7 mt -100.97 99.8 9.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.152 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 9.5 mmm180 -98.74 103.44 15.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.908 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 324' ' ' ILE . . . . . 0.891 HG23 HG12 ' A' ' 336' ' ' ILE . 58.7 mt -81.01 134.86 26.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.128 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . 0.407 HG22 ' CE2' ' A' ' 337' ' ' PHE . 45.5 t . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.16 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 335' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.919 0.39 . . . . 0.0 110.911 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 336' ' ' ILE . . . . . 0.891 HG12 HG23 ' A' ' 324' ' ' ILE . 30.2 mt -145.63 143.48 21.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.114 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . 0.407 ' CE2' HG22 ' A' ' 325' ' ' VAL . 27.5 m-85 -110.67 123.52 50.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.859 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . 0.579 HG11 ' CD1' ' A' ' 314' ' ' LEU . 93.8 t -126.0 126.57 69.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.136 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -101.36 160.61 14.27 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.905 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 340' ' ' PHE . . . . . 0.439 ' HB2' ' CG2' ' A' ' 346' ' ' VAL . 35.9 m-85 -134.68 165.86 24.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.862 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 16.9 t -87.79 -55.34 3.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.831 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -89.54 168.04 12.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.895 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -81.96 -43.16 18.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.883 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -56.93 -54.11 50.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.938 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 345' ' ' GLU . . . . . 0.558 ' HA ' HD22 ' A' ' 317' ' ' LEU . 20.8 mm-40 -41.22 -35.81 0.66 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.888 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . 0.439 ' CG2' ' HB2' ' A' ' 340' ' ' PHE . 53.0 t -74.86 -50.28 25.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.11 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 15.5 mtpp -53.71 -35.75 61.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.879 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 35.3 mm-40 -71.46 -44.06 65.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.926 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -43.58 -40.1 3.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.099 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 350' ' ' LEU . . . . . . . . . . . . . 54.6 mt -58.88 -39.0 80.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.923 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 56.1 mmtt -45.12 -36.69 3.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.932 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 352' ' ' CYS . . . . . . . . . . . . . 64.6 m -71.2 71.99 0.62 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.908 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . 0.401 ' O ' ' C ' ' A' ' 354' ' ' ARG . 16.7 p30 -116.85 -176.46 2.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.913 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . 0.401 ' C ' ' O ' ' A' ' 353' ' ' ASN . 54.0 ttt-85 37.29 49.88 0.96 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.83 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 355' ' ' GLU . . . . . 0.438 ' C ' ' OE1' ' A' ' 355' ' ' GLU . 0.0 OUTLIER -135.94 173.38 11.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.899 -179.983 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 356' ' ' TYR . . . . . 0.434 ' N ' ' CD1' ' A' ' 356' ' ' TYR . 2.7 m-85 -131.7 137.14 48.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.902 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 357' ' ' MET . . . . . 0.425 ' CG ' HG13 ' A' ' 362' ' ' ILE . 0.1 OUTLIER -139.04 128.06 23.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.87 179.89 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 83.03 -28.75 3.58 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.479 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 125.26 28.46 1.1 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.5 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 360' ' ' ARG . . . . . . . . . . . . . 33.7 mtt-85 -151.41 156.99 41.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.861 0.363 . . . . 0.0 110.873 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 361' ' ' TYR . . . . . 0.438 ' CG ' ' O ' ' A' ' 361' ' ' TYR . 2.3 p90 -69.66 125.43 26.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.921 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 362' ' ' ILE . . . . . 0.425 HG13 ' CG ' ' A' ' 357' ' ' MET . 17.3 mm -107.18 151.94 8.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.191 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 363' ' ' GLU . . . . . 0.577 ' HB3' ' CZ ' ' A' ' 365' ' ' PHE . 59.9 mm-40 -143.42 112.16 6.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.881 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 15.9 t -87.81 120.85 37.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.151 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 365' ' ' PHE . . . . . 0.577 ' CZ ' ' HB3' ' A' ' 363' ' ' GLU . 70.7 m-85 -124.85 133.32 53.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.847 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 366' ' ' ARG . . . . . 0.43 ' HB3' ' NH1' ' A' ' 366' ' ' ARG . 6.2 ttp-105 -82.25 111.75 18.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.92 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.876 -179.905 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 N-CA-C 112.492 -0.243 . . . . 0.0 112.492 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 22.0 t 61.19 42.3 12.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.874 0.368 . . . . 0.0 110.866 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 1.5 t -95.17 172.24 8.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.833 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 145.68 92.44 0.13 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.438 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 37.4 m -150.06 113.37 4.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.894 0.378 . . . . 0.0 110.835 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 3.8 t -49.95 136.21 18.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.891 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' GLY . . . . . 0.435 ' O ' ' C ' ' A' ' 291' ' ' THR . . . -158.41 111.24 0.47 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.487 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . 0.435 ' C ' ' O ' ' A' ' 290' ' ' GLY . 93.3 m -34.47 125.06 0.51 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.856 0.36 . . . . 0.0 111.178 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 64.3 p -102.87 164.84 11.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.181 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' CYS . . . . . . . . . . . . . 23.0 m -67.63 102.35 1.17 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.864 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . 0.679 ' HB2' HG21 ' A' ' 346' ' ' VAL . 28.5 m-70 -38.85 132.0 1.29 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.866 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 63.0 m -139.66 142.35 36.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.142 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 296' ' ' VAL . . . . . 0.542 ' CG1' HG13 ' A' ' 346' ' ' VAL . 29.2 m -118.5 151.06 20.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.145 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . 0.429 ' C ' HD12 ' A' ' 298' ' ' LEU . 5.5 ttpm? -119.62 138.51 53.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.868 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . 0.429 HD12 ' C ' ' A' ' 297' ' ' LYS . 7.4 mp -126.36 128.47 47.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.927 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 27.2 ptt180 -131.93 163.39 28.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.839 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . 0.472 ' C ' HD13 ' A' ' 362' ' ' ILE . . . 90.99 28.23 16.14 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.527 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -98.22 148.45 34.52 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.545 0.688 . . . . 0.0 111.115 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -165.9 0.17 Allowed 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.702 2.268 . . . . 0.0 112.303 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -93.21 -13.97 27.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.863 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -102.68 27.6 6.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.935 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 305' ' ' VAL . . . . . . . . . . . . . 10.6 p -90.41 141.78 13.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.068 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 306' ' ' THR . . . . . . . . . . . . . 35.2 p -139.26 -179.05 5.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.137 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -55.26 -35.91 65.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.876 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 28.1 tttp -58.13 -59.37 5.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.881 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -46.1 -47.68 17.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.882 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 58.4 t -58.34 -44.94 89.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.098 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 311' ' ' MET . . . . . . . . . . . . . 4.0 mmt -58.49 -52.0 67.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.884 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -64.12 -29.27 70.41 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.86 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 313' ' ' PHE . . . . . 0.475 ' C ' ' CD1' ' A' ' 313' ' ' PHE . 3.1 t80 -75.49 -41.34 55.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.907 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.452 ' CD1' HG11 ' A' ' 338' ' ' VAL . 46.5 mt -81.65 -25.83 35.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.922 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . 0.852 ' HB1' ' HA ' ' A' ' 316' ' ' PRO . . . -46.37 166.56 0.16 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.647 0.736 . . . . 0.0 111.084 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 316' ' ' PRO . . . . . 0.852 ' HA ' ' HB1' ' A' ' 315' ' ' ALA . 54.4 Cg_endo -69.68 -3.58 7.67 Favored 'Cis proline' 0 C--O 1.232 0.205 0 C-N-CA 122.66 -1.808 . . . . 0.0 112.386 -0.044 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 317' ' ' LEU . . . . . 0.668 HD22 ' HA ' ' A' ' 345' ' ' GLU . 20.8 mt -53.19 156.32 2.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.908 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 9.6 tttp -130.83 102.71 16.12 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.593 0.711 . . . . 0.0 110.895 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 319' ' ' PRO . . . . . 0.506 ' HA ' ' CD2' ' A' ' 340' ' ' PHE . 53.5 Cg_endo -69.77 -179.07 2.66 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.691 2.261 . . . . 0.0 112.333 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 320' ' ' VAL . . . . . 0.415 HG23 ' HA ' ' A' ' 340' ' ' PHE . 21.7 t -100.72 -39.25 6.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.112 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -156.15 129.92 8.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.086 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 322' ' ' ILE . . . . . 0.49 HG23 HG22 ' A' ' 338' ' ' VAL . 54.3 mt -105.78 99.79 9.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.124 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 18.6 mtp85 -94.0 118.62 31.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.874 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 51.7 mt -87.06 124.37 40.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.139 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . 0.687 HG21 ' HB3' ' A' ' 335' ' ' TYR . 53.7 t -64.88 109.33 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.152 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 29.6 mmt180 -99.99 103.48 15.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.895 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 327' ' ' ASN . . . . . 0.478 ' OD1' ' N ' ' A' ' 331' ' ' ASN . 5.8 p-10 -47.2 173.43 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.879 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -47.69 -56.36 7.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.105 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 12.1 m80 -86.06 38.14 0.75 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.822 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . 0.429 ' N ' ' OD1' ' A' ' 327' ' ' ASN . . . 44.6 87.93 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.519 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 331' ' ' ASN . . . . . 0.478 ' N ' ' OD1' ' A' ' 327' ' ' ASN . 31.8 t-20 -158.19 132.99 8.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.915 0.388 . . . . 0.0 110.869 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 23.6 mttt -75.49 95.16 3.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.947 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 333' ' ' THR . . . . . 0.661 HG23 ' O ' ' A' ' 333' ' ' THR . 8.8 t -98.36 74.27 2.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.12 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . 0.542 ' O ' ' CG ' ' A' ' 335' ' ' TYR . . . 35.91 70.44 0.2 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.502 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 335' ' ' TYR . . . . . 0.687 ' HB3' HG21 ' A' ' 325' ' ' VAL . 14.9 m-85 -170.07 121.95 0.67 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.833 0.349 . . . . 0.0 110.914 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 67.5 mt -145.27 117.13 2.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.167 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . 0.664 ' CE2' HG22 ' A' ' 325' ' ' VAL . 71.5 m-85 -87.47 121.35 29.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.835 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . 0.49 HG22 HG23 ' A' ' 322' ' ' ILE . 46.4 t -124.43 132.06 71.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.138 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 43.4 m-20 -107.95 161.01 15.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.866 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 340' ' ' PHE . . . . . 0.555 ' CD2' ' HB3' ' A' ' 345' ' ' GLU . 62.1 m-85 -138.08 168.78 19.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.895 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 9.5 t -85.22 -62.2 1.59 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.829 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -99.51 150.0 22.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.902 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 343' ' ' GLU . . . . . 0.56 ' HG3' ' CE1' ' A' ' 294' ' ' HIS . 23.3 tt0 -54.72 -45.27 74.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.888 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -40.17 -64.19 0.53 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.871 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . 0.668 ' HA ' HD22 ' A' ' 317' ' ' LEU . 16.0 mm-40 -39.43 -46.17 1.62 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.875 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . 0.679 HG21 ' HB2' ' A' ' 294' ' ' HIS . 65.9 t -67.38 -52.24 44.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.112 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 20.6 mtpp -50.73 -39.85 52.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.865 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -73.87 -30.07 62.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.931 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -56.68 -35.56 68.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.055 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 350' ' ' LEU . . . . . . . . . . . . . 83.7 mt -65.5 -35.77 81.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.963 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 76.4 mttt -45.92 -50.29 14.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.914 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 352' ' ' CYS . . . . . . . . . . . . . 31.7 m -69.06 72.23 0.26 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.92 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -107.68 158.94 16.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.902 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 70.0 mtt180 54.22 46.72 24.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.907 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 355' ' ' GLU . . . . . 0.478 ' C ' ' CD1' ' A' ' 356' ' ' TYR . 1.5 mm-40 -98.55 173.84 6.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.932 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 356' ' ' TYR . . . . . 0.478 ' CD1' ' C ' ' A' ' 355' ' ' GLU . 2.9 m-85 -139.22 115.98 10.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.958 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 357' ' ' MET . . . . . . . . . . . . . 3.6 ptt? -142.07 145.96 34.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.902 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 78.01 -46.81 2.74 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.487 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 359' ' ' GLY . . . . . 0.433 ' O ' ' CG ' ' A' ' 360' ' ' ARG . . . 141.74 34.89 0.1 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.477 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 360' ' ' ARG . . . . . 0.433 ' CG ' ' O ' ' A' ' 359' ' ' GLY . 56.8 mtt180 -164.3 156.04 16.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.793 0.33 . . . . 0.0 110.897 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 361' ' ' TYR . . . . . 0.519 ' O ' ' CD1' ' A' ' 361' ' ' TYR . 1.8 p90 -70.66 133.48 46.7 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.871 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 362' ' ' ILE . . . . . 0.472 HD13 ' C ' ' A' ' 300' ' ' GLY . 27.2 mm -111.98 143.75 21.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.128 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 363' ' ' GLU . . . . . 0.53 ' HB3' ' CZ ' ' A' ' 365' ' ' PHE . 21.1 mm-40 -130.96 113.18 13.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.904 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 21.6 t -88.68 141.85 13.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.129 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 365' ' ' PHE . . . . . 0.53 ' CZ ' ' HB3' ' A' ' 363' ' ' GLU . 56.7 m-85 -141.8 141.49 33.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.906 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 31.7 ttt180 -87.71 114.78 24.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.841 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -80.99 100.22 8.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.869 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 24.7 ttmt -50.82 -53.1 34.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.864 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 26.7 t -50.68 -58.06 6.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.85 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 111.99 -95.79 0.82 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.495 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 144.92 55.36 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.692 2.261 . . . . 0.0 112.327 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 372' ' ' SER . . . . . . . . . . . . . 56.9 p -130.15 -48.8 1.1 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.861 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 3.0 m -59.01 111.58 1.36 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.797 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.442 179.969 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 N-CA-C 112.499 -0.24 . . . . 0.0 112.499 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 3.4 m -110.13 42.09 1.6 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.853 0.359 . . . . 0.0 110.874 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 34.0 t -82.7 114.71 21.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.842 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -122.12 40.58 2.03 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.482 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 7.5 t -95.45 39.09 1.13 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.891 0.377 . . . . 0.0 110.856 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 8.6 t -116.9 106.04 13.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.849 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 174.49 -36.87 0.11 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.532 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . 0.574 ' O ' ' CE1' ' A' ' 294' ' ' HIS . 52.0 m -37.37 -41.41 0.42 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.851 0.358 . . . . 0.0 111.101 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 30.3 m -69.31 143.98 53.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.122 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 293' ' ' CYS . . . . . . . . . . . . . 5.3 t 67.22 51.28 0.92 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.879 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . 0.946 ' CB ' HG21 ' A' ' 346' ' ' VAL . 22.7 m-70 -55.65 112.83 1.24 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.876 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 6.3 m -134.0 133.85 41.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.121 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 296' ' ' VAL . . . . . 0.453 HG13 HG13 ' A' ' 346' ' ' VAL . 36.0 m -112.05 148.64 15.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.147 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . 0.56 ' C ' HD12 ' A' ' 298' ' ' LEU . 8.2 ttpm? -117.96 150.6 38.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.884 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . 0.56 HD12 ' C ' ' A' ' 297' ' ' LYS . 7.0 mp -132.92 152.23 51.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.956 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 13.2 ptt180 -154.16 176.44 12.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.825 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 82.79 -21.36 7.79 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.555 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -58.2 151.78 45.19 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.637 0.732 . . . . 0.0 111.062 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.8 178.6 4.43 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.705 2.27 . . . . 0.0 112.313 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -85.17 -15.66 42.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.902 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 35.7 t-20 -99.24 35.75 1.87 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.904 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 305' ' ' VAL . . . . . . . . . . . . . 6.3 p -100.8 142.55 15.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.155 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 306' ' ' THR . . . . . . . . . . . . . 25.5 p -128.46 164.74 22.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.13 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -44.35 -50.25 9.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.881 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -43.53 -52.12 6.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.865 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -56.13 -43.87 78.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.889 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 92.2 t -61.98 -39.06 82.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.153 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 311' ' ' MET . . . . . . . . . . . . . 4.1 mmt -63.67 -44.17 94.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.858 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -67.96 -29.06 68.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.907 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 313' ' ' PHE . . . . . 0.437 ' CE2' HD21 ' A' ' 298' ' ' LEU . 36.6 t80 -72.64 -47.06 50.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.9 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.447 ' CD1' HG11 ' A' ' 338' ' ' VAL . 49.4 mt -79.04 -18.27 53.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.904 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . 0.872 ' HB1' ' HA ' ' A' ' 316' ' ' PRO . . . -51.25 166.78 0.31 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.613 0.72 . . . . 0.0 111.082 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 316' ' ' PRO . . . . . 0.872 ' HA ' ' HB1' ' A' ' 315' ' ' ALA . 54.0 Cg_endo -69.72 -3.81 7.87 Favored 'Cis proline' 0 C--O 1.232 0.204 0 C-N-CA 122.72 -1.783 . . . . 0.0 112.321 -0.004 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 317' ' ' LEU . . . . . 0.487 ' N ' ' HA ' ' A' ' 315' ' ' ALA . 19.4 mt -50.72 165.28 0.11 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.897 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 35.3 tttt -140.4 105.05 6.51 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.609 0.718 . . . . 0.0 110.889 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -177.61 1.94 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.684 2.256 . . . . 0.0 112.359 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 59.1 t -100.58 -41.41 8.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.145 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -158.2 134.57 9.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.079 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 322' ' ' ILE . . . . . . . . . . . . . 60.9 mt -105.6 101.56 12.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.121 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 20.5 mmt85 -96.29 96.79 9.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.847 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . 0.808 HG21 ' HZ1' ' A' ' 332' ' ' LYS . 74.6 mt -68.0 122.14 18.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.124 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . 0.494 HG22 ' CD2' ' A' ' 337' ' ' PHE . 47.0 t -59.39 103.58 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.156 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 53.0 mtt180 -92.16 110.41 21.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.876 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -56.26 -45.4 80.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.887 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . 0.429 ' O ' ' C ' ' A' ' 329' ' ' HIS . . . -169.5 156.26 6.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.11 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 329' ' ' HIS . . . . . 0.429 ' C ' ' O ' ' A' ' 328' ' ' ALA . 5.1 t-160 35.09 50.23 0.47 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.862 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 39.7 77.42 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.536 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -115.84 161.27 19.01 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.922 0.392 . . . . 0.0 110.896 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 332' ' ' LYS . . . . . 0.808 ' HZ1' HG21 ' A' ' 324' ' ' ILE . 0.0 OUTLIER -98.68 78.25 2.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.905 179.881 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 9.9 t -165.54 127.52 2.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.139 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 132.03 -112.8 1.21 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.471 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 335' ' ' TYR . . . . . 0.4 ' HB2' HG21 ' A' ' 325' ' ' VAL . 11.7 m-85 -135.34 -179.19 5.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.876 0.369 . . . . 0.0 110.866 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 55.3 mt -137.64 122.96 24.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.158 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . 0.494 ' CD2' HG22 ' A' ' 325' ' ' VAL . 30.8 m-85 -98.05 126.58 43.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.87 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . 0.447 HG11 ' CD1' ' A' ' 314' ' ' LEU . 99.1 t -124.0 131.01 73.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.132 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -105.55 160.41 15.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.879 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -137.94 166.0 25.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.887 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 2.1 m -90.64 -44.19 9.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.891 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -98.63 169.39 9.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.926 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 343' ' ' GLU . . . . . 0.422 ' HB3' ' CE1' ' A' ' 294' ' ' HIS . 2.2 mp0 -85.15 -55.48 4.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.882 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -43.32 -46.72 6.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.863 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -50.05 -39.04 40.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.912 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . 0.946 HG21 ' CB ' ' A' ' 294' ' ' HIS . 46.3 t -70.35 -58.24 5.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.15 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 15.7 mtmt -50.03 -26.21 4.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.91 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 25.2 mm100 -82.54 -38.95 23.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.918 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -47.32 -30.93 3.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.131 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 350' ' ' LEU . . . . . 0.476 HD23 HG12 ' A' ' 364' ' ' VAL . 48.0 mt -63.78 -36.96 85.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.873 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -47.19 -44.2 21.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.92 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 352' ' ' CYS . . . . . . . . . . . . . 8.0 m -64.59 83.19 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.922 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . 0.449 ' O ' ' CG ' ' A' ' 354' ' ' ARG . 48.8 t30 -140.43 177.91 7.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.868 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . 0.449 ' CG ' ' O ' ' A' ' 353' ' ' ASN . 7.9 ptp85 44.78 37.22 2.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.904 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 355' ' ' GLU . . . . . 0.423 ' C ' ' CD ' ' A' ' 355' ' ' GLU . 0.0 OUTLIER -125.69 172.63 9.63 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.904 -179.974 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 356' ' ' TYR . . . . . 0.414 ' N ' ' CD1' ' A' ' 356' ' ' TYR . 1.8 m-85 -118.94 146.61 44.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.911 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 357' ' ' MET . . . . . . . . . . . . . 3.2 ptt? -164.24 125.58 2.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.887 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 86.02 -31.75 3.95 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.449 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 359' ' ' GLY . . . . . 0.461 ' O ' ' CG ' ' A' ' 360' ' ' ARG . . . 126.91 30.6 0.8 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.509 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 360' ' ' ARG . . . . . 0.461 ' CG ' ' O ' ' A' ' 359' ' ' GLY . 59.8 mtt180 -164.76 164.59 21.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.743 0.306 . . . . 0.0 110.93 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 361' ' ' TYR . . . . . . . . . . . . . 27.3 p90 -67.05 159.34 28.93 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.891 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 12.5 mm -138.07 125.22 28.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.11 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 363' ' ' GLU . . . . . 0.438 ' HB3' ' CZ ' ' A' ' 365' ' ' PHE . 28.2 mm-40 -118.85 118.23 30.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.824 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 364' ' ' VAL . . . . . 0.476 HG12 HD23 ' A' ' 350' ' ' LEU . 93.8 t -95.15 143.78 11.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.123 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 365' ' ' PHE . . . . . 0.438 ' CZ ' ' HB3' ' A' ' 363' ' ' GLU . 68.6 m-85 -141.97 148.95 39.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.863 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 35.7 ttp85 -96.98 112.18 24.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.884 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -86.39 97.19 10.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.881 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.16 -31.71 73.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.883 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 62.1 m -78.4 -60.65 2.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.842 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 108.28 -154.72 16.45 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.505 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 1.82 4.13 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.675 2.25 . . . . 0.0 112.287 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 372' ' ' SER . . . . . . . . . . . . . 8.7 t -134.16 133.84 41.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.878 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 47.2 t -97.72 -44.12 6.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.831 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.277 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.472 179.979 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.285 0 N-CA-C 112.469 -0.252 . . . . 0.0 112.469 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 34.4 m -72.01 108.33 5.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.873 0.368 . . . . 0.0 110.868 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 1.3 t -106.12 -58.57 1.9 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.856 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 86.46 178.91 49.47 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.524 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 48.7 m -101.99 109.03 20.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.864 0.364 . . . . 0.0 110.863 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 62.8 p -151.91 145.4 24.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.867 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 137.41 90.83 0.26 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.524 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 66.9 p -46.6 167.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.87 0.367 . . . . 0.0 111.105 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 24.2 m -61.26 127.24 30.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.143 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 293' ' ' CYS . . . . . . . . . . . . . 4.4 t -134.52 151.01 50.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.879 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . 0.705 ' HB3' HG21 ' A' ' 346' ' ' VAL . 3.8 m170 -110.64 83.91 1.84 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.838 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 12.1 m -125.64 142.43 51.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.147 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 27.0 m -118.64 147.47 22.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.124 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . 0.402 ' NZ ' ' HB3' ' A' ' 297' ' ' LYS . 0.2 OUTLIER -120.85 138.78 53.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.925 179.858 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 6.9 mp -119.57 141.9 48.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.926 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 299' ' ' ARG . . . . . 0.435 ' HB2' ' CE1' ' A' ' 335' ' ' TYR . 13.3 ptt180 -141.58 151.14 42.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.887 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 96.24 16.66 36.99 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.488 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -78.87 147.29 70.19 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.566 0.698 . . . . 0.0 111.105 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.69 169.79 18.0 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.698 2.265 . . . . 0.0 112.386 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 303' ' ' PHE . . . . . 0.458 ' O ' ' CG ' ' A' ' 303' ' ' PHE . 10.3 t80 -70.93 -8.93 56.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.858 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -111.51 41.42 1.89 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.923 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 305' ' ' VAL . . . . . . . . . . . . . 7.7 p -101.98 149.23 6.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.132 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 306' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -148.31 167.26 25.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.178 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -49.68 -20.41 0.81 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.921 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 9.9 ttmm -74.88 -53.32 9.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.852 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -51.67 -34.16 37.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.87 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 54.2 t -69.74 -46.01 75.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.146 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 311' ' ' MET . . . . . 0.43 ' HG2' ' CD1' ' A' ' 322' ' ' ILE . 4.1 mmt -53.37 -48.25 68.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.87 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -68.17 -25.5 65.28 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.929 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 313' ' ' PHE . . . . . 0.494 ' C ' ' CD1' ' A' ' 313' ' ' PHE . 2.6 t80 -75.58 -46.81 29.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.886 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.544 ' CD1' HG11 ' A' ' 338' ' ' VAL . 65.4 mt -78.01 -25.39 47.94 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.919 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . 0.859 ' HB1' ' HA ' ' A' ' 316' ' ' PRO . . . -44.4 166.25 0.12 Allowed Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.585 0.707 . . . . 0.0 111.08 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 316' ' ' PRO . . . . . 0.859 ' HA ' ' HB1' ' A' ' 315' ' ' ALA . 53.5 Cg_endo -69.72 -3.77 7.84 Favored 'Cis proline' 0 C--N 1.341 0.178 0 C-N-CA 122.664 -1.806 . . . . 0.0 112.361 0.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 317' ' ' LEU . . . . . 0.485 ' N ' ' HA ' ' A' ' 315' ' ' ALA . 27.7 mt -50.03 170.8 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.895 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 33.3 tttt -145.24 105.05 4.38 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.551 0.691 . . . . 0.0 110.923 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 319' ' ' PRO . . . . . 0.498 ' HA ' ' CD2' ' A' ' 340' ' ' PHE . 53.5 Cg_endo -69.79 -175.94 1.33 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.692 2.261 . . . . 0.0 112.33 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 31.1 t -101.12 -39.78 7.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.12 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -156.84 131.64 8.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.123 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 322' ' ' ILE . . . . . 0.548 HG12 HG13 ' A' ' 338' ' ' VAL . 66.7 mt -110.23 108.74 26.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.131 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 27.7 mmm-85 -108.18 121.85 45.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.877 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . 0.429 HG21 ' HG2' ' A' ' 332' ' ' LYS . 60.8 mt -89.71 120.59 38.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.131 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . 0.432 HG21 ' HB3' ' A' ' 335' ' ' TYR . 20.6 t -47.54 100.53 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.107 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 56.0 mtm-85 -96.43 124.06 40.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.904 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -52.42 178.52 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.87 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -51.02 -56.25 13.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.068 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 4.5 m80 -74.15 -62.55 1.47 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.877 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 159.23 99.4 0.15 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.478 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -172.97 120.32 0.36 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.889 0.376 . . . . 0.0 110.884 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 332' ' ' LYS . . . . . 0.429 ' HG2' HG21 ' A' ' 324' ' ' ILE . 12.0 mttp -54.38 98.04 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.878 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 333' ' ' THR . . . . . 0.497 ' O ' ' N ' ' A' ' 335' ' ' TYR . 26.8 p -79.48 54.62 1.78 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.116 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . 0.432 ' O ' ' C ' ' A' ' 335' ' ' TYR . . . 58.48 -77.78 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.452 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 335' ' ' TYR . . . . . 0.497 ' N ' ' O ' ' A' ' 333' ' ' THR . 3.6 m-85 -34.54 148.32 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.84 0.352 . . . . 0.0 110.938 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 336' ' ' ILE . . . . . 0.412 HG12 HG23 ' A' ' 324' ' ' ILE . 43.5 mt -145.95 147.51 18.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.169 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -119.89 128.46 53.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.879 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . 0.548 HG13 HG12 ' A' ' 322' ' ' ILE . 21.7 t -129.31 136.82 58.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.167 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -113.74 155.46 25.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.857 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 340' ' ' PHE . . . . . 0.499 ' HB2' HG23 ' A' ' 346' ' ' VAL . 53.5 m-85 -132.08 166.35 21.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.848 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 36.2 p -88.53 -58.12 2.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.896 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 67.3 m-80 -87.63 159.13 18.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.925 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -78.28 -23.54 47.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.902 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -67.64 -49.25 63.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.894 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -48.58 -50.3 33.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.848 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . 0.705 HG21 ' HB3' ' A' ' 294' ' ' HIS . 54.9 t -60.8 -56.01 20.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.143 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 24.9 mtpp -51.38 -32.62 26.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.877 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -83.27 -24.03 32.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.879 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -65.0 -26.25 68.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.075 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 350' ' ' LEU . . . . . 0.615 HD23 HG12 ' A' ' 364' ' ' VAL . 42.8 mt -75.34 -7.83 55.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.919 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 1.5 mmmp? -72.95 -32.61 65.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.915 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 352' ' ' CYS . . . . . . . . . . . . . 15.5 m -79.69 72.36 6.37 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.899 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -122.55 174.08 7.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.906 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 23.6 mtt180 53.22 28.42 7.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.847 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 355' ' ' GLU . . . . . 0.411 ' C ' ' OE1' ' A' ' 355' ' ' GLU . 0.0 OUTLIER -117.7 174.45 6.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.906 -179.951 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 356' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -124.8 128.14 48.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.925 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 357' ' ' MET . . . . . 0.445 ' HG3' ' CD1' ' A' ' 362' ' ' ILE . 0.0 OUTLIER -130.77 130.92 44.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.875 179.914 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 83.14 -41.7 2.93 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.462 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 359' ' ' GLY . . . . . 0.447 ' O ' ' CG ' ' A' ' 360' ' ' ARG . . . 141.92 33.27 0.12 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.468 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 360' ' ' ARG . . . . . 0.447 ' CG ' ' O ' ' A' ' 359' ' ' GLY . 71.5 mtt180 -165.19 161.64 19.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.794 0.331 . . . . 0.0 110.924 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 361' ' ' TYR . . . . . 0.443 ' O ' HD13 ' A' ' 362' ' ' ILE . 13.6 p90 -63.74 144.27 57.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.976 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 362' ' ' ILE . . . . . 0.445 ' CD1' ' HG3' ' A' ' 357' ' ' MET . 6.5 mm -130.72 135.05 61.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.161 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 363' ' ' GLU . . . . . 0.513 ' HB2' ' CZ ' ' A' ' 365' ' ' PHE . 15.7 mt-10 -126.35 112.71 15.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.864 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 364' ' ' VAL . . . . . 0.615 HG12 HD23 ' A' ' 350' ' ' LEU . 57.3 t -88.61 124.0 41.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.129 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 365' ' ' PHE . . . . . 0.513 ' CZ ' ' HB2' ' A' ' 363' ' ' GLU . 21.9 m-85 -121.66 142.74 49.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.856 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . 0.438 ' HB3' ' CZ ' ' A' ' 366' ' ' ARG . 9.8 ttp-105 -84.94 127.98 34.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.871 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -112.54 79.26 1.2 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.921 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.41 -21.69 61.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.881 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 46.9 m -62.41 -42.89 99.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.865 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 107.85 -158.48 14.88 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.483 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -178.84 2.54 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.676 2.251 . . . . 0.0 112.329 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 372' ' ' SER . . . . . 0.415 ' O ' ' C ' ' A' ' 373' ' ' SER . 15.2 m -115.54 -52.99 2.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.838 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 373' ' ' SER . . . . . 0.415 ' C ' ' O ' ' A' ' 372' ' ' SER . 59.6 p -36.12 145.49 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.828 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.496 179.995 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 N-CA-C 112.497 -0.241 . . . . 0.0 112.497 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 45.8 t -79.92 86.09 5.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.861 0.362 . . . . 0.0 110.831 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 4.6 m 39.84 38.93 0.5 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.852 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -126.3 51.01 0.85 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.471 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 97.1 p -50.11 -34.19 21.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.858 0.361 . . . . 0.0 110.831 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 2.0 m -100.9 127.12 47.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.885 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . -179.34 30.78 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.473 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 41.3 p -138.16 172.49 12.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.89 0.376 . . . . 0.0 111.11 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 79.2 p -85.69 107.55 17.62 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.165 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 293' ' ' CYS . . . . . . . . . . . . . 5.7 m -127.63 131.9 49.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.898 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . 0.841 ' HB3' HG21 ' A' ' 346' ' ' VAL . 33.6 m80 -129.42 106.12 8.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.9 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 26.5 m -139.42 139.65 37.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.161 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 296' ' ' VAL . . . . . 0.501 ' CG1' HG13 ' A' ' 346' ' ' VAL . 33.2 m -112.27 148.88 15.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.154 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . 0.563 ' HE3' ' CD1' ' A' ' 335' ' ' TYR . 56.4 tttt -122.55 131.19 53.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.931 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 7.9 mp -108.82 154.55 21.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.885 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 299' ' ' ARG . . . . . 0.507 ' HD2' ' CE1' ' A' ' 335' ' ' TYR . 13.0 ttt-85 -162.08 136.02 6.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.878 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 128.6 -18.19 5.74 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.487 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -65.64 151.42 94.69 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.547 0.689 . . . . 0.0 111.117 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -176.4 1.48 Allowed 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.679 2.253 . . . . 0.0 112.347 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 303' ' ' PHE . . . . . 0.484 ' C ' ' CD1' ' A' ' 303' ' ' PHE . 0.5 OUTLIER -76.43 -27.74 56.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.931 179.986 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 23.8 p-10 -92.81 43.76 1.13 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.893 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 305' ' ' VAL . . . . . . . . . . . . . 12.7 p -101.98 141.02 19.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.106 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 306' ' ' THR . . . . . . . . . . . . . 66.8 p -130.93 169.38 15.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.169 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -46.7 -45.91 19.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.903 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 20.9 ttmm -48.29 -57.07 6.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.919 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 25.4 m120 -48.45 -41.76 30.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.904 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 310' ' ' VAL . . . . . 0.443 HG21 HD13 ' A' ' 336' ' ' ILE . 95.9 t -69.33 -42.01 81.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.109 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 311' ' ' MET . . . . . . . . . . . . . 3.6 mmt -58.41 -50.38 73.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.896 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -65.77 -24.83 67.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.883 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 313' ' ' PHE . . . . . 0.602 ' C ' ' CD1' ' A' ' 313' ' ' PHE . 0.5 OUTLIER -83.77 -28.68 28.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.888 -179.938 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.598 HD11 HG21 ' A' ' 338' ' ' VAL . 33.1 mt -90.9 -23.66 20.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.865 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . 0.825 ' HB1' ' HA ' ' A' ' 316' ' ' PRO . . . -52.1 166.02 0.44 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.546 0.688 . . . . 0.0 111.136 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 316' ' ' PRO . . . . . 0.825 ' HA ' ' HB1' ' A' ' 315' ' ' ALA . 53.6 Cg_endo -69.72 -7.6 9.98 Favored 'Cis proline' 0 C--O 1.231 0.161 0 C-N-CA 122.703 -1.791 . . . . 0.0 112.328 -0.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 317' ' ' LEU . . . . . 0.413 ' N ' ' HA ' ' A' ' 315' ' ' ALA . 47.3 mt -56.04 144.35 29.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.883 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 14.3 tptp -120.42 110.73 35.51 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.563 0.696 . . . . 0.0 110.86 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 319' ' ' PRO . . . . . 0.513 ' HA ' ' CD1' ' A' ' 340' ' ' PHE . 53.7 Cg_endo -69.78 -163.83 0.12 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.694 2.262 . . . . 0.0 112.328 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 21.7 t -118.61 -41.25 2.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.131 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -151.69 124.13 8.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.075 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 322' ' ' ILE . . . . . . . . . . . . . 65.4 mt -98.86 102.39 13.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.141 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 9.2 tpt180 -86.1 116.04 24.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.82 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . 0.665 HG21 ' HE3' ' A' ' 332' ' ' LYS . 72.5 mt -88.63 117.11 31.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.115 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 50.7 t -84.57 89.06 2.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.124 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.47 -179.6 7.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.913 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -117.92 175.16 5.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.878 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -41.07 -70.61 0.1 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.096 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 11.1 m170 -58.42 -51.84 68.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.83 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 142.6 33.74 0.1 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.467 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -111.35 117.45 33.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.893 0.377 . . . . 0.0 110.87 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 332' ' ' LYS . . . . . 0.665 ' HE3' HG21 ' A' ' 324' ' ' ILE . 8.1 mptt -71.68 107.35 4.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.899 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 333' ' ' THR . . . . . 0.412 ' O ' ' C ' ' A' ' 334' ' ' GLY . 70.7 p -86.07 69.91 10.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.135 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . 0.522 ' O ' ' CG ' ' A' ' 335' ' ' TYR . . . 36.91 77.79 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.499 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 335' ' ' TYR . . . . . 0.563 ' CD1' ' HE3' ' A' ' 297' ' ' LYS . 7.0 m-85 -169.61 122.09 0.73 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.811 0.338 . . . . 0.0 110.995 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 336' ' ' ILE . . . . . 0.443 HD13 HG21 ' A' ' 310' ' ' VAL . 85.4 mt -149.73 136.93 13.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.188 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . 0.58 ' CD1' ' OE2' ' A' ' 367' ' ' GLU . 55.5 m-85 -108.71 116.08 31.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.889 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . 0.598 HG21 HD11 ' A' ' 314' ' ' LEU . 87.0 t -112.62 127.67 69.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.117 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -105.36 139.19 40.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.854 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 340' ' ' PHE . . . . . 0.513 ' CD1' ' HA ' ' A' ' 319' ' ' PRO . 64.2 m-85 -117.22 157.86 25.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.887 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 2.4 m -79.11 -56.07 4.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.872 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 47.3 m-20 -91.93 158.3 16.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.871 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 343' ' ' GLU . . . . . 0.429 ' HG2' ' CE1' ' A' ' 294' ' ' HIS . 53.7 mt-10 -71.46 -44.84 64.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.892 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -47.91 -50.5 26.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.874 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -46.19 -45.65 16.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.91 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . 0.841 HG21 ' HB3' ' A' ' 294' ' ' HIS . 66.7 t -68.14 -52.08 41.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.118 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 25.1 mtpp -51.37 -38.44 53.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.903 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 70.4 mm-40 -78.13 -42.85 30.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.886 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -42.8 -42.4 3.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.054 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 350' ' ' LEU . . . . . 0.602 HD23 HG12 ' A' ' 364' ' ' VAL . 40.3 mt -58.85 -42.95 90.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.879 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 65.6 mmtt -42.89 -48.05 5.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.893 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 352' ' ' CYS . . . . . . . . . . . . . 19.9 m -69.11 72.68 0.28 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.883 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -112.55 156.01 23.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.923 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 7.6 ttt85 66.72 29.27 8.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.896 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 355' ' ' GLU . . . . . 0.428 ' HB2' ' CE2' ' A' ' 313' ' ' PHE . 4.4 mm-40 -83.87 173.4 11.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.861 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 356' ' ' TYR . . . . . 0.45 ' N ' ' CD1' ' A' ' 356' ' ' TYR . 1.3 m-85 -131.8 127.41 36.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.904 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 357' ' ' MET . . . . . . . . . . . . . 3.9 ptt? -154.74 142.32 19.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.859 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 78.45 -42.86 2.24 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.448 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 135.65 29.76 0.36 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.542 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 360' ' ' ARG . . . . . . . . . . . . . 61.3 mtt-85 -158.67 158.09 33.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.789 0.328 . . . . 0.0 110.929 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 361' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -66.88 157.17 33.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.941 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 9.1 mm -140.15 149.55 21.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.145 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 363' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -137.17 121.0 17.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.907 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 364' ' ' VAL . . . . . 0.602 HG12 HD23 ' A' ' 350' ' ' LEU . 72.0 t -90.48 131.83 36.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.166 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -125.76 138.62 53.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.874 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . 0.554 ' HB2' HD21 ' A' ' 350' ' ' LEU . 18.2 ttp180 -92.67 109.31 20.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.863 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . 0.58 ' OE2' ' CD1' ' A' ' 337' ' ' PHE . 20.1 mt-10 -64.02 81.88 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.866 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 10.5 ptpp? -55.36 -31.24 61.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.863 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 30.5 t -131.75 56.96 1.79 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.84 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . -74.52 145.21 33.98 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.45 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 120.48 7.26 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.646 2.231 . . . . 0.0 112.355 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 372' ' ' SER . . . . . . . . . . . . . 6.6 t -97.33 -45.83 6.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.875 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 13.2 t -112.19 170.46 8.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.835 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.479 -179.999 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 N-CA-C 112.463 -0.255 . . . . 0.0 112.463 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 3.5 m -133.49 111.76 10.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.839 0.352 . . . . 0.0 110.852 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 28.7 t -126.39 148.33 49.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.862 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -176.22 153.59 14.88 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.501 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 50.4 p -61.74 153.39 28.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.895 0.379 . . . . 0.0 110.886 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 28.9 p -128.98 89.28 2.85 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.85 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 100.31 52.95 1.11 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.473 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 85.2 m -152.86 129.82 11.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.92 0.39 . . . . 0.0 111.138 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 67.0 p -118.93 116.15 25.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.111 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 293' ' ' CYS . . . . . . . . . . . . . 9.9 m -104.99 174.89 5.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.882 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . 0.84 ' HB3' HG21 ' A' ' 346' ' ' VAL . 33.4 m80 -129.36 84.25 2.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.858 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 25.5 m -121.17 142.65 49.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.182 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 296' ' ' VAL . . . . . 0.548 HG22 ' O ' ' A' ' 338' ' ' VAL . 28.2 m -119.15 149.49 21.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.121 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . 0.527 ' HG3' ' CE1' ' A' ' 337' ' ' PHE . 16.8 ttmt -117.37 143.62 45.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.896 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . 0.445 HD12 ' C ' ' A' ' 297' ' ' LYS . 7.1 mp -122.0 121.43 37.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.917 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 299' ' ' ARG . . . . . 0.618 ' NE ' ' CD2' ' A' ' 365' ' ' PHE . 25.4 mtt180 -122.36 162.01 22.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.896 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 95.12 -23.28 34.07 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.511 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -56.13 152.49 21.93 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.588 0.708 . . . . 0.0 111.11 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.71 -173.14 0.66 Allowed 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.701 2.267 . . . . 0.0 112.376 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -90.7 -26.03 19.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.891 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -95.34 44.44 1.09 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.886 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 305' ' ' VAL . . . . . 0.408 ' CG1' ' NZ ' ' A' ' 332' ' ' LYS . 10.8 p -105.22 139.69 25.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.134 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 306' ' ' THR . . . . . . . . . . . . . 41.6 p -124.33 171.2 10.09 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.151 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -48.61 -54.14 15.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.862 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 21.5 ttmt -41.34 -48.81 3.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.91 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -56.95 -41.06 77.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.908 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 87.2 t -65.7 -51.23 64.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.093 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 311' ' ' MET . . . . . . . . . . . . . 3.2 mmt -51.58 -40.06 59.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.851 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -74.09 -30.81 62.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.885 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 313' ' ' PHE . . . . . 0.607 ' CZ ' HG21 ' A' ' 362' ' ' ILE . 27.2 t80 -73.24 -41.67 63.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.892 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.785 ' CD1' HG11 ' A' ' 338' ' ' VAL . 86.9 mt -80.95 -26.11 36.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.922 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . 0.677 ' HB1' ' HA ' ' A' ' 316' ' ' PRO . . . -45.54 161.54 0.24 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.569 0.7 . . . . 0.0 111.097 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 316' ' ' PRO . . . . . 0.677 ' HA ' ' HB1' ' A' ' 315' ' ' ALA . 53.9 Cg_endo -69.71 -13.76 12.32 Favored 'Cis proline' 0 C--O 1.232 0.219 0 C-N-CA 122.725 -1.781 . . . . 0.0 112.341 -0.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 317' ' ' LEU . . . . . 0.406 HD13 ' O ' ' A' ' 345' ' ' GLU . 83.1 mt -43.09 135.13 3.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.916 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 4.9 tmtt? -111.71 100.54 48.65 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.574 0.702 . . . . 0.0 110.905 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 319' ' ' PRO . . . . . 0.514 ' HA ' ' CD2' ' A' ' 340' ' ' PHE . 53.9 Cg_endo -69.77 -175.39 1.14 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.644 2.23 . . . . 0.0 112.36 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 39.0 t -100.04 -43.63 11.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.102 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -157.3 144.19 18.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.138 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 322' ' ' ILE . . . . . 0.46 HG23 HG22 ' A' ' 338' ' ' VAL . 60.4 mt -116.15 103.41 15.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.112 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 55.2 mtt-85 -98.42 116.3 30.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.862 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . 0.409 HG21 ' HE2' ' A' ' 332' ' ' LYS . 60.0 mt -85.87 124.89 40.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.114 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . 0.554 ' CG2' ' CD2' ' A' ' 337' ' ' PHE . 15.8 t -80.55 118.49 28.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.104 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 3.1 ptp180 -90.26 163.58 14.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.859 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 327' ' ' ASN . . . . . 0.452 ' CB ' ' OD1' ' A' ' 331' ' ' ASN . 1.2 t30 -77.68 150.64 34.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.859 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . 0.428 ' C ' ' O ' ' A' ' 327' ' ' ASN . . . -34.82 -68.93 0.11 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.088 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 9.6 m170 -51.7 -58.78 5.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.845 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 146.04 66.29 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.52 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 331' ' ' ASN . . . . . 0.452 ' OD1' ' CB ' ' A' ' 327' ' ' ASN . 8.9 p30 -144.79 145.81 31.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.923 0.392 . . . . 0.0 110.872 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 332' ' ' LYS . . . . . 0.429 ' HD3' ' C ' ' A' ' 332' ' ' LYS . 5.6 tmtt? -59.7 105.54 0.38 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.928 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 333' ' ' THR . . . . . 0.422 ' CG2' ' O ' ' A' ' 325' ' ' VAL . 2.5 t -95.65 173.5 7.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.147 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . 0.496 ' O ' ' CD1' ' A' ' 335' ' ' TYR . . . -86.36 61.95 4.37 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.474 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 335' ' ' TYR . . . . . 0.496 ' CD1' ' O ' ' A' ' 334' ' ' GLY . 32.2 m-85 -154.28 138.75 16.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.835 0.35 . . . . 0.0 110.897 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 78.5 mt -146.9 149.11 16.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.145 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . 0.554 ' CD2' ' CG2' ' A' ' 325' ' ' VAL . 17.4 m-85 -121.38 122.02 38.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.902 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . 0.785 HG11 ' CD1' ' A' ' 314' ' ' LEU . 38.1 t -121.21 126.02 74.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.114 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -104.14 157.29 17.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.884 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 340' ' ' PHE . . . . . 0.607 ' HB2' HG23 ' A' ' 346' ' ' VAL . 69.4 m-85 -134.52 167.96 19.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.881 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 30.8 t -87.65 -57.2 3.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.881 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -89.91 160.18 16.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.893 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 343' ' ' GLU . . . . . 0.516 ' HB3' ' CE1' ' A' ' 294' ' ' HIS . 10.5 pt-20 -78.05 -14.35 59.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.874 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -75.73 -44.51 41.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.906 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . 0.521 ' HB3' ' CD2' ' A' ' 340' ' ' PHE . 45.5 mt-10 -55.4 -40.17 71.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.883 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . 0.84 HG21 ' HB3' ' A' ' 294' ' ' HIS . 67.3 t -74.17 -41.28 51.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.158 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 33.5 mtpt -59.89 -29.54 68.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.882 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -88.16 -28.34 21.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.907 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -55.57 -35.72 66.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.082 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 350' ' ' LEU . . . . . 0.602 HD23 HG12 ' A' ' 364' ' ' VAL . 42.6 mt -67.41 -38.63 84.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.905 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 16.8 mmtp -56.63 -25.47 53.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.909 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 352' ' ' CYS . . . . . . . . . . . . . 40.4 t -78.44 57.9 2.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.86 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -110.57 170.64 7.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.906 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 13.4 mmt180 61.85 29.24 17.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.83 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 355' ' ' GLU . . . . . 0.516 ' C ' ' CD1' ' A' ' 356' ' ' TYR . 12.4 mm-40 -97.68 172.5 7.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.908 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 356' ' ' TYR . . . . . 0.516 ' CD1' ' C ' ' A' ' 355' ' ' GLU . 1.3 m-85 -138.44 122.87 18.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.931 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 357' ' ' MET . . . . . . . . . . . . . 1.7 ptt? -148.23 155.74 41.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.878 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 60.57 7.93 8.71 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.449 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 83.76 27.18 39.21 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.517 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 360' ' ' ARG . . . . . . . . . . . . . 15.1 mmm180 -147.68 177.43 9.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.8 0.333 . . . . 0.0 110.893 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 361' ' ' TYR . . . . . . . . . . . . . 29.2 p90 -92.39 149.3 21.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.891 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 362' ' ' ILE . . . . . 0.607 HG21 ' CZ ' ' A' ' 313' ' ' PHE . 14.5 mm -118.64 149.93 20.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.127 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 363' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -141.02 112.67 7.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.891 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 364' ' ' VAL . . . . . 0.602 HG12 HD23 ' A' ' 350' ' ' LEU . 11.2 t -88.23 140.7 15.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.148 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 365' ' ' PHE . . . . . 0.618 ' CD2' ' NE ' ' A' ' 299' ' ' ARG . 72.4 m-85 -139.93 143.7 36.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.891 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 17.7 ttp85 -91.81 122.19 34.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.836 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . 0.411 ' OE1' ' N ' ' A' ' 297' ' ' LYS . 5.7 mp0 -106.73 127.6 53.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.829 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 52.2 tttm -98.02 -33.65 11.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.881 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 1.4 p -84.43 6.87 21.68 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.84 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 59.34 -172.89 4.42 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.481 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.83 114.15 3.62 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.635 2.223 . . . . 0.0 112.325 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 372' ' ' SER . . . . . . . . . . . . . 76.8 p -63.85 119.77 10.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.845 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 2.9 t -88.72 142.43 27.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.849 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.442 179.999 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . 0.44 ' O ' ' C ' ' A' ' 285' ' ' SER . . . . . . . . 0 N--CA 1.451 -0.336 0 N-CA-C 112.504 -0.239 . . . . 0.0 112.504 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 285' ' ' SER . . . . . 0.44 ' C ' ' O ' ' A' ' 284' ' ' GLY . 35.6 p 34.96 43.28 0.1 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.844 0.354 . . . . 0.0 110.865 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 2.3 m -88.35 42.27 1.06 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.846 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -134.32 -54.65 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.437 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 1.4 t -86.5 146.95 26.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.878 0.37 . . . . 0.0 110.894 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 9.1 m -51.56 141.99 15.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.871 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . -173.59 -52.12 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.504 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 13.5 t -90.6 -30.87 16.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.861 0.362 . . . . 0.0 111.167 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 88.5 m -91.21 85.7 5.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.179 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 293' ' ' CYS . . . . . . . . . . . . . 96.9 m -117.33 128.3 54.91 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.897 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . 0.417 ' CB ' HG21 ' A' ' 346' ' ' VAL . 15.4 m-70 -96.6 92.1 6.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.897 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 54.5 m -121.41 150.1 42.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.141 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 296' ' ' VAL . . . . . 0.669 HG13 HG13 ' A' ' 346' ' ' VAL . 27.3 m -118.02 146.16 22.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.113 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . 0.558 ' HG3' ' CE1' ' A' ' 337' ' ' PHE . 16.3 ttmt -117.67 142.68 46.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.917 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . 0.473 HD12 ' C ' ' A' ' 297' ' ' LYS . 7.9 mp -123.67 135.63 54.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.913 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 9.7 ttm-85 -144.76 132.94 21.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.877 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 129.18 -19.89 5.38 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.455 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -57.75 152.15 38.28 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.571 0.7 . . . . 0.0 111.1 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.72 177.38 5.61 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.711 2.274 . . . . 0.0 112.338 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -72.37 -24.11 61.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.9 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -98.71 47.78 0.98 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.891 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 305' ' ' VAL . . . . . . . . . . . . . 9.4 p -104.62 141.44 20.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.148 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 306' ' ' THR . . . . . . . . . . . . . 66.6 p -136.3 162.86 31.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.155 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -37.85 -46.74 0.97 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.923 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 36.4 tttm -45.5 -56.83 4.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.886 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 21.2 m120 -50.82 -49.11 59.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.905 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 86.9 t -58.0 -41.54 80.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.082 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 311' ' ' MET . . . . . . . . . . . . . 1.9 mmt -61.12 -53.08 61.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.86 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.64 -36.23 78.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.905 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -70.67 -44.28 67.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.878 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.481 ' CD1' HG11 ' A' ' 338' ' ' VAL . 32.9 mt -73.41 -25.59 60.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.934 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . 0.811 ' HB1' ' HA ' ' A' ' 316' ' ' PRO . . . -51.25 165.4 0.4 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.579 0.704 . . . . 0.0 111.102 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 316' ' ' PRO . . . . . 0.811 ' HA ' ' HB1' ' A' ' 315' ' ' ALA . 54.1 Cg_endo -69.75 -9.52 11.04 Favored 'Cis proline' 0 C--O 1.232 0.183 0 C-N-CA 122.673 -1.803 . . . . 0.0 112.367 -0.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 317' ' ' LEU . . . . . 0.447 HD22 ' CD ' ' A' ' 345' ' ' GLU . 33.8 mt -54.96 139.03 42.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.888 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 318' ' ' LYS . . . . . 0.401 ' HA ' ' HD2' ' A' ' 319' ' ' PRO . 0.0 OUTLIER -113.32 109.48 51.47 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.591 0.71 . . . . 0.0 110.904 179.866 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 319' ' ' PRO . . . . . 0.492 ' HA ' ' CD2' ' A' ' 340' ' ' PHE . 53.5 Cg_endo -69.78 -171.94 0.53 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.673 2.249 . . . . 0.0 112.329 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 80.2 t -104.51 -39.55 5.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.098 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -164.18 129.09 2.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.118 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 322' ' ' ILE . . . . . 0.591 HG23 HG22 ' A' ' 338' ' ' VAL . 50.8 mt -100.53 105.25 17.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.147 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 15.4 mmm180 -99.04 119.98 38.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.856 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . 0.43 ' O ' ' C ' ' A' ' 325' ' ' VAL . 64.0 mt -91.38 117.48 34.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.148 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . 0.607 HG21 ' HB3' ' A' ' 335' ' ' TYR . 22.4 t -35.38 145.14 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.115 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 326' ' ' ARG . . . . . 0.447 ' C ' ' O ' ' A' ' 325' ' ' VAL . 1.6 ptt-85 -34.37 108.7 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.861 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 327' ' ' ASN . . . . . 0.429 ' CG ' ' N ' ' A' ' 328' ' ' ALA . 8.2 p-10 -107.58 -52.23 2.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.923 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . 0.429 ' N ' ' CG ' ' A' ' 327' ' ' ASN . . . -63.42 -63.58 1.14 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.109 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 6.1 m170 -45.43 -47.84 13.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.826 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -104.01 -91.05 2.19 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.502 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 331' ' ' ASN . . . . . 0.4 ' O ' ' C ' ' A' ' 332' ' ' LYS . 5.6 t-20 -166.74 136.25 3.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.843 0.354 . . . . 0.0 110.909 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 332' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' A' ' 331' ' ' ASN . 0.5 OUTLIER -38.17 126.14 1.3 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.882 179.949 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 333' ' ' THR . . . . . 0.432 ' CG2' ' HB ' ' A' ' 325' ' ' VAL . 0.0 OUTLIER -126.34 143.9 51.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.104 179.997 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -62.94 -16.87 57.76 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.521 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 335' ' ' TYR . . . . . 0.607 ' HB3' HG21 ' A' ' 325' ' ' VAL . 3.9 m-85 -69.28 137.28 52.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.881 0.372 . . . . 0.0 110.921 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 73.6 mt -147.4 129.3 6.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.126 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . 0.558 ' CE1' ' HG3' ' A' ' 297' ' ' LYS . 61.6 m-85 -104.25 127.52 51.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.893 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . 0.591 HG22 HG23 ' A' ' 322' ' ' ILE . 22.5 t -126.07 135.72 63.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.128 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -106.05 161.19 14.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.852 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 340' ' ' PHE . . . . . 0.57 ' CD2' ' HB3' ' A' ' 345' ' ' GLU . 41.6 m-85 -138.06 171.03 15.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.842 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 3.9 m -81.46 -64.35 1.2 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.855 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -95.42 166.04 12.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.863 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 343' ' ' GLU . . . . . 0.401 ' H ' ' CD ' ' A' ' 343' ' ' GLU . 1.0 OUTLIER -76.11 -16.09 59.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.861 -179.956 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -70.99 -50.8 30.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.892 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . 0.57 ' HB3' ' CD2' ' A' ' 340' ' ' PHE . 16.5 mm-40 -50.67 -41.03 55.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.904 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . 0.669 HG13 HG13 ' A' ' 296' ' ' VAL . 95.0 t -68.1 -53.2 31.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.132 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp -52.31 -44.65 65.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.897 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -64.5 -40.56 95.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.919 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -42.52 -43.06 3.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.15 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 350' ' ' LEU . . . . . . . . . . . . . 21.4 mt -57.42 -36.77 71.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.9 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 1.5 mmmp? -44.73 -50.55 9.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.859 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 352' ' ' CYS . . . . . . . . . . . . . 3.5 m -73.97 80.33 1.68 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.871 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -121.63 149.61 42.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.898 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? 73.18 35.82 0.9 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.907 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 355' ' ' GLU . . . . . 0.431 ' C ' ' CD1' ' A' ' 356' ' ' TYR . 3.1 mm-40 -95.89 173.52 7.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.87 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 356' ' ' TYR . . . . . 0.488 ' N ' ' CD1' ' A' ' 356' ' ' TYR . 1.1 m-85 -134.55 124.22 25.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.93 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 357' ' ' MET . . . . . . . . . . . . . 2.4 ptt? -147.82 139.53 23.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.859 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 78.98 -14.37 14.44 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.455 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 113.25 6.08 22.49 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.461 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 360' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -134.03 168.49 18.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.785 0.326 . . . . 0.0 110.899 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 361' ' ' TYR . . . . . . . . . . . . . 8.4 p90 -84.59 157.31 21.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.878 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 362' ' ' ILE . . . . . 0.437 HG22 ' N ' ' A' ' 363' ' ' GLU . 10.7 mm -133.69 156.93 41.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.122 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 363' ' ' GLU . . . . . 0.458 ' HB3' ' CZ ' ' A' ' 365' ' ' PHE . 7.4 mm-40 -142.95 123.66 14.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.909 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 364' ' ' VAL . . . . . 0.497 ' O ' ' CD1' ' A' ' 365' ' ' PHE . 53.1 t -98.7 141.65 16.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.101 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 365' ' ' PHE . . . . . 0.497 ' CD1' ' O ' ' A' ' 364' ' ' VAL . 28.5 m-85 -144.37 137.04 26.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.854 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . 0.474 ' HB3' ' CZ ' ' A' ' 366' ' ' ARG . 9.4 ttp-105 -81.65 119.32 23.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.885 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -82.84 100.37 10.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.865 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . 0.413 ' C ' ' HD3' ' A' ' 368' ' ' LYS . 0.0 OUTLIER -63.57 -17.8 63.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.923 179.977 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 78.4 p -111.27 -62.52 1.53 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.851 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 107.06 -158.25 15.19 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.5 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 86.23 0.59 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.68 2.254 . . . . 0.0 112.369 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 372' ' ' SER . . . . . . . . . . . . . 68.8 m -90.73 104.28 16.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.884 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 14.6 m 52.83 39.23 28.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.848 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.364 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.513 -179.987 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.297 0 N-CA-C 112.491 -0.244 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 48.6 m -127.89 111.14 13.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.864 0.364 . . . . 0.0 110.869 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 33.3 m -144.19 130.16 19.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.87 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -88.96 -131.15 3.97 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.49 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 93.7 p -51.49 173.72 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.883 0.373 . . . . 0.0 110.845 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 25.3 m -82.98 -45.9 13.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.834 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 151.41 -125.9 1.97 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.501 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 58.0 m -121.9 83.61 2.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.903 0.383 . . . . 0.0 111.156 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 70.6 p -139.98 146.48 39.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.108 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 293' ' ' CYS . . . . . . . . . . . . . 1.8 t -114.0 175.13 5.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.867 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . 0.737 ' CB ' HG21 ' A' ' 346' ' ' VAL . 48.9 m80 -38.81 121.65 1.08 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.895 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 28.1 m -129.28 144.89 51.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.121 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 296' ' ' VAL . . . . . 0.602 ' CG1' HG13 ' A' ' 346' ' ' VAL . 27.8 m -117.19 147.93 20.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.135 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . 0.486 ' HG3' ' CE1' ' A' ' 337' ' ' PHE . 9.2 ttmm -116.01 135.58 53.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.901 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 6.4 mp -122.92 126.66 47.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.909 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 299' ' ' ARG . . . . . 0.547 ' NH1' ' CZ ' ' A' ' 335' ' ' TYR . 0.7 OUTLIER -127.01 167.96 15.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.873 179.945 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 76.82 38.32 31.59 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.477 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -104.64 152.31 39.41 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.568 0.699 . . . . 0.0 111.099 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 -172.79 0.62 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.669 2.246 . . . . 0.0 112.312 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -87.21 -31.18 20.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.88 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -87.42 39.98 0.9 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.907 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 305' ' ' VAL . . . . . . . . . . . . . 7.2 p -102.37 136.99 32.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.144 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 306' ' ' THR . . . . . . . . . . . . . 52.8 p -136.73 173.5 11.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.13 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -46.62 -30.8 2.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.881 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -69.18 -59.21 3.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.913 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -44.11 -34.4 1.79 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.909 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 22.0 t -74.6 -46.05 43.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.12 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 311' ' ' MET . . . . . . . . . . . . . 5.5 mmt -53.68 -44.45 69.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.892 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -67.47 -30.69 70.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.903 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 313' ' ' PHE . . . . . 0.624 ' CE2' HG21 ' A' ' 362' ' ' ILE . 2.4 t80 -74.68 -39.05 62.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.919 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 34.5 mt -81.01 -21.6 40.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.913 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . 0.865 ' HB1' ' HA ' ' A' ' 316' ' ' PRO . . . -51.93 166.57 0.38 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.561 0.696 . . . . 0.0 111.142 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 316' ' ' PRO . . . . . 0.865 ' HA ' ' HB1' ' A' ' 315' ' ' ALA . 53.9 Cg_endo -69.75 -8.49 10.51 Favored 'Cis proline' 0 C--O 1.232 0.194 0 C-N-CA 122.694 -1.794 . . . . 0.0 112.342 -0.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 317' ' ' LEU . . . . . . . . . . . . . 46.0 mt -48.09 165.72 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.943 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 318' ' ' LYS . . . . . 0.401 ' HA ' ' HD2' ' A' ' 319' ' ' PRO . 6.7 tttp -140.31 104.96 6.56 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.59 0.71 . . . . 0.0 110.91 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 319' ' ' PRO . . . . . 0.427 ' HA ' ' CD2' ' A' ' 340' ' ' PHE . 53.1 Cg_endo -69.75 -168.64 0.28 Allowed 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.72 2.28 . . . . 0.0 112.345 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 25.6 t -111.23 -38.07 3.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.127 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -156.06 140.6 16.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.119 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 322' ' ' ILE . . . . . 0.539 HG23 HG22 ' A' ' 338' ' ' VAL . 53.1 mt -118.57 115.26 47.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.128 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -105.56 128.19 53.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.887 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 73.2 mt -94.06 136.89 24.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.089 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . 0.458 HG21 ' CE2' ' A' ' 337' ' ' PHE . 43.4 t -98.94 113.69 34.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.109 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 12.5 mtt85 -99.95 131.03 46.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.844 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -44.9 165.68 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.921 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -55.15 -55.76 27.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.085 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 46.1 m80 -57.88 -59.59 5.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.935 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 152.1 43.93 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.518 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -118.56 156.59 28.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.888 0.375 . . . . 0.0 110.868 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 25.5 mttm -82.48 86.79 6.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.877 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 9.3 t -77.53 155.61 31.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.117 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . 0.436 ' O ' ' CG ' ' A' ' 335' ' ' TYR . . . -70.36 81.43 0.38 Allowed Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.441 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 335' ' ' TYR . . . . . 0.547 ' CZ ' ' NH1' ' A' ' 299' ' ' ARG . 8.7 m-85 -166.99 124.73 1.28 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.819 0.343 . . . . 0.0 110.959 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 96.9 mt -144.98 144.99 21.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.146 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . 0.486 ' CE1' ' HG3' ' A' ' 297' ' ' LYS . 68.7 m-85 -120.51 131.78 54.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.86 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . 0.539 HG22 HG23 ' A' ' 322' ' ' ILE . 46.7 t -130.58 140.66 48.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.103 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -110.62 159.22 17.76 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.878 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 340' ' ' PHE . . . . . 0.427 ' CD2' ' HA ' ' A' ' 319' ' ' PRO . 71.3 m-85 -134.72 172.02 13.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.875 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 40.8 t -79.33 -66.36 0.88 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.874 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 342' ' ' ASN . . . . . 0.613 ' ND2' ' H ' ' A' ' 342' ' ' ASN . 0.0 OUTLIER -98.7 176.94 5.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.908 -179.992 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 343' ' ' GLU . . . . . 0.572 ' HB3' ' CE1' ' A' ' 294' ' ' HIS . 3.1 pm0 -84.81 -16.25 42.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.863 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -68.91 -33.36 73.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.86 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . 0.424 ' HB3' ' CD2' ' A' ' 340' ' ' PHE . 52.0 mt-10 -68.55 -51.01 47.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.834 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . 0.737 HG21 ' CB ' ' A' ' 294' ' ' HIS . 87.1 t -58.63 -52.16 63.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.104 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 33.4 mtpt -46.95 -45.49 20.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.884 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 22.5 mm-40 -67.78 -33.5 74.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.9 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 349' ' ' ALA . . . . . 0.405 ' HB3' ' O ' ' A' ' 346' ' ' VAL . . . -55.19 -36.06 65.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.107 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 350' ' ' LEU . . . . . 0.525 HD11 ' HB2' ' A' ' 366' ' ' ARG . 69.2 mt -64.66 -42.58 95.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.898 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 58.1 mmtt -42.57 -48.55 5.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.858 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 352' ' ' CYS . . . . . . . . . . . . . 16.1 m -70.68 73.95 0.57 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.869 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -110.65 152.9 25.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.923 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 22.0 mtt85 61.78 37.6 15.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.893 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 355' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -92.47 174.17 7.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.865 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 356' ' ' TYR . . . . . 0.454 ' N ' ' CD1' ' A' ' 356' ' ' TYR . 1.4 m-85 -126.58 105.62 8.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.937 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 357' ' ' MET . . . . . 0.403 ' O ' ' CG ' ' A' ' 357' ' ' MET . 0.1 OUTLIER -127.37 118.82 24.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.914 179.923 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 90.09 -36.99 3.42 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.468 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 131.03 29.53 0.61 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.497 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 360' ' ' ARG . . . . . . . . . . . . . 47.0 mtt-85 -152.99 140.42 19.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.782 0.325 . . . . 0.0 110.878 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 361' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -54.1 129.95 36.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.962 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 362' ' ' ILE . . . . . 0.624 HG21 ' CE2' ' A' ' 313' ' ' PHE . 32.4 mm -109.14 146.12 15.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.113 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 363' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -138.26 112.14 8.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.87 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 364' ' ' VAL . . . . . 0.42 HG12 HD23 ' A' ' 350' ' ' LEU . 58.8 t -86.56 136.15 23.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.148 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -131.82 129.73 40.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.909 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . 0.525 ' HB2' HD11 ' A' ' 350' ' ' LEU . 18.8 ttt180 -78.46 115.98 18.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.897 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -97.19 104.82 16.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.89 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.3 -43.83 73.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.898 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 3.9 m -70.0 -58.57 3.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.88 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 109.48 -161.87 12.92 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.498 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.76 2.61 3.38 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.74 2.294 . . . . 0.0 112.286 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 372' ' ' SER . . . . . . . . . . . . . 19.8 p -38.38 -39.06 0.41 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.813 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 373' ' ' SER . . . . . 0.421 ' O ' ' C ' ' A' ' 374' ' ' GLY . 63.9 p -100.4 121.01 40.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.869 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 374' ' ' GLY . . . . . 0.421 ' C ' ' O ' ' A' ' 373' ' ' SER . . . . . . . . 0 N--CA 1.451 -0.342 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.493 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.366 0 N-CA-C 112.539 -0.224 . . . . 0.0 112.539 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 16.0 m -105.12 92.23 4.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.852 0.358 . . . . 0.0 110.825 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 23.3 t -122.95 114.49 20.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.835 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -152.54 -96.95 0.14 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.462 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 40.9 t -73.3 132.49 43.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.913 0.387 . . . . 0.0 110.857 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 60.9 p -41.58 -49.52 4.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.86 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 176.77 -43.48 0.1 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.487 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 9.7 t -81.56 128.3 33.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.866 0.365 . . . . 0.0 111.115 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 67.2 p -72.86 135.29 45.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.116 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 293' ' ' CYS . . . . . . . . . . . . . 1.9 t -114.42 150.31 34.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.884 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . 0.583 ' HB3' HG21 ' A' ' 346' ' ' VAL . 39.4 m-70 -101.94 95.41 6.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.891 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 38.9 m -137.45 139.35 40.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.18 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 296' ' ' VAL . . . . . 0.505 HG22 ' O ' ' A' ' 338' ' ' VAL . 14.4 m -118.64 153.92 20.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.137 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . 0.572 ' HE2' ' CE1' ' A' ' 337' ' ' PHE . 2.1 tppp? -112.38 145.94 39.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.875 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . 0.473 HD12 ' C ' ' A' ' 297' ' ' LYS . 6.9 mp -132.78 108.57 9.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.902 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 21.9 ptt180 -119.14 146.9 44.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.909 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 114.29 -9.13 22.58 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.447 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -68.48 151.51 97.18 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.572 0.701 . . . . 0.0 111.095 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.71 173.35 11.06 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.676 2.25 . . . . 0.0 112.317 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 303' ' ' PHE . . . . . 0.437 ' C ' ' CD1' ' A' ' 303' ' ' PHE . 6.1 t80 -74.07 -33.23 63.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.854 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 55.7 m-20 -90.44 48.51 1.56 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.861 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 305' ' ' VAL . . . . . 0.542 HG22 ' N ' ' A' ' 306' ' ' THR . 9.5 p -105.07 164.22 4.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.165 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 306' ' ' THR . . . . . 0.542 ' N ' HG22 ' A' ' 305' ' ' VAL . 0.0 OUTLIER -149.19 171.06 17.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.169 -179.968 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 307' ' ' GLU . . . . . 0.435 ' N ' ' OG1' ' A' ' 306' ' ' THR . 38.6 mt-10 -54.98 -23.38 18.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.914 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 53.6 tttp -70.74 -65.52 0.72 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.926 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -40.14 -37.88 0.68 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.876 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 310' ' ' VAL . . . . . 0.462 HG13 HD22 ' A' ' 298' ' ' LEU . 46.9 t -65.64 -50.47 71.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.144 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 311' ' ' MET . . . . . 0.429 ' O ' ' HB2' ' A' ' 315' ' ' ALA . 3.4 mmt -51.38 -39.24 56.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.875 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -66.53 -39.72 88.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.913 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -70.46 -46.24 64.19 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.836 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.755 ' CD1' HG11 ' A' ' 338' ' ' VAL . 29.9 mt -72.83 -26.16 61.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.956 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . 0.726 ' HB1' ' HA ' ' A' ' 316' ' ' PRO . . . -48.49 162.89 0.33 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.616 0.722 . . . . 0.0 111.074 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 316' ' ' PRO . . . . . 0.726 ' HA ' ' HB1' ' A' ' 315' ' ' ALA . 53.9 Cg_endo -69.74 -10.61 11.54 Favored 'Cis proline' 0 C--N 1.342 0.195 0 C-N-CA 122.693 -1.794 . . . . 0.0 112.383 -0.036 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 317' ' ' LEU . . . . . . . . . . . . . 33.9 mt -39.48 157.97 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.963 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 36.6 tttm -135.05 96.77 14.09 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.602 0.715 . . . . 0.0 110.877 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 319' ' ' PRO . . . . . 0.519 ' HA ' ' CD2' ' A' ' 340' ' ' PHE . 54.3 Cg_endo -69.76 -175.67 1.23 Allowed 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.666 2.244 . . . . 0.0 112.355 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 38.8 t -100.1 -43.62 11.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.112 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -155.74 141.07 17.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.083 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 322' ' ' ILE . . . . . 0.471 HG23 HG22 ' A' ' 338' ' ' VAL . 56.8 mt -117.13 100.72 10.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.123 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -100.22 105.06 16.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.89 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . 0.697 ' HA ' HG23 ' A' ' 336' ' ' ILE . 83.5 mt -69.69 114.0 6.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.162 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . 0.453 HG22 ' CD2' ' A' ' 337' ' ' PHE . 59.8 t -49.56 106.46 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.075 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 75.3 mtm180 -90.03 137.96 31.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.838 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 327' ' ' ASN . . . . . 0.437 ' O ' ' C ' ' A' ' 328' ' ' ALA . 28.2 t30 -73.27 157.54 36.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.883 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . 0.437 ' C ' ' O ' ' A' ' 327' ' ' ASN . . . -34.7 -56.65 0.54 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.084 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 9.3 m-70 -69.44 -48.68 60.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.882 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 134.59 74.78 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.49 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 12.1 m-80 -148.33 -178.18 6.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.861 0.362 . . . . 0.0 110.88 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 332' ' ' LYS . . . . . 0.402 ' HG2' HG21 ' A' ' 324' ' ' ILE . 20.1 mttp -118.73 121.1 39.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.906 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 333' ' ' THR . . . . . 0.44 ' O ' ' C ' ' A' ' 334' ' ' GLY . 61.6 p -125.89 74.96 1.46 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.171 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . 0.476 ' O ' ' CG ' ' A' ' 335' ' ' TYR . . . 34.7 67.44 0.27 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.462 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 335' ' ' TYR . . . . . 0.476 ' CG ' ' O ' ' A' ' 334' ' ' GLY . 5.8 m-85 -168.45 120.03 0.8 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.838 0.351 . . . . 0.0 110.971 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 336' ' ' ILE . . . . . 0.697 HG23 ' HA ' ' A' ' 324' ' ' ILE . 28.5 mt -144.54 143.27 23.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.109 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . 0.572 ' CE1' ' HE2' ' A' ' 297' ' ' LYS . 15.7 m-85 -108.32 120.99 43.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.875 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . 0.755 HG11 ' CD1' ' A' ' 314' ' ' LEU . 39.3 t -121.03 124.27 71.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.124 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -103.58 159.12 15.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.851 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 340' ' ' PHE . . . . . 0.519 ' CD2' ' HA ' ' A' ' 319' ' ' PRO . 66.7 m-85 -134.93 160.57 37.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.877 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 17.7 t -83.41 -50.43 8.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.808 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 60.5 m-20 -98.32 159.8 14.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.909 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -74.53 -43.57 55.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.929 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -48.38 -41.37 28.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.863 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . 0.439 ' HB3' ' CD2' ' A' ' 340' ' ' PHE . 29.6 mt-10 -56.46 -47.17 79.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.885 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . 0.583 HG21 ' HB3' ' A' ' 294' ' ' HIS . 48.8 t -57.64 -56.87 12.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.113 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.59 -38.19 20.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.929 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 17.9 mm100 -72.84 -37.69 67.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.946 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -52.54 -39.52 61.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.115 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 350' ' ' LEU . . . . . 0.422 HD23 HG12 ' A' ' 364' ' ' VAL . 81.4 mt -67.38 -25.13 65.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.958 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 6.5 mmpt? -60.73 -59.7 4.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.895 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 352' ' ' CYS . . . . . . . . . . . . . 69.5 m -65.71 74.05 0.07 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.886 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 55.9 p30 -118.16 168.58 10.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.877 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 19.7 mtt180 61.54 28.96 18.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.908 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 355' ' ' GLU . . . . . 0.42 ' C ' ' CD1' ' A' ' 356' ' ' TYR . 7.0 mm-40 -86.71 174.2 8.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.859 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 356' ' ' TYR . . . . . 0.51 ' N ' ' CD1' ' A' ' 356' ' ' TYR . 0.9 OUTLIER -133.92 99.7 4.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.893 -179.825 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 357' ' ' MET . . . . . . . . . . . . . 5.3 ptt? -126.61 141.93 51.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.936 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 79.22 -43.37 2.48 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.452 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 359' ' ' GLY . . . . . 0.472 ' O ' ' CG ' ' A' ' 360' ' ' ARG . . . 140.92 32.67 0.14 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.481 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 360' ' ' ARG . . . . . 0.472 ' CG ' ' O ' ' A' ' 359' ' ' GLY . 58.1 mtt-85 -164.85 158.15 17.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.802 0.334 . . . . 0.0 110.879 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 361' ' ' TYR . . . . . . . . . . . . . 27.0 p90 -71.83 144.1 49.23 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.908 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 31.2 mm -115.09 142.46 27.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.13 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 363' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -131.15 113.68 14.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.856 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 364' ' ' VAL . . . . . 0.422 HG12 HD23 ' A' ' 350' ' ' LEU . 20.1 t -89.32 134.43 28.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.181 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -131.43 140.82 49.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.886 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 2.1 tmm_? -85.88 124.49 32.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.906 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . 0.412 ' OE1' ' CE1' ' A' ' 337' ' ' PHE . 16.3 mt-10 -106.1 134.02 49.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.935 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 24.2 mtpt -91.48 -53.77 4.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.873 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . 0.41 ' C ' ' HD2' ' A' ' 371' ' ' PRO . 22.9 m -63.38 -52.55 61.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.84 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 118.51 -75.99 0.29 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.465 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 371' ' ' PRO . . . . . 0.41 ' HD2' ' C ' ' A' ' 369' ' ' SER . 53.7 Cg_endo -69.75 142.88 49.18 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.685 2.257 . . . . 0.0 112.368 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 372' ' ' SER . . . . . . . . . . . . . 81.3 p -38.86 154.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.852 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 43.5 m -72.83 159.0 34.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.886 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.474 179.984 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 N-CA-C 112.442 -0.263 . . . . 0.0 112.442 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 3.5 m -99.84 120.63 40.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.854 0.359 . . . . 0.0 110.879 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 78.3 p -136.54 120.41 17.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.878 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -111.15 84.5 0.36 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.459 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 18.2 m -42.07 -55.8 3.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.889 0.376 . . . . 0.0 110.855 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 49.9 m -97.33 -52.51 3.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.875 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 79.54 134.28 1.1 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.502 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 75.0 p -44.14 164.18 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.84 0.352 . . . . 0.0 111.178 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 292' ' ' THR . . . . . 0.503 HG23 ' CE1' ' A' ' 294' ' ' HIS . 32.4 m -57.38 98.66 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.142 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 293' ' ' CYS . . . . . . . . . . . . . 25.0 m -123.65 98.58 5.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.844 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . 0.837 ' HB3' HG21 ' A' ' 346' ' ' VAL . 34.6 m80 -109.11 122.51 47.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.856 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . 0.592 HG23 ' OD1' ' A' ' 339' ' ' ASP . 5.0 m -137.12 136.62 38.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.189 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 296' ' ' VAL . . . . . 0.71 ' CG1' HG13 ' A' ' 346' ' ' VAL . 26.8 m -118.13 146.79 22.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.162 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . 0.494 ' HG3' ' CE1' ' A' ' 337' ' ' PHE . 8.3 ttmm -114.2 141.85 47.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.87 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . 0.759 HD21 ' CE2' ' A' ' 313' ' ' PHE . 7.4 mp -123.0 149.93 43.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.915 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 64.0 mtt180 -143.91 165.41 27.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.906 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 87.71 -21.25 23.59 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.5 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -58.28 152.09 44.48 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.571 0.701 . . . . 0.0 111.13 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.8 179.25 3.85 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.667 2.244 . . . . 0.0 112.323 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 303' ' ' PHE . . . . . 0.539 ' CD2' ' O ' ' A' ' 332' ' ' LYS . 93.1 m-85 -86.45 -38.09 17.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.864 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -85.4 46.28 1.28 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.929 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 305' ' ' VAL . . . . . . . . . . . . . 12.3 p -103.09 141.39 19.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.14 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 306' ' ' THR . . . . . . . . . . . . . 41.6 p -121.99 169.94 10.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.173 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 41.7 mp0 -50.3 -51.47 44.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.823 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 12.2 tttp -45.02 -45.13 10.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.89 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -61.02 -49.12 78.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.901 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 78.5 t -59.5 -48.58 86.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.14 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 311' ' ' MET . . . . . . . . . . . . . 4.4 mmt -51.08 -42.78 60.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.84 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -69.69 -25.56 63.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.93 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 313' ' ' PHE . . . . . 0.873 ' CZ ' HG21 ' A' ' 362' ' ' ILE . 37.1 t80 -76.26 -45.86 30.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.869 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.682 ' CD1' HG11 ' A' ' 338' ' ' VAL . 89.4 mt -79.24 -20.46 48.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.905 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . 0.725 ' HB1' ' HA ' ' A' ' 316' ' ' PRO . . . -49.86 162.62 0.46 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.571 0.7 . . . . 0.0 111.095 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 316' ' ' PRO . . . . . 0.725 ' HA ' ' HB1' ' A' ' 315' ' ' ALA . 53.2 Cg_endo -69.8 -8.51 10.62 Favored 'Cis proline' 0 C--O 1.232 0.198 0 C-N-CA 122.675 -1.802 . . . . 0.0 112.305 0.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 317' ' ' LEU . . . . . . . . . . . . . 17.5 mt -46.7 156.69 0.18 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.893 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 318' ' ' LYS . . . . . 0.401 ' HA ' ' HD2' ' A' ' 319' ' ' PRO . 18.0 ttpt -133.44 105.51 12.07 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.604 0.716 . . . . 0.0 110.89 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 319' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 318' ' ' LYS . 53.6 Cg_endo -69.76 -174.65 0.95 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.688 2.259 . . . . 0.0 112.345 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 21.8 t -108.08 -31.64 2.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.126 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -161.27 130.3 4.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.126 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 322' ' ' ILE . . . . . . . . . . . . . 68.2 mt -107.21 106.82 21.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.139 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 32.7 mmt180 -104.75 101.95 11.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.848 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 66.0 mt -74.68 131.99 34.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.136 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . 0.541 HG22 ' CE2' ' A' ' 337' ' ' PHE . 46.5 t -72.44 90.54 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.127 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 12.5 ptt-85 -87.25 126.63 34.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.907 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 10.2 m-20 -118.15 169.17 9.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.857 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . 50.89 39.07 21.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.107 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 6.8 m80 61.44 41.83 12.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.902 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 116.03 83.16 1.03 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.451 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -170.68 112.68 0.41 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.924 0.392 . . . . 0.0 110.9 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 332' ' ' LYS . . . . . 0.539 ' O ' ' CD2' ' A' ' 303' ' ' PHE . 0.1 OUTLIER -74.52 98.83 3.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.894 179.935 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 24.2 p -90.74 68.28 6.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.132 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . 0.597 ' O ' ' CD1' ' A' ' 335' ' ' TYR . . . 40.21 52.15 3.5 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.469 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 335' ' ' TYR . . . . . 0.597 ' CD1' ' O ' ' A' ' 334' ' ' GLY . 17.2 m-85 -155.88 134.68 11.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.839 0.352 . . . . 0.0 110.93 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 336' ' ' ILE . . . . . 0.43 HG13 ' C ' ' A' ' 335' ' ' TYR . 84.7 mt -149.18 138.11 15.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.145 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . 0.541 ' CE2' HG22 ' A' ' 325' ' ' VAL . 30.9 m-85 -110.51 125.28 53.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.863 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . 0.682 HG11 ' CD1' ' A' ' 314' ' ' LEU . 24.2 t -125.5 143.02 40.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.12 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 339' ' ' ASP . . . . . 0.592 ' OD1' HG23 ' A' ' 295' ' ' THR . 4.5 m-20 -119.37 156.68 29.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.905 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 340' ' ' PHE . . . . . 0.528 ' CD2' ' HB3' ' A' ' 345' ' ' GLU . 57.0 m-85 -134.88 166.23 23.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.86 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 1.9 m -85.41 -55.41 4.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.86 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -99.6 162.86 12.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.877 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 343' ' ' GLU . . . . . 0.574 ' HB3' ' CE1' ' A' ' 294' ' ' HIS . 1.2 pm0 -81.13 -15.28 56.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.864 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -71.15 -34.13 70.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.884 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . 0.528 ' HB3' ' CD2' ' A' ' 340' ' ' PHE . 27.1 mt-10 -68.23 -44.84 74.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.932 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . 0.837 HG21 ' HB3' ' A' ' 294' ' ' HIS . 55.4 t -63.66 -47.22 92.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.155 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 32.0 mttm -49.53 -38.89 32.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.914 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 3.7 mm100 -71.88 -46.09 59.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.892 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -49.45 -36.44 22.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.12 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 350' ' ' LEU . . . . . 0.599 HD11 ' HD3' ' A' ' 366' ' ' ARG . 55.5 mt -66.62 -42.77 86.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.938 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 66.6 mttt -58.1 -38.39 76.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.878 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 352' ' ' CYS . . . . . 0.438 ' HB3' ' CD ' ' A' ' 355' ' ' GLU . 72.3 m -76.11 83.9 2.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.873 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -120.71 169.99 9.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.865 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 27.9 mmm180 53.85 39.18 30.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.896 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 355' ' ' GLU . . . . . 0.439 ' OE2' ' CE1' ' A' ' 313' ' ' PHE . 12.3 mt-10 -95.39 174.73 6.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.884 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 356' ' ' TYR . . . . . 0.418 ' N ' ' CD1' ' A' ' 356' ' ' TYR . 1.6 m-85 -122.88 105.38 9.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.928 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 357' ' ' MET . . . . . 0.651 ' HG3' HD11 ' A' ' 362' ' ' ILE . 0.0 OUTLIER -130.31 123.69 30.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.904 179.884 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 85.13 -33.06 3.42 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.471 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 129.72 29.15 0.71 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.481 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 360' ' ' ARG . . . . . . . . . . . . . 36.6 mtt85 -162.32 145.38 11.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.836 0.35 . . . . 0.0 110.83 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 361' ' ' TYR . . . . . 0.636 ' O ' HD13 ' A' ' 362' ' ' ILE . 37.1 p90 -47.01 165.93 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.91 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 362' ' ' ILE . . . . . 0.873 HG21 ' CZ ' ' A' ' 313' ' ' PHE . 42.7 mm -139.93 145.79 25.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.136 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 363' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -134.63 115.71 14.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.842 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 50.6 t -96.61 142.81 13.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.092 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -144.07 126.75 16.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.868 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . 0.599 ' HD3' HD11 ' A' ' 350' ' ' LEU . 8.1 ttp-105 -68.82 139.09 55.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.862 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -129.08 166.92 18.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.883 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 19.6 mttp -118.29 82.02 1.77 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.861 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 3.3 t 52.8 52.21 14.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.84 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 92.67 153.16 29.86 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.476 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 88.83 0.53 Allowed 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.645 2.23 . . . . 0.0 112.339 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 372' ' ' SER . . . . . . . . . . . . . 18.2 m 41.93 41.87 2.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.91 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 23.3 t -101.6 148.54 25.1 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.858 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.478 -179.975 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . 0.441 ' O ' ' C ' ' A' ' 285' ' ' SER . . . . . . . . 0 N--CA 1.452 -0.296 0 N-CA-C 112.505 -0.238 . . . . 0.0 112.505 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 285' ' ' SER . . . . . 0.441 ' C ' ' O ' ' A' ' 284' ' ' GLY . 53.1 p 35.32 41.38 0.08 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.862 0.363 . . . . 0.0 110.85 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 66.7 m 39.8 50.74 2.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.799 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -93.19 158.33 23.75 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.485 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 16.9 m -96.91 -58.58 1.99 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.875 0.369 . . . . 0.0 110.881 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 7.0 t -52.42 163.57 0.4 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.925 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 144.26 173.38 15.62 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.49 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 9.0 t -100.7 144.27 29.87 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.875 0.369 . . . . 0.0 111.136 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 64.2 p -83.08 101.79 11.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.121 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 293' ' ' CYS . . . . . . . . . . . . . 4.4 m -123.63 150.55 44.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.903 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . 0.688 ' HB3' HG21 ' A' ' 346' ' ' VAL . 25.3 m80 -128.37 107.31 9.65 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.851 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 50.1 m -132.69 151.73 51.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.127 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 296' ' ' VAL . . . . . 0.485 ' CG1' HG13 ' A' ' 346' ' ' VAL . 26.3 m -129.65 157.37 42.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.167 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 4.5 ttpm? -125.89 152.4 45.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.899 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . 0.754 HD21 ' CE2' ' A' ' 313' ' ' PHE . 6.8 mp -126.35 131.3 51.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.844 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 34.1 ttp85 -136.44 127.78 28.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.872 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 125.41 -8.68 7.85 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.459 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -69.73 150.14 96.67 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.592 0.71 . . . . 0.0 111.092 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 174.32 9.7 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.669 2.246 . . . . 0.0 112.366 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 303' ' ' PHE . . . . . 0.489 ' C ' ' CD1' ' A' ' 303' ' ' PHE . 2.4 t80 -75.54 -27.07 58.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.876 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 25.6 p30 -92.86 46.38 1.23 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.891 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 305' ' ' VAL . . . . . 0.452 ' CG1' ' HE3' ' A' ' 332' ' ' LYS . 9.8 p -106.93 144.27 16.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.151 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 306' ' ' THR . . . . . . . . . . . . . 61.1 p -132.76 167.52 20.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.182 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -43.89 -52.59 6.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.9 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 36.7 tttt -41.25 -55.91 2.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.899 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -50.91 -48.83 60.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.908 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 310' ' ' VAL . . . . . 0.475 HG21 HG21 ' A' ' 336' ' ' ILE . 61.9 t -57.87 -42.36 82.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.133 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 311' ' ' MET . . . . . 0.468 ' HG2' ' CD1' ' A' ' 322' ' ' ILE . 2.6 mmt -61.17 -52.69 63.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.833 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -65.5 -28.0 68.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.892 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 313' ' ' PHE . . . . . 0.754 ' CE2' HD21 ' A' ' 298' ' ' LEU . 14.9 t80 -71.11 -43.81 66.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.875 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.628 HD11 HG21 ' A' ' 338' ' ' VAL . 61.6 mt -80.86 -26.12 37.16 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.953 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . 0.671 ' HB1' ' HA ' ' A' ' 316' ' ' PRO . . . -41.31 161.06 0.13 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.553 0.692 . . . . 0.0 111.108 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 316' ' ' PRO . . . . . 0.671 ' HA ' ' HB1' ' A' ' 315' ' ' ALA . 53.5 Cg_endo -69.86 -9.43 11.21 Favored 'Cis proline' 0 C--O 1.232 0.183 0 C-N-CA 122.657 -1.81 . . . . 0.0 112.348 0.071 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 317' ' ' LEU . . . . . . . . . . . . . 73.0 mt -44.62 149.77 0.38 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.944 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 26.2 tttp -127.54 101.33 24.38 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.596 0.712 . . . . 0.0 110.964 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 319' ' ' PRO . . . . . 0.511 ' HA ' ' CD2' ' A' ' 340' ' ' PHE . 53.2 Cg_endo -69.76 -169.96 0.36 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.718 2.278 . . . . 0.0 112.301 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 320' ' ' VAL . . . . . 0.41 HG23 ' HA ' ' A' ' 340' ' ' PHE . 53.0 t -110.27 -37.18 3.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.137 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -159.18 134.61 8.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.097 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 322' ' ' ILE . . . . . 0.468 ' CD1' ' HG2' ' A' ' 311' ' ' MET . 48.6 mt -110.52 100.52 10.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.106 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -96.03 108.3 20.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.89 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 95.9 mt -74.14 118.43 19.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.132 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . 0.485 HG21 ' HB3' ' A' ' 335' ' ' TYR . 25.5 t -62.02 102.05 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.131 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -98.26 152.8 19.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.836 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -94.53 177.27 5.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.924 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -44.94 -69.52 0.13 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.096 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 6.5 m80 -84.78 49.01 1.63 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.895 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 44.97 59.31 4.5 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.488 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -123.34 75.03 1.28 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.886 0.374 . . . . 0.0 110.868 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 332' ' ' LYS . . . . . 0.452 ' HE3' ' CG1' ' A' ' 305' ' ' VAL . 43.7 tttm -51.15 112.98 0.81 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.894 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 333' ' ' THR . . . . . 0.435 ' O ' ' C ' ' A' ' 334' ' ' GLY . 24.0 p -103.53 79.56 1.7 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.144 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . 0.529 ' O ' ' CG ' ' A' ' 335' ' ' TYR . . . 34.99 78.52 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.495 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 335' ' ' TYR . . . . . 0.529 ' CG ' ' O ' ' A' ' 334' ' ' GLY . 9.1 m-85 -168.82 117.96 0.7 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.843 0.354 . . . . 0.0 110.927 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 336' ' ' ILE . . . . . 0.475 HG21 HG21 ' A' ' 310' ' ' VAL . 53.4 mt -138.0 124.94 27.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.12 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -99.29 122.3 42.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.864 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . 0.628 HG21 HD11 ' A' ' 314' ' ' LEU . 44.1 t -119.7 134.34 63.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.102 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -109.88 164.74 12.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.859 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 340' ' ' PHE . . . . . 0.511 ' CD2' ' HA ' ' A' ' 319' ' ' PRO . 76.1 m-85 -143.37 170.95 14.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.854 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 3.0 p -96.32 -45.99 6.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.872 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -92.43 163.55 13.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.879 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 -87.62 -33.93 18.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.909 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -63.98 -41.05 97.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.901 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -56.34 -49.26 74.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.917 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . 0.688 HG21 ' HB3' ' A' ' 294' ' ' HIS . 71.9 t -58.77 -41.74 83.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.1 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 9.9 mtpm? -58.11 -43.25 87.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.892 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -65.53 -37.71 87.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.907 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 349' ' ' ALA . . . . . 0.567 ' O ' HG11 ' A' ' 364' ' ' VAL . . . -54.46 -17.17 2.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.141 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 350' ' ' LEU . . . . . 0.428 HD23 HG12 ' A' ' 364' ' ' VAL . 32.1 mt -92.33 -23.21 19.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.921 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.96 -7.81 9.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.866 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 352' ' ' CYS . . . . . . . . . . . . . 75.7 m -112.24 98.34 7.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.854 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . 0.487 ' O ' ' C ' ' A' ' 354' ' ' ARG . 6.9 p-10 -118.54 -179.64 3.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.907 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . 0.487 ' C ' ' O ' ' A' ' 353' ' ' ASN . 0.0 OUTLIER 31.44 38.25 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.843 179.969 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 355' ' ' GLU . . . . . 0.486 ' N ' ' O ' ' A' ' 353' ' ' ASN . 3.9 mm-40 -81.2 174.67 11.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.877 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 356' ' ' TYR . . . . . 0.494 ' N ' ' CD1' ' A' ' 356' ' ' TYR . 1.0 OUTLIER -134.05 110.28 9.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.929 -179.912 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 357' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.02 124.98 22.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.891 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 87.53 -37.28 3.24 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.515 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 133.92 29.78 0.45 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.495 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 360' ' ' ARG . . . . . . . . . . . . . 55.5 mtt180 -159.63 145.56 15.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.829 0.347 . . . . 0.0 110.884 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 361' ' ' TYR . . . . . 0.499 ' O ' HD13 ' A' ' 362' ' ' ILE . 48.6 p90 -50.56 159.65 0.49 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.906 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 362' ' ' ILE . . . . . 0.499 HD13 ' O ' ' A' ' 361' ' ' TYR . 4.6 mm -143.35 129.15 16.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.137 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 363' ' ' GLU . . . . . 0.494 ' HB3' ' CZ ' ' A' ' 365' ' ' PHE . 6.5 mm-40 -119.3 112.21 19.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.895 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 364' ' ' VAL . . . . . 0.567 HG11 ' O ' ' A' ' 349' ' ' ALA . 38.4 t -88.03 131.83 34.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.104 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 365' ' ' PHE . . . . . 0.494 ' CZ ' ' HB3' ' A' ' 363' ' ' GLU . 25.7 m-85 -130.25 150.99 51.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.848 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 28.5 ttt180 -95.57 122.33 38.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.836 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -101.75 156.95 17.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.919 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.6 95.59 5.22 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.911 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 18.3 t 56.59 41.41 28.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.934 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 44.53 74.72 0.2 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.529 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 108.17 2.01 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.695 2.264 . . . . 0.0 112.354 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 372' ' ' SER . . . . . . . . . . . . . 1.5 t -114.49 -45.47 3.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.866 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 25.7 m -118.84 118.66 32.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.903 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.492 -179.957 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 N-CA-C 112.53 -0.228 . . . . 0.0 112.53 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 30.8 m -157.62 139.87 14.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.861 0.363 . . . . 0.0 110.888 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 97.6 p -88.51 42.11 1.05 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.87 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 164.91 54.9 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.457 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 5.1 t -84.33 -48.11 10.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.844 0.354 . . . . 0.0 110.854 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 11.0 t -90.36 86.12 6.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.844 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . -163.49 -58.21 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.519 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 70.8 p -104.41 109.98 22.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.877 0.37 . . . . 0.0 111.125 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 38.3 p -122.05 40.21 3.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.173 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 293' ' ' CYS . . . . . . . . . . . . . 20.0 p -60.27 165.43 3.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.839 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . 0.726 ' HB2' HG21 ' A' ' 346' ' ' VAL . 13.9 m-70 -118.76 133.78 55.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.89 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . 0.443 HG23 ' OD1' ' A' ' 339' ' ' ASP . 32.3 m -138.89 116.37 11.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.129 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 296' ' ' VAL . . . . . 0.658 ' CG1' HG13 ' A' ' 346' ' ' VAL . 29.6 m -98.13 160.67 3.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.138 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . 0.578 ' HD3' ' CE1' ' A' ' 337' ' ' PHE . 31.3 ttpt -139.34 150.14 45.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.892 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . 0.475 HD21 ' CE1' ' A' ' 313' ' ' PHE . 6.8 mp -124.71 135.51 53.09 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.931 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 18.0 ttt-85 -133.56 138.42 46.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.9 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 110.23 10.57 21.93 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.511 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -75.96 143.65 74.6 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.57 0.7 . . . . 0.0 111.09 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 -170.08 0.37 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.667 2.245 . . . . 0.0 112.339 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -90.67 -10.56 42.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.84 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -101.42 25.98 7.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.895 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 305' ' ' VAL . . . . . 0.408 ' CG1' ' HE3' ' A' ' 332' ' ' LYS . 9.2 p -94.66 140.23 17.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.103 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 306' ' ' THR . . . . . 0.401 ' O ' ' N ' ' A' ' 308' ' ' LYS . 21.3 p -137.03 160.69 38.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.132 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -38.1 -32.61 0.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.877 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 308' ' ' LYS . . . . . 0.444 ' O ' ' N ' ' A' ' 311' ' ' MET . 23.6 ttmt -63.38 -67.7 0.4 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.921 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . 0.41 ' C ' ' O ' ' A' ' 308' ' ' LYS . 9.4 m-80 -37.65 -45.66 0.8 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.92 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 61.7 t -57.82 -43.55 84.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.116 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 311' ' ' MET . . . . . 0.444 ' N ' ' O ' ' A' ' 308' ' ' LYS . 4.7 mmt -59.73 -50.67 72.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.893 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 15.2 mp0 -62.31 -36.38 81.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.906 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 313' ' ' PHE . . . . . 0.475 ' CE1' HD21 ' A' ' 298' ' ' LEU . 3.5 t80 -65.09 -44.63 88.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.873 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.585 ' CD1' HG11 ' A' ' 338' ' ' VAL . 54.6 mt -78.43 -21.07 49.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.905 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . 0.871 ' HB1' ' HA ' ' A' ' 316' ' ' PRO . . . -51.58 166.84 0.34 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.573 0.702 . . . . 0.0 111.143 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 316' ' ' PRO . . . . . 0.871 ' HA ' ' HB1' ' A' ' 315' ' ' ALA . 54.1 Cg_endo -69.73 -4.58 8.33 Favored 'Cis proline' 0 C--O 1.232 0.202 0 C-N-CA 122.66 -1.809 . . . . 0.0 112.348 -0.028 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 317' ' ' LEU . . . . . 0.468 ' N ' ' HA ' ' A' ' 315' ' ' ALA . 21.1 mt -54.1 161.1 1.35 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.885 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 46.2 tttt -134.46 107.19 11.01 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.586 0.708 . . . . 0.0 110.925 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 319' ' ' PRO . . . . . 0.476 ' HA ' ' CD2' ' A' ' 340' ' ' PHE . 53.7 Cg_endo -69.79 -175.76 1.27 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.713 2.275 . . . . 0.0 112.358 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 320' ' ' VAL . . . . . 0.459 HG23 ' C ' ' A' ' 340' ' ' PHE . 42.3 t -102.4 -35.74 4.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.107 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -164.14 138.12 5.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.092 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 322' ' ' ILE . . . . . 0.48 HG23 HG22 ' A' ' 338' ' ' VAL . 80.5 mt -112.22 111.51 36.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.121 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 87.0 mtt180 -110.01 103.33 12.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.849 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 94.4 mt -64.26 118.24 6.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.141 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . 0.915 HG22 ' CD2' ' A' ' 337' ' ' PHE . 27.1 t -57.67 92.23 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.157 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 18.1 ptt-85 -99.94 113.18 25.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.854 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -51.36 -70.43 0.09 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.907 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -158.72 153.11 24.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.079 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 24.7 m170 43.68 29.24 0.27 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.852 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 73.17 74.42 0.8 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.44 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -129.75 84.62 2.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.88 0.371 . . . . 0.0 110.85 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 332' ' ' LYS . . . . . 0.408 ' HE3' ' CG1' ' A' ' 305' ' ' VAL . 9.7 mtpm? -57.04 114.82 2.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.882 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 333' ' ' THR . . . . . 0.422 ' O ' ' C ' ' A' ' 334' ' ' GLY . 34.7 p -113.71 69.28 0.7 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.108 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 333' ' ' THR . . . 36.37 61.55 0.83 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.462 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 335' ' ' TYR . . . . . 0.555 ' HB3' HG21 ' A' ' 325' ' ' VAL . 10.6 m-85 -162.3 131.15 4.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.854 0.359 . . . . 0.0 110.915 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 58.7 mt -141.54 113.79 3.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.158 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . 0.915 ' CD2' HG22 ' A' ' 325' ' ' VAL . 18.0 m-85 -87.88 129.85 35.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.893 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . 0.585 HG11 ' CD1' ' A' ' 314' ' ' LEU . 22.0 t -134.33 135.34 54.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.174 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 339' ' ' ASP . . . . . 0.443 ' OD1' HG23 ' A' ' 295' ' ' THR . 7.0 m-20 -111.75 162.68 14.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.877 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 340' ' ' PHE . . . . . 0.562 ' HB2' HG23 ' A' ' 346' ' ' VAL . 60.3 m-85 -136.64 172.3 13.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.882 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 29.3 t -79.42 -67.6 0.74 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.878 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -100.05 173.25 6.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.876 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 343' ' ' GLU . . . . . 0.551 ' HB2' ' CE1' ' A' ' 294' ' ' HIS . 11.0 pt-20 -75.19 -40.36 59.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.923 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 344' ' ' GLU . . . . . 0.413 ' N ' ' HG3' ' A' ' 343' ' ' GLU . 34.5 tt0 -44.23 -50.75 8.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.913 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -53.96 -61.81 2.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.897 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . 0.726 HG21 ' HB2' ' A' ' 294' ' ' HIS . 60.5 t -50.21 -47.04 25.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.086 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 45.2 mtpt -50.95 -39.3 54.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.946 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -79.44 -29.11 41.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.903 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -57.54 -27.05 62.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.074 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 350' ' ' LEU . . . . . 0.56 HD23 HG12 ' A' ' 364' ' ' VAL . 92.6 mt -77.21 -34.99 56.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.912 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 18.3 mmtp -46.33 -43.35 15.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.886 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 352' ' ' CYS . . . . . . . . . . . . . 8.3 m -62.05 85.04 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.897 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . 0.483 ' O ' ' C ' ' A' ' 354' ' ' ARG . 33.7 p-10 -122.9 -176.9 3.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.873 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . 0.483 ' C ' ' O ' ' A' ' 353' ' ' ASN . 2.9 ppt_? 30.59 44.59 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.894 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 355' ' ' GLU . . . . . 0.446 ' C ' ' OE1' ' A' ' 355' ' ' GLU . 0.0 OUTLIER -118.1 173.1 6.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.891 -179.906 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 356' ' ' TYR . . . . . 0.476 ' N ' ' CD1' ' A' ' 356' ' ' TYR . 1.3 m-85 -128.47 149.29 50.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.902 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 357' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -166.66 125.79 1.48 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.868 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 87.74 -15.2 56.12 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.476 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 105.15 19.77 10.39 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.483 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 360' ' ' ARG . . . . . . . . . . . . . 10.5 mmt180 -146.03 158.86 43.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.828 0.347 . . . . 0.0 110.875 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 361' ' ' TYR . . . . . . . . . . . . . 9.1 p90 -66.22 151.51 46.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.905 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 362' ' ' ILE . . . . . 0.462 HG22 ' N ' ' A' ' 363' ' ' GLU . 15.7 mm -135.3 155.27 37.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.145 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 363' ' ' GLU . . . . . 0.462 ' N ' HG22 ' A' ' 362' ' ' ILE . 49.5 mm-40 -147.57 114.82 6.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.842 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 364' ' ' VAL . . . . . 0.56 HG12 HD23 ' A' ' 350' ' ' LEU . 58.4 t -88.22 140.12 16.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.114 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -137.37 154.79 49.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.831 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 3.0 tmm_? -101.87 109.05 20.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.849 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -93.28 130.62 38.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.892 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 10.7 ptpp? -81.67 128.56 34.09 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.911 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 77.9 p 38.28 40.43 0.34 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.841 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 61.92 -171.85 9.19 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.496 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.83 177.5 5.57 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.674 2.249 . . . . 0.0 112.343 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 372' ' ' SER . . . . . . . . . . . . . 74.9 m -140.4 148.01 40.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.844 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 33.1 p -108.51 108.12 18.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.912 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.285 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.437 -179.985 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 N-CA-C 112.479 -0.249 . . . . 0.0 112.479 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 2.7 m -171.91 176.91 3.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.847 0.356 . . . . 0.0 110.882 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 63.3 p -141.36 110.08 6.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.912 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -78.69 -139.43 1.59 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.508 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 34.9 p -90.0 43.45 1.15 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.833 0.349 . . . . 0.0 110.841 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 85.1 p -39.8 133.83 1.5 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.854 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 290' ' ' GLY . . . . . 0.438 ' O ' ' C ' ' A' ' 291' ' ' THR . . . 50.05 -117.23 4.62 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.487 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . 0.438 ' C ' ' O ' ' A' ' 290' ' ' GLY . 77.2 p 35.06 45.02 0.15 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.885 0.374 . . . . 0.0 111.124 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 9.7 t -132.05 172.61 12.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.102 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 293' ' ' CYS . . . . . . . . . . . . . 21.6 m 41.77 47.16 3.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.861 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . 0.573 ' CE1' ' HB3' ' A' ' 343' ' ' GLU . 75.1 m80 -47.28 122.45 4.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.83 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 69.0 m -135.45 149.81 49.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.13 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 296' ' ' VAL . . . . . 0.511 HG13 HG13 ' A' ' 346' ' ' VAL . 30.8 m -125.74 156.73 35.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.115 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . 0.579 ' HD3' ' CE1' ' A' ' 337' ' ' PHE . 13.4 ttpt -130.35 143.67 50.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.877 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 6.8 mp -118.23 151.86 36.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.9 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 299' ' ' ARG . . . . . 0.513 ' HB2' ' CE1' ' A' ' 335' ' ' TYR . 8.8 ttm-85 -146.42 136.37 23.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.901 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 98.9 48.13 1.81 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.454 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -114.61 148.36 40.14 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.601 0.715 . . . . 0.0 111.05 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 153.3 69.16 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.681 2.254 . . . . 0.0 112.306 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -58.49 -30.47 67.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.905 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -85.0 34.41 0.55 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.847 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 305' ' ' VAL . . . . . 0.479 HG12 ' HB3' ' A' ' 332' ' ' LYS . 9.0 p -96.02 139.64 18.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.126 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 306' ' ' THR . . . . . 0.45 ' O ' ' C ' ' A' ' 307' ' ' GLU . 70.7 p -136.2 155.51 50.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.171 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 307' ' ' GLU . . . . . 0.45 ' C ' ' O ' ' A' ' 306' ' ' THR . 30.2 mt-10 -34.46 -38.48 0.07 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.884 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 29.7 ttmt -57.43 -55.52 33.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.916 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -49.79 -46.7 51.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.906 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 85.0 t -61.55 -40.79 87.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.155 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 311' ' ' MET . . . . . 0.404 ' O ' ' HB2' ' A' ' 315' ' ' ALA . 4.1 mmt -58.71 -40.75 84.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.896 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -68.94 -31.55 70.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.909 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 313' ' ' PHE . . . . . 0.72 ' CE2' HG21 ' A' ' 362' ' ' ILE . 1.9 t80 -74.13 -48.93 26.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.919 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.91 ' CD1' HG11 ' A' ' 338' ' ' VAL . 27.8 mt -72.45 -24.95 61.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.944 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . 0.791 ' HB1' ' HA ' ' A' ' 316' ' ' PRO . . . -49.73 164.52 0.34 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.577 0.703 . . . . 0.0 111.127 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 316' ' ' PRO . . . . . 0.791 ' HA ' ' HB1' ' A' ' 315' ' ' ALA . 54.0 Cg_endo -69.79 -7.43 10.02 Favored 'Cis proline' 0 C--O 1.232 0.188 0 C-N-CA 122.701 -1.791 . . . . 0.0 112.358 0.067 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 317' ' ' LEU . . . . . 0.642 HD13 ' O ' ' A' ' 345' ' ' GLU . 33.0 mt -57.57 134.29 56.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.926 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.88 111.7 56.32 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.56 0.695 . . . . 0.0 110.906 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -176.62 1.54 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.707 2.271 . . . . 0.0 112.327 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 320' ' ' VAL . . . . . 0.417 HG23 ' C ' ' A' ' 340' ' ' PHE . 93.0 t -100.52 -40.27 7.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.092 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -160.56 131.67 5.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.095 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 322' ' ' ILE . . . . . . . . . . . . . 86.5 mt -102.11 119.96 51.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.122 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 61.5 mtm180 -115.54 98.69 6.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.884 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . 0.708 HG23 HG12 ' A' ' 336' ' ' ILE . 41.8 mt -74.72 125.0 33.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.108 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . 0.524 HG22 ' CE2' ' A' ' 337' ' ' PHE . 88.0 t -58.14 112.98 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.126 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 19.4 mmt85 -87.31 119.56 27.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.893 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -75.3 -55.62 5.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.922 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -118.26 -68.95 0.88 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.083 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 21.3 m80 -121.51 -67.37 0.97 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.858 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -148.77 31.64 1.22 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.464 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -79.46 115.71 19.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.894 0.378 . . . . 0.0 110.889 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 332' ' ' LYS . . . . . 0.479 ' HB3' HG12 ' A' ' 305' ' ' VAL . 8.0 mptt -75.05 95.16 2.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.898 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 8.9 t -173.11 148.09 1.66 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.131 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 109.17 -87.85 0.5 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.513 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 335' ' ' TYR . . . . . 0.513 ' CE1' ' HB2' ' A' ' 299' ' ' ARG . 18.2 m-85 -143.59 160.57 40.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.842 0.354 . . . . 0.0 110.937 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 336' ' ' ILE . . . . . 0.708 HG12 HG23 ' A' ' 324' ' ' ILE . 85.5 mt -138.91 113.75 8.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.171 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . 0.579 ' CE1' ' HD3' ' A' ' 297' ' ' LYS . 77.0 m-85 -84.95 135.87 33.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.91 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . 0.91 HG11 ' CD1' ' A' ' 314' ' ' LEU . 58.0 t -137.64 120.15 19.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.15 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -97.38 158.06 15.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.838 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 340' ' ' PHE . . . . . 0.517 ' CZ ' HD13 ' A' ' 314' ' ' LEU . 41.8 m-85 -133.18 172.19 13.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.874 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 48.5 t -83.23 -63.08 1.43 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.872 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -96.02 159.8 14.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.891 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 343' ' ' GLU . . . . . 0.573 ' HB3' ' CE1' ' A' ' 294' ' ' HIS . 10.7 pt-20 -68.64 -47.25 67.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.875 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -45.87 -55.34 6.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.931 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . 0.642 ' O ' HD13 ' A' ' 317' ' ' LEU . 35.6 mt-10 -41.92 -44.83 3.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.879 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . 0.511 HG13 HG13 ' A' ' 296' ' ' VAL . 83.8 t -69.86 -48.57 63.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.159 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 18.8 mtpp -46.07 -42.47 13.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.921 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 348' ' ' GLN . . . . . 0.401 ' O ' ' N ' ' A' ' 351' ' ' LYS . 15.7 mm100 -70.44 -41.43 72.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.873 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -40.49 -43.47 1.85 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.048 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 350' ' ' LEU . . . . . 0.566 HD21 ' HB2' ' A' ' 366' ' ' ARG . 22.6 mt -64.08 -40.72 96.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.913 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 351' ' ' LYS . . . . . 0.401 ' N ' ' O ' ' A' ' 348' ' ' GLN . 15.6 mmtp -54.38 -25.55 25.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.881 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 352' ' ' CYS . . . . . . . . . . . . . 85.6 m -95.93 52.17 1.3 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.864 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . 0.408 ' CG ' ' N ' ' A' ' 354' ' ' ARG . 1.8 t30 -100.38 164.05 12.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.907 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . 0.408 ' N ' ' CG ' ' A' ' 353' ' ' ASN . 11.2 ttm180 68.99 33.33 3.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.886 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 355' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -102.57 174.01 6.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.909 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 356' ' ' TYR . . . . . 0.462 ' N ' ' CD1' ' A' ' 356' ' ' TYR . 1.3 m-85 -124.62 135.3 52.98 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.952 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 357' ' ' MET . . . . . 0.637 ' HG3' HD11 ' A' ' 362' ' ' ILE . 0.0 OUTLIER -148.59 123.33 9.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.867 179.98 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 82.87 -13.59 42.44 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.478 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 110.56 5.22 28.02 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.487 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 360' ' ' ARG . . . . . 0.426 ' NH1' ' HB3' ' A' ' 360' ' ' ARG . 5.1 mmm180 -123.8 130.67 52.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.836 0.35 . . . . 0.0 110.886 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 361' ' ' TYR . . . . . . . . . . . . . 20.4 p90 -49.38 128.5 17.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.915 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 362' ' ' ILE . . . . . 0.72 HG21 ' CE2' ' A' ' 313' ' ' PHE . 37.1 mm -106.51 144.96 14.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.136 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 363' ' ' GLU . . . . . . . . . . . . . 56.0 mm-40 -139.67 112.29 7.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.841 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 364' ' ' VAL . . . . . 0.436 ' O ' ' CD1' ' A' ' 365' ' ' PHE . 15.0 t -85.25 149.57 4.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.117 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 365' ' ' PHE . . . . . 0.436 ' CD1' ' O ' ' A' ' 364' ' ' VAL . 43.0 m-85 -148.64 121.62 8.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.886 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . 0.566 ' HB2' HD21 ' A' ' 350' ' ' LEU . 1.3 tmm_? -69.17 127.78 34.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.888 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -103.46 150.92 23.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.9 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . 0.405 ' O ' ' C ' ' A' ' 369' ' ' SER . 0.0 OUTLIER -91.88 67.49 5.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.876 179.954 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . 0.405 ' C ' ' O ' ' A' ' 368' ' ' LYS . 80.8 p 36.79 54.5 1.15 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.814 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . -171.4 158.49 29.71 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.472 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 0.74 5.22 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.657 2.238 . . . . 0.0 112.34 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 372' ' ' SER . . . . . . . . . . . . . 1.7 t 74.34 54.03 0.09 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.869 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 26.8 t -101.51 170.21 8.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.876 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.466 179.983 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.35 0 N-CA-C 112.509 -0.237 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 88.8 p -111.93 145.66 39.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.879 0.371 . . . . 0.0 110.884 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 23.2 t -50.43 -48.8 56.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.816 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 92.21 -98.82 2.47 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.512 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 71.7 m -63.32 90.09 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.877 0.37 . . . . 0.0 110.874 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 80.2 p -63.85 -49.36 73.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.912 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 109.96 -82.42 0.3 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.501 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . 0.496 ' CG2' ' O ' ' A' ' 369' ' ' SER . 12.2 t -78.32 127.53 32.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.891 0.377 . . . . 0.0 111.158 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 21.7 m -90.7 96.86 10.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.141 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 293' ' ' CYS . . . . . . . . . . . . . 29.3 p -145.9 167.16 23.95 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.878 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . 0.9 ' CB ' HG21 ' A' ' 346' ' ' VAL . 1.5 m-70 -126.93 105.1 8.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.884 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 36.6 m -132.06 142.42 49.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.171 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 296' ' ' VAL . . . . . . . . . . . . . 31.6 m -115.68 150.05 17.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.127 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . 0.58 ' C ' HD12 ' A' ' 298' ' ' LEU . 17.0 ttpt -120.59 138.11 54.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.875 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . 0.58 HD12 ' C ' ' A' ' 297' ' ' LYS . 6.1 mp -120.23 141.38 49.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.897 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 20.3 ptt180 -149.82 145.94 26.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.931 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 107.18 14.22 19.19 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.512 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -83.85 151.59 61.24 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.607 0.718 . . . . 0.0 111.088 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -165.97 0.17 Allowed 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.724 2.283 . . . . 0.0 112.365 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -90.35 -17.79 26.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.849 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -93.3 14.58 17.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.892 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 305' ' ' VAL . . . . . . . . . . . . . 11.8 p -78.84 138.55 19.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.108 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 306' ' ' THR . . . . . . . . . . . . . 39.0 p -145.35 177.45 8.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.128 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -49.42 -31.61 10.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.897 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 20.1 ttpt -67.78 -60.98 2.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.914 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -46.57 -38.62 9.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.866 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 53.6 t -69.47 -46.76 75.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.172 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 311' ' ' MET . . . . . 0.427 ' HG2' HD11 ' A' ' 322' ' ' ILE . 2.8 mmt -56.66 -49.65 74.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.908 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -66.52 -24.72 66.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.882 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -74.57 -38.75 62.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.91 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.474 ' CD1' HG11 ' A' ' 338' ' ' VAL . 27.1 mt -88.12 -24.37 23.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.882 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . 0.695 ' HB1' ' HA ' ' A' ' 316' ' ' PRO . . . -48.4 161.95 0.37 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.561 0.696 . . . . 0.0 111.15 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 316' ' ' PRO . . . . . 0.695 ' HA ' ' HB1' ' A' ' 315' ' ' ALA . 53.0 Cg_endo -69.83 -2.45 7.25 Favored 'Cis proline' 0 C--N 1.342 0.198 0 C-N-CA 122.621 -1.825 . . . . 0.0 112.299 0.054 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 317' ' ' LEU . . . . . 0.487 ' N ' ' HA ' ' A' ' 315' ' ' ALA . 24.7 mt -55.62 124.59 17.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.864 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -102.65 105.29 43.62 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.517 0.675 . . . . 0.0 110.895 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 -175.54 1.18 Allowed 'Trans proline' 0 N--CA 1.465 -0.155 0 C-N-CA 122.728 2.285 . . . . 0.0 112.36 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 97.7 t -100.03 -43.45 11.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.147 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -156.88 139.67 15.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.14 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 322' ' ' ILE . . . . . 0.427 HD11 ' HG2' ' A' ' 311' ' ' MET . 90.6 mt -108.39 108.49 25.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.084 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -103.12 98.08 8.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.878 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 71.9 mt -70.38 118.22 14.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.105 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . 0.504 ' CG2' ' CD2' ' A' ' 337' ' ' PHE . 35.2 t -81.8 120.09 32.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.125 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 87.9 mtt180 -99.39 37.95 1.49 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.853 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 327' ' ' ASN . . . . . 0.467 ' H ' HG12 ' A' ' 325' ' ' VAL . 49.3 t30 47.19 50.66 14.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.923 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . 43.67 37.69 1.66 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.085 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 14.3 m80 -159.79 174.66 14.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.881 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -80.81 53.12 4.54 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.522 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -144.05 111.84 6.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.87 0.367 . . . . 0.0 110.903 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -68.15 103.88 1.66 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.915 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 333' ' ' THR . . . . . 0.418 ' OG1' ' N ' ' A' ' 334' ' ' GLY . 2.8 t -103.99 175.97 5.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.174 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . 0.418 ' N ' ' OG1' ' A' ' 333' ' ' THR . . . -58.02 -39.54 92.11 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.502 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 335' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -44.7 118.5 1.61 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.895 0.379 . . . . 0.0 110.932 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 73.7 mt -143.72 124.44 9.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.126 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . 0.504 ' CD2' ' CG2' ' A' ' 325' ' ' VAL . 25.9 m-85 -100.24 126.82 46.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.907 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . 0.474 HG11 ' CD1' ' A' ' 314' ' ' LEU . 31.2 t -126.83 132.79 69.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.147 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -106.2 162.14 13.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.853 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -136.62 161.0 37.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.86 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 46.0 m -76.83 -61.02 2.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.825 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -92.3 157.98 16.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.872 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 343' ' ' GLU . . . . . 0.587 ' HB3' ' CE1' ' A' ' 294' ' ' HIS . 8.3 pt-20 -70.22 -41.8 73.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.852 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 344' ' ' GLU . . . . . 0.41 ' O ' ' C ' ' A' ' 345' ' ' GLU . 36.3 mm-40 -47.07 -61.01 2.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.917 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 344' ' ' GLU . 30.2 mt-10 -37.47 -44.44 0.65 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.878 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . 0.9 HG21 ' CB ' ' A' ' 294' ' ' HIS . 39.6 t -58.81 -54.11 38.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.133 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -49.78 -37.08 28.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.914 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -71.65 -46.23 59.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.902 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -46.1 -34.72 4.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.071 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 350' ' ' LEU . . . . . . . . . . . . . 65.5 mt -71.36 -41.01 70.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.935 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 27.5 mmtp -40.25 -52.41 2.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.879 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 352' ' ' CYS . . . . . . . . . . . . . 89.7 m -74.27 80.23 1.83 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.903 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -107.83 171.25 7.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.87 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 10.6 ptm180 41.99 50.43 4.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.907 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 355' ' ' GLU . . . . . 0.506 ' C ' ' CD1' ' A' ' 356' ' ' TYR . 9.8 mm-40 -98.08 174.38 6.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.916 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 356' ' ' TYR . . . . . 0.506 ' CD1' ' C ' ' A' ' 355' ' ' GLU . 1.0 OUTLIER -137.96 117.91 13.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.922 -179.862 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 357' ' ' MET . . . . . . . . . . . . . 4.4 ptt? -143.71 139.61 29.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.89 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 82.02 -33.76 2.63 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.5 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 129.14 15.89 2.01 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.499 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 360' ' ' ARG . . . . . . . . . . . . . 15.7 mmm180 -142.67 148.98 38.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.78 0.324 . . . . 0.0 110.889 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 361' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -61.0 152.7 27.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.961 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 362' ' ' ILE . . . . . . . . . . . . . 8.5 mm -135.55 145.26 31.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.17 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 363' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -135.7 119.18 16.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.893 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 4.1 t -91.68 128.57 43.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.106 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -125.9 139.38 53.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.861 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 15.9 ttt-85 -88.17 114.02 24.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.835 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 64.4 mm-40 -82.52 121.58 26.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.872 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 13.9 pttm -95.03 -41.6 9.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.874 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . 0.496 ' O ' ' CG2' ' A' ' 291' ' ' THR . 45.6 t -51.58 -49.41 62.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.871 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 104.18 -164.97 14.96 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.477 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 176.82 6.26 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.717 2.278 . . . . 0.0 112.375 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 372' ' ' SER . . . . . . . . . . . . . 1.4 t -134.45 85.55 2.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.848 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 40.0 m -110.54 133.96 52.82 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.86 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.521 179.997 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.274 0 N-CA-C 112.482 -0.247 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 63.6 m -51.4 149.7 4.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.87 0.367 . . . . 0.0 110.895 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 11.3 t -114.07 -45.55 3.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.848 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 106.76 98.55 2.57 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.508 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 27.6 t -119.59 105.56 11.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.874 0.368 . . . . 0.0 110.859 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 67.3 m -129.69 116.69 19.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.854 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . -165.84 -45.84 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.463 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 40.2 p -155.25 138.01 15.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.896 0.379 . . . . 0.0 111.145 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 10.1 m -126.28 88.66 2.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.154 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 293' ' ' CYS . . . . . . . . . . . . . 27.0 p -105.9 169.66 8.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.856 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . 0.948 ' CB ' HG21 ' A' ' 346' ' ' VAL . 12.3 m-70 -80.35 120.41 24.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.824 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 96.5 m -139.38 147.19 41.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.098 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 296' ' ' VAL . . . . . 0.428 HG13 HG13 ' A' ' 346' ' ' VAL . 29.9 m -127.59 146.81 32.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.176 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . 0.567 ' HD3' ' CE1' ' A' ' 337' ' ' PHE . 30.6 ttpt -117.02 145.99 43.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.936 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 6.4 mp -117.17 129.08 55.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.897 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 6.4 ttt85 -129.13 150.09 50.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.876 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 91.06 36.83 6.51 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.494 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -109.84 152.36 42.91 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.519 0.676 . . . . 0.0 111.105 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 -178.51 2.38 Favored 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.692 2.261 . . . . 0.0 112.316 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -89.51 -4.21 58.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.901 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -100.34 3.28 43.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.907 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 305' ' ' VAL . . . . . . . . . . . . . 4.1 p -65.11 153.13 8.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.088 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 306' ' ' THR . . . . . 0.439 ' OG1' ' N ' ' A' ' 307' ' ' GLU . 0.0 OUTLIER -149.12 170.84 17.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.104 -179.93 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 307' ' ' GLU . . . . . 0.439 ' N ' ' OG1' ' A' ' 306' ' ' THR . 30.7 mt-10 -54.71 -24.38 21.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.864 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 21.4 tttm -74.78 -51.44 14.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.881 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -54.23 -32.84 56.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.881 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 310' ' ' VAL . . . . . 0.51 ' HB ' HD13 ' A' ' 322' ' ' ILE . 30.0 t -70.81 -45.83 71.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.126 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 311' ' ' MET . . . . . . . . . . . . . 4.1 mmt -57.58 -53.13 61.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.919 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -63.41 -24.39 67.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.901 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 313' ' ' PHE . . . . . 0.812 ' CZ ' HG21 ' A' ' 362' ' ' ILE . 31.2 t80 -77.6 -49.75 13.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.879 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.579 ' CD1' HG11 ' A' ' 338' ' ' VAL . 74.2 mt -74.44 -22.65 59.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.913 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . 0.737 ' HB1' ' HA ' ' A' ' 316' ' ' PRO . . . -46.22 163.33 0.23 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.551 0.691 . . . . 0.0 111.149 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 316' ' ' PRO . . . . . 0.737 ' HA ' ' HB1' ' A' ' 315' ' ' ALA . 53.5 Cg_endo -69.79 -6.55 9.54 Favored 'Cis proline' 0 C--O 1.232 0.195 0 C-N-CA 122.68 -1.8 . . . . 0.0 112.316 0.027 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 317' ' ' LEU . . . . . 0.419 ' N ' ' HA ' ' A' ' 315' ' ' ALA . 81.6 mt -52.66 135.6 34.52 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.875 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 14.6 tptm -113.96 103.39 55.22 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.539 0.685 . . . . 0.0 110.892 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -169.9 0.36 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.636 2.224 . . . . 0.0 112.361 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 47.2 t -103.34 -46.24 10.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.093 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -156.06 138.28 14.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.062 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 322' ' ' ILE . . . . . 0.51 HD13 ' HB ' ' A' ' 310' ' ' VAL . 66.2 mt -114.21 122.86 69.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.135 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 65.9 mmt-85 -118.05 107.78 14.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.832 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . 0.577 HG23 HG12 ' A' ' 336' ' ' ILE . 52.3 mt -77.56 119.97 27.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.133 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 18.8 t -80.72 113.09 19.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.132 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 -85.7 163.38 18.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.907 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -76.32 159.73 30.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.894 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -52.46 -54.59 30.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.105 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -52.51 -43.63 65.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.827 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . 0.445 ' O ' ' C ' ' A' ' 331' ' ' ASN . . . 141.53 -46.23 0.91 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.513 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 331' ' ' ASN . . . . . 0.445 ' C ' ' O ' ' A' ' 330' ' ' GLY . 95.6 m-20 -34.77 132.38 0.32 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.924 0.392 . . . . 0.0 110.908 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 11.7 tttp -66.8 83.83 0.11 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.88 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 10.0 t -158.72 132.5 7.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.143 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 155.44 -138.97 6.33 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.491 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 335' ' ' TYR . . . . . 0.415 ' C ' HG13 ' A' ' 336' ' ' ILE . 6.9 m-85 -101.28 175.84 5.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.828 0.347 . . . . 0.0 110.947 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 336' ' ' ILE . . . . . 0.577 HG12 HG23 ' A' ' 324' ' ' ILE . 54.2 mt -144.49 123.75 6.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.141 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . 0.567 ' CE1' ' HD3' ' A' ' 297' ' ' LYS . 62.1 m-85 -93.65 135.99 34.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.863 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . 0.579 HG11 ' CD1' ' A' ' 314' ' ' LEU . 41.5 t -134.96 122.92 39.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.14 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -98.24 160.52 14.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.853 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -139.79 162.92 33.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.912 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 2.8 m -98.88 -42.3 7.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.851 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 342' ' ' ASN . . . . . 0.408 ' O ' ' C ' ' A' ' 343' ' ' GLU . 19.5 m-80 -99.56 111.08 23.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.86 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 343' ' ' GLU . . . . . 0.545 ' CG ' ' CE1' ' A' ' 294' ' ' HIS . 0.5 OUTLIER -37.37 -60.61 0.66 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.85 -179.97 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 344' ' ' GLU . . . . . 0.454 ' C ' ' O ' ' A' ' 343' ' ' GLU . 13.1 tt0 -34.3 -51.37 0.45 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.873 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -47.48 -45.56 26.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.892 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . 0.948 HG21 ' CB ' ' A' ' 294' ' ' HIS . 23.7 t -57.49 -51.67 66.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.14 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 49.3 mtpt -54.46 -43.14 71.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.896 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 60.0 mm-40 -65.29 -39.18 92.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.943 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -48.02 -40.87 24.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.072 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 350' ' ' LEU . . . . . 0.53 HD11 ' HE ' ' A' ' 366' ' ' ARG . 39.7 mt -65.0 -40.91 95.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.913 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 34.2 mmtm -46.18 -46.22 17.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.916 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 352' ' ' CYS . . . . . . . . . . . . . 58.0 m -69.76 69.42 0.29 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.893 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 14.6 p30 -109.83 171.84 7.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.851 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? 55.75 33.22 20.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.851 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 355' ' ' GLU . . . . . 0.47 ' C ' ' CD1' ' A' ' 356' ' ' TYR . 2.5 mm-40 -97.09 173.68 7.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.903 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 356' ' ' TYR . . . . . 0.521 ' N ' ' CD1' ' A' ' 356' ' ' TYR . 0.9 OUTLIER -138.65 130.29 27.65 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.953 -179.877 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 357' ' ' MET . . . . . 0.608 ' HG2' HD11 ' A' ' 362' ' ' ILE . 5.8 ptt? -152.16 120.13 6.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.865 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 92.56 -23.29 28.75 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.522 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 125.96 -5.52 7.86 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.446 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 360' ' ' ARG . . . . . . . . . . . . . 15.4 mmm180 -119.34 158.52 25.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.873 0.368 . . . . 0.0 110.864 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 361' ' ' TYR . . . . . 0.547 ' CG ' ' O ' ' A' ' 361' ' ' TYR . 3.0 p90 -77.2 117.48 18.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.951 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 362' ' ' ILE . . . . . 0.812 HG21 ' CZ ' ' A' ' 313' ' ' PHE . 45.9 mm -83.23 117.01 28.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.112 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 363' ' ' GLU . . . . . 0.588 ' HG3' ' CZ ' ' A' ' 365' ' ' PHE . 4.2 tp10 -111.23 112.06 23.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.919 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 7.0 t -87.16 144.72 8.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.131 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 365' ' ' PHE . . . . . 0.588 ' CZ ' ' HG3' ' A' ' 363' ' ' GLU . 58.0 m-85 -140.85 133.24 28.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.916 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . 0.53 ' HE ' HD11 ' A' ' 350' ' ' LEU . 6.0 ttm180 -84.73 115.51 22.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.907 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -104.19 46.79 0.9 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.877 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -39.33 -44.07 1.25 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.904 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . 0.444 ' O ' ' C ' ' A' ' 370' ' ' GLY . 95.6 p -79.48 -37.02 37.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.885 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . 0.444 ' C ' ' O ' ' A' ' 369' ' ' SER . . . -32.84 96.31 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.465 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 371' ' ' PRO . . . . . 0.419 ' N ' ' O ' ' A' ' 369' ' ' SER . 54.1 Cg_endo -69.74 -0.7 7.27 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.71 2.273 . . . . 0.0 112.388 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 372' ' ' SER . . . . . . . . . . . . . 7.6 t -47.67 118.87 2.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.888 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 8.2 t -136.21 125.46 24.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.873 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.521 179.977 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.288 0 N-CA-C 112.466 -0.254 . . . . 0.0 112.466 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 44.3 m -81.04 106.04 12.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.9 0.381 . . . . 0.0 110.847 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 21.1 m -126.79 169.72 12.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.902 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -69.26 165.19 49.7 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.495 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 44.0 t -143.01 156.12 44.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.876 0.369 . . . . 0.0 110.86 -179.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 2.9 t -156.98 154.58 29.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.871 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . -173.67 -69.03 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.489 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 72.0 p -123.66 107.74 11.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.876 0.369 . . . . 0.0 111.151 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 292' ' ' THR . . . . . 0.439 HG23 ' O ' ' A' ' 292' ' ' THR . 14.8 t -104.61 39.77 1.62 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.142 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 293' ' ' CYS . . . . . . . . . . . . . 15.0 m -52.05 120.84 5.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.875 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . 0.838 ' HB3' HG21 ' A' ' 346' ' ' VAL . 34.2 m80 -82.82 90.92 6.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.879 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 19.5 m -131.01 132.14 44.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.129 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 296' ' ' VAL . . . . . 0.472 ' CG1' HG13 ' A' ' 346' ' ' VAL . 34.9 m -104.01 154.72 5.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.133 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . 0.571 ' HE2' ' CZ ' ' A' ' 337' ' ' PHE . 2.1 tppp? -113.26 142.34 45.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.94 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 6.9 mp -128.69 119.78 25.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.906 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 19.2 ptt85 -127.68 165.65 19.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.868 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 94.36 -24.08 29.0 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.497 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -57.36 151.78 36.13 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.558 0.694 . . . . 0.0 111.103 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 163.11 39.49 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.703 2.269 . . . . 0.0 112.37 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 303' ' ' PHE . . . . . 0.557 ' C ' ' CD1' ' A' ' 303' ' ' PHE . 0.5 OUTLIER -69.05 -24.52 64.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.877 -179.979 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -93.58 36.72 1.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.916 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 305' ' ' VAL . . . . . . . . . . . . . 9.9 p -94.8 146.15 7.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.16 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 306' ' ' THR . . . . . . . . . . . . . 7.1 p -128.27 159.87 33.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.159 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -43.17 -43.45 4.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.885 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 56.1 tttt -52.89 -61.79 2.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.885 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -41.48 -46.81 3.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.864 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 92.4 t -60.2 -55.9 21.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.142 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 311' ' ' MET . . . . . . . . . . . . . 3.6 mmt -43.14 -45.55 5.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.885 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -62.33 -41.66 98.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.855 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -67.05 -44.24 80.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.833 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.637 HD13 HG11 ' A' ' 338' ' ' VAL . 94.3 mt -75.99 -25.7 56.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.914 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . 0.594 ' HB1' ' HA ' ' A' ' 316' ' ' PRO . . . -50.65 158.48 1.08 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.613 0.72 . . . . 0.0 111.076 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 316' ' ' PRO . . . . . 0.594 ' HA ' ' HB1' ' A' ' 315' ' ' ALA . 54.2 Cg_endo -69.72 -19.55 11.14 Favored 'Cis proline' 0 C--N 1.342 0.185 0 C-N-CA 122.702 -1.791 . . . . 0.0 112.362 -0.031 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 317' ' ' LEU . . . . . 0.591 HD21 ' OE1' ' A' ' 348' ' ' GLN . 60.3 mt -38.33 125.34 1.31 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.915 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 318' ' ' LYS . . . . . 0.446 ' CE ' ' HA ' ' A' ' 318' ' ' LYS . 0.6 OUTLIER -105.44 103.37 42.53 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.625 0.726 . . . . 0.0 110.905 179.83 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.81 -172.07 0.54 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.698 2.265 . . . . 0.0 112.301 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 79.6 t -103.45 -44.52 9.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.149 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -157.6 134.45 10.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.079 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 322' ' ' ILE . . . . . 0.477 HG23 HG22 ' A' ' 338' ' ' VAL . 64.5 mt -105.99 105.09 18.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.111 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 73.9 mtt-85 -108.69 107.98 18.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.849 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . 0.599 HG23 HG12 ' A' ' 336' ' ' ILE . 59.9 mt -72.22 128.02 34.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.125 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . 0.556 ' CG2' ' CD2' ' A' ' 337' ' ' PHE . 66.8 t -74.03 128.41 36.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.143 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 62.7 mtm-85 -96.03 -177.81 4.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.905 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -109.88 -58.71 2.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.936 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -131.79 -69.23 0.61 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.119 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 8.3 m-70 -112.81 -28.3 7.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.892 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 168.85 41.9 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.507 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 331' ' ' ASN . . . . . 0.472 ' O ' HG23 ' A' ' 333' ' ' THR . 34.5 m-20 -105.92 79.71 1.45 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.901 0.382 . . . . 0.0 110.899 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 332' ' ' LYS . . . . . 0.532 ' HG3' HG21 ' A' ' 324' ' ' ILE . 0.6 OUTLIER -47.3 124.67 6.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.903 179.921 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 333' ' ' THR . . . . . 0.472 HG23 ' O ' ' A' ' 331' ' ' ASN . 27.6 p -125.29 76.62 1.56 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.141 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . 0.516 ' O ' ' CG ' ' A' ' 335' ' ' TYR . . . 33.92 69.74 0.16 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.461 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 335' ' ' TYR . . . . . 0.516 ' CG ' ' O ' ' A' ' 334' ' ' GLY . 13.7 m-85 -167.39 112.88 0.73 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.891 0.377 . . . . 0.0 110.882 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 336' ' ' ILE . . . . . 0.599 HG12 HG23 ' A' ' 324' ' ' ILE . 42.6 mt -134.39 130.16 53.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.134 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . 0.571 ' CZ ' ' HE2' ' A' ' 297' ' ' LYS . 7.2 m-85 -98.15 127.86 44.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.9 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . 0.637 HG11 HD13 ' A' ' 314' ' ' LEU . 75.0 t -127.38 120.65 55.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.129 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -95.86 156.01 16.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.876 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -134.42 165.42 25.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.921 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 2.0 m -93.98 -53.34 4.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.858 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 35.8 m-20 -95.16 128.49 42.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.87 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -49.45 -43.46 44.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.903 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -45.5 -55.82 5.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.858 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . 0.5 ' HA ' HD22 ' A' ' 317' ' ' LEU . 62.1 mt-10 -43.76 -53.68 5.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.876 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . 0.838 HG21 ' HB3' ' A' ' 294' ' ' HIS . 66.7 t -54.55 -50.5 58.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.17 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -54.34 -33.67 59.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.895 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 348' ' ' GLN . . . . . 0.591 ' OE1' HD21 ' A' ' 317' ' ' LEU . 68.2 mt-30 -78.45 -36.63 45.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.894 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -47.1 -38.67 11.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.054 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 350' ' ' LEU . . . . . 0.532 HD11 ' HG3' ' A' ' 366' ' ' ARG . 49.5 mt -63.35 -39.43 94.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.898 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 18.9 mmtm -47.31 -45.4 24.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.886 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 352' ' ' CYS . . . . . . . . . . . . . 4.1 m -75.21 64.94 1.5 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.915 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -108.71 160.83 15.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.871 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 25.0 ttp180 63.09 34.72 13.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.865 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 355' ' ' GLU . . . . . 0.455 ' C ' ' CD1' ' A' ' 356' ' ' TYR . 3.9 mm-40 -94.82 172.78 7.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.886 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 356' ' ' TYR . . . . . 0.473 ' N ' ' CD1' ' A' ' 356' ' ' TYR . 1.3 m-85 -135.68 120.05 17.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.912 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 357' ' ' MET . . . . . . . . . . . . . 3.3 ptt? -145.45 143.9 30.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.857 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 75.98 -9.96 16.25 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.492 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 106.4 18.33 11.21 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.483 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 360' ' ' ARG . . . . . . . . . . . . . 20.2 mmt180 -145.46 178.11 8.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.836 0.35 . . . . 0.0 110.862 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 361' ' ' TYR . . . . . . . . . . . . . 18.9 p90 -90.67 163.83 14.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.932 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 362' ' ' ILE . . . . . 0.417 HG22 ' N ' ' A' ' 363' ' ' GLU . 8.0 mm -141.6 155.34 20.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.112 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 363' ' ' GLU . . . . . 0.549 ' HB3' ' CZ ' ' A' ' 365' ' ' PHE . 13.8 mt-10 -147.47 119.45 8.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.851 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 20.0 t -89.01 140.06 16.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.139 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 365' ' ' PHE . . . . . 0.549 ' CZ ' ' HB3' ' A' ' 363' ' ' GLU . 16.8 m-85 -140.92 128.3 21.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.889 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . 0.532 ' HG3' HD11 ' A' ' 350' ' ' LEU . 36.4 mtp180 -73.21 143.0 47.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.865 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -130.6 78.09 1.82 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.939 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -55.36 -46.0 76.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.936 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 39.8 m -72.38 -51.42 20.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.874 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 67.55 87.8 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.512 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -4.96 15.07 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.71 2.273 . . . . 0.0 112.306 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 372' ' ' SER . . . . . 0.551 ' OG ' ' CE2' ' A' ' 337' ' ' PHE . 3.3 m -76.48 106.04 7.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.888 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 53.3 p -55.97 121.48 9.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.866 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.519 179.994 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.268 0 N-CA-C 112.452 -0.259 . . . . 0.0 112.452 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 71.0 p -130.2 104.16 7.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.901 0.381 . . . . 0.0 110.872 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 82.9 p -112.09 135.72 52.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.87 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 168.89 -58.23 0.2 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.447 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 72.4 p 41.14 41.87 1.48 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.873 0.368 . . . . 0.0 110.87 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 83.9 p -158.9 119.92 3.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.857 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . -148.75 -120.84 1.11 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.492 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 74.0 p -121.66 128.85 52.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.848 0.356 . . . . 0.0 111.11 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 18.4 p 39.63 47.01 1.61 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.149 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 293' ' ' CYS . . . . . . . . . . . . . 68.8 m -50.43 130.21 23.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.879 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . 0.777 ' CB ' HG21 ' A' ' 346' ' ' VAL . 6.1 m80 -85.16 123.06 30.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.889 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 95.4 m -138.44 137.29 37.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.146 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 296' ' ' VAL . . . . . 0.434 ' CG2' ' HB ' ' A' ' 338' ' ' VAL . 35.9 m -110.69 152.24 12.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.158 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . 0.539 ' HG3' ' CE1' ' A' ' 337' ' ' PHE . 0.2 OUTLIER -118.08 136.01 53.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.848 179.992 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . 0.438 HD21 ' CE2' ' A' ' 313' ' ' PHE . 6.7 mp -113.98 142.28 46.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.89 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 299' ' ' ARG . . . . . 0.535 ' HD3' ' CE2' ' A' ' 335' ' ' TYR . 25.1 tpt85 -148.79 134.14 18.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.868 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 126.07 -23.88 5.77 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.446 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -56.62 147.55 50.46 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.568 0.699 . . . . 0.0 111.105 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 -172.45 0.57 Allowed 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.673 2.249 . . . . 0.0 112.325 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 303' ' ' PHE . . . . . 0.429 ' O ' ' CG ' ' A' ' 303' ' ' PHE . 73.1 t80 -89.56 -3.41 58.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.895 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 36.3 t30 -110.41 29.34 7.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.871 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 305' ' ' VAL . . . . . . . . . . . . . 9.1 p -97.04 148.91 5.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.12 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 306' ' ' THR . . . . . . . . . . . . . 23.5 p -134.89 161.23 35.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.129 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -39.77 -49.28 2.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.868 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 33.1 ttmt -46.84 -58.87 3.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.92 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 32.7 m120 -45.17 -45.17 11.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.899 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 61.6 t -57.81 -43.6 84.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.149 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 311' ' ' MET . . . . . 0.405 ' HG2' HD11 ' A' ' 322' ' ' ILE . 3.3 mmt -59.28 -50.49 73.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.869 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -64.28 -29.74 70.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.917 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 313' ' ' PHE . . . . . 0.438 ' CE2' HD21 ' A' ' 298' ' ' LEU . 4.4 t80 -72.27 -31.78 66.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.893 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.482 HD13 ' HZ ' ' A' ' 340' ' ' PHE . 92.1 mt -90.93 -22.95 20.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.906 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . 0.614 ' HB1' ' HA ' ' A' ' 316' ' ' PRO . . . -44.06 159.32 0.24 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.557 0.694 . . . . 0.0 111.127 179.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 316' ' ' PRO . . . . . 0.614 ' HA ' ' HB1' ' A' ' 315' ' ' ALA . 53.6 Cg_endo -69.73 -8.98 10.73 Favored 'Cis proline' 0 C--N 1.341 0.183 0 C-N-CA 122.662 -1.807 . . . . 0.0 112.357 -0.034 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 317' ' ' LEU . . . . . 0.521 HD21 ' OE1' ' A' ' 348' ' ' GLN . 26.4 mt -46.72 161.15 0.07 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.899 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 29.2 tttm -143.79 105.0 4.91 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.563 0.697 . . . . 0.0 110.884 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 319' ' ' PRO . . . . . 0.425 ' HA ' ' CD2' ' A' ' 340' ' ' PHE . 53.8 Cg_endo -69.71 -173.6 0.74 Allowed 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.706 2.271 . . . . 0.0 112.36 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 93.7 t -103.18 -41.11 7.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.136 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -157.47 139.08 13.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.109 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 322' ' ' ILE . . . . . 0.405 HD11 ' HG2' ' A' ' 311' ' ' MET . 92.0 mt -106.79 106.77 21.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.151 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 45.2 mtt180 -102.47 105.29 15.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.884 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 55.8 mt -73.93 119.85 21.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.122 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . 0.482 HG22 ' CD2' ' A' ' 337' ' ' PHE . 94.4 t -57.6 123.94 10.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.13 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 49.3 mtt180 -83.63 178.77 7.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.848 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -133.04 -64.94 0.72 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.854 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -113.22 -63.44 1.45 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.114 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 7.1 m-70 -111.35 -72.47 0.72 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.865 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -170.48 32.11 0.15 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.52 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 331' ' ' ASN . . . . . 0.564 ' O ' HG22 ' A' ' 333' ' ' THR . 1.4 p-10 -89.55 136.37 33.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.925 0.393 . . . . 0.0 110.883 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 2.7 tmtt? -59.93 105.17 0.36 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.932 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 333' ' ' THR . . . . . 0.564 HG22 ' O ' ' A' ' 331' ' ' ASN . 4.0 t -173.47 132.15 0.46 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.15 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 118.49 -110.92 2.03 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.494 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 335' ' ' TYR . . . . . 0.535 ' CE2' ' HD3' ' A' ' 299' ' ' ARG . 2.8 m-85 -124.41 -177.93 3.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.855 0.36 . . . . 0.0 110.919 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 72.8 mt -142.45 114.34 3.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.123 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . 0.539 ' CE1' ' HG3' ' A' ' 297' ' ' LYS . 15.6 m-85 -88.5 135.35 33.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.918 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . 0.434 ' HB ' ' CG2' ' A' ' 296' ' ' VAL . 63.3 t -132.5 129.91 59.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.11 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -103.18 161.8 13.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.886 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 340' ' ' PHE . . . . . 0.482 ' HZ ' HD13 ' A' ' 314' ' ' LEU . 55.6 m-85 -139.57 166.53 24.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.868 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 32.2 m -82.59 -62.06 1.71 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.874 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 21.1 m-80 -91.87 158.01 16.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.893 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 343' ' ' GLU . . . . . 0.483 ' HB3' ' CE1' ' A' ' 294' ' ' HIS . 1.7 pp20? -73.92 -28.56 61.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.85 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 45.7 mm-40 -59.3 -53.05 62.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.91 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -46.27 -51.74 13.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.907 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . 0.777 HG21 ' CB ' ' A' ' 294' ' ' HIS . 21.2 t -49.96 -50.64 18.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.146 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 6.2 mtpm? -51.61 -48.76 63.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.875 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 348' ' ' GLN . . . . . 0.521 ' OE1' HD21 ' A' ' 317' ' ' LEU . 75.4 mt-30 -62.38 -26.13 68.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.914 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 349' ' ' ALA . . . . . 0.511 ' HB3' ' O ' ' A' ' 346' ' ' VAL . . . -63.23 -35.92 81.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.101 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 350' ' ' LEU . . . . . 0.455 HD21 ' HB2' ' A' ' 366' ' ' ARG . 57.6 mt -63.74 -40.94 97.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.978 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 5.4 mtmp? -46.63 -51.15 16.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.934 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 352' ' ' CYS . . . . . . . . . . . . . 4.2 m -69.36 85.19 0.4 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.897 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . 0.452 ' O ' ' C ' ' A' ' 354' ' ' ARG . 1.1 p30 -124.91 -176.37 3.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.91 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . 0.482 ' CD ' ' O ' ' A' ' 354' ' ' ARG . 0.0 OUTLIER 32.44 38.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.883 -179.925 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 355' ' ' GLU . . . . . 0.469 ' C ' ' CD1' ' A' ' 356' ' ' TYR . 57.1 mm-40 -86.95 176.16 7.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.87 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 356' ' ' TYR . . . . . 0.469 ' CD1' ' C ' ' A' ' 355' ' ' GLU . 1.2 m-85 -135.31 107.95 7.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.964 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 357' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -138.38 145.83 41.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.918 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 72.89 -6.13 14.48 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.494 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 102.96 21.91 9.78 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.479 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 360' ' ' ARG . . . . . . . . . . . . . 14.2 mmt180 -148.71 175.7 10.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.807 0.337 . . . . 0.0 110.9 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 361' ' ' TYR . . . . . 0.73 ' O ' HD13 ' A' ' 362' ' ' ILE . 10.8 p90 -82.59 172.21 13.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.924 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 362' ' ' ILE . . . . . 0.73 HD13 ' O ' ' A' ' 361' ' ' TYR . 25.7 mm -142.27 155.53 18.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.11 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 363' ' ' GLU . . . . . 0.553 ' HB3' ' CZ ' ' A' ' 365' ' ' PHE . 7.0 mm-40 -147.87 112.92 5.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.888 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 17.2 t -91.46 143.53 11.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.078 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 365' ' ' PHE . . . . . 0.553 ' CZ ' ' HB3' ' A' ' 363' ' ' GLU . 32.0 m-85 -143.09 122.38 13.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.898 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . 0.455 ' HB2' HD21 ' A' ' 350' ' ' LEU . 35.2 ttp85 -75.84 112.69 12.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.847 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -85.64 98.24 10.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.854 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . 0.412 ' HD3' ' C ' ' A' ' 368' ' ' LYS . 0.0 OUTLIER -70.03 -32.66 70.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.928 179.936 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 7.8 t -75.33 -51.4 13.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.873 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 76.85 -156.33 45.84 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.477 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 175.02 8.69 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.667 2.245 . . . . 0.0 112.369 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 372' ' ' SER . . . . . . . . . . . . . 4.4 m -43.14 122.18 2.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.829 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 3.6 m -84.23 42.0 0.86 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.915 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.494 -179.961 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . 0.442 ' O ' ' C ' ' A' ' 285' ' ' SER . . . . . . . . 0 N--CA 1.451 -0.321 0 N-CA-C 112.506 -0.238 . . . . 0.0 112.506 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 285' ' ' SER . . . . . 0.442 ' C ' ' O ' ' A' ' 284' ' ' GLY . 3.9 m 34.89 51.16 0.5 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.873 0.368 . . . . 0.0 110.888 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 21.5 t -66.03 -67.27 0.46 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.833 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 156.14 106.91 0.26 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.456 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 66.7 p -119.73 120.07 35.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.897 0.38 . . . . 0.0 110.89 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 10.2 m -131.99 100.14 4.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.832 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 104.61 112.47 3.71 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.474 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 31.1 p -100.37 143.92 29.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.889 0.376 . . . . 0.0 111.153 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 7.2 t -125.06 -39.09 2.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.17 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 293' ' ' CYS . . . . . . . . . . . . . 91.9 m -122.52 165.84 15.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.88 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . 0.584 ' CB ' HG21 ' A' ' 346' ' ' VAL . 3.0 m-70 -126.82 104.3 7.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.869 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 87.4 m -126.34 144.57 50.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.106 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 296' ' ' VAL . . . . . 0.763 ' CG1' HG13 ' A' ' 346' ' ' VAL . 19.6 m -121.72 157.65 25.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.136 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 8.8 ttpp -128.43 142.34 51.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.873 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . 0.491 HD21 ' CE1' ' A' ' 313' ' ' PHE . 7.6 mp -114.93 149.83 36.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.89 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 7.7 ttt180 -150.41 140.2 21.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.893 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . 0.685 ' O ' HD13 ' A' ' 362' ' ' ILE . . . 103.43 44.94 1.62 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.474 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -113.84 151.42 44.71 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.597 0.713 . . . . 0.0 111.091 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -171.95 0.53 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.637 2.225 . . . . 0.0 112.319 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -87.55 -7.69 57.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.897 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 33.0 m120 -108.97 32.01 5.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.88 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 305' ' ' VAL . . . . . . . . . . . . . 4.5 p -96.2 139.89 18.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.139 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 306' ' ' THR . . . . . . . . . . . . . 67.7 p -142.97 170.63 15.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.146 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -46.68 -35.35 5.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.883 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 11.4 tmtt? -59.7 -50.32 74.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.884 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 34.8 m120 -55.09 -48.89 72.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.944 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 76.6 t -58.17 -55.31 22.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.14 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 311' ' ' MET . . . . . . . . . . . . . 2.3 mmt -46.35 -44.47 16.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.889 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -73.99 -26.28 60.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.875 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 313' ' ' PHE . . . . . 0.591 ' CD2' ' SD ' ' A' ' 357' ' ' MET . 1.9 t80 -78.37 -30.9 48.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.822 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.463 ' CD1' HG11 ' A' ' 338' ' ' VAL . 93.9 mt -91.5 -24.53 19.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.952 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . 0.756 ' HB1' ' HA ' ' A' ' 316' ' ' PRO . . . -48.68 163.87 0.3 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.592 0.711 . . . . 0.0 111.098 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 316' ' ' PRO . . . . . 0.756 ' HA ' ' HB1' ' A' ' 315' ' ' ALA . 53.7 Cg_endo -69.72 -3.2 7.5 Favored 'Cis proline' 0 C--O 1.231 0.165 0 C-N-CA 122.713 -1.786 . . . . 0.0 112.341 -0.026 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 317' ' ' LEU . . . . . 0.485 ' N ' ' HA ' ' A' ' 315' ' ' ALA . 13.5 mt -55.63 142.95 31.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.93 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -120.52 106.31 40.21 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.588 0.708 . . . . 0.0 110.883 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 -164.54 0.13 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.72 2.28 . . . . 0.0 112.369 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 24.5 t -113.62 -45.04 4.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.104 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -153.59 128.94 9.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.09 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 322' ' ' ILE . . . . . 0.583 HG23 HG22 ' A' ' 338' ' ' VAL . 49.3 mt -107.67 99.86 9.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.144 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -100.19 104.73 16.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.875 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . 0.51 HG12 HG23 ' A' ' 336' ' ' ILE . 58.4 mt -73.73 118.34 19.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.104 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . 0.441 HG22 ' CE2' ' A' ' 337' ' ' PHE . 84.5 t -52.64 107.68 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.109 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 7.2 ptp180 -96.61 166.19 11.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.883 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -116.79 -175.77 2.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.891 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -46.29 -43.44 15.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.116 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 34.5 m80 -110.83 39.0 2.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.868 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 48.24 51.41 20.62 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.46 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 22.7 m-20 -107.11 106.21 16.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.856 0.36 . . . . 0.0 110.865 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 332' ' ' LYS . . . . . . . . . . . . . 55.4 mttp -57.41 123.91 17.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.918 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 333' ' ' THR . . . . . 0.519 ' O ' ' CD2' ' A' ' 335' ' ' TYR . 64.5 p -118.69 72.52 0.88 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.113 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . 0.463 ' O ' ' CD1' ' A' ' 335' ' ' TYR . . . 34.52 53.12 0.78 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.466 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 335' ' ' TYR . . . . . 0.519 ' CD2' ' O ' ' A' ' 333' ' ' THR . 19.2 m-85 -152.34 120.69 6.34 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.915 0.388 . . . . 0.0 110.928 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 336' ' ' ILE . . . . . 0.51 HG23 HG12 ' A' ' 324' ' ' ILE . 42.6 mt -139.93 132.02 33.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.137 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . 0.441 ' CE2' HG22 ' A' ' 325' ' ' VAL . 22.7 m-85 -99.52 142.78 30.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.849 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . 0.583 HG22 HG23 ' A' ' 322' ' ' ILE . 27.6 t -146.33 131.53 12.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.181 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -103.22 168.09 9.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.856 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 340' ' ' PHE . . . . . 0.477 ' HB2' ' CG2' ' A' ' 346' ' ' VAL . 65.6 m-85 -148.22 157.56 43.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.852 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 13.1 t -70.16 -64.6 0.86 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.856 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -99.39 177.43 5.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.863 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 343' ' ' GLU . . . . . 0.583 ' HB3' ' CE1' ' A' ' 294' ' ' HIS . 20.1 pt-20 -78.22 -45.84 21.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.868 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 344' ' ' GLU . . . . . 0.403 ' N ' ' HG3' ' A' ' 343' ' ' GLU . 19.0 mt-10 -42.26 -60.03 1.61 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.892 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -45.3 -32.45 1.99 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.873 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . 0.763 HG13 ' CG1' ' A' ' 296' ' ' VAL . 74.9 t -82.6 -36.75 13.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.114 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -64.22 -35.43 80.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.915 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 45.9 mm-40 -76.03 -40.01 54.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.92 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -51.82 -33.53 36.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.141 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 350' ' ' LEU . . . . . 0.61 HD23 HG12 ' A' ' 364' ' ' VAL . 96.8 mt -72.48 -40.15 67.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.935 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 46.7 mttm -46.27 -40.69 11.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.885 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 352' ' ' CYS . . . . . . . . . . . . . 33.1 m -78.77 80.45 5.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.915 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . 0.438 ' O ' ' C ' ' A' ' 354' ' ' ARG . 31.5 p-10 -109.28 178.56 4.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.86 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . 0.438 ' C ' ' O ' ' A' ' 353' ' ' ASN . 20.7 ptt180 35.42 42.86 0.13 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.922 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 355' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -89.45 173.9 8.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.85 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 356' ' ' TYR . . . . . 0.497 ' N ' ' CD1' ' A' ' 356' ' ' TYR . 1.1 m-85 -128.13 115.56 18.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.952 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 357' ' ' MET . . . . . 0.591 ' SD ' ' CD2' ' A' ' 313' ' ' PHE . 4.6 ptt? -145.81 127.52 15.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.866 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 81.36 -17.94 12.11 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.526 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 113.25 19.03 6.89 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.467 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 360' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -143.87 134.71 25.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.812 0.339 . . . . 0.0 110.9 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 361' ' ' TYR . . . . . 0.557 ' O ' ' CD1' ' A' ' 361' ' ' TYR . 12.6 p90 -56.27 127.23 29.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.897 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 362' ' ' ILE . . . . . 0.685 HD13 ' O ' ' A' ' 300' ' ' GLY . 4.2 mm -106.31 151.57 8.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.163 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 363' ' ' GLU . . . . . 0.421 ' HB3' ' CZ ' ' A' ' 365' ' ' PHE . 28.1 mm-40 -143.4 116.93 9.14 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.846 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 364' ' ' VAL . . . . . 0.61 HG12 HD23 ' A' ' 350' ' ' LEU . 21.7 t -88.82 142.53 12.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.15 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 365' ' ' PHE . . . . . 0.442 ' CD1' ' O ' ' A' ' 364' ' ' VAL . 10.3 m-85 -139.93 146.87 39.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.909 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . 0.506 ' HB2' HD11 ' A' ' 350' ' ' LEU . 0.0 OUTLIER -86.68 109.36 19.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.878 -179.896 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -87.8 79.92 8.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.888 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . 0.435 ' HG2' ' N ' ' A' ' 369' ' ' SER . 0.0 OUTLIER -42.16 -28.98 0.21 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.948 179.946 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . 0.435 ' N ' ' HG2' ' A' ' 368' ' ' LYS . 44.5 t -86.74 -62.7 1.45 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.856 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 122.93 -157.21 17.45 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.498 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 135.52 30.54 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.704 2.269 . . . . 0.0 112.332 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 372' ' ' SER . . . . . . . . . . . . . 31.3 t -95.32 82.56 3.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.86 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 76.5 p -134.62 159.52 40.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.866 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.492 179.999 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 N-CA-C 112.535 -0.226 . . . . 0.0 112.535 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 41.9 p 38.34 42.15 0.5 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.856 0.36 . . . . 0.0 110.83 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 2.5 t -136.84 114.47 11.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.858 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 101.35 -43.8 1.66 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.498 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 84.1 p -64.72 -48.13 75.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.866 0.365 . . . . 0.0 110.848 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 23.5 t -93.26 -46.51 7.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.83 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 60.5 -137.11 48.96 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.444 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . 0.415 ' O ' ' C ' ' A' ' 292' ' ' THR . 30.1 m -135.77 111.53 9.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.852 0.358 . . . . 0.0 111.151 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 292' ' ' THR . . . . . 0.415 ' C ' ' O ' ' A' ' 291' ' ' THR . 9.4 t -35.49 128.26 0.59 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.162 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 293' ' ' CYS . . . . . . . . . . . . . 40.1 t -131.94 146.52 52.15 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.91 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . 0.632 ' HB3' HG21 ' A' ' 346' ' ' VAL . 11.3 m80 -96.73 99.17 10.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.861 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 63.1 m -136.17 145.36 45.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.178 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 296' ' ' VAL . . . . . 0.52 ' CG1' HG13 ' A' ' 346' ' ' VAL . 29.8 m -118.86 147.21 22.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.154 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . 0.568 ' HD3' ' CD1' ' A' ' 335' ' ' TYR . 8.8 ttmm -116.87 146.33 42.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.944 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . 0.465 HD21 ' CD2' ' A' ' 313' ' ' PHE . 6.9 mp -115.55 157.55 23.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.917 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -158.02 130.22 7.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.859 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 123.1 -23.2 6.96 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.484 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -57.17 147.71 55.4 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.594 0.711 . . . . 0.0 111.066 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 -176.54 1.52 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.71 2.273 . . . . 0.0 112.301 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 303' ' ' PHE . . . . . 0.413 ' O ' ' CB ' ' A' ' 332' ' ' LYS . 34.5 p90 -78.1 -35.74 48.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.904 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -88.59 48.46 1.64 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.858 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 305' ' ' VAL . . . . . 0.458 HG12 ' HG2' ' A' ' 332' ' ' LYS . 11.4 p -99.24 141.38 16.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.163 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 306' ' ' THR . . . . . 0.414 ' O ' ' C ' ' A' ' 307' ' ' GLU . 69.2 p -132.43 153.27 51.01 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.096 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 307' ' ' GLU . . . . . 0.414 ' C ' ' O ' ' A' ' 306' ' ' THR . 26.1 mt-10 -35.68 -52.17 0.68 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.891 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 14.7 ttpt -40.83 -47.25 2.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.892 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -57.85 -54.87 42.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.873 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 56.2 t -55.9 -50.4 69.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.159 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 311' ' ' MET . . . . . . . . . . . . . 2.7 mmt -48.91 -52.46 24.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.866 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -67.31 -24.73 65.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.871 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 313' ' ' PHE . . . . . 0.465 ' CD2' HD21 ' A' ' 298' ' ' LEU . 11.2 t80 -77.34 -35.66 54.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.848 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.482 ' CD1' HG11 ' A' ' 338' ' ' VAL . 85.9 mt -86.04 -20.61 28.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.94 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . 0.641 ' HB1' ' HA ' ' A' ' 316' ' ' PRO . . . -47.09 159.96 0.37 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.588 0.708 . . . . 0.0 111.08 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 316' ' ' PRO . . . . . 0.641 ' HA ' ' HB1' ' A' ' 315' ' ' ALA . 53.8 Cg_endo -69.78 -21.5 10.2 Favored 'Cis proline' 0 C--O 1.232 0.188 0 C-N-CA 122.677 -1.801 . . . . 0.0 112.357 0.055 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 317' ' ' LEU . . . . . 0.588 HD11 ' CB ' ' A' ' 348' ' ' GLN . 22.2 mt -41.38 139.07 1.11 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.887 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -118.51 110.55 38.88 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.576 0.703 . . . . 0.0 110.876 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 319' ' ' PRO . . . . . 0.405 ' HA ' ' CD2' ' A' ' 340' ' ' PHE . 54.2 Cg_endo -69.71 -178.33 2.27 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.68 2.253 . . . . 0.0 112.384 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 19.4 t -104.12 -34.14 3.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.151 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -162.73 132.93 4.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.115 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 322' ' ' ILE . . . . . 0.414 HG23 HG22 ' A' ' 338' ' ' VAL . 66.2 mt -107.75 117.21 52.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.153 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 19.4 mmt180 -111.47 107.08 16.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.843 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . 0.625 HG23 HG12 ' A' ' 336' ' ' ILE . 70.8 mt -84.61 138.21 19.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.156 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . 0.523 HG21 ' CE2' ' A' ' 337' ' ' PHE . 62.1 t -106.82 145.28 14.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.095 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 6.7 ptp85 -95.94 172.66 7.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.89 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 327' ' ' ASN . . . . . 0.41 ' O ' ' C ' ' A' ' 328' ' ' ALA . 52.1 t30 -92.86 155.45 17.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.875 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . 0.41 ' C ' ' O ' ' A' ' 327' ' ' ASN . . . -36.52 -54.67 0.86 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.056 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 7.7 m170 -62.36 -61.03 2.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.816 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 145.52 63.94 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.485 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -138.88 158.48 44.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.921 0.391 . . . . 0.0 110.904 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 332' ' ' LYS . . . . . 0.458 ' HG2' HG12 ' A' ' 305' ' ' VAL . 0.0 OUTLIER -55.11 -59.24 5.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.876 179.908 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 9.3 t -39.43 145.23 0.12 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.143 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 148.76 -98.49 0.19 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.461 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 335' ' ' TYR . . . . . 0.568 ' CD1' ' HD3' ' A' ' 297' ' ' LYS . 79.3 m-85 -150.51 145.9 26.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.811 0.338 . . . . 0.0 110.957 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 336' ' ' ILE . . . . . 0.625 HG12 HG23 ' A' ' 324' ' ' ILE . 60.0 mt -127.28 121.52 57.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.132 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . 0.523 ' CE2' HG21 ' A' ' 325' ' ' VAL . 39.1 m-85 -96.1 136.2 36.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.876 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . 0.482 HG11 ' CD1' ' A' ' 314' ' ' LEU . 25.5 t -134.73 132.17 54.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.105 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -105.69 157.94 17.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.883 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 340' ' ' PHE . . . . . 0.405 ' CD2' ' HA ' ' A' ' 319' ' ' PRO . 53.3 m-85 -133.85 162.06 33.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.879 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 34.4 p -64.73 -66.61 0.52 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.877 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 342' ' ' ASN . . . . . 0.401 ' OD1' ' N ' ' A' ' 342' ' ' ASN . 2.8 p-10 -99.75 170.8 8.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.918 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 343' ' ' GLU . . . . . 0.586 ' HB3' ' CE1' ' A' ' 294' ' ' HIS . 1.4 pp20? -70.14 -51.01 34.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.89 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 344' ' ' GLU . . . . . 0.425 ' N ' ' CD ' ' A' ' 343' ' ' GLU . 10.4 tt0 -40.36 -57.98 1.64 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.906 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -39.74 -36.15 0.4 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.899 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . 0.632 HG21 ' HB3' ' A' ' 294' ' ' HIS . 24.6 t -70.08 -48.27 63.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.106 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 347' ' ' LYS . . . . . 0.423 ' NZ ' ' HB2' ' A' ' 347' ' ' LYS . 5.1 mtmp? -52.87 -39.46 62.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.934 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 348' ' ' GLN . . . . . 0.588 ' CB ' HD11 ' A' ' 317' ' ' LEU . 85.5 mt-30 -73.31 -26.66 61.15 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.933 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -64.03 -35.96 82.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.095 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 350' ' ' LEU . . . . . . . . . . . . . 15.9 mt -73.22 -37.06 66.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.912 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 26.3 mmmt -47.44 -47.18 27.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.901 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 352' ' ' CYS . . . . . . . . . . . . . 15.9 m -70.3 72.55 0.47 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.877 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 14.9 p30 -109.09 162.76 13.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.932 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 20.5 mmt180 61.86 35.63 16.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.848 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 355' ' ' GLU . . . . . 0.46 ' C ' ' CD1' ' A' ' 356' ' ' TYR . 20.9 mm-40 -91.48 173.65 7.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.891 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 356' ' ' TYR . . . . . 0.491 ' N ' ' CD1' ' A' ' 356' ' ' TYR . 1.2 m-85 -136.3 128.06 29.11 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.922 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 357' ' ' MET . . . . . . . . . . . . . 3.6 ptt? -156.6 140.38 16.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.912 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 76.95 -9.29 25.47 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.456 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 102.93 16.85 20.38 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.461 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 360' ' ' ARG . . . . . . . . . . . . . 10.3 mmt180 -144.29 153.36 41.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.801 0.334 . . . . 0.0 110.881 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 361' ' ' TYR . . . . . 0.441 ' CD1' ' C ' ' A' ' 361' ' ' TYR . 1.0 OUTLIER -64.88 166.26 9.4 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.911 -179.84 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 362' ' ' ILE . . . . . 0.401 HG12 ' C ' ' A' ' 361' ' ' TYR . 15.7 mm -146.75 137.54 18.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.136 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 363' ' ' GLU . . . . . 0.565 ' HG3' ' CE2' ' A' ' 365' ' ' PHE . 14.7 pt-20 -133.99 112.07 10.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.895 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 364' ' ' VAL . . . . . 0.533 ' O ' ' CD1' ' A' ' 365' ' ' PHE . 14.2 t -84.51 154.07 3.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.099 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 365' ' ' PHE . . . . . 0.565 ' CE2' ' HG3' ' A' ' 363' ' ' GLU . 28.8 m-85 -145.99 156.46 43.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.851 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 32.8 ttp85 -97.86 120.4 38.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.912 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -101.61 74.37 1.51 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.881 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . 0.419 ' HD3' ' C ' ' A' ' 368' ' ' LYS . 0.0 OUTLIER -49.91 -24.49 2.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.9 179.958 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 15.1 m -71.92 -60.97 1.96 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.878 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 96.85 -157.87 21.24 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.464 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 171.86 13.69 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.7 2.267 . . . . 0.0 112.335 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 372' ' ' SER . . . . . . . . . . . . . 30.8 t -109.31 95.91 5.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.808 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 5.6 m -50.19 150.02 2.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.858 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.472 -179.952 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 N-CA-C 112.488 -0.245 . . . . 0.0 112.488 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 285' ' ' SER . . . . . 0.425 ' O ' ' C ' ' A' ' 286' ' ' SER . 1.2 t -153.6 158.89 41.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.86 0.362 . . . . 0.0 110.855 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 286' ' ' SER . . . . . 0.425 ' C ' ' O ' ' A' ' 285' ' ' SER . 1.7 t -36.6 -58.67 0.71 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.882 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . 134.21 77.2 0.1 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.495 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 96.8 p -158.5 119.64 3.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.894 0.378 . . . . 0.0 110.86 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 1.7 t -108.75 143.75 37.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.886 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 101.79 136.67 9.35 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.514 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 23.7 m -101.65 131.1 48.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.821 0.343 . . . . 0.0 111.151 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 87.5 m -97.61 -45.42 6.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.177 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 293' ' ' CYS . . . . . . . . . . . . . 35.9 m -97.08 115.51 27.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.846 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . 0.553 ' HB3' HG21 ' A' ' 346' ' ' VAL . 7.8 m-70 -84.13 97.26 9.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.874 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 24.7 m -136.49 143.5 43.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.148 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 296' ' ' VAL . . . . . 0.521 ' CG1' HG13 ' A' ' 346' ' ' VAL . 27.0 m -128.92 150.45 34.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.106 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 28.3 ttpp -119.1 132.36 56.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.902 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 7.3 mp -105.95 103.1 12.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.869 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 299' ' ' ARG . . . . . 0.541 ' HD3' ' CE1' ' A' ' 335' ' ' TYR . 38.0 tpt85 -104.45 122.68 46.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.896 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . 0.411 ' C ' ' O ' ' A' ' 361' ' ' TYR . . . 133.36 -25.1 3.67 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.501 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . 0.456 ' HA ' ' CD1' ' A' ' 362' ' ' ILE . . . -59.52 144.11 85.0 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.571 0.7 . . . . 0.0 111.095 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -167.74 0.24 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.665 2.243 . . . . 0.0 112.341 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 303' ' ' PHE . . . . . 0.411 ' CD1' ' C ' ' A' ' 303' ' ' PHE . 1.8 p90 -95.81 -12.8 24.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.87 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -93.33 3.01 56.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.94 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 305' ' ' VAL . . . . . 0.4 HG11 ' HB1' ' A' ' 301' ' ' ALA . 7.5 p -78.39 143.23 12.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.109 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 306' ' ' THR . . . . . . . . . . . . . 16.6 p -131.92 162.73 29.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.115 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -38.93 -49.16 1.66 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.932 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 30.2 ttmt -50.87 -58.69 5.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.86 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -49.91 -43.01 49.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.891 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 310' ' ' VAL . . . . . 0.525 HG12 HD12 ' A' ' 314' ' ' LEU . 99.0 t -60.56 -49.09 85.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.155 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 311' ' ' MET . . . . . . . . . . . . . 3.1 mmt -50.11 -39.09 41.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.822 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -71.7 -35.49 70.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.898 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 313' ' ' PHE . . . . . 0.449 ' C ' ' CD1' ' A' ' 313' ' ' PHE . 1.6 t80 -74.82 -31.06 61.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.86 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.758 HD11 HG21 ' A' ' 338' ' ' VAL . 50.5 mt -84.24 -26.18 28.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.95 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . 0.756 ' HB1' ' HA ' ' A' ' 316' ' ' PRO . . . -51.45 163.3 0.59 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.576 0.703 . . . . 0.0 111.105 179.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 316' ' ' PRO . . . . . 0.756 ' HA ' ' HB1' ' A' ' 315' ' ' ALA . 54.1 Cg_endo -69.81 -16.24 12.36 Favored 'Cis proline' 0 C--O 1.232 0.21 0 C-N-CA 122.696 -1.793 . . . . 0.0 112.377 0.005 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 317' ' ' LEU . . . . . 0.576 HD11 ' HB3' ' A' ' 348' ' ' GLN . 23.9 mt -46.7 129.37 11.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.896 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 318' ' ' LYS . . . . . 0.416 ' NZ ' ' HA ' ' A' ' 318' ' ' LYS . 0.2 OUTLIER -105.72 105.75 54.04 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.571 0.701 . . . . 0.0 110.87 179.819 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 319' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 178.46 4.57 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.711 2.274 . . . . 0.0 112.297 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 61.8 t -100.01 -37.06 5.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.093 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -160.83 137.95 9.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.118 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 322' ' ' ILE . . . . . 0.49 HG23 HG22 ' A' ' 338' ' ' VAL . 74.0 mt -110.69 109.31 27.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.13 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 63.8 mmt-85 -107.1 105.12 14.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.898 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . 0.555 HG21 ' HG3' ' A' ' 332' ' ' LYS . 67.1 mt -76.42 126.97 37.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.127 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . 0.466 HG22 ' CD2' ' A' ' 337' ' ' PHE . 48.8 t -64.07 125.29 20.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.16 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 21.3 mtm-85 -97.15 127.95 43.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.874 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -91.38 -58.11 2.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.866 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -99.64 -73.57 0.63 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.116 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 33.0 m80 -124.28 -71.42 0.71 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.855 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -146.41 63.91 0.44 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.513 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -126.87 172.1 10.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.942 0.401 . . . . 0.0 110.898 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 332' ' ' LYS . . . . . 0.555 ' HG3' HG21 ' A' ' 324' ' ' ILE . 6.7 mptt -102.29 93.84 5.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.92 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 2.2 t -84.46 67.64 9.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.161 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 38.81 39.18 0.82 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.548 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 335' ' ' TYR . . . . . 0.541 ' CE1' ' HD3' ' A' ' 299' ' ' ARG . 8.4 m-85 -151.94 133.38 14.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.905 0.383 . . . . 0.0 110.896 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 336' ' ' ILE . . . . . 0.513 HG12 HG23 ' A' ' 324' ' ' ILE . 88.7 mt -151.04 116.19 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.103 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . 0.466 ' CD2' HG22 ' A' ' 325' ' ' VAL . 31.6 m-85 -90.55 134.76 34.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.845 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . 0.758 HG21 HD11 ' A' ' 314' ' ' LEU . 17.4 t -134.62 141.49 43.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.113 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -113.82 161.33 17.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.849 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -139.18 167.56 21.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.864 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 22.7 m -72.28 -68.46 0.47 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.828 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 342' ' ' ASN . . . . . 0.571 ' ND2' ' H ' ' A' ' 345' ' ' GLU . 2.3 p-10 -99.11 -176.04 3.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.883 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 343' ' ' GLU . . . . . 0.428 ' O ' ' N ' ' A' ' 346' ' ' VAL . 12.0 pt-20 -83.56 -47.26 11.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.884 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 344' ' ' GLU . . . . . 0.533 ' N ' HD22 ' A' ' 342' ' ' ASN . 7.3 mm-40 -44.01 -30.13 0.69 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.914 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . 0.571 ' H ' ' ND2' ' A' ' 342' ' ' ASN . 16.7 mt-10 -73.59 -35.8 65.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.876 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . 0.553 HG21 ' HB3' ' A' ' 294' ' ' HIS . 61.7 t -68.85 -59.12 3.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.163 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.81 -29.04 62.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.893 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 348' ' ' GLN . . . . . 0.576 ' HB3' HD11 ' A' ' 317' ' ' LEU . 29.6 mt-30 -73.11 -32.44 64.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.948 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -62.0 -36.44 81.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.089 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 350' ' ' LEU . . . . . 0.687 HD23 HG12 ' A' ' 364' ' ' VAL . 57.1 mt -60.99 -24.78 66.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.913 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 20.8 mmtp -49.72 -44.87 48.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.948 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 352' ' ' CYS . . . . . . . . . . . . . 22.3 m -78.21 72.28 4.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.865 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -109.24 147.71 32.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.883 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 50.4 ttm-85 70.15 30.44 3.49 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.883 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 355' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -88.52 173.74 8.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.936 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 356' ' ' TYR . . . . . 0.425 ' N ' ' CD1' ' A' ' 356' ' ' TYR . 1.7 m-85 -125.31 117.73 24.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.911 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 357' ' ' MET . . . . . 0.444 ' SD ' ' CD2' ' A' ' 313' ' ' PHE . 4.3 ptm -142.26 123.36 14.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.907 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 86.29 -20.37 22.24 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.51 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 117.24 13.45 7.61 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.494 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 360' ' ' ARG . . . . . . . . . . . . . 21.5 mmt-85 -140.75 158.52 43.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.815 0.34 . . . . 0.0 110.823 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 361' ' ' TYR . . . . . 0.731 ' O ' HD13 ' A' ' 362' ' ' ILE . 13.0 p90 -67.14 163.62 19.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.94 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 362' ' ' ILE . . . . . 0.731 HD13 ' O ' ' A' ' 361' ' ' TYR . 15.1 mm -140.57 144.58 27.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.154 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 363' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -138.42 112.19 8.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.861 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 364' ' ' VAL . . . . . 0.687 HG12 HD23 ' A' ' 350' ' ' LEU . 45.9 t -84.6 134.54 26.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.155 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 365' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -131.01 152.94 49.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.913 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . 0.403 ' HG3' HD11 ' A' ' 350' ' ' LEU . 51.6 mtm180 -101.43 113.35 26.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.866 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -92.04 104.7 17.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.87 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 44.3 mttm -48.04 -55.51 9.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.9 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 33.8 m -99.99 -49.55 4.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.876 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 65.43 144.92 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.473 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 371' ' ' PRO . . . . . 0.417 ' O ' ' C ' ' A' ' 372' ' ' SER . 54.1 Cg_endo -69.73 -37.01 9.82 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.708 2.272 . . . . 0.0 112.373 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 372' ' ' SER . . . . . 0.417 ' C ' ' O ' ' A' ' 371' ' ' PRO . 23.0 t -37.13 -53.3 1.02 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.908 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 55.5 p -164.19 141.26 6.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.857 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.339 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.524 179.985 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 N-CA-C 112.519 -0.232 . . . . 0.0 112.519 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 285' ' ' SER . . . . . 0.446 ' O ' ' C ' ' A' ' 286' ' ' SER . 1.5 t -131.65 -51.54 0.99 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.864 0.364 . . . . 0.0 110.87 -179.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 286' ' ' SER . . . . . 0.446 ' C ' ' O ' ' A' ' 285' ' ' SER . 51.3 p 34.52 42.32 0.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.901 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -134.44 -99.56 0.64 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.486 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 288' ' ' SER . . . . . . . . . . . . . 13.9 t -59.06 117.64 4.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.898 0.38 . . . . 0.0 110.864 -179.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 61.9 p -64.67 149.67 48.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.83 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 290' ' ' GLY . . . . . . . . . . . . . . . 121.63 -153.43 16.72 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.469 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 291' ' ' THR . . . . . . . . . . . . . 1.3 m 64.01 54.32 1.72 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.909 0.385 . . . . 0.0 111.119 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 72.6 p -108.74 111.07 22.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.134 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 293' ' ' CYS . . . . . . . . . . . . . 37.8 m -122.29 137.12 54.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.858 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 31.9 m80 -122.65 118.19 27.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.886 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 85.0 m -140.55 143.44 35.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.116 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 296' ' ' VAL . . . . . 0.454 HG23 ' HB ' ' A' ' 338' ' ' VAL . 27.2 m -116.99 147.77 20.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.123 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 13.9 ttmt -125.37 137.38 54.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.921 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 6.8 mp -120.86 118.31 29.63 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.919 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 299' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -115.75 155.62 27.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.828 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 86.86 36.58 9.09 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.451 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -102.2 147.72 34.36 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.622 0.725 . . . . 0.0 111.113 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 302' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 175.98 7.37 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.713 2.275 . . . . 0.0 112.372 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 56.0 t80 -80.97 -29.26 35.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.876 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -86.89 35.44 0.69 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.903 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 305' ' ' VAL . . . . . . . . . . . . . 11.8 p -98.45 145.05 10.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.116 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 306' ' ' THR . . . . . . . . . . . . . 64.4 p -141.36 164.97 28.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.099 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -44.88 -34.95 2.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.915 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? -57.74 -47.06 83.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.909 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 23.2 m120 -60.19 -59.41 5.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.9 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 85.2 t -48.89 -41.51 13.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.152 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 311' ' ' MET . . . . . . . . . . . . . 2.0 mmt -62.09 -44.76 95.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.861 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -68.24 -26.41 65.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.881 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 313' ' ' PHE . . . . . 0.424 ' CD1' ' C ' ' A' ' 313' ' ' PHE . 5.5 t80 -75.33 -40.91 57.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.866 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.579 ' CD1' HG11 ' A' ' 338' ' ' VAL . 57.9 mt -83.1 -24.89 32.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.921 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . 0.533 ' HB1' ' HA ' ' A' ' 316' ' ' PRO . . . -44.58 156.74 0.33 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.579 0.704 . . . . 0.0 111.133 179.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 316' ' ' PRO . . . . . 0.533 ' HA ' ' HB1' ' A' ' 315' ' ' ALA . 53.6 Cg_endo -69.85 -19.09 11.52 Favored 'Cis proline' 0 C--O 1.232 0.21 0 C-N-CA 122.661 -1.808 . . . . 0.0 112.332 0.08 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 317' ' ' LEU . . . . . 0.558 HD22 ' HA ' ' A' ' 345' ' ' GLU . 35.7 mt -39.01 138.4 0.57 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.894 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 12.6 tppt? -119.64 107.49 40.57 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.551 0.691 . . . . 0.0 110.889 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 319' ' ' PRO . . . . . 0.426 ' HA ' ' CD2' ' A' ' 340' ' ' PHE . 54.0 Cg_endo -69.78 -171.02 0.43 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.648 2.232 . . . . 0.0 112.333 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 65.2 t -106.68 -41.75 6.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.11 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 321' ' ' ALA . . . . . . . . . . . . . . . -155.06 129.8 9.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.118 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 322' ' ' ILE . . . . . 0.495 HG23 HG22 ' A' ' 338' ' ' VAL . 91.7 mt -100.97 99.8 9.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.152 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 323' ' ' ARG . . . . . . . . . . . . . 9.5 mmm180 -98.74 103.44 15.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.908 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . 0.947 HG21 ' HG2' ' A' ' 332' ' ' LYS . 58.7 mt -81.01 134.86 26.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.128 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . 0.407 HG22 ' CE2' ' A' ' 337' ' ' PHE . 45.5 t -64.56 80.83 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.16 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 25.6 ptt180 -87.63 139.75 30.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.919 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 327' ' ' ASN . . . . . 0.58 HD21 HG21 ' A' ' 333' ' ' THR . 28.3 m120 -57.04 -179.31 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.87 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -51.94 -54.12 33.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.122 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 329' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -65.13 -54.57 27.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.904 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 144.02 66.64 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.469 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 331' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -133.81 129.68 36.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.913 0.387 . . . . 0.0 110.901 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 332' ' ' LYS . . . . . 0.947 ' HG2' HG21 ' A' ' 324' ' ' ILE . 33.2 mttt -59.76 131.4 50.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.933 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 333' ' ' THR . . . . . 0.58 HG21 HD21 ' A' ' 327' ' ' ASN . 81.0 p -125.88 74.75 1.44 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.12 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . 0.45 ' O ' ' C ' ' A' ' 335' ' ' TYR . . . 46.2 -89.0 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.484 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 335' ' ' TYR . . . . . 0.501 ' N ' ' O ' ' A' ' 333' ' ' THR . 93.2 m-85 -34.24 140.29 0.07 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.919 0.39 . . . . 0.0 110.911 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 336' ' ' ILE . . . . . 0.891 HG12 HG23 ' A' ' 324' ' ' ILE . 30.2 mt -145.63 143.48 21.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.114 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . 0.407 ' CE2' HG22 ' A' ' 325' ' ' VAL . 27.5 m-85 -110.67 123.52 50.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.859 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . 0.579 HG11 ' CD1' ' A' ' 314' ' ' LEU . 93.8 t -126.0 126.57 69.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.136 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 339' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -101.36 160.61 14.27 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.905 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 340' ' ' PHE . . . . . 0.439 ' HB2' ' CG2' ' A' ' 346' ' ' VAL . 35.9 m-85 -134.68 165.86 24.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.862 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 16.9 t -87.79 -55.34 3.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.831 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -89.54 168.04 12.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.895 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -81.96 -43.16 18.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.883 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -56.93 -54.11 50.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.938 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . 0.558 ' HA ' HD22 ' A' ' 317' ' ' LEU . 20.8 mm-40 -41.22 -35.81 0.66 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.888 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . 0.439 ' CG2' ' HB2' ' A' ' 340' ' ' PHE . 53.0 t -74.86 -50.28 25.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.11 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 347' ' ' LYS . . . . . . . . . . . . . 15.5 mtpp -53.71 -35.75 61.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.879 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 348' ' ' GLN . . . . . . . . . . . . . 35.3 mm-40 -71.46 -44.06 65.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.926 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -43.58 -40.1 3.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.099 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 350' ' ' LEU . . . . . . . . . . . . . 54.6 mt -58.88 -39.0 80.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.923 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 56.1 mmtt -45.12 -36.69 3.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.932 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 352' ' ' CYS . . . . . . . . . . . . . 64.6 m -71.2 71.99 0.62 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.908 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . 0.401 ' O ' ' C ' ' A' ' 354' ' ' ARG . 16.7 p30 -116.85 -176.46 2.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.913 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . 0.401 ' C ' ' O ' ' A' ' 353' ' ' ASN . 54.0 ttt-85 37.29 49.88 0.96 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.83 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 355' ' ' GLU . . . . . 0.438 ' C ' ' OE1' ' A' ' 355' ' ' GLU . 0.0 OUTLIER -135.94 173.38 11.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.899 -179.983 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 356' ' ' TYR . . . . . 0.434 ' N ' ' CD1' ' A' ' 356' ' ' TYR . 2.7 m-85 -131.7 137.14 48.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.902 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 357' ' ' MET . . . . . 0.425 ' CG ' HG13 ' A' ' 362' ' ' ILE . 0.1 OUTLIER -139.04 128.06 23.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.87 179.89 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 358' ' ' GLY . . . . . . . . . . . . . . . 83.03 -28.75 3.58 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.479 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 359' ' ' GLY . . . . . . . . . . . . . . . 125.26 28.46 1.1 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.5 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 360' ' ' ARG . . . . . . . . . . . . . 33.7 mtt-85 -151.41 156.99 41.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.861 0.363 . . . . 0.0 110.873 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 361' ' ' TYR . . . . . 0.438 ' CG ' ' O ' ' A' ' 361' ' ' TYR . 2.3 p90 -69.66 125.43 26.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.921 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 362' ' ' ILE . . . . . 0.425 HG13 ' CG ' ' A' ' 357' ' ' MET . 17.3 mm -107.18 151.94 8.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.191 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 363' ' ' GLU . . . . . 0.577 ' HB3' ' CZ ' ' A' ' 365' ' ' PHE . 59.9 mm-40 -143.42 112.16 6.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.881 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 15.9 t -87.81 120.85 37.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.151 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 365' ' ' PHE . . . . . 0.577 ' CZ ' ' HB3' ' A' ' 363' ' ' GLU . 70.7 m-85 -124.85 133.32 53.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.847 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . 0.43 ' HB3' ' NH1' ' A' ' 366' ' ' ARG . 6.2 ttp-105 -82.25 111.75 18.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.92 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 367' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -82.07 106.01 13.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.876 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 2.2 ttmp? -59.44 -46.87 87.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.881 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 65.3 p -93.41 -48.69 6.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.836 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 82.48 -168.39 47.97 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.518 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 371' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.69 95.0 0.53 Allowed 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.733 2.289 . . . . 0.0 112.331 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 372' ' ' SER . . . . . . . . . . . . . 1.6 t -112.71 126.84 55.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.863 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 48.3 t -165.17 124.4 1.77 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.883 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 374' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.382 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.498 -179.973 . . . . . . . . 0 0 . 1 stop_ save_